data_2kli_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kli _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.899 0.381 . . . . 1.0 110.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.18 -46.98 65.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -66.01 -47.31 74.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.222 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.4 mp -59.68 -41.07 84.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -74.83 -22.33 58.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.586 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.421 ' O ' HG11 ' A' ' 39' ' ' VAL . 41.3 ttp180 -66.72 -36.83 83.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.614 -0.434 . . . . 1.0 109.973 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.71 -30.98 41.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.317 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -72.39 -48.5 41.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.543 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 36' ' ' ARG . 4.3 p -55.29 -33.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.858 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -72.23 -39.13 68.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.63 -40.63 97.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.988 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.25 -52.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 47' ' ' GLY . 31.2 ttp85 -52.2 -43.55 64.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.877 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.66 75.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 1.0 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -81.55 -50.35 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.77 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -77.39 -7.6 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 1.0 110.087 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.91 19.05 1.25 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.413 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.466 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 1.6 m -76.03 142.74 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.047 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.5 m-20 -57.69 -33.28 68.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -153.29 120.97 5.98 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 119.128 -1.029 . . . . 1.0 113.536 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.75 135.23 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HZ3' ' CG1' ' A' ' 167' ' ' VAL . 9.1 pttp -146.45 162.06 39.07 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.552 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.01 136.78 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.007 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 165' ' ' LEU . 79.5 t80 -123.4 120.56 33.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.052 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' OG1' ' A' ' 63' ' ' THR . 27.2 ptt180 -101.08 171.98 7.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -134.01 134.19 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 1.0 112.138 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.74 129.32 25.53 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.345 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.47 -25.93 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.739 2.293 . . . . 1.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 -9.82 59.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.984 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.4 36.35 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.816 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -86.72 141.76 28.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.38 0.59 . . . . 1.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.3 145.98 15.95 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.434 -1.067 . . . . 1.0 110.434 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' NE ' ' A' ' 55' ' ' ARG . 28.6 p -129.86 147.88 51.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.25 0.547 . . . . 1.0 112.303 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.06 101.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.36 3.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.18 147.26 24.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.1 tt0 -166.88 126.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.245 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.44 53.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -121.92 141.84 50.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.555 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.93 97.64 1.88 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.47 -90.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.02 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.83 -0.348 . . . . 1.0 111.101 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -70.72 -55.61 8.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.5 mt -92.95 154.48 41.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.92 167.82 23.1 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.099 1.866 . . . . 1.0 112.518 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 p -89.27 132.05 35.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.125 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.09 -4.41 20.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.618 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -59.36 139.89 56.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.35 0.595 . . . . 1.0 112.239 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.8 80.2 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 mt -101.23 131.73 47.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 1.0 110.76 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -88.14 119.41 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.485 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.9 m-85 -108.64 132.5 21.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.285 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.73 157.52 27.99 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.125 1.883 . . . . 1.0 111.702 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.14 66.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.76 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -23.72 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -55.53 -29.07 58.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 1.0 110.634 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.4 mt -121.35 133.43 24.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.4 -106.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.538 2.159 . . . . 1.0 112.336 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -152.49 -64.71 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.832 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -43.02 -41.97 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.723 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.02 97.22 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -65.57 -28.44 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.526 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -56.72 -55.31 35.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.267 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 9.4 mp -54.13 -40.75 67.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.587 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.91 -40.19 92.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.09 -8.42 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.56 -0.746 . . . . 1.0 110.11 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tp -107.49 -43.58 4.5 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.389 0.885 . . . . 1.0 113.389 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.71 -1.52 12.08 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.53 0.937 . . . . 1.0 113.53 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 28.9 mp0 27.51 69.64 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 101' ' ' ARG . 11.5 p -116.9 -49.67 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.437 -2.431 . . . . 1.0 104.437 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.48 ' N ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 mtt180 61.55 78.96 0.27 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.058 -1.428 . . . . 1.0 114.35 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.79 132.32 5.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.76 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.5 mp -107.06 126.26 63.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 27.3 t -82.85 167.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.249 0.833 . . . . 1.0 113.249 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.498 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 3.5 m-20 -50.84 118.22 3.0 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.692 -1.14 . . . . 1.0 112.261 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -57.66 -10.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.742 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.5 -36.25 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.889 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.5 -15.31 25.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 1.0 110.134 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 52.81 59.98 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.032 -0.986 . . . . 1.0 113.424 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -94.25 137.34 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 1.0 105.401 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -127.9 139.94 52.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.017 1.488 . . . . 1.0 115.017 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-N 114.154 -1.385 . . . . 1.0 107.338 176.934 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mmt-85 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.722 0.296 . . . . 1.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.92 144.86 5.49 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.516 2.144 . . . . 1.0 111.801 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 3.1 m -113.33 120.1 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 1.0 111.349 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.46 148.97 0.4 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.903 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 140' ' ' VAL . 93.2 Cg_exo -45.85 -48.16 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.212 1.941 . . . . 1.0 111.275 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.2 p -43.83 -34.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.493 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 53.0 t-80 -82.67 -32.62 28.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.715 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' PRO . 52.4 t -53.09 -51.01 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.32 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.13 -43.06 93.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 1.0 110.26 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -46.21 -50.42 15.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -71.76 -49.44 38.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.537 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.1 tptm -58.94 -41.29 87.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.46 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.5 p -54.24 -30.3 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.3 mtt -87.01 -0.61 56.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.228 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.26 25.03 75.8 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.293 -0.867 . . . . 1.0 112.359 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.87 122.57 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.23 -33.14 49.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.439 ' OG ' ' OH ' ' A' ' 176' ' ' TYR . 2.4 t -137.42 171.16 14.89 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.592 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 7.3 p -161.42 139.98 9.66 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.198 0.444 . . . . 1.0 112.198 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.589 ' H ' ' HG ' ' A' ' 168' ' ' SER . 65.1 tp -115.19 138.66 50.67 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 1.5 m -132.14 155.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.468 0.651 . . . . 1.0 111.828 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 59.9 t -158.12 90.46 2.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.83 -1.077 . . . . 1.0 109.313 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.76 133.4 54.11 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.562 2.842 . . . . 1.0 113.946 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.8 mt -89.79 106.34 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.776 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 20.6 ptm -127.39 144.91 50.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.0 111.864 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.631 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 22.9 t-80 -114.15 114.06 25.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.631 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 22.2 m-70 59.01 -118.38 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.591 ' H ' ' CD ' ' A' ' 160' ' ' GLN . 2.3 pm0 -95.38 3.06 54.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.545 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.2 tt0 -112.06 149.49 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 117.28 33.66 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 114.532 -1.213 . . . . 1.0 108.841 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 81.7 m95 -97.2 -25.84 15.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.887 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.88 -168.19 23.42 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.971 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 tp -141.11 128.65 21.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.797 0.332 . . . . 1.0 111.239 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -93.9 137.91 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.533 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 9.0 p -150.87 133.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.541 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.589 ' HG ' ' H ' ' A' ' 152' ' ' LEU . 1.1 p -115.77 145.4 42.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.009 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.07 140.62 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.157 0.503 . . . . 1.0 111.011 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.465 ' HE2' ' HH ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -154.03 154.35 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.483 -0.781 . . . . 1.0 109.638 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.97 72.81 10.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.446 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.465 0.29 0 C-N-CA 120.399 -0.52 . . . . 1.0 112.323 179.344 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.465 ' HH ' ' HE2' ' A' ' 170' ' ' HIS . 36.1 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.809 0.338 . . . . 1.0 110.802 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.8 p -99.07 139.99 33.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.285 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.23 -36.01 76.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.65 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.7 -54.96 35.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.334 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.21 -32.05 73.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 1.0 110.643 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.54 -42.27 91.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.497 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.9 -52.71 63.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.455 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -44.77 -46.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.275 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.43 -37.85 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -48.68 -37.83 19.6 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.8 -40.92 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.383 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 42.3 tp -53.54 -32.65 51.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.68 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.57 -32.58 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.617 . . . . 1.0 109.616 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -58.68 -41.7 86.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -53.23 -52.85 57.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.4 -41.66 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.886 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.437 ' H ' ' HG ' ' A' ' 192' ' ' SER . 2.7 m -50.34 -29.78 10.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.7 mm -77.79 -38.52 25.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.023 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.67 67.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.108 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.4 tp -64.24 -34.61 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -75.23 -55.91 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.881 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.79 -26.62 47.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.893 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.4 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.302 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.55 -39.38 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.154 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.505 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.1 mp -68.55 -56.43 8.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.107 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -55.56 -43.07 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.891 0.377 . . . . 1.0 110.357 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.419 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.931 0.396 . . . . 1.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.19 -32.65 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.245 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -78.39 -54.72 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.243 0.46 . . . . 1.0 112.243 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.4 ' O ' HG21 ' A' ' 38' ' ' THR . 4.7 tp -58.35 -37.42 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.494 ' O ' ' OG1' ' A' ' 38' ' ' THR . 80.8 mt -74.36 -33.93 63.23 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -49.76 -37.93 31.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 1.0 109.993 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.39 -30.26 57.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.394 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 52.9 p -70.58 -44.54 67.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.533 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.15 -37.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.63 -39.53 84.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.13 -37.55 83.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.98 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.4 t -68.39 -43.56 84.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.4 ttp180 -57.03 -50.08 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.865 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.75 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.847 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -79.14 -51.88 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.781 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.95 -6.47 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.015 0.436 . . . . 1.0 110.089 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.96 17.65 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.0 112.393 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -78.53 149.43 33.08 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.077 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.6 m-20 -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.664 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 51.2 ttp180 -155.01 131.86 10.75 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 119.124 -1.03 . . . . 1.0 113.499 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.15 133.59 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 176.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -146.61 160.29 42.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.594 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.11 135.08 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.975 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.7 t80 -117.38 120.27 37.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.058 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -99.83 166.35 11.13 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 11.5 t80 -131.21 135.99 47.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.091 0.472 . . . . 1.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.9 m-20 -102.22 147.79 34.46 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.329 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.42 -21.59 71.26 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.726 2.284 . . . . 1.0 112.909 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.83 -2.44 47.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.044 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.54 -8.58 54.99 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.916 -0.659 . . . . 1.0 112.842 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -90.24 143.5 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.318 0.559 . . . . 1.0 111.005 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -120.47 137.88 12.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.6 p -124.31 145.36 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.197 0.522 . . . . 1.0 112.34 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -104.49 120.57 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.08 4.74 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.78 146.24 24.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.9 tt0 -166.38 127.36 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.398 -0.921 . . . . 1.0 113.222 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 129.5 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 6.8 ptp85 -116.85 140.61 49.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.216 -0.594 . . . . 1.0 111.524 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.47 98.53 1.89 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.78 -90.23 0.04 OUTLIER Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.188 -1.165 . . . . 1.0 110.188 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -176.38 33.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.116 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -71.38 -54.25 11.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.88 145.93 30.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.88 166.37 29.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.081 1.854 . . . . 1.0 112.564 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.521 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 16.2 m -88.86 135.94 33.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.108 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.535 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 45.6 mt -108.7 -0.99 19.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.615 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -60.59 138.95 57.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.588 . . . . 1.0 112.239 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.16 -4.95 85.37 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.338 -0.846 . . . . 1.0 111.05 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.62 130.14 45.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.861 0.362 . . . . 1.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -87.06 121.84 30.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.503 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' GLY . 28.7 m-85 -103.01 136.23 19.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.259 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.11 145.7 24.8 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.126 1.884 . . . . 1.0 111.708 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.37 69.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.15 -20.56 1.45 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 40.4 p30 -60.08 -30.67 69.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.792 0.329 . . . . 1.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.565 ' O ' ' O ' ' A' ' 88' ' ' PRO . 45.6 mt -113.74 101.0 53.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.262 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -45.57 -116.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.536 2.158 . . . . 1.0 112.351 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -154.3 -44.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.907 0.384 . . . . 1.0 111.832 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.4 -39.1 82.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.707 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.33 81.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 1.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -67.98 -28.63 67.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.562 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' LEU . 55.0 mtp180 -53.65 -57.71 9.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.244 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' ALA . 45.7 mt -54.7 -38.29 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.556 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 6.6 m-85 -65.5 -30.71 71.51 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -93.62 -14.24 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.127 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' ARG . 11.8 tp -107.1 -46.16 3.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -114.99 -3.36 12.65 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.451 0.908 . . . . 1.0 113.451 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.595 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 13.0 mm-40 29.19 69.8 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.487 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -110.04 -51.06 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 175.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.595 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER 63.18 70.4 0.54 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.292 172.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.35 134.31 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.556 -0.457 . . . . 1.0 111.793 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.51 127.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 10.4 p -83.25 167.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 15.7 t0 -53.55 119.41 4.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.312 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.88 -10.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.735 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 1.3 pp20? -86.47 -37.76 17.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.921 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.97 -13.91 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.405 0.622 . . . . 1.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 50.34 52.63 14.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.041 -0.981 . . . . 1.0 113.35 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -93.27 133.44 36.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -126.13 141.07 52.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 m . . . . . 0 N--CA 1.452 -0.335 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.363 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.777 0.323 . . . . 1.0 110.275 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' OG ' ' A' ' 112' ' ' SER . 91.0 Cg_endo -81.35 143.48 13.88 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.573 2.182 . . . . 1.0 111.745 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 1.5 m -112.99 123.34 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.073 0.463 . . . . 1.0 111.319 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.85 154.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.895 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.39 -26.94 79.76 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.221 1.947 . . . . 1.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 22.2 t -61.26 -43.0 99.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -77.84 -29.65 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.714 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.0 -53.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.275 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.487 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 80.1 t60 -64.68 -42.78 95.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.268 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -44.29 -50.56 8.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.405 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mp -71.59 -49.6 38.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.461 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.6 tptm -56.98 -40.83 77.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.487 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 30.9 m -54.2 -32.82 56.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 50.3 mtt -83.98 -2.01 55.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.164 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.68 26.43 74.48 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.277 -0.874 . . . . 1.0 112.353 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 170' ' ' HIS . 9.1 p -109.01 127.04 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.08 -30.9 39.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -137.97 170.45 16.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.145 -0.622 . . . . 1.0 111.512 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 168' ' ' SER . 39.4 t -162.66 138.45 7.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.135 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.3 tp -113.63 139.72 48.79 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.8 156.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.457 0.646 . . . . 1.0 111.783 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 66.7 t -156.65 100.38 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.812 -1.085 . . . . 1.0 109.327 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.88 127.11 13.27 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.603 2.869 . . . . 1.0 113.899 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.51 106.08 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.812 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.2 ptm -130.73 146.65 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.834 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.615 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 30.5 t-80 -117.24 116.11 26.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.615 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 3.7 m-70 57.66 -122.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -92.81 7.59 43.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -116.61 150.56 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.011 1.115 . . . . 1.0 114.011 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.93 116.27 31.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.547 -1.206 . . . . 1.0 108.851 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -95.27 -26.34 15.98 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.924 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.5 -168.7 24.8 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.158 -1.02 . . . . 1.0 111.972 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.8 tp -145.32 136.76 25.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.803 0.335 . . . . 1.0 111.142 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.2 tp -100.91 145.5 28.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.9 129.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.6 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 151' ' ' SER . 4.8 p -112.96 145.84 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.077 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.664 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -148.01 138.54 22.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.219 0.533 . . . . 1.0 110.973 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.453 ' ND1' ' CG ' ' A' ' 49' ' ' ASP . 21.3 t60 -150.64 151.73 32.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.702 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.441 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -79.7 67.46 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.424 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 120.376 -0.53 . . . . 1.0 112.297 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.804 0.335 . . . . 1.0 110.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.6 m -95.27 148.31 22.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.245 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -67.19 -37.33 83.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.19 -54.48 40.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.349 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.64 -31.59 72.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.846 0.355 . . . . 1.0 110.598 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.14 -41.85 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.509 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' GLN . 94.5 mm-40 -61.54 -52.86 62.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.377 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.6 t -43.06 -44.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.255 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.31 -36.88 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 36.6 tp60 -52.32 -37.86 56.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.58 -32.15 67.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.391 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.75 -27.85 69.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.53 -37.02 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.69 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.492 ' O ' ' OG ' ' A' ' 192' ' ' SER . 56.5 t0 -53.89 -42.33 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.717 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -52.35 -56.3 15.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.19 -41.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.902 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.9 p -51.82 -35.26 43.75 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.4 mt -78.97 -35.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.046 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.07 61.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.08 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.12 -36.7 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.181 0.515 . . . . 1.0 109.622 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -73.23 -53.63 10.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.958 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 197' ' ' GLN . 19.3 tm0? -55.3 -27.23 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.908 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.07 -33.91 57.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.298 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -58.0 -40.99 82.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.153 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.6 mp -64.96 -58.48 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.093 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.4 t -53.03 -42.22 65.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 1.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.4 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.885 0.374 . . . . 1.0 110.565 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.67 -52.28 27.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.231 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.87 -48.35 82.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 tp -60.96 -30.95 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.598 0.592 . . . . 1.0 112.598 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -75.57 -24.16 56.61 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.595 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 39' ' ' VAL . 73.1 mtp180 -66.83 -36.08 81.52 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.94 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.1 -25.16 43.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -74.77 -50.68 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.577 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 40' ' ' GLU . 3.4 p -53.52 -36.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.923 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 96.8 mt-10 -74.53 -37.37 63.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -64.79 -51.77 60.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 1.0 112.021 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.23 -50.39 79.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.9 tmm_? -51.36 -43.61 61.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.69 73.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -80.47 -47.17 14.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.17 -6.83 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.175 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.83 17.11 0.49 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.41 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -73.44 140.35 46.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.083 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.6 m-20 -61.99 -29.86 70.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -152.99 118.69 5.34 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 119.231 -0.988 . . . . 1.0 113.517 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.24 137.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -146.23 161.81 39.44 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.547 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.91 135.27 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.017 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.7 t80 -117.9 116.54 27.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.012 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -98.16 164.76 12.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -131.75 139.56 48.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 1.0 112.12 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -103.79 148.35 35.67 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.718 -0.673 . . . . 1.0 109.296 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.21 -21.85 72.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.732 2.288 . . . . 1.0 112.924 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -80.01 -4.47 52.76 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.974 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.86 46.5 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.871 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -89.13 146.07 25.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.335 0.567 . . . . 1.0 110.888 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.88 144.35 15.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 m -128.55 147.31 50.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.133 0.492 . . . . 1.0 112.309 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.67 119.09 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.05 0.14 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.64 150.46 23.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.1 tt0 -166.05 125.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.372 -0.931 . . . . 1.0 113.166 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.14 48.7 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.0 141.55 51.77 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.238 -0.585 . . . . 1.0 111.516 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.32 104.67 2.63 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.4 -89.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.8 tt0 -176.94 34.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.174 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -70.98 -53.57 14.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.2 mt -94.76 144.13 27.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 107.921 -1.141 . . . . 1.0 107.921 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.09 170.34 20.35 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.043 1.828 . . . . 1.0 112.504 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -92.32 136.22 33.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.173 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.541 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 38.5 mt -109.63 -2.35 17.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.543 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.7 tp -58.52 139.55 55.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.568 . . . . 1.0 112.289 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.38 84.36 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.058 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.1 133.97 43.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.863 0.364 . . . . 1.0 110.766 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -89.07 117.01 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.515 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -107.98 134.91 19.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.78 158.11 27.88 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.123 1.882 . . . . 1.0 111.663 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.76 -20.1 63.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.779 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.66 -22.46 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 10.3 p30 -55.54 -27.78 50.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.323 . . . . 1.0 110.649 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 90.6 mt -127.96 99.58 25.34 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.279 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 47.6 Cg_exo -41.71 -101.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.544 2.163 . . . . 1.0 112.312 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 43.7 tp10 -153.54 -59.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.809 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -43.46 -38.67 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.714 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.92 54.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 1.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -61.64 -31.4 71.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -58.04 -49.58 76.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.284 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.0 mt -53.85 -36.97 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.7 -29.15 69.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -89.66 -15.38 32.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.092 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.82 -46.34 3.98 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.399 0.889 . . . . 1.0 113.399 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.99 -3.0 14.1 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.553 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 25.21 67.01 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.876 ' H ' HH21 ' A' ' 133' ' ' ARG . 13.0 t -107.24 -52.52 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.503 -2.406 . . . . 1.0 104.503 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.683 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 11.5 mtm180 64.38 65.57 0.65 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.312 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.11 133.39 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.726 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.473 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.7 mp -109.25 127.38 66.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 108.353 -0.981 . . . . 1.0 108.353 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 25.9 t -83.2 168.11 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.512 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 1.8 m-20 -51.33 114.52 1.25 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.268 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.82 -10.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.789 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 105' ' ' ASP . 4.4 pt-20 -88.5 -35.96 16.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.912 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -15.03 9.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.412 0.625 . . . . 1.0 110.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 49.97 51.5 16.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 1.0 113.396 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 m -94.2 138.2 32.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.405 -2.072 . . . . 1.0 105.405 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -128.27 137.93 52.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.05 1.5 . . . . 1.0 115.05 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.452 -0.33 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.307 177.35 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.876 HH21 ' H ' ' A' ' 100' ' ' VAL . 26.1 mtt-85 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.671 0.272 . . . . 1.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.07 150.29 5.08 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.515 2.143 . . . . 1.0 111.837 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.406 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -97.44 145.69 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.027 0.442 . . . . 1.0 111.382 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.4 m-20 -91.1 147.02 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.553 -0.749 . . . . 1.0 110.913 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -38.75 -28.69 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.199 1.933 . . . . 1.0 111.288 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 136' ' ' ASP . 47.9 t -67.6 -53.15 30.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.4 t-80 -73.54 -24.99 60.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.4 t -50.99 -55.94 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.353 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.14 -41.46 94.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -43.17 -50.4 6.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.51 -48.1 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.525 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.3 tmtm? -57.27 -43.07 82.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.511 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.8 p -55.2 -27.34 45.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 39.4 mtt -92.25 -3.48 55.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.186 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.12 22.77 72.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.357 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.83 122.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.72 -0.392 . . . . 1.0 109.953 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.36 -37.22 57.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -130.22 170.57 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.579 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 3.4 p -158.92 139.64 12.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.02 0.438 . . . . 1.0 112.157 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.783 ' H ' ' HG ' ' A' ' 168' ' ' SER . 46.9 tp -116.31 140.02 49.77 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 3.1 m -134.33 154.54 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.463 0.649 . . . . 1.0 111.739 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 74.6 t -157.21 108.21 1.89 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.767 -1.106 . . . . 1.0 109.267 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.78 113.88 3.9 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.659 2.906 . . . . 1.0 113.847 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.72 105.88 3.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.78 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.7 ptm -132.19 147.07 52.4 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.835 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.628 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 11.7 t-80 -118.07 115.58 25.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.628 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 79.8 m-70 59.32 -122.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.99 7.59 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.883 0.327 . . . . 1.0 111.883 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.3 mp0 -114.65 146.03 41.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.94 117.41 33.98 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 114.525 -1.216 . . . . 1.0 108.809 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.15 -26.67 15.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.899 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.27 -170.88 28.79 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.261 -0.971 . . . . 1.0 112.041 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.9 tp -141.67 137.29 31.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 1.0 111.216 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 5.1 tp -99.11 142.8 30.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.31 135.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.595 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.783 ' HG ' ' H ' ' A' ' 152' ' ' LEU . 1.3 p -120.8 142.51 49.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.046 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.618 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -150.03 127.99 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.127 0.489 . . . . 1.0 111.021 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.561 ' O ' ' O ' ' A' ' 171' ' ' ALA . 3.8 p80 -166.58 156.52 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.704 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 170' ' ' HIS . . . -46.14 -170.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.607 -0.269 . . . . 1.0 111.448 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.261 179.599 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 120.822 0.344 . . . . 1.0 110.744 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 t -99.68 143.12 30.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.23 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.14 -31.93 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.646 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.05 -54.52 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.337 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.42 -30.64 71.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.904 0.383 . . . . 1.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.16 -35.1 74.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.538 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.58 -52.75 28.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.407 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -44.44 -47.38 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 187' ' ' LEU . 27.3 m -75.01 -36.81 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.672 ' NE2' HH22 ' A' ' 101' ' ' ARG . 58.7 tt0 -46.94 -35.84 6.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.6 tt -72.1 -43.46 64.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.412 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 184' ' ' VAL . 39.0 tp -53.96 -33.17 56.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.662 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.95 -37.27 62.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.618 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -56.21 -38.09 70.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.705 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -53.16 -51.83 60.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.12 -42.46 79.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.265 -0.879 . . . . 1.0 109.889 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.3 m -51.86 -37.12 50.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.61 -33.47 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.048 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.37 -47.13 58.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.101 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.0 tp -62.4 -33.12 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.527 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.96 -53.59 8.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.898 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -56.28 -28.36 58.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.68 -34.3 52.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.17 -39.98 80.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.86 -57.62 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.4 t -58.14 -44.17 87.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.059 -0.972 . . . . 1.0 110.373 179.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.397 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.294 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.18 -52.7 45.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -55.05 -50.09 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.687 0.625 . . . . 1.0 112.687 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.8 mt -64.42 -23.97 67.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.541 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.457 ' O ' HG11 ' A' ' 39' ' ' VAL . 61.0 ttt180 -58.23 -36.1 72.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.651 -0.419 . . . . 1.0 109.925 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.35 38.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.3 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 50.6 p -69.36 -49.87 51.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.507 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 36' ' ' ARG . 3.9 p -53.08 -36.32 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 75.2 mm-40 -65.24 -38.41 90.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.841 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.15 -44.91 87.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.924 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.08 -44.08 95.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.3 tmm_? -62.43 -51.64 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.843 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.06 81.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.847 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.76 -51.49 9.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.794 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.51 -5.58 48.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.087 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.29 17.71 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.716 -0.675 . . . . 1.0 112.415 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.494 ' O ' ' CD ' ' A' ' 43' ' ' ARG . 1.2 m -74.48 141.85 44.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.108 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -57.48 -33.39 67.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -152.28 119.82 6.03 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 119.18 -1.008 . . . . 1.0 113.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -139.14 134.88 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -145.62 161.9 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.377 -0.529 . . . . 1.0 111.566 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.44 136.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.006 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 165' ' ' LEU . 43.8 t80 -121.0 119.11 31.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.113 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -100.07 170.08 8.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.925 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.418 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 72.3 t80 -134.32 138.78 45.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.526 -0.47 . . . . 1.0 112.124 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -102.45 148.79 35.97 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.306 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.36 -21.22 66.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.729 2.286 . . . . 1.0 112.965 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.3 -0.57 41.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.563 -0.455 . . . . 1.0 111.038 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.33 -11.51 54.72 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.855 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.6 m-70 -89.34 146.44 24.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.383 0.592 . . . . 1.0 110.976 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.8 144.68 15.37 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 p -129.26 148.21 51.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.184 0.516 . . . . 1.0 112.275 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.78 120.99 57.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.937 -1.134 . . . . 1.0 107.937 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.04 8.1 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.06 146.37 23.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE1' ' OG ' ' A' ' 76' ' ' SER . 52.4 tt0 -166.75 127.69 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.296 -0.962 . . . . 1.0 113.186 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.1 139.07 47.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -127.53 141.46 51.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.138 -0.625 . . . . 1.0 111.569 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.15 107.59 3.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.417 -1.073 . . . . 1.0 110.417 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.23 16.95 0.1 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.264 -1.134 . . . . 1.0 110.264 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.7 tt0 71.99 28.87 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.791 -0.364 . . . . 1.0 111.104 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -57.55 -58.24 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -90.65 158.63 42.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.31 162.49 33.69 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.09 1.86 . . . . 1.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.441 ' OG ' ' OE1' ' A' ' 67' ' ' GLU . 24.7 t -85.9 108.9 18.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.119 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.9 mt -84.1 -1.47 54.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.56 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.44 139.54 58.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.349 0.595 . . . . 1.0 112.289 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.0 -4.12 74.36 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.121 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 8.8 mp -102.41 131.04 49.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 1.0 110.774 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.01 119.81 25.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.95 132.96 20.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.302 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -79.61 155.8 24.43 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.214 1.943 . . . . 1.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -21.08 65.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.798 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.19 -22.07 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.03 -27.8 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 1.0 110.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.6 mt -107.86 106.28 58.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.332 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.5 Cg_exo -48.47 -125.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.505 2.136 . . . . 1.0 112.35 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.6 pt-20 -142.91 -43.08 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 22.7 pt-20 -68.83 -39.8 79.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.723 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.09 84.1 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.007 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -63.24 -30.62 71.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.553 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -56.66 -51.13 69.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.323 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 10.4 mp -55.71 -35.33 65.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -63.36 -31.49 72.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 1.0 109.625 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -87.16 -15.16 39.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.042 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.48 -42.67 4.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.03 -4.78 13.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.517 0.932 . . . . 1.0 113.517 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.597 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 96.4 mt-30 27.06 69.65 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 6.8 t -109.76 -49.21 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.435 -2.431 . . . . 1.0 104.435 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.682 ' NH1' HE22 ' A' ' 185' ' ' GLN . 0.6 OUTLIER 63.06 70.56 0.54 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.137 -1.392 . . . . 1.0 114.311 172.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.11 136.74 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.706 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.71 127.76 64.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 34.3 t -83.53 166.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.498 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 4.1 m-20 -53.68 119.44 4.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.26 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.0 m -58.01 -13.2 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.876 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -87.61 -38.04 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.89 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.32 -13.72 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.384 0.611 . . . . 1.0 110.059 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 51.3 54.77 10.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 113.409 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -93.94 133.62 37.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -128.21 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.486 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 80.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-N 114.17 -1.377 . . . . 1.0 107.316 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 1.6 mmp_? . . . . . 0 N--CA 1.461 0.087 0 N-CA-C 110.286 -0.265 . . . . 1.0 110.286 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.75 147.63 6.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.494 2.129 . . . . 1.0 111.816 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 m -95.72 151.58 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 1.0 111.329 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.486 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.3 m-20 -84.89 156.32 61.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.909 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -56.34 -26.52 62.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.216 1.944 . . . . 1.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.6 OUTLIER -74.51 -34.81 63.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.06 -0.718 . . . . 1.0 109.06 176.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.49 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 46.2 t-80 -81.47 -31.56 32.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.657 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -52.29 -50.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.33 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 145' ' ' SER . 86.5 t60 -65.99 -43.88 86.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.28 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -44.19 -52.07 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -46.2 52.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.501 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.0 OUTLIER -59.51 -42.76 92.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.52 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 141' ' ' HIS . 17.7 t -53.83 -32.53 53.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 40.7 mtt -84.51 -1.89 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.113 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.1 23.85 76.03 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.352 -0.84 . . . . 1.0 112.233 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.03 124.92 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.52 24.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -131.5 169.37 16.18 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.565 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.0 m -162.61 139.47 7.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.106 0.479 . . . . 1.0 112.15 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.57 139.69 50.21 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 1.9 m -135.13 157.81 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.803 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 59.3 t -158.98 91.91 1.95 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.388 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.46 115.37 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.636 2.891 . . . . 1.0 113.922 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.29 105.87 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.859 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.442 ' O ' ' OG ' ' A' ' 192' ' ' SER . 16.7 ptm -130.92 146.43 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.0 111.836 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 84.5 t60 -119.51 115.68 24.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 49.1 t60 64.02 -126.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.493 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.5 mt-30 -92.66 5.28 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.855 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 46.9 mp0 -115.09 150.69 35.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.24 117.34 33.79 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 114.517 -1.219 . . . . 1.0 108.86 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -97.4 -28.83 13.83 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.65 -171.93 24.22 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.22 -0.99 . . . . 1.0 111.962 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.9 tp -138.8 129.69 26.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.565 -0.318 . . . . 1.0 111.205 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -94.52 139.06 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 169' ' ' HIS . 9.7 p -151.19 132.83 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.532 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.619 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 1.5 m -115.22 140.57 48.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.05 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.619 ' ND1' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -135.5 141.48 45.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 1.0 110.992 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -158.2 154.27 27.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.5 -0.773 . . . . 1.0 109.742 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.94 67.94 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.298 -179.267 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.809 0.337 . . . . 1.0 110.721 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -96.17 153.93 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.641 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.99 -53.49 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.324 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 37.4 mp0 -71.41 -24.22 62.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.884 0.373 . . . . 1.0 110.677 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -61.44 -45.65 93.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.505 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 10.9 pt20 -67.56 -48.66 66.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.417 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.45 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 46.4 t -43.68 -51.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.243 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.48 -36.05 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.682 HE22 ' NH1' ' A' ' 101' ' ' ARG . 63.0 tp60 -48.24 -37.95 17.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.89 -40.27 65.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.375 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.71 -32.42 63.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.687 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.54 -37.7 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.701 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -56.96 -40.36 76.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.741 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.66 -54.09 38.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.39 -40.69 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.923 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 157' ' ' MET . 3.5 t -50.1 -30.17 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.63 -39.43 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.056 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.67 67.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.133 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.01 -35.64 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.465 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -76.48 -54.77 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.863 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -55.94 -28.52 57.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.949 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.23 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.336 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.43 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 83.6 tt0 -57.77 -39.76 78.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.133 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.9 tp -68.52 -58.04 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.047 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.7 m -56.86 -44.25 81.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.43 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 7.8 tp . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.425 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 1.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.2 p-10 -61.96 -42.54 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.259 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 96.3 mt-30 -68.81 -52.0 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.542 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.4 mp -60.78 -34.54 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.22 -23.67 60.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -62.56 -52.85 61.81 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.632 -0.427 . . . . 1.0 109.965 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.02 77.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.359 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.538 ' HG1' ' N ' ' A' ' 39' ' ' VAL . 43.3 p -67.82 -46.5 71.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.526 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.538 ' N ' ' HG1' ' A' ' 38' ' ' THR . 10.1 t -59.28 -38.42 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.903 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.31 -37.74 77.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.778 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.31 -43.98 80.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 1.0 112.01 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.44 -51.11 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.861 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.4 tmt_? -52.73 -44.6 66.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.834 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.82 68.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.806 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -83.21 -46.2 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.734 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.53 -8.5 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 1.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 49.56 17.88 1.44 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.632 -0.713 . . . . 1.0 112.405 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -77.07 144.85 38.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.159 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 94.1 m-20 -54.56 -34.16 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.55 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 9.0 ttm180 -152.61 122.62 7.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.168 -1.013 . . . . 1.0 113.595 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.42 132.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.705 ' HZ3' ' HE2' ' A' ' 169' ' ' HIS . 19.5 pttm -146.64 155.74 42.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.576 -177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.66 138.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.97 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -122.43 119.81 32.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.058 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -100.21 170.64 8.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.436 . . . . 1.0 109.864 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 62.9 t80 -133.22 141.89 48.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.0 m-20 -105.52 149.42 37.82 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.371 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.35 -25.95 63.73 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.696 2.264 . . . . 1.0 112.961 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -76.52 -5.38 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.941 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.19 -12.69 44.46 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.839 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.03 144.64 26.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.388 0.594 . . . . 1.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 143.85 15.3 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.9 p -127.37 146.69 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.346 0.498 . . . . 1.0 112.346 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.19 118.34 46.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -111.9 4.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.38 21.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.9 tt0 -166.46 127.44 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.362 -0.935 . . . . 1.0 113.215 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.06 140.66 39.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -129.75 141.89 50.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.512 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.94 106.16 2.84 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.431 -1.068 . . . . 1.0 110.431 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.19 -88.72 0.01 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.294 -1.122 . . . . 1.0 110.294 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' GLY . 23.0 pt-20 -176.77 31.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.109 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -66.51 -54.12 27.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HB3' HH21 ' A' ' 50' ' ' ARG . 28.6 mt -95.33 151.93 39.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 171.57 16.42 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.07 1.846 . . . . 1.0 112.504 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.4 m -92.73 135.29 34.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.148 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.58 -9.22 15.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.618 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.583 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 17.6 tp -50.73 138.79 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.363 0.601 . . . . 1.0 112.212 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -1.87 79.27 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.51 125.92 46.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 1.0 110.757 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -84.08 122.23 28.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.488 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -108.07 138.81 20.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.25 155.06 16.74 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.136 1.89 . . . . 1.0 111.646 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.411 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -65.56 -21.11 66.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.827 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 87' ' ' ILE . . . -49.8 -24.82 6.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 19.1 p-10 -47.86 -13.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 1.0 110.663 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 85' ' ' GLY . 3.5 pt -135.91 137.96 26.57 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.224 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 61.5 Cg_endo -80.68 -114.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 1.0 112.374 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.407 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.0 mm-40 -141.82 -66.12 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.91 0.386 . . . . 1.0 111.881 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -47.79 -43.09 27.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.682 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.78 -53.07 30.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.964 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.467 HH21 ' CD2' ' A' ' 162' ' ' LEU . 24.6 ttt180 -54.47 -27.86 40.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' LEU . 22.1 mmt180 -63.68 -46.15 86.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.297 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 98' ' ' ALA . 39.6 mt -49.99 -42.61 49.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.564 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 30.3 m-85 -64.99 -29.88 70.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -90.24 -18.96 24.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.102 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -104.76 -45.34 4.62 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.426 0.899 . . . . 1.0 113.426 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -111.1 -2.78 15.72 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.7 mt-30 28.29 67.2 0.08 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.014 1.116 . . . . 1.0 114.014 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.38 -50.51 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.385 -2.45 . . . . 1.0 104.385 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.481 HH12 ' CD ' ' A' ' 185' ' ' GLN . 3.0 mtp180 64.79 70.38 0.48 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.072 -1.422 . . . . 1.0 114.304 172.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -150.67 130.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.784 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 103' ' ' ILE . 1.7 mp -106.64 126.58 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 11.9 p -81.81 166.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.224 0.824 . . . . 1.0 113.224 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 13.6 m-20 -52.2 120.82 5.88 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.658 -1.156 . . . . 1.0 112.328 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 37.1 t -57.6 -11.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.737 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' A' ' 109' ' ' GLN . 17.0 pt-20 -83.04 -38.95 21.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.851 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.98 1.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.396 0.617 . . . . 1.0 110.114 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' A' ' 107' ' ' GLU . 19.5 pt20 35.43 58.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.018 -0.992 . . . . 1.0 113.392 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -94.32 135.27 35.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.386 -2.079 . . . . 1.0 105.386 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -129.98 145.59 51.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 CA-C-N 114.132 -1.394 . . . . 1.0 107.31 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.593 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.636 0.255 . . . . 1.0 110.327 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.9 145.98 16.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.587 2.191 . . . . 1.0 111.818 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 135' ' ' VAL . 2.9 m -118.03 127.19 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.447 . . . . 1.0 111.389 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -39.94 163.74 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.888 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.94 -19.68 34.94 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.265 1.977 . . . . 1.0 111.234 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.2 p -66.22 -37.52 85.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.515 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 40.4 t-80 -80.69 -28.34 36.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.632 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 t -52.31 -53.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.322 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 145' ' ' SER . 85.2 t60 -66.88 -42.15 86.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.296 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -47.66 -56.9 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.503 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -68.49 -50.38 52.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.527 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 21.1 tptm -57.35 -40.08 77.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 t -54.06 -32.49 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.5 mtt -83.46 1.15 43.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.264 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.52 25.3 75.64 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.214 -0.903 . . . . 1.0 112.33 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.17 122.91 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.835 -0.432 . . . . 1.0 109.835 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.09 -30.43 49.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.0 t -140.11 172.89 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.09 -0.644 . . . . 1.0 111.551 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 p -162.84 139.96 7.77 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.081 0.467 . . . . 1.0 112.141 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.1 tp -118.3 138.79 52.14 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.04 158.98 43.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.418 0.628 . . . . 1.0 111.859 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.453 ' CG1' HH21 ' A' ' 101' ' ' ARG . 88.5 t -154.32 96.44 2.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.849 -1.069 . . . . 1.0 109.313 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 154' ' ' VAL . 54.7 Cg_endo -63.97 139.23 66.65 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.571 2.847 . . . . 1.0 113.957 -175.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.59 105.56 17.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.736 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.458 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.1 mtp -117.54 139.06 51.45 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.906 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.632 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 26.6 t-80 -113.74 113.58 25.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.632 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 46.5 m-70 57.6 -123.0 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -94.23 10.99 31.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 51.0 mp0 -119.87 153.64 35.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.047 1.129 . . . . 1.0 114.047 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.467 ' CD2' HH21 ' A' ' 92' ' ' ARG . 14.8 tp -108.83 112.25 24.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.882 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -95.5 -28.61 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.905 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -154.88 -175.9 26.5 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.21 -0.995 . . . . 1.0 111.944 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.45 133.6 24.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.812 0.339 . . . . 1.0 111.215 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.7 tp -99.93 135.78 40.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.2 t -148.17 120.87 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.381 -0.528 . . . . 1.0 111.538 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 p -108.89 148.74 30.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.705 ' HE2' ' HZ3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -149.06 148.22 29.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 1.0 111.018 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.663 ' HE2' ' HH ' ' A' ' 176' ' ' TYR . 3.0 p-80 -158.92 155.41 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.678 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.74 69.95 4.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.552 -0.295 . . . . 1.0 111.43 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 120.41 -0.516 . . . . 1.0 112.326 -179.526 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.663 ' HH ' ' HE2' ' A' ' 170' ' ' HIS . 13.7 m-85 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.832 0.349 . . . . 1.0 110.756 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -96.5 146.69 24.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.05 -40.08 78.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.6 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.11 -54.48 37.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.419 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.05 -35.31 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.374 . . . . 1.0 110.738 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.61 -38.71 88.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.505 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.1 -55.67 32.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.2 t -43.87 -43.46 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 86.0 t -74.99 -37.64 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.481 ' CD ' HH12 ' A' ' 101' ' ' ARG . 60.9 tt0 -48.27 -37.21 15.66 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.92 -40.2 63.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.751 -1.113 . . . . 1.0 109.344 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 44.0 tp -54.99 -32.34 61.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.692 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.83 -35.25 67.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.679 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -56.28 -39.58 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.695 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -53.64 -54.58 35.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.67 -44.11 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.226 -0.897 . . . . 1.0 109.834 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 157' ' ' MET . 10.1 t -51.68 -37.72 51.87 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 71.6 mt -78.2 -32.2 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.082 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.4 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.074 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.409 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.7 pp -68.18 -24.26 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.24 -57.14 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.862 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.9 -27.34 66.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.885 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.56 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.355 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.421 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 41.3 tp10 -55.66 -37.02 67.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.163 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 -55.34 12.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.075 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.3 p -54.83 -42.07 71.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 1.0 110.303 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.421 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 27.3 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.422 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.843 0.354 . . . . 1.0 110.515 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.2 p-10 -64.04 -40.26 95.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.236 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.8 mt-30 -71.21 -54.24 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.5 mp -56.41 -44.79 81.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 33.3 mt -68.88 -26.38 65.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.522 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -56.43 -38.82 72.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.945 0.402 . . . . 1.0 109.998 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.66 58.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 43.2 p -70.04 -45.44 67.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.479 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.61 -39.29 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.869 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -68.23 -37.89 81.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.817 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.2 -41.36 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.013 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.74 -45.91 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.866 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.0 tmm_? -53.74 -48.32 69.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.885 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.76 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.24 -52.49 7.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.776 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.86 -7.39 55.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.959 0.409 . . . . 1.0 110.114 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.14 17.79 0.38 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.457 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.41 ' HG1' ' HG ' ' A' ' 168' ' ' SER . 15.1 t -77.37 146.77 36.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.1 m-20 -56.39 -33.08 65.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 41.7 ttm-85 -153.39 127.44 9.02 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 119.174 -1.01 . . . . 1.0 113.533 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.72 132.33 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.973 -1.121 . . . . 1.0 107.973 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -145.73 161.07 40.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.54 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.38 137.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.955 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 165' ' ' LEU . 67.3 t80 -122.26 119.85 32.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.074 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -100.07 171.11 8.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -133.96 136.68 44.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 1.0 112.084 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.42 126.45 33.14 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.353 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.94 -28.61 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.68 2.253 . . . . 1.0 112.923 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -74.29 -7.73 53.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.029 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.06 -13.57 34.11 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.014 -0.612 . . . . 1.0 112.825 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.94 145.94 25.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.352 0.576 . . . . 1.0 110.862 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.61 145.45 15.71 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.9 p -128.82 148.28 50.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 1.0 112.328 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.25 120.49 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 m -110.58 0.51 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.0 151.04 21.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 50' ' ' ARG . 1.9 pp20? -169.25 131.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.36 -0.936 . . . . 1.0 113.209 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.45 142.56 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.4 ' C ' HH12 ' A' ' 43' ' ' ARG . 10.0 ptt85 -133.22 143.96 49.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.481 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.53 112.87 3.9 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.22 34.04 2.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 54.57 31.52 15.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.14 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -60.65 -55.56 31.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' HB2' ' HE ' ' A' ' 50' ' ' ARG . 81.9 mt -95.86 147.21 32.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 57.9 Cg_endo -70.67 170.77 16.86 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.128 1.885 . . . . 1.0 112.528 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.411 ' HA ' HH22 ' A' ' 50' ' ' ARG . 23.1 t -89.08 130.11 35.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.158 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.8 mt -101.13 1.56 39.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.594 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.62 135.01 57.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.323 0.582 . . . . 1.0 112.24 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.63 -7.49 77.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 7.8 mp -96.99 132.04 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.885 0.374 . . . . 1.0 110.737 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 m -90.87 117.9 29.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.455 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 m-85 -109.42 135.82 20.27 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.293 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.98 157.35 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.12 1.88 . . . . 1.0 111.628 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.9 -17.78 63.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.51 -22.23 0.99 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.31 -29.82 64.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.86 0.362 . . . . 1.0 110.634 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.499 ' CG2' ' HE ' ' A' ' 92' ' ' ARG . 58.4 mt -98.66 146.74 32.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.228 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -96.18 -142.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.465 2.11 . . . . 1.0 112.331 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 90' ' ' GLU . 1.2 pt-20 -121.94 -76.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.794 -0.363 . . . . 1.0 111.825 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 89' ' ' GLU . 22.7 pt-20 -45.84 -40.53 9.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.779 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.61 68.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.657 -0.417 . . . . 1.0 111.014 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.499 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 21.3 ttm180 -59.82 -29.46 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.555 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' LEU . 35.1 mtp180 -58.91 -46.79 87.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 98' ' ' ALA . 43.0 mt -55.12 -36.74 66.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.569 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -63.49 -35.18 79.6 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -91.32 -15.85 28.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 2.8 tp -105.8 -45.53 4.36 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.33 0.863 . . . . 1.0 113.33 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.31 -3.67 12.46 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.515 0.931 . . . . 1.0 113.515 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.3 mt-30 30.08 69.68 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.01 1.115 . . . . 1.0 114.01 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.9 -51.21 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.439 HH21 HG22 ' A' ' 154' ' ' VAL . 0.8 OUTLIER 62.82 74.09 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.997 -1.456 . . . . 1.0 114.286 172.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.85 132.42 5.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.72 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.84 128.15 63.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 44.9 t -82.36 165.99 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.272 0.841 . . . . 1.0 113.272 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.508 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 12.9 m-20 -52.74 123.28 10.9 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.772 -1.104 . . . . 1.0 112.308 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -58.96 -10.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.707 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.0 pt-20 -85.94 -39.48 16.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.867 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.434 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -60.68 -15.29 27.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.372 0.606 . . . . 1.0 110.066 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 50.86 57.72 6.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.047 -0.979 . . . . 1.0 113.345 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t -94.47 136.09 35.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.349 -2.093 . . . . 1.0 105.349 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -129.6 142.42 50.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.98 1.474 . . . . 1.0 114.98 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 2.8 m . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 114.181 -1.372 . . . . 1.0 107.341 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.737 0.303 . . . . 1.0 110.254 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 112' ' ' SER . 75.5 Cg_exo -49.23 144.46 17.04 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.508 2.139 . . . . 1.0 111.808 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.411 ' CG2' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -112.8 123.39 68.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 1.0 111.322 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.02 154.55 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.907 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.5 -21.73 73.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 1.0 111.261 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 12.8 p -63.05 -37.07 85.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.493 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 1.1 t-80 -80.83 -28.96 35.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.7 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.7 t -52.94 -55.2 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.339 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -66.96 -44.98 79.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.257 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -44.21 -50.99 8.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.473 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.67 -46.44 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.454 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -57.76 -42.64 84.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.456 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.5 m -53.72 -34.34 58.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.2 mtt -82.35 -4.25 56.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.179 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 72.16 25.26 74.98 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.268 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.97 120.84 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.96 -33.16 34.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.534 ' HG ' ' H ' ' A' ' 151' ' ' SER . 44.4 t -138.48 170.49 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.199 -0.6 . . . . 1.0 111.569 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' A' ' 150' ' ' SER . 46.9 t -163.01 139.82 7.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 1.0 112.185 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.9 tp -116.32 116.23 27.37 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.39 157.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.54 0.686 . . . . 1.0 111.79 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 84.3 t -156.02 95.73 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.295 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HD2' ' NE ' ' A' ' 101' ' ' ARG . 58.4 Cg_endo -65.81 139.74 58.51 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.536 2.824 . . . . 1.0 113.929 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.8 mt -98.15 107.47 19.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 83.1 mtp -121.12 143.37 49.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 1.0 111.775 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -121.81 114.41 21.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 160' ' ' GLN . 47.2 t60 65.05 -127.65 0.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 159' ' ' HIS . 0.5 OUTLIER -94.53 10.01 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -120.19 158.62 26.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.9 117.31 32.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.872 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -95.18 -26.55 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.832 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.61 -173.04 26.5 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.987 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.2 tp -142.33 131.44 23.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 1.0 111.251 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 1.9 tp -96.84 143.32 27.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 8.6 p -150.0 130.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.524 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 151' ' ' SER . 18.2 t -112.1 141.77 45.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.011 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.401 ' NE2' ' CG2' ' A' ' 167' ' ' VAL . 68.0 m-70 -139.55 142.04 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.108 0.48 . . . . 1.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -155.98 152.27 27.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.778 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.33 71.01 9.39 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.034 -0.266 . . . . 1.0 111.418 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.325 179.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.779 0.323 . . . . 1.0 110.818 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.1 p -92.75 154.26 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 182' ' ' GLN . 13.8 pt20 -70.23 -39.01 75.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.624 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.23 -54.17 49.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.532 -0.303 . . . . 1.0 111.369 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -65.67 -30.04 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.378 . . . . 1.0 110.718 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.57 -31.89 71.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.494 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 178' ' ' GLN . 0.3 OUTLIER -71.91 -55.96 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.504 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 51.4 t -42.97 -45.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.257 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.41 -33.69 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 182' ' ' GLN . 7.4 tt0 -50.91 -42.17 59.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.66 -41.45 83.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.694 -1.139 . . . . 1.0 109.354 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.02 -28.87 59.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.697 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.475 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -70.8 -26.44 63.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.615 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -70.99 -36.0 72.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.682 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -53.8 -58.62 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 188' ' ' ALA . 17.9 m -60.27 -38.17 76.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.891 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 15.8 m -52.39 -35.55 51.84 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.95 -36.08 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.518 -0.764 . . . . 1.0 110.127 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.91 -46.81 61.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.084 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.65 -34.56 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.69 -54.13 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.883 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -55.93 -28.56 57.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.955 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.05 -34.9 57.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.269 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -57.22 -38.57 73.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.183 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.35 -59.21 3.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.169 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 t -65.46 -50.91 63.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 1.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.417 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.81 0.338 . . . . 1.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -60.51 -49.2 78.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.267 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.51 -51.0 69.15 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.5 mt -56.67 -42.28 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.403 ' O ' ' OG1' ' A' ' 38' ' ' THR . 48.6 mt -67.0 -24.1 66.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.561 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -60.84 -40.39 92.66 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.654 -0.418 . . . . 1.0 109.973 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 -30.58 60.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 44.8 p -69.51 -46.94 65.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.534 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.55 -40.96 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.883 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 78.7 mm-40 -72.64 -36.7 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.96 -55.15 24.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.767 -0.651 . . . . 1.0 112.023 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.67 -44.09 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.827 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 tmm_? -51.91 -45.47 64.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.817 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.7 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.839 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -81.26 -47.23 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.821 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -77.21 -6.08 51.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.971 0.415 . . . . 1.0 110.124 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.59 17.6 0.5 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.464 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.521 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -76.28 143.4 40.93 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.053 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 70' ' ' GLY . 50.0 p30 -65.96 -21.95 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.886 0.699 . . . . 1.0 112.886 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.689 HH21 ' CD2' ' A' ' 169' ' ' HIS . 44.4 ttp180 -155.12 119.29 4.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 119.221 -0.992 . . . . 1.0 113.579 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.54 133.67 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.701 ' HZ1' ' HE2' ' A' ' 169' ' ' HIS . 22.0 pttm -147.22 160.11 42.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.432 -0.507 . . . . 1.0 111.625 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.94 137.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.002 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 165' ' ' LEU . 38.7 t80 -121.36 119.33 31.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.074 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -100.11 167.83 10.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.33 134.19 46.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 1.0 112.102 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -103.52 129.26 25.75 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.357 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.72 -23.88 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.698 2.265 . . . . 1.0 112.953 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.69 -8.58 58.84 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.994 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.2 39.75 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.836 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -90.49 140.96 29.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.33 0.565 . . . . 1.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.24 135.57 11.7 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.9 p -124.0 144.05 50.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 1.0 112.278 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.6 t -100.53 122.87 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.95 -1.129 . . . . 1.0 107.95 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.3 3.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.572 0.582 . . . . 1.0 112.572 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.96 149.41 19.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.454 -0.572 . . . . 1.0 109.454 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -166.19 126.84 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.167 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.88 144.38 33.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -134.57 141.28 46.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.52 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.76 110.34 3.66 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.444 -1.063 . . . . 1.0 110.444 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.1 15.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.8 tt0 72.6 21.6 3.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.116 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -52.27 -57.03 10.96 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.7 146.93 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 107.791 -1.188 . . . . 1.0 107.791 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.25 162.81 40.95 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.068 1.845 . . . . 1.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 p -86.93 132.16 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.578 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 31.5 mt -105.83 -5.69 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.647 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.1 tp -48.26 134.34 14.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 1.0 112.259 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.05 -40.48 3.07 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.87 112.57 1.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.39 . . . . 1.0 110.739 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -74.77 124.25 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.455 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.26 132.64 20.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.274 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.64 149.16 26.56 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.155 1.904 . . . . 1.0 111.713 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.87 68.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -22.75 0.64 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -54.89 -33.64 62.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 1.0 110.672 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 87' ' ' ILE . 24.7 mm -108.6 132.4 21.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.264 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.22 -120.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.601 2.2 . . . . 1.0 112.292 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.72 -71.93 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.904 0.383 . . . . 1.0 111.828 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 22.2 pt-20 -42.8 -42.86 3.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.781 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -65.05 -52.64 54.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.75 -29.49 59.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.548 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LEU . 66.6 mtp85 -60.07 -47.38 86.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.319 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.4 mt -51.7 -44.95 63.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.589 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.7 m-85 -59.64 -30.21 68.56 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -90.87 -13.05 34.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.126 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' ARG . 1.5 tp -105.61 -45.97 4.29 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.82 0.89 15.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.462 0.912 . . . . 1.0 113.462 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.9 mt-30 28.1 66.39 0.09 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.131 1.16 . . . . 1.0 114.131 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 102' ' ' VAL . 8.2 p -119.32 -47.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 173.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.433 ' N ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 mtt180 64.79 -22.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.272 170.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 100' ' ' VAL . 8.7 t -56.33 129.64 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.768 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 28.3 mt -107.11 132.68 53.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -80.64 166.76 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' GLU . 9.0 m-20 -51.36 120.38 5.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.233 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -56.07 -10.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.823 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.8 pt-20 -88.61 -37.33 15.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.905 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.8 -15.09 10.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.395 0.617 . . . . 1.0 110.088 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.406 ' HG3' HH11 ' A' ' 111' ' ' ARG . 40.9 tp60 51.58 59.91 4.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.019 -0.991 . . . . 1.0 113.437 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.6 m -91.68 138.0 31.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 105.447 -2.057 . . . . 1.0 105.447 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HG3' ' A' ' 109' ' ' GLN . 67.3 mtm-85 -130.98 139.1 49.97 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.455 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 11.9 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.391 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.433 HH21 ' CB ' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.683 0.278 . . . . 1.0 110.338 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.6 149.8 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.62 2.213 . . . . 1.0 111.777 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.495 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 18.9 m -99.97 149.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.036 0.445 . . . . 1.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.667 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -89.65 144.21 31.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.947 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -38.92 -21.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.236 1.957 . . . . 1.0 111.258 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.5 t -78.49 -46.27 20.04 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 136' ' ' ASP . 40.1 t-80 -77.66 -38.78 46.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.639 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 141' ' ' HIS . 2.6 m -51.82 -43.09 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.342 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.497 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 47.1 t-80 -66.2 -43.44 86.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.225 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -46.98 -50.11 19.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.555 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.32 -50.98 49.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.456 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' GLY . 45.4 tptt -55.56 -40.66 72.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 27.8 m -54.82 -33.32 61.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 45.3 mtt -84.2 -2.87 57.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.218 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.67 24.61 75.36 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.221 -0.899 . . . . 1.0 112.341 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.46 124.12 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.93 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.465 ' OG ' ' OH ' ' A' ' 176' ' ' TYR . 1.9 t -119.34 153.89 34.42 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.564 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.662 ' H ' ' HH ' ' A' ' 176' ' ' TYR . 1.7 t -147.13 128.49 14.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.173 -0.467 . . . . 1.0 112.106 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.97 105.36 8.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 m -110.93 164.75 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.423 0.63 . . . . 1.0 111.838 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.0 p -161.08 110.44 1.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.331 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.85 139.66 44.06 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.54 2.827 . . . . 1.0 113.865 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.45 105.91 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.766 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.55 142.92 50.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.239 0.543 . . . . 1.0 111.899 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 51.8 t60 -114.09 115.52 27.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 17.5 m-70 60.33 -123.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -93.49 7.03 46.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.884 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -116.28 151.99 34.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.6 115.43 29.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.807 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -95.41 -28.12 15.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.87 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.34 -168.35 23.09 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.167 -1.016 . . . . 1.0 111.963 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -142.95 140.49 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 1.0 111.122 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.1 tp -110.07 145.46 37.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -149.07 128.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.58 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.4 m -117.59 142.64 46.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.0 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.701 ' HE2' ' HZ1' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -149.82 144.04 25.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.135 0.493 . . . . 1.0 111.016 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -152.84 150.99 29.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.685 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.85 69.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.467 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 120.398 -0.521 . . . . 1.0 112.34 179.404 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.662 ' HH ' ' H ' ' A' ' 151' ' ' SER . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.803 0.335 . . . . 1.0 110.788 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.2 m -95.78 140.01 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.47 -35.23 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.595 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.25 -52.06 67.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.0 111.428 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -68.14 -33.73 75.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.937 0.399 . . . . 1.0 110.667 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.16 -50.77 68.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.516 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.535 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 61.3 tp60 -59.11 -54.48 46.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.424 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.36 -46.93 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.31 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.89 -37.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.535 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 42.8 tt0 -48.0 -38.78 17.84 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.79 -41.95 67.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.34 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 184' ' ' VAL . 11.5 tp -54.84 -32.8 60.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.666 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.0 -39.3 61.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.685 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.84 -37.92 71.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.754 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -54.66 -52.9 60.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.54 -44.82 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.906 . . . . 1.0 109.91 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 m -51.87 -38.52 56.36 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 76.7 mt -77.76 -32.18 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.061 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.82 67.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.41 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.7 pp -67.37 -24.09 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.444 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -76.16 -56.06 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.868 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -57.45 -26.37 61.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.917 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.93 -34.93 57.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -58.52 -39.3 79.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.91 -59.23 3.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.123 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.6 p -58.25 -43.61 87.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 1.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.42 179.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.1 tp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.883 0.373 . . . . 1.0 110.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 42.9 p-10 -55.62 -38.36 69.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.246 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.4 mt-30 -72.32 -51.33 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.6 mp -57.4 -45.54 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.445 ' O ' ' OG1' ' A' ' 38' ' ' THR . 66.6 mt -69.73 -27.19 64.76 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.558 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -55.08 -38.02 67.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.023 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.81 -31.89 57.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.374 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 43.7 p -68.26 -45.78 72.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.481 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.07 -38.98 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -77.75 -37.73 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -59.8 -53.68 55.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 13.3 p -60.15 -44.61 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.867 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.4 ttp180 -49.87 -44.91 50.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.847 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.87 74.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.772 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -81.33 -50.45 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.96 -6.7 55.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.976 0.417 . . . . 1.0 110.123 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.35 18.85 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.703 -0.68 . . . . 1.0 112.478 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.41 141.05 43.29 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.028 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 70' ' ' GLY . 96.0 m-20 -66.74 -23.9 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.539 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 43.2 ttt85 -152.76 121.41 6.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 119.186 -1.006 . . . . 1.0 113.551 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.17 135.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -146.52 162.55 38.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.427 -0.509 . . . . 1.0 111.549 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.33 135.77 31.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.024 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 165' ' ' LEU . 62.1 t80 -118.36 118.53 32.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -99.83 168.31 9.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 67.6 t80 -134.97 138.93 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.071 0.462 . . . . 1.0 112.133 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.8 m-20 -103.06 147.87 34.77 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.378 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.51 -19.9 65.45 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.69 2.26 . . . . 1.0 112.948 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -82.3 -1.73 50.47 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.41 -11.37 54.42 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.824 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -89.3 144.82 25.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.361 0.58 . . . . 1.0 110.961 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.23 144.01 15.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.7 p -128.47 146.98 50.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.23 0.538 . . . . 1.0 112.3 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.89 118.65 52.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.15 6.61 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.68 23.12 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 37.1 tt0 -166.44 128.68 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.369 -0.933 . . . . 1.0 113.13 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.89 138.22 46.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 44.0 ptt85 -131.19 141.28 50.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.498 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.33 109.05 3.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 49.32 -85.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.6 pt-20 178.2 31.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.135 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -68.71 -25.62 64.86 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 mt -122.85 148.47 53.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 11.8 Cg_exo -74.03 164.55 34.16 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.016 1.81 . . . . 1.0 112.428 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -85.99 134.21 33.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' H ' HH22 ' A' ' 50' ' ' ARG . 91.6 mt -109.53 -3.02 17.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.641 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.21 139.01 57.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.603 . . . . 1.0 112.191 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.28 -3.24 84.03 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.351 -0.84 . . . . 1.0 111.015 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 tp -101.2 128.43 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 1.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -85.88 125.19 33.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.444 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -103.15 128.63 27.21 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.36 161.15 25.78 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.126 1.884 . . . . 1.0 111.666 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.12 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.776 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.53 -29.3 0.71 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.141 -0.784 . . . . 1.0 111.141 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.99 -28.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.798 0.332 . . . . 1.0 110.62 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.8 mt -137.93 99.54 9.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.258 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' ILE . 42.4 Cg_exo -40.63 -103.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.534 2.156 . . . . 1.0 112.325 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.431 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 92.7 mt-10 -135.65 -71.34 0.47 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.797 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -42.67 -38.77 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.775 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.45 -53.14 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.97 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -57.2 -31.8 65.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.542 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 97' ' ' LEU . 77.3 mtt85 -60.47 -47.29 86.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.565 -0.289 . . . . 1.0 111.213 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.0 mt -50.23 -43.89 53.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.52 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 68.1 m-85 -59.29 -33.23 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -92.34 -21.0 20.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.061 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tp -106.63 -50.45 3.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.82 -5.81 12.07 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 101' ' ' ARG . 95.1 mt-30 53.13 71.96 0.46 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.539 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 1.9 p -63.28 59.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.825 ' N ' ' O ' ' A' ' 99' ' ' GLN . 40.6 ptt85 -56.41 -1.62 0.06 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.07 -1.423 . . . . 1.0 114.31 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 100' ' ' VAL . 14.9 p -152.68 131.81 3.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.458 -0.497 . . . . 1.0 111.732 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mt -112.11 131.02 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 25.1 t -83.22 168.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.512 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 1.3 m-20 -55.15 119.07 4.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.758 -1.11 . . . . 1.0 112.267 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.02 -11.62 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.718 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 2.1 pp20? -84.87 -39.87 17.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.902 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.68 -12.91 4.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 1.0 110.075 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 49.9 59.08 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.433 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -93.41 136.26 33.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.361 -2.088 . . . . 1.0 105.361 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -125.57 136.72 53.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 93.6 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.358 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.693 0.282 . . . . 1.0 110.24 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.24 154.29 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.598 2.199 . . . . 1.0 111.817 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 16.0 m -98.85 148.05 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.117 0.485 . . . . 1.0 111.294 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.6 OUTLIER -92.28 143.58 27.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.439 -0.8 . . . . 1.0 110.898 -178.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -38.67 -22.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.236 1.958 . . . . 1.0 111.227 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -74.9 -46.72 34.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.604 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 45.6 t-80 -78.39 -29.22 47.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.734 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.15 -55.01 16.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.321 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.448 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 86.7 t60 -63.79 -46.61 84.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.273 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -44.14 -48.61 9.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.488 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.71 -46.53 58.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.43 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 147' ' ' GLY . 18.1 tptm -59.3 -40.08 85.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.49 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.448 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 17.9 m -54.27 -32.91 57.38 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.9 mtt -84.26 -2.2 56.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.208 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.87 22.51 75.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.287 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.65 123.59 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -35.39 30.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.4 p -130.88 168.53 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.534 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 p -161.44 139.69 9.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.038 0.447 . . . . 1.0 112.16 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.0 tp -116.84 136.49 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.433 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 2.2 m -131.6 158.72 43.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.651 . . . . 1.0 111.821 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 55.3 t -159.01 90.81 2.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.327 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.52 114.61 1.65 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.559 2.839 . . . . 1.0 113.936 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.4 mt -71.86 105.37 3.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.8 ptm -135.1 147.04 49.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 1.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.457 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 30.3 t-80 -118.22 115.12 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 77.9 t60 59.9 -123.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.598 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 30.7 tt0 -93.04 8.44 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -114.94 143.87 44.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.4 115.55 30.4 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.489 -1.232 . . . . 1.0 108.853 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -100.63 -27.93 13.13 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.725 -0.39 . . . . 1.0 111.852 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.1 -171.73 24.38 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.283 -0.96 . . . . 1.0 112.031 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -139.99 131.26 26.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.803 0.335 . . . . 1.0 111.193 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -96.75 136.86 36.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -149.61 129.98 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.574 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -116.43 146.83 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.017 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -145.09 142.75 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 1.0 111.029 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 11.7 t60 -150.86 151.42 32.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 1.0 109.752 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.433 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.76 69.73 9.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.471 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 N--CA 1.466 0.334 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.3 179.305 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 1.0 110.819 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.0 m -67.37 133.54 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.307 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.42 -35.61 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.616 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.74 -54.82 40.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.63 -0.259 . . . . 1.0 111.333 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.63 -32.13 73.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 1.0 110.682 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 tp -62.24 -41.27 98.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.481 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.32 -56.3 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.543 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -45.0 -45.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.574 -0.451 . . . . 1.0 110.27 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -75.44 -36.72 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -47.68 -36.79 11.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.02 -40.38 68.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.386 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.5 tp -55.61 -31.76 62.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.692 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.95 -39.34 56.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.641 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.468 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.4 m-20 -57.12 -39.03 74.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.732 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -53.21 -52.64 58.24 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.2 -40.55 65.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.82 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 5.5 p -51.54 -33.61 32.86 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.02 -36.62 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.062 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -46.45 65.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.114 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.8 tp -61.57 -36.14 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.164 0.507 . . . . 1.0 109.666 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.84 -53.46 9.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.93 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.56 -28.84 57.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.73 -33.93 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.216 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.38 -41.14 84.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.2 -58.59 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.5 p -57.75 -43.97 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 1.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.457 179.739 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.853 0.359 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 25.2 p-10 -63.09 -51.02 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.261 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 98.8 mt-30 -61.32 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mm -57.8 -37.94 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.591 0.589 . . . . 1.0 112.591 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.34 -23.32 61.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -64.97 -42.32 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.011 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.12 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.374 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -69.41 -46.66 66.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -55.2 -37.16 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.835 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.35 -38.7 85.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.777 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -62.22 -41.77 98.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.973 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.0 -40.97 84.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.879 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.2 tmm_? -57.95 -50.16 74.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.871 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.76 86.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.9 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -77.48 -52.88 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.824 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.67 -3.64 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 1.0 110.14 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.24 17.11 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.487 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -77.89 147.56 35.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.058 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 70' ' ' GLY . 33.2 p-10 -69.02 -11.6 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 1.0 112.895 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.603 ' NH2' ' CD2' ' A' ' 169' ' ' HIS . 30.7 ttp180 -163.73 122.0 1.91 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 119.115 -1.034 . . . . 1.0 113.487 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.96 133.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -145.36 159.65 42.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.556 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.65 135.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.015 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.5 t80 -118.32 118.28 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.054 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -99.24 166.97 10.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -132.22 134.05 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.569 -0.452 . . . . 1.0 112.15 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.48 129.56 25.79 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.727 -0.669 . . . . 1.0 109.283 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.86 -26.91 2.19 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.675 2.25 . . . . 1.0 112.976 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.21 -7.83 55.72 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.996 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.52 -11.61 42.85 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.048 -0.596 . . . . 1.0 112.832 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -88.46 142.75 27.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.363 0.582 . . . . 1.0 110.941 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -122.37 141.57 14.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 78.7 p -127.21 146.56 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.267 0.556 . . . . 1.0 112.374 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.75 118.82 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.03 -1.59 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.37 150.5 21.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -168.65 131.31 1.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.35 -0.94 . . . . 1.0 113.125 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.46 144.92 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -133.25 144.52 49.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.574 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.04 113.17 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.59 19.07 0.13 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 70' ' ' GLY . 38.6 tt0 68.72 28.9 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.194 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -58.2 -55.52 33.96 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt -95.43 149.87 36.74 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.31 170.01 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.066 1.844 . . . . 1.0 112.506 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -89.92 127.71 36.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.143 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 mt -98.88 -1.31 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.655 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.39 135.3 57.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.359 0.599 . . . . 1.0 112.179 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.61 -8.11 74.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 8.1 mp -98.11 131.79 44.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.399 . . . . 1.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.0 m -90.56 120.83 31.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.383 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 62' ' ' GLY . 8.7 m-85 -106.39 135.69 19.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.34 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.53 154.24 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.192 1.928 . . . . 1.0 111.672 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -69.44 -24.44 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.796 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.58 -20.09 0.19 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ALA . 88.8 m-20 -58.46 -30.76 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 1.0 110.659 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.0 mt -111.91 132.73 21.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.75 -111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.536 2.157 . . . . 1.0 112.27 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 13.2 tm-20 -150.99 -66.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.804 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 21.1 pt-20 -44.56 -43.7 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.743 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.38 98.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.916 0.389 . . . . 1.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.34 -28.01 69.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.578 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.9 mtp85 -56.95 -49.85 74.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.272 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.03 -38.1 62.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.581 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 m-85 -64.24 -29.85 70.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -90.31 -13.66 34.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.128 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.16 -43.78 4.31 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.57 -3.73 13.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.541 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.8 mt-30 27.24 70.69 0.05 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.112 1.153 . . . . 1.0 114.112 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.502 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 11.2 p -112.64 -48.36 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.43 -2.434 . . . . 1.0 104.43 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.617 ' NH1' ' NE2' ' A' ' 185' ' ' GLN . 12.1 mtm180 63.42 74.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.077 -1.42 . . . . 1.0 114.24 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.54 135.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.761 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 mt -107.86 125.9 64.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 7.5 p -82.79 166.28 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.436 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 23.7 t0 -54.33 120.25 6.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.713 -1.131 . . . . 1.0 112.336 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.7 m -56.72 -9.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 108' ' ' ALA . 1.1 pp20? -87.27 -35.83 18.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.831 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 107' ' ' GLU . . . -61.32 -16.83 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.363 0.601 . . . . 1.0 110.076 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 51.38 53.05 13.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.086 -0.961 . . . . 1.0 113.45 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.03 135.6 34.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.385 -2.08 . . . . 1.0 105.385 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -129.46 142.8 50.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 81.9 p . . . . . 0 N--CA 1.453 -0.3 0 CA-C-N 114.11 -1.405 . . . . 1.0 107.322 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 110.309 -0.256 . . . . 1.0 110.309 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.91 142.65 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.515 2.143 . . . . 1.0 111.896 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.7 t -133.35 140.1 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 1.0 111.355 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.552 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -39.76 156.17 0.16 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.883 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.21 -7.33 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.196 1.93 . . . . 1.0 111.308 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 m -56.45 -51.47 68.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.43 ' CE1' HG21 ' A' ' 140' ' ' VAL . 5.1 p-80 -71.7 -25.74 62.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.591 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.43 HG21 ' CE1' ' A' ' 139' ' ' HIS . 27.9 t -56.91 -64.13 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.364 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.645 ' CE1' ' HG ' ' A' ' 145' ' ' SER . 31.7 t-80 -69.25 -50.69 44.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.202 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.446 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' CD2' ' NE2' ' A' ' 169' ' ' HIS . 85.1 mt -73.56 -45.32 54.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.508 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 41.9 tptt -60.18 -41.7 93.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.645 ' HG ' ' CE1' ' A' ' 141' ' ' HIS . 15.2 m -53.42 -31.11 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.5 mtt -89.82 -2.04 58.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.199 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.11 26.16 71.53 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.251 -0.886 . . . . 1.0 112.348 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.37 120.7 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.971 0.386 . . . . 1.0 109.962 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.14 -34.47 32.46 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -134.92 170.06 16.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.595 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.637 ' HG ' ' CE1' ' A' ' 169' ' ' HIS . 39.1 m -163.68 139.82 6.7 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.037 0.446 . . . . 1.0 112.124 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.541 ' H ' ' HG ' ' A' ' 168' ' ' SER . 21.9 tp -114.03 139.26 49.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.46 156.78 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.437 0.637 . . . . 1.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.4 t -156.84 91.6 2.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.818 -1.083 . . . . 1.0 109.262 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.45 130.58 39.3 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 123.694 2.929 . . . . 1.0 113.893 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.89 104.83 16.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.795 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.8 mtp -119.2 144.63 46.61 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.871 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.407 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 86.1 t60 -124.73 113.3 17.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.951 -1.129 . . . . 1.0 107.951 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 53.3 t60 65.17 -127.17 0.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.524 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.8 mm100 -95.15 12.21 29.55 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -120.72 157.47 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.95 115.53 29.64 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 114.493 -1.231 . . . . 1.0 108.848 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.407 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.5 m95 -93.44 -25.78 17.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.958 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.58 -167.94 22.75 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.152 -1.023 . . . . 1.0 111.941 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.6 tp -144.21 129.78 19.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.767 0.317 . . . . 1.0 111.231 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.56 138.31 31.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.33 133.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.597 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.601 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 25.1 p -114.47 142.91 45.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.029 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.637 ' CE1' ' HG ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -133.92 139.51 46.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 1.0 111.08 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.446 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.7 p-80 -156.09 155.07 31.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.747 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.24 69.51 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.469 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.349 179.635 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.446 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 5.9 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.784 0.326 . . . . 1.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -99.21 150.88 21.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.81 -38.76 89.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.654 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 47.6 mp0 -65.59 -55.34 18.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.289 . . . . 1.0 111.333 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.53 -34.23 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.942 0.401 . . . . 1.0 110.717 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.89 -39.48 94.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.467 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -58.73 -53.66 55.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.415 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -46.4 -45.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 187' ' ' LEU . 40.0 t -74.75 -37.96 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.617 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 49.4 tp60 -47.84 -35.33 10.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.44 -40.08 64.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.734 -1.121 . . . . 1.0 109.367 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 184' ' ' VAL . 42.5 tp -55.07 -31.79 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.715 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.51 -38.07 62.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.64 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -55.54 -39.53 70.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.73 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -52.09 -52.39 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.07 -41.17 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.9 m -52.45 -36.17 54.1 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.62 -41.54 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.082 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.23 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.099 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.49 -35.85 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.07 -53.91 11.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.904 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -55.66 -26.43 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.921 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -34.92 58.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.286 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.73 -38.98 76.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 8.6 mp -66.99 -58.44 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.131 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.5 t -50.54 -40.85 52.92 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.312 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.369 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.923 0.392 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.18 -41.11 94.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.252 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -71.1 -54.13 12.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.33 -32.44 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -75.53 -25.12 56.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.729 -0.389 . . . . 1.0 111.555 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' O ' HG13 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.34 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.616 -0.434 . . . . 1.0 109.974 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.24 -30.12 43.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.407 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.5 p -74.77 -49.02 22.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.553 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 36' ' ' ARG . 5.2 p -53.43 -33.9 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.833 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -72.94 -35.52 67.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.38 -43.18 91.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.972 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.21 -51.74 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.89 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.2 ttp180 -49.95 -43.84 50.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.868 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.41 75.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -80.73 -50.73 9.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.32 -6.84 54.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.0 110.072 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.51 18.94 1.06 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.682 -0.69 . . . . 1.0 112.445 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 1.2 m -75.87 142.29 42.18 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' GLY . 90.5 m-20 -58.32 -32.88 68.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -152.45 120.8 6.33 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.595 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.89 135.53 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -144.77 161.0 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.551 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.33 137.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.011 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.7 t80 -122.27 118.48 28.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.014 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -99.57 170.59 8.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 27.8 t80 -134.57 136.74 43.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.039 0.447 . . . . 1.0 112.166 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 m-20 -102.17 148.53 35.53 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.299 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.61 -22.96 70.35 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.681 2.254 . . . . 1.0 112.971 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -79.39 -2.07 40.06 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.029 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.18 -10.5 56.77 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.894 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 148.03 22.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.344 0.572 . . . . 1.0 110.95 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.87 149.7 18.53 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.424 -1.07 . . . . 1.0 110.424 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 1.0 112.347 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.67 116.67 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -112.36 5.23 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.07 145.89 23.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 83.0 tt0 -166.2 126.97 1.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.378 -0.929 . . . . 1.0 113.216 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.06 138.07 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.558 HH11 ' HG ' ' A' ' 76' ' ' SER . 36.9 ptt180 -129.61 142.43 50.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.544 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.49 106.23 2.99 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.84 -87.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLY . 19.5 pt-20 -179.27 31.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.115 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 49' ' ' ASP . 7.1 ttp180 -70.11 -51.2 33.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.52 124.63 47.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.33 169.44 3.93 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.133 1.889 . . . . 1.0 112.49 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.558 ' HG ' HH11 ' A' ' 69' ' ' ARG . 31.3 m -91.87 141.47 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.151 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.551 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 33.3 mt -113.28 -2.14 14.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.623 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.0 tp -56.83 138.17 53.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.329 0.585 . . . . 1.0 112.279 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -4.04 84.49 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.425 -0.807 . . . . 1.0 111.088 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 3.6 tt -100.47 117.72 35.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 1.0 110.82 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 p -76.88 123.55 26.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -107.17 135.07 19.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.288 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.92 150.97 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.128 1.885 . . . . 1.0 111.649 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.55 -25.78 66.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.849 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.45 -21.2 0.25 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 m-20 -54.84 -32.65 60.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 1.0 110.592 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CD1' HH21 ' A' ' 92' ' ' ARG . 3.5 pt -121.0 99.49 46.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.244 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 87' ' ' ILE . 51.2 Cg_exo -42.11 -107.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.5 2.134 . . . . 1.0 112.317 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 19.7 pt-20 -152.4 -46.14 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 1.0 111.83 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 24.4 pt-20 -60.66 -39.09 87.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.71 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.9 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.528 HH21 ' CD1' ' A' ' 87' ' ' ILE . 29.4 ttm105 -66.34 -29.88 70.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.556 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -55.92 -55.29 34.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.318 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -53.04 -43.42 66.59 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.543 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.35 -32.64 70.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.566 ' NH2' ' SD ' ' A' ' 157' ' ' MET . 9.6 mmp_? -87.34 -11.03 50.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.136 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 tp -106.85 -44.96 4.3 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.31 0.856 . . . . 1.0 113.31 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.57 -1.96 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.565 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 97.6 mt-30 26.15 69.03 0.05 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.093 1.146 . . . . 1.0 114.093 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.622 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 31.4 m -113.04 -50.96 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.405 -2.443 . . . . 1.0 104.405 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.622 ' HE ' ' N ' ' A' ' 100' ' ' VAL . 3.5 mtm180 63.66 72.38 0.47 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.052 -1.431 . . . . 1.0 114.256 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 p -148.87 133.0 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.477 -0.489 . . . . 1.0 111.735 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.46 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 2.4 mt -109.2 124.67 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 108.331 -0.989 . . . . 1.0 108.331 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 11.6 p -83.16 167.71 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.274 0.842 . . . . 1.0 113.274 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 9.5 m-20 -55.54 119.18 5.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.711 -1.131 . . . . 1.0 112.268 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.67 -10.34 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.754 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 105' ' ' ASP . 18.5 pt-20 -88.46 -36.93 16.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.906 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -16.79 37.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.416 0.626 . . . . 1.0 110.145 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.444 HE21 ' HE ' ' A' ' 111' ' ' ARG . 44.8 tp60 51.8 58.35 5.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.982 -1.008 . . . . 1.0 113.455 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -94.1 137.82 32.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.444 ' HE ' HE21 ' A' ' 109' ' ' GLN . 98.3 mtt180 -127.82 133.21 49.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 23.6 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-N 114.195 -1.366 . . . . 1.0 107.382 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 10.7 tpp180 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.708 0.29 . . . . 1.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 56.8 Cg_exo -52.33 147.6 28.24 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.512 2.142 . . . . 1.0 111.791 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.435 ' HB ' ' ND1' ' A' ' 139' ' ' HIS . 6.9 m -97.75 153.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.042 0.449 . . . . 1.0 111.373 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -89.09 155.81 49.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.891 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.23 -20.42 24.75 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.267 1.978 . . . . 1.0 111.164 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.0 t -69.89 -51.97 28.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.729 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -73.38 -27.28 61.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.634 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 25.4 t -52.9 -53.13 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.322 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.544 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 72.1 t60 -66.05 -44.09 85.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -42.02 -48.56 4.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.467 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.462 ' CD2' ' HE2' ' A' ' 169' ' ' HIS . 53.2 mt -74.19 -43.74 56.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.502 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' GLY . 40.1 tptt -61.02 -42.55 98.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.544 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 16.2 m -54.26 -32.29 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 42.9 mtt -88.18 -0.98 57.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.217 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.14 24.93 76.26 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.197 -0.911 . . . . 1.0 112.31 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.84 120.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.47 -30.88 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.54 ' OG ' ' CD2' ' A' ' 170' ' ' HIS . 98.7 p -139.46 171.76 13.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.137 -0.625 . . . . 1.0 111.563 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.46 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 8.3 p -161.93 140.44 9.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.211 -0.45 . . . . 1.0 112.171 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.4 139.42 50.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -133.22 154.41 39.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.479 0.657 . . . . 1.0 111.821 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 54.8 t -158.19 91.29 2.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.72 134.7 54.82 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.521 2.814 . . . . 1.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.9 mt -94.76 107.89 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.772 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.566 ' SD ' ' NH2' ' A' ' 96' ' ' ARG . 15.8 ptm -128.7 146.89 50.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.906 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.44 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 65.7 t60 -117.79 115.41 24.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 60.5 t60 61.52 -124.61 0.83 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.789 -0.449 . . . . 1.0 109.789 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 36.5 mt-30 -93.24 5.01 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.43 150.74 32.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.85 116.35 31.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.831 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -93.85 -24.87 17.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.898 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.79 -165.32 21.88 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.979 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.6 tp -143.55 133.31 23.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 1.0 111.179 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.5 tp -95.11 140.66 29.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.02 135.23 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.608 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.6 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 0.9 OUTLIER -120.02 139.95 51.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.049 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.6 ' ND1' ' O ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -136.51 142.15 43.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 1.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.54 ' CD2' ' OG ' ' A' ' 150' ' ' SER . 4.2 p-80 -156.48 153.75 29.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.712 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.69 72.2 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.418 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' OG ' ' A' ' 150' ' ' SER . 54.6 tt0 . . . . . 0 N--CA 1.465 0.291 0 C-N-CA 120.396 -0.522 . . . . 1.0 112.359 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 9.4 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.719 0.295 . . . . 1.0 110.847 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.3 p -100.19 146.59 26.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.75 -35.67 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -65.67 -55.59 16.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.302 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.43 -34.95 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 1.0 110.683 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.25 -34.66 74.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.49 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -66.88 -51.8 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.36 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.4 t -45.2 -48.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.317 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.1 p -74.59 -37.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -48.06 -37.15 14.42 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.54 -40.22 70.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 184' ' ' VAL . 34.5 tp -55.2 -30.97 61.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.738 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.74 -39.01 64.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.618 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.59 -40.23 71.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.76 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -51.05 -52.94 38.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.05 -41.14 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.839 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -36.17 57.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.15 -37.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.001 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.24 68.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.068 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.6 tp -62.42 -33.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -73.74 -53.75 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.895 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -55.73 -27.65 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.95 -34.5 57.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.291 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -58.35 -40.27 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.117 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.36 -58.55 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.46 -0.337 . . . . 1.0 111.084 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.0 p -46.22 -38.35 8.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 1.0 110.355 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.429 179.832 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.904 0.383 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -69.8 -52.42 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.275 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.6 -50.04 74.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 tp -60.76 -32.35 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 38' ' ' THR . 83.5 mt -76.5 -25.77 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.535 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.89 -42.22 94.98 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.003 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.88 -26.62 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.364 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.3 p -73.66 -45.4 52.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.534 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.05 -37.7 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.873 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.39 -34.8 70.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.9 -43.36 96.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.99 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.58 -45.87 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.916 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.9 ttp180 -52.89 -47.46 67.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.884 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.808 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.65 -51.63 9.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.24 -6.08 49.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 1.0 110.111 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 16.83 0.37 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.459 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.422 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.2 m -76.48 144.86 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.036 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -61.75 -29.3 70.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.947 0.721 . . . . 1.0 112.947 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 18.7 ttt85 -149.19 122.0 8.71 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.187 -1.005 . . . . 1.0 113.522 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.71 130.64 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -145.23 156.22 43.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.556 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.8 139.65 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.045 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.6 t80 -124.75 120.34 31.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -100.35 171.43 7.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.896 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 8.8 t80 -133.52 138.17 45.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 1.0 112.142 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.7 m-20 -103.59 147.71 34.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.386 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.71 -26.44 75.3 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.797 2.331 . . . . 1.0 112.906 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -76.32 -5.9 49.16 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.976 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.16 -11.55 51.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.923 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -86.48 142.85 28.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.343 0.572 . . . . 1.0 110.962 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -123.22 143.24 15.0 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -126.59 147.01 49.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.229 0.538 . . . . 1.0 112.282 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.53 115.26 31.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.12 -1.56 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.09 147.25 20.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 40.3 tt0 -164.68 125.51 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.409 -0.917 . . . . 1.0 113.214 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.44 134.75 49.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.507 HH11 ' CB ' ' A' ' 76' ' ' SER . 15.3 mtm180 -121.93 138.93 54.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.531 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.51 107.0 2.97 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.364 -1.094 . . . . 1.0 110.364 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.5 30.12 1.32 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.255 -1.138 . . . . 1.0 110.255 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 58.89 27.18 15.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.119 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -57.63 -58.83 6.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.25 147.61 38.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 52.3 Cg_endo -68.69 160.69 48.46 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.089 1.859 . . . . 1.0 112.552 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.507 ' CB ' HH11 ' A' ' 69' ' ' ARG . 5.4 p -80.84 126.02 30.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.181 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -101.0 -8.62 22.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.59 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 tp -53.61 138.24 35.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 -2.65 79.58 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -99.88 128.33 45.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 1.0 110.77 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.8 122.17 29.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.45 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.42 132.73 20.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.25 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.59 151.95 25.71 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.096 1.864 . . . . 1.0 111.629 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' C ' ' OD1' ' A' ' 86' ' ' ASP . . . -60.12 -25.02 65.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.812 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.84 -24.29 1.25 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 17.9 p-10 -54.68 -26.57 34.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 1.0 110.619 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.9 mt -127.84 132.88 24.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.297 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.87 -104.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.563 2.176 . . . . 1.0 112.277 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -161.28 -43.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 1.0 111.845 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.4 -42.83 88.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.757 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.36 76.31 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.947 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -66.2 -27.5 68.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.546 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' LEU . 30.3 mmt180 -54.54 -58.93 5.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.275 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.6 mt -55.09 -37.66 67.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.549 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.7 m-85 -66.69 -39.13 87.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.549 -0.751 . . . . 1.0 110.137 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ARG . 4.4 tp -107.13 -43.32 4.64 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.99 -3.66 12.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 97.1 mt-30 27.42 70.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.066 1.136 . . . . 1.0 114.066 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.566 ' H ' HH22 ' A' ' 133' ' ' ARG . 14.3 t -110.72 -50.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.699 HH22 ' NE2' ' A' ' 185' ' ' GLN . 12.4 mtm180 64.81 72.75 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.053 -1.431 . . . . 1.0 114.248 172.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.3 t -149.37 131.42 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.67 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.81 126.06 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 41.4 t -81.29 165.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.194 0.813 . . . . 1.0 113.194 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.491 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 22.5 t0 -51.7 120.77 5.56 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.664 -1.153 . . . . 1.0 112.315 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 16.9 t -57.13 -12.7 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.702 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 12.6 pt-20 -80.22 -38.73 30.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.96 -16.54 59.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 1.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 51.19 60.08 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.991 -1.004 . . . . 1.0 113.39 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.6 p -94.56 138.88 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.16 146.49 51.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.48 . . . . 1.0 114.997 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 114.1 -1.409 . . . . 1.0 107.337 176.671 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.566 HH22 ' H ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.767 0.318 . . . . 1.0 110.288 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.96 145.45 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.586 2.191 . . . . 1.0 111.746 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 2.4 m -113.01 122.42 67.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 1.0 111.346 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.496 ' O ' HG11 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -39.34 155.92 0.14 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.883 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.3 Cg_endo -63.0 -13.82 37.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.221 1.947 . . . . 1.0 111.317 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.76 -29.94 58.99 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.417 ' ND1' ' CG2' ' A' ' 135' ' ' VAL . 40.2 t-80 -86.4 -38.05 17.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.351 -0.84 . . . . 1.0 110.679 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 137' ' ' PRO . 4.0 m -52.16 -47.23 44.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.351 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.678 ' CE1' ' HG ' ' A' ' 145' ' ' SER . 32.1 t-80 -65.49 -44.04 88.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.273 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -45.24 -48.75 12.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.96 -48.47 53.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.45 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 16.4 tptp -58.08 -41.71 84.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.484 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.678 ' HG ' ' CE1' ' A' ' 141' ' ' HIS . 32.4 m -54.41 -30.6 52.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.3 mtt -87.28 -1.34 57.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.158 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.38 28.15 71.7 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.292 -0.867 . . . . 1.0 112.337 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -109.93 123.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.77 -32.51 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 8.6 t -137.18 169.54 17.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.551 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -158.6 139.45 12.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.045 0.45 . . . . 1.0 112.162 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.81 136.73 52.72 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.8 159.39 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.458 0.647 . . . . 1.0 111.824 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.0 t -157.04 91.79 2.41 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.869 -1.06 . . . . 1.0 109.346 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.02 126.35 19.91 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.617 2.878 . . . . 1.0 113.904 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.8 mt -81.55 106.17 13.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.839 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.428 ' O ' ' OG ' ' A' ' 192' ' ' SER . 73.8 mtp -123.91 144.9 49.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.793 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.409 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 81.2 t60 -120.89 113.39 20.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 77.7 t60 61.35 -121.11 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 4.7 tt0 -95.94 6.31 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.873 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 161' ' ' GLU . 43.8 mp0 -115.79 154.09 30.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.14 116.57 31.32 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.557 -1.201 . . . . 1.0 108.88 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.409 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.7 m95 -94.93 -25.79 16.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.922 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.84 20.52 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.237 -0.982 . . . . 1.0 111.953 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.8 tp -143.05 130.69 21.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.766 0.317 . . . . 1.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -95.33 132.5 40.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.71 137.47 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.597 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -122.22 144.12 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.094 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -139.68 143.72 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.139 0.495 . . . . 1.0 110.974 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -159.43 155.42 26.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.707 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.55 67.51 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.436 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 N--CA 1.466 0.328 0 C-N-CA 120.429 -0.509 . . . . 1.0 112.314 -179.483 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.408 ' HH ' ' HG ' ' A' ' 150' ' ' SER . 10.3 m-85 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.806 0.336 . . . . 1.0 110.767 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.9 t -92.22 145.69 24.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.288 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -63.61 -43.34 97.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.588 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 46.8 mp0 -60.92 -55.64 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.044 -0.262 . . . . 1.0 111.394 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.66 -29.09 69.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 1.0 110.651 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.93 -35.17 77.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.523 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -69.5 -53.52 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.388 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.1 t -43.47 -47.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.296 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.8 m -74.69 -36.81 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.699 ' NE2' HH22 ' A' ' 101' ' ' ARG . 53.9 tt0 -48.4 -38.18 18.89 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.14 -40.75 71.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.356 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.4 tt -54.81 -31.83 59.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.725 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.93 -33.86 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.605 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -57.68 -40.82 80.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.716 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -51.35 -53.5 35.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.63 -40.83 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.92 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 157' ' ' MET . 5.8 t -52.09 -36.54 51.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.02 -34.84 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.035 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.87 -46.52 62.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.056 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.43 -33.53 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.67 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.911 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 197' ' ' GLN . 9.7 tm0? -55.49 -29.41 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.918 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.55 53.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.287 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.413 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.1 tt0 -57.64 -39.36 76.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.01 -57.98 4.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.125 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -56.41 -44.35 80.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 1.0 110.339 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.413 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 5.2 tp . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.875 0.369 . . . . 1.0 110.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -52.38 -52.69 52.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.307 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -60.15 -48.43 81.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 1.0 112.254 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.68 -40.47 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.592 0.59 . . . . 1.0 112.592 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 mt -69.89 -22.52 63.22 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.531 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 39' ' ' VAL . 93.4 mtt-85 -65.3 -35.29 80.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.706 -0.397 . . . . 1.0 109.975 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.98 -28.66 39.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.343 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -74.17 -48.96 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.56 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 4.0 p -53.47 -36.28 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.3 mt-10 -75.51 -32.83 60.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -66.64 -51.45 56.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.04 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.8 p -64.96 -48.24 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.811 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.497 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 tmt_? -51.65 -44.13 62.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.886 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.15 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.867 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -79.76 -48.91 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.45 -5.64 48.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.101 0.477 . . . . 1.0 110.198 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.65 17.39 0.26 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.433 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 1.2 m -75.63 144.78 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.1 m-20 -55.86 -34.6 65.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.553 HH22 ' C ' ' A' ' 74' ' ' LEU . 35.0 ttm180 -149.53 126.14 10.99 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.184 -1.006 . . . . 1.0 113.521 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 t -135.93 130.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.032 -1.099 . . . . 1.0 108.032 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -144.34 157.54 44.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.519 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -99.35 138.68 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.03 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -122.57 120.73 34.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -99.72 169.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -133.6 134.71 43.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.031 0.444 . . . . 1.0 112.165 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.54 129.1 26.66 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.343 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -25.77 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.739 2.293 . . . . 1.0 112.888 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.6 -6.15 52.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.015 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.45 -11.5 43.08 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.051 -0.595 . . . . 1.0 112.92 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -88.71 142.76 27.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.361 0.581 . . . . 1.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -123.13 142.63 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.43 -1.068 . . . . 1.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.7 p -128.05 146.01 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.217 0.532 . . . . 1.0 112.269 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.96 111.3 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.66 8.0 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.19 147.13 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 72.5 tt0 -167.34 128.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.352 -0.939 . . . . 1.0 113.184 -177.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.18 131.17 54.93 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -117.4 136.65 53.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.55 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.04 88.84 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.39 -87.88 0.05 OUTLIER Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.266 -1.133 . . . . 1.0 110.266 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -175.76 34.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.884 -0.326 . . . . 1.0 111.147 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -70.11 -55.71 8.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.553 ' C ' HH22 ' A' ' 50' ' ' ARG . 12.5 mt -94.97 157.85 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 176.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 3.3 Cg_exo -78.51 165.32 25.29 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.154 1.903 . . . . 1.0 112.476 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 p -87.01 127.98 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.177 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.13 1.06 38.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.549 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -65.25 138.65 58.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.346 0.593 . . . . 1.0 112.264 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.6 -2.85 77.92 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.111 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 8.5 mp -100.76 128.96 46.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.866 0.365 . . . . 1.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.23 121.81 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.411 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 62' ' ' GLY . 7.5 m-85 -107.68 136.77 19.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.39 157.79 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.166 1.91 . . . . 1.0 111.664 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -66.18 -25.59 67.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.78 -19.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 84' ' ' ALA . 85.3 m-20 -54.87 -34.16 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.359 . . . . 1.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 87' ' ' ILE . 21.7 mm -109.12 133.71 20.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.258 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 58.7 Cg_endo -80.89 -120.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.491 2.127 . . . . 1.0 112.335 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.5 mm-40 -138.87 -56.58 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.759 -0.376 . . . . 1.0 111.849 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -59.46 -39.57 84.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.733 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.62 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.963 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -63.22 -30.32 71.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.508 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -58.21 -50.48 73.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.0 111.26 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.6 mt -55.13 -36.25 65.56 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.604 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.24 -32.05 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 96' ' ' ARG . 9.2 mmm180 -83.62 -15.12 50.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.157 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.84 -42.72 4.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.74 -4.97 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 26.27 69.96 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.429 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 1.7 m -110.63 -49.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.527 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 9.3 mtm180 63.09 68.86 0.6 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.066 -1.425 . . . . 1.0 114.335 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -148.77 133.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.849 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 3.4 mt -106.12 124.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 9.0 p -82.57 167.59 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.459 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 3.0 m-20 -51.61 115.06 1.44 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.327 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.81 -11.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.722 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 105' ' ' ASP . 3.2 pt-20 -88.45 -33.57 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.845 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.08 -16.97 36.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.438 0.637 . . . . 1.0 110.143 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 53.28 59.97 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.969 -1.014 . . . . 1.0 113.435 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -92.37 134.34 35.01 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -124.86 138.23 54.26 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.481 . . . . 1.0 114.997 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 114.209 -1.36 . . . . 1.0 107.342 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.424 ' CG ' HH11 ' A' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.7 0.286 . . . . 1.0 110.299 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.13 149.75 17.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.573 2.182 . . . . 1.0 111.783 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' A' ' 139' ' ' HIS . 5.7 m -101.42 153.53 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 1.0 111.375 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 12.2 m-20 -88.98 146.2 36.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.903 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -42.62 -23.76 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.278 1.985 . . . . 1.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.1 p -67.66 -40.36 84.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.619 ' CD2' ' C ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER -78.97 -26.69 43.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.641 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -51.33 -53.16 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 1.0 110.38 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 145' ' ' SER . 51.1 t-80 -68.25 -43.35 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.261 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -47.1 -57.19 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.455 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -50.0 55.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.7 tptm -56.33 -39.53 72.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.407 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' HIS . 29.4 t -54.47 -32.48 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.4 mtt -83.45 -2.04 54.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.196 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.67 24.22 74.01 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.34 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.27 124.55 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.2 -31.98 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.743 0.645 . . . . 1.0 112.743 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -135.13 169.73 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 1.0 111.565 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 5.0 p -161.56 139.48 9.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.163 0.431 . . . . 1.0 112.163 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.1 tp -114.83 139.25 49.9 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 3.1 m -135.68 156.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.423 0.63 . . . . 1.0 111.845 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 71.5 t -157.8 93.13 2.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.851 -1.068 . . . . 1.0 109.341 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.32 115.84 2.66 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.581 2.854 . . . . 1.0 113.973 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.08 105.07 4.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.794 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 75.5 mtp -121.78 146.14 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.168 0.508 . . . . 1.0 111.846 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 25.6 t-80 -123.18 112.88 18.22 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.47 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.9 t-80 64.89 -125.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.47 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.7 mt-30 -95.19 8.56 42.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.868 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.8 mp0 -118.42 155.08 31.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.897 1.073 . . . . 1.0 113.897 -177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.09 118.0 35.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.504 -1.225 . . . . 1.0 108.885 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CD2' ' OE2' ' A' ' 199' ' ' GLU . 77.9 m95 -97.51 -27.73 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.736 -0.386 . . . . 1.0 111.981 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.06 -173.45 25.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.189 -1.005 . . . . 1.0 111.965 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.0 tp -139.15 131.33 28.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.849 0.357 . . . . 1.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.94 137.86 34.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.9 p -150.91 132.76 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.572 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 p -116.02 145.55 42.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.0 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -132.54 140.31 48.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 1.0 110.975 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -147.44 142.75 27.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.757 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.79 67.42 9.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.441 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 120.43 -0.508 . . . . 1.0 112.349 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.826 0.346 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -101.45 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.314 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -68.96 -34.98 76.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.683 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.91 -55.92 16.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.401 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 38.9 mp0 -67.75 -34.1 76.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.0 110.734 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.8 tp -62.28 -31.43 72.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.484 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.93 -52.73 22.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.458 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.0 t -44.86 -45.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.282 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.3 p -75.06 -37.32 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -47.58 -38.1 13.75 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.34 -40.15 74.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.727 -1.124 . . . . 1.0 109.437 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.9 tt -54.34 -30.91 53.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.64 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.02 67.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.637 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.457 ' O ' ' OG ' ' A' ' 192' ' ' SER . 45.3 t0 -55.31 -39.57 70.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.717 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -53.75 -53.9 45.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 82.2 t -58.42 -42.28 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.861 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 7.5 p -51.35 -36.62 43.8 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -77.68 -34.97 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.031 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.5 -46.36 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.047 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -64.08 -33.15 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.19 -55.83 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.875 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.28 -25.72 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.21 59.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.263 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.545 ' OE2' ' CD2' ' A' ' 163' ' ' TRP . 92.0 mt-10 -58.65 -39.96 82.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.198 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.38 -60.06 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.101 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 92.8 p -54.22 -40.72 67.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.348 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.042 -0.98 . . . . 1.0 110.442 179.554 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.916 0.389 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -65.21 -40.57 94.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.321 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.72 -53.7 14.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tp -59.23 -34.04 52.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.581 0.585 . . . . 1.0 112.581 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 38' ' ' THR . 96.2 mt -74.59 -25.48 59.29 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.553 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -60.08 -54.11 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.951 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.78 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.32 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 46.2 p -65.71 -46.96 77.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.3 -31.45 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.848 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.36 -36.23 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 1.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -58.9 -43.24 90.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.953 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.0 t -66.33 -38.77 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.876 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.5 ttt180 -57.31 -52.54 64.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.06 87.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.745 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -79.43 -53.98 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.716 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -76.94 -4.76 45.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.0 110.176 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.12 16.74 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.397 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' ND1' ' A' ' 170' ' ' HIS . 14.6 t -77.41 145.9 36.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.106 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 70' ' ' GLY . 49.2 p30 -68.46 -10.5 55.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.946 0.721 . . . . 1.0 112.946 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.678 HH21 ' CD2' ' A' ' 169' ' ' HIS . 46.1 ttp180 -164.39 120.59 1.56 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.137 -1.025 . . . . 1.0 113.579 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.74 132.52 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -145.69 158.82 43.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.56 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.76 137.56 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.994 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -119.8 119.1 32.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.07 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -99.52 166.22 11.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.87 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -131.55 137.05 48.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 1.0 112.159 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.27 126.39 33.51 Favored Pre-proline 0 C--N 1.334 -0.104 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.07 -25.59 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.737 2.291 . . . . 1.0 112.901 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -76.71 -6.28 51.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.977 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.15 38.0 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.997 -0.62 . . . . 1.0 112.831 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -89.58 143.0 27.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.421 0.611 . . . . 1.0 110.919 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.74 140.95 14.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -128.64 146.86 50.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.248 0.547 . . . . 1.0 112.243 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.02 111.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -100.52 6.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.601 0.593 . . . . 1.0 112.601 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.41 146.99 23.02 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 42.5 tt0 -166.92 128.16 1.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.336 -0.946 . . . . 1.0 113.235 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.12 140.73 43.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.533 HH12 ' C ' ' A' ' 75' ' ' PRO . 5.2 ptm85 -131.37 142.67 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.25 110.4 3.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.456 -1.057 . . . . 1.0 110.456 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.54 -87.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.239 -1.145 . . . . 1.0 110.239 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.9 pt-20 -179.99 26.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.152 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.33 -32.24 73.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 69' ' ' ARG . 12.2 mt -118.23 142.74 31.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.533 ' C ' HH12 ' A' ' 69' ' ' ARG . 68.4 Cg_endo -73.85 170.57 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.072 1.848 . . . . 1.0 112.457 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.5 p -93.92 139.35 31.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.176 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -110.34 -3.37 16.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.633 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.17 137.89 55.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.307 0.575 . . . . 1.0 112.282 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.91 82.78 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.49 122.72 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.887 0.375 . . . . 1.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.1 t -79.05 122.43 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.515 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -105.38 131.11 22.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.37 150.07 22.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.185 1.923 . . . . 1.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.69 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.828 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.22 -22.68 0.58 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.51 -31.16 63.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 1.0 110.659 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 88' ' ' PRO . 3.5 pt -118.47 100.42 51.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.316 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.3 Cg_exo -44.29 -110.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.487 2.124 . . . . 1.0 112.347 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -149.53 -58.45 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.751 -0.38 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.56 -40.93 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.77 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.84 90.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.014 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -68.56 -29.7 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.572 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -55.3 -55.63 29.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.226 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.89 -40.16 72.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -57.9 -34.03 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -88.5 -9.8 51.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.103 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tp -107.18 -45.6 4.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.373 0.879 . . . . 1.0 113.373 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.39 -1.75 12.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.2 mt-30 28.44 71.64 0.05 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.116 1.154 . . . . 1.0 114.116 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 102' ' ' VAL . 35.4 m -117.53 -47.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.489 HH21 HG21 ' A' ' 154' ' ' VAL . 2.4 mpp_? 62.52 -26.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.143 -1.389 . . . . 1.0 114.354 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 100' ' ' VAL . 11.8 p -56.14 129.48 17.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.445 -0.502 . . . . 1.0 111.788 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.7 mt -105.37 129.94 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.452 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 9.8 p -81.34 168.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -50.08 120.57 4.55 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.289 -177.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.6 -14.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.741 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.23 -36.56 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.914 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.79 -14.44 8.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.393 0.616 . . . . 1.0 110.101 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 51.5 59.8 4.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 1.0 113.409 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 m -92.09 137.57 32.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -126.63 135.45 51.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 45.6 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-N 114.126 -1.397 . . . . 1.0 107.402 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 mmt-85 . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.691 0.282 . . . . 1.0 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.26 149.45 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.495 2.13 . . . . 1.0 111.864 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.524 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 19.0 m -100.8 148.76 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 1.0 111.416 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -87.73 154.89 53.39 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.909 -178.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -50.38 -21.28 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.268 1.979 . . . . 1.0 111.279 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.63 -39.8 30.68 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.524 ' ND1' ' CG1' ' A' ' 135' ' ' VAL . 51.4 t-80 -81.52 -40.48 23.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.666 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 141' ' ' HIS . 3.1 m -52.07 -43.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.357 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.49 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 79.8 t60 -67.48 -43.99 79.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.256 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -43.3 -46.77 6.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.488 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.74 -43.84 62.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.574 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.1 tmtm? -60.69 -42.67 97.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.441 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 98.5 p -54.46 -31.32 55.4 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.6 mtt -89.47 -2.03 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.199 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.48 23.41 77.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.256 -0.884 . . . . 1.0 112.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 170' ' ' HIS . 11.5 t -104.09 121.14 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.889 -0.411 . . . . 1.0 109.889 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.87 44.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 t -131.45 167.48 19.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.156 -0.618 . . . . 1.0 111.545 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.2 p -162.47 141.92 9.34 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.137 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 38.3 tp -127.72 110.21 12.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.08 157.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.461 0.648 . . . . 1.0 111.849 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.547 ' N ' HG23 ' A' ' 153' ' ' VAL . 84.3 t -153.39 93.95 3.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.311 -176.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.26 120.33 8.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.527 2.818 . . . . 1.0 113.957 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.4 mt -74.79 104.54 5.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.787 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.7 mtp -122.62 146.42 47.46 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.337 -0.545 . . . . 1.0 111.83 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 159' ' ' HIS . 72.0 t60 -126.42 114.17 17.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.019 -1.104 . . . . 1.0 108.019 175.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 158' ' ' HIS . 8.0 m-70 63.29 -125.97 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -95.6 10.73 35.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.876 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 55.3 mt-10 -119.71 153.56 35.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.923 1.082 . . . . 1.0 113.923 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.68 113.91 27.51 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.513 -1.221 . . . . 1.0 108.925 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 89.1 m95 -98.06 -28.64 13.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.916 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.37 -174.38 23.61 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.4 tp -142.46 130.41 21.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 1.0 111.224 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.4 tp -96.25 140.7 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.4 t -146.2 111.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.394 -0.523 . . . . 1.0 111.531 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.5 t -100.17 139.23 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.013 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.698 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -148.79 144.66 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.193 0.521 . . . . 1.0 110.944 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.523 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.8 p-80 -153.97 151.81 29.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.66 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.02 66.68 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.345 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 120.355 -0.538 . . . . 1.0 112.303 179.539 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.523 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 33.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.839 0.352 . . . . 1.0 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.5 t -99.68 146.49 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.272 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.35 -37.69 88.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.655 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.62 -56.16 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.327 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 33.3 mp0 -65.69 -34.09 77.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 1.0 110.639 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.48 -40.01 89.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.463 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.13 -51.0 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.423 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.5 t -46.99 -49.38 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.331 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.2 -37.63 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 43.4 tt0 -45.4 -36.43 4.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.82 -41.7 74.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.383 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 184' ' ' VAL . 5.4 tt -54.73 -33.16 60.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.638 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.16 -40.23 59.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.633 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.5 -38.33 71.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.684 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.94 -53.44 52.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.53 -43.83 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.838 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -51.94 -37.63 53.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.3 mt -78.71 -32.02 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.91 62.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.01 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.49 -26.47 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.06 -55.72 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 1.0 109.925 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 -27.86 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.919 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.64 56.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.301 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.36 -37.41 72.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.13 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.1 mt -68.34 -58.2 4.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.108 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 m -55.15 -42.18 72.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.293 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.402 179.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.918 0.39 . . . . 1.0 110.572 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.66 -50.74 42.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.303 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.16 -44.49 95.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.5 mp -62.59 -36.09 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -77.69 -20.82 53.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.446 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' O ' HG12 ' A' ' 39' ' ' VAL . 77.4 mtp180 -73.05 -33.71 65.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.639 -0.424 . . . . 1.0 109.972 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -33.62 28.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.36 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 2.1 t -70.74 -45.11 65.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.573 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.1 p -56.72 -36.55 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.839 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.1 mt-10 -75.46 -38.05 59.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 1.0 110.81 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.24 -51.12 65.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.966 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.28 -50.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.6 tmm_? -49.68 -41.63 43.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.9 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -35.79 73.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -79.64 -47.37 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 mt -76.53 -6.37 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.027 0.441 . . . . 1.0 110.177 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.62 16.46 0.19 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.462 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 50' ' ' ARG . 1.5 m -74.92 144.82 43.1 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.4 m-20 -62.4 -27.47 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.662 HH22 ' H ' ' A' ' 77' ' ' LEU . 59.9 ttt85 -153.54 121.56 6.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 119.127 -1.029 . . . . 1.0 113.562 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.34 134.43 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -146.01 160.26 42.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.577 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.9 134.97 32.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.004 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.9 t80 -119.15 118.55 31.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.021 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -99.03 165.72 11.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -132.08 136.17 46.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 1.0 112.155 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.69 129.68 24.89 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.714 -0.675 . . . . 1.0 109.341 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.59 -29.31 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.684 2.256 . . . . 1.0 112.933 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -72.72 -17.66 61.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.948 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.89 -15.24 12.49 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.839 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -84.93 141.85 30.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.375 0.588 . . . . 1.0 110.957 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.73 139.69 13.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.3 p -125.3 144.87 50.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.207 0.527 . . . . 1.0 112.312 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.33 116.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 65' ' ' VAL . 10.7 p -110.09 2.75 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.98 145.91 24.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' CD ' HH22 ' A' ' 50' ' ' ARG . 35.0 tt0 -165.78 127.48 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.37 -0.932 . . . . 1.0 113.233 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.06 135.21 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.489 HH22 ' CB ' ' A' ' 72' ' ' GLU . 7.6 ptm180 -125.49 142.15 51.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.533 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.36 104.36 2.71 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.469 -1.052 . . . . 1.0 110.469 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.51 -89.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.489 ' CB ' HH22 ' A' ' 69' ' ' ARG . 22.2 pt-20 -177.31 29.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.153 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -66.61 -54.26 25.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.47 144.68 28.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.804 -1.184 . . . . 1.0 107.804 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.03 166.83 28.97 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.019 1.813 . . . . 1.0 112.58 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 t -92.21 136.7 32.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.096 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.662 ' H ' HH22 ' A' ' 50' ' ' ARG . 59.0 mt -111.24 -3.24 15.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.618 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.6 tp -55.77 139.83 44.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.287 0.565 . . . . 1.0 112.335 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -3.2 84.59 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.6 tp -101.48 128.62 47.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 1.0 110.773 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.16 122.79 29.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.491 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -104.82 132.88 20.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.283 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.74 151.21 28.08 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.134 1.889 . . . . 1.0 111.714 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.4 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.799 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.64 -22.73 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -55.26 -31.08 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.465 HG21 HD12 ' A' ' 87' ' ' ILE . 29.1 mm -111.51 132.88 21.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 60.0 Cg_endo -80.55 -119.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.54 2.16 . . . . 1.0 112.313 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 86.4 tt0 -139.78 -69.0 0.42 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.823 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.62 -40.49 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.804 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.53 62.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -62.29 -31.24 71.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.572 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.4 -48.08 81.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 133' ' ' ARG . 63.9 mt -54.69 -39.1 67.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.824 -0.351 . . . . 1.0 110.529 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -61.1 -32.86 72.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -88.19 -12.59 43.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.109 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 tp -105.54 -46.97 4.04 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.336 0.865 . . . . 1.0 113.336 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.72 -1.15 13.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' ALA . 91.8 mt-30 27.58 65.61 0.09 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.973 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 33.8 m -97.48 -46.37 12.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.374 -2.454 . . . . 1.0 104.374 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.973 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 0.4 OUTLIER 57.83 55.36 5.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.139 -1.392 . . . . 1.0 114.208 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 62.9 t -148.88 133.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.833 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.81 126.22 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.43 168.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' OD2' ' OE2' ' A' ' 107' ' ' GLU . 13.2 t0 -53.28 118.38 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.326 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 24.4 t -55.46 -12.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.76 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 14.0 pt-20 -87.59 -38.36 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.846 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -57.56 -13.62 4.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.513 0.673 . . . . 1.0 110.211 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 50.84 56.31 8.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.958 -1.019 . . . . 1.0 113.399 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 m -94.51 134.15 37.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.34 -2.096 . . . . 1.0 105.34 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -129.44 142.21 50.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 114.963 1.468 . . . . 1.0 114.963 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.66 ' HG ' HH22 ' A' ' 133' ' ' ARG . 1.8 t . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 114.125 -1.398 . . . . 1.0 107.306 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.66 HH22 ' HG ' ' A' ' 112' ' ' SER . 8.3 mmm180 . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 110.306 -0.257 . . . . 1.0 110.306 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.456 ' C ' ' O ' ' A' ' 133' ' ' ARG . 2.8 Cg_exo -30.73 147.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.564 2.176 . . . . 1.0 111.753 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.3 m -94.4 147.8 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 1.0 111.362 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.614 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -91.08 144.07 29.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.873 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.38 -27.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.196 1.93 . . . . 1.0 111.279 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.6 t -71.99 -57.5 4.24 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.437 ' NE2' ' CD1' ' A' ' 143' ' ' LEU . 42.0 t-80 -68.21 -27.83 66.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.688 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.62 -52.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.323 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 76.3 t60 -63.58 -41.28 98.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.256 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -45.43 -51.82 10.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.497 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.437 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 4.5 mp -72.07 -49.13 39.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 2.4 tmtt? -57.32 -42.62 82.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.446 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.9 m -53.65 -32.01 49.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.4 mtt -85.61 -2.48 58.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 1.0 109.188 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.88 24.24 74.29 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.314 -0.857 . . . . 1.0 112.353 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 3.2 m -106.66 123.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.27 -35.18 55.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -132.75 170.71 14.86 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.545 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.613 ' HG ' ' CE1' ' A' ' 169' ' ' HIS . 14.1 t -162.0 139.71 8.72 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.062 0.458 . . . . 1.0 112.158 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.32 138.96 50.4 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 2.8 m -133.61 157.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.496 0.665 . . . . 1.0 111.828 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 73.0 t -157.56 91.57 2.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.268 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.14 115.73 2.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.575 2.85 . . . . 1.0 113.931 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.98 105.7 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.825 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.6 ptm -131.15 147.43 52.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.22 0.533 . . . . 1.0 111.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -122.67 115.66 22.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.491 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 8.9 t60 64.77 -128.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.491 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.5 mm-40 -92.48 9.12 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -117.58 152.19 35.64 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.002 1.112 . . . . 1.0 114.002 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.96 116.92 32.84 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 114.498 -1.228 . . . . 1.0 108.873 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -95.94 -27.81 14.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.902 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.06 -170.42 27.91 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.247 -0.978 . . . . 1.0 112.029 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -141.38 131.91 25.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 1.0 111.19 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -96.02 141.55 29.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.406 HG21 ' HE2' ' A' ' 169' ' ' HIS . 8.6 p -150.92 135.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.566 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 151' ' ' SER . 2.6 m -121.15 150.61 41.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.027 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.613 ' CE1' ' HG ' ' A' ' 151' ' ' SER . 92.5 m-70 -147.74 146.82 29.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.121 0.486 . . . . 1.0 111.005 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 17.0 t60 -156.36 152.46 27.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.408 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -84.66 65.02 8.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 1.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.314 -179.54 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.829 0.347 . . . . 1.0 110.758 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.2 m -95.22 150.35 20.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.19 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.6 -40.81 96.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.666 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.02 -54.9 35.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.405 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -66.97 -32.25 73.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 1.0 110.709 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.29 -38.22 76.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.507 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.23 -51.52 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.406 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.7 t -43.17 -48.79 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.8 m -74.63 -37.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.51 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 56.2 tt0 -47.76 -37.44 13.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.76 -40.2 63.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.393 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 48.8 tp -54.69 -32.88 60.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.682 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.26 -34.93 68.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.645 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' A' ' 192' ' ' SER . 43.6 t0 -55.24 -39.15 69.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.96 -53.76 44.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -58.21 -41.86 81.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.176 -0.92 . . . . 1.0 109.825 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 7.0 p -51.71 -35.76 44.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 84.3 mt -78.29 -34.26 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.038 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.98 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.127 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.3 tp -63.56 -31.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.46 -56.96 4.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.873 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -55.41 -27.14 45.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.64 -34.53 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.301 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.402 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.7 tt0 -57.15 -39.98 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.101 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 10.2 mp -67.82 -56.07 10.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.05 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.9 m -51.53 -41.49 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 1.0 110.311 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 1.0 110.533 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.3 -43.17 99.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.256 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -69.1 -53.74 18.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -55.83 -46.74 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.7 -23.36 66.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.526 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' HG11 ' A' ' 39' ' ' VAL . 18.9 ttm180 -61.42 -36.02 79.16 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.639 -0.425 . . . . 1.0 109.993 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.44 -25.18 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.302 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 p -76.54 -47.0 24.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.546 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -52.79 -37.95 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.883 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 pt-20 -79.08 -32.36 44.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.91 -52.9 62.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.952 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.7 p -64.22 -44.4 97.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.902 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.6 tmm_? -48.98 -44.47 40.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.74 75.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -80.64 -50.66 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.751 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' THR . 1.9 tp -77.13 -8.16 57.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.081 0.467 . . . . 1.0 110.208 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 45.39 17.46 0.13 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.402 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.472 ' HG1' ' HG ' ' A' ' 168' ' ' SER . 9.3 t -75.71 145.39 40.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.029 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.2 m-20 -56.47 -34.75 67.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.891 0.701 . . . . 1.0 112.891 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -150.66 126.83 10.57 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.204 -0.998 . . . . 1.0 113.523 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -141.77 130.43 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.939 -1.134 . . . . 1.0 107.939 176.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -144.35 161.26 39.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.58 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.81 133.45 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.055 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 72.1 t80 -118.14 117.42 29.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.019 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -100.81 169.07 9.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -133.9 138.66 45.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.161 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-20 -102.23 126.66 32.74 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.283 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.6 -27.09 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.722 2.281 . . . . 1.0 112.89 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.3 -9.68 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.004 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.79 21.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.868 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.53 139.77 32.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.308 0.554 . . . . 1.0 110.932 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -116.1 134.09 11.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.379 -1.088 . . . . 1.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -125.89 144.84 50.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.282 0.563 . . . . 1.0 112.229 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.09 126.2 61.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -113.1 4.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.31 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.7 tt0 -166.29 127.98 1.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.347 -0.941 . . . . 1.0 113.16 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.98 131.2 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -118.5 138.39 52.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.544 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.9 95.08 1.12 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.61 -89.21 0.05 OUTLIER Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.194 -1.162 . . . . 1.0 110.194 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.66 36.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.77 -0.372 . . . . 1.0 111.116 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -73.96 -54.38 8.04 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.0 mt -93.74 146.42 31.71 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.0 167.18 27.82 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.004 1.803 . . . . 1.0 112.518 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.5 p -88.14 139.51 30.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.108 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.562 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 34.8 mt -113.21 -2.45 14.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.593 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 45.1 tp -60.18 140.61 56.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.346 0.593 . . . . 1.0 112.25 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -4.27 86.23 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.391 -0.822 . . . . 1.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.6 mt -99.89 140.0 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 1.0 110.737 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -97.59 121.79 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.458 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 7.4 m-85 -106.74 131.41 21.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.26 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.68 152.55 29.35 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.145 1.897 . . . . 1.0 111.658 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.57 -20.98 66.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.773 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.62 -24.24 0.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.8 m-20 -53.39 -27.79 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 1.0 110.551 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.9 mt -120.98 132.34 24.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.59 -116.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.538 2.159 . . . . 1.0 112.329 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -126.09 -75.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.815 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -42.65 -37.1 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.775 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.9 -48.63 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -60.27 -32.09 70.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.519 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' LEU . 79.9 mtp180 -58.5 -46.2 87.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' GLN . 68.2 mt -56.26 -35.99 68.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.584 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 100' ' ' VAL . 8.7 m-85 -63.22 -42.8 99.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -87.43 -17.18 32.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.076 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.0 tp -106.7 -48.1 3.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -119.18 -7.47 10.29 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.583 0.957 . . . . 1.0 113.583 -175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 101' ' ' ARG . 92.2 mt-30 51.74 67.26 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 102' ' ' VAL . 35.2 m -69.2 63.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 99' ' ' GLN . 32.2 ptt180 -66.08 14.76 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.026 -1.443 . . . . 1.0 114.29 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' A' ' 100' ' ' VAL . 2.0 t -147.63 128.08 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.488 -0.485 . . . . 1.0 111.758 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.38 129.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.97 169.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.263 0.838 . . . . 1.0 113.263 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.69 120.85 5.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.304 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.68 -15.39 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.806 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.639 ' C ' ' H ' ' A' ' 109' ' ' GLN . 18.5 pt-20 -84.87 -38.25 19.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.866 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.89 3.03 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.378 0.609 . . . . 1.0 110.096 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 35.89 59.49 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.046 -0.979 . . . . 1.0 113.384 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 t -92.66 134.76 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -126.09 139.74 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.104 -1.407 . . . . 1.0 107.377 177.447 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.699 0.285 . . . . 1.0 110.27 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.6 156.35 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 C-N-CA 122.601 2.201 . . . . 1.0 111.758 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.39 140.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.027 0.442 . . . . 1.0 111.341 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 139' ' ' HIS . 3.5 m-20 -94.93 148.2 34.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.913 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -38.36 -26.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.215 1.943 . . . . 1.0 111.237 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -76.19 -47.22 24.91 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.3 t-80 -76.12 -28.81 57.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.653 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -50.56 -47.9 27.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.403 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 145' ' ' SER . 80.2 t60 -65.59 -42.16 92.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -45.93 -56.07 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.453 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.7 mt -72.12 -50.44 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.496 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 44.3 tptt -57.56 -43.32 84.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.415 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 141' ' ' HIS . 33.9 t -53.78 -34.18 58.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.238 -0.652 . . . . 1.0 109.238 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.1 mtt -84.3 -7.33 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.2 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.45 23.87 76.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.9 122.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.97 31.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 151' ' ' SER . 1.5 t -142.98 170.42 15.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.573 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 30.9 t -162.04 140.31 9.04 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.205 -0.452 . . . . 1.0 112.173 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.64 116.36 28.61 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -117.07 158.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.447 0.641 . . . . 1.0 111.791 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 79.5 t -155.65 95.24 2.47 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.363 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.02 113.46 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.558 2.839 . . . . 1.0 113.928 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.2 106.62 5.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 17.1 ptm -133.57 146.41 50.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.917 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 78.5 t60 -117.68 115.64 25.46 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 34.0 m-70 59.1 -123.53 1.25 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.48 8.56 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.63 149.71 39.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.983 1.105 . . . . 1.0 113.983 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.0 tp -107.54 115.92 31.01 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.545 -1.207 . . . . 1.0 108.857 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.65 -30.41 13.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.965 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.56 -170.14 24.77 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.205 -0.998 . . . . 1.0 111.937 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -138.18 128.49 26.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 1.0 111.16 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -92.09 138.01 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 10.8 p -149.58 135.3 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.593 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.472 ' HG ' ' HG1' ' A' ' 48' ' ' THR . 12.3 t -117.36 146.15 43.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.049 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.508 ' CE1' ' OG ' ' A' ' 151' ' ' SER . 78.1 m-70 -143.68 141.43 30.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 1.0 111.043 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -152.72 151.88 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.69 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.94 9.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.583 -0.28 . . . . 1.0 111.489 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.467 0.388 0 C-N-CA 120.319 -0.552 . . . . 1.0 112.302 179.307 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 1.0 110.748 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -93.19 143.12 26.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.284 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -62.14 -39.51 92.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.33 -54.95 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.61 -0.268 . . . . 1.0 111.366 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.63 -32.39 73.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.974 0.416 . . . . 1.0 110.765 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.64 -42.71 88.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.86 -50.85 70.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.45 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.19 -48.42 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.24 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -74.03 -39.23 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.571 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 57.3 tt0 -46.18 -35.57 5.22 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.3 tp -71.44 -38.37 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.685 -1.143 . . . . 1.0 109.35 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 9.8 tp -56.28 -31.04 63.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.686 . . . . 1.0 109.631 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.28 -36.41 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.602 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -59.57 -38.75 81.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.747 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -52.74 -55.15 24.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.82 -40.5 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.904 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 157' ' ' MET . 6.1 t -52.02 -35.53 47.24 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.2 mt -79.12 -36.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.081 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -47.22 63.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.062 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 tp -61.0 -33.48 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -75.51 -53.9 7.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.967 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -55.34 -28.31 52.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -34.86 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.294 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -56.51 -40.25 74.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.198 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 10.6 mp -68.29 -56.59 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.172 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.4 m -58.32 -45.59 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 1.0 110.292 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.427 179.638 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.912 0.386 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.46 -50.55 73.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.317 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.77 -48.6 79.95 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG22 HD13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -62.54 -29.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.605 ' O ' HG22 ' A' ' 38' ' ' THR . 96.6 mt -77.85 -20.93 52.2 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 39' ' ' VAL . 73.4 mtp180 -72.44 -34.16 67.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.032 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.19 31.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.349 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 35' ' ' LEU . 2.5 t -74.29 -44.87 50.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.55 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.2 p -55.69 -36.02 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.59 -36.86 68.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.021 0.438 . . . . 1.0 110.872 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.55 -52.15 48.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.979 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.15 -51.22 75.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -49.17 -43.93 42.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.21 -47.43 14.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.91 -6.62 53.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.76 16.67 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.714 -0.676 . . . . 1.0 112.458 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -75.01 144.66 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.391 -0.524 . . . . 1.0 110.083 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.0 m-20 -57.21 -34.29 68.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 29.5 ttm180 -149.55 124.14 9.75 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.212 -0.995 . . . . 1.0 113.526 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 11.9 t -135.21 131.57 52.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -143.74 152.04 40.77 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.569 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.9 t -98.46 139.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.983 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.0 t80 -124.76 121.63 35.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.001 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -99.95 171.78 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.86 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -134.12 138.19 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.558 -0.457 . . . . 1.0 112.15 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 m-20 -104.81 149.33 37.39 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.269 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.21 -26.64 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.741 2.294 . . . . 1.0 112.946 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -76.54 -3.73 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.055 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.88 -10.29 57.13 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.032 -0.604 . . . . 1.0 112.811 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 95.9 m-70 -90.42 147.06 23.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.338 0.569 . . . . 1.0 110.941 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . -130.12 151.41 19.4 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -131.3 149.69 52.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.256 0.55 . . . . 1.0 112.274 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.73 115.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.023 -1.103 . . . . 1.0 108.023 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.69 -2.41 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.635 0.606 . . . . 1.0 112.635 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.15 20.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.7 tt0 -167.41 127.14 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.332 -0.947 . . . . 1.0 113.159 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 142.05 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.119 -1.067 . . . . 1.0 108.119 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' O ' ' NH2' ' A' ' 43' ' ' ARG . 35.9 ptt-85 -132.87 141.96 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.544 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.33 111.54 3.7 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.363 -1.095 . . . . 1.0 110.363 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.32 40.05 3.41 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.309 -1.116 . . . . 1.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 48.53 26.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.119 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -54.13 -56.34 19.05 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 10.7 mt -93.76 152.03 40.38 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' C ' HH22 ' A' ' 50' ' ' ARG . 56.4 Cg_endo -69.58 156.97 62.36 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.114 1.876 . . . . 1.0 112.573 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -76.44 113.98 14.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 56.5 mt -87.39 -6.76 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.595 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.2 tp -60.25 139.98 57.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.305 0.574 . . . . 1.0 112.209 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.82 -3.51 84.84 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.8 mt -99.58 136.61 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 1.0 110.737 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 81' ' ' THR . 15.4 t -94.3 120.62 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.482 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' GLY . 7.3 m-85 -108.73 133.26 20.71 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.283 178.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 149.29 34.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.147 1.898 . . . . 1.0 111.719 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.34 -25.63 64.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.779 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.01 -20.95 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ALA . 32.6 t70 -51.78 -23.38 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.0 110.608 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.15 132.73 24.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.34 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.58 -108.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.53 2.154 . . . . 1.0 112.319 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -142.58 -72.46 0.31 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.1 pt-20 -41.42 -43.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.721 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -63.65 -49.48 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -58.23 -29.08 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -55.81 -47.63 76.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.218 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 8.4 mp -54.45 -38.68 66.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.572 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.573 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.4 m-85 -60.03 -24.99 64.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.227 0.537 . . . . 1.0 109.572 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -94.74 -19.02 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.123 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mp -109.5 -45.51 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.03 -11.08 15.37 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.581 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 82.7 mt-30 25.35 70.77 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.082 1.141 . . . . 1.0 114.082 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -141.77 -55.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 104.44 -2.43 . . . . 1.0 104.44 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.575 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 5.6 mmp_? 52.84 103.85 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.038 -1.437 . . . . 1.0 114.297 173.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -144.77 132.66 16.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.768 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 HG22 ' A' ' 103' ' ' ILE . 58.3 mt -108.64 123.86 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.71 168.08 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.58 120.43 5.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.242 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -56.73 -10.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -86.61 -37.08 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.39 -17.84 55.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.372 0.606 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 53.44 60.43 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.056 -0.974 . . . . 1.0 113.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -93.51 135.16 35.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.0 mtp-105 -130.06 142.44 50.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 1.5 m . . . . . 0 N--CA 1.452 -0.326 0 CA-C-N 114.189 -1.368 . . . . 1.0 107.357 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 15.8 mmm180 . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.69 0.281 . . . . 1.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.528 ' O ' ' OG ' ' A' ' 112' ' ' SER . 73.7 Cg_exo -47.72 145.36 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.536 2.157 . . . . 1.0 111.774 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 139' ' ' HIS . 15.7 t -128.46 135.34 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.994 0.426 . . . . 1.0 111.354 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 138' ' ' CYS . 0.8 OUTLIER -44.2 154.73 0.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.883 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -56.32 -7.16 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.243 1.962 . . . . 1.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.461 ' H ' ' C ' ' A' ' 136' ' ' ASP . 42.0 t -58.42 -50.58 73.2 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.442 ' CD2' ' HB ' ' A' ' 135' ' ' VAL . 0.1 OUTLIER -73.32 -27.38 61.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.329 -0.851 . . . . 1.0 110.689 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.433 ' N ' ' CD2' ' A' ' 139' ' ' HIS . 22.3 t -52.01 -54.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 1.0 110.362 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 145' ' ' SER . 10.2 m80 -68.99 -46.06 69.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.215 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -47.43 -55.96 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.48 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.407 ' CD1' ' ND1' ' A' ' 139' ' ' HIS . 89.1 mt -66.83 -50.48 62.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.514 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 42.7 tptt -57.56 -42.09 82.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 m -54.28 -34.92 61.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mtt -84.73 -3.77 58.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.242 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.97 25.84 70.47 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.261 -0.881 . . . . 1.0 112.324 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.2 t -106.71 114.92 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.011 0.405 . . . . 1.0 109.945 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.78 -30.1 61.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.517 ' OG ' ' NE2' ' A' ' 170' ' ' HIS . 97.4 p -138.67 170.14 16.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.615 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 p -161.85 130.86 4.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.46 114.97 29.23 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.7 p -113.42 157.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.455 0.645 . . . . 1.0 111.853 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.488 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 58.9 t -157.7 124.54 2.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.281 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.33 149.87 22.06 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.602 2.868 . . . . 1.0 113.906 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.52 107.43 15.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.409 -0.814 . . . . 1.0 109.799 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.581 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 81.5 mtp -121.23 140.63 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 111.834 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 22.2 t-80 -118.15 113.9 22.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 46.9 t60 68.08 -129.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.504 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 58.8 mt-30 -95.33 8.78 42.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -120.99 159.84 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.963 1.097 . . . . 1.0 113.963 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.71 117.97 34.91 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.543 -1.208 . . . . 1.0 108.896 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -96.24 -28.47 14.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.95 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.2 -173.95 26.29 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.215 -0.993 . . . . 1.0 112.006 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -140.99 126.38 18.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 1.0 111.278 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 0.6 OUTLIER -95.14 135.61 36.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.572 ' N ' ' CD1' ' A' ' 166' ' ' LEU . 85.3 t -145.55 137.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.567 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.527 ' C ' ' ND1' ' A' ' 169' ' ' HIS . 20.6 m -125.26 144.49 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.33 152.82 36.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 1.0 111.013 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.517 ' NE2' ' OG ' ' A' ' 150' ' ' SER . 1.1 p-80 -158.15 154.08 26.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.03 67.91 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.421 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.5 tp10 . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.348 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.86 0.362 . . . . 1.0 110.789 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -92.31 150.04 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.304 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 179' ' ' GLU . 12.3 pt20 -67.34 -42.94 82.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.625 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.449 ' N ' ' CG ' ' A' ' 178' ' ' GLN . 79.1 mm-40 -61.74 -55.14 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 111.359 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.33 -30.69 71.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 1.0 110.698 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.3 tp -61.72 -34.83 76.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.499 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.49 -53.7 21.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.376 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 49.3 t -44.34 -47.39 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.226 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.24 -37.44 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -48.63 -37.14 17.44 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 21.1 tp -72.79 -40.62 65.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.71 -1.132 . . . . 1.0 109.3 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.22 -32.29 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.633 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.03 -37.24 64.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.671 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -56.8 -41.54 77.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.758 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -52.63 -54.31 34.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.69 -41.55 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.837 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.1 m -50.46 -29.67 10.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 193' ' ' ILE . 11.2 mm -77.26 -42.35 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.049 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.05 88.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.1 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.09 -31.31 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.485 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.33 -56.29 4.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -55.04 -28.88 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 202' ' ' LEU . . . -77.56 -34.2 53.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.304 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -58.42 -38.59 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.63 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.036 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.3 t -69.77 -55.57 9.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 1.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 198' ' ' ALA . 19.0 mt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.435 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' CD2' HH11 ' A' ' 55' ' ' ARG . 61.0 tp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.903 0.382 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -51.86 -49.5 62.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.22 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.43 -46.56 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.5 mp -59.9 -40.03 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.97 -22.04 58.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.693 -0.403 . . . . 1.0 111.504 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.1 ttm-85 -68.57 -36.77 79.22 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.652 -0.419 . . . . 1.0 109.991 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.01 -29.3 39.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.369 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -71.14 -48.39 52.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 36' ' ' ARG . 2.8 p -54.05 -35.16 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.842 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.12 -39.89 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.88 -40.65 98.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.932 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.32 -51.21 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.867 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' GLY . 23.4 ttp85 -50.78 -44.94 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.909 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.4 79.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.848 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -79.56 -51.44 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.751 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.11 -6.51 53.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.009 0.433 . . . . 1.0 110.081 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.1 16.99 0.54 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.695 -0.684 . . . . 1.0 112.45 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -73.73 141.66 46.34 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 70' ' ' GLY . 78.9 m-20 -60.13 -29.21 68.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.447 ' H ' ' CG2' ' A' ' 48' ' ' THR . 59.8 ttp180 -154.4 119.07 4.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 119.17 -1.012 . . . . 1.0 113.578 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.85 136.09 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -145.63 160.87 41.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.41 -0.516 . . . . 1.0 111.579 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.9 t -97.76 137.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.999 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.9 t80 -121.29 119.35 31.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 1.0 111.031 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.431 HH11 ' CD2' ' A' ' 31' ' ' LEU . 63.8 mtm180 -99.97 170.47 8.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 6.7 t80 -134.96 137.61 43.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.061 0.458 . . . . 1.0 112.172 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -103.14 148.59 35.87 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.325 179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.92 -23.87 67.95 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.739 2.293 . . . . 1.0 112.902 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.61 -2.9 41.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.27 -12.71 51.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.954 -0.641 . . . . 1.0 112.876 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -88.79 146.2 25.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.326 0.563 . . . . 1.0 110.95 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -125.35 145.58 15.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.467 -1.053 . . . . 1.0 110.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -128.36 146.96 50.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.291 0.567 . . . . 1.0 112.341 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.1 118.2 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.12 9.2 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.9 142.8 23.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 48.9 tt0 -165.99 126.67 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.368 -0.933 . . . . 1.0 113.181 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.66 140.66 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 36.4 ptt85 -132.2 143.38 49.91 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.203 -0.599 . . . . 1.0 111.539 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.84 106.94 3.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.366 -1.094 . . . . 1.0 110.366 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 55.2 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 70' ' ' GLY . 44.7 tt0 -176.94 35.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.089 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -72.94 -51.98 16.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -95.07 121.16 63.05 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 107.803 -1.184 . . . . 1.0 107.803 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.39 162.92 11.23 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.054 1.836 . . . . 1.0 112.557 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.1 t -83.83 135.16 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.3 mt -109.64 -7.66 15.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.592 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 tp -49.4 138.06 13.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.347 0.594 . . . . 1.0 112.288 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.54 -4.04 79.34 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.063 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.6 tt -98.22 115.22 27.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 1.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.8 126.41 30.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.445 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 80' ' ' LEU . 61.5 m-85 -108.26 139.82 21.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.82 152.28 19.28 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.131 1.887 . . . . 1.0 111.675 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -59.8 -26.45 65.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.819 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.05 -21.7 1.05 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 49.0 p-10 -58.0 -29.67 65.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.588 ' O ' ' O ' ' A' ' 88' ' ' PRO . 4.4 mm -110.17 99.8 41.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.228 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.7 Cg_exo -48.41 -126.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.091 . . . . 1.0 112.3 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.79 -60.64 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.811 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.59 -41.02 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.758 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.96 99.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 1.0 110.932 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 34.9 ttm180 -63.82 -28.86 70.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.591 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 97' ' ' LEU . 31.9 mmt180 -56.73 -53.77 53.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.286 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 98' ' ' ALA . 32.3 mt -54.02 -36.01 62.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.651 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -66.49 -35.95 81.55 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -85.05 -16.15 41.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.114 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.1 mp -106.04 -42.84 4.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -114.25 -4.58 13.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.527 0.936 . . . . 1.0 113.527 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.1 mt-30 27.93 69.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.05 1.13 . . . . 1.0 114.05 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.557 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 58.3 t -110.73 -50.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.417 -2.438 . . . . 1.0 104.417 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.681 HH12 ' NE2' ' A' ' 185' ' ' GLN . 10.5 mtm180 63.72 72.02 0.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.088 -1.414 . . . . 1.0 114.269 172.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -152.1 133.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.782 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 103' ' ' ILE . 1.7 mp -107.41 127.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 12.7 p -83.01 167.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.266 0.839 . . . . 1.0 113.266 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 5.9 m-20 -54.62 120.03 6.12 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.315 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.53 -10.99 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.771 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 17.4 pt-20 -85.38 -40.42 16.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.876 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.23 -12.61 3.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.433 0.635 . . . . 1.0 110.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 49.4 52.0 15.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.051 -0.977 . . . . 1.0 113.396 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.6 m -94.44 136.56 34.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -128.12 141.71 51.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.432 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 4.2 t . . . . . 0 N--CA 1.452 -0.338 0 CA-C-N 114.098 -1.41 . . . . 1.0 107.323 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.06 142.86 7.92 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.56 2.174 . . . . 1.0 111.768 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.474 ' HB ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -107.26 117.54 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.016 0.436 . . . . 1.0 111.312 -177.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -39.85 153.95 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.947 177.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -56.96 -20.43 36.58 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.237 1.958 . . . . 1.0 111.233 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.6 t -65.79 -46.97 76.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.017 -0.734 . . . . 1.0 109.017 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.806 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -74.7 -27.94 60.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.632 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.48 -54.72 13.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.318 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 145' ' ' SER . 49.7 t-80 -65.93 -44.48 84.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.279 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -44.49 -51.69 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.482 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.78 -47.03 50.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.522 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.8 OUTLIER -59.45 -42.06 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.503 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' HIS . 85.0 p -53.77 -30.65 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.6 mtt -86.91 -0.47 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.238 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.97 24.41 76.48 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.22 -0.9 . . . . 1.0 112.36 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 170' ' ' HIS . 11.4 t -106.9 122.57 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.15 -26.27 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -142.58 171.87 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.573 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.02 136.78 12.4 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.51 136.23 52.28 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.02 155.41 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.436 0.636 . . . . 1.0 111.845 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.4 t -157.67 90.0 2.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.333 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.22 140.24 52.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.552 2.835 . . . . 1.0 113.923 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.1 mt -98.52 105.65 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.799 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 81.3 mtp -119.42 141.13 49.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.553 . . . . 1.0 111.818 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.45 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 42.0 t-80 -116.61 112.03 20.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 4.9 t60 62.86 -123.7 0.63 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.478 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 17.2 pt20 -94.64 7.72 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 162' ' ' LEU . 26.4 tp10 -117.23 153.4 32.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 161' ' ' GLU . 6.5 tt -107.72 117.36 33.9 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 114.55 -1.205 . . . . 1.0 108.816 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -96.97 -27.87 14.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.858 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.06 23.53 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -141.59 127.81 19.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.0 111.263 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.3 tp -92.92 134.06 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.55 134.84 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.578 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.78 142.43 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.99 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -134.56 132.17 38.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 1.0 110.96 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 19.0 t60 -168.53 161.41 11.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.766 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.709 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -46.22 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.428 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.661 ' N ' ' OE1' ' A' ' 172' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 120.391 -0.523 . . . . 1.0 112.343 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.856 0.36 . . . . 1.0 110.795 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -106.43 143.95 33.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.254 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.79 -28.3 66.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.617 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.14 -54.58 27.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.594 -0.275 . . . . 1.0 111.325 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.58 -33.88 76.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.944 0.402 . . . . 1.0 110.688 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.66 -39.99 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.501 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.548 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 78.5 mm-40 -61.98 -51.96 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.352 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.1 t -45.27 -48.95 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 187' ' ' LEU . 63.9 t -74.27 -38.71 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.681 ' NE2' HH12 ' A' ' 101' ' ' ARG . 56.9 tt0 -45.93 -36.02 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.59 -39.68 67.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.764 -1.107 . . . . 1.0 109.333 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 184' ' ' VAL . 35.0 tp -54.95 -32.92 61.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.85 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.655 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.453 ' O ' ' OG ' ' A' ' 192' ' ' SER . 46.9 t0 -56.91 -39.36 74.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.697 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -53.38 -53.91 44.37 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.2 t -56.7 -43.67 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.36 -0.836 . . . . 1.0 109.869 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.3 p -51.7 -37.43 50.73 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.2 mt -78.39 -32.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.025 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.36 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 1.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.419 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.6 pp -66.62 -26.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.52 -55.71 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.846 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.26 -26.88 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.95 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.48 -35.73 58.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -56.94 -39.34 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.221 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.5 tp -66.97 -56.31 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.119 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.9 m -47.16 -39.16 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 1.0 110.307 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.081 -0.961 . . . . 1.0 110.47 179.78 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.823 0.344 . . . . 1.0 110.553 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 40.6 p-10 -65.33 -37.88 88.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.313 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.0 mt-30 -73.3 -53.71 10.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -57.2 -40.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.51 ' O ' ' OG1' ' A' ' 38' ' ' THR . 69.9 mt -71.29 -33.28 69.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.631 -0.427 . . . . 1.0 111.589 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -49.53 -37.96 28.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.634 -0.426 . . . . 1.0 109.993 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.16 -26.4 52.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.35 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.585 ' HG1' ' N ' ' A' ' 39' ' ' VAL . 46.5 p -74.85 -44.33 49.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.557 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 ' N ' ' HG1' ' A' ' 38' ' ' THR . 56.8 t -59.13 -38.89 76.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.548 . . . . 1.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.27 -38.22 56.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.55 -49.35 75.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.995 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.92 -47.99 90.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.942 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.2 ttp180 -49.71 -43.99 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.853 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -81.52 -47.95 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.804 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -78.0 -7.08 56.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 1.0 110.084 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 50.18 19.51 2.76 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.668 -0.696 . . . . 1.0 112.494 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 1.9 m -76.91 141.9 40.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.065 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.0 m-20 -62.6 -28.45 69.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.602 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 60.5 ttp180 -152.98 124.87 7.88 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.145 -1.022 . . . . 1.0 113.54 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -146.7 136.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -146.81 162.45 38.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.566 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.71 136.47 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.035 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -122.89 121.67 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.024 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' CG ' ' N ' ' A' ' 56' ' ' PHE . 36.6 ttm-85 -101.47 168.93 9.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.85 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' N ' ' CG ' ' A' ' 55' ' ' ARG . 71.0 t80 -131.2 136.7 48.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.053 0.454 . . . . 1.0 112.124 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.5 148.74 35.63 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.379 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.69 -22.53 64.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.728 2.286 . . . . 1.0 112.94 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -79.69 -3.09 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.544 -0.463 . . . . 1.0 111.041 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.7 -10.42 52.86 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.815 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -90.19 145.83 24.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.377 0.588 . . . . 1.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.61 142.92 14.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.3 p -128.39 147.5 50.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.152 0.501 . . . . 1.0 112.346 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.7 t -101.14 121.35 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 m -108.98 1.84 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.62 149.12 24.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.6 tt0 -166.83 127.18 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.394 -0.922 . . . . 1.0 113.248 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 133.89 54.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.549 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 58.6 mtm180 -117.45 139.74 50.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.22 107.05 2.56 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.32 18.17 0.06 OUTLIER Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.268 -1.133 . . . . 1.0 110.268 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' GLY . 43.6 tt0 70.57 30.91 3.01 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.115 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 36.7 ttm180 -57.83 -59.57 5.03 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.8 164.8 20.67 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.81 171.75 17.43 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.043 1.829 . . . . 1.0 112.533 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -90.42 121.37 32.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -92.76 -11.85 32.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.624 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 tp -50.4 137.23 19.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.17 82.37 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.384 -0.825 . . . . 1.0 111.051 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 80' ' ' LEU . 4.3 tt -97.68 115.9 28.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 1.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 t -76.46 122.5 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.465 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.75 132.16 21.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.318 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.11 152.39 27.73 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.195 1.93 . . . . 1.0 111.698 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.36 -21.14 66.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.81 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.73 -22.29 0.14 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.3 m-20 -48.44 -23.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.331 . . . . 1.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CD1' HH21 ' A' ' 92' ' ' ARG . 2.9 pt -133.67 142.04 42.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.55 -104.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.525 2.15 . . . . 1.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -147.64 -64.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 1.0 111.788 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.04 -41.12 46.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.716 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.63 99.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.96 0.41 . . . . 1.0 111.005 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.528 HH21 ' CD1' ' A' ' 87' ' ' ILE . 23.6 ttm105 -64.54 -27.93 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' LEU . 68.7 mtm180 -58.53 -53.56 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.327 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 8.4 mp -52.73 -41.33 63.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.55 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.2 m-85 -64.1 -35.91 82.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -85.2 -8.96 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.072 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.4 tp -105.86 -43.34 4.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.42 -0.08 12.62 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 98' ' ' ALA . 93.6 mt-30 28.45 68.28 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 t -117.73 -48.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.381 -2.452 . . . . 1.0 104.381 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 101' ' ' ARG . 6.2 mtp180 50.57 76.5 0.15 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.26 171.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.15 139.17 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.757 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 103' ' ' ILE . 2.8 mp -107.24 125.2 63.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 24.3 t -83.49 166.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 113.256 0.835 . . . . 1.0 113.256 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.485 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 3.1 m-20 -48.85 120.32 3.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.252 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.1 m -57.77 -12.18 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.764 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -87.01 -37.33 17.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.46 -16.19 44.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.372 0.606 . . . . 1.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 53.06 60.32 3.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.002 -0.999 . . . . 1.0 113.427 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.1 m -92.89 133.98 35.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -128.35 141.67 51.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 114.073 -1.422 . . . . 1.0 107.298 176.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.487 ' NH1' ' CD2' ' A' ' 94' ' ' LEU . 2.5 mmp_? . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.711 0.291 . . . . 1.0 110.338 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.488 ' O ' ' OG ' ' A' ' 112' ' ' SER . 88.2 Cg_exo -46.0 145.21 5.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.525 2.15 . . . . 1.0 111.797 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.602 ' CG2' ' ND1' ' A' ' 139' ' ' HIS . 6.5 m -118.1 127.01 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 1.0 111.361 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -43.12 139.39 2.29 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.9 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -39.91 -46.8 3.85 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.163 1.909 . . . . 1.0 111.24 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 9.9 p -43.83 -41.68 5.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.602 ' ND1' ' CG2' ' A' ' 135' ' ' VAL . 13.1 t-80 -79.94 -38.52 32.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.368 -0.833 . . . . 1.0 110.687 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.6 t -50.9 -50.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.3 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 77.0 t60 -64.13 -39.86 94.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.253 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -43.95 -47.48 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.447 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.78 -45.4 61.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.511 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -60.17 -42.49 95.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.492 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.8 m -54.17 -33.33 57.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.6 mtt -86.99 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.156 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.26 26.16 66.75 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.291 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.74 120.87 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.33 33.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 172' ' ' GLU . 37.7 m -127.89 153.99 46.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.155 -0.618 . . . . 1.0 111.585 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.87 129.55 19.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.052 0.453 . . . . 1.0 112.178 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.96 141.78 50.97 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' CG2' ' A' ' 154' ' ' VAL . 2.3 m -129.65 155.42 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.845 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 2.1 t -150.72 97.82 3.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.891 -1.05 . . . . 1.0 109.287 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.84 139.52 36.65 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.536 2.824 . . . . 1.0 113.889 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.24 104.52 16.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.718 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 88.3 mtp -119.06 141.07 49.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.843 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 159' ' ' HIS . 39.3 t-80 -125.31 112.93 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 26.4 t60 75.08 -135.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.48 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 25.4 mt-30 -96.16 12.38 31.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.412 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 63.7 mt-10 -120.19 161.43 21.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.79 116.83 32.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.544 -1.207 . . . . 1.0 108.851 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.4 m95 -99.04 -29.3 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.847 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.96 179.7 28.31 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.217 -0.992 . . . . 1.0 111.927 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 tp -139.96 130.68 25.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 1.0 111.193 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.9 tp -99.6 145.27 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.62 125.81 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.556 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -110.51 143.25 41.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.049 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.607 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -141.95 143.53 33.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 19.2 t60 -153.29 153.24 32.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.657 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.445 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.59 68.46 9.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.433 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.431 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.1 tp10 . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 120.401 -0.52 . . . . 1.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 N--CA 1.461 0.081 0 CA-C-O 120.913 0.387 . . . . 1.0 110.804 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -91.21 143.44 26.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.234 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.57 -55.3 28.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.661 0.267 . . . . 1.0 111.388 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -65.07 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 1.0 110.653 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.71 -30.47 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.576 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -73.88 -52.67 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.406 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.94 -45.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.283 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' LEU . 5.4 p -73.18 -39.38 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -49.8 -36.59 26.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.5 tp -69.88 -31.22 68.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.704 -1.134 . . . . 1.0 109.41 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.6 tt -63.32 -28.17 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.72 70.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.664 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -53.36 -44.61 68.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -52.56 -55.53 21.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.047 -0.724 . . . . 1.0 109.047 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.66 -40.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.903 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.8 m -50.22 -29.13 8.8 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.451 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 11.2 mm -77.28 -48.53 24.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.064 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.63 87.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.084 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 196' ' ' ALA . 4.0 tp -59.91 -37.48 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 195' ' ' ILE . . . -72.97 -51.64 17.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.848 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 193' ' ' ILE . 2.9 mp0 -55.61 -26.59 44.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.81 55.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -59.08 -41.37 87.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.05 -60.14 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.024 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.2 p -58.97 -43.84 91.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.422 179.793 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.886 0.374 . . . . 1.0 110.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.8 p-10 -63.66 -44.63 93.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.251 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 93.8 mt-30 -67.0 -53.19 33.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mt -55.24 -48.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.0 112.629 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' O ' ' OG1' ' A' ' 38' ' ' THR . 48.0 mt -62.81 -25.25 68.16 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.641 -0.423 . . . . 1.0 111.609 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -57.42 -36.63 71.59 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.636 -0.426 . . . . 1.0 110.036 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.68 41.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.391 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 43.0 p -73.57 -48.4 33.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.556 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 36' ' ' ARG . 3.2 p -53.3 -35.12 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 95.4 mt-10 -77.76 -33.71 52.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.44 -50.51 71.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.978 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.4 p -64.24 -45.56 95.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.91 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 18.3 ttt-85 -49.09 -46.42 44.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.05 82.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.782 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -78.31 -52.11 9.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.761 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.55 -5.61 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 1.0 110.167 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.75 18.0 0.33 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.599 -0.728 . . . . 1.0 112.399 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.484 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.1 m -75.86 144.0 41.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 1.0 110.14 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 70' ' ' GLY . 97.4 m-20 -64.29 -26.81 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.87 0.693 . . . . 1.0 112.87 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 24.4 ttt180 -149.98 121.27 7.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.103 -1.039 . . . . 1.0 113.476 -178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 3.2 t -140.32 130.53 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.957 -1.127 . . . . 1.0 107.957 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -143.33 155.32 44.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.626 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.79 137.44 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.009 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -121.36 119.7 32.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -99.76 170.29 8.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.871 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 48.9 t80 -135.05 141.66 46.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.155 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 4.0 m-20 -104.0 150.47 38.31 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.269 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.49 -29.18 53.31 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.699 2.266 . . . . 1.0 112.901 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.47 -4.99 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.586 -0.446 . . . . 1.0 110.935 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.36 -14.54 36.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.803 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 99.2 m-70 -84.65 143.79 29.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.398 0.599 . . . . 1.0 110.959 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -119.67 139.28 13.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -125.08 143.85 50.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.289 0.566 . . . . 1.0 112.25 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.27 120.16 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.61 3.47 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.52 149.87 24.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 79.2 tt0 -166.15 125.46 1.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.433 -0.907 . . . . 1.0 113.266 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.13 135.86 47.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 7.1 ptp85 -129.78 141.97 50.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.552 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.36 106.32 3.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.454 -1.058 . . . . 1.0 110.454 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.19 -88.55 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.261 -1.136 . . . . 1.0 110.261 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.7 tt0 -177.36 32.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.064 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.57 -33.94 73.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.73 142.63 29.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 64.0 Cg_endo -73.36 170.35 20.1 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.077 1.851 . . . . 1.0 112.535 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 14.9 m -93.53 137.93 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.189 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.8 mt -109.63 -3.9 16.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.641 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 14.2 tp -56.69 137.75 53.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.278 0.561 . . . . 1.0 112.286 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.97 86.03 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -101.61 118.77 37.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.907 0.384 . . . . 1.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 122.43 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.463 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 m-85 -106.26 133.69 20.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.336 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.7 152.28 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.175 1.917 . . . . 1.0 111.71 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.9 -23.39 67.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.796 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.86 -22.93 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -54.05 -21.72 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -129.0 132.83 24.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.302 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.17 -107.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.531 2.154 . . . . 1.0 112.341 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.11 -69.09 0.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.815 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -42.34 -42.38 3.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.96 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -56.44 -30.37 62.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.566 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -57.47 -45.11 85.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.231 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 98' ' ' ALA . 50.5 mt -54.96 -36.68 65.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.582 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.557 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.6 m-85 -61.17 -26.53 67.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -93.87 -18.23 22.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.12 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -109.44 -46.86 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.374 0.879 . . . . 1.0 113.374 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -107.96 -10.87 15.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -174.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.596 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 79.8 mt-30 26.12 69.29 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -137.46 -54.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.624 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 5.4 mmp_? 49.57 101.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.111 -1.404 . . . . 1.0 114.288 171.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.61 136.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.464 -0.494 . . . . 1.0 111.743 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 103' ' ' ILE . 70.8 mt -107.61 123.16 62.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.508 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 23.4 t -84.17 168.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.508 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 4.0 m-20 -50.4 118.48 3.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.262 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.54 -11.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.313 -0.858 . . . . 1.0 110.75 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.572 ' C ' ' H ' ' A' ' 109' ' ' GLN . 4.8 pt-20 -88.61 -35.86 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.915 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.59 0.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.4 0.619 . . . . 1.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' A' ' 107' ' ' GLU . 10.1 pt20 35.35 60.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.106 -0.952 . . . . 1.0 113.504 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -93.96 134.99 35.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.384 -2.08 . . . . 1.0 105.384 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -131.09 141.85 50.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 114.184 -1.371 . . . . 1.0 107.354 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.491 HH21 HH22 ' A' ' 101' ' ' ARG . 11.3 tpp180 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.715 0.293 . . . . 1.0 110.336 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 133' ' ' ARG . 3.5 Cg_exo -30.36 143.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.615 2.21 . . . . 1.0 111.774 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.8 115.69 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.107 0.479 . . . . 1.0 111.363 -178.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.557 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -40.27 147.14 0.38 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.912 178.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.522 ' O ' HG21 ' A' ' 140' ' ' VAL . 17.7 Cg_endo -52.86 -12.41 1.94 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.221 1.947 . . . . 1.0 111.258 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.02 -39.32 50.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.537 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 3.3 t-80 -83.34 -34.2 25.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.366 -0.834 . . . . 1.0 110.633 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 136' ' ' ASP . 2.9 m -53.94 -45.88 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.299 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.56 ' CE1' ' HG ' ' A' ' 145' ' ' SER . 42.7 t-80 -67.41 -44.92 77.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.197 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -46.59 -51.16 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.47 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.3 -49.22 57.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 17.8 tptp -58.0 -40.25 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.449 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.56 ' HG ' ' CE1' ' A' ' 141' ' ' HIS . 34.9 m -53.73 -33.47 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.62 0.88 44.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.191 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.62 23.96 75.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.247 -0.888 . . . . 1.0 112.334 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.46 121.8 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.913 -0.402 . . . . 1.0 109.913 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.72 49.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -135.53 170.12 16.45 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.112 -0.635 . . . . 1.0 111.593 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.559 ' HG ' ' CE1' ' A' ' 169' ' ' HIS . 10.7 t -162.05 139.82 8.72 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.521 ' H ' ' HG ' ' A' ' 168' ' ' SER . 35.9 tp -115.33 133.58 55.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.4 p -132.37 155.58 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.06 -0.656 . . . . 1.0 111.818 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 77.2 t -156.53 109.93 2.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.334 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.62 114.17 3.42 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.634 2.889 . . . . 1.0 113.87 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.51 107.02 7.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.808 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . 0.596 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 17.0 ptm -132.15 144.19 50.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.824 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -114.31 114.73 26.33 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 46.8 t-80 61.48 -123.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.507 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.2 tt0 -94.04 6.16 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.901 0.334 . . . . 1.0 111.901 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 43.9 mp0 -115.65 149.82 37.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.991 1.108 . . . . 1.0 113.991 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.28 116.83 32.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.562 -1.199 . . . . 1.0 108.912 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -99.22 -30.47 12.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.917 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.26 -174.1 24.76 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.187 -1.006 . . . . 1.0 111.958 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 tp -141.09 131.11 24.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 1.0 111.201 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.7 136.21 34.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.56 ' CG1' ' NE2' ' A' ' 169' ' ' HIS . 31.0 t -148.52 122.74 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.527 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 152' ' ' LEU . 2.0 p -108.09 143.27 37.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.971 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.56 ' NE2' ' CG1' ' A' ' 167' ' ' VAL . 54.3 m-70 -137.03 143.2 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.096 0.474 . . . . 1.0 111.048 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -152.95 151.92 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.703 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.56 68.97 9.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.403 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.465 0.324 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.102 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 1.0 110.799 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 t -96.26 139.2 32.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -63.17 -40.34 97.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.671 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -65.49 -55.73 16.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.31 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.89 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 1.0 110.64 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.2 tp -59.56 -40.23 86.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.539 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.76 -50.84 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.416 -0.357 . . . . 1.0 111.358 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.39 -47.16 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 75.3 t -73.39 -40.71 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 57.0 tt0 -45.99 -34.83 4.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.67 -38.07 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.404 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 10.9 tp -54.84 -31.36 59.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.698 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.55 70.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.648 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.463 ' O ' ' OG ' ' A' ' 192' ' ' SER . 47.8 t0 -57.19 -42.1 80.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.72 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -52.7 -55.35 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.136 -0.69 . . . . 1.0 109.136 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.07 -43.17 84.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.826 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 8.3 p -52.0 -37.27 52.64 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.1 mt -78.11 -33.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.079 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.71 66.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.037 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.421 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.7 pp -67.13 -23.78 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.53 -56.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.794 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.2 -26.9 63.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.909 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -36.27 58.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.263 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.2 -38.13 70.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.8 mt -68.08 -55.94 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.055 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.2 p -53.0 -41.16 64.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.281 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.02 -0.99 . . . . 1.0 110.423 179.531 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 1.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -53.6 -53.07 56.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.306 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.02 -46.42 90.81 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.63 -38.98 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.38 -21.15 60.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.555 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -70.32 -40.21 74.31 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.034 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.43 -33.56 62.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.349 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.2 p -68.17 -46.39 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.573 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -56.18 -38.89 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.874 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.64 -37.43 56.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -57.43 -53.14 61.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.951 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.35 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.896 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.3 ttp-105 -51.13 -47.21 62.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.905 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.71 78.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.4 -50.93 10.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.26 -5.59 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 1.0 110.206 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.3 19.2 1.07 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.442 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.3 m -76.08 141.99 41.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.374 -0.531 . . . . 1.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 70' ' ' GLY . 37.3 p30 -67.8 -24.16 65.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 71.2 ttt-85 -153.98 120.31 5.44 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.176 -1.01 . . . . 1.0 113.538 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.21 139.18 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.549 ' HZ1' HH22 ' A' ' 50' ' ' ARG . 28.4 pttt -148.04 160.59 42.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.553 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -99.41 139.15 21.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.078 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -121.58 120.47 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.01 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.2 ttp-105 -99.43 166.59 11.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 1.0 109.911 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 43.2 t80 -132.36 142.77 49.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.074 0.464 . . . . 1.0 112.117 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 m-20 -105.34 149.88 38.26 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.32 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.78 -30.32 58.95 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.735 2.29 . . . . 1.0 112.896 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.95 -5.43 34.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.607 -0.437 . . . . 1.0 111.022 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.77 -14.24 38.19 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.998 -0.62 . . . . 1.0 112.83 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.64 142.77 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.436 0.618 . . . . 1.0 110.896 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.35 140.17 14.25 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.0 p -127.1 145.71 50.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.242 0.544 . . . . 1.0 112.253 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.54 121.26 56.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 p -115.97 9.01 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.71 145.52 21.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.2 tt0 -168.69 129.93 1.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.447 -0.901 . . . . 1.0 113.212 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.36 140.42 44.57 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.39 143.85 50.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.523 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.6 108.19 3.36 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.21 -84.92 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 70' ' ' GLY . 16.1 pt-20 177.89 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.859 -0.337 . . . . 1.0 111.15 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.591 ' NH1' ' NE2' ' A' ' 170' ' ' HIS . 10.4 ptp180 -65.76 -31.6 72.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.3 150.28 45.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.01 162.88 28.79 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.066 1.844 . . . . 1.0 112.494 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -90.79 113.62 25.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.98 -1.18 57.83 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.554 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.2 tp -52.8 135.63 35.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 1.0 112.216 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.89 -1.43 78.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 81' ' ' THR . 3.7 tt -95.22 120.31 35.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 1.0 110.743 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.414 ' N ' HD22 ' A' ' 80' ' ' LEU . 6.2 p -87.75 127.34 35.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.446 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -109.23 139.02 20.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.288 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.67 161.48 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.214 1.943 . . . . 1.0 111.608 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.87 67.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.781 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.43 -23.43 3.08 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.68 -26.9 68.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 1.0 110.663 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 88' ' ' PRO . 60.8 mt -112.18 99.98 47.95 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.3 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 87' ' ' ILE . 84.2 Cg_exo -49.4 -121.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.584 2.189 . . . . 1.0 112.318 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -145.64 -58.32 0.32 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.8 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -51.3 -42.09 60.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.805 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.85 -49.87 66.61 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -29.92 68.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.534 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.18 -48.27 80.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.278 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HB2' ' HE ' ' A' ' 133' ' ' ARG . 74.2 mt -51.89 -40.2 60.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.652 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.7 -24.91 67.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.459 ' HE ' ' CA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -90.98 -21.29 21.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.16 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -105.57 -45.94 4.3 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.404 0.89 . . . . 1.0 113.404 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.72 -5.83 16.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' ALA . 96.3 mt-30 24.68 66.87 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.401 ' CG2' ' NH2' ' A' ' 133' ' ' ARG . 3.1 m -108.44 -50.78 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 1.0 104.43 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.767 ' H ' HH22 ' A' ' 133' ' ' ARG . 1.2 mtt180 65.67 68.03 0.48 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.069 -1.423 . . . . 1.0 114.233 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.558 ' H ' HH12 ' A' ' 133' ' ' ARG . 44.6 t -148.92 130.85 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.754 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 89.8 mt -110.93 128.51 67.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 12.9 t -82.39 168.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 113.307 0.854 . . . . 1.0 113.307 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -47.49 117.34 1.76 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.805 -1.088 . . . . 1.0 112.325 -178.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.08 -10.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.745 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -87.4 -35.41 18.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.872 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.03 48.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.367 0.603 . . . . 1.0 110.149 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 52.78 59.41 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.974 . . . . 1.0 113.456 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -93.79 138.61 31.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -133.82 144.12 48.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.003 1.483 . . . . 1.0 115.003 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-N 114.127 -1.397 . . . . 1.0 107.404 177.062 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.767 HH22 ' H ' ' A' ' 101' ' ' ARG . 17.8 ttm105 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.765 0.317 . . . . 1.0 110.28 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -44.23 145.79 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.512 2.141 . . . . 1.0 111.833 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.5 m -122.38 130.07 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.014 0.435 . . . . 1.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -42.47 163.45 0.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.913 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.3 -11.07 17.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.226 1.951 . . . . 1.0 111.257 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.727 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -60.23 -55.42 33.98 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.976 -0.749 . . . . 1.0 108.976 178.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.727 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 18.0 t-80 -72.34 -27.16 62.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.631 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.05 -60.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.335 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -66.1 -41.98 89.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.24 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -42.51 -48.72 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.546 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 139' ' ' HIS . 30.2 mt -72.08 -47.01 54.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.46 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 147' ' ' GLY . 38.7 tptt -55.99 -42.97 77.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -55.1 -30.2 59.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 41.7 mtt -90.02 -7.98 52.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.118 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.96 28.96 59.7 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.337 -0.847 . . . . 1.0 112.327 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.4 t -108.94 124.36 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.03 -31.17 39.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.6 p -134.12 169.4 17.22 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.594 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -159.06 139.47 12.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.023 0.439 . . . . 1.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.02 141.89 48.3 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.96 156.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.418 0.628 . . . . 1.0 111.914 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.3 t -157.62 98.53 1.91 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.337 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.24 117.74 4.83 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.571 2.848 . . . . 1.0 113.9 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.82 106.3 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.809 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.2 ptm -129.34 143.33 50.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.848 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 70.0 t60 -110.42 113.96 27.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 21.3 m-70 57.97 -119.67 1.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -93.63 2.55 56.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -112.56 150.69 30.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.959 1.096 . . . . 1.0 113.959 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.03 116.84 32.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.491 -1.231 . . . . 1.0 108.867 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -96.96 -28.52 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.921 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.41 -173.81 28.33 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.949 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.0 tp -138.18 133.54 33.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 1.0 111.214 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -99.45 140.03 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.44 111.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 142.04 31.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.106 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -146.71 148.51 32.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.141 0.496 . . . . 1.0 111.043 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' HIS . . . . . 0.591 ' NE2' ' NH1' ' A' ' 73' ' ' ARG . 7.0 t60 -152.63 148.57 27.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -72.74 69.11 0.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 120.345 -0.542 . . . . 1.0 112.293 179.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.324 . . . . 1.0 110.85 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -94.01 149.3 21.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.291 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.93 -40.78 78.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.678 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.87 -55.81 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.366 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.15 -31.34 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 1.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.2 tp -60.82 -38.12 84.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.456 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -63.42 -52.98 59.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.395 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.5 t -43.95 -49.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.317 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.7 m -75.06 -36.28 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLN . . . . . 0.635 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 47.6 tp60 -46.89 -36.64 7.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.099 -1.075 . . . . 1.0 108.099 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.53 -40.76 66.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.374 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' VAL . 33.9 tp -54.76 -33.1 60.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.645 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.94 61.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.603 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . 0.47 ' O ' ' OG ' ' A' ' 192' ' ' SER . 50.6 t0 -57.37 -41.15 79.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.661 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -52.33 -52.38 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.89 -43.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.888 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.644 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 9.6 p -51.92 -38.07 54.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.644 ' N ' ' HG ' ' A' ' 192' ' ' SER . 1.6 mp -77.65 -32.64 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.027 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -46.13 64.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.117 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.74 -26.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.43 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -77.03 -56.31 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.946 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.13 -26.77 63.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.869 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.84 -35.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.24 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -56.91 -38.98 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.8 -57.16 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.09 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 t -60.4 -46.08 91.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 1.0 110.321 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.427 179.768 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.9 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.899 0.381 . . . . 1.0 110.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.18 -46.98 65.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -66.01 -47.31 74.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.222 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.4 mp -59.68 -41.07 84.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -74.83 -22.33 58.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.586 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' O ' HG11 ' A' ' 39' ' ' VAL . 41.3 ttp180 -66.72 -36.83 83.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.614 -0.434 . . . . 1.0 109.973 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.71 -30.98 41.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.317 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -72.39 -48.5 41.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.543 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 36' ' ' ARG . 4.3 p -55.29 -33.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.858 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -72.23 -39.13 68.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.63 -40.63 97.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.988 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.25 -52.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 47' ' ' GLY . 31.2 ttp85 -52.2 -43.55 64.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.877 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.66 75.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 1.0 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -81.55 -50.35 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.77 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -77.39 -7.6 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 1.0 110.087 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.91 19.05 1.25 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.413 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.466 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 1.6 m -76.03 142.74 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.047 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.5 m-20 -57.69 -33.28 68.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -153.29 120.97 5.98 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 119.128 -1.029 . . . . 1.0 113.536 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.75 135.23 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HZ2' HAB1 ' A' ' 203' ' ' CYC . 9.1 pttp -146.45 162.06 39.07 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.552 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.01 136.78 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.007 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.577 ' CD1' HBB3 ' A' ' 203' ' ' CYC . 79.5 t80 -123.4 120.56 33.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.052 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' OG1' ' A' ' 63' ' ' THR . 27.2 ptt180 -101.08 171.98 7.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -134.01 134.19 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 1.0 112.138 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.74 129.32 25.53 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.345 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.47 -25.93 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.739 2.293 . . . . 1.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 -9.82 59.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.984 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.4 36.35 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.816 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -86.72 141.76 28.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.38 0.59 . . . . 1.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.3 145.98 15.95 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.434 -1.067 . . . . 1.0 110.434 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' NE ' ' A' ' 55' ' ' ARG . 28.6 p -129.86 147.88 51.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.25 0.547 . . . . 1.0 112.303 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.06 101.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.36 3.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.18 147.26 24.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.1 tt0 -166.88 126.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.245 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.44 53.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -121.92 141.84 50.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.555 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.93 97.64 1.88 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.47 -90.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.02 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.83 -0.348 . . . . 1.0 111.101 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -70.72 -55.61 8.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.5 mt -92.95 154.48 41.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.92 167.82 23.1 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.099 1.866 . . . . 1.0 112.518 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 p -89.27 132.05 35.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.125 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.09 -4.41 20.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.618 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -59.36 139.89 56.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.35 0.595 . . . . 1.0 112.239 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.8 80.2 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 mt -101.23 131.73 47.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 1.0 110.76 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -88.14 119.41 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.485 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.9 m-85 -108.64 132.5 21.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.285 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.73 157.52 27.99 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.125 1.883 . . . . 1.0 111.702 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.14 66.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.76 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -23.72 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -55.53 -29.07 58.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 1.0 110.634 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.4 mt -121.35 133.43 24.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.507 ' HG3' HMD2 ' A' ' 203' ' ' CYC . 71.8 Cg_endo -78.4 -106.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.538 2.159 . . . . 1.0 112.336 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -152.49 -64.71 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.832 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -43.02 -41.97 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.723 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.466 ' HB3' HAD1 ' A' ' 203' ' ' CYC . . . -61.8 -41.02 97.22 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.958 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -65.57 -28.44 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.526 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -56.72 -55.31 35.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.267 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 9.4 mp -54.13 -40.75 67.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.587 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.91 -40.19 92.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.09 -8.42 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.56 -0.746 . . . . 1.0 110.11 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tp -107.49 -43.58 4.5 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.389 0.885 . . . . 1.0 113.389 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.71 -1.52 12.08 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.53 0.937 . . . . 1.0 113.53 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 28.9 mp0 27.51 69.64 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 101' ' ' ARG . 11.5 p -116.9 -49.67 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.437 -2.431 . . . . 1.0 104.437 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.48 ' N ' ' CG1' ' A' ' 100' ' ' VAL . 2.6 mtt180 61.55 78.96 0.27 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.058 -1.428 . . . . 1.0 114.35 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.79 132.32 5.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.76 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.5 mp -107.06 126.26 63.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 27.3 t -82.85 167.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.249 0.833 . . . . 1.0 113.249 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.498 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 3.5 m-20 -50.84 118.22 3.0 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.692 -1.14 . . . . 1.0 112.261 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -57.66 -10.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.742 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.5 -36.25 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.889 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.5 -15.31 25.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 1.0 110.134 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 52.81 59.98 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.032 -0.986 . . . . 1.0 113.424 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -94.25 137.34 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 1.0 105.401 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -127.9 139.94 52.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.017 1.488 . . . . 1.0 115.017 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 t -105.05 154.2 20.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.154 -1.385 . . . . 1.0 107.338 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 114' ' ' SER . 11.0 tp -157.17 159.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 119.666 -0.814 . . . . 1.0 112.105 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.5 ' N ' HG13 ' A' ' 113' ' ' ILE . 73.5 m -85.78 167.84 14.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.241 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 116' ' ' PRO . 9.0 mt-30 -150.66 159.91 33.52 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.666 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' GLN . 48.1 Cg_exo -37.72 165.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.682 2.255 . . . . 1.0 112.238 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -46.09 140.87 3.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.532 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.8 p -149.85 160.85 43.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.623 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -148.65 172.33 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.57 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.01 1.75 61.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.0 tp -69.51 -37.98 77.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 1.0 110.542 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.7 p -63.22 -20.63 65.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.614 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.2 -30.39 17.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.844 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 ttm105 69.16 59.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.861 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.76 125.82 85.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.091 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.6 129.55 11.48 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.559 2.172 . . . . 1.0 111.195 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt 44.27 -117.08 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 3.1 84.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.616 -0.594 . . . . 1.0 111.616 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -148.36 158.49 40.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.672 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -50.56 166.31 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.417 2.078 . . . . 1.0 111.681 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.53 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 8.0 mp -79.07 12.36 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.301 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 131' ' ' LEU . 93.4 mm-40 -134.89 165.81 24.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.045 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mmt-85 -124.71 78.57 63.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.301 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.92 144.86 5.49 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.516 2.144 . . . . 1.0 111.801 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 3.1 m -113.33 120.1 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 1.0 111.349 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.46 148.97 0.4 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.903 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 140' ' ' VAL . 93.2 Cg_exo -45.85 -48.16 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.212 1.941 . . . . 1.0 111.275 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.2 p -43.83 -34.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.493 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 53.0 t-80 -82.67 -32.62 28.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.715 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' PRO . 52.4 t -53.09 -51.01 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.32 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.13 -43.06 93.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 1.0 110.26 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -46.21 -50.42 15.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.4 mp -71.76 -49.44 38.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.537 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.1 tptm -58.94 -41.29 87.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.46 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.5 p -54.24 -30.3 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.3 mtt -87.01 -0.61 56.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.228 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.26 25.03 75.8 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.293 -0.867 . . . . 1.0 112.359 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.87 122.57 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.23 -33.14 49.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.439 ' OG ' ' OH ' ' A' ' 176' ' ' TYR . 2.4 t -137.42 171.16 14.89 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.592 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 7.3 p -161.42 139.98 9.66 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.198 0.444 . . . . 1.0 112.198 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.589 ' H ' ' HG ' ' A' ' 168' ' ' SER . 65.1 tp -115.19 138.66 50.67 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 1.5 m -132.14 155.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.468 0.651 . . . . 1.0 111.828 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 59.9 t -158.12 90.46 2.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.83 -1.077 . . . . 1.0 109.313 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.76 133.4 54.11 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.562 2.842 . . . . 1.0 113.946 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.8 mt -89.79 106.34 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.776 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 20.6 ptm -127.39 144.91 50.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.0 111.864 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.631 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 22.9 t-80 -114.15 114.06 25.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.631 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 22.2 m-70 59.01 -118.38 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.591 ' H ' ' CD ' ' A' ' 160' ' ' GLN . 2.3 pm0 -95.38 3.06 54.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.545 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.2 tt0 -112.06 149.49 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.37 117.28 33.66 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 114.532 -1.213 . . . . 1.0 108.841 178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 81.7 m95 -97.2 -25.84 15.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.887 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.88 -168.19 23.42 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.971 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 tp -141.11 128.65 21.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.797 0.332 . . . . 1.0 111.239 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -93.9 137.91 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.533 ' CG1' ' HZ3' ' A' ' 52' ' ' LYS . 9.0 p -150.87 133.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.541 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.589 ' HG ' ' H ' ' A' ' 152' ' ' LEU . 1.1 p -115.77 145.4 42.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.009 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.07 140.62 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.157 0.503 . . . . 1.0 111.011 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.465 ' HE2' ' HH ' ' A' ' 176' ' ' TYR . 0.3 OUTLIER -154.03 154.35 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.483 -0.781 . . . . 1.0 109.638 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.97 72.81 10.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.446 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -174.16 129.72 0.48 Allowed Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 120.399 -0.52 . . . . 1.0 112.323 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.93 78.52 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.667 2.245 . . . . 1.0 110.912 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -114.79 146.17 35.49 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.024 -0.989 . . . . 1.0 112.703 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.97 149.49 36.91 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.831 2.354 . . . . 1.0 111.123 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.465 ' HH ' ' HE2' ' A' ' 170' ' ' HIS . 36.1 m-85 -108.14 154.04 22.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.809 0.338 . . . . 1.0 110.802 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.8 p -99.07 139.99 33.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.285 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.23 -36.01 76.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.65 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.7 -54.96 35.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.334 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.21 -32.05 73.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 1.0 110.643 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.54 -42.27 91.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.497 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.9 -52.71 63.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.455 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -44.77 -46.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.275 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.43 -37.85 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -48.68 -37.83 19.6 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.8 -40.92 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.383 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 42.3 tp -53.54 -32.65 51.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.68 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.57 -32.58 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.617 . . . . 1.0 109.616 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -58.68 -41.7 86.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -53.23 -52.85 57.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.4 -41.66 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.886 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.437 ' H ' ' HG ' ' A' ' 192' ' ' SER . 2.7 m -50.34 -29.78 10.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.7 mm -77.79 -38.52 25.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.023 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.67 67.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.108 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 10.4 tp -64.24 -34.61 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -75.23 -55.91 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.881 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.79 -26.62 47.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.893 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.4 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.302 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.55 -39.38 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.154 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.505 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.1 mp -68.55 -56.43 8.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.107 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -55.56 -43.07 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.891 0.377 . . . . 1.0 110.357 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.419 179.708 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.577 HBB3 ' CD1' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.9 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.931 0.396 . . . . 1.0 110.566 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.19 -32.65 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.245 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -78.39 -54.72 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.243 0.46 . . . . 1.0 112.243 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.4 ' O ' HG21 ' A' ' 38' ' ' THR . 4.7 tp -58.35 -37.42 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.494 ' O ' ' OG1' ' A' ' 38' ' ' THR . 80.8 mt -74.36 -33.93 63.23 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -49.76 -37.93 31.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 1.0 109.993 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.39 -30.26 57.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.394 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 52.9 p -70.58 -44.54 67.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.533 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.8 t -59.15 -37.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.63 -39.53 84.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.13 -37.55 83.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.98 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.4 t -68.39 -43.56 84.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.4 ttp180 -57.03 -50.08 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.865 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.75 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.847 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -79.14 -51.88 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.781 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.95 -6.47 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.015 0.436 . . . . 1.0 110.089 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.96 17.65 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.0 112.393 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.8 t -78.53 149.43 33.08 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.077 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.6 m-20 -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.664 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 51.2 ttp180 -155.01 131.86 10.75 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 119.124 -1.03 . . . . 1.0 113.499 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.15 133.59 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 176.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -146.61 160.29 42.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.594 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.11 135.08 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.975 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.553 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 29.7 t80 -117.38 120.27 37.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.058 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.4 ttm-85 -99.83 166.35 11.13 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 11.5 t80 -131.21 135.99 47.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.091 0.472 . . . . 1.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.9 m-20 -102.22 147.79 34.46 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.329 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.42 -21.59 71.26 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.726 2.284 . . . . 1.0 112.909 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.83 -2.44 47.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.044 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.54 -8.58 54.99 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.916 -0.659 . . . . 1.0 112.842 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -90.24 143.5 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.318 0.559 . . . . 1.0 111.005 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -120.47 137.88 12.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.6 p -124.31 145.36 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.197 0.522 . . . . 1.0 112.34 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -104.49 120.57 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.08 4.74 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.78 146.24 24.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.9 tt0 -166.38 127.36 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.398 -0.921 . . . . 1.0 113.222 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 129.5 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 6.8 ptp85 -116.85 140.61 49.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.216 -0.594 . . . . 1.0 111.524 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.47 98.53 1.89 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.78 -90.23 0.04 OUTLIER Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.188 -1.165 . . . . 1.0 110.188 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -176.38 33.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.116 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -71.38 -54.25 11.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.88 145.93 30.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.88 166.37 29.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.081 1.854 . . . . 1.0 112.564 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.521 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 16.2 m -88.86 135.94 33.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.108 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.535 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 45.6 mt -108.7 -0.99 19.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.615 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -60.59 138.95 57.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.588 . . . . 1.0 112.239 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.16 -4.95 85.37 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.338 -0.846 . . . . 1.0 111.05 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.62 130.14 45.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.861 0.362 . . . . 1.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -87.06 121.84 30.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.503 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' GLY . 28.7 m-85 -103.01 136.23 19.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.259 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.11 145.7 24.8 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.126 1.884 . . . . 1.0 111.708 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.37 69.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.15 -20.56 1.45 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 40.4 p30 -60.08 -30.67 69.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.792 0.329 . . . . 1.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.565 ' O ' ' O ' ' A' ' 88' ' ' PRO . 45.6 mt -113.74 101.0 53.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.262 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -45.57 -116.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.536 2.158 . . . . 1.0 112.351 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -154.3 -44.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.907 0.384 . . . . 1.0 111.832 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.4 -39.1 82.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.707 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.422 ' HB1' HAD2 ' A' ' 203' ' ' CYC . . . -61.93 -36.33 81.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 1.0 110.982 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -67.98 -28.63 67.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.562 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' LEU . 55.0 mtp180 -53.65 -57.71 9.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.244 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 98' ' ' ALA . 45.7 mt -54.7 -38.29 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.556 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 6.6 m-85 -65.5 -30.71 71.51 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -93.62 -14.24 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.127 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' ARG . 11.8 tp -107.1 -46.16 3.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -114.99 -3.36 12.65 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.451 0.908 . . . . 1.0 113.451 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.595 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 13.0 mm-40 29.19 69.8 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.487 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -110.04 -51.06 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 175.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.595 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER 63.18 70.4 0.54 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.292 172.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.1 p -152.35 134.31 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.556 -0.457 . . . . 1.0 111.793 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.51 127.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 10.4 p -83.25 167.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 15.7 t0 -53.55 119.41 4.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.312 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.88 -10.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.735 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 1.3 pp20? -86.47 -37.76 17.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.921 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.97 -13.91 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.405 0.622 . . . . 1.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 50.34 52.63 14.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.041 -0.981 . . . . 1.0 113.35 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -93.27 133.44 36.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -126.13 141.07 52.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 m -91.91 144.34 25.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.363 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.16 149.76 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.161 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.8 t -87.29 164.9 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.266 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.53 152.16 55.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.603 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -37.86 -37.84 0.61 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.659 2.24 . . . . 1.0 112.294 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.37 159.79 15.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.535 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.3 m -111.27 170.9 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -48.49 -41.32 29.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.502 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 93.95 3.24 64.03 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt 59.9 -69.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 1.0 110.546 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 120' ' ' GLY . 32.5 t -48.69 -28.83 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.601 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.687 ' O ' ' C ' ' A' ' 124' ' ' ARG . . . -50.0 -43.73 50.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.687 ' C ' ' O ' ' A' ' 123' ' ' ALA . 38.4 ttm180 1.62 90.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.815 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.29 107.02 54.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.054 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -47.28 146.24 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.509 2.14 . . . . 1.0 111.179 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.6 mt 44.44 -165.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.57 -0.529 . . . . 1.0 109.57 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.41 88.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.64 -0.584 . . . . 1.0 111.64 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.1 151.65 45.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 121.0 -0.28 . . . . 1.0 110.661 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.5 160.57 48.1 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.367 2.045 . . . . 1.0 111.68 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 8.8 mp -78.27 -5.17 51.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -139.24 165.59 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.654 -0.419 . . . . 1.0 111.084 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -125.2 114.93 25.93 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.275 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.431 ' O ' ' OG ' ' A' ' 112' ' ' SER . 91.0 Cg_endo -81.35 143.48 13.88 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.573 2.182 . . . . 1.0 111.745 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 1.5 m -112.99 123.34 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.073 0.463 . . . . 1.0 111.319 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.85 154.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.895 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.39 -26.94 79.76 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.221 1.947 . . . . 1.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 22.2 t -61.26 -43.0 99.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.5 ' HA ' HBC2 ' A' ' 203' ' ' CYC . 46.8 t-80 -77.84 -29.65 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.0 -53.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.275 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.487 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 80.1 t60 -64.68 -42.78 95.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.268 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -44.29 -50.56 8.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.405 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mp -71.59 -49.6 38.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.461 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.6 tptm -56.98 -40.83 77.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.487 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 30.9 m -54.2 -32.82 56.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 50.3 mtt -83.98 -2.01 55.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.164 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.68 26.43 74.48 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.277 -0.874 . . . . 1.0 112.353 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 170' ' ' HIS . 9.1 p -109.01 127.04 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.08 -30.9 39.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -137.97 170.45 16.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.145 -0.622 . . . . 1.0 111.512 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 168' ' ' SER . 39.4 t -162.66 138.45 7.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.135 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 18.3 tp -113.63 139.72 48.79 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.8 156.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.457 0.646 . . . . 1.0 111.783 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 66.7 t -156.65 100.38 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.812 -1.085 . . . . 1.0 109.327 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.88 127.11 13.27 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.603 2.869 . . . . 1.0 113.899 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.51 106.08 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.812 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.2 ptm -130.73 146.65 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.834 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.615 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 30.5 t-80 -117.24 116.11 26.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.615 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 3.7 m-70 57.66 -122.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -92.81 7.59 43.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -116.61 150.56 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.011 1.115 . . . . 1.0 114.011 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.93 116.27 31.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.547 -1.206 . . . . 1.0 108.851 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -95.27 -26.34 15.98 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.924 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.5 -168.7 24.8 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.158 -1.02 . . . . 1.0 111.972 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.8 tp -145.32 136.76 25.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.803 0.335 . . . . 1.0 111.142 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.2 tp -100.91 145.5 28.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.7 p -150.9 129.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.6 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 151' ' ' SER . 4.8 p -112.96 145.84 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.077 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.664 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -148.01 138.54 22.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.219 0.533 . . . . 1.0 110.973 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.453 ' ND1' ' CG ' ' A' ' 49' ' ' ASP . 21.3 t60 -150.64 151.73 32.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.702 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.441 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -79.7 67.46 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.424 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -177.08 135.38 0.39 Allowed Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 120.376 -0.53 . . . . 1.0 112.297 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 174' ' ' ARG . 23.7 Cg_exo -38.8 -53.36 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.672 2.248 . . . . 1.0 110.896 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 173' ' ' PRO . 68.1 ttt180 29.95 101.56 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.999 -1.001 . . . . 1.0 112.801 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.96 154.51 22.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.78 2.32 . . . . 1.0 111.162 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -113.82 140.27 48.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.804 0.335 . . . . 1.0 110.78 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.6 m -95.27 148.31 22.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.245 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -67.19 -37.33 83.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.19 -54.48 40.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.349 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.64 -31.59 72.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.846 0.355 . . . . 1.0 110.598 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.14 -41.85 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.509 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' GLN . 94.5 mm-40 -61.54 -52.86 62.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.377 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.6 t -43.06 -44.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.255 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.31 -36.88 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 36.6 tp60 -52.32 -37.86 56.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.58 -32.15 67.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.391 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.75 -27.85 69.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.53 -37.02 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.69 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.492 ' O ' ' OG ' ' A' ' 192' ' ' SER . 56.5 t0 -53.89 -42.33 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.717 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -52.35 -56.3 15.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.19 -41.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.902 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.9 p -51.82 -35.26 43.75 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.4 mt -78.97 -35.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.046 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.07 61.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.08 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tp -62.12 -36.7 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.181 0.515 . . . . 1.0 109.622 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -73.23 -53.63 10.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.958 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 197' ' ' GLN . 19.3 tm0? -55.3 -27.23 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.908 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.07 -33.91 57.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.298 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -58.0 -40.99 82.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.153 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.48 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 9.6 mp -64.96 -58.48 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.093 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.4 t -53.03 -42.22 65.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 1.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.43 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.4 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.553 HBB1 ' CD1' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.6 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.885 0.374 . . . . 1.0 110.565 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.67 -52.28 27.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.231 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.87 -48.35 82.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 tp -60.96 -30.95 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.598 0.592 . . . . 1.0 112.598 -176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -75.57 -24.16 56.61 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.595 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' O ' HG13 ' A' ' 39' ' ' VAL . 73.1 mtp180 -66.83 -36.08 81.52 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.94 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.1 -25.16 43.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.7 p -74.77 -50.68 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.577 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 40' ' ' GLU . 3.4 p -53.52 -36.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.923 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 96.8 mt-10 -74.53 -37.37 63.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -64.79 -51.77 60.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 1.0 112.021 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.23 -50.39 79.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.9 tmm_? -51.36 -43.61 61.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.69 73.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -80.47 -47.17 14.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.17 -6.83 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.175 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.83 17.11 0.49 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.41 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -73.44 140.35 46.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.083 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.6 m-20 -61.99 -29.86 70.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -152.99 118.69 5.34 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 119.231 -0.988 . . . . 1.0 113.517 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.24 137.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -146.23 161.81 39.44 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.547 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.91 135.27 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.017 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.7 t80 -117.9 116.54 27.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.012 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -98.16 164.76 12.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.849 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -131.75 139.56 48.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 1.0 112.12 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -103.79 148.35 35.67 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.718 -0.673 . . . . 1.0 109.296 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.21 -21.85 72.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.732 2.288 . . . . 1.0 112.924 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -80.01 -4.47 52.76 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.974 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.86 46.5 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.871 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -89.13 146.07 25.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.335 0.567 . . . . 1.0 110.888 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.88 144.35 15.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 m -128.55 147.31 50.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.133 0.492 . . . . 1.0 112.309 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.67 119.09 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.05 0.14 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.64 150.46 23.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.1 tt0 -166.05 125.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.372 -0.931 . . . . 1.0 113.166 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.62 136.14 48.7 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.0 141.55 51.77 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.238 -0.585 . . . . 1.0 111.516 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.32 104.67 2.63 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.4 -89.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.8 tt0 -176.94 34.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.174 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -70.98 -53.57 14.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.2 mt -94.76 144.13 27.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 107.921 -1.141 . . . . 1.0 107.921 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.09 170.34 20.35 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.043 1.828 . . . . 1.0 112.504 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -92.32 136.22 33.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.173 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 38.5 mt -109.63 -2.35 17.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.543 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.7 tp -58.52 139.55 55.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.568 . . . . 1.0 112.289 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.38 84.36 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.058 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.1 133.97 43.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.863 0.364 . . . . 1.0 110.766 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -89.07 117.01 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.515 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -107.98 134.91 19.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.78 158.11 27.88 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.123 1.882 . . . . 1.0 111.663 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.76 -20.1 63.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.779 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.66 -22.46 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 10.3 p30 -55.54 -27.78 50.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.323 . . . . 1.0 110.649 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 90.6 mt -127.96 99.58 25.34 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.279 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 47.6 Cg_exo -41.71 -101.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.544 2.163 . . . . 1.0 112.312 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 43.7 tp10 -153.54 -59.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.809 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -43.46 -38.67 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.714 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.92 54.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 1.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -61.64 -31.4 71.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -58.04 -49.58 76.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.284 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.0 mt -53.85 -36.97 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.7 -29.15 69.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -89.66 -15.38 32.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.092 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.82 -46.34 3.98 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.399 0.889 . . . . 1.0 113.399 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.99 -3.0 14.1 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.553 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 25.21 67.01 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.876 ' H ' HH21 ' A' ' 133' ' ' ARG . 13.0 t -107.24 -52.52 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.503 -2.406 . . . . 1.0 104.503 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.683 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 11.5 mtm180 64.38 65.57 0.65 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.312 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 35.7 m -150.11 133.39 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.726 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.473 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.7 mp -109.25 127.38 66.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 108.353 -0.981 . . . . 1.0 108.353 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 25.9 t -83.2 168.11 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.512 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 1.8 m-20 -51.33 114.52 1.25 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.268 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.82 -10.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.789 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 105' ' ' ASP . 4.4 pt-20 -88.5 -35.96 16.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.912 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -15.03 9.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.412 0.625 . . . . 1.0 110.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 49.97 51.5 16.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 1.0 113.396 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 m -94.2 138.2 32.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.405 -2.072 . . . . 1.0 105.405 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -128.27 137.93 52.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.05 1.5 . . . . 1.0 115.05 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.454 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 54.2 m -100.34 153.03 19.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.307 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 112' ' ' SER . 14.6 pt -157.5 163.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.732 -0.787 . . . . 1.0 112.189 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.8 t -86.58 163.62 17.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.228 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -153.32 149.93 22.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.695 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 117' ' ' GLU . 48.2 Cg_exo -37.21 157.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.637 2.225 . . . . 1.0 112.254 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' PRO . 44.2 mt-10 55.89 158.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.8 m -145.02 152.81 40.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.641 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 0.3 OUTLIER -42.79 -76.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.517 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.83 3.59 73.64 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 8.5 mp -93.26 125.12 37.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 1.0 110.555 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -64.69 -58.11 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -67.98 -29.26 68.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.82 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 123' ' ' ALA . 19.6 tpt180 57.84 145.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.6 m -62.65 149.88 87.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.133 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.38 132.58 26.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.584 2.19 . . . . 1.0 111.177 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 129' ' ' GLU . 22.3 mt 43.49 -126.8 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.22 -6.63 3.03 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.642 -0.583 . . . . 1.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 127' ' ' LEU . 45.6 mm-40 -95.5 154.58 39.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.574 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -42.85 152.91 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.323 2.015 . . . . 1.0 111.738 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.0 mt -78.57 -7.51 57.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.344 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.52 166.25 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.087 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.876 HH21 ' H ' ' A' ' 100' ' ' VAL . 26.1 mtt-85 -119.99 77.58 23.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.286 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.07 150.29 5.08 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.515 2.143 . . . . 1.0 111.837 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.406 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -97.44 145.69 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.027 0.442 . . . . 1.0 111.382 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.4 m-20 -91.1 147.02 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.553 -0.749 . . . . 1.0 110.913 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -38.75 -28.69 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.199 1.933 . . . . 1.0 111.288 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 136' ' ' ASP . 47.9 t -67.6 -53.15 30.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 136' ' ' ASP . 19.4 t-80 -73.54 -24.99 60.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.4 t -50.99 -55.94 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.353 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.14 -41.46 94.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -43.17 -50.4 6.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.51 -48.1 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.525 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.3 tmtm? -57.27 -43.07 82.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.511 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.8 p -55.2 -27.34 45.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 39.4 mtt -92.25 -3.48 55.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.186 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.12 22.77 72.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.357 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.83 122.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.72 -0.392 . . . . 1.0 109.953 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.36 -37.22 57.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -130.22 170.57 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.579 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 3.4 p -158.92 139.64 12.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.02 0.438 . . . . 1.0 112.157 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.783 ' H ' ' HG ' ' A' ' 168' ' ' SER . 46.9 tp -116.31 140.02 49.77 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.401 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 3.1 m -134.33 154.54 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.463 0.649 . . . . 1.0 111.739 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 74.6 t -157.21 108.21 1.89 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.767 -1.106 . . . . 1.0 109.267 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.78 113.88 3.9 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.659 2.906 . . . . 1.0 113.847 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.72 105.88 3.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.78 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.7 ptm -132.19 147.07 52.4 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.835 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.628 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 11.7 t-80 -118.07 115.58 25.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.628 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 79.8 m-70 59.32 -122.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.99 7.59 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.883 0.327 . . . . 1.0 111.883 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.3 mp0 -114.65 146.03 41.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.94 117.41 33.98 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 114.525 -1.216 . . . . 1.0 108.809 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -96.15 -26.67 15.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.899 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.27 -170.88 28.79 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.261 -0.971 . . . . 1.0 112.041 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.445 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.9 tp -141.67 137.29 31.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 1.0 111.216 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 5.1 tp -99.11 142.8 30.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.31 135.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.595 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.783 ' HG ' ' H ' ' A' ' 152' ' ' LEU . 1.3 p -120.8 142.51 49.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.046 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.618 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -150.03 127.99 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.127 0.489 . . . . 1.0 111.021 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.561 ' O ' ' O ' ' A' ' 171' ' ' ALA . 3.8 p80 -166.58 156.52 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.704 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 170' ' ' HIS . . . -46.14 -170.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.607 -0.269 . . . . 1.0 111.448 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -103.61 104.96 45.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.261 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.443 ' CD ' ' H ' ' A' ' 174' ' ' ARG . 36.2 Cg_endo -92.35 -48.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.676 2.251 . . . . 1.0 110.908 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.443 ' H ' ' CD ' ' A' ' 173' ' ' PRO . 9.6 ptp180 -179.43 156.83 0.84 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.065 -0.971 . . . . 1.0 112.691 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.89 162.89 2.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.848 2.365 . . . . 1.0 111.119 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -111.82 146.38 37.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 1.0 110.744 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 t -99.68 143.12 30.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.23 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.14 -31.93 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.646 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.05 -54.52 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.337 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.42 -30.64 71.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.904 0.383 . . . . 1.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.16 -35.1 74.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.538 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.58 -52.75 28.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.407 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -44.44 -47.38 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 187' ' ' LEU . 27.3 m -75.01 -36.81 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.672 ' NE2' HH22 ' A' ' 101' ' ' ARG . 58.7 tt0 -46.94 -35.84 6.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.6 tt -72.1 -43.46 64.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.412 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 184' ' ' VAL . 39.0 tp -53.96 -33.17 56.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.662 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.95 -37.27 62.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.618 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -56.21 -38.09 70.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.705 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -53.16 -51.83 60.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.12 -42.46 79.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.265 -0.879 . . . . 1.0 109.889 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.3 m -51.86 -37.12 50.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.61 -33.47 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.048 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.37 -47.13 58.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.101 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.0 tp -62.4 -33.12 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.527 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.96 -53.59 8.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.898 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -56.28 -28.36 58.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.68 -34.3 52.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.17 -39.98 80.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.86 -57.62 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.4 t -58.14 -44.17 87.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.059 -0.972 . . . . 1.0 110.373 179.657 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.438 HBC1 ' HA ' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.397 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.294 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.18 -52.7 45.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -55.05 -50.09 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.687 0.625 . . . . 1.0 112.687 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 29.8 mt -64.42 -23.97 67.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.541 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' O ' HG11 ' A' ' 39' ' ' VAL . 61.0 ttt180 -58.23 -36.1 72.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.651 -0.419 . . . . 1.0 109.925 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.35 38.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.3 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 50.6 p -69.36 -49.87 51.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.507 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 36' ' ' ARG . 3.9 p -53.08 -36.32 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 75.2 mm-40 -65.24 -38.41 90.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.841 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.15 -44.91 87.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.924 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.08 -44.08 95.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.3 tmm_? -62.43 -51.64 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.843 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.49 -40.06 81.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.847 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.76 -51.49 9.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.794 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.51 -5.58 48.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.087 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.29 17.71 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.716 -0.675 . . . . 1.0 112.415 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.494 ' O ' ' CD ' ' A' ' 43' ' ' ARG . 1.2 m -74.48 141.85 44.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.108 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -57.48 -33.39 67.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -152.28 119.82 6.03 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 119.18 -1.008 . . . . 1.0 113.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -139.14 134.88 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.628 ' NZ ' HAB2 ' A' ' 203' ' ' CYC . 29.3 pttt -145.62 161.9 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.377 -0.529 . . . . 1.0 111.566 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.44 136.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.006 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.563 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 43.8 t80 -121.0 119.11 31.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.113 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -100.07 170.08 8.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.925 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.418 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 72.3 t80 -134.32 138.78 45.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.526 -0.47 . . . . 1.0 112.124 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -102.45 148.79 35.97 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.306 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.36 -21.22 66.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.729 2.286 . . . . 1.0 112.965 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.3 -0.57 41.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.563 -0.455 . . . . 1.0 111.038 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.33 -11.51 54.72 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.855 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.6 m-70 -89.34 146.44 24.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.383 0.592 . . . . 1.0 110.976 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.8 144.68 15.37 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 p -129.26 148.21 51.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.184 0.516 . . . . 1.0 112.275 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.78 120.99 57.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.937 -1.134 . . . . 1.0 107.937 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.04 8.1 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.06 146.37 23.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' OE1' ' OG ' ' A' ' 76' ' ' SER . 52.4 tt0 -166.75 127.69 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.296 -0.962 . . . . 1.0 113.186 -178.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.1 139.07 47.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -127.53 141.46 51.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.138 -0.625 . . . . 1.0 111.569 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.15 107.59 3.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.417 -1.073 . . . . 1.0 110.417 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.23 16.95 0.1 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.264 -1.134 . . . . 1.0 110.264 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.7 tt0 71.99 28.87 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.791 -0.364 . . . . 1.0 111.104 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -57.55 -58.24 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -90.65 158.63 42.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.31 162.49 33.69 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.09 1.86 . . . . 1.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.441 ' OG ' ' OE1' ' A' ' 67' ' ' GLU . 24.7 t -85.9 108.9 18.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.119 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 48.9 mt -84.1 -1.47 54.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.56 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.4 tp -62.44 139.54 58.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.349 0.595 . . . . 1.0 112.289 -177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.0 -4.12 74.36 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.121 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.499 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 8.8 mp -102.41 131.04 49.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 1.0 110.774 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.01 119.81 25.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.95 132.96 20.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.302 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -79.61 155.8 24.43 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.214 1.943 . . . . 1.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.9 -21.08 65.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.798 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.19 -22.07 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.03 -27.8 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 1.0 110.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.6 mt -107.86 106.28 58.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.332 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.5 Cg_exo -48.47 -125.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.505 2.136 . . . . 1.0 112.35 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.6 pt-20 -142.91 -43.08 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 22.7 pt-20 -68.83 -39.8 79.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.723 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.09 84.1 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.007 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -63.24 -30.62 71.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.553 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -56.66 -51.13 69.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.323 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 10.4 mp -55.71 -35.33 65.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 7.9 m-85 -63.36 -31.49 72.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 1.0 109.625 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -87.16 -15.16 39.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.042 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.48 -42.67 4.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.03 -4.78 13.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.517 0.932 . . . . 1.0 113.517 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.597 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 96.4 mt-30 27.06 69.65 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 6.8 t -109.76 -49.21 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.435 -2.431 . . . . 1.0 104.435 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.682 ' NH1' HE22 ' A' ' 185' ' ' GLN . 0.6 OUTLIER 63.06 70.56 0.54 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.137 -1.392 . . . . 1.0 114.311 172.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.11 136.74 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.706 178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.71 127.76 64.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 34.3 t -83.53 166.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.498 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 4.1 m-20 -53.68 119.44 4.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.26 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.0 m -58.01 -13.2 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.876 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -87.61 -38.04 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.89 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.32 -13.72 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.384 0.611 . . . . 1.0 110.059 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 51.3 54.77 10.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 113.409 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -93.94 133.62 37.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -128.21 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.486 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 80.0 p -99.54 147.03 25.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.17 -1.377 . . . . 1.0 107.316 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.0 mt -146.9 152.27 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.681 -0.807 . . . . 1.0 112.135 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.1 t -91.5 171.36 9.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.21 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.4 OUTLIER -149.17 152.84 36.95 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.667 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.38 -13.65 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.635 2.223 . . . . 1.0 112.239 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.39 -28.12 69.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 119' ' ' TRP . 29.5 t 54.89 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.675 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.493 ' N ' ' OG ' ' A' ' 118' ' ' SER . 38.6 m95 53.8 170.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.502 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.94 29.69 45.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 tt -150.69 -61.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 1.0 110.564 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.0 p -60.7 -22.79 64.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.14 -14.61 56.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 60.92 79.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.7 m -99.51 146.8 32.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.114 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.68 129.87 14.08 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.54 2.16 . . . . 1.0 111.202 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.7 mt 43.26 -134.25 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.67 11.64 76.8 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.689 -0.564 . . . . 1.0 111.689 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.81 148.35 17.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.661 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -43.48 157.55 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.354 2.036 . . . . 1.0 111.706 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.446 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 25.3 mt -82.06 25.71 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.244 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 131' ' ' LEU . 25.7 mm100 -134.08 163.96 28.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.096 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 1.6 mmp_? -122.39 80.37 45.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.286 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.75 147.63 6.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.494 2.129 . . . . 1.0 111.816 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 m -95.72 151.58 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 1.0 111.329 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.486 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.3 m-20 -84.89 156.32 61.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.909 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -56.34 -26.52 62.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.216 1.944 . . . . 1.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.6 OUTLIER -74.51 -34.81 63.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.06 -0.718 . . . . 1.0 109.06 176.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.526 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 46.2 t-80 -81.47 -31.56 32.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.657 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -52.29 -50.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.33 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 145' ' ' SER . 86.5 t60 -65.99 -43.88 86.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.28 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -44.19 -52.07 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.16 -46.2 52.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.501 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.0 OUTLIER -59.51 -42.76 92.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.52 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 141' ' ' HIS . 17.7 t -53.83 -32.53 53.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 40.7 mtt -84.51 -1.89 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.113 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.1 23.85 76.03 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.352 -0.84 . . . . 1.0 112.233 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.9 t -105.03 124.92 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.52 24.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -131.5 169.37 16.18 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.565 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.0 m -162.61 139.47 7.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.106 0.479 . . . . 1.0 112.15 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.57 139.69 50.21 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.427 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 1.9 m -135.13 157.81 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.803 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 59.3 t -158.98 91.91 1.95 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.388 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.46 115.37 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.636 2.891 . . . . 1.0 113.922 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.29 105.87 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.859 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.442 ' O ' ' OG ' ' A' ' 192' ' ' SER . 16.7 ptm -130.92 146.43 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.0 111.836 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 84.5 t60 -119.51 115.68 24.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.493 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 49.1 t60 64.02 -126.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.493 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.5 mt-30 -92.66 5.28 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.855 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 46.9 mp0 -115.09 150.69 35.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.24 117.34 33.79 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 114.517 -1.219 . . . . 1.0 108.86 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -97.4 -28.83 13.83 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.864 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.65 -171.93 24.22 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.22 -0.99 . . . . 1.0 111.962 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.9 tp -138.8 129.69 26.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.565 -0.318 . . . . 1.0 111.205 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -94.52 139.06 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 169' ' ' HIS . 9.7 p -151.19 132.83 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.532 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.619 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 1.5 m -115.22 140.57 48.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.05 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.619 ' ND1' ' O ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -135.5 141.48 45.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 1.0 110.992 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -158.2 154.27 27.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.5 -0.773 . . . . 1.0 109.742 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.94 67.94 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -178.79 134.75 0.3 Allowed Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.298 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 174' ' ' ARG . 20.0 Cg_exo -38.34 -38.39 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.726 2.284 . . . . 1.0 110.82 176.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' PRO . 59.2 ttm-85 26.88 78.8 0.24 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 114.983 -1.008 . . . . 1.0 112.678 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.55 148.2 83.22 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.861 2.374 . . . . 1.0 111.136 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -110.96 141.45 44.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.809 0.337 . . . . 1.0 110.721 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -96.17 153.93 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.641 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.99 -53.49 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.324 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 37.4 mp0 -71.41 -24.22 62.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.884 0.373 . . . . 1.0 110.677 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -61.44 -45.65 93.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.505 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.45 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 10.9 pt20 -67.56 -48.66 66.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.417 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.45 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 46.4 t -43.68 -51.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.243 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.48 -36.05 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.682 HE22 ' NH1' ' A' ' 101' ' ' ARG . 63.0 tp60 -48.24 -37.95 17.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.89 -40.27 65.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.375 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.71 -32.42 63.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.687 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.54 -37.7 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.701 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -56.96 -40.36 76.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.741 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.66 -54.09 38.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.39 -40.69 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.923 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 157' ' ' MET . 3.5 t -50.1 -30.17 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.63 -39.43 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.056 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.67 67.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.133 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.01 -35.64 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -76.48 -54.77 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.863 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -55.94 -28.52 57.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.949 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -35.23 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.336 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.43 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 83.6 tt0 -57.77 -39.76 78.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.133 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.9 tp -68.52 -58.04 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.047 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.7 m -56.86 -44.25 81.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.43 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 7.8 tp . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.425 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.628 HAB2 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 1.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.2 p-10 -61.96 -42.54 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.259 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 96.3 mt-30 -68.81 -52.0 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.542 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.4 mp -60.78 -34.54 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.22 -23.67 60.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -62.56 -52.85 61.81 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.632 -0.427 . . . . 1.0 109.965 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.02 77.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.359 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.538 ' HG1' ' N ' ' A' ' 39' ' ' VAL . 43.3 p -67.82 -46.5 71.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.526 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.538 ' N ' ' HG1' ' A' ' 38' ' ' THR . 10.1 t -59.28 -38.42 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.903 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.31 -37.74 77.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.778 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.31 -43.98 80.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 1.0 112.01 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.44 -51.11 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.861 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.4 tmt_? -52.73 -44.6 66.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.834 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.82 68.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.806 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -83.21 -46.2 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.734 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.53 -8.5 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 1.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 49.56 17.88 1.44 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.632 -0.713 . . . . 1.0 112.405 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -77.07 144.85 38.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.159 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 94.1 m-20 -54.56 -34.16 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 9.0 ttm180 -152.61 122.62 7.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.168 -1.013 . . . . 1.0 113.595 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.42 132.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.705 ' HZ3' ' HE2' ' A' ' 169' ' ' HIS . 19.5 pttm -146.64 155.74 42.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.576 -177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.66 138.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.97 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.645 ' CD1' HBB2 ' A' ' 203' ' ' CYC . 58.9 t80 -122.43 119.81 32.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.058 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -100.21 170.64 8.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.436 . . . . 1.0 109.864 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 62.9 t80 -133.22 141.89 48.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.0 m-20 -105.52 149.42 37.82 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.371 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.35 -25.95 63.73 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.696 2.264 . . . . 1.0 112.961 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -76.52 -5.38 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.941 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.19 -12.69 44.46 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.839 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.03 144.64 26.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.388 0.594 . . . . 1.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 143.85 15.3 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.9 p -127.37 146.69 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.346 0.498 . . . . 1.0 112.346 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.19 118.34 46.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -111.9 4.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.38 21.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.9 tt0 -166.46 127.44 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.362 -0.935 . . . . 1.0 113.215 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.06 140.66 39.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -129.75 141.89 50.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.512 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.94 106.16 2.84 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.431 -1.068 . . . . 1.0 110.431 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.19 -88.72 0.01 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.294 -1.122 . . . . 1.0 110.294 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' GLY . 23.0 pt-20 -176.77 31.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.109 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -66.51 -54.12 27.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.411 ' HB3' HH21 ' A' ' 50' ' ' ARG . 28.6 mt -95.33 151.93 39.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 171.57 16.42 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.07 1.846 . . . . 1.0 112.504 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.4 m -92.73 135.29 34.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.148 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.58 -9.22 15.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.618 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.583 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 17.6 tp -50.73 138.79 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.363 0.601 . . . . 1.0 112.212 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -1.87 79.27 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.51 125.92 46.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 1.0 110.757 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.9 t -84.08 122.23 28.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.488 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.581 ' CG ' HAB1 ' A' ' 203' ' ' CYC . 47.7 m-85 -108.07 138.81 20.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.25 155.06 16.74 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.136 1.89 . . . . 1.0 111.646 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.411 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -65.56 -21.11 66.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.827 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 87' ' ' ILE . . . -49.8 -24.82 6.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 19.1 p-10 -47.86 -13.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 1.0 110.663 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.509 ' H ' ' C ' ' A' ' 85' ' ' GLY . 3.5 pt -135.91 137.96 26.57 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.224 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HG3' HMD1 ' A' ' 203' ' ' CYC . 61.5 Cg_endo -80.68 -114.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 1.0 112.374 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.0 mm-40 -141.82 -66.12 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.91 0.386 . . . . 1.0 111.881 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -47.79 -43.09 27.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.682 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.418 ' HB1' HBD1 ' A' ' 203' ' ' CYC . . . -67.78 -53.07 30.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.964 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.467 HH21 ' CD2' ' A' ' 162' ' ' LEU . 24.6 ttt180 -54.47 -27.86 40.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' LEU . 22.1 mmt180 -63.68 -46.15 86.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.297 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 98' ' ' ALA . 39.6 mt -49.99 -42.61 49.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.564 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 30.3 m-85 -64.99 -29.88 70.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -90.24 -18.96 24.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.102 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -104.76 -45.34 4.62 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.426 0.899 . . . . 1.0 113.426 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -111.1 -2.78 15.72 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.7 mt-30 28.29 67.2 0.08 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.014 1.116 . . . . 1.0 114.014 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.38 -50.51 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.385 -2.45 . . . . 1.0 104.385 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.481 HH12 ' CD ' ' A' ' 185' ' ' GLN . 3.0 mtp180 64.79 70.38 0.48 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.072 -1.422 . . . . 1.0 114.304 172.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 64.1 t -150.67 130.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.784 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.424 ' CD1' ' N ' ' A' ' 103' ' ' ILE . 1.7 mp -106.64 126.58 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 11.9 p -81.81 166.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.224 0.824 . . . . 1.0 113.224 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.471 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 13.6 m-20 -52.2 120.82 5.88 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.658 -1.156 . . . . 1.0 112.328 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 37.1 t -57.6 -11.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.737 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' A' ' 109' ' ' GLN . 17.0 pt-20 -83.04 -38.95 21.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.851 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.98 1.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.396 0.617 . . . . 1.0 110.114 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.561 ' H ' ' C ' ' A' ' 107' ' ' GLU . 19.5 pt20 35.43 58.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.018 -0.992 . . . . 1.0 113.392 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -94.32 135.27 35.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.386 -2.079 . . . . 1.0 105.386 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -129.98 145.59 51.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.97 114.45 14.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.132 -1.394 . . . . 1.0 107.31 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 pt -119.21 -167.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 119.69 -0.804 . . . . 1.0 112.091 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 76.6 p -87.98 161.84 17.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.231 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -144.04 154.7 58.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.665 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.25 -6.62 15.76 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.681 2.254 . . . . 1.0 112.254 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.73 156.66 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -139.03 171.38 14.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.632 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 120' ' ' GLY . 50.8 t-105 62.96 179.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.553 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 119' ' ' TRP . . . 87.42 23.43 40.11 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.981 -0.847 . . . . 1.0 110.981 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -154.05 -18.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 1.0 110.587 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.8 m -59.93 -28.49 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.17 -17.49 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 57.98 91.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.3 144.64 30.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.075 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.2 140.98 31.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.553 2.169 . . . . 1.0 111.246 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 9.1 mp 43.45 -113.24 0.27 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.1 21.39 67.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' PRO . 44.1 mt-10 -139.37 154.4 71.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.611 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 129' ' ' GLU . 79.6 Cg_exo -42.81 168.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.464 2.109 . . . . 1.0 111.654 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.08 9.87 6.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.288 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.488 ' O ' ' NH2' ' A' ' 133' ' ' ARG . 14.1 pt20 -139.62 163.44 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.678 -0.409 . . . . 1.0 111.063 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.593 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -118.43 108.62 41.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.327 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.9 145.98 16.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.587 2.191 . . . . 1.0 111.818 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 135' ' ' VAL . 2.9 m -118.03 127.19 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.447 . . . . 1.0 111.389 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.557 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -39.94 163.74 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.888 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.94 -19.68 34.94 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.265 1.977 . . . . 1.0 111.234 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.2 p -66.22 -37.52 85.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.515 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 40.4 t-80 -80.69 -28.34 36.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.632 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 29.3 t -52.31 -53.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.322 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 145' ' ' SER . 85.2 t60 -66.88 -42.15 86.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.296 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -47.66 -56.9 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.503 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -68.49 -50.38 52.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.527 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 21.1 tptm -57.35 -40.08 77.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 t -54.06 -32.49 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.5 mtt -83.46 1.15 43.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.264 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.52 25.3 75.64 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.214 -0.903 . . . . 1.0 112.33 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.17 122.91 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.835 -0.432 . . . . 1.0 109.835 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.09 -30.43 49.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.0 t -140.11 172.89 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.09 -0.644 . . . . 1.0 111.551 -178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 p -162.84 139.96 7.77 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.081 0.467 . . . . 1.0 112.141 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.1 tp -118.3 138.79 52.14 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.3 m -133.04 158.98 43.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.418 0.628 . . . . 1.0 111.859 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.453 ' CG1' HH21 ' A' ' 101' ' ' ARG . 88.5 t -154.32 96.44 2.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.849 -1.069 . . . . 1.0 109.313 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 154' ' ' VAL . 54.7 Cg_endo -63.97 139.23 66.65 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.571 2.847 . . . . 1.0 113.957 -175.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.59 105.56 17.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.736 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.458 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.1 mtp -117.54 139.06 51.45 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.906 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.632 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 26.6 t-80 -113.74 113.58 25.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.632 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 46.5 m-70 57.6 -123.0 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -94.23 10.99 31.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 51.0 mp0 -119.87 153.64 35.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.047 1.129 . . . . 1.0 114.047 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.467 ' CD2' HH21 ' A' ' 92' ' ' ARG . 14.8 tp -108.83 112.25 24.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.882 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -95.5 -28.61 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.905 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -154.88 -175.9 26.5 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.21 -0.995 . . . . 1.0 111.944 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.45 133.6 24.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.812 0.339 . . . . 1.0 111.215 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.7 tp -99.93 135.78 40.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.2 t -148.17 120.87 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.381 -0.528 . . . . 1.0 111.538 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 p -108.89 148.74 30.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.705 ' HE2' ' HZ3' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -149.06 148.22 29.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 1.0 111.018 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.663 ' HE2' ' HH ' ' A' ' 176' ' ' TYR . 3.0 p-80 -158.92 155.41 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.678 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.74 69.95 4.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.552 -0.295 . . . . 1.0 111.43 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -175.07 172.13 1.18 Allowed Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 120.41 -0.516 . . . . 1.0 112.326 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 174' ' ' ARG . 42.3 Cg_endo -89.11 -47.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.697 2.265 . . . . 1.0 110.914 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 173' ' ' PRO . 7.3 tpp180 23.32 88.29 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.058 -0.974 . . . . 1.0 112.723 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.08 151.32 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.791 2.327 . . . . 1.0 111.112 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.663 ' HH ' ' HE2' ' A' ' 170' ' ' HIS . 13.7 m-85 -109.99 144.21 38.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.756 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -96.5 146.69 24.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.05 -40.08 78.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.6 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.11 -54.48 37.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.419 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.05 -35.31 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.374 . . . . 1.0 110.738 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.61 -38.71 88.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.505 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.1 -55.67 32.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.2 t -43.87 -43.46 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 86.0 t -74.99 -37.64 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.481 ' CD ' HH12 ' A' ' 101' ' ' ARG . 60.9 tt0 -48.27 -37.21 15.66 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.92 -40.2 63.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.751 -1.113 . . . . 1.0 109.344 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 44.0 tp -54.99 -32.34 61.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.692 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.83 -35.25 67.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.679 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -56.28 -39.58 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.695 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -53.64 -54.58 35.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.67 -44.11 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.226 -0.897 . . . . 1.0 109.834 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 157' ' ' MET . 10.1 t -51.68 -37.72 51.87 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 71.6 mt -78.2 -32.2 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.082 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.4 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.074 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.409 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.7 pp -68.18 -24.26 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.24 -57.14 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.862 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.9 -27.34 66.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.885 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.56 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.355 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.421 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 41.3 tp10 -55.66 -37.02 67.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.163 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 -55.34 12.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.075 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.3 p -54.83 -42.07 71.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 1.0 110.303 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.421 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 27.3 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.422 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.645 HBB2 ' CD1' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.843 0.354 . . . . 1.0 110.515 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.2 p-10 -64.04 -40.26 95.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.236 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.52 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.8 mt-30 -71.21 -54.24 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.5 mp -56.41 -44.79 81.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' O ' ' OG1' ' A' ' 38' ' ' THR . 33.3 mt -68.88 -26.38 65.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.522 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -56.43 -38.82 72.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.945 0.402 . . . . 1.0 109.998 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.66 58.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 43.2 p -70.04 -45.44 67.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.479 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.61 -39.29 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.869 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -68.23 -37.89 81.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.817 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.2 -41.36 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.013 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.74 -45.91 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.866 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.0 tmm_? -53.74 -48.32 69.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.885 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.76 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.24 -52.49 7.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.776 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.86 -7.39 55.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.959 0.409 . . . . 1.0 110.114 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.14 17.79 0.38 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.457 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.41 ' HG1' ' HG ' ' A' ' 168' ' ' SER . 15.1 t -77.37 146.77 36.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.1 m-20 -56.39 -33.08 65.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 41.7 ttm-85 -153.39 127.44 9.02 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 119.174 -1.01 . . . . 1.0 113.533 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.72 132.33 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.973 -1.121 . . . . 1.0 107.973 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -145.73 161.07 40.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.54 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.38 137.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.955 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.549 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 67.3 t80 -122.26 119.85 32.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.074 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -100.07 171.11 8.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -133.96 136.68 44.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 1.0 112.084 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.42 126.45 33.14 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.353 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.94 -28.61 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.68 2.253 . . . . 1.0 112.923 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -74.29 -7.73 53.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.029 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.06 -13.57 34.11 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.014 -0.612 . . . . 1.0 112.825 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.94 145.94 25.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.352 0.576 . . . . 1.0 110.862 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.418 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.61 145.45 15.71 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.9 p -128.82 148.28 50.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 1.0 112.328 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.25 120.49 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 m -110.58 0.51 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.0 151.04 21.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 50' ' ' ARG . 1.9 pp20? -169.25 131.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.36 -0.936 . . . . 1.0 113.209 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.45 142.56 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.4 ' C ' HH12 ' A' ' 43' ' ' ARG . 10.0 ptt85 -133.22 143.96 49.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.481 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.53 112.87 3.9 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.22 34.04 2.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 54.57 31.52 15.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.14 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -60.65 -55.56 31.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' HB2' ' HE ' ' A' ' 50' ' ' ARG . 81.9 mt -95.86 147.21 32.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 57.9 Cg_endo -70.67 170.77 16.86 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.128 1.885 . . . . 1.0 112.528 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.411 ' HA ' HH22 ' A' ' 50' ' ' ARG . 23.1 t -89.08 130.11 35.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.158 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.8 mt -101.13 1.56 39.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.594 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.62 135.01 57.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.323 0.582 . . . . 1.0 112.24 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.63 -7.49 77.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 7.8 mp -96.99 132.04 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.885 0.374 . . . . 1.0 110.737 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 m -90.87 117.9 29.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.455 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 m-85 -109.42 135.82 20.27 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.293 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.98 157.35 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.12 1.88 . . . . 1.0 111.628 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.9 -17.78 63.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.823 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.51 -22.23 0.99 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.31 -29.82 64.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.86 0.362 . . . . 1.0 110.634 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.499 ' CG2' ' HE ' ' A' ' 92' ' ' ARG . 58.4 mt -98.66 146.74 32.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.228 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.449 ' HB3' HMC1 ' A' ' 203' ' ' CYC . 5.0 Cg_endo -96.18 -142.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.465 2.11 . . . . 1.0 112.331 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' A' ' 90' ' ' GLU . 1.2 pt-20 -121.94 -76.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.794 -0.363 . . . . 1.0 111.825 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HG3' ' A' ' 89' ' ' GLU . 22.7 pt-20 -45.84 -40.53 9.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.779 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.446 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -66.84 -48.61 68.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.657 -0.417 . . . . 1.0 111.014 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.499 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 21.3 ttm180 -59.82 -29.46 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.555 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' LEU . 35.1 mtp180 -58.91 -46.79 87.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 98' ' ' ALA . 43.0 mt -55.12 -36.74 66.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.569 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CZ ' ' O2A' ' A' ' 203' ' ' CYC . 9.9 m-85 -63.49 -35.18 79.6 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -91.32 -15.85 28.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 2.8 tp -105.8 -45.53 4.36 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.33 0.863 . . . . 1.0 113.33 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.31 -3.67 12.46 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.515 0.931 . . . . 1.0 113.515 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.3 mt-30 30.08 69.68 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.01 1.115 . . . . 1.0 114.01 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.9 -51.21 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.439 HH21 HG22 ' A' ' 154' ' ' VAL . 0.8 OUTLIER 62.82 74.09 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.997 -1.456 . . . . 1.0 114.286 172.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.85 132.42 5.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.72 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.84 128.15 63.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 44.9 t -82.36 165.99 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.272 0.841 . . . . 1.0 113.272 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.508 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 12.9 m-20 -52.74 123.28 10.9 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.772 -1.104 . . . . 1.0 112.308 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -58.96 -10.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.707 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.0 pt-20 -85.94 -39.48 16.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.867 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.434 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -60.68 -15.29 27.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.372 0.606 . . . . 1.0 110.066 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 50.86 57.72 6.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.047 -0.979 . . . . 1.0 113.345 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t -94.47 136.09 35.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.349 -2.093 . . . . 1.0 105.349 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -129.6 142.42 50.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.98 1.474 . . . . 1.0 114.98 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 2.8 m -108.3 161.57 14.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.181 -1.372 . . . . 1.0 107.341 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.433 ' CG1' ' H ' ' A' ' 114' ' ' SER . 15.5 tt -166.9 168.64 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.708 -0.797 . . . . 1.0 112.153 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.433 ' H ' ' CG1' ' A' ' 113' ' ' ILE . 40.7 t -90.41 164.67 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.18 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -151.76 149.5 23.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.645 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -37.81 -41.02 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.679 2.253 . . . . 1.0 112.246 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CD ' ' CH2' ' A' ' 119' ' ' TRP . 93.0 mt-10 -74.47 -74.12 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.533 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 t 41.73 38.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.574 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.478 ' CH2' ' CD ' ' A' ' 117' ' ' GLU . 5.5 m-90 -53.97 -35.55 61.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.99 65.22 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.6 mp 46.0 69.56 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 1.0 110.598 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.4 m -60.67 -27.46 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.585 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.52 -19.17 3.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.811 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 59.52 85.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.84 108.27 59.2 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.111 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -46.12 133.49 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.536 2.157 . . . . 1.0 111.223 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.659 ' C ' ' H ' ' A' ' 129' ' ' GLU . 8.5 mp 46.49 -117.7 0.76 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.46 -25.62 0.08 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.646 -0.582 . . . . 1.0 111.646 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.659 ' H ' ' C ' ' A' ' 127' ' ' LEU . 52.9 mt-10 -83.25 153.81 66.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 122.677 -0.307 . . . . 1.0 110.675 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 78.6 Cg_exo -42.28 164.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.431 2.088 . . . . 1.0 111.634 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 mt -80.11 1.88 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.261 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -138.25 160.33 39.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.056 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 130' ' ' PRO . 7.0 mpt_? -121.05 81.61 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 112' ' ' SER . 75.5 Cg_exo -49.23 144.46 17.04 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.508 2.139 . . . . 1.0 111.808 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.411 ' CG2' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -112.8 123.39 68.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 1.0 111.322 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.02 154.55 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.907 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.5 -21.73 73.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 1.0 111.261 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 12.8 p -63.05 -37.07 85.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.493 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 1.1 t-80 -80.83 -28.96 35.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.7 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.7 t -52.94 -55.2 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.339 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -66.96 -44.98 79.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.257 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -44.21 -50.99 8.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.473 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.67 -46.44 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.454 179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -57.76 -42.64 84.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.456 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.5 m -53.72 -34.34 58.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.2 mtt -82.35 -4.25 56.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.179 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 72.16 25.26 74.98 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.268 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.97 120.84 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.96 -33.16 34.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.534 ' HG ' ' H ' ' A' ' 151' ' ' SER . 44.4 t -138.48 170.49 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.199 -0.6 . . . . 1.0 111.569 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.534 ' H ' ' HG ' ' A' ' 150' ' ' SER . 46.9 t -163.01 139.82 7.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 1.0 112.185 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.9 tp -116.32 116.23 27.37 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.39 157.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.54 0.686 . . . . 1.0 111.79 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.481 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 84.3 t -156.02 95.73 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.295 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.41 ' HD2' ' NE ' ' A' ' 101' ' ' ARG . 58.4 Cg_endo -65.81 139.74 58.51 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.536 2.824 . . . . 1.0 113.929 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.8 mt -98.15 107.47 19.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 83.1 mtp -121.12 143.37 49.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 1.0 111.775 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -121.81 114.41 21.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 160' ' ' GLN . 47.2 t60 65.05 -127.65 0.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 159' ' ' HIS . 0.5 OUTLIER -94.53 10.01 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -120.19 158.62 26.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.9 117.31 32.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.872 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -95.18 -26.55 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.832 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.61 -173.04 26.5 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.987 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.2 tp -142.33 131.44 23.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 1.0 111.251 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.481 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 1.9 tp -96.84 143.32 27.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.401 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 8.6 p -150.0 130.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.524 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 151' ' ' SER . 18.2 t -112.1 141.77 45.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.011 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.401 ' NE2' ' CG2' ' A' ' 167' ' ' VAL . 68.0 m-70 -139.55 142.04 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.108 0.48 . . . . 1.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -155.98 152.27 27.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.778 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -82.33 71.01 9.39 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.034 -0.266 . . . . 1.0 111.418 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -174.91 168.05 1.86 Allowed Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.325 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -92.45 11.24 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.744 2.296 . . . . 1.0 110.908 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -30.95 113.35 0.32 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.032 -0.985 . . . . 1.0 112.692 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.13 152.28 21.25 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.867 2.378 . . . . 1.0 111.059 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.3 140.88 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.1 p -92.75 154.26 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 182' ' ' GLN . 13.8 pt20 -70.23 -39.01 75.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.624 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.23 -54.17 49.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.532 -0.303 . . . . 1.0 111.369 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -65.67 -30.04 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.378 . . . . 1.0 110.718 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.57 -31.89 71.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.494 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 178' ' ' GLN . 0.3 OUTLIER -71.91 -55.96 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.504 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 51.4 t -42.97 -45.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.257 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.41 -33.69 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 182' ' ' GLN . 7.4 tt0 -50.91 -42.17 59.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.66 -41.45 83.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.694 -1.139 . . . . 1.0 109.354 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.02 -28.87 59.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.697 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.475 ' O ' ' OG ' ' A' ' 192' ' ' SER . . . -70.8 -26.44 63.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.615 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -70.99 -36.0 72.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.682 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -53.8 -58.62 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 188' ' ' ALA . 17.9 m -60.27 -38.17 76.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.891 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 15.8 m -52.39 -35.55 51.84 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.95 -36.08 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.518 -0.764 . . . . 1.0 110.127 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.91 -46.81 61.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.084 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.65 -34.56 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.69 -54.13 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.883 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -55.93 -28.56 57.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.955 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.05 -34.9 57.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.269 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -57.22 -38.57 73.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.183 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.35 -59.21 3.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.169 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 t -65.46 -50.91 63.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 1.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.417 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.549 HBB1 ' CD1' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.81 0.338 . . . . 1.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -60.51 -49.2 78.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.267 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.51 -51.0 69.15 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.5 mt -56.67 -42.28 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.403 ' O ' ' OG1' ' A' ' 38' ' ' THR . 48.6 mt -67.0 -24.1 66.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.561 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -60.84 -40.39 92.66 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.654 -0.418 . . . . 1.0 109.973 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 -30.58 60.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 44.8 p -69.51 -46.94 65.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.534 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 38.2 t -57.55 -40.96 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.883 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 78.7 mm-40 -72.64 -36.7 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.96 -55.15 24.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.767 -0.651 . . . . 1.0 112.023 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.67 -44.09 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.827 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 tmm_? -51.91 -45.47 64.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.817 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.7 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.839 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -81.26 -47.23 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.821 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -77.21 -6.08 51.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.971 0.415 . . . . 1.0 110.124 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.59 17.6 0.5 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.464 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.521 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -76.28 143.4 40.93 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.053 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 70' ' ' GLY . 50.0 p30 -65.96 -21.95 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.886 0.699 . . . . 1.0 112.886 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.689 HH21 ' CD2' ' A' ' 169' ' ' HIS . 44.4 ttp180 -155.12 119.29 4.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 119.221 -0.992 . . . . 1.0 113.579 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -137.54 133.67 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.701 ' HZ1' ' HE2' ' A' ' 169' ' ' HIS . 22.0 pttm -147.22 160.11 42.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.432 -0.507 . . . . 1.0 111.625 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.94 137.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.002 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.593 ' CD2' HBB2 ' A' ' 203' ' ' CYC . 38.7 t80 -121.36 119.33 31.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.074 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -100.11 167.83 10.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.33 134.19 46.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 1.0 112.102 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -103.52 129.26 25.75 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.357 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.72 -23.88 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.698 2.265 . . . . 1.0 112.953 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.69 -8.58 58.84 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.994 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.2 39.75 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.836 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -90.49 140.96 29.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.33 0.565 . . . . 1.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.24 135.57 11.7 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.9 p -124.0 144.05 50.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 1.0 112.278 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.6 t -100.53 122.87 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.95 -1.129 . . . . 1.0 107.95 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.3 3.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.572 0.582 . . . . 1.0 112.572 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.96 149.41 19.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.454 -0.572 . . . . 1.0 109.454 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.578 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -166.19 126.84 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.167 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.88 144.38 33.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -134.57 141.28 46.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.52 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.76 110.34 3.66 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.444 -1.063 . . . . 1.0 110.444 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.1 15.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.8 tt0 72.6 21.6 3.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.116 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -52.27 -57.03 10.96 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.7 146.93 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 107.791 -1.188 . . . . 1.0 107.791 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.25 162.81 40.95 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.068 1.845 . . . . 1.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 p -86.93 132.16 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.578 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 31.5 mt -105.83 -5.69 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.647 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.1 tp -48.26 134.34 14.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 1.0 112.259 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.05 -40.48 3.07 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.87 112.57 1.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.39 . . . . 1.0 110.739 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -74.77 124.25 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.455 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.26 132.64 20.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.274 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.64 149.16 26.56 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.155 1.904 . . . . 1.0 111.713 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.87 68.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -22.75 0.64 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -54.89 -33.64 62.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 1.0 110.672 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 87' ' ' ILE . 24.7 mm -108.6 132.4 21.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.264 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -80.22 -120.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.601 2.2 . . . . 1.0 112.292 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.72 -71.93 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.904 0.383 . . . . 1.0 111.828 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.416 ' OE2' ' OG ' ' A' ' 114' ' ' SER . 22.2 pt-20 -42.8 -42.86 3.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.781 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB2' HAD1 ' A' ' 203' ' ' CYC . . . -65.05 -52.64 54.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.75 -29.49 59.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.548 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LEU . 66.6 mtp85 -60.07 -47.38 86.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.319 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.4 mt -51.7 -44.95 63.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.589 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 27.7 m-85 -59.64 -30.21 68.56 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -90.87 -13.05 34.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.126 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' ARG . 1.5 tp -105.61 -45.97 4.29 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.82 0.89 15.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.462 0.912 . . . . 1.0 113.462 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.9 mt-30 28.1 66.39 0.09 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.131 1.16 . . . . 1.0 114.131 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 102' ' ' VAL . 8.2 p -119.32 -47.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 173.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.433 ' N ' ' CG1' ' A' ' 100' ' ' VAL . 1.6 mtt180 64.79 -22.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.272 170.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 100' ' ' VAL . 8.7 t -56.33 129.64 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.768 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 28.3 mt -107.11 132.68 53.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.9 m -80.64 166.76 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 107' ' ' GLU . 9.0 m-20 -51.36 120.38 5.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.233 -178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -56.07 -10.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.823 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.8 pt-20 -88.61 -37.33 15.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.905 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.8 -15.09 10.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.395 0.617 . . . . 1.0 110.088 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.406 ' HG3' HH11 ' A' ' 111' ' ' ARG . 40.9 tp60 51.58 59.91 4.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.019 -0.991 . . . . 1.0 113.437 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.6 m -91.68 138.0 31.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 105.447 -2.057 . . . . 1.0 105.447 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HG3' ' A' ' 109' ' ' GLN . 67.3 mtm-85 -130.98 139.1 49.97 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.455 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 11.9 m -142.48 114.49 8.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.391 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 114' ' ' SER . 0.6 OUTLIER -119.68 -164.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.658 -0.817 . . . . 1.0 112.159 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.483 ' H ' HG22 ' A' ' 113' ' ' ILE . 71.2 m -88.96 166.21 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.264 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -141.3 157.71 65.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.655 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.29 -8.78 21.22 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.648 2.232 . . . . 1.0 112.307 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -140.55 130.08 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.553 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.2 t -146.93 132.83 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -154.17 174.51 14.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.72 70.78 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.014 -0.834 . . . . 1.0 111.014 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.2 mp -70.61 -46.9 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 1.0 110.575 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -69.55 -22.11 63.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.629 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.95 -39.53 71.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.808 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 49.01 93.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.15 118.04 32.98 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.107 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' LEU . 90.1 Cg_exo -46.16 130.98 14.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.563 2.175 . . . . 1.0 111.157 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 9.3 mp 43.79 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.95 -11.7 67.62 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -79.71 153.64 75.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.939 -0.304 . . . . 1.0 110.663 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -45.06 152.15 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.351 2.034 . . . . 1.0 111.652 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.8 mp -81.38 0.27 38.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.228 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.534 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 14.7 pt20 -150.61 161.55 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.095 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' NH1' ' O ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -118.51 82.8 20.0 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.338 178.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.6 149.8 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.62 2.213 . . . . 1.0 111.777 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.495 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 18.9 m -99.97 149.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.036 0.445 . . . . 1.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.667 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.2 OUTLIER -89.65 144.21 31.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.947 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -38.92 -21.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.236 1.957 . . . . 1.0 111.258 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.5 t -78.49 -46.27 20.04 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 136' ' ' ASP . 40.1 t-80 -77.66 -38.78 46.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.639 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 141' ' ' HIS . 2.6 m -51.82 -43.09 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.342 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.497 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 47.1 t-80 -66.2 -43.44 86.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.225 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -46.98 -50.11 19.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.555 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.32 -50.98 49.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.456 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' GLY . 45.4 tptt -55.56 -40.66 72.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 27.8 m -54.82 -33.32 61.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 45.3 mtt -84.2 -2.87 57.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.218 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.67 24.61 75.36 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.221 -0.899 . . . . 1.0 112.341 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.46 124.12 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.93 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.465 ' OG ' ' OH ' ' A' ' 176' ' ' TYR . 1.9 t -119.34 153.89 34.42 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.564 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.662 ' H ' ' HH ' ' A' ' 176' ' ' TYR . 1.7 t -147.13 128.49 14.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.173 -0.467 . . . . 1.0 112.106 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.97 105.36 8.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 m -110.93 164.75 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.423 0.63 . . . . 1.0 111.838 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 3.0 p -161.08 110.44 1.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.331 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.85 139.66 44.06 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.54 2.827 . . . . 1.0 113.865 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.45 105.91 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.766 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.55 142.92 50.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.239 0.543 . . . . 1.0 111.899 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 51.8 t60 -114.09 115.52 27.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 17.5 m-70 60.33 -123.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -93.49 7.03 46.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.884 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -116.28 151.99 34.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.6 115.43 29.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.807 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -95.41 -28.12 15.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.87 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.34 -168.35 23.09 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.167 -1.016 . . . . 1.0 111.963 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -142.95 140.49 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 1.0 111.122 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.1 tp -110.07 145.46 37.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -149.07 128.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.58 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.4 m -117.59 142.64 46.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.0 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.701 ' HE2' ' HZ1' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -149.82 144.04 25.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.135 0.493 . . . . 1.0 111.016 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -152.84 150.99 29.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.685 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.85 69.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.467 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -147.3 118.49 4.58 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.398 -0.521 . . . . 1.0 112.34 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -89.76 71.93 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.714 2.276 . . . . 1.0 110.887 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -139.23 163.85 42.97 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.063 -0.972 . . . . 1.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.81 164.08 20.6 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.823 2.349 . . . . 1.0 111.086 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.662 ' HH ' ' H ' ' A' ' 151' ' ' SER . 0.7 OUTLIER -106.53 154.74 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.803 0.335 . . . . 1.0 110.788 178.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.2 m -95.78 140.01 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.47 -35.23 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.595 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.25 -52.06 67.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.0 111.428 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -68.14 -33.73 75.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.937 0.399 . . . . 1.0 110.667 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.16 -50.77 68.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.516 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.535 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 61.3 tp60 -59.11 -54.48 46.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.424 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.36 -46.93 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.31 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.89 -37.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.535 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 42.8 tt0 -48.0 -38.78 17.84 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.79 -41.95 67.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.34 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 184' ' ' VAL . 11.5 tp -54.84 -32.8 60.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.666 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.0 -39.3 61.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.685 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.84 -37.92 71.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.754 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -54.66 -52.9 60.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.54 -44.82 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.906 . . . . 1.0 109.91 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 m -51.87 -38.52 56.36 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 76.7 mt -77.76 -32.18 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.061 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.82 67.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.41 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.7 pp -67.37 -24.09 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.444 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -76.16 -56.06 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.868 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -57.45 -26.37 61.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.917 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.93 -34.93 57.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -58.52 -39.3 79.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.91 -59.23 3.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.123 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.6 p -58.25 -43.61 87.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 1.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.42 179.851 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.593 HBB2 ' CD2' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 46.1 tp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.883 0.373 . . . . 1.0 110.529 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 42.9 p-10 -55.62 -38.36 69.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.246 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.4 mt-30 -72.32 -51.33 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.6 mp -57.4 -45.54 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.445 ' O ' ' OG1' ' A' ' 38' ' ' THR . 66.6 mt -69.73 -27.19 64.76 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.558 -178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -55.08 -38.02 67.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.023 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.81 -31.89 57.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.374 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 43.7 p -68.26 -45.78 72.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.481 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.07 -38.98 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -77.75 -37.73 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -59.8 -53.68 55.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 13.3 p -60.15 -44.61 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.867 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.563 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.4 ttp180 -49.87 -44.91 50.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.847 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.87 74.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.772 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -81.33 -50.45 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.96 -6.7 55.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.976 0.417 . . . . 1.0 110.123 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.35 18.85 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.703 -0.68 . . . . 1.0 112.478 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.41 141.05 43.29 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.028 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 70' ' ' GLY . 96.0 m-20 -66.74 -23.9 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.539 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 43.2 ttt85 -152.76 121.41 6.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 119.186 -1.006 . . . . 1.0 113.551 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.17 135.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -146.52 162.55 38.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.427 -0.509 . . . . 1.0 111.549 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.33 135.77 31.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.024 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 165' ' ' LEU . 62.1 t80 -118.36 118.53 32.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -99.83 168.31 9.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 67.6 t80 -134.97 138.93 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.071 0.462 . . . . 1.0 112.133 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.8 m-20 -103.06 147.87 34.77 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.378 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.51 -19.9 65.45 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.69 2.26 . . . . 1.0 112.948 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -82.3 -1.73 50.47 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.41 -11.37 54.42 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.824 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -89.3 144.82 25.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.361 0.58 . . . . 1.0 110.961 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.23 144.01 15.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.7 p -128.47 146.98 50.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.23 0.538 . . . . 1.0 112.3 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.89 118.65 52.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.15 6.61 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.68 23.12 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 37.1 tt0 -166.44 128.68 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.369 -0.933 . . . . 1.0 113.13 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.89 138.22 46.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 44.0 ptt85 -131.19 141.28 50.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.498 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.33 109.05 3.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 49.32 -85.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.6 pt-20 178.2 31.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.135 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -68.71 -25.62 64.86 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 mt -122.85 148.47 53.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 11.8 Cg_exo -74.03 164.55 34.16 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.016 1.81 . . . . 1.0 112.428 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -85.99 134.21 33.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' H ' HH22 ' A' ' 50' ' ' ARG . 91.6 mt -109.53 -3.02 17.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.641 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.21 139.01 57.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.603 . . . . 1.0 112.191 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.28 -3.24 84.03 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.351 -0.84 . . . . 1.0 111.015 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 tp -101.2 128.43 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 1.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -85.88 125.19 33.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.444 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -103.15 128.63 27.21 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.36 161.15 25.78 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.126 1.884 . . . . 1.0 111.666 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.12 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.776 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.53 -29.3 0.71 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.141 -0.784 . . . . 1.0 111.141 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.99 -28.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.798 0.332 . . . . 1.0 110.62 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.8 mt -137.93 99.54 9.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.258 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' ILE . 42.4 Cg_exo -40.63 -103.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.534 2.156 . . . . 1.0 112.325 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.431 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 92.7 mt-10 -135.65 -71.34 0.47 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.797 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -42.67 -38.77 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.775 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.45 -53.14 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.97 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -57.2 -31.8 65.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.542 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 97' ' ' LEU . 77.3 mtt85 -60.47 -47.29 86.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.565 -0.289 . . . . 1.0 111.213 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.0 mt -50.23 -43.89 53.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.52 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 68.1 m-85 -59.29 -33.23 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -92.34 -21.0 20.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.061 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tp -106.63 -50.45 3.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.82 -5.81 12.07 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 101' ' ' ARG . 95.1 mt-30 53.13 71.96 0.46 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.539 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 1.9 p -63.28 59.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.825 ' N ' ' O ' ' A' ' 99' ' ' GLN . 40.6 ptt85 -56.41 -1.62 0.06 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.07 -1.423 . . . . 1.0 114.31 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 100' ' ' VAL . 14.9 p -152.68 131.81 3.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.458 -0.497 . . . . 1.0 111.732 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mt -112.11 131.02 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.512 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 25.1 t -83.22 168.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.512 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 1.3 m-20 -55.15 119.07 4.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.758 -1.11 . . . . 1.0 112.267 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.02 -11.62 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.718 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 2.1 pp20? -84.87 -39.87 17.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.902 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.68 -12.91 4.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 1.0 110.075 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 49.9 59.08 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.433 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -93.41 136.26 33.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.361 -2.088 . . . . 1.0 105.361 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -125.57 136.72 53.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 93.6 p -102.81 150.07 23.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.358 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 112' ' ' SER . 19.4 pt -155.19 159.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.696 -0.802 . . . . 1.0 112.113 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.7 t -86.4 164.01 17.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.185 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -149.28 157.17 39.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.722 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.93 -1.58 11.58 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.708 2.272 . . . . 1.0 112.262 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 118' ' ' SER . 84.7 tt0 -57.02 -23.89 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.524 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.3 p 82.29 142.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.627 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -49.35 -98.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.487 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.27 4.94 68.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -90.99 4.31 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.367 . . . . 1.0 110.595 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 124' ' ' ARG . 88.5 p -60.39 -21.46 62.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.542 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.79 1.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.826 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 122' ' ' SER . 12.1 tpt180 55.62 90.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.885 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.96 132.26 21.03 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.105 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 127' ' ' LEU . 85.6 Cg_endo -74.16 125.98 10.17 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.553 2.169 . . . . 1.0 111.143 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLU . 61.1 mt 40.38 -111.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.3 20.41 0.11 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.681 -0.567 . . . . 1.0 111.681 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' LEU . 37.0 mm-40 -114.25 156.51 44.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.679 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -41.55 148.72 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.384 2.056 . . . . 1.0 111.711 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 40.7 mt -76.08 -20.3 57.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.484 ' O ' ' NE ' ' A' ' 133' ' ' ARG . 87.7 mt-30 -133.65 165.44 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.066 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' NE ' ' O ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -133.46 87.26 38.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.24 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.24 154.29 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.598 2.199 . . . . 1.0 111.817 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 16.0 m -98.85 148.05 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.117 0.485 . . . . 1.0 111.294 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.6 OUTLIER -92.28 143.58 27.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.439 -0.8 . . . . 1.0 110.898 -178.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -38.67 -22.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.236 1.958 . . . . 1.0 111.227 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -74.9 -46.72 34.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.604 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 45.6 t-80 -78.39 -29.22 47.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.734 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.15 -55.01 16.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.321 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.448 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 86.7 t60 -63.79 -46.61 84.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.273 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CD1' ' OC ' ' A' ' 203' ' ' CYC . 21.2 t80 -44.14 -48.61 9.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.488 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.623 ' CD1' HMA3 ' A' ' 203' ' ' CYC . 1.0 OUTLIER -71.71 -46.53 58.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.43 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 147' ' ' GLY . 18.1 tptm -59.3 -40.08 85.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.49 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.448 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 17.9 m -54.27 -32.91 57.38 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.9 mtt -84.26 -2.2 56.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.208 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.87 22.51 75.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.287 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.65 123.59 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -35.39 30.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.4 p -130.88 168.53 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.534 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 p -161.44 139.69 9.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.038 0.447 . . . . 1.0 112.16 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.0 tp -116.84 136.49 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.511 ' CG1' HBA2 ' A' ' 203' ' ' CYC . 2.2 m -131.6 158.72 43.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.651 . . . . 1.0 111.821 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 55.3 t -159.01 90.81 2.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.327 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.52 114.61 1.65 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.559 2.839 . . . . 1.0 113.936 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.4 mt -71.86 105.37 3.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.8 ptm -135.1 147.04 49.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 1.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.457 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 30.3 t-80 -118.22 115.12 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 77.9 t60 59.9 -123.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.598 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 30.7 tt0 -93.04 8.44 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -114.94 143.87 44.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.4 115.55 30.4 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.489 -1.232 . . . . 1.0 108.853 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -100.63 -27.93 13.13 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.725 -0.39 . . . . 1.0 111.852 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.1 -171.73 24.38 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.283 -0.96 . . . . 1.0 112.031 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -139.99 131.26 26.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.803 0.335 . . . . 1.0 111.193 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -96.75 136.86 36.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -149.61 129.98 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.574 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -116.43 146.83 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.017 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -145.09 142.75 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 1.0 111.029 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 11.7 t60 -150.86 151.42 32.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 1.0 109.752 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.433 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.76 69.73 9.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.471 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -173.25 126.72 0.48 Allowed Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.3 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -88.54 111.13 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.582 2.188 . . . . 1.0 110.889 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -157.38 163.42 24.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.694 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.85 152.4 22.11 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.786 2.324 . . . . 1.0 111.098 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.88 127.0 53.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.805 0.336 . . . . 1.0 110.819 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.0 m -67.37 133.54 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.307 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.42 -35.61 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.616 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.74 -54.82 40.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.63 -0.259 . . . . 1.0 111.333 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.63 -32.13 73.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 1.0 110.682 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 tp -62.24 -41.27 98.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.481 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.32 -56.3 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.543 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -45.0 -45.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.574 -0.451 . . . . 1.0 110.27 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -75.44 -36.72 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -47.68 -36.79 11.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.02 -40.38 68.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.386 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.5 tp -55.61 -31.76 62.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.692 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.95 -39.34 56.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.641 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.468 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.4 m-20 -57.12 -39.03 74.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.732 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -53.21 -52.64 58.24 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.2 -40.55 65.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.82 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 5.5 p -51.54 -33.61 32.86 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.02 -36.62 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.062 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -46.45 65.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.114 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.8 tp -61.57 -36.14 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.164 0.507 . . . . 1.0 109.666 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.84 -53.46 9.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.93 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.56 -28.84 57.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.73 -33.93 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.216 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.38 -41.14 84.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.2 -58.59 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.5 p -57.75 -43.97 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 1.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.457 179.739 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.623 HMA3 ' CD1' ' A' ' 143' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.853 0.359 . . . . 1.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 25.2 p-10 -63.09 -51.02 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.261 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 98.8 mt-30 -61.32 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mm -57.8 -37.94 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.591 0.589 . . . . 1.0 112.591 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.34 -23.32 61.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -64.97 -42.32 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.011 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.12 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.374 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -69.41 -46.66 66.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 t -55.2 -37.16 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.835 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.35 -38.7 85.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.777 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -62.22 -41.77 98.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.973 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.0 -40.97 84.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.879 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.2 tmm_? -57.95 -50.16 74.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.871 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.76 86.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.9 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -77.48 -52.88 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.824 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.67 -3.64 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 1.0 110.14 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.24 17.11 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.487 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.2 t -77.89 147.56 35.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.058 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 70' ' ' GLY . 33.2 p-10 -69.02 -11.6 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 1.0 112.895 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.603 ' NH2' ' CD2' ' A' ' 169' ' ' HIS . 30.7 ttp180 -163.73 122.0 1.91 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 119.115 -1.034 . . . . 1.0 113.487 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.96 133.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HZ2' HBB3 ' A' ' 203' ' ' CYC . 17.8 pttp -145.36 159.65 42.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.556 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.65 135.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.015 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' CD1' HBB2 ' A' ' 203' ' ' CYC . 75.5 t80 -118.32 118.28 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.054 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -99.24 166.97 10.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -132.22 134.05 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.569 -0.452 . . . . 1.0 112.15 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.48 129.56 25.79 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.727 -0.669 . . . . 1.0 109.283 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.86 -26.91 2.19 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.675 2.25 . . . . 1.0 112.976 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.21 -7.83 55.72 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.996 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.52 -11.61 42.85 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.048 -0.596 . . . . 1.0 112.832 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -88.46 142.75 27.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.363 0.582 . . . . 1.0 110.941 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -122.37 141.57 14.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 78.7 p -127.21 146.56 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.267 0.556 . . . . 1.0 112.374 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.3 t -95.75 118.82 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.03 -1.59 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.37 150.5 21.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -168.65 131.31 1.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.35 -0.94 . . . . 1.0 113.125 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.46 144.92 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -133.25 144.52 49.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.574 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.04 113.17 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.59 19.07 0.13 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 70' ' ' GLY . 38.6 tt0 68.72 28.9 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.194 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -58.2 -55.52 33.96 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt -95.43 149.87 36.74 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.31 170.01 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.066 1.844 . . . . 1.0 112.506 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -89.92 127.71 36.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.143 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 mt -98.88 -1.31 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.655 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 tp -61.39 135.3 57.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.359 0.599 . . . . 1.0 112.179 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.61 -8.11 74.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 8.1 mp -98.11 131.79 44.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.399 . . . . 1.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.0 m -90.56 120.83 31.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.383 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 62' ' ' GLY . 8.7 m-85 -106.39 135.69 19.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.34 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.53 154.24 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.192 1.928 . . . . 1.0 111.672 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -69.44 -24.44 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.796 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.58 -20.09 0.19 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ALA . 88.8 m-20 -58.46 -30.76 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 1.0 110.659 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.0 mt -111.91 132.73 21.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.75 -111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.536 2.157 . . . . 1.0 112.27 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 13.2 tm-20 -150.99 -66.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.804 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 21.1 pt-20 -44.56 -43.7 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.743 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.576 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -63.19 -43.38 98.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.916 0.389 . . . . 1.0 110.974 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -64.34 -28.01 69.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.578 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.9 mtp85 -56.95 -49.85 74.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.272 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.03 -38.1 62.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.581 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 95' ' ' PHE . 8.4 m-85 -64.24 -29.85 70.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -90.31 -13.66 34.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.128 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.16 -43.78 4.31 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.57 -3.73 13.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.541 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.8 mt-30 27.24 70.69 0.05 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.112 1.153 . . . . 1.0 114.112 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.502 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 11.2 p -112.64 -48.36 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.43 -2.434 . . . . 1.0 104.43 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.617 ' NH1' ' NE2' ' A' ' 185' ' ' GLN . 12.1 mtm180 63.42 74.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.077 -1.42 . . . . 1.0 114.24 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.54 135.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.761 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.0 mt -107.86 125.9 64.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 7.5 p -82.79 166.28 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.436 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 23.7 t0 -54.33 120.25 6.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.713 -1.131 . . . . 1.0 112.336 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.7 m -56.72 -9.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 108' ' ' ALA . 1.1 pp20? -87.27 -35.83 18.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.831 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' A' ' 107' ' ' GLU . . . -61.32 -16.83 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.363 0.601 . . . . 1.0 110.076 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 51.38 53.05 13.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.086 -0.961 . . . . 1.0 113.45 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.03 135.6 34.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.385 -2.08 . . . . 1.0 105.385 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -129.46 142.8 50.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 81.9 p -101.43 154.06 19.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.11 -1.405 . . . . 1.0 107.322 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 112' ' ' SER . 20.4 pt -154.92 158.28 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 119.649 -0.821 . . . . 1.0 112.164 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.0 p -89.67 172.3 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.189 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 150.09 53.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -35.85 -74.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.614 2.21 . . . . 1.0 112.297 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -86.27 -44.25 12.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.506 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 t 60.02 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.596 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.56 -173.24 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.576 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.86 57.85 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.1 mp -83.87 -50.13 8.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 1.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 124' ' ' ARG . 19.7 m -63.68 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.01 0.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.788 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 122' ' ' SER . 54.0 ttp180 62.38 102.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.906 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.15 126.78 49.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' O ' ' C ' ' A' ' 127' ' ' LEU . 84.6 Cg_endo -76.5 178.48 7.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.549 2.166 . . . . 1.0 111.204 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 126' ' ' PRO . 45.5 mt -28.59 -72.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.467 -0.493 . . . . 1.0 109.676 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 41.26 33.91 0.88 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.591 -0.604 . . . . 1.0 111.591 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 130' ' ' PRO . 2.7 pt-20 -115.29 83.75 10.7 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.68 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 132' ' ' GLN . 83.4 Cg_exo -45.6 179.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.392 2.062 . . . . 1.0 111.685 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.83 16.81 0.19 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.304 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 130' ' ' PRO . 2.8 pt20 -164.81 168.37 17.86 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.104 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -143.89 132.43 11.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.309 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.91 142.65 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.515 2.143 . . . . 1.0 111.896 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.7 t -133.35 140.1 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 1.0 111.355 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.552 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -39.76 156.17 0.16 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.883 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.21 -7.33 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.196 1.93 . . . . 1.0 111.308 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 m -56.45 -51.47 68.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.43 ' CE1' HG21 ' A' ' 140' ' ' VAL . 5.1 p-80 -71.7 -25.74 62.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.591 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.43 HG21 ' CE1' ' A' ' 139' ' ' HIS . 27.9 t -56.91 -64.13 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.364 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.645 ' CE1' ' HG ' ' A' ' 145' ' ' SER . 31.7 t-80 -69.25 -50.69 44.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.202 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.79 ' CD2' HBA1 ' A' ' 203' ' ' CYC . 68.0 t80 -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.446 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' CD2' ' NE2' ' A' ' 169' ' ' HIS . 85.1 mt -73.56 -45.32 54.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.508 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 41.9 tptt -60.18 -41.7 93.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.645 ' HG ' ' CE1' ' A' ' 141' ' ' HIS . 15.2 m -53.42 -31.11 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.5 mtt -89.82 -2.04 58.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.199 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.11 26.16 71.53 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.251 -0.886 . . . . 1.0 112.348 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.37 120.7 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.971 0.386 . . . . 1.0 109.962 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.14 -34.47 32.46 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -134.92 170.06 16.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.595 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.637 ' HG ' ' CE1' ' A' ' 169' ' ' HIS . 39.1 m -163.68 139.82 6.7 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.037 0.446 . . . . 1.0 112.124 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.541 ' H ' ' HG ' ' A' ' 168' ' ' SER . 21.9 tp -114.03 139.26 49.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.5 m -132.46 156.78 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.437 0.637 . . . . 1.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.4 t -156.84 91.6 2.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.818 -1.083 . . . . 1.0 109.262 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.45 130.58 39.3 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 123.694 2.929 . . . . 1.0 113.893 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.89 104.83 16.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.795 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.8 mtp -119.2 144.63 46.61 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.871 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.407 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 86.1 t60 -124.73 113.3 17.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.951 -1.129 . . . . 1.0 107.951 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 53.3 t60 65.17 -127.17 0.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.524 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.8 mm100 -95.15 12.21 29.55 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -120.72 157.47 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.95 115.53 29.64 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 114.493 -1.231 . . . . 1.0 108.848 177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.407 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.5 m95 -93.44 -25.78 17.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.958 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.58 -167.94 22.75 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.152 -1.023 . . . . 1.0 111.941 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.507 HD22 HMB2 ' A' ' 203' ' ' CYC . 4.6 tp -144.21 129.78 19.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.767 0.317 . . . . 1.0 111.231 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.56 138.31 31.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.33 133.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.597 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.601 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 25.1 p -114.47 142.91 45.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.029 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.637 ' CE1' ' HG ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -133.92 139.51 46.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 1.0 111.08 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.446 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.7 p-80 -156.09 155.07 31.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.747 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.24 69.51 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.469 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 177.15 153.57 0.42 Allowed Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.349 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -44.34 -58.68 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.713 2.276 . . . . 1.0 110.831 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 43.72 72.41 1.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.696 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.61 149.41 89.88 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.798 2.332 . . . . 1.0 111.044 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.446 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 5.9 m-85 -114.36 141.53 47.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 1.0 110.82 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -99.21 150.88 21.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.81 -38.76 89.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.654 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 47.6 mp0 -65.59 -55.34 18.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.289 . . . . 1.0 111.333 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.53 -34.23 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.942 0.401 . . . . 1.0 110.717 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.89 -39.48 94.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.467 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -58.73 -53.66 55.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.415 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -46.4 -45.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 187' ' ' LEU . 40.0 t -74.75 -37.96 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.617 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 49.4 tp60 -47.84 -35.33 10.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.44 -40.08 64.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.734 -1.121 . . . . 1.0 109.367 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 184' ' ' VAL . 42.5 tp -55.07 -31.79 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.715 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.51 -38.07 62.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.64 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -55.54 -39.53 70.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.73 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -52.09 -52.39 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.07 -41.17 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.9 m -52.45 -36.17 54.1 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.62 -41.54 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.082 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.23 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.099 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.49 -35.85 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.07 -53.91 11.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.904 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -55.66 -26.43 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.921 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -34.92 58.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.286 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.73 -38.98 76.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 8.6 mp -66.99 -58.44 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.131 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.5 t -50.54 -40.85 52.92 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.312 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.369 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.79 HBA1 ' CD2' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.923 0.392 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.18 -41.11 94.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.252 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -71.1 -54.13 12.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tp -58.33 -32.44 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -75.53 -25.12 56.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.729 -0.389 . . . . 1.0 111.555 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' O ' HG13 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.34 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.616 -0.434 . . . . 1.0 109.974 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.24 -30.12 43.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.407 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.5 p -74.77 -49.02 22.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.553 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 36' ' ' ARG . 5.2 p -53.43 -33.9 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.833 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -72.94 -35.52 67.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.38 -43.18 91.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.972 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.21 -51.74 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.89 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.2 ttp180 -49.95 -43.84 50.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.868 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.41 75.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -80.73 -50.73 9.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.32 -6.84 54.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.0 110.072 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.51 18.94 1.06 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.682 -0.69 . . . . 1.0 112.445 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.437 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 1.2 m -75.87 142.29 42.18 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' GLY . 90.5 m-20 -58.32 -32.88 68.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -152.45 120.8 6.33 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.595 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.89 135.53 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 20.8 pttp -144.77 161.0 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.551 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.33 137.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.011 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.7 t80 -122.27 118.48 28.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.014 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -99.57 170.59 8.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 27.8 t80 -134.57 136.74 43.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.039 0.447 . . . . 1.0 112.166 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 m-20 -102.17 148.53 35.53 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.299 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.61 -22.96 70.35 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.681 2.254 . . . . 1.0 112.971 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -79.39 -2.07 40.06 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.029 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.18 -10.5 56.77 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.894 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 148.03 22.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.344 0.572 . . . . 1.0 110.95 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.87 149.7 18.53 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.424 -1.07 . . . . 1.0 110.424 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 1.0 112.347 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.67 116.67 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -112.36 5.23 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.07 145.89 23.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 83.0 tt0 -166.2 126.97 1.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.378 -0.929 . . . . 1.0 113.216 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.06 138.07 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.558 HH11 ' HG ' ' A' ' 76' ' ' SER . 36.9 ptt180 -129.61 142.43 50.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.544 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.49 106.23 2.99 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.84 -87.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLY . 19.5 pt-20 -179.27 31.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.115 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 49' ' ' ASP . 7.1 ttp180 -70.11 -51.2 33.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.52 124.63 47.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.33 169.44 3.93 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.133 1.889 . . . . 1.0 112.49 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.558 ' HG ' HH11 ' A' ' 69' ' ' ARG . 31.3 m -91.87 141.47 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.151 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.551 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 33.3 mt -113.28 -2.14 14.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.623 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.0 tp -56.83 138.17 53.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.329 0.585 . . . . 1.0 112.279 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -4.04 84.49 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.425 -0.807 . . . . 1.0 111.088 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' CD2' ' C ' ' A' ' 80' ' ' LEU . 3.6 tt -100.47 117.72 35.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 1.0 110.82 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 76.9 p -76.88 123.55 26.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.447 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -107.17 135.07 19.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.288 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.92 150.97 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.128 1.885 . . . . 1.0 111.649 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.55 -25.78 66.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.849 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.45 -21.2 0.25 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 m-20 -54.84 -32.65 60.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 1.0 110.592 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CD1' HH21 ' A' ' 92' ' ' ARG . 3.5 pt -121.0 99.49 46.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.244 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 87' ' ' ILE . 51.2 Cg_exo -42.11 -107.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.5 2.134 . . . . 1.0 112.317 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 19.7 pt-20 -152.4 -46.14 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 1.0 111.83 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 24.4 pt-20 -60.66 -39.09 87.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.71 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.9 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.528 HH21 ' CD1' ' A' ' 87' ' ' ILE . 29.4 ttm105 -66.34 -29.88 70.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.556 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -55.92 -55.29 34.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.318 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.5 tp -53.04 -43.42 66.59 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.543 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.35 -32.64 70.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' NH2' ' SD ' ' A' ' 157' ' ' MET . 9.6 mmp_? -87.34 -11.03 50.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.136 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 tp -106.85 -44.96 4.3 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.31 0.856 . . . . 1.0 113.31 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.57 -1.96 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.565 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 97.6 mt-30 26.15 69.03 0.05 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.093 1.146 . . . . 1.0 114.093 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.622 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 31.4 m -113.04 -50.96 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.405 -2.443 . . . . 1.0 104.405 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.622 ' HE ' ' N ' ' A' ' 100' ' ' VAL . 3.5 mtm180 63.66 72.38 0.47 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.052 -1.431 . . . . 1.0 114.256 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 p -148.87 133.0 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.477 -0.489 . . . . 1.0 111.735 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.46 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 2.4 mt -109.2 124.67 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 108.331 -0.989 . . . . 1.0 108.331 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 11.6 p -83.16 167.71 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.274 0.842 . . . . 1.0 113.274 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 9.5 m-20 -55.54 119.18 5.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.711 -1.131 . . . . 1.0 112.268 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.67 -10.34 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.754 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 105' ' ' ASP . 18.5 pt-20 -88.46 -36.93 16.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.906 -178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -16.79 37.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.416 0.626 . . . . 1.0 110.145 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.444 HE21 ' HE ' ' A' ' 111' ' ' ARG . 44.8 tp60 51.8 58.35 5.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.982 -1.008 . . . . 1.0 113.455 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -94.1 137.82 32.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.444 ' HE ' HE21 ' A' ' 109' ' ' GLN . 98.3 mtt180 -127.82 133.21 49.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.449 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 23.6 m -103.58 152.43 21.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.195 -1.366 . . . . 1.0 107.382 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 112' ' ' SER . 17.3 pt -156.53 160.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 119.689 -0.804 . . . . 1.0 112.189 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.0 m -89.18 165.94 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.229 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 117' ' ' GLU . 36.1 mt-30 -153.05 150.88 25.05 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.639 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -41.37 74.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.651 2.234 . . . . 1.0 112.243 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' A' ' 115' ' ' GLN . 6.3 pt-20 178.36 55.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.55 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 t -57.41 -33.95 68.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.645 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.32 -168.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.593 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.27 60.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 40.4 mt -74.45 -24.76 59.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 1.0 110.565 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 m -54.59 -28.4 45.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.602 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.93 51.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 56.48 86.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.26 109.27 59.89 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.097 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.55 130.95 15.32 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.568 2.179 . . . . 1.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.2 mt 43.63 -124.83 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.77 15.12 5.93 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -112.1 152.11 44.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.683 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.56 156.32 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.407 2.072 . . . . 1.0 111.663 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.66 -0.67 34.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.284 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.61 162.09 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.111 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.423 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 10.7 tpp180 -120.8 86.65 41.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.258 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.438 ' O ' ' OG ' ' A' ' 112' ' ' SER . 56.8 Cg_exo -52.33 147.6 28.24 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.512 2.142 . . . . 1.0 111.791 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.435 ' HB ' ' ND1' ' A' ' 139' ' ' HIS . 6.9 m -97.75 153.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.042 0.449 . . . . 1.0 111.373 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -89.09 155.81 49.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.891 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.23 -20.42 24.75 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.267 1.978 . . . . 1.0 111.164 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.426 ' C ' HBC3 ' A' ' 203' ' ' CYC . 45.0 t -69.89 -51.97 28.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.729 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -73.38 -27.28 61.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.634 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 25.4 t -52.9 -53.13 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.322 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.544 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 72.1 t60 -66.05 -44.09 85.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.584 ' CD2' HAA2 ' A' ' 203' ' ' CYC . 52.6 t80 -42.02 -48.56 4.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.467 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.462 ' CD2' ' HE2' ' A' ' 169' ' ' HIS . 53.2 mt -74.19 -43.74 56.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.502 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' GLY . 40.1 tptt -61.02 -42.55 98.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.544 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 16.2 m -54.26 -32.29 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 42.9 mtt -88.18 -0.98 57.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.217 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.14 24.93 76.26 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.197 -0.911 . . . . 1.0 112.31 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.84 120.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.47 -30.88 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.54 ' OG ' ' CD2' ' A' ' 170' ' ' HIS . 98.7 p -139.46 171.76 13.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.137 -0.625 . . . . 1.0 111.563 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.46 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 8.3 p -161.93 140.44 9.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.211 -0.45 . . . . 1.0 112.171 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.4 139.42 50.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 0.3 OUTLIER -133.22 154.41 39.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.479 0.657 . . . . 1.0 111.821 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 54.8 t -158.19 91.29 2.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.72 134.7 54.82 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.521 2.814 . . . . 1.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.9 mt -94.76 107.89 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.772 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.566 ' SD ' ' NH2' ' A' ' 96' ' ' ARG . 15.8 ptm -128.7 146.89 50.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.906 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.44 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 65.7 t60 -117.79 115.41 24.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 60.5 t60 61.52 -124.61 0.83 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.789 -0.449 . . . . 1.0 109.789 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 36.5 mt-30 -93.24 5.01 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.43 150.74 32.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.85 116.35 31.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.831 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -93.85 -24.87 17.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.898 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.79 -165.32 21.88 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.979 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.6 tp -143.55 133.31 23.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 1.0 111.179 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.416 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.5 tp -95.11 140.66 29.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.02 135.23 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.608 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.6 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 0.9 OUTLIER -120.02 139.95 51.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.049 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.6 ' ND1' ' O ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -136.51 142.15 43.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 1.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.54 ' CD2' ' OG ' ' A' ' 150' ' ' SER . 4.2 p-80 -156.48 153.75 29.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.712 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.69 72.2 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.418 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.43 ' O ' ' OG ' ' A' ' 150' ' ' SER . 54.6 tt0 -173.2 135.16 0.69 Allowed Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.396 -0.522 . . . . 1.0 112.359 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -84.72 47.44 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.681 2.254 . . . . 1.0 110.885 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -78.65 131.77 66.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.031 -0.986 . . . . 1.0 112.756 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.55 149.97 35.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.856 2.37 . . . . 1.0 111.079 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 9.4 m-85 -108.77 150.07 28.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.847 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.3 p -100.19 146.59 26.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.75 -35.67 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 58.0 mp0 -65.67 -55.59 16.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.302 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.43 -34.95 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 1.0 110.683 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.25 -34.66 74.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.49 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -66.88 -51.8 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.36 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.4 t -45.2 -48.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.317 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.1 p -74.59 -37.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -48.06 -37.15 14.42 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.54 -40.22 70.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 184' ' ' VAL . 34.5 tp -55.2 -30.97 61.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.738 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.74 -39.01 64.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.618 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.59 -40.23 71.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.76 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -51.05 -52.94 38.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.05 -41.14 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.839 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -36.17 57.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.15 -37.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.001 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.24 68.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.068 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.6 tp -62.42 -33.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -73.74 -53.75 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.895 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -55.73 -27.65 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.95 -34.5 57.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.291 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -58.35 -40.27 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.117 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.36 -58.55 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.46 -0.337 . . . . 1.0 111.084 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.0 p -46.22 -38.35 8.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 1.0 110.355 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.429 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.584 HAA2 ' CD2' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.904 0.383 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -69.8 -52.42 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.275 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.6 -50.04 74.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 tp -60.76 -32.35 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -176.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' O ' ' OG1' ' A' ' 38' ' ' THR . 83.5 mt -76.5 -25.77 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.535 -178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.89 -42.22 94.98 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.003 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.88 -26.62 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.364 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 71.3 p -73.66 -45.4 52.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.534 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.4 t -55.05 -37.7 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.873 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.39 -34.8 70.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.9 -43.36 96.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.99 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.58 -45.87 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.916 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.9 ttp180 -52.89 -47.46 67.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.884 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.808 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.65 -51.63 9.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.24 -6.08 49.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 1.0 110.111 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 16.83 0.37 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.459 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.422 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.2 m -76.48 144.86 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.036 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -61.75 -29.3 70.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.947 0.721 . . . . 1.0 112.947 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 18.7 ttt85 -149.19 122.0 8.71 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.187 -1.005 . . . . 1.0 113.522 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -137.71 130.64 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.593 ' HZ1' HAB2 ' A' ' 203' ' ' CYC . 36.7 pttt -145.23 156.22 43.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.556 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.8 139.65 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.045 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.557 ' CD1' HBB3 ' A' ' 203' ' ' CYC . 55.6 t80 -124.75 120.34 31.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -100.35 171.43 7.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.896 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 8.8 t80 -133.52 138.17 45.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 1.0 112.142 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.7 m-20 -103.59 147.71 34.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.386 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.71 -26.44 75.3 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.797 2.331 . . . . 1.0 112.906 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -76.32 -5.9 49.16 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.976 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.16 -11.55 51.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.923 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -86.48 142.85 28.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.343 0.572 . . . . 1.0 110.962 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -123.22 143.24 15.0 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -126.59 147.01 49.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.229 0.538 . . . . 1.0 112.282 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.53 115.26 31.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.12 -1.56 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.09 147.25 20.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 40.3 tt0 -164.68 125.51 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.409 -0.917 . . . . 1.0 113.214 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.44 134.75 49.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.507 HH11 ' CB ' ' A' ' 76' ' ' SER . 15.3 mtm180 -121.93 138.93 54.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.531 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.51 107.0 2.97 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.364 -1.094 . . . . 1.0 110.364 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.5 30.12 1.32 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.255 -1.138 . . . . 1.0 110.255 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 58.89 27.18 15.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.119 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -57.63 -58.83 6.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.25 147.61 38.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 52.3 Cg_endo -68.69 160.69 48.46 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.089 1.859 . . . . 1.0 112.552 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.507 ' CB ' HH11 ' A' ' 69' ' ' ARG . 5.4 p -80.84 126.02 30.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.181 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -101.0 -8.62 22.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.59 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 tp -53.61 138.24 35.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 -2.65 79.58 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -99.88 128.33 45.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 1.0 110.77 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.8 122.17 29.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.45 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.42 132.73 20.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.25 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.59 151.95 25.71 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.096 1.864 . . . . 1.0 111.629 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' C ' ' OD1' ' A' ' 86' ' ' ASP . . . -60.12 -25.02 65.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.812 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.84 -24.29 1.25 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 17.9 p-10 -54.68 -26.57 34.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 1.0 110.619 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.9 mt -127.84 132.88 24.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.297 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 89.3 Cg_endo -76.87 -104.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.563 2.176 . . . . 1.0 112.277 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -161.28 -43.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 1.0 111.845 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.4 -42.83 88.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.757 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.589 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -59.67 -36.36 76.31 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -66.2 -27.5 68.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.546 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' LEU . 30.3 mmt180 -54.54 -58.93 5.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.275 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.6 mt -55.09 -37.66 67.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.549 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.7 m-85 -66.69 -39.13 87.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.7 tpp180 -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.549 -0.751 . . . . 1.0 110.137 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ARG . 4.4 tp -107.13 -43.32 4.64 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.99 -3.66 12.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 97.1 mt-30 27.42 70.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.066 1.136 . . . . 1.0 114.066 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.566 ' H ' HH22 ' A' ' 133' ' ' ARG . 14.3 t -110.72 -50.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.699 HH22 ' NE2' ' A' ' 185' ' ' GLN . 12.4 mtm180 64.81 72.75 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.053 -1.431 . . . . 1.0 114.248 172.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.3 t -149.37 131.42 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.67 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.81 126.06 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 41.4 t -81.29 165.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.194 0.813 . . . . 1.0 113.194 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.491 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 22.5 t0 -51.7 120.77 5.56 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.664 -1.153 . . . . 1.0 112.315 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 16.9 t -57.13 -12.7 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.702 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 12.6 pt-20 -80.22 -38.73 30.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.96 -16.54 59.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 1.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 51.19 60.08 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.991 -1.004 . . . . 1.0 113.39 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.6 p -94.56 138.88 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.16 146.49 51.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.48 . . . . 1.0 114.997 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 t -134.4 115.39 13.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.1 -1.409 . . . . 1.0 107.337 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.521 ' N ' ' CD1' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -120.07 -165.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.686 -0.806 . . . . 1.0 112.114 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.48 ' H ' HG21 ' A' ' 113' ' ' ILE . 33.3 t -85.06 161.2 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.45 -0.796 . . . . 1.0 110.201 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -140.74 159.94 60.66 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.685 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.84 -158.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.621 2.214 . . . . 1.0 112.296 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -47.0 138.96 6.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.572 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t 169.48 -60.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.592 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.423 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 36.9 t-105 47.0 -131.86 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.569 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 91.38 2.67 70.27 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.5 mt -68.87 -35.19 76.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 1.0 110.544 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.6 m -58.74 -27.87 65.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.61 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.799 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 56.9 86.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.1 m -104.33 110.08 63.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.129 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 127' ' ' LEU . 95.3 Cg_exo -46.39 138.97 13.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.529 2.153 . . . . 1.0 111.211 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.7 tp 43.26 -164.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 87.31 -5.03 85.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.57 -0.612 . . . . 1.0 111.57 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.54 155.2 68.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.689 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.38 158.98 52.49 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.431 2.087 . . . . 1.0 111.636 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.4 mt -78.76 -10.47 59.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.278 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.58 159.12 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.634 -0.427 . . . . 1.0 111.061 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.566 HH22 ' H ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -122.97 81.24 50.6 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.288 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.96 145.45 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.586 2.191 . . . . 1.0 111.746 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.487 ' CG2' ' O ' ' A' ' 135' ' ' VAL . 2.4 m -113.01 122.42 67.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 1.0 111.346 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.505 ' OD1' ' HHD' ' A' ' 203' ' ' CYC . 0.1 OUTLIER -39.34 155.92 0.14 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.883 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.651 ' O ' HG23 ' A' ' 140' ' ' VAL . 43.3 Cg_endo -63.0 -13.82 37.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.221 1.947 . . . . 1.0 111.317 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.76 -29.94 58.99 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.628 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 40.2 t-80 -86.4 -38.05 17.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.351 -0.84 . . . . 1.0 110.679 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 137' ' ' PRO . 4.0 m -52.16 -47.23 44.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.351 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.678 ' CE1' ' HG ' ' A' ' 145' ' ' SER . 32.1 t-80 -65.49 -44.04 88.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.273 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -45.24 -48.75 12.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.96 -48.47 53.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.45 178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 16.4 tptp -58.08 -41.71 84.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.484 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.678 ' HG ' ' CE1' ' A' ' 141' ' ' HIS . 32.4 m -54.41 -30.6 52.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.3 mtt -87.28 -1.34 57.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.158 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.38 28.15 71.7 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.292 -0.867 . . . . 1.0 112.337 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -109.93 123.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.77 -32.51 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 8.6 t -137.18 169.54 17.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.551 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -158.6 139.45 12.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.045 0.45 . . . . 1.0 112.162 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.81 136.73 52.72 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.8 159.39 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.458 0.647 . . . . 1.0 111.824 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 79.0 t -157.04 91.79 2.41 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.869 -1.06 . . . . 1.0 109.346 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.02 126.35 19.91 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.617 2.878 . . . . 1.0 113.904 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.8 mt -81.55 106.17 13.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.839 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.428 ' O ' ' OG ' ' A' ' 192' ' ' SER . 73.8 mtp -123.91 144.9 49.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.793 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.409 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 81.2 t60 -120.89 113.39 20.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 77.7 t60 61.35 -121.11 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 4.7 tt0 -95.94 6.31 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.873 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 161' ' ' GLU . 43.8 mp0 -115.79 154.09 30.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.9 tt -111.14 116.57 31.32 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.557 -1.201 . . . . 1.0 108.88 177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.409 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.7 m95 -94.93 -25.79 16.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.922 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.84 20.52 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.237 -0.982 . . . . 1.0 111.953 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.8 tp -143.05 130.69 21.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.766 0.317 . . . . 1.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -95.33 132.5 40.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.71 137.47 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.597 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -122.22 144.12 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.094 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -139.68 143.72 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.139 0.495 . . . . 1.0 110.974 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -159.43 155.42 26.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.707 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.55 67.51 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.436 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -176.22 131.99 0.4 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 120.429 -0.509 . . . . 1.0 112.314 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 174' ' ' ARG . 24.9 Cg_exo -39.02 -48.6 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.649 2.232 . . . . 1.0 110.91 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 173' ' ' PRO . 23.6 ttm180 29.1 81.45 0.22 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.009 -0.996 . . . . 1.0 112.733 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.34 150.38 88.71 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.796 2.331 . . . . 1.0 111.195 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.408 ' HH ' ' HG ' ' A' ' 150' ' ' SER . 10.3 m-85 -110.83 139.26 46.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.806 0.336 . . . . 1.0 110.767 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.9 t -92.22 145.69 24.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.288 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -63.61 -43.34 97.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.588 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 46.8 mp0 -60.92 -55.64 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.044 -0.262 . . . . 1.0 111.394 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.66 -29.09 69.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 1.0 110.651 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.93 -35.17 77.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.523 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -69.5 -53.52 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.388 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.1 t -43.47 -47.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.296 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.8 m -74.69 -36.81 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.699 ' NE2' HH22 ' A' ' 101' ' ' ARG . 53.9 tt0 -48.4 -38.18 18.89 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.14 -40.75 71.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.356 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.4 tt -54.81 -31.83 59.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.725 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.93 -33.86 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.605 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -57.68 -40.82 80.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.716 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -51.35 -53.5 35.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.63 -40.83 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.92 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 157' ' ' MET . 5.8 t -52.09 -36.54 51.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.02 -34.84 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.035 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.87 -46.52 62.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.056 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.43 -33.53 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.67 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.911 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 197' ' ' GLN . 9.7 tm0? -55.49 -29.41 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.918 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.55 53.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.287 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.413 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.1 tt0 -57.64 -39.36 76.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.01 -57.98 4.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.125 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -56.41 -44.35 80.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 1.0 110.339 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.413 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 5.2 tp . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.628 HMA2 ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.875 0.369 . . . . 1.0 110.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -52.38 -52.69 52.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.307 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -60.15 -48.43 81.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 1.0 112.254 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 57.3 mt -57.68 -40.47 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.592 0.59 . . . . 1.0 112.592 -177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.7 mt -69.89 -22.52 63.22 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.531 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 39' ' ' VAL . 93.4 mtt-85 -65.3 -35.29 80.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.706 -0.397 . . . . 1.0 109.975 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.98 -28.66 39.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.343 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.5 p -74.17 -48.96 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.56 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 4.0 p -53.47 -36.28 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.3 mt-10 -75.51 -32.83 60.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -66.64 -51.45 56.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.04 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.497 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.8 p -64.96 -48.24 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.811 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.497 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 tmt_? -51.65 -44.13 62.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.886 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.15 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.867 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -79.76 -48.91 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.45 -5.64 48.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.101 0.477 . . . . 1.0 110.198 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.65 17.39 0.26 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.433 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' NE ' ' A' ' 43' ' ' ARG . 1.2 m -75.63 144.78 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.1 m-20 -55.86 -34.6 65.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.553 HH22 ' C ' ' A' ' 74' ' ' LEU . 35.0 ttm180 -149.53 126.14 10.99 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.184 -1.006 . . . . 1.0 113.521 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 t -135.93 130.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.032 -1.099 . . . . 1.0 108.032 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -144.34 157.54 44.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.519 -178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -99.35 138.68 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.03 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.644 ' CD2' HBB1 ' A' ' 203' ' ' CYC . 29.2 t80 -122.57 120.73 34.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.083 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.9 mtp85 -99.72 169.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -133.6 134.71 43.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.031 0.444 . . . . 1.0 112.165 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.54 129.1 26.66 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.343 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -25.77 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.739 2.293 . . . . 1.0 112.888 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.6 -6.15 52.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.015 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.45 -11.5 43.08 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.051 -0.595 . . . . 1.0 112.92 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -88.71 142.76 27.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.361 0.581 . . . . 1.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -123.13 142.63 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.43 -1.068 . . . . 1.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.7 p -128.05 146.01 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.217 0.532 . . . . 1.0 112.269 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.96 111.3 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.66 8.0 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.19 147.13 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 72.5 tt0 -167.34 128.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.352 -0.939 . . . . 1.0 113.184 -177.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.18 131.17 54.93 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -117.4 136.65 53.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.55 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.04 88.84 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.39 -87.88 0.05 OUTLIER Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.266 -1.133 . . . . 1.0 110.266 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -175.76 34.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.884 -0.326 . . . . 1.0 111.147 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -70.11 -55.71 8.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.553 ' C ' HH22 ' A' ' 50' ' ' ARG . 12.5 mt -94.97 157.85 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 176.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 3.3 Cg_exo -78.51 165.32 25.29 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.154 1.903 . . . . 1.0 112.476 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 p -87.01 127.98 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.177 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.7 mt -101.13 1.06 38.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.58 -178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.549 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -65.25 138.65 58.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.346 0.593 . . . . 1.0 112.264 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.6 -2.85 77.92 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.111 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.517 ' CD1' ' N ' ' A' ' 80' ' ' LEU . 8.5 mp -100.76 128.96 46.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.866 0.365 . . . . 1.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.23 121.81 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.411 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 62' ' ' GLY . 7.5 m-85 -107.68 136.77 19.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.39 157.79 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.166 1.91 . . . . 1.0 111.664 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -66.18 -25.59 67.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.78 -19.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 84' ' ' ALA . 85.3 m-20 -54.87 -34.16 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.359 . . . . 1.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 87' ' ' ILE . 21.7 mm -109.12 133.71 20.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.258 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD3' ' HD ' ' A' ' 203' ' ' CYC . 58.7 Cg_endo -80.89 -120.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.491 2.127 . . . . 1.0 112.335 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.5 mm-40 -138.87 -56.58 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.759 -0.376 . . . . 1.0 111.849 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -59.46 -39.57 84.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.733 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.62 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.963 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -63.22 -30.32 71.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.508 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -58.21 -50.48 73.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.0 111.26 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.6 mt -55.13 -36.25 65.56 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.604 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 6.6 m-85 -64.24 -32.05 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 96' ' ' ARG . 9.2 mmm180 -83.62 -15.12 50.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.157 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.84 -42.72 4.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.74 -4.97 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.527 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 26.27 69.96 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.429 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 1.7 m -110.63 -49.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.527 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 9.3 mtm180 63.09 68.86 0.6 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.066 -1.425 . . . . 1.0 114.335 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -148.77 133.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.849 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 3.4 mt -106.12 124.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 9.0 p -82.57 167.59 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.459 ' H ' ' CG2' ' A' ' 104' ' ' VAL . 3.0 m-20 -51.61 115.06 1.44 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.327 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.7 t -54.81 -11.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.722 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 105' ' ' ASP . 3.2 pt-20 -88.45 -33.57 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.845 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.08 -16.97 36.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.438 0.637 . . . . 1.0 110.143 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 53.28 59.97 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.969 -1.014 . . . . 1.0 113.435 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -92.37 134.34 35.01 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -124.86 138.23 54.26 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.481 . . . . 1.0 114.997 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.432 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 0.1 OUTLIER -113.11 158.15 20.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.209 -1.36 . . . . 1.0 107.342 176.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 14.9 tt -165.86 167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.67 -0.812 . . . . 1.0 112.143 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.549 ' HG ' ' N ' ' A' ' 115' ' ' GLN . 28.4 t -89.38 164.67 14.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.549 ' N ' ' HG ' ' A' ' 114' ' ' SER . 24.3 mp0 -136.96 149.95 68.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.648 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -35.29 -40.18 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.663 2.242 . . . . 1.0 112.212 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 118' ' ' SER . 45.0 mt-10 -64.84 -37.48 87.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.0 t 58.27 149.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.631 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 5.5 m0 42.39 -139.6 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.5 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 3.16 64.08 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.42 -7.46 59.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 1.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.6 t -58.23 -26.81 63.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.619 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.16 -33.4 62.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.807 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 60.32 79.26 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.884 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 m -98.41 144.22 27.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.107 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 127' ' ' LEU . 73.6 Cg_endo -72.73 130.07 15.33 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.531 2.154 . . . . 1.0 111.186 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 126' ' ' PRO . 35.0 mt 41.77 -122.64 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.89 10.17 64.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.644 -0.582 . . . . 1.0 111.644 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -157.61 144.7 13.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.722 -0.281 . . . . 1.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.06 150.65 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.378 2.052 . . . . 1.0 111.676 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.7 mt -80.02 24.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.271 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -130.98 163.75 26.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.039 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.424 ' CG ' HH11 ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.97 117.17 24.01 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.299 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.13 149.75 17.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.573 2.182 . . . . 1.0 111.783 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' A' ' 139' ' ' HIS . 5.7 m -101.42 153.53 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 1.0 111.375 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 12.2 m-20 -88.98 146.2 36.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.903 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -42.62 -23.76 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.278 1.985 . . . . 1.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.1 p -67.66 -40.36 84.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.619 ' CD2' ' C ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER -78.97 -26.69 43.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.641 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -51.33 -53.16 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 1.0 110.38 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.474 ' O ' ' N ' ' A' ' 145' ' ' SER . 51.1 t-80 -68.25 -43.35 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.261 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -47.1 -57.19 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.455 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.46 -50.0 55.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.481 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.7 tptm -56.33 -39.53 72.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.407 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 141' ' ' HIS . 29.4 t -54.47 -32.48 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.4 mtt -83.45 -2.04 54.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.196 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.67 24.22 74.01 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.34 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 24.0 t -109.27 124.55 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.2 -31.98 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.743 0.645 . . . . 1.0 112.743 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -135.13 169.73 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 1.0 111.565 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 5.0 p -161.56 139.48 9.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.163 0.431 . . . . 1.0 112.163 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.1 tp -114.83 139.25 49.9 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 3.1 m -135.68 156.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.423 0.63 . . . . 1.0 111.845 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 71.5 t -157.8 93.13 2.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.851 -1.068 . . . . 1.0 109.341 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.32 115.84 2.66 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.581 2.854 . . . . 1.0 113.973 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.08 105.07 4.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.794 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 75.5 mtp -121.78 146.14 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.168 0.508 . . . . 1.0 111.846 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 25.6 t-80 -123.18 112.88 18.22 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.47 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.9 t-80 64.89 -125.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.47 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.7 mt-30 -95.19 8.56 42.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.868 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.8 mp0 -118.42 155.08 31.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.897 1.073 . . . . 1.0 113.897 -177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.09 118.0 35.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.504 -1.225 . . . . 1.0 108.885 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CD2' ' OE2' ' A' ' 199' ' ' GLU . 77.9 m95 -97.51 -27.73 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.736 -0.386 . . . . 1.0 111.981 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.06 -173.45 25.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.189 -1.005 . . . . 1.0 111.965 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.465 ' CD2' HMB3 ' A' ' 203' ' ' CYC . 5.0 tp -139.15 131.33 28.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.849 0.357 . . . . 1.0 111.149 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.94 137.86 34.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.9 p -150.91 132.76 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.572 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 p -116.02 145.55 42.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.0 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -132.54 140.31 48.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 1.0 110.975 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -147.44 142.75 27.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.757 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.79 67.42 9.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.441 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -177.04 133.45 0.37 Allowed Pre-proline 0 N--CA 1.466 0.342 0 C-N-CA 120.43 -0.508 . . . . 1.0 112.349 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -85.23 112.05 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.654 2.236 . . . . 1.0 110.85 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -146.37 146.68 28.41 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.021 -0.99 . . . . 1.0 112.698 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.07 149.57 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.873 2.382 . . . . 1.0 111.118 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.66 151.38 25.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.826 0.346 . . . . 1.0 110.831 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -101.45 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.314 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -68.96 -34.98 76.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.683 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.91 -55.92 16.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.401 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 38.9 mp0 -67.75 -34.1 76.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.0 110.734 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.8 tp -62.28 -31.43 72.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.484 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.93 -52.73 22.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.458 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.0 t -44.86 -45.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.282 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.3 p -75.06 -37.32 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -47.58 -38.1 13.75 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.34 -40.15 74.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.727 -1.124 . . . . 1.0 109.437 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.9 tt -54.34 -30.91 53.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.64 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.66 -36.02 67.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.637 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.457 ' O ' ' OG ' ' A' ' 192' ' ' SER . 45.3 t0 -55.31 -39.57 70.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.717 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -53.75 -53.9 45.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 82.2 t -58.42 -42.28 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.861 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 7.5 p -51.35 -36.62 43.8 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -77.68 -34.97 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.031 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.5 -46.36 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.047 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.9 tt -64.08 -33.15 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.19 -55.83 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.875 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.28 -25.72 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.21 59.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.263 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.545 ' OE2' ' CD2' ' A' ' 163' ' ' TRP . 92.0 mt-10 -58.65 -39.96 82.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.198 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.38 -60.06 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.101 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 92.8 p -54.22 -40.72 67.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.348 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.042 -0.98 . . . . 1.0 110.442 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.644 HBB1 ' CD2' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.916 0.389 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -65.21 -40.57 94.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.321 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.72 -53.7 14.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tp -59.23 -34.04 52.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.581 0.585 . . . . 1.0 112.581 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.447 ' O ' ' OG1' ' A' ' 38' ' ' THR . 96.2 mt -74.59 -25.48 59.29 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.553 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -60.08 -54.11 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.951 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.78 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.32 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 46.2 p -65.71 -46.96 77.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 t -52.3 -31.45 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.848 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.36 -36.23 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 1.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -58.9 -43.24 90.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.953 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 74.0 t -66.33 -38.77 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.876 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.5 ttt180 -57.31 -52.54 64.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.06 87.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.745 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -79.43 -53.98 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.716 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -76.94 -4.76 45.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.0 110.176 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.12 16.74 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.397 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' ND1' ' A' ' 170' ' ' HIS . 14.6 t -77.41 145.9 36.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.106 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 70' ' ' GLY . 49.2 p30 -68.46 -10.5 55.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.946 0.721 . . . . 1.0 112.946 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.678 HH21 ' CD2' ' A' ' 169' ' ' HIS . 46.1 ttp180 -164.39 120.59 1.56 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.137 -1.025 . . . . 1.0 113.579 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.74 132.52 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -145.69 158.82 43.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.56 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.76 137.56 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.994 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.483 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 28.4 t80 -119.8 119.1 32.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.07 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -99.52 166.22 11.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.87 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -131.55 137.05 48.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 1.0 112.159 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.27 126.39 33.51 Favored Pre-proline 0 C--N 1.334 -0.104 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.07 -25.59 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.737 2.291 . . . . 1.0 112.901 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -76.71 -6.28 51.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.977 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.15 38.0 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.997 -0.62 . . . . 1.0 112.831 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -89.58 143.0 27.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.421 0.611 . . . . 1.0 110.919 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.74 140.95 14.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -128.64 146.86 50.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.248 0.547 . . . . 1.0 112.243 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.02 111.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -100.52 6.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.601 0.593 . . . . 1.0 112.601 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.41 146.99 23.02 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 42.5 tt0 -166.92 128.16 1.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.336 -0.946 . . . . 1.0 113.235 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.12 140.73 43.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.533 HH12 ' C ' ' A' ' 75' ' ' PRO . 5.2 ptm85 -131.37 142.67 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.25 110.4 3.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.456 -1.057 . . . . 1.0 110.456 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.54 -87.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.239 -1.145 . . . . 1.0 110.239 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.9 pt-20 -179.99 26.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.152 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.33 -32.24 73.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 69' ' ' ARG . 12.2 mt -118.23 142.74 31.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.533 ' C ' HH12 ' A' ' 69' ' ' ARG . 68.4 Cg_endo -73.85 170.57 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.072 1.848 . . . . 1.0 112.457 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.5 p -93.92 139.35 31.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.176 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -110.34 -3.37 16.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.633 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.17 137.89 55.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.307 0.575 . . . . 1.0 112.282 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.91 82.78 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.49 122.72 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.887 0.375 . . . . 1.0 110.782 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.1 t -79.05 122.43 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.515 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -105.38 131.11 22.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.37 150.07 22.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.185 1.923 . . . . 1.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.69 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.828 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.22 -22.68 0.58 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' ' NC ' ' A' ' 203' ' ' CYC . 90.7 m-20 -56.51 -31.16 63.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 1.0 110.659 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 88' ' ' PRO . 3.5 pt -118.47 100.42 51.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.316 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.3 Cg_exo -44.29 -110.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.487 2.124 . . . . 1.0 112.347 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -149.53 -58.45 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.751 -0.38 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.56 -40.93 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.77 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.42 ' HB2' HMD2 ' A' ' 203' ' ' CYC . . . -62.17 -38.84 90.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.014 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -68.56 -29.7 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.572 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -55.3 -55.63 29.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.226 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.89 -40.16 72.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 6.0 m-85 -57.9 -34.03 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -88.5 -9.8 51.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.103 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tp -107.18 -45.6 4.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.373 0.879 . . . . 1.0 113.373 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.39 -1.75 12.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.2 mt-30 28.44 71.64 0.05 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.116 1.154 . . . . 1.0 114.116 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 102' ' ' VAL . 35.4 m -117.53 -47.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.489 HH21 HG21 ' A' ' 154' ' ' VAL . 2.4 mpp_? 62.52 -26.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.143 -1.389 . . . . 1.0 114.354 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.553 ' H ' ' C ' ' A' ' 100' ' ' VAL . 11.8 p -56.14 129.48 17.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.445 -0.502 . . . . 1.0 111.788 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.44 HD12 HAA2 ' A' ' 203' ' ' CYC . 16.7 mt -105.37 129.94 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.452 ' CG2' ' H ' ' A' ' 105' ' ' ASP . 9.8 p -81.34 168.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -50.08 120.57 4.55 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.289 -177.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.6 -14.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.741 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.23 -36.56 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.914 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.79 -14.44 8.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.393 0.616 . . . . 1.0 110.101 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 51.5 59.8 4.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 1.0 113.409 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 m -92.09 137.57 32.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -126.63 135.45 51.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 45.6 t -104.33 150.02 24.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.126 -1.397 . . . . 1.0 107.402 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 112' ' ' SER . 20.2 pt -154.08 157.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.705 -0.798 . . . . 1.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 t -89.35 167.42 13.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.492 -0.777 . . . . 1.0 110.243 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -131.85 154.44 81.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.62 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.6 -6.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.691 2.261 . . . . 1.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' A' ' 118' ' ' SER . 22.5 pt-20 -158.03 -162.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.564 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 119' ' ' TRP . 8.8 p 62.59 127.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.417 ' CG ' ' O ' ' A' ' 118' ' ' SER . 94.2 m95 -154.24 -129.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.28 14.03 67.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.6 mt -60.32 -35.23 75.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 1.0 110.52 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.1 m -59.39 -29.85 68.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.15 54.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 64.91 62.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.27 143.81 73.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.124 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.42 132.26 18.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.556 2.171 . . . . 1.0 111.249 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.4 mt 43.52 -119.57 0.61 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.39 -0.76 67.84 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.528 ' CD ' HH22 ' A' ' 133' ' ' ARG . 1.3 pp20? -156.76 149.53 18.25 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.667 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 91.7 Cg_exo -43.51 149.13 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.467 2.111 . . . . 1.0 111.697 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 8.3 mp -78.85 27.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 89.0 mt-30 -131.25 164.04 26.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.121 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.528 HH22 ' CD ' ' A' ' 129' ' ' GLU . 19.9 mmt-85 -122.43 78.92 45.84 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.26 149.45 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.495 2.13 . . . . 1.0 111.864 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.524 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 19.0 m -100.8 148.76 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 1.0 111.416 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -87.73 154.89 53.39 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.909 -178.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -50.38 -21.28 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.268 1.979 . . . . 1.0 111.279 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.63 -39.8 30.68 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.538 ' HA ' HBC2 ' A' ' 203' ' ' CYC . 51.4 t-80 -81.52 -40.48 23.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.666 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 141' ' ' HIS . 3.1 m -52.07 -43.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.357 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.49 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 79.8 t60 -67.48 -43.99 79.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.256 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -43.3 -46.77 6.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.488 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.74 -43.84 62.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.574 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.1 tmtm? -60.69 -42.67 97.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.441 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 98.5 p -54.46 -31.32 55.4 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.6 mtt -89.47 -2.03 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.199 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.48 23.41 77.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.256 -0.884 . . . . 1.0 112.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 170' ' ' HIS . 11.5 t -104.09 121.14 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.889 -0.411 . . . . 1.0 109.889 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.87 44.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 t -131.45 167.48 19.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.156 -0.618 . . . . 1.0 111.545 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.2 p -162.47 141.92 9.34 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.137 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 38.3 tp -127.72 110.21 12.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.08 157.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.461 0.648 . . . . 1.0 111.849 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.547 ' N ' HG23 ' A' ' 153' ' ' VAL . 84.3 t -153.39 93.95 3.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.311 -176.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.26 120.33 8.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.527 2.818 . . . . 1.0 113.957 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.4 mt -74.79 104.54 5.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.787 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.7 mtp -122.62 146.42 47.46 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.337 -0.545 . . . . 1.0 111.83 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 159' ' ' HIS . 72.0 t60 -126.42 114.17 17.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.019 -1.104 . . . . 1.0 108.019 175.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 158' ' ' HIS . 8.0 m-70 63.29 -125.97 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -95.6 10.73 35.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.876 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 55.3 mt-10 -119.71 153.56 35.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.923 1.082 . . . . 1.0 113.923 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.68 113.91 27.51 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.513 -1.221 . . . . 1.0 108.925 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 89.1 m95 -98.06 -28.64 13.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.916 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.37 -174.38 23.61 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.4 tp -142.46 130.41 21.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 1.0 111.224 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.4 tp -96.25 140.7 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.4 t -146.2 111.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.394 -0.523 . . . . 1.0 111.531 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.5 t -100.17 139.23 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.013 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.698 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -148.79 144.66 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.193 0.521 . . . . 1.0 110.944 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.523 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.8 p-80 -153.97 151.81 29.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.66 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.02 66.68 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.345 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -176.02 134.68 0.45 Allowed Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.355 -0.538 . . . . 1.0 112.303 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.489 ' O ' ' C ' ' A' ' 174' ' ' ARG . 34.6 Cg_exo -41.95 -45.7 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.669 2.246 . . . . 1.0 110.823 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 173' ' ' PRO . 30.4 ttm180 21.75 84.32 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.099 -0.955 . . . . 1.0 112.711 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.11 154.36 57.93 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.844 2.362 . . . . 1.0 111.103 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.523 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 33.6 m-85 -110.94 138.33 47.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.803 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.5 t -99.68 146.49 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.272 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.35 -37.69 88.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.655 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.62 -56.16 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.327 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 33.3 mp0 -65.69 -34.09 77.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 1.0 110.639 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.48 -40.01 89.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.463 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.13 -51.0 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.423 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.5 t -46.99 -49.38 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.331 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.2 -37.63 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 43.4 tt0 -45.4 -36.43 4.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.82 -41.7 74.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.383 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 184' ' ' VAL . 5.4 tt -54.73 -33.16 60.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.638 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.16 -40.23 59.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.633 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.5 -38.33 71.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.684 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.94 -53.44 52.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.53 -43.83 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.838 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -51.94 -37.63 53.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.3 mt -78.71 -32.02 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.91 62.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.01 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 pp -65.49 -26.47 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.06 -55.72 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 1.0 109.925 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 -27.86 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.919 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.64 56.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.301 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.36 -37.41 72.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.13 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.1 mt -68.34 -58.2 4.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.108 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 m -55.15 -42.18 72.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.293 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.402 179.771 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.538 HBC2 ' HA ' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.5 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.918 0.39 . . . . 1.0 110.572 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.66 -50.74 42.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.303 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.16 -44.49 95.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.5 mp -62.59 -36.09 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -77.69 -20.82 53.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.446 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' O ' HG12 ' A' ' 39' ' ' VAL . 77.4 mtp180 -73.05 -33.71 65.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.639 -0.424 . . . . 1.0 109.972 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -33.62 28.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.36 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 2.1 t -70.74 -45.11 65.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.573 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.1 p -56.72 -36.55 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.839 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.1 mt-10 -75.46 -38.05 59.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 1.0 110.81 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.24 -51.12 65.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.966 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.28 -50.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.6 tmm_? -49.68 -41.63 43.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.9 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -35.79 73.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -79.64 -47.37 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 mt -76.53 -6.37 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.027 0.441 . . . . 1.0 110.177 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.62 16.46 0.19 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.462 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.465 HG21 ' H ' ' A' ' 50' ' ' ARG . 1.5 m -74.92 144.82 43.1 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.4 m-20 -62.4 -27.47 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.662 HH22 ' H ' ' A' ' 77' ' ' LEU . 59.9 ttt85 -153.54 121.56 6.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 119.127 -1.029 . . . . 1.0 113.562 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.34 134.43 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.829 ' HZ1' HAB2 ' A' ' 203' ' ' CYC . 32.8 pttt -146.01 160.26 42.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.577 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.9 134.97 32.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.004 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CD1' HBB2 ' A' ' 203' ' ' CYC . 71.9 t80 -119.15 118.55 31.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.021 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -99.03 165.72 11.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -132.08 136.17 46.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 1.0 112.155 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.69 129.68 24.89 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.714 -0.675 . . . . 1.0 109.341 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.59 -29.31 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.684 2.256 . . . . 1.0 112.933 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -72.72 -17.66 61.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.948 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.89 -15.24 12.49 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.839 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -84.93 141.85 30.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.375 0.588 . . . . 1.0 110.957 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.73 139.69 13.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.3 p -125.3 144.87 50.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.207 0.527 . . . . 1.0 112.312 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.33 116.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 65' ' ' VAL . 10.7 p -110.09 2.75 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.98 145.91 24.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' CD ' HH22 ' A' ' 50' ' ' ARG . 35.0 tt0 -165.78 127.48 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.37 -0.932 . . . . 1.0 113.233 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.06 135.21 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.489 HH22 ' CB ' ' A' ' 72' ' ' GLU . 7.6 ptm180 -125.49 142.15 51.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.533 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.36 104.36 2.71 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.469 -1.052 . . . . 1.0 110.469 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.51 -89.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.489 ' CB ' HH22 ' A' ' 69' ' ' ARG . 22.2 pt-20 -177.31 29.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.153 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -66.61 -54.26 25.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.47 144.68 28.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.804 -1.184 . . . . 1.0 107.804 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.03 166.83 28.97 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.019 1.813 . . . . 1.0 112.58 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 t -92.21 136.7 32.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.096 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.662 ' H ' HH22 ' A' ' 50' ' ' ARG . 59.0 mt -111.24 -3.24 15.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.618 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.6 tp -55.77 139.83 44.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.287 0.565 . . . . 1.0 112.335 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -3.2 84.59 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.6 tp -101.48 128.62 47.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 1.0 110.773 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.16 122.79 29.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.491 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -104.82 132.88 20.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.283 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.74 151.21 28.08 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.134 1.889 . . . . 1.0 111.714 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.4 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.799 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.64 -22.73 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -55.26 -31.08 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.465 HG21 HD12 ' A' ' 87' ' ' ILE . 29.1 mm -111.51 132.88 21.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.246 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 60.0 Cg_endo -80.55 -119.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.54 2.16 . . . . 1.0 112.313 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 86.4 tt0 -139.78 -69.0 0.42 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.823 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.62 -40.49 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.804 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.53 62.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -62.29 -31.24 71.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.572 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.4 -48.08 81.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 133' ' ' ARG . 63.9 mt -54.69 -39.1 67.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.824 -0.351 . . . . 1.0 110.529 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CZ ' ' O1A' ' A' ' 203' ' ' CYC . 11.4 m-85 -61.1 -32.86 72.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -88.19 -12.59 43.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.109 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 tp -105.54 -46.97 4.04 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.336 0.865 . . . . 1.0 113.336 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.72 -1.15 13.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' ALA . 91.8 mt-30 27.58 65.61 0.09 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.973 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 33.8 m -97.48 -46.37 12.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.374 -2.454 . . . . 1.0 104.374 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.973 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 0.4 OUTLIER 57.83 55.36 5.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.139 -1.392 . . . . 1.0 114.208 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 62.9 t -148.88 133.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.833 178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.81 126.22 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.43 168.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' OD2' ' OE2' ' A' ' 107' ' ' GLU . 13.2 t0 -53.28 118.38 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.326 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 24.4 t -55.46 -12.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.76 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 14.0 pt-20 -87.59 -38.36 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.846 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -57.56 -13.62 4.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.513 0.673 . . . . 1.0 110.211 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 50.84 56.31 8.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.958 -1.019 . . . . 1.0 113.399 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 m -94.51 134.15 37.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.34 -2.096 . . . . 1.0 105.34 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -129.44 142.21 50.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 114.963 1.468 . . . . 1.0 114.963 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.66 ' HG ' HH22 ' A' ' 133' ' ' ARG . 1.8 t -139.53 113.41 8.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.125 -1.398 . . . . 1.0 107.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.688 ' H ' ' CD1' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -119.57 -167.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.676 -0.81 . . . . 1.0 112.12 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -92.98 160.62 14.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.43 -0.804 . . . . 1.0 110.247 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 117' ' ' GLU . 53.2 mt-30 -140.25 152.34 66.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.603 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -36.14 -30.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.636 2.224 . . . . 1.0 112.238 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' GLN . 94.6 mt-10 -114.45 152.77 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.6 p -168.79 60.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.501 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 76.8 t-105 -143.61 166.77 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.489 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 96.51 3.55 59.73 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.2 mp -64.26 -29.77 70.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.809 0.338 . . . . 1.0 110.542 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 m -54.15 -24.78 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.7 -40.5 40.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 61.69 75.2 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.914 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.56 118.91 65.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.095 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.58 131.4 12.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.525 2.15 . . . . 1.0 111.125 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 mt 44.1 -131.88 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 0.91 85.37 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.648 -0.581 . . . . 1.0 111.648 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -155.51 146.44 16.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.964 -0.295 . . . . 1.0 110.662 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.54 153.6 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.357 2.038 . . . . 1.0 111.66 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.496 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 8.6 mp -80.72 27.77 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.291 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -133.55 167.52 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.077 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.66 HH22 ' HG ' ' A' ' 112' ' ' SER . 8.3 mmm180 -126.24 67.34 63.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.306 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.456 ' C ' ' O ' ' A' ' 133' ' ' ARG . 2.8 Cg_exo -30.73 147.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.564 2.176 . . . . 1.0 111.753 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.3 m -94.4 147.8 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 1.0 111.362 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.614 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -91.08 144.07 29.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.873 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.38 -27.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.196 1.93 . . . . 1.0 111.279 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.6 t -71.99 -57.5 4.24 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.437 ' NE2' ' CD1' ' A' ' 143' ' ' LEU . 42.0 t-80 -68.21 -27.83 66.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.688 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 37.7 t -51.62 -52.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.323 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 76.3 t60 -63.58 -41.28 98.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.256 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -45.43 -51.82 10.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.497 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.437 ' CD1' ' NE2' ' A' ' 139' ' ' HIS . 4.5 mp -72.07 -49.13 39.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 2.4 tmtt? -57.32 -42.62 82.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.446 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.9 m -53.65 -32.01 49.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.4 mtt -85.61 -2.48 58.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 1.0 109.188 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.88 24.24 74.29 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.314 -0.857 . . . . 1.0 112.353 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 3.2 m -106.66 123.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.27 -35.18 55.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -132.75 170.71 14.86 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.545 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.613 ' HG ' ' CE1' ' A' ' 169' ' ' HIS . 14.1 t -162.0 139.71 8.72 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.062 0.458 . . . . 1.0 112.158 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.32 138.96 50.4 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 154' ' ' VAL . 2.8 m -133.61 157.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.496 0.665 . . . . 1.0 111.828 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.419 ' CG2' ' O ' ' A' ' 153' ' ' VAL . 73.0 t -157.56 91.57 2.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.268 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.14 115.73 2.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.575 2.85 . . . . 1.0 113.931 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.98 105.7 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.825 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.6 ptm -131.15 147.43 52.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.22 0.533 . . . . 1.0 111.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -122.67 115.66 22.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.491 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 8.9 t60 64.77 -128.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.491 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.5 mm-40 -92.48 9.12 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -117.58 152.19 35.64 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.002 1.112 . . . . 1.0 114.002 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.96 116.92 32.84 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 114.498 -1.228 . . . . 1.0 108.873 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -95.94 -27.81 14.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.902 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.06 -170.42 27.91 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.247 -0.978 . . . . 1.0 112.029 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -141.38 131.91 25.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 1.0 111.19 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -96.02 141.55 29.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.406 HG21 ' HE2' ' A' ' 169' ' ' HIS . 8.6 p -150.92 135.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.566 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 151' ' ' SER . 2.6 m -121.15 150.61 41.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.027 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.613 ' CE1' ' HG ' ' A' ' 151' ' ' SER . 92.5 m-70 -147.74 146.82 29.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.121 0.486 . . . . 1.0 111.005 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 17.0 t60 -156.36 152.46 27.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.408 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -84.66 65.02 8.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 1.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -178.29 136.6 0.35 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.314 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -36.63 -51.79 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.686 2.257 . . . . 1.0 110.884 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 30.94 77.11 0.34 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.076 -0.965 . . . . 1.0 112.74 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.88 150.58 85.53 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.849 2.366 . . . . 1.0 111.103 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -111.55 140.03 46.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 1.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.2 m -95.22 150.35 20.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.19 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.6 -40.81 96.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.666 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.02 -54.9 35.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.405 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -66.97 -32.25 73.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 1.0 110.709 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.29 -38.22 76.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.507 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.23 -51.52 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.406 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.7 t -43.17 -48.79 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.8 m -74.63 -37.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.51 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 56.2 tt0 -47.76 -37.44 13.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.76 -40.2 63.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.393 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 48.8 tp -54.69 -32.88 60.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.682 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.26 -34.93 68.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.645 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' A' ' 192' ' ' SER . 43.6 t0 -55.24 -39.15 69.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.794 178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.96 -53.76 44.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -58.21 -41.86 81.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.176 -0.92 . . . . 1.0 109.825 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 7.0 p -51.71 -35.76 44.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 84.3 mt -78.29 -34.26 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.038 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.98 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.127 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 8.3 tp -63.56 -31.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.46 -56.96 4.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.873 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -55.41 -27.14 45.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.64 -34.53 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.301 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.402 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.7 tt0 -57.15 -39.98 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.101 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 10.2 mp -67.82 -56.07 10.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.05 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.9 m -51.53 -41.49 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 1.0 110.311 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.829 HAB2 ' HZ1' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 1.0 110.533 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.3 -43.17 99.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.256 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -69.1 -53.74 18.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.4 mm -55.83 -46.74 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.7 -23.36 66.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.526 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.48 ' O ' HG11 ' A' ' 39' ' ' VAL . 18.9 ttm180 -61.42 -36.02 79.16 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.639 -0.425 . . . . 1.0 109.993 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.44 -25.18 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.302 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.9 p -76.54 -47.0 24.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.546 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -52.79 -37.95 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.883 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 pt-20 -79.08 -32.36 44.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.91 -52.9 62.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.952 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.7 p -64.22 -44.4 97.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.902 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 47' ' ' GLY . 6.6 tmm_? -48.98 -44.47 40.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.74 75.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -80.64 -50.66 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.751 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' THR . 1.9 tp -77.13 -8.16 57.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.081 0.467 . . . . 1.0 110.208 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 45.39 17.46 0.13 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.402 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.472 ' HG1' ' HG ' ' A' ' 168' ' ' SER . 9.3 t -75.71 145.39 40.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.029 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.2 m-20 -56.47 -34.75 67.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.891 0.701 . . . . 1.0 112.891 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -150.66 126.83 10.57 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.204 -0.998 . . . . 1.0 113.523 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -141.77 130.43 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.939 -1.134 . . . . 1.0 107.939 176.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' NZ ' ' OB ' ' A' ' 203' ' ' CYC . 20.4 pttm -144.35 161.26 39.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.58 -177.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.81 133.45 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.055 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.522 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 72.1 t80 -118.14 117.42 29.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.019 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -100.81 169.07 9.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -133.9 138.66 45.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.161 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-20 -102.23 126.66 32.74 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.283 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.6 -27.09 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.722 2.281 . . . . 1.0 112.89 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.3 -9.68 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.004 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.79 21.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.868 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.53 139.77 32.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.308 0.554 . . . . 1.0 110.932 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -116.1 134.09 11.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.379 -1.088 . . . . 1.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -125.89 144.84 50.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.282 0.563 . . . . 1.0 112.229 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.09 126.2 61.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -113.1 4.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.31 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.7 tt0 -166.29 127.98 1.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.347 -0.941 . . . . 1.0 113.16 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.98 131.2 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -118.5 138.39 52.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.544 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.9 95.08 1.12 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.61 -89.21 0.05 OUTLIER Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.194 -1.162 . . . . 1.0 110.194 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.66 36.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.77 -0.372 . . . . 1.0 111.116 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -73.96 -54.38 8.04 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.0 mt -93.74 146.42 31.71 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.0 167.18 27.82 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.004 1.803 . . . . 1.0 112.518 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.5 p -88.14 139.51 30.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.108 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.562 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 34.8 mt -113.21 -2.45 14.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.593 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 45.1 tp -60.18 140.61 56.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.346 0.593 . . . . 1.0 112.25 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -4.27 86.23 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.391 -0.822 . . . . 1.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.6 mt -99.89 140.0 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 1.0 110.737 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -97.59 121.79 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.458 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 7.4 m-85 -106.74 131.41 21.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.26 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.68 152.55 29.35 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.145 1.897 . . . . 1.0 111.658 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.57 -20.98 66.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.773 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.62 -24.24 0.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.8 m-20 -53.39 -27.79 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 1.0 110.551 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.9 mt -120.98 132.34 24.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.59 -116.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.538 2.159 . . . . 1.0 112.329 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -126.09 -75.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.815 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -42.65 -37.1 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.775 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB1' HBD2 ' A' ' 203' ' ' CYC . . . -69.9 -48.63 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.937 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -60.27 -32.09 70.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.519 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' LEU . 79.9 mtp180 -58.5 -46.2 87.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' GLN . 68.2 mt -56.26 -35.99 68.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.584 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 100' ' ' VAL . 8.7 m-85 -63.22 -42.8 99.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -87.43 -17.18 32.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.076 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.0 tp -106.7 -48.1 3.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -119.18 -7.47 10.29 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.583 0.957 . . . . 1.0 113.583 -175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 101' ' ' ARG . 92.2 mt-30 51.74 67.26 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 102' ' ' VAL . 35.2 m -69.2 63.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 99' ' ' GLN . 32.2 ptt180 -66.08 14.76 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.026 -1.443 . . . . 1.0 114.29 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' A' ' 100' ' ' VAL . 2.0 t -147.63 128.08 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.488 -0.485 . . . . 1.0 111.758 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.38 129.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.97 169.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.263 0.838 . . . . 1.0 113.263 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 173' ' ' PRO . 0.4 OUTLIER -51.69 120.85 5.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.304 -178.14 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 82.3 t -59.68 -15.39 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.806 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.639 ' C ' ' H ' ' A' ' 109' ' ' GLN . 18.5 pt-20 -84.87 -38.25 19.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.866 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.89 3.03 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.378 0.609 . . . . 1.0 110.096 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.639 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 35.89 59.49 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.046 -0.979 . . . . 1.0 113.384 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 t -92.66 134.76 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -126.09 139.74 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.411 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 28.5 t -104.57 150.28 24.77 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.104 -1.407 . . . . 1.0 107.377 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' A' ' 112' ' ' SER . 18.9 pt -154.62 158.15 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.676 -0.809 . . . . 1.0 112.136 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 t -88.06 165.64 15.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.28 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.12 156.05 37.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.665 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -34.92 145.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.709 2.272 . . . . 1.0 112.26 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -52.76 140.43 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.491 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.5 t -163.15 -125.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -56.69 -43.32 80.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 122' ' ' SER . . . 69.57 9.95 62.7 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.8 mt 56.11 4.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 1.0 110.608 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 120' ' ' GLY . 34.8 t -59.85 -29.4 68.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.606 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.85 -11.57 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.808 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 58.33 86.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.65 109.93 60.6 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.11 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.69 135.51 16.85 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.551 2.168 . . . . 1.0 111.167 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 129' ' ' GLU . 7.7 tp 42.88 -117.19 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 1.0 109.603 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.76 14.47 0.08 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.639 -0.584 . . . . 1.0 111.639 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 127' ' ' LEU . 75.8 mt-10 -148.13 152.16 39.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.63 141.55 55.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.438 2.092 . . . . 1.0 111.69 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.76 19.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.308 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -131.93 168.38 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.049 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.4 ttt85 -134.97 96.47 14.45 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.27 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.6 156.35 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 C-N-CA 122.601 2.201 . . . . 1.0 111.758 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 27.1 m -99.39 140.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.027 0.442 . . . . 1.0 111.341 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 139' ' ' HIS . 3.5 m-20 -94.93 148.2 34.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.913 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -38.36 -26.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.215 1.943 . . . . 1.0 111.237 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -76.19 -47.22 24.91 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.3 t-80 -76.12 -28.81 57.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.653 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -50.56 -47.9 27.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.403 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.545 ' O ' ' N ' ' A' ' 145' ' ' SER . 80.2 t60 -65.59 -42.16 92.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -45.93 -56.07 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.453 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 50.7 mt -72.12 -50.44 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.496 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 44.3 tptt -57.56 -43.32 84.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.415 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 141' ' ' HIS . 33.9 t -53.78 -34.18 58.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.238 -0.652 . . . . 1.0 109.238 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.1 mtt -84.3 -7.33 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.2 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.45 23.87 76.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.9 122.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.97 31.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 151' ' ' SER . 1.5 t -142.98 170.42 15.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.573 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 30.9 t -162.04 140.31 9.04 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.205 -0.452 . . . . 1.0 112.173 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 62.2 tp -114.64 116.36 28.61 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -117.07 158.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.447 0.641 . . . . 1.0 111.791 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 79.5 t -155.65 95.24 2.47 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.363 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.02 113.46 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.558 2.839 . . . . 1.0 113.928 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.2 106.62 5.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 17.1 ptm -133.57 146.41 50.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.917 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 78.5 t60 -117.68 115.64 25.46 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 34.0 m-70 59.1 -123.53 1.25 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.48 8.56 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.63 149.71 39.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.983 1.105 . . . . 1.0 113.983 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.0 tp -107.54 115.92 31.01 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.545 -1.207 . . . . 1.0 108.857 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -96.65 -30.41 13.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.965 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.56 -170.14 24.77 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.205 -0.998 . . . . 1.0 111.937 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.475 HD23 HMB3 ' A' ' 203' ' ' CYC . 5.4 tp -138.18 128.49 26.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 1.0 111.16 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -92.09 138.01 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 10.8 p -149.58 135.3 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.593 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.472 ' HG ' ' HG1' ' A' ' 48' ' ' THR . 12.3 t -117.36 146.15 43.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.049 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.508 ' CE1' ' OG ' ' A' ' 151' ' ' SER . 78.1 m-70 -143.68 141.43 30.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 1.0 111.043 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -152.72 151.88 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.69 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.94 9.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.583 -0.28 . . . . 1.0 111.489 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -176.37 164.66 1.72 Allowed Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 120.319 -0.552 . . . . 1.0 112.302 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.494 ' CB ' ' OD2' ' A' ' 105' ' ' ASP . 31.5 Cg_endo -95.35 89.61 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.703 2.269 . . . . 1.0 110.928 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -115.45 92.91 34.53 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.755 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.16 152.78 29.37 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.813 2.342 . . . . 1.0 111.086 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -111.01 140.93 45.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 1.0 110.748 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -93.19 143.12 26.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.284 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -62.14 -39.51 92.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.33 -54.95 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.61 -0.268 . . . . 1.0 111.366 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.63 -32.39 73.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.974 0.416 . . . . 1.0 110.765 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.64 -42.71 88.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.86 -50.85 70.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.45 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.19 -48.42 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.24 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -74.03 -39.23 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.571 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 57.3 tt0 -46.18 -35.57 5.22 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.3 tp -71.44 -38.37 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.685 -1.143 . . . . 1.0 109.35 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 9.8 tp -56.28 -31.04 63.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.686 . . . . 1.0 109.631 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.28 -36.41 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.602 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -59.57 -38.75 81.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.747 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -52.74 -55.15 24.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.82 -40.5 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.904 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 157' ' ' MET . 6.1 t -52.02 -35.53 47.24 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.2 mt -79.12 -36.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.081 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -47.22 63.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.062 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.8 tp -61.0 -33.48 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -75.51 -53.9 7.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.967 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -55.34 -28.31 52.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -34.86 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.294 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -56.51 -40.25 74.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.198 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 200' ' ' LEU . 10.6 mp -68.29 -56.59 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.172 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.4 m -58.32 -45.59 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 1.0 110.292 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.427 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.522 HBB1 ' CD1' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.1 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.912 0.386 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.46 -50.55 73.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.317 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.77 -48.6 79.95 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG22 HD13 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -62.54 -29.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.605 ' O ' HG22 ' A' ' 38' ' ' THR . 96.6 mt -77.85 -20.93 52.2 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 39' ' ' VAL . 73.4 mtp180 -72.44 -34.16 67.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.032 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.19 31.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.349 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 35' ' ' LEU . 2.5 t -74.29 -44.87 50.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.55 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.2 p -55.69 -36.02 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.59 -36.86 68.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.021 0.438 . . . . 1.0 110.872 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.55 -52.15 48.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.979 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.15 -51.22 75.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -49.17 -43.93 42.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.21 -47.43 14.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.91 -6.62 53.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.76 16.67 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.714 -0.676 . . . . 1.0 112.458 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 m -75.01 144.66 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.391 -0.524 . . . . 1.0 110.083 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.0 m-20 -57.21 -34.29 68.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 74' ' ' LEU . 29.5 ttm180 -149.55 124.14 9.75 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.212 -0.995 . . . . 1.0 113.526 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 11.9 t -135.21 131.57 52.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -143.74 152.04 40.77 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.569 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.9 t -98.46 139.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.983 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.0 t80 -124.76 121.63 35.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.001 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -99.95 171.78 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.86 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -134.12 138.19 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.558 -0.457 . . . . 1.0 112.15 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 m-20 -104.81 149.33 37.39 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.269 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.21 -26.64 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.741 2.294 . . . . 1.0 112.946 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -76.54 -3.73 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.055 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.88 -10.29 57.13 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.032 -0.604 . . . . 1.0 112.811 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 95.9 m-70 -90.42 147.06 23.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.338 0.569 . . . . 1.0 110.941 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . -130.12 151.41 19.4 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -131.3 149.69 52.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.256 0.55 . . . . 1.0 112.274 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.73 115.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.023 -1.103 . . . . 1.0 108.023 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.69 -2.41 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.635 0.606 . . . . 1.0 112.635 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.15 20.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.7 tt0 -167.41 127.14 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.332 -0.947 . . . . 1.0 113.159 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 142.05 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.119 -1.067 . . . . 1.0 108.119 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' O ' ' NH2' ' A' ' 43' ' ' ARG . 35.9 ptt-85 -132.87 141.96 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.544 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.33 111.54 3.7 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.363 -1.095 . . . . 1.0 110.363 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.32 40.05 3.41 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.309 -1.116 . . . . 1.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 48.53 26.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.119 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -54.13 -56.34 19.05 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 10.7 mt -93.76 152.03 40.38 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' C ' HH22 ' A' ' 50' ' ' ARG . 56.4 Cg_endo -69.58 156.97 62.36 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.114 1.876 . . . . 1.0 112.573 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -76.44 113.98 14.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 56.5 mt -87.39 -6.76 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.595 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.2 tp -60.25 139.98 57.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.305 0.574 . . . . 1.0 112.209 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.82 -3.51 84.84 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.8 mt -99.58 136.61 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 1.0 110.737 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 81' ' ' THR . 15.4 t -94.3 120.62 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.482 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' GLY . 7.3 m-85 -108.73 133.26 20.71 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.283 178.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 149.29 34.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.147 1.898 . . . . 1.0 111.719 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.34 -25.63 64.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.779 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.01 -20.95 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' NC ' ' A' ' 203' ' ' CYC . 32.6 t70 -51.78 -23.38 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.0 110.608 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.4 mt -127.15 132.73 24.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.34 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.58 -108.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.53 2.154 . . . . 1.0 112.319 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -142.58 -72.46 0.31 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.1 pt-20 -41.42 -43.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.721 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -63.65 -49.48 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -58.23 -29.08 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' NH2' ' CD2' ' A' ' 121' ' ' LEU . 33.2 mtm180 -55.81 -47.63 76.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.218 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 8.4 mp -54.45 -38.68 66.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.572 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.573 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.4 m-85 -60.03 -24.99 64.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.227 0.537 . . . . 1.0 109.572 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.5 mtp85 -94.74 -19.02 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.123 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mp -109.5 -45.51 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.03 -11.08 15.37 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.581 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 82.7 mt-30 25.35 70.77 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.082 1.141 . . . . 1.0 114.082 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.413 HG22 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -141.77 -55.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 104.44 -2.43 . . . . 1.0 104.44 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.575 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 5.6 mmp_? 52.84 103.85 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.038 -1.437 . . . . 1.0 114.297 173.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 19.2 m -144.77 132.66 16.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.768 176.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.423 HD12 HG22 ' A' ' 103' ' ' ILE . 58.3 mt -108.64 123.86 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.71 168.08 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.58 120.43 5.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.242 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -56.73 -10.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -86.61 -37.08 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.39 -17.84 55.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.372 0.606 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 53.44 60.43 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.056 -0.974 . . . . 1.0 113.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -93.51 135.16 35.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.0 mtp-105 -130.06 142.44 50.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.528 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 1.5 m -106.96 155.78 19.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.189 -1.368 . . . . 1.0 107.357 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.452 ' CG2' ' O ' ' A' ' 112' ' ' SER . 17.7 pt -156.31 159.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.769 -0.772 . . . . 1.0 112.223 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.442 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 86.4 p -86.51 163.64 17.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.214 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 114' ' ' SER . 8.2 mp0 -137.2 158.76 71.9 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.47 -12.3 18.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.662 2.241 . . . . 1.0 112.239 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -152.24 125.98 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.458 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.4 t 175.08 114.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.655 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -150.6 -173.64 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.479 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.86 4.5 56.81 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.0 mp -63.11 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 1.0 110.559 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.4 m -54.23 -26.77 30.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.61 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.97 -27.48 19.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.827 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 58.56 90.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.896 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.03 104.52 52.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.16 129.35 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.498 2.132 . . . . 1.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.1 tp 43.15 -110.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.44 12.94 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.599 -0.6 . . . . 1.0 111.599 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 130' ' ' PRO . 33.7 mt-10 -134.78 154.26 79.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 1.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 129' ' ' GLU . 78.4 Cg_exo -42.0 167.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.41 2.073 . . . . 1.0 111.658 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.9 mt -78.55 -6.95 56.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.254 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -134.06 168.51 18.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 15.8 mmm180 -133.85 86.58 37.93 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.294 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.528 ' O ' ' OG ' ' A' ' 112' ' ' SER . 73.7 Cg_exo -47.72 145.36 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.536 2.157 . . . . 1.0 111.774 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.473 HG12 HBD2 ' A' ' 203' ' ' CYC . 15.7 t -128.46 135.34 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.994 0.426 . . . . 1.0 111.354 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 138' ' ' CYS . 0.8 OUTLIER -44.2 154.73 0.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.883 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -56.32 -7.16 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.243 1.962 . . . . 1.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.461 ' H ' ' C ' ' A' ' 136' ' ' ASP . 42.0 t -58.42 -50.58 73.2 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.442 ' CD2' ' HB ' ' A' ' 135' ' ' VAL . 0.1 OUTLIER -73.32 -27.38 61.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.329 -0.851 . . . . 1.0 110.689 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.433 ' N ' ' CD2' ' A' ' 139' ' ' HIS . 22.3 t -52.01 -54.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 1.0 110.362 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.481 ' O ' ' N ' ' A' ' 145' ' ' SER . 10.2 m80 -68.99 -46.06 69.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.215 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.409 ' CD2' ' CBA' ' A' ' 203' ' ' CYC . 6.3 t80 -47.43 -55.96 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.48 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.407 ' CD1' ' ND1' ' A' ' 139' ' ' HIS . 89.1 mt -66.83 -50.48 62.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.514 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 42.7 tptt -57.56 -42.09 82.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 m -54.28 -34.92 61.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mtt -84.73 -3.77 58.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.242 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.97 25.84 70.47 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.261 -0.881 . . . . 1.0 112.324 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.2 t -106.71 114.92 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.011 0.405 . . . . 1.0 109.945 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.78 -30.1 61.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.517 ' OG ' ' NE2' ' A' ' 170' ' ' HIS . 97.4 p -138.67 170.14 16.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.615 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 p -161.85 130.86 4.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.46 114.97 29.23 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.488 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.7 p -113.42 157.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.455 0.645 . . . . 1.0 111.853 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.488 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 58.9 t -157.7 124.54 2.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.281 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.33 149.87 22.06 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.602 2.868 . . . . 1.0 113.906 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.52 107.43 15.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.409 -0.814 . . . . 1.0 109.799 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.581 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 81.5 mtp -121.23 140.63 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 111.834 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 22.2 t-80 -118.15 113.9 22.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 46.9 t60 68.08 -129.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.504 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 58.8 mt-30 -95.33 8.78 42.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -120.99 159.84 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.963 1.097 . . . . 1.0 113.963 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.71 117.97 34.91 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.543 -1.208 . . . . 1.0 108.896 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -96.24 -28.47 14.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.95 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.2 -173.95 26.29 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.215 -0.993 . . . . 1.0 112.006 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -140.99 126.38 18.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 1.0 111.278 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 167' ' ' VAL . 0.6 OUTLIER -95.14 135.61 36.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.572 ' N ' ' CD1' ' A' ' 166' ' ' LEU . 85.3 t -145.55 137.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.567 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.527 ' C ' ' ND1' ' A' ' 169' ' ' HIS . 20.6 m -125.26 144.49 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.33 152.82 36.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 1.0 111.013 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.517 ' NE2' ' OG ' ' A' ' 150' ' ' SER . 1.1 p-80 -158.15 154.08 26.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.03 67.91 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.421 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.41 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.5 tp10 -177.62 131.43 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.348 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -38.16 -51.22 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.695 2.263 . . . . 1.0 110.918 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 31.41 84.44 0.17 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.033 -0.985 . . . . 1.0 112.691 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.69 151.09 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.773 2.315 . . . . 1.0 111.114 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -114.49 137.85 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -92.31 150.04 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.304 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 179' ' ' GLU . 12.3 pt20 -67.34 -42.94 82.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.625 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.449 ' N ' ' CG ' ' A' ' 178' ' ' GLN . 79.1 mm-40 -61.74 -55.14 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 111.359 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.33 -30.69 71.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 1.0 110.698 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.3 tp -61.72 -34.83 76.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.499 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.49 -53.7 21.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.376 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 49.3 t -44.34 -47.39 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.226 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.24 -37.44 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -48.63 -37.14 17.44 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 21.1 tp -72.79 -40.62 65.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.71 -1.132 . . . . 1.0 109.3 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.22 -32.29 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.633 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.03 -37.24 64.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.671 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -56.8 -41.54 77.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.758 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -52.63 -54.31 34.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.69 -41.55 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.837 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.1 m -50.46 -29.67 10.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 193' ' ' ILE . 11.2 mm -77.26 -42.35 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.049 179.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.05 88.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.1 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.09 -31.31 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.485 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.33 -56.29 4.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -55.04 -28.88 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 202' ' ' LEU . . . -77.56 -34.2 53.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.304 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -58.42 -38.59 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.63 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.036 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.3 t -69.77 -55.57 9.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 1.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 198' ' ' ALA . 19.0 mt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.435 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.52 ' NC ' ' O ' ' A' ' 86' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' CD2' HH11 ' A' ' 55' ' ' ARG . 61.0 tp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.903 0.382 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -51.86 -49.5 62.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.22 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.43 -46.56 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.5 mp -59.9 -40.03 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.97 -22.04 58.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.693 -0.403 . . . . 1.0 111.504 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.1 ttm-85 -68.57 -36.77 79.22 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.652 -0.419 . . . . 1.0 109.991 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.01 -29.3 39.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.369 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -71.14 -48.39 52.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 36' ' ' ARG . 2.8 p -54.05 -35.16 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.842 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.12 -39.89 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.88 -40.65 98.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.932 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.32 -51.21 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.867 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.554 ' O ' ' N ' ' A' ' 47' ' ' GLY . 23.4 ttp85 -50.78 -44.94 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.909 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.4 79.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.848 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -79.56 -51.44 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.751 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.11 -6.51 53.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.009 0.433 . . . . 1.0 110.081 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.1 16.99 0.54 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.695 -0.684 . . . . 1.0 112.45 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.447 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -73.73 141.66 46.34 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 70' ' ' GLY . 78.9 m-20 -60.13 -29.21 68.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.447 ' H ' ' CG2' ' A' ' 48' ' ' THR . 59.8 ttp180 -154.4 119.07 4.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 119.17 -1.012 . . . . 1.0 113.578 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.85 136.09 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 18.0 pttp -145.63 160.87 41.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.41 -0.516 . . . . 1.0 111.579 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.9 t -97.76 137.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.999 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.422 ' CD1' HAB2 ' A' ' 203' ' ' CYC . 60.9 t80 -121.29 119.35 31.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 1.0 111.031 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.431 HH11 ' CD2' ' A' ' 31' ' ' LEU . 63.8 mtm180 -99.97 170.47 8.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 6.7 t80 -134.96 137.61 43.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.061 0.458 . . . . 1.0 112.172 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -103.14 148.59 35.87 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.325 179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.92 -23.87 67.95 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.739 2.293 . . . . 1.0 112.902 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.61 -2.9 41.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.27 -12.71 51.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.954 -0.641 . . . . 1.0 112.876 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -88.79 146.2 25.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.326 0.563 . . . . 1.0 110.95 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -125.35 145.58 15.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.467 -1.053 . . . . 1.0 110.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -128.36 146.96 50.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.291 0.567 . . . . 1.0 112.341 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.1 118.2 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.6 p -115.12 9.2 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 -177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.9 142.8 23.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 48.9 tt0 -165.99 126.67 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.368 -0.933 . . . . 1.0 113.181 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.66 140.66 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 176.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 36.4 ptt85 -132.2 143.38 49.91 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.203 -0.599 . . . . 1.0 111.539 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.84 106.94 3.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.366 -1.094 . . . . 1.0 110.366 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 55.2 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 70' ' ' GLY . 44.7 tt0 -176.94 35.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.089 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -72.94 -51.98 16.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -95.07 121.16 63.05 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 107.803 -1.184 . . . . 1.0 107.803 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.39 162.92 11.23 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.054 1.836 . . . . 1.0 112.557 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.1 t -83.83 135.16 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.3 mt -109.64 -7.66 15.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.592 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 tp -49.4 138.06 13.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.347 0.594 . . . . 1.0 112.288 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.54 -4.04 79.34 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.063 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.6 tt -98.22 115.22 27.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 1.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.8 126.41 30.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.445 -178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 80' ' ' LEU . 61.5 m-85 -108.26 139.82 21.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.82 152.28 19.28 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.131 1.887 . . . . 1.0 111.675 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -59.8 -26.45 65.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.819 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.05 -21.7 1.05 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 49.0 p-10 -58.0 -29.67 65.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.588 ' O ' ' O ' ' A' ' 88' ' ' PRO . 4.4 mm -110.17 99.8 41.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.228 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.7 Cg_exo -48.41 -126.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.091 . . . . 1.0 112.3 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.79 -60.64 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.811 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.59 -41.02 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.758 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.468 ' HB2' HAD1 ' A' ' 203' ' ' CYC . . . -63.18 -42.96 99.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 1.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 34.9 ttm180 -63.82 -28.86 70.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.591 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 97' ' ' LEU . 31.9 mmt180 -56.73 -53.77 53.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.286 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 98' ' ' ALA . 32.3 mt -54.02 -36.01 62.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.651 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -66.49 -35.95 81.55 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -85.05 -16.15 41.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.114 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.1 mp -106.04 -42.84 4.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.53 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -114.25 -4.58 13.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.527 0.936 . . . . 1.0 113.527 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.1 mt-30 27.93 69.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.05 1.13 . . . . 1.0 114.05 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.557 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 58.3 t -110.73 -50.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.417 -2.438 . . . . 1.0 104.417 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.681 HH12 ' NE2' ' A' ' 185' ' ' GLN . 10.5 mtm180 63.72 72.02 0.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.088 -1.414 . . . . 1.0 114.269 172.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.7 t -152.1 133.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.782 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.422 ' CD1' ' N ' ' A' ' 103' ' ' ILE . 1.7 mp -107.41 127.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 105' ' ' ASP . 12.7 p -83.01 167.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.266 0.839 . . . . 1.0 113.266 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' N ' ' CG2' ' A' ' 104' ' ' VAL . 5.9 m-20 -54.62 120.03 6.12 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.315 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.53 -10.99 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.771 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 17.4 pt-20 -85.38 -40.42 16.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.876 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.23 -12.61 3.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.433 0.635 . . . . 1.0 110.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 49.4 52.0 15.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.051 -0.977 . . . . 1.0 113.396 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.6 m -94.44 136.56 34.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -128.12 141.71 51.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.432 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 4.2 t -99.33 153.66 18.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.098 -1.41 . . . . 1.0 107.323 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 112' ' ' SER . 19.7 pt -155.03 159.52 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 119.663 -0.815 . . . . 1.0 112.164 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.8 p -87.15 167.84 13.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.254 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -146.06 154.11 50.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.689 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.54 -39.81 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.637 2.225 . . . . 1.0 112.264 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.62 -33.74 74.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.3 t -71.69 162.27 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.481 ' O ' ' CG ' ' A' ' 119' ' ' TRP . 73.8 t-105 -146.21 27.79 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.548 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.67 64.91 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.996 -0.841 . . . . 1.0 110.996 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.4 mt 44.52 47.5 8.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.372 . . . . 1.0 110.562 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.1 t -56.53 -26.69 55.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.604 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.96 -16.95 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.828 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 61.59 79.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.858 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.2 t -85.19 131.0 49.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.081 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 127' ' ' LEU . 97.6 Cg_endo -75.56 141.61 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.562 2.175 . . . . 1.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.428 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 21.0 mt 41.42 -160.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.09 27.69 57.66 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 127' ' ' LEU . 8.3 mp0 -118.13 152.33 50.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.635 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.538 ' CG ' ' NH2' ' A' ' 133' ' ' ARG . 61.1 Cg_endo -70.69 164.95 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.404 2.069 . . . . 1.0 111.65 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 8.7 mp -77.99 -7.26 56.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.316 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -134.42 168.26 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.068 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.538 ' NH2' ' CG ' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -129.88 84.44 60.84 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.284 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.06 142.86 7.92 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.56 2.174 . . . . 1.0 111.768 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.474 ' HB ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -107.26 117.54 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.016 0.436 . . . . 1.0 111.312 -177.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -39.85 153.95 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.947 177.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -56.96 -20.43 36.58 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.237 1.958 . . . . 1.0 111.233 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.6 t -65.79 -46.97 76.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.017 -0.734 . . . . 1.0 109.017 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.806 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -74.7 -27.94 60.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.632 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.48 -54.72 13.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.318 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 145' ' ' SER . 49.7 t-80 -65.93 -44.48 84.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.279 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -44.49 -51.69 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.482 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.78 -47.03 50.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.522 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.8 OUTLIER -59.45 -42.06 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.503 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 141' ' ' HIS . 85.0 p -53.77 -30.65 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.6 mtt -86.91 -0.47 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.238 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.97 24.41 76.48 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.22 -0.9 . . . . 1.0 112.36 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.439 HG13 ' N ' ' A' ' 170' ' ' HIS . 11.4 t -106.9 122.57 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.15 -26.27 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -142.58 171.87 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.573 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.02 136.78 12.4 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.51 136.23 52.28 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -135.02 155.41 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.436 0.636 . . . . 1.0 111.845 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.4 t -157.67 90.0 2.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.333 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.22 140.24 52.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.552 2.835 . . . . 1.0 113.923 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.1 mt -98.52 105.65 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.799 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 81.3 mtp -119.42 141.13 49.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.553 . . . . 1.0 111.818 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.45 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 42.0 t-80 -116.61 112.03 20.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 4.9 t60 62.86 -123.7 0.63 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.478 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 17.2 pt20 -94.64 7.72 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 162' ' ' LEU . 26.4 tp10 -117.23 153.4 32.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 161' ' ' GLU . 6.5 tt -107.72 117.36 33.9 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 114.55 -1.205 . . . . 1.0 108.816 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -96.97 -27.87 14.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.858 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.06 23.53 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -141.59 127.81 19.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.0 111.263 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.3 tp -92.92 134.06 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.55 134.84 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.578 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.78 142.43 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.99 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -134.56 132.17 38.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 1.0 110.96 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 19.0 t60 -168.53 161.41 11.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.766 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.709 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -46.22 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.428 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.661 ' N ' ' OE1' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -91.78 107.29 21.34 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 120.391 -0.523 . . . . 1.0 112.343 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 171' ' ' ALA . 26.7 Cg_endo -92.61 -156.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.67 2.247 . . . . 1.0 110.849 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -91.0 173.83 5.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.046 -0.979 . . . . 1.0 112.698 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.34 155.96 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.876 2.384 . . . . 1.0 111.108 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -108.23 150.19 27.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.856 0.36 . . . . 1.0 110.795 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -106.43 143.95 33.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.254 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.79 -28.3 66.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.617 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.14 -54.58 27.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.594 -0.275 . . . . 1.0 111.325 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.58 -33.88 76.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.944 0.402 . . . . 1.0 110.688 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.66 -39.99 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.501 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.548 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 78.5 mm-40 -61.98 -51.96 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.352 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.1 t -45.27 -48.95 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 187' ' ' LEU . 63.9 t -74.27 -38.71 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.681 ' NE2' HH12 ' A' ' 101' ' ' ARG . 56.9 tt0 -45.93 -36.02 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.59 -39.68 67.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.764 -1.107 . . . . 1.0 109.333 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 184' ' ' VAL . 35.0 tp -54.95 -32.92 61.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.85 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.655 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.453 ' O ' ' OG ' ' A' ' 192' ' ' SER . 46.9 t0 -56.91 -39.36 74.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.697 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -53.38 -53.91 44.37 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.2 t -56.7 -43.67 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.36 -0.836 . . . . 1.0 109.869 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.3 p -51.7 -37.43 50.73 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.2 mt -78.39 -32.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.025 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.36 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 1.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.419 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.6 pp -66.62 -26.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.52 -55.71 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.846 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.26 -26.88 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.95 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.48 -35.73 58.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -56.94 -39.34 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.221 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.5 tp -66.97 -56.31 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.119 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.9 m -47.16 -39.16 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 1.0 110.307 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.081 -0.961 . . . . 1.0 110.47 179.78 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.621 ' HC ' HBA1 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.823 0.344 . . . . 1.0 110.553 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 40.6 p-10 -65.33 -37.88 88.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.313 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.0 mt-30 -73.3 -53.71 10.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.51 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -57.2 -40.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.51 ' O ' ' OG1' ' A' ' 38' ' ' THR . 69.9 mt -71.29 -33.28 69.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.631 -0.427 . . . . 1.0 111.589 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -49.53 -37.96 28.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.634 -0.426 . . . . 1.0 109.993 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.16 -26.4 52.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.35 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.585 ' HG1' ' N ' ' A' ' 39' ' ' VAL . 46.5 p -74.85 -44.33 49.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.557 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 ' N ' ' HG1' ' A' ' 38' ' ' THR . 56.8 t -59.13 -38.89 76.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.548 . . . . 1.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.27 -38.22 56.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.55 -49.35 75.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.995 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.92 -47.99 90.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.942 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.2 ttp180 -49.71 -43.99 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.853 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -81.52 -47.95 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.804 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -78.0 -7.08 56.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 1.0 110.084 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 50.18 19.51 2.76 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.668 -0.696 . . . . 1.0 112.494 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.487 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 1.9 m -76.91 141.9 40.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.065 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.0 m-20 -62.6 -28.45 69.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.602 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 60.5 ttp180 -152.98 124.87 7.88 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.145 -1.022 . . . . 1.0 113.54 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -146.7 136.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -146.81 162.45 38.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.566 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.71 136.47 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.035 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.623 ' CD2' HBB1 ' A' ' 203' ' ' CYC . 28.1 t80 -122.89 121.67 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.024 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' CG ' ' N ' ' A' ' 56' ' ' PHE . 36.6 ttm-85 -101.47 168.93 9.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.85 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' N ' ' CG ' ' A' ' 55' ' ' ARG . 71.0 t80 -131.2 136.7 48.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.053 0.454 . . . . 1.0 112.124 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.5 148.74 35.63 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.379 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.69 -22.53 64.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.728 2.286 . . . . 1.0 112.94 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -79.69 -3.09 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.544 -0.463 . . . . 1.0 111.041 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.7 -10.42 52.86 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.815 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -90.19 145.83 24.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.377 0.588 . . . . 1.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.61 142.92 14.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.3 p -128.39 147.5 50.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.152 0.501 . . . . 1.0 112.346 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.7 t -101.14 121.35 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 m -108.98 1.84 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.62 149.12 24.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.6 tt0 -166.83 127.18 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.394 -0.922 . . . . 1.0 113.248 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 133.89 54.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.549 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 58.6 mtm180 -117.45 139.74 50.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.22 107.05 2.56 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.32 18.17 0.06 OUTLIER Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.268 -1.133 . . . . 1.0 110.268 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' GLY . 43.6 tt0 70.57 30.91 3.01 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.115 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 36.7 ttm180 -57.83 -59.57 5.03 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.8 164.8 20.67 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.81 171.75 17.43 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.043 1.829 . . . . 1.0 112.533 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -90.42 121.37 32.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -92.76 -11.85 32.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.624 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 tp -50.4 137.23 19.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.17 82.37 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.384 -0.825 . . . . 1.0 111.051 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.427 ' C ' ' CD2' ' A' ' 80' ' ' LEU . 4.3 tt -97.68 115.9 28.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 1.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.0 t -76.46 122.5 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.465 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.75 132.16 21.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.318 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.11 152.39 27.73 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.195 1.93 . . . . 1.0 111.698 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.36 -21.14 66.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.81 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.73 -22.29 0.14 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.3 m-20 -48.44 -23.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.331 . . . . 1.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CD1' HH21 ' A' ' 92' ' ' ARG . 2.9 pt -133.67 142.04 42.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.55 -104.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.525 2.15 . . . . 1.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -147.64 -64.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 1.0 111.788 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.04 -41.12 46.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.716 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.585 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -63.15 -41.63 99.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.96 0.41 . . . . 1.0 111.005 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.528 HH21 ' CD1' ' A' ' 87' ' ' ILE . 23.6 ttm105 -64.54 -27.93 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' LEU . 68.7 mtm180 -58.53 -53.56 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.327 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 94' ' ' LEU . 8.4 mp -52.73 -41.33 63.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.55 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.2 m-85 -64.1 -35.91 82.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -85.2 -8.96 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.072 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.4 tp -105.86 -43.34 4.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.42 -0.08 12.62 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 98' ' ' ALA . 93.6 mt-30 28.45 68.28 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 t -117.73 -48.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.381 -2.452 . . . . 1.0 104.381 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 101' ' ' ARG . 6.2 mtp180 50.57 76.5 0.15 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.26 171.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 m -145.15 139.17 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.757 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 103' ' ' ILE . 2.8 mp -107.24 125.2 63.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' CG1' ' N ' ' A' ' 105' ' ' ASP . 24.3 t -83.49 166.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 113.256 0.835 . . . . 1.0 113.256 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.485 ' N ' ' CG1' ' A' ' 104' ' ' VAL . 3.1 m-20 -48.85 120.32 3.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.252 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.1 m -57.77 -12.18 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.764 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -87.01 -37.33 17.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.46 -16.19 44.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.372 0.606 . . . . 1.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 53.06 60.32 3.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.002 -0.999 . . . . 1.0 113.427 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.1 m -92.89 133.98 35.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -128.35 141.67 51.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.488 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -101.81 150.74 22.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.073 -1.422 . . . . 1.0 107.298 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 112' ' ' SER . 22.4 pt -155.12 159.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.678 -0.809 . . . . 1.0 112.162 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.549 ' HG ' ' N ' ' A' ' 115' ' ' GLN . 48.2 t -88.11 162.03 16.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.186 178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.549 ' N ' ' HG ' ' A' ' 114' ' ' SER . 5.6 pt20 -150.21 154.54 36.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.668 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.11 165.18 24.14 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.626 2.217 . . . . 1.0 112.236 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 119' ' ' TRP . 85.0 tt0 46.22 -100.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.586 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 119' ' ' TRP . 34.3 t 41.96 -93.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.59 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.529 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 51.9 t-105 45.87 -174.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.566 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 92.2 1.68 69.31 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.9 tp -70.86 -33.19 70.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 1.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.8 p -55.95 -20.01 14.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.57 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.77 -23.04 4.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.816 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 58.8 84.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -98.54 140.77 22.03 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.53 137.65 23.17 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.525 2.15 . . . . 1.0 111.205 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt 43.66 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.02 -24.87 13.65 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.641 -0.584 . . . . 1.0 111.641 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.76 152.85 89.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.609 ' CG ' HH21 ' A' ' 133' ' ' ARG . 55.6 Cg_endo -67.05 166.28 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 1.0 111.686 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.35 0.15 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.309 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -137.99 168.72 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.609 HH21 ' CG ' ' A' ' 130' ' ' PRO . 2.5 mmp_? -133.09 83.63 50.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.338 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.488 ' O ' ' OG ' ' A' ' 112' ' ' SER . 88.2 Cg_exo -46.0 145.21 5.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.525 2.15 . . . . 1.0 111.797 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.602 ' CG2' ' ND1' ' A' ' 139' ' ' HIS . 6.5 m -118.1 127.01 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 1.0 111.361 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.461 ' H ' ' CMD' ' A' ' 203' ' ' CYC . 2.7 m-20 -43.12 139.39 2.29 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.9 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -39.91 -46.8 3.85 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.163 1.909 . . . . 1.0 111.24 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 9.9 p -43.83 -41.68 5.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.602 ' ND1' ' CG2' ' A' ' 135' ' ' VAL . 13.1 t-80 -79.94 -38.52 32.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.368 -0.833 . . . . 1.0 110.687 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.6 t -50.9 -50.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.3 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 77.0 t60 -64.13 -39.86 94.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.253 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -43.95 -47.48 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.447 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.78 -45.4 61.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.511 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -60.17 -42.49 95.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.492 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.8 m -54.17 -33.33 57.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.6 mtt -86.99 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.156 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.26 26.16 66.75 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.291 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.74 120.87 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.33 33.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 173' ' ' PRO . 37.7 m -127.89 153.99 46.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.155 -0.618 . . . . 1.0 111.585 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.87 129.55 19.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.052 0.453 . . . . 1.0 112.178 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.96 141.78 50.97 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' CG2' ' A' ' 154' ' ' VAL . 2.3 m -129.65 155.42 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.845 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 2.1 t -150.72 97.82 3.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.891 -1.05 . . . . 1.0 109.287 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.84 139.52 36.65 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.536 2.824 . . . . 1.0 113.889 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.24 104.52 16.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.718 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 88.3 mtp -119.06 141.07 49.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.843 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' O ' ' CB ' ' A' ' 159' ' ' HIS . 39.3 t-80 -125.31 112.93 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 26.4 t60 75.08 -135.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.48 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 25.4 mt-30 -96.16 12.38 31.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 63.7 mt-10 -120.19 161.43 21.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.79 116.83 32.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.544 -1.207 . . . . 1.0 108.851 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.4 m95 -99.04 -29.3 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.847 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.96 179.7 28.31 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.217 -0.992 . . . . 1.0 111.927 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 tp -139.96 130.68 25.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 1.0 111.193 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.9 tp -99.6 145.27 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.62 125.81 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.556 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -110.51 143.25 41.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.049 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.607 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -141.95 143.53 33.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 19.2 t60 -153.29 153.24 32.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.657 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.445 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.59 68.46 9.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.433 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.431 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.1 tp10 -177.04 131.41 0.35 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 120.401 -0.52 . . . . 1.0 112.302 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 174' ' ' ARG . 21.4 Cg_exo -39.08 -44.73 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.68 2.253 . . . . 1.0 110.885 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 173' ' ' PRO . 42.3 ttm180 23.17 104.6 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.009 -0.996 . . . . 1.0 112.689 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.72 156.18 24.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.793 2.329 . . . . 1.0 111.1 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -115.18 137.67 51.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 1.0 110.804 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -91.21 143.44 26.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.234 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.57 -55.3 28.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.661 0.267 . . . . 1.0 111.388 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -65.07 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 1.0 110.653 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.71 -30.47 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.576 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -73.88 -52.67 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.406 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.94 -45.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.283 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' LEU . 5.4 p -73.18 -39.38 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -49.8 -36.59 26.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.5 tp -69.88 -31.22 68.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.704 -1.134 . . . . 1.0 109.41 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.6 tt -63.32 -28.17 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.72 70.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.664 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -53.36 -44.61 68.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -52.56 -55.53 21.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.047 -0.724 . . . . 1.0 109.047 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.66 -40.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.903 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.8 m -50.22 -29.13 8.8 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.451 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 11.2 mm -77.28 -48.53 24.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.064 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.63 87.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.084 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 196' ' ' ALA . 4.0 tp -59.91 -37.48 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 195' ' ' ILE . . . -72.97 -51.64 17.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.848 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 193' ' ' ILE . 2.9 mp0 -55.61 -26.59 44.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.81 55.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -59.08 -41.37 87.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.05 -60.14 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.024 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.2 p -58.97 -43.84 91.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.422 179.793 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.623 HBB1 ' CD2' ' A' ' 54' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.886 0.374 . . . . 1.0 110.555 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.8 p-10 -63.66 -44.63 93.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.251 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 93.8 mt-30 -67.0 -53.19 33.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mt -55.24 -48.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.0 112.629 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' O ' ' OG1' ' A' ' 38' ' ' THR . 48.0 mt -62.81 -25.25 68.16 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.641 -0.423 . . . . 1.0 111.609 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.537 ' NH1' ' OE2' ' A' ' 40' ' ' GLU . 0.5 OUTLIER -57.42 -36.63 71.59 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.636 -0.426 . . . . 1.0 110.036 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.68 41.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.391 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 35' ' ' LEU . 43.0 p -73.57 -48.4 33.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.556 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 36' ' ' ARG . 3.2 p -53.3 -35.12 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 95.4 mt-10 -77.76 -33.71 52.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.44 -50.51 71.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.978 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 43' ' ' ARG . 12.4 p -64.24 -45.56 95.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.91 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 18.3 ttt-85 -49.09 -46.42 44.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.05 82.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.782 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -78.31 -52.11 9.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.761 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.55 -5.61 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 1.0 110.167 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.75 18.0 0.33 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.599 -0.728 . . . . 1.0 112.399 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.484 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.1 m -75.86 144.0 41.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 1.0 110.14 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 70' ' ' GLY . 97.4 m-20 -64.29 -26.81 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.87 0.693 . . . . 1.0 112.87 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.537 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 24.4 ttt180 -149.98 121.27 7.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.103 -1.039 . . . . 1.0 113.476 -178.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 3.2 t -140.32 130.53 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.957 -1.127 . . . . 1.0 107.957 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -143.33 155.32 44.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.626 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.79 137.44 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.009 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 24.4 t80 -121.36 119.7 32.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.033 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -99.76 170.29 8.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.871 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 48.9 t80 -135.05 141.66 46.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.155 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 4.0 m-20 -104.0 150.47 38.31 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.269 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.49 -29.18 53.31 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.699 2.266 . . . . 1.0 112.901 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.47 -4.99 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.586 -0.446 . . . . 1.0 110.935 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.36 -14.54 36.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.803 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 99.2 m-70 -84.65 143.79 29.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.398 0.599 . . . . 1.0 110.959 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -119.67 139.28 13.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -125.08 143.85 50.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.289 0.566 . . . . 1.0 112.25 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.27 120.16 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.61 3.47 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.52 149.87 24.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 79.2 tt0 -166.15 125.46 1.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.433 -0.907 . . . . 1.0 113.266 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.13 135.86 47.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 7.1 ptp85 -129.78 141.97 50.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.552 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.36 106.32 3.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.454 -1.058 . . . . 1.0 110.454 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.19 -88.55 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.261 -1.136 . . . . 1.0 110.261 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.7 tt0 -177.36 32.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.064 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.57 -33.94 73.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.73 142.63 29.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 64.0 Cg_endo -73.36 170.35 20.1 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.077 1.851 . . . . 1.0 112.535 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 14.9 m -93.53 137.93 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.189 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.8 mt -109.63 -3.9 16.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.641 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 14.2 tp -56.69 137.75 53.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.278 0.561 . . . . 1.0 112.286 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.97 86.03 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.8 tt -101.61 118.77 37.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.907 0.384 . . . . 1.0 110.746 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 122.43 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.463 -178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 m-85 -106.26 133.69 20.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.336 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.7 152.28 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.175 1.917 . . . . 1.0 111.71 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.9 -23.39 67.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.796 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.86 -22.93 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -54.05 -21.72 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.1 mt -129.0 132.83 24.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.302 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.17 -107.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.531 2.154 . . . . 1.0 112.341 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.11 -69.09 0.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.815 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -42.34 -42.38 3.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' HMD2 ' A' ' 203' ' ' CYC . . . -66.14 -52.96 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.976 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -56.44 -30.37 62.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.566 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -57.47 -45.11 85.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.231 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 98' ' ' ALA . 50.5 mt -54.96 -36.68 65.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.582 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.557 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.6 m-85 -61.17 -26.53 67.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 mtp85 -93.87 -18.23 22.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.12 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.1 mp -109.44 -46.86 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.374 0.879 . . . . 1.0 113.374 -176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -107.96 -10.87 15.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -174.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.596 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 79.8 mt-30 26.12 69.29 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.423 HG22 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -137.46 -54.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.624 ' H ' ' HE ' ' A' ' 101' ' ' ARG . 5.4 mmp_? 49.57 101.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.111 -1.404 . . . . 1.0 114.288 171.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.61 136.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.464 -0.494 . . . . 1.0 111.743 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 103' ' ' ILE . 70.8 mt -107.61 123.16 62.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.508 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 23.4 t -84.17 168.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.508 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 4.0 m-20 -50.4 118.48 3.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.262 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.54 -11.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.313 -0.858 . . . . 1.0 110.75 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.572 ' C ' ' H ' ' A' ' 109' ' ' GLN . 4.8 pt-20 -88.61 -35.86 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.915 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.59 0.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.4 0.619 . . . . 1.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.572 ' H ' ' C ' ' A' ' 107' ' ' GLU . 10.1 pt20 35.35 60.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.106 -0.952 . . . . 1.0 113.504 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -93.96 134.99 35.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.384 -2.08 . . . . 1.0 105.384 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -131.09 141.85 50.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 1.9 t -142.89 116.56 9.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.184 -1.371 . . . . 1.0 107.354 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -119.34 -163.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 119.673 -0.811 . . . . 1.0 112.181 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.527 ' H ' HG23 ' A' ' 113' ' ' ILE . 49.0 m -88.02 164.43 15.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 116' ' ' PRO . 39.2 mt-30 -143.12 151.29 55.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.651 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 115' ' ' GLN . 41.5 Cg_exo -35.09 -40.7 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.686 2.257 . . . . 1.0 112.241 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -145.76 147.68 32.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.538 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.2 p -130.19 152.79 49.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.577 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 87.4 t90 -153.01 171.74 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.537 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.545 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 92.73 6.32 63.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.452 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 10.1 mp -81.63 -72.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 1.0 110.595 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.9 p -65.25 -20.43 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.6 75.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 56.23 86.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.8 142.94 25.6 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.29 130.31 13.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.597 2.198 . . . . 1.0 111.151 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.503 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 5.3 tp 47.66 -134.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.503 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 55.06 16.47 8.34 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.678 -0.569 . . . . 1.0 111.678 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -102.05 152.23 38.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.929 -0.309 . . . . 1.0 110.599 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.92 160.0 50.75 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.408 2.072 . . . . 1.0 111.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.94 -14.47 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.297 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -134.57 169.41 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.491 HH21 HH22 ' A' ' 101' ' ' ARG . 11.3 tpp180 -138.72 73.46 40.67 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.336 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 133' ' ' ARG . 3.5 Cg_exo -30.36 143.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.615 2.21 . . . . 1.0 111.774 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.8 115.69 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.107 0.479 . . . . 1.0 111.363 -178.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.557 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -40.27 147.14 0.38 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.912 178.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.522 ' O ' HG21 ' A' ' 140' ' ' VAL . 17.7 Cg_endo -52.86 -12.41 1.94 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.221 1.947 . . . . 1.0 111.258 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.02 -39.32 50.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.572 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 3.3 t-80 -83.34 -34.2 25.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.366 -0.834 . . . . 1.0 110.633 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 136' ' ' ASP . 2.9 m -53.94 -45.88 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.299 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.56 ' CE1' ' HG ' ' A' ' 145' ' ' SER . 42.7 t-80 -67.41 -44.92 77.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.197 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -46.59 -51.16 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.47 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.3 -49.22 57.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 17.8 tptp -58.0 -40.25 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.449 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.56 ' HG ' ' CE1' ' A' ' 141' ' ' HIS . 34.9 m -53.73 -33.47 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.62 0.88 44.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.191 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.62 23.96 75.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.247 -0.888 . . . . 1.0 112.334 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.46 121.8 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.913 -0.402 . . . . 1.0 109.913 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.72 49.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.4 t -135.53 170.12 16.45 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.112 -0.635 . . . . 1.0 111.593 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.559 ' HG ' ' CE1' ' A' ' 169' ' ' HIS . 10.7 t -162.05 139.82 8.72 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 -177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.521 ' H ' ' HG ' ' A' ' 168' ' ' SER . 35.9 tp -115.33 133.58 55.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.4 p -132.37 155.58 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.06 -0.656 . . . . 1.0 111.818 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 77.2 t -156.53 109.93 2.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.334 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.62 114.17 3.42 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.634 2.889 . . . . 1.0 113.87 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.51 107.02 7.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.808 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . 0.596 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 17.0 ptm -132.15 144.19 50.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.824 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -114.31 114.73 26.33 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 46.8 t-80 61.48 -123.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.507 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.2 tt0 -94.04 6.16 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.901 0.334 . . . . 1.0 111.901 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 43.9 mp0 -115.65 149.82 37.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.991 1.108 . . . . 1.0 113.991 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.28 116.83 32.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.562 -1.199 . . . . 1.0 108.912 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -99.22 -30.47 12.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.917 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.26 -174.1 24.76 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.187 -1.006 . . . . 1.0 111.958 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 tp -141.09 131.11 24.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 1.0 111.201 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.4 tp -93.7 136.21 34.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.56 ' CG1' ' NE2' ' A' ' 169' ' ' HIS . 31.0 t -148.52 122.74 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.527 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 152' ' ' LEU . 2.0 p -108.09 143.27 37.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.971 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.56 ' NE2' ' CG1' ' A' ' 167' ' ' VAL . 54.3 m-70 -137.03 143.2 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.096 0.474 . . . . 1.0 111.048 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.692 ' CG ' ' HE ' ' A' ' 174' ' ' ARG . 2.5 p-80 -152.95 151.92 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.703 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.56 68.97 9.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.403 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 179.67 153.91 0.62 Allowed Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -89.54 101.76 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.695 2.263 . . . . 1.0 110.934 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.692 ' HE ' ' CG ' ' A' ' 170' ' ' HIS . 6.9 ptt85 -128.62 100.11 22.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.068 -0.969 . . . . 1.0 112.686 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.99 152.65 17.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.89 2.394 . . . . 1.0 111.089 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -110.53 145.8 37.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.864 -0.335 . . . . 1.0 110.799 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 t -96.26 139.2 32.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -63.17 -40.34 97.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.671 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -65.49 -55.73 16.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.31 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.89 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 1.0 110.64 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.2 tp -59.56 -40.23 86.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.539 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.76 -50.84 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.416 -0.357 . . . . 1.0 111.358 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.39 -47.16 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 75.3 t -73.39 -40.71 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 57.0 tt0 -45.99 -34.83 4.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.67 -38.07 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.404 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 10.9 tp -54.84 -31.36 59.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.698 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.55 70.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.648 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.463 ' O ' ' OG ' ' A' ' 192' ' ' SER . 47.8 t0 -57.19 -42.1 80.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.72 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -52.7 -55.35 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.136 -0.69 . . . . 1.0 109.136 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.07 -43.17 84.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.826 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 8.3 p -52.0 -37.27 52.64 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.1 mt -78.11 -33.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.079 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.71 66.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.037 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.421 ' C ' ' CD1' ' A' ' 195' ' ' ILE . 2.7 pp -67.13 -23.78 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.53 -56.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.794 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.2 -26.9 63.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.909 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -36.27 58.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.263 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.2 -38.13 70.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.8 mt -68.08 -55.94 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.055 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.2 p -53.0 -41.16 64.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.281 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.02 -0.99 . . . . 1.0 110.423 179.531 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.572 HMA2 ' HE2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 1.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -53.6 -53.07 56.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.306 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.02 -46.42 90.81 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.4 mm -60.63 -38.98 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.38 -21.15 60.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.555 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -70.32 -40.21 74.31 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.034 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.43 -33.56 62.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.349 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.2 p -68.17 -46.39 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.573 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -56.18 -38.89 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.874 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.64 -37.43 56.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -57.43 -53.14 61.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.951 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -63.35 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.896 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.3 ttp-105 -51.13 -47.21 62.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.905 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.71 78.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.4 -50.93 10.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.26 -5.59 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 1.0 110.206 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.3 19.2 1.07 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.442 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.455 ' CG2' ' H ' ' A' ' 50' ' ' ARG . 1.3 m -76.08 141.99 41.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.374 -0.531 . . . . 1.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 70' ' ' GLY . 37.3 p30 -67.8 -24.16 65.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.58 ' O ' ' ND1' ' A' ' 169' ' ' HIS . 71.2 ttt-85 -153.98 120.31 5.44 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.176 -1.01 . . . . 1.0 113.538 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.21 139.18 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.585 ' CE ' HAB2 ' A' ' 203' ' ' CYC . 28.4 pttt -148.04 160.59 42.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.553 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -99.41 139.15 21.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.078 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' CD2' HBB2 ' A' ' 203' ' ' CYC . 16.0 t80 -121.58 120.47 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.01 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.2 ttp-105 -99.43 166.59 11.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 1.0 109.911 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.535 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 43.2 t80 -132.36 142.77 49.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.074 0.464 . . . . 1.0 112.117 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 m-20 -105.34 149.88 38.26 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.32 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.78 -30.32 58.95 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.735 2.29 . . . . 1.0 112.896 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.95 -5.43 34.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.607 -0.437 . . . . 1.0 111.022 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.77 -14.24 38.19 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.998 -0.62 . . . . 1.0 112.83 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.64 142.77 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.436 0.618 . . . . 1.0 110.896 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.35 140.17 14.25 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.0 p -127.1 145.71 50.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.242 0.544 . . . . 1.0 112.253 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.54 121.26 56.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.3 p -115.97 9.01 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.71 145.52 21.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.2 tt0 -168.69 129.93 1.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.447 -0.901 . . . . 1.0 113.212 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.36 140.42 44.57 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.39 143.85 50.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.523 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.6 108.19 3.36 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.21 -84.92 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 70' ' ' GLY . 16.1 pt-20 177.89 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.859 -0.337 . . . . 1.0 111.15 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.591 ' NH1' ' NE2' ' A' ' 170' ' ' HIS . 10.4 ptp180 -65.76 -31.6 72.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -116.3 150.28 45.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 177.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.01 162.88 28.79 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.066 1.844 . . . . 1.0 112.494 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -90.79 113.62 25.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.98 -1.18 57.83 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.554 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.2 tp -52.8 135.63 35.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 1.0 112.216 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.89 -1.43 78.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 81' ' ' THR . 3.7 tt -95.22 120.31 35.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 1.0 110.743 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.414 ' N ' HD22 ' A' ' 80' ' ' LEU . 6.2 p -87.75 127.34 35.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.446 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.628 ' CD1' HBB3 ' A' ' 203' ' ' CYC . 35.1 m-85 -109.23 139.02 20.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.288 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.67 161.48 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.214 1.943 . . . . 1.0 111.608 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.87 67.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.781 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.43 -23.43 3.08 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.68 -26.9 68.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 1.0 110.663 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 88' ' ' PRO . 60.8 mt -112.18 99.98 47.95 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.3 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 87' ' ' ILE . 84.2 Cg_exo -49.4 -121.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.584 2.189 . . . . 1.0 112.318 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -145.64 -58.32 0.32 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.8 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -51.3 -42.09 60.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.805 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.85 -49.87 66.61 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -29.92 68.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.534 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.18 -48.27 80.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.278 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HB2' ' HE ' ' A' ' 133' ' ' ARG . 74.2 mt -51.89 -40.2 60.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.652 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.7 -24.91 67.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.459 ' HE ' ' CA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -90.98 -21.29 21.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.16 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -105.57 -45.94 4.3 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.404 0.89 . . . . 1.0 113.404 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.72 -5.83 16.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' ALA . 96.3 mt-30 24.68 66.87 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.401 ' CG2' ' NH2' ' A' ' 133' ' ' ARG . 3.1 m -108.44 -50.78 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 1.0 104.43 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.767 ' H ' HH22 ' A' ' 133' ' ' ARG . 1.2 mtt180 65.67 68.03 0.48 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.069 -1.423 . . . . 1.0 114.233 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.558 ' H ' HH12 ' A' ' 133' ' ' ARG . 44.6 t -148.92 130.85 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.754 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 89.8 mt -110.93 128.51 67.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' CG1' ' H ' ' A' ' 105' ' ' ASP . 12.9 t -82.39 168.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 113.307 0.854 . . . . 1.0 113.307 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' H ' ' CG1' ' A' ' 104' ' ' VAL . 0.5 OUTLIER -47.49 117.34 1.76 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.805 -1.088 . . . . 1.0 112.325 -178.52 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.08 -10.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.745 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -87.4 -35.41 18.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.872 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.03 48.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.367 0.603 . . . . 1.0 110.149 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 52.78 59.41 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.974 . . . . 1.0 113.456 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -93.79 138.61 31.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -133.82 144.12 48.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.003 1.483 . . . . 1.0 115.003 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -129.49 113.99 15.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.127 -1.397 . . . . 1.0 107.404 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.678 ' H ' ' CD1' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -119.93 -168.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.745 -0.782 . . . . 1.0 112.214 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.2 t -88.25 154.65 20.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.482 -0.781 . . . . 1.0 110.207 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -151.37 153.61 32.62 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.578 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 115' ' ' GLN . 39.5 Cg_exo -35.44 157.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.635 2.223 . . . . 1.0 112.27 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.66 142.0 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.515 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.8 t -150.69 146.84 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -56.92 -44.57 82.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.48 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.92 32.32 62.2 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 121' ' ' LEU . 9.3 mp 50.83 78.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 1.0 110.559 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.4 m -58.39 -33.95 70.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.76 -53.46 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.826 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -171.94 143.91 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.974 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.35 84.18 9.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.073 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' C ' ' A' ' 127' ' ' LEU . 78.9 Cg_endo -84.35 126.67 3.71 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.529 2.153 . . . . 1.0 111.208 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 126' ' ' PRO . 69.5 mt 36.63 -108.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.51 8.17 18.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.609 -0.597 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -153.96 149.91 21.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.662 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.25 168.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.446 2.097 . . . . 1.0 111.675 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.29 19.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.286 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 18.7 mm100 -133.47 171.38 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.036 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.767 HH22 ' H ' ' A' ' 101' ' ' ARG . 17.8 ttm105 -131.41 80.53 67.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.28 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -44.23 145.79 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.512 2.141 . . . . 1.0 111.833 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.5 m -122.38 130.07 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.014 0.435 . . . . 1.0 111.423 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.704 ' OD1' HMD1 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -42.47 163.45 0.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.913 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.3 -11.07 17.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.226 1.951 . . . . 1.0 111.257 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.727 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -60.23 -55.42 33.98 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.976 -0.749 . . . . 1.0 108.976 178.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.727 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 18.0 t-80 -72.34 -27.16 62.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.631 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.05 -60.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.335 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -66.1 -41.98 89.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.24 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -42.51 -48.72 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.546 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 139' ' ' HIS . 30.2 mt -72.08 -47.01 54.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.46 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 147' ' ' GLY . 38.7 tptt -55.99 -42.97 77.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -55.1 -30.2 59.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 41.7 mtt -90.02 -7.98 52.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.118 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.96 28.96 59.7 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.337 -0.847 . . . . 1.0 112.327 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 14.4 t -108.94 124.36 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.03 -31.17 39.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.6 p -134.12 169.4 17.22 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.594 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -159.06 139.47 12.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.023 0.439 . . . . 1.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.02 141.89 48.3 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.96 156.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.418 0.628 . . . . 1.0 111.914 -178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.3 t -157.62 98.53 1.91 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.337 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.24 117.74 4.83 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.571 2.848 . . . . 1.0 113.9 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.82 106.3 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.809 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.2 ptm -129.34 143.33 50.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.848 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 70.0 t60 -110.42 113.96 27.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 21.3 m-70 57.97 -119.67 1.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -93.63 2.55 56.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -112.56 150.69 30.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.959 1.096 . . . . 1.0 113.959 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.03 116.84 32.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.491 -1.231 . . . . 1.0 108.867 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -96.96 -28.52 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.921 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.41 -173.81 28.33 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.949 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.42 HD23 HMB3 ' A' ' 203' ' ' CYC . 4.0 tp -138.18 133.54 33.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 1.0 111.214 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -99.45 140.03 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.44 111.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.512 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 142.04 31.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.106 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.58 ' ND1' ' O ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -146.71 148.51 32.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.141 0.496 . . . . 1.0 111.043 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.591 ' NE2' ' NH1' ' A' ' 73' ' ' ARG . 7.0 t60 -152.63 148.57 27.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -72.74 69.11 0.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -173.22 167.09 2.82 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.345 -0.542 . . . . 1.0 112.293 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -89.74 6.75 4.21 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.64 2.227 . . . . 1.0 110.831 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -34.25 115.12 0.48 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.104 -0.953 . . . . 1.0 112.669 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.26 155.28 22.17 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.804 2.336 . . . . 1.0 111.056 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -108.83 141.75 40.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.779 0.324 . . . . 1.0 110.85 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -94.01 149.3 21.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.291 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.93 -40.78 78.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.678 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.87 -55.81 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.366 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.15 -31.34 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 1.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.2 tp -60.82 -38.12 84.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.456 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -63.42 -52.98 59.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.395 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.5 t -43.95 -49.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.317 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.7 m -75.06 -36.28 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.635 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 47.6 tp60 -46.89 -36.64 7.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.099 -1.075 . . . . 1.0 108.099 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.53 -40.76 66.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.374 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' VAL . 33.9 tp -54.76 -33.1 60.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.645 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.14 -35.94 61.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.603 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . 0.47 ' O ' ' OG ' ' A' ' 192' ' ' SER . 50.6 t0 -57.37 -41.15 79.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.661 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -52.33 -52.38 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.89 -43.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.888 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.644 ' HG ' ' N ' ' A' ' 193' ' ' ILE . 9.6 p -51.92 -38.07 54.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.644 ' N ' ' HG ' ' A' ' 192' ' ' SER . 1.6 mp -77.65 -32.64 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.027 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -46.13 64.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.117 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.74 -26.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.43 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -77.03 -56.31 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.946 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.13 -26.77 63.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.869 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.84 -35.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.24 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -56.91 -38.98 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.8 -57.16 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.09 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 t -60.4 -46.08 91.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 1.0 110.321 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.427 179.768 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' CYC . . . . . 0.713 HMA1 ' CD2' ' A' ' 139' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 195' ' ' ILE . 6.9 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.899 0.381 . . . . 1.0 110.581 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.18 -46.98 65.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -66.01 -47.31 74.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.222 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.87 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -59.68 -41.07 84.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -74.83 -22.33 58.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.586 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.3 ttp180 -66.72 -36.83 83.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.614 -0.434 . . . . 1.0 109.973 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.71 -30.98 41.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.317 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.87 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.0 p -72.39 -48.5 41.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.543 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.3 p -55.29 -33.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.858 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -72.23 -39.13 68.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.63 -40.63 97.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.988 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.25 -52.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 47' ' ' GLY . 31.2 ttp85 -52.2 -43.55 64.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.877 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.66 75.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 1.0 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -81.55 -50.35 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.77 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -77.39 -7.6 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 1.0 110.087 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.91 19.05 1.25 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.413 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.6 m -76.03 142.74 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.047 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.5 m-20 -57.69 -33.28 68.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 48' ' ' THR . 58.1 ttp180 -153.29 120.97 5.98 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 119.128 -1.029 . . . . 1.0 113.536 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.75 135.23 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 9.1 pttp -146.45 162.06 39.07 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.552 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.01 136.78 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.007 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 165' ' ' LEU . 79.5 t80 -123.4 120.56 33.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.052 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' OG1' ' A' ' 63' ' ' THR . 27.2 ptt180 -101.08 171.98 7.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -134.01 134.19 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 1.0 112.138 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.74 129.32 25.53 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.345 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.47 -25.93 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.739 2.293 . . . . 1.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 -9.82 59.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.984 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.4 36.35 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.816 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -86.72 141.76 28.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.38 0.59 . . . . 1.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.3 145.98 15.95 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.434 -1.067 . . . . 1.0 110.434 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' NE ' ' A' ' 55' ' ' ARG . 28.6 p -129.86 147.88 51.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.25 0.547 . . . . 1.0 112.303 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.06 101.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.36 3.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.18 147.26 24.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.1 tt0 -166.88 126.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.245 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.44 53.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -121.92 141.84 50.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.555 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.93 97.64 1.88 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.47 -90.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.02 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.83 -0.348 . . . . 1.0 111.101 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -70.72 -55.61 8.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.5 mt -92.95 154.48 41.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.92 167.82 23.1 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.099 1.866 . . . . 1.0 112.518 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 p -89.27 132.05 35.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.125 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.09 -4.41 20.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.618 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -59.36 139.89 56.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.35 0.595 . . . . 1.0 112.239 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.8 80.2 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 mt -101.23 131.73 47.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 1.0 110.76 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -88.14 119.41 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.485 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.9 m-85 -108.64 132.5 21.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.285 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.73 157.52 27.99 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.125 1.883 . . . . 1.0 111.702 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.14 66.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.76 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -23.72 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -55.53 -29.07 58.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 1.0 110.634 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.4 mt -121.35 133.43 24.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.4 -106.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.538 2.159 . . . . 1.0 112.336 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -152.49 -64.71 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.832 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -43.02 -41.97 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.723 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.02 97.22 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -65.57 -28.44 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.526 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -56.72 -55.31 35.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.267 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 94' ' ' LEU . 9.4 mp -54.13 -40.75 67.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.587 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.91 -40.19 92.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.09 -8.42 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.56 -0.746 . . . . 1.0 110.11 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tp -107.49 -43.58 4.5 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.389 0.885 . . . . 1.0 113.389 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.71 -1.52 12.08 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.53 0.937 . . . . 1.0 113.53 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 28.9 mp0 27.51 69.64 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.5 p -116.9 -49.67 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.437 -2.431 . . . . 1.0 104.437 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.595 ' N ' HG13 ' A' ' 100' ' ' VAL . 2.6 mtt180 61.55 78.96 0.27 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.058 -1.428 . . . . 1.0 114.35 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.79 132.32 5.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.76 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.5 mp -107.06 126.26 63.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 105' ' ' ASP . 27.3 t -82.85 167.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.249 0.833 . . . . 1.0 113.249 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.681 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.5 m-20 -50.84 118.22 3.0 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.692 -1.14 . . . . 1.0 112.261 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -57.66 -10.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.742 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.5 -36.25 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.889 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.5 -15.31 25.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 1.0 110.134 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 52.81 59.98 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.032 -0.986 . . . . 1.0 113.424 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -94.25 137.34 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 1.0 105.401 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -127.9 139.94 52.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.017 1.488 . . . . 1.0 115.017 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-N 114.154 -1.385 . . . . 1.0 107.338 176.934 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mmt-85 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.722 0.296 . . . . 1.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.92 144.86 5.49 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.516 2.144 . . . . 1.0 111.801 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 135' ' ' VAL . 3.1 m -113.33 120.1 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 1.0 111.349 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.46 148.97 0.4 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.903 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 140' ' ' VAL . 93.2 Cg_exo -45.85 -48.16 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.212 1.941 . . . . 1.0 111.275 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.2 p -43.83 -34.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.672 ' CE1' HD13 ' A' ' 143' ' ' LEU . 53.0 t-80 -82.67 -32.62 28.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.715 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' PRO . 52.4 t -53.09 -51.01 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.32 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.13 -43.06 93.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 1.0 110.26 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -46.21 -50.42 15.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.4 mp -71.76 -49.44 38.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.537 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.1 tptm -58.94 -41.29 87.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.46 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.5 p -54.24 -30.3 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.3 mtt -87.01 -0.61 56.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.228 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.26 25.03 75.8 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.293 -0.867 . . . . 1.0 112.359 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 150' ' ' SER . 21.6 t -105.87 122.57 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.23 -33.14 49.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 148' ' ' VAL . 2.4 t -137.42 171.16 14.89 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.592 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 7.3 p -161.42 139.98 9.66 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.198 0.444 . . . . 1.0 112.198 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 65.1 tp -115.19 138.66 50.67 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.5 m -132.14 155.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.468 0.651 . . . . 1.0 111.828 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.9 t -158.12 90.46 2.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.83 -1.077 . . . . 1.0 109.313 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.76 133.4 54.11 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.562 2.842 . . . . 1.0 113.946 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.8 mt -89.79 106.34 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.776 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 20.6 ptm -127.39 144.91 50.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.0 111.864 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.498 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 75.6 t60 -114.15 114.06 25.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.43 ' CD2' ' NE2' ' A' ' 158' ' ' HIS . 22.2 m-70 59.01 -118.38 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.649 ' CD ' ' H ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER -95.38 3.06 54.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.545 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.2 tt0 -112.06 149.49 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 162' ' ' LEU . 11.0 mp -107.37 117.28 33.66 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 114.532 -1.213 . . . . 1.0 108.841 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 81.7 m95 -97.2 -25.84 15.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.887 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.88 -168.19 23.42 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.971 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 tp -141.11 128.65 21.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.797 0.332 . . . . 1.0 111.239 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -93.9 137.91 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.584 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.0 p -150.87 133.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.541 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 p -115.77 145.4 42.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.009 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.07 140.62 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.157 0.503 . . . . 1.0 111.011 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -154.03 154.35 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.483 -0.781 . . . . 1.0 109.638 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.97 72.81 10.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.446 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.465 0.29 0 C-N-CA 120.399 -0.52 . . . . 1.0 112.323 179.344 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.809 0.338 . . . . 1.0 110.802 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.8 p -99.07 139.99 33.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.285 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.23 -36.01 76.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.65 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.7 -54.96 35.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.334 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.21 -32.05 73.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 1.0 110.643 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.54 -42.27 91.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.497 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.9 -52.71 63.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.455 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -44.77 -46.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.275 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.43 -37.85 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -48.68 -37.83 19.6 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.8 -40.92 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.383 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 42.3 tp -53.54 -32.65 51.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.68 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.57 -32.58 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.617 . . . . 1.0 109.616 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -58.68 -41.7 86.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -53.23 -52.85 57.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.4 -41.66 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.886 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.7 m -50.34 -29.78 10.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.7 mm -77.79 -38.52 25.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.023 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.67 67.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.108 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 31' ' ' LEU . 10.4 tp -64.24 -34.61 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.23 -55.91 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.881 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.79 -26.62 47.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.893 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.4 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.302 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.55 -39.38 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.154 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.1 mp -68.55 -56.43 8.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.107 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -55.56 -43.07 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.891 0.377 . . . . 1.0 110.357 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.419 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 195' ' ' ILE . 5.9 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.931 0.396 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.19 -32.65 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.245 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -78.39 -54.72 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.243 0.46 . . . . 1.0 112.243 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 38' ' ' THR . 4.7 tp -58.35 -37.42 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HG ' HG23 ' A' ' 34' ' ' ILE . 80.8 mt -74.36 -33.93 63.23 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -49.76 -37.93 31.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 1.0 109.993 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.39 -30.26 57.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.394 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 34' ' ' ILE . 52.9 p -70.58 -44.54 67.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.533 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 53' ' ' VAL . 49.8 t -59.15 -37.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.846 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.63 -39.53 84.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.13 -37.55 83.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.98 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.4 t -68.39 -43.56 84.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.4 ttp180 -57.03 -50.08 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.865 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.75 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.847 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -79.14 -51.88 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.781 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.95 -6.47 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.015 0.436 . . . . 1.0 110.089 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.96 17.65 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.0 112.393 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 51' ' ' VAL . 6.8 t -78.53 149.43 33.08 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.077 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.6 m-20 -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.705 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 51.2 ttp180 -155.01 131.86 10.75 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 119.124 -1.03 . . . . 1.0 113.499 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 48' ' ' THR . 0.3 OUTLIER -139.15 133.59 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.504 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 47.7 pttt -146.61 160.29 42.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.594 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 39' ' ' VAL . 71.2 t -99.11 135.08 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.975 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.7 t80 -117.38 120.27 37.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.058 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH2' HD21 ' A' ' 31' ' ' LEU . 46.4 ttm-85 -99.83 166.35 11.13 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 11.5 t80 -131.21 135.99 47.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.091 0.472 . . . . 1.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.9 m-20 -102.22 147.79 34.46 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.329 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.42 -21.59 71.26 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.726 2.284 . . . . 1.0 112.909 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.83 -2.44 47.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.044 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.54 -8.58 54.99 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.916 -0.659 . . . . 1.0 112.842 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -90.24 143.5 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.318 0.559 . . . . 1.0 111.005 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -120.47 137.88 12.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.6 p -124.31 145.36 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.197 0.522 . . . . 1.0 112.34 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -104.49 120.57 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.08 4.74 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -153.78 146.24 24.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.9 tt0 -166.38 127.36 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.398 -0.921 . . . . 1.0 113.222 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 129.5 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 6.8 ptp85 -116.85 140.61 49.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.216 -0.594 . . . . 1.0 111.524 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.47 98.53 1.89 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.78 -90.23 0.04 OUTLIER Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.188 -1.165 . . . . 1.0 110.188 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -176.38 33.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.116 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -71.38 -54.25 11.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.88 145.93 30.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.88 166.37 29.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.081 1.854 . . . . 1.0 112.564 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.521 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 16.2 m -88.86 135.94 33.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.108 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 45.6 mt -108.7 -0.99 19.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.615 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -60.59 138.95 57.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.588 . . . . 1.0 112.239 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.16 -4.95 85.37 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.338 -0.846 . . . . 1.0 111.05 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.62 130.14 45.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.861 0.362 . . . . 1.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -87.06 121.84 30.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.503 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 62' ' ' GLY . 28.7 m-85 -103.01 136.23 19.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.259 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.11 145.7 24.8 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.126 1.884 . . . . 1.0 111.708 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.37 69.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.15 -20.56 1.45 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 40.4 p30 -60.08 -30.67 69.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.792 0.329 . . . . 1.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.565 ' O ' ' O ' ' A' ' 88' ' ' PRO . 45.6 mt -113.74 101.0 53.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.262 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -45.57 -116.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.536 2.158 . . . . 1.0 112.351 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -154.3 -44.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.907 0.384 . . . . 1.0 111.832 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.4 -39.1 82.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.707 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.33 81.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 1.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -67.98 -28.63 67.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.562 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' LEU . 55.0 mtp180 -53.65 -57.71 9.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.244 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.7 mt -54.7 -38.29 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.556 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 6.6 m-85 -65.5 -30.71 71.51 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -93.62 -14.24 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.127 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' ARG . 11.8 tp -107.1 -46.16 3.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.99 -3.36 12.65 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.451 0.908 . . . . 1.0 113.451 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.619 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 13.0 mm-40 29.19 69.8 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -110.04 -51.06 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 175.046 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.619 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER 63.18 70.4 0.54 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.292 172.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.1 p -152.35 134.31 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.556 -0.457 . . . . 1.0 111.793 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.51 127.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.659 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.4 p -83.25 167.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.659 ' N ' HG22 ' A' ' 104' ' ' VAL . 15.7 t0 -53.55 119.41 4.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.312 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.88 -10.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.735 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 1.3 pp20? -86.47 -37.76 17.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.921 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.97 -13.91 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.405 0.622 . . . . 1.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 50.34 52.63 14.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.041 -0.981 . . . . 1.0 113.35 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -93.27 133.44 36.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -126.13 141.07 52.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 m . . . . . 0 N--CA 1.452 -0.335 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.363 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HE ' ' HD2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.777 0.323 . . . . 1.0 110.275 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.462 ' HD2' ' HE ' ' A' ' 133' ' ' ARG . 91.0 Cg_endo -81.35 143.48 13.88 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.573 2.182 . . . . 1.0 111.745 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.54 HG21 ' ND1' ' A' ' 139' ' ' HIS . 1.5 m -112.99 123.34 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.073 0.463 . . . . 1.0 111.319 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.85 154.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.895 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.39 -26.94 79.76 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.221 1.947 . . . . 1.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 22.2 t -61.26 -43.0 99.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.797 ' CE1' HD13 ' A' ' 143' ' ' LEU . 46.8 t-80 -77.84 -29.65 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.0 -53.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.275 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.487 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 80.1 t60 -64.68 -42.78 95.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.268 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -44.29 -50.56 8.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.405 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.797 HD13 ' CE1' ' A' ' 139' ' ' HIS . 3.1 mp -71.59 -49.6 38.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.461 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.6 tptm -56.98 -40.83 77.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.487 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 30.9 m -54.2 -32.82 56.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 50.3 mtt -83.98 -2.01 55.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.164 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.68 26.43 74.48 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.277 -0.874 . . . . 1.0 112.353 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.1 p -109.01 127.04 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.08 -30.9 39.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -137.97 170.45 16.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.145 -0.622 . . . . 1.0 111.512 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -162.66 138.45 7.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.135 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 176' ' ' TYR . 18.3 tp -113.63 139.72 48.79 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -128.8 156.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.457 0.646 . . . . 1.0 111.783 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 153' ' ' VAL . 66.7 t -156.65 100.38 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.812 -1.085 . . . . 1.0 109.327 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.88 127.11 13.27 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.603 2.869 . . . . 1.0 113.899 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.51 106.08 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.812 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.2 ptm -130.73 146.65 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.834 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.528 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 30.5 t-80 -117.24 116.11 26.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.499 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 61.6 m170 57.66 -122.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.81 7.59 43.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -116.61 150.56 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.011 1.115 . . . . 1.0 114.011 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.93 116.27 31.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.547 -1.206 . . . . 1.0 108.851 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 82.7 m95 -95.27 -26.34 15.98 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.924 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.5 -168.7 24.8 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.158 -1.02 . . . . 1.0 111.972 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.8 tp -145.32 136.76 25.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.803 0.335 . . . . 1.0 111.142 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.2 tp -100.91 145.5 28.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.7 p -150.9 129.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.6 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.8 p -112.96 145.84 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.077 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.705 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -148.01 138.54 22.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.219 0.533 . . . . 1.0 110.973 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 148' ' ' VAL . 21.3 t60 -150.64 151.73 32.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.702 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.441 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -79.7 67.46 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.424 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 120.376 -0.53 . . . . 1.0 112.297 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CG ' HD13 ' A' ' 152' ' ' LEU . 42.6 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.804 0.335 . . . . 1.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.6 m -95.27 148.31 22.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.245 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -67.19 -37.33 83.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.19 -54.48 40.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.349 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.64 -31.59 72.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.846 0.355 . . . . 1.0 110.598 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.439 HD11 HH12 ' A' ' 101' ' ' ARG . 28.2 tp -60.14 -41.85 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' GLN . 24.7 mm100 -61.54 -52.86 62.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.377 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.6 t -43.06 -44.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.255 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.31 -36.88 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 36.6 tp60 -52.32 -37.86 56.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.58 -32.15 67.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.391 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.75 -27.85 69.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.53 -37.02 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.69 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -53.89 -42.33 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.717 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -52.35 -56.3 15.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.19 -41.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.902 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.9 p -51.82 -35.26 43.75 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.4 mt -78.97 -35.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.046 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.07 61.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.08 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 31' ' ' LEU . 9.0 tp -62.12 -36.7 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.181 0.515 . . . . 1.0 109.622 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -73.23 -53.63 10.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.958 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 197' ' ' GLN . 19.3 tm0? -55.3 -27.23 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.908 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.07 -33.91 57.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.298 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -58.0 -40.99 82.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.153 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.6 mp -64.96 -58.48 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.093 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.4 t -53.03 -42.22 65.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 1.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.4 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.6 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.885 0.374 . . . . 1.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.67 -52.28 27.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.231 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.87 -48.35 82.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.789 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.96 -30.95 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.598 0.592 . . . . 1.0 112.598 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -75.57 -24.16 56.61 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.595 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.1 mtp180 -66.83 -36.08 81.52 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.94 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.1 -25.16 43.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 34' ' ' ILE . 68.7 p -74.77 -50.68 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.577 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.4 p -53.52 -36.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.923 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 96.8 mt-10 -74.53 -37.37 63.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -64.79 -51.77 60.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 1.0 112.021 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.23 -50.39 79.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.9 tmm_? -51.36 -43.61 61.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.69 73.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -80.47 -47.17 14.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.17 -6.83 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.175 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.83 17.11 0.49 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.41 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -73.44 140.35 46.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.083 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.6 m-20 -61.99 -29.86 70.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 48' ' ' THR . 43.1 ttp180 -152.99 118.69 5.34 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 119.231 -0.988 . . . . 1.0 113.517 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.24 137.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -146.23 161.81 39.44 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.547 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.91 135.27 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.017 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.7 t80 -117.9 116.54 27.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.012 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 27.3 ttm180 -98.16 164.76 12.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.849 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -131.75 139.56 48.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 1.0 112.12 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -103.79 148.35 35.67 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.718 -0.673 . . . . 1.0 109.296 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.21 -21.85 72.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.732 2.288 . . . . 1.0 112.924 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -80.01 -4.47 52.76 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.974 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.86 46.5 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.871 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -89.13 146.07 25.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.335 0.567 . . . . 1.0 110.888 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.88 144.35 15.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 m -128.55 147.31 50.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.133 0.492 . . . . 1.0 112.309 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.67 119.09 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.05 0.14 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.64 150.46 23.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.1 tt0 -166.05 125.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.372 -0.931 . . . . 1.0 113.166 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -108.62 136.14 48.7 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.0 141.55 51.77 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.238 -0.585 . . . . 1.0 111.516 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.32 104.67 2.63 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.4 -89.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.8 tt0 -176.94 34.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.174 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -70.98 -53.57 14.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.2 mt -94.76 144.13 27.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 107.921 -1.141 . . . . 1.0 107.921 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.09 170.34 20.35 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.043 1.828 . . . . 1.0 112.504 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -92.32 136.22 33.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.173 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 38.5 mt -109.63 -2.35 17.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.543 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.7 tp -58.52 139.55 55.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.568 . . . . 1.0 112.289 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.38 84.36 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.058 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.1 133.97 43.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.863 0.364 . . . . 1.0 110.766 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -89.07 117.01 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.515 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -107.98 134.91 19.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.78 158.11 27.88 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.123 1.882 . . . . 1.0 111.663 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.76 -20.1 63.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.779 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.66 -22.46 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 10.3 p30 -55.54 -27.78 50.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.323 . . . . 1.0 110.649 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 90.6 mt -127.96 99.58 25.34 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.279 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' ILE . 47.6 Cg_exo -41.71 -101.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.544 2.163 . . . . 1.0 112.312 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 43.7 tp10 -153.54 -59.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.809 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -43.46 -38.67 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.714 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.92 54.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 1.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -61.64 -31.4 71.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -58.04 -49.58 76.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.284 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.0 mt -53.85 -36.97 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.7 -29.15 69.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -89.66 -15.38 32.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.092 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.82 -46.34 3.98 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.399 0.889 . . . . 1.0 113.399 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.99 -3.0 14.1 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 25.21 67.01 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.879 ' H ' HH21 ' A' ' 133' ' ' ARG . 13.0 t -107.24 -52.52 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.503 -2.406 . . . . 1.0 104.503 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.814 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 11.5 mtm180 64.38 65.57 0.65 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.312 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 103' ' ' ILE . 35.7 m -150.11 133.39 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.726 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -109.25 127.38 66.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 108.353 -0.981 . . . . 1.0 108.353 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.9 t -83.2 168.11 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.696 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.8 m-20 -51.33 114.52 1.25 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.268 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' VAL . 9.5 p -54.82 -10.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.789 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.5 -35.96 16.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.912 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -15.03 9.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.412 0.625 . . . . 1.0 110.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 49.97 51.5 16.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 1.0 113.396 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 m -94.2 138.2 32.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.405 -2.072 . . . . 1.0 105.405 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -128.27 137.93 52.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.05 1.5 . . . . 1.0 115.05 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.452 -0.33 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.307 177.35 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.879 HH21 ' H ' ' A' ' 100' ' ' VAL . 26.1 mtt-85 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.671 0.272 . . . . 1.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.07 150.29 5.08 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.515 2.143 . . . . 1.0 111.837 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.406 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -97.44 145.69 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.027 0.442 . . . . 1.0 111.382 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.4 m-20 -91.1 147.02 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.553 -0.749 . . . . 1.0 110.913 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -38.75 -28.69 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.199 1.933 . . . . 1.0 111.288 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 136' ' ' ASP . 47.9 t -67.6 -53.15 30.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.671 ' CE1' HD11 ' A' ' 143' ' ' LEU . 19.4 t-80 -73.54 -24.99 60.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.4 t -50.99 -55.94 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.353 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.14 -41.46 94.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -43.17 -50.4 6.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 139' ' ' HIS . 77.4 mt -72.51 -48.1 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.525 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.3 tmtm? -57.27 -43.07 82.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.511 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.8 p -55.2 -27.34 45.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 39.4 mtt -92.25 -3.48 55.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.186 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.12 22.77 72.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.357 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.648 HG11 ' HB2' ' A' ' 169' ' ' HIS . 10.2 m -104.83 122.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.72 -0.392 . . . . 1.0 109.953 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.36 -37.22 57.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -130.22 170.57 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.579 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 3.4 p -158.92 139.64 12.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.02 0.438 . . . . 1.0 112.157 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 tp -116.31 140.02 49.77 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -134.33 154.54 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.463 0.649 . . . . 1.0 111.739 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 153' ' ' VAL . 74.6 t -157.21 108.21 1.89 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.767 -1.106 . . . . 1.0 109.267 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.78 113.88 3.9 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.659 2.906 . . . . 1.0 113.847 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.72 105.88 3.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.78 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.7 ptm -132.19 147.07 52.4 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.835 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.608 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 53.4 t60 -118.07 115.58 25.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 35.5 m80 59.32 -122.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -92.99 7.59 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.883 0.327 . . . . 1.0 111.883 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 44.3 mp0 -114.65 146.03 41.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 162' ' ' LEU . 6.5 mp -106.94 117.41 33.98 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 114.525 -1.216 . . . . 1.0 108.809 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.2 m95 -96.15 -26.67 15.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.899 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.27 -170.88 28.79 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.261 -0.971 . . . . 1.0 112.041 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.9 tp -141.67 137.29 31.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 1.0 111.216 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 5.1 tp -99.11 142.8 30.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.31 135.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.595 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 p -120.8 142.51 49.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.046 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.648 ' HB2' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -150.03 127.99 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.127 0.489 . . . . 1.0 111.021 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.561 ' O ' ' O ' ' A' ' 171' ' ' ALA . 15.2 p-80 -166.58 156.52 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.704 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 170' ' ' HIS . . . -46.14 -170.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.607 -0.269 . . . . 1.0 111.448 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.261 179.599 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 120.822 0.344 . . . . 1.0 110.744 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 t -99.68 143.12 30.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.23 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.14 -31.93 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.646 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.05 -54.52 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.337 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.42 -30.64 71.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.904 0.383 . . . . 1.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.16 -35.1 74.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.538 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.58 -52.75 28.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.407 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -44.44 -47.38 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 187' ' ' LEU . 27.3 m -75.01 -36.81 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -46.94 -35.84 6.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 186' ' ' LEU . 3.6 tt -72.1 -43.46 64.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.412 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 184' ' ' VAL . 39.0 tp -53.96 -33.17 56.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.662 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.47 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.95 -37.27 62.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.618 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -56.21 -38.09 70.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.705 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -53.16 -51.83 60.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.12 -42.46 79.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.265 -0.879 . . . . 1.0 109.889 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.3 m -51.86 -37.12 50.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.61 -33.47 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.048 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.37 -47.13 58.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.101 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.0 tp -62.4 -33.12 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.96 -53.59 8.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.898 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -56.28 -28.36 58.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.68 -34.3 52.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.17 -39.98 80.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.86 -57.62 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.4 t -58.14 -44.17 87.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.059 -0.972 . . . . 1.0 110.373 179.657 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 198' ' ' ALA . 16.0 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.397 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.294 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.18 -52.7 45.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -55.05 -50.09 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.687 0.625 . . . . 1.0 112.687 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 mt -64.42 -23.97 67.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.541 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.553 ' O ' HG12 ' A' ' 39' ' ' VAL . 61.0 ttt180 -58.23 -36.1 72.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.651 -0.419 . . . . 1.0 109.925 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.35 38.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.3 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.413 ' HG1' ' H ' ' A' ' 39' ' ' VAL . 50.6 p -69.36 -49.87 51.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.507 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.9 p -53.08 -36.32 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 75.2 mm-40 -65.24 -38.41 90.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.841 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.15 -44.91 87.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.924 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.08 -44.08 95.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.3 tmm_? -62.43 -51.64 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.843 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' N ' ' HE ' ' A' ' 43' ' ' ARG . . . -58.49 -40.06 81.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.847 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.76 -51.49 9.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.794 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.51 -5.58 48.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.087 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.29 17.71 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.716 -0.675 . . . . 1.0 112.415 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -74.48 141.85 44.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.108 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -57.48 -33.39 67.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' H ' HG22 ' A' ' 48' ' ' THR . 46.2 ttp180 -152.28 119.82 6.03 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 119.18 -1.008 . . . . 1.0 113.577 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -139.14 134.88 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -145.62 161.9 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.377 -0.529 . . . . 1.0 111.566 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.44 136.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.006 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 165' ' ' LEU . 43.8 t80 -121.0 119.11 31.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.113 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -100.07 170.08 8.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.925 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 72.3 t80 -134.32 138.78 45.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.526 -0.47 . . . . 1.0 112.124 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -102.45 148.79 35.97 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.306 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.36 -21.22 66.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.729 2.286 . . . . 1.0 112.965 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.3 -0.57 41.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.563 -0.455 . . . . 1.0 111.038 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.33 -11.51 54.72 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.855 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.6 m-70 -89.34 146.44 24.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.383 0.592 . . . . 1.0 110.976 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.8 144.68 15.37 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 p -129.26 148.21 51.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.184 0.516 . . . . 1.0 112.275 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.78 120.99 57.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.937 -1.134 . . . . 1.0 107.937 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' C ' HD11 ' A' ' 78' ' ' LEU . 4.3 m -112.04 8.1 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' N ' HD11 ' A' ' 78' ' ' LEU . . . -154.06 146.37 23.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -166.75 127.69 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.296 -0.962 . . . . 1.0 113.186 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.1 139.07 47.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -127.53 141.46 51.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.138 -0.625 . . . . 1.0 111.569 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.15 107.59 3.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.417 -1.073 . . . . 1.0 110.417 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.23 16.95 0.1 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.264 -1.134 . . . . 1.0 110.264 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.7 tt0 71.99 28.87 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.791 -0.364 . . . . 1.0 111.104 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -57.55 -58.24 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -90.65 158.63 42.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.31 162.49 33.69 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.09 1.86 . . . . 1.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -85.9 108.9 18.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.119 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' NH1' ' A' ' 50' ' ' ARG . 48.9 mt -84.1 -1.47 54.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.46 HD11 ' C ' ' A' ' 65' ' ' VAL . 8.4 tp -62.44 139.54 58.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.349 0.595 . . . . 1.0 112.289 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.567 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.0 -4.12 74.36 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.121 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.8 mp -102.41 131.04 49.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 1.0 110.774 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.01 119.81 25.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.95 132.96 20.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.302 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -79.61 155.8 24.43 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.214 1.943 . . . . 1.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -67.9 -21.08 65.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.798 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.19 -22.07 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.03 -27.8 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 1.0 110.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.6 mt -107.86 106.28 58.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.332 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.5 Cg_exo -48.47 -125.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.505 2.136 . . . . 1.0 112.35 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.6 pt-20 -142.91 -43.08 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 22.7 pt-20 -68.83 -39.8 79.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.723 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.09 84.1 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.007 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.433 HH21 HD22 ' A' ' 162' ' ' LEU . 76.7 ttt180 -63.24 -30.62 71.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.553 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -56.66 -51.13 69.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.323 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.4 mp -55.71 -35.33 65.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -63.36 -31.49 72.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 1.0 109.625 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -87.16 -15.16 39.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.042 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.48 -42.67 4.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.03 -4.78 13.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.517 0.932 . . . . 1.0 113.517 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.632 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 96.4 mt-30 27.06 69.65 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 6.8 t -109.76 -49.21 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.435 -2.431 . . . . 1.0 104.435 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.702 ' NH1' HE22 ' A' ' 185' ' ' GLN . 0.6 OUTLIER 63.06 70.56 0.54 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.137 -1.392 . . . . 1.0 114.311 172.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.566 ' C ' HD12 ' A' ' 103' ' ' ILE . 15.0 p -153.11 136.74 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.706 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.566 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -108.71 127.76 64.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 105' ' ' ASP . 34.3 t -83.53 166.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.675 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.1 m-20 -53.68 119.44 4.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.26 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.0 m -58.01 -13.2 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.876 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -87.61 -38.04 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.89 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.32 -13.72 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.384 0.611 . . . . 1.0 110.059 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 51.3 54.77 10.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 113.409 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -93.94 133.62 37.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -128.21 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 80.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-N 114.17 -1.377 . . . . 1.0 107.316 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 133' ' ' ARG . 1.6 mmp_? . . . . . 0 N--CA 1.461 0.087 0 N-CA-C 110.286 -0.265 . . . . 1.0 110.286 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.75 147.63 6.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.494 2.129 . . . . 1.0 111.816 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 m -95.72 151.58 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 1.0 111.329 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.3 m-20 -84.89 156.32 61.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.909 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -56.34 -26.52 62.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.216 1.944 . . . . 1.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.6 OUTLIER -74.51 -34.81 63.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.06 -0.718 . . . . 1.0 109.06 176.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.504 ' CE1' HD13 ' A' ' 143' ' ' LEU . 46.2 t-80 -81.47 -31.56 32.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.657 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -52.29 -50.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.33 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -65.99 -43.88 86.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.28 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -44.19 -52.07 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -73.16 -46.2 52.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.501 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.0 OUTLIER -59.51 -42.76 92.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.52 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 t -53.83 -32.53 53.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 40.7 mtt -84.51 -1.89 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.113 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.1 23.85 76.03 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.352 -0.84 . . . . 1.0 112.233 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.9 t -105.03 124.92 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.52 24.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -131.5 169.37 16.18 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.565 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.0 m -162.61 139.47 7.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.106 0.479 . . . . 1.0 112.15 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.57 139.69 50.21 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.9 m -135.13 157.81 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.803 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.3 t -158.98 91.91 1.95 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.388 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.46 115.37 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.636 2.891 . . . . 1.0 113.922 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.29 105.87 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.859 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.442 ' O ' ' OG ' ' A' ' 192' ' ' SER . 16.7 ptm -130.92 146.43 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.0 111.836 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 84.5 t60 -119.51 115.68 24.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 10.6 t-80 64.02 -126.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.456 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 85.9 mt-30 -92.66 5.28 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.855 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 46.9 mp0 -115.09 150.69 35.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.433 HD22 HH21 ' A' ' 92' ' ' ARG . 13.1 tp -106.24 117.34 33.79 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 114.517 -1.219 . . . . 1.0 108.86 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.425 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 84.0 m95 -97.4 -28.83 13.83 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.864 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.65 -171.93 24.22 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.22 -0.99 . . . . 1.0 111.962 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.9 tp -138.8 129.69 26.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.565 -0.318 . . . . 1.0 111.205 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -94.52 139.06 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 169' ' ' HIS . 9.7 p -151.19 132.83 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.532 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.739 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 1.5 m -115.22 140.57 48.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.05 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.739 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -135.5 141.48 45.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 1.0 110.992 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.44 ' O ' HG13 ' A' ' 148' ' ' VAL . 1.6 p-80 -158.2 154.27 27.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.5 -0.773 . . . . 1.0 109.742 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.94 67.94 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.298 -179.267 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.809 0.337 . . . . 1.0 110.721 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -96.17 153.93 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.641 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.99 -53.49 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.324 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 37.4 mp0 -71.41 -24.22 62.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.884 0.373 . . . . 1.0 110.677 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -61.44 -45.65 93.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.505 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 10.9 pt20 -67.56 -48.66 66.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.417 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 46.4 t -43.68 -51.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.243 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.48 -36.05 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.702 HE22 ' NH1' ' A' ' 101' ' ' ARG . 63.0 tp60 -48.24 -37.95 17.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.89 -40.27 65.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.375 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.71 -32.42 63.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.687 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.54 -37.7 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.701 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -56.96 -40.36 76.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.741 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.66 -54.09 38.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.39 -40.69 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.923 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 157' ' ' MET . 3.5 t -50.1 -30.17 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.63 -39.43 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.056 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.67 67.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.133 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.01 -35.64 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.465 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -76.48 -54.77 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.863 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -55.94 -28.52 57.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.949 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.36 -35.23 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.336 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.43 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 83.6 tt0 -57.77 -39.76 78.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.133 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.9 tp -68.52 -58.04 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.047 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.7 m -56.86 -44.25 81.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.43 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 7.8 tp . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.425 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 1.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.2 p-10 -61.96 -42.54 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.259 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 96.3 mt-30 -68.81 -52.0 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -60.78 -34.54 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.22 -23.67 60.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -62.56 -52.85 61.81 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.632 -0.427 . . . . 1.0 109.965 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.02 77.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.359 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.3 p -67.82 -46.5 71.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.526 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 68' ' ' ALA . 10.1 t -59.28 -38.42 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.903 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.31 -37.74 77.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.778 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.31 -43.98 80.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 1.0 112.01 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.44 -51.11 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.861 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.4 tmt_? -52.73 -44.6 66.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.834 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.82 68.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.806 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -83.21 -46.2 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.734 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.53 -8.5 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 1.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 49.56 17.88 1.44 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.632 -0.713 . . . . 1.0 112.405 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -77.07 144.85 38.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.159 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 94.1 m-20 -54.56 -34.16 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.597 ' H ' HG22 ' A' ' 48' ' ' THR . 9.0 ttm180 -152.61 122.62 7.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.168 -1.013 . . . . 1.0 113.595 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 t -130.42 132.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -146.64 155.74 42.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.576 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.66 138.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.97 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -122.43 119.81 32.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.058 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -100.21 170.64 8.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.436 . . . . 1.0 109.864 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.9 t80 -133.22 141.89 48.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.0 m-20 -105.52 149.42 37.82 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.371 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.35 -25.95 63.73 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.696 2.264 . . . . 1.0 112.961 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -76.52 -5.38 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.941 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.19 -12.69 44.46 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.839 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.03 144.64 26.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.388 0.594 . . . . 1.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 143.85 15.3 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.9 p -127.37 146.69 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.346 0.498 . . . . 1.0 112.346 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.19 118.34 46.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -111.9 4.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.38 21.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.9 tt0 -166.46 127.44 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.362 -0.935 . . . . 1.0 113.215 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -107.06 140.66 39.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -129.75 141.89 50.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.512 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.94 106.16 2.84 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.431 -1.068 . . . . 1.0 110.431 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.19 -88.72 0.01 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.294 -1.122 . . . . 1.0 110.294 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' GLY . 23.0 pt-20 -176.77 31.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.109 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -66.51 -54.12 27.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD13 HH21 ' A' ' 50' ' ' ARG . 28.6 mt -95.33 151.93 39.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 171.57 16.42 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.07 1.846 . . . . 1.0 112.504 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.4 m -92.73 135.29 34.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.148 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.58 -9.22 15.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.618 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.583 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 17.6 tp -50.73 138.79 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.363 0.601 . . . . 1.0 112.212 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -1.87 79.27 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 61.3 tp -100.51 125.92 46.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 1.0 110.757 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 81' ' ' THR . 8.9 t -84.08 122.23 28.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.488 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CZ ' HD23 ' A' ' 80' ' ' LEU . 47.7 m-85 -108.07 138.81 20.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.25 155.06 16.74 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.136 1.89 . . . . 1.0 111.646 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.531 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -65.56 -21.11 66.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.827 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 87' ' ' ILE . . . -49.8 -24.82 6.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 19.1 p-10 -47.86 -13.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 1.0 110.663 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.479 ' N ' ' C ' ' A' ' 85' ' ' GLY . 3.5 pt -135.91 137.96 26.57 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.224 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.68 -114.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 1.0 112.374 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -141.82 -66.12 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.91 0.386 . . . . 1.0 111.881 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -47.79 -43.09 27.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.682 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.78 -53.07 30.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.964 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.481 HH21 ' CD2' ' A' ' 162' ' ' LEU . 24.6 ttt180 -54.47 -27.86 40.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' LEU . 22.1 mmt180 -63.68 -46.15 86.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.297 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 98' ' ' ALA . 39.6 mt -49.99 -42.61 49.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.564 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 30.3 m-85 -64.99 -29.88 70.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -90.24 -18.96 24.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.102 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -104.76 -45.34 4.62 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.426 0.899 . . . . 1.0 113.426 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.1 -2.78 15.72 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.7 mt-30 28.29 67.2 0.08 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.014 1.116 . . . . 1.0 114.014 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.38 -50.51 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.385 -2.45 . . . . 1.0 104.385 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.692 HH21 HG13 ' A' ' 154' ' ' VAL . 3.0 mtp180 64.79 70.38 0.48 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.072 -1.422 . . . . 1.0 114.304 172.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.581 ' C ' HD12 ' A' ' 103' ' ' ILE . 64.1 t -150.67 130.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.784 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.581 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.64 126.58 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.636 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.9 p -81.81 166.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.224 0.824 . . . . 1.0 113.224 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 104' ' ' VAL . 13.6 m-20 -52.2 120.82 5.88 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.658 -1.156 . . . . 1.0 112.328 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 106' ' ' VAL . 37.1 t -57.6 -11.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.737 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 109' ' ' GLN . 17.0 pt-20 -83.04 -38.95 21.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.851 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.98 1.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.396 0.617 . . . . 1.0 110.114 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 107' ' ' GLU . 19.5 pt20 35.43 58.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.018 -0.992 . . . . 1.0 113.392 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -94.32 135.27 35.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.386 -2.079 . . . . 1.0 105.386 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -129.98 145.59 51.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 CA-C-N 114.132 -1.394 . . . . 1.0 107.31 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.636 0.255 . . . . 1.0 110.327 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.9 145.98 16.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.587 2.191 . . . . 1.0 111.818 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.628 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.9 m -118.03 127.19 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.447 . . . . 1.0 111.389 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -39.94 163.74 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.888 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.94 -19.68 34.94 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.265 1.977 . . . . 1.0 111.234 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.2 p -66.22 -37.52 85.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.628 ' ND1' HG21 ' A' ' 135' ' ' VAL . 40.4 t-80 -80.69 -28.34 36.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.632 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 106' ' ' VAL . 29.3 t -52.31 -53.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.322 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 145' ' ' SER . 85.2 t60 -66.88 -42.15 86.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.296 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -47.66 -56.9 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.503 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.521 HD13 ' NE2' ' A' ' 139' ' ' HIS . 1.2 tp -68.49 -50.38 52.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.527 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 21.1 tptm -57.35 -40.08 77.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 t -54.06 -32.49 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.5 mtt -83.46 1.15 43.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.264 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.52 25.3 75.64 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.214 -0.903 . . . . 1.0 112.33 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 169' ' ' HIS . 12.0 t -109.17 122.91 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.835 -0.432 . . . . 1.0 109.835 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.09 -30.43 49.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 148' ' ' VAL . 9.0 t -140.11 172.89 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.09 -0.644 . . . . 1.0 111.551 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 p -162.84 139.96 7.77 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.081 0.467 . . . . 1.0 112.141 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.1 tp -118.3 138.79 52.14 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.424 ' C ' HG23 ' A' ' 154' ' ' VAL . 2.3 m -133.04 158.98 43.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.418 0.628 . . . . 1.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.692 HG13 HH21 ' A' ' 101' ' ' ARG . 88.5 t -154.32 96.44 2.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.849 -1.069 . . . . 1.0 109.313 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.97 139.23 66.65 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.571 2.847 . . . . 1.0 113.957 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.59 105.56 17.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.736 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.449 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.1 mtp -117.54 139.06 51.45 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.906 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 72.1 t60 -113.74 113.58 25.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.437 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 31.5 m170 57.6 -123.0 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -94.23 10.99 31.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 51.0 mp0 -119.87 153.64 35.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.047 1.129 . . . . 1.0 114.047 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.481 ' CD2' HH21 ' A' ' 92' ' ' ARG . 14.8 tp -108.83 112.25 24.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.882 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -95.5 -28.61 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.905 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -154.88 -175.9 26.5 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.21 -0.995 . . . . 1.0 111.944 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.45 133.6 24.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.812 0.339 . . . . 1.0 111.215 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.7 tp -99.93 135.78 40.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.2 t -148.17 120.87 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.381 -0.528 . . . . 1.0 111.538 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 p -108.89 148.74 30.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.692 ' ND1' ' N ' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.06 148.22 29.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 1.0 111.018 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.0 p-80 -158.92 155.41 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.678 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.74 69.95 4.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.552 -0.295 . . . . 1.0 111.43 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 120.41 -0.516 . . . . 1.0 112.326 -179.526 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.832 0.349 . . . . 1.0 110.756 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -96.5 146.69 24.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.05 -40.08 78.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.6 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.11 -54.48 37.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.419 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.05 -35.31 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.374 . . . . 1.0 110.738 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.61 -38.71 88.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.505 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.1 -55.67 32.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.2 t -43.87 -43.46 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 86.0 t -74.99 -37.64 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.496 ' CD ' HH12 ' A' ' 101' ' ' ARG . 60.9 tt0 -48.27 -37.21 15.66 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.92 -40.2 63.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.751 -1.113 . . . . 1.0 109.344 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 44.0 tp -54.99 -32.34 61.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.692 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.83 -35.25 67.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.679 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -56.28 -39.58 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.695 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -53.64 -54.58 35.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.67 -44.11 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.226 -0.897 . . . . 1.0 109.834 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 157' ' ' MET . 10.1 t -51.68 -37.72 51.87 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 71.6 mt -78.2 -32.2 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.082 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.4 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.074 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -68.18 -24.26 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -77.24 -57.14 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.862 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -59.9 -27.34 66.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.885 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.56 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.355 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.421 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 41.3 tp10 -55.66 -37.02 67.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.163 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 -55.34 12.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.075 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.3 p -54.83 -42.07 71.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 1.0 110.303 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.421 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 27.3 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.422 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 198' ' ' ALA . 17.4 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.843 0.354 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.2 p-10 -64.04 -40.26 95.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.236 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.8 mt-30 -71.21 -54.24 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -56.41 -44.79 81.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.88 -26.38 65.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.522 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -56.43 -38.82 72.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.945 0.402 . . . . 1.0 109.998 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.66 58.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.2 p -70.04 -45.44 67.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.479 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 68' ' ' ALA . 55.2 t -57.61 -39.29 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.869 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -68.23 -37.89 81.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.817 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.2 -41.36 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.013 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.74 -45.91 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.866 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.0 tmm_? -53.74 -48.32 69.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.885 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.76 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.24 -52.49 7.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.776 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.86 -7.39 55.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.959 0.409 . . . . 1.0 110.114 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.14 17.79 0.38 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.457 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.642 HG21 HG13 ' A' ' 51' ' ' VAL . 15.1 t -77.37 146.77 36.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.1 m-20 -56.39 -33.08 65.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 41.7 ttm-85 -153.39 127.44 9.02 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 119.174 -1.01 . . . . 1.0 113.533 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.72 132.33 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.973 -1.121 . . . . 1.0 107.973 176.236 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -145.73 161.07 40.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.54 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.38 137.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.955 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 165' ' ' LEU . 67.3 t80 -122.26 119.85 32.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.074 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -100.07 171.11 8.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 67.0 t80 -133.96 136.68 44.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 1.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.42 126.45 33.14 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.353 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.94 -28.61 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.68 2.253 . . . . 1.0 112.923 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -74.29 -7.73 53.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.029 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.06 -13.57 34.11 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.014 -0.612 . . . . 1.0 112.825 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.94 145.94 25.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.352 0.576 . . . . 1.0 110.862 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.61 145.45 15.71 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.9 p -128.82 148.28 50.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 1.0 112.328 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.25 120.49 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 m -110.58 0.51 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -159.0 151.04 21.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 50' ' ' ARG . 1.9 pp20? -169.25 131.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.36 -0.936 . . . . 1.0 113.209 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -113.45 142.56 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' C ' HH12 ' A' ' 43' ' ' ARG . 10.0 ptt85 -133.22 143.96 49.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.481 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.53 112.87 3.9 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.22 34.04 2.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 54.57 31.52 15.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.14 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.452 ' NH1' ' HB3' ' A' ' 171' ' ' ALA . 26.6 ttm180 -60.65 -55.56 31.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.457 ' HB2' ' HE ' ' A' ' 50' ' ' ARG . 81.9 mt -95.86 147.21 32.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 57.9 Cg_endo -70.67 170.77 16.86 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.128 1.885 . . . . 1.0 112.528 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' HH22 ' A' ' 50' ' ' ARG . 23.1 t -89.08 130.11 35.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.158 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.8 mt -101.13 1.56 39.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.594 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.62 135.01 57.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.323 0.582 . . . . 1.0 112.24 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 92.63 -7.49 77.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.698 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.8 mp -96.99 132.04 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.885 0.374 . . . . 1.0 110.737 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 m -90.87 117.9 29.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.455 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 m-85 -109.42 135.82 20.27 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.293 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.98 157.35 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.12 1.88 . . . . 1.0 111.628 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.9 -17.78 63.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.823 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.51 -22.23 0.99 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.31 -29.82 64.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.86 0.362 . . . . 1.0 110.634 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.525 ' CG2' ' HE ' ' A' ' 92' ' ' ARG . 58.4 mt -98.66 146.74 32.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.228 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 5.0 Cg_endo -96.18 -142.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.465 2.11 . . . . 1.0 112.331 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 1.2 pt-20 -121.94 -76.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.794 -0.363 . . . . 1.0 111.825 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -45.84 -40.53 9.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.779 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.61 68.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.657 -0.417 . . . . 1.0 111.014 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 21.3 ttm180 -59.82 -29.46 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.555 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' LEU . 35.1 mtp180 -58.91 -46.79 87.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 98' ' ' ALA . 43.0 mt -55.12 -36.74 66.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.569 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -63.49 -35.18 79.6 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -91.32 -15.85 28.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 2.8 tp -105.8 -45.53 4.36 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.33 0.863 . . . . 1.0 113.33 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.31 -3.67 12.46 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.515 0.931 . . . . 1.0 113.515 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.3 mt-30 30.08 69.68 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.01 1.115 . . . . 1.0 114.01 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.9 -51.21 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.634 HH21 HG22 ' A' ' 154' ' ' VAL . 0.8 OUTLIER 62.82 74.09 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.997 -1.456 . . . . 1.0 114.286 172.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.85 132.42 5.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.72 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 103' ' ' ILE . 2.1 mp -107.84 128.15 63.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.664 HG12 ' N ' ' A' ' 105' ' ' ASP . 44.9 t -82.36 165.99 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.272 0.841 . . . . 1.0 113.272 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.664 ' N ' HG12 ' A' ' 104' ' ' VAL . 12.9 m-20 -52.74 123.28 10.9 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.772 -1.104 . . . . 1.0 112.308 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -58.96 -10.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.707 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.0 pt-20 -85.94 -39.48 16.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.867 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.434 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -60.68 -15.29 27.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.372 0.606 . . . . 1.0 110.066 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 50.86 57.72 6.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.047 -0.979 . . . . 1.0 113.345 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t -94.47 136.09 35.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.349 -2.093 . . . . 1.0 105.349 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -129.6 142.42 50.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.98 1.474 . . . . 1.0 114.98 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 2.8 m . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 114.181 -1.372 . . . . 1.0 107.341 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.737 0.303 . . . . 1.0 110.254 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.409 ' O ' ' OG ' ' A' ' 112' ' ' SER . 75.5 Cg_exo -49.23 144.46 17.04 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.508 2.139 . . . . 1.0 111.808 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 139' ' ' HIS . 27.0 m -112.8 123.39 68.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 1.0 111.322 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.02 154.55 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.907 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.5 -21.73 73.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 1.0 111.261 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 12.8 p -63.05 -37.07 85.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.658 ' CE1' HG21 ' A' ' 135' ' ' VAL . 1.1 t-80 -80.83 -28.96 35.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.7 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.7 t -52.94 -55.2 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.339 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -66.96 -44.98 79.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.257 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -44.21 -50.99 8.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.473 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.532 HD13 ' NE2' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -72.67 -46.44 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.454 179.098 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -57.76 -42.64 84.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.456 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.5 m -53.72 -34.34 58.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.2 mtt -82.35 -4.25 56.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.179 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 72.16 25.26 74.98 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.268 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.97 120.84 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.96 -33.16 34.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.4 t -138.48 170.49 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.199 -0.6 . . . . 1.0 111.569 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -163.01 139.82 7.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 1.0 112.185 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.9 tp -116.32 116.23 27.37 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.39 157.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.54 0.686 . . . . 1.0 111.79 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.634 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -156.02 95.73 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.295 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HD2' ' NE ' ' A' ' 101' ' ' ARG . 58.4 Cg_endo -65.81 139.74 58.51 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.536 2.824 . . . . 1.0 113.929 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.8 mt -98.15 107.47 19.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 83.1 mtp -121.12 143.37 49.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 1.0 111.775 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.431 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 84.0 t60 -121.81 114.41 21.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 160' ' ' GLN . 47.2 t60 65.05 -127.65 0.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 159' ' ' HIS . 0.5 OUTLIER -94.53 10.01 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -120.19 158.62 26.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.9 117.31 32.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.872 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 80.0 m95 -95.18 -26.55 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.61 -173.04 26.5 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.987 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.2 tp -142.33 131.44 23.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 1.0 111.251 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 1.9 tp -96.84 143.32 27.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.6 p -150.0 130.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.524 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.589 ' OG ' HG21 ' A' ' 48' ' ' THR . 18.2 t -112.1 141.77 45.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.011 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.401 ' NE2' ' CG2' ' A' ' 167' ' ' VAL . 68.0 m-70 -139.55 142.04 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.108 0.48 . . . . 1.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -155.98 152.27 27.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.778 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.452 ' HB3' ' NH1' ' A' ' 73' ' ' ARG . . . -82.33 71.01 9.39 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.034 -0.266 . . . . 1.0 111.418 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.325 179.768 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.779 0.323 . . . . 1.0 110.818 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.1 p -92.75 154.26 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 182' ' ' GLN . 13.8 pt20 -70.23 -39.01 75.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.624 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.23 -54.17 49.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.532 -0.303 . . . . 1.0 111.369 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -65.67 -30.04 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.378 . . . . 1.0 110.718 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.57 -31.89 71.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.494 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 178' ' ' GLN . 0.3 OUTLIER -71.91 -55.96 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.504 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 51.4 t -42.97 -45.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.257 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.41 -33.69 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 182' ' ' GLN . 59.6 tt0 -50.91 -42.17 59.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 186' ' ' LEU . 9.0 mp -67.66 -41.45 83.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.694 -1.139 . . . . 1.0 109.354 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.02 -28.87 59.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.697 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 191' ' ' VAL . . . -70.8 -26.44 63.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.615 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -70.99 -36.0 72.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.682 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -53.8 -58.62 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 188' ' ' ALA . 17.9 m -60.27 -38.17 76.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.891 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 15.8 m -52.39 -35.55 51.84 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.95 -36.08 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.518 -0.764 . . . . 1.0 110.127 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.91 -46.81 61.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.084 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.65 -34.56 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.69 -54.13 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.883 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -55.93 -28.56 57.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.955 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.05 -34.9 57.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.269 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -57.22 -38.57 73.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.183 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.35 -59.21 3.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.169 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 t -65.46 -50.91 63.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 1.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.417 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.81 0.338 . . . . 1.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -60.51 -49.2 78.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.267 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.51 -51.0 69.15 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 38' ' ' THR . 52.5 mt -56.67 -42.28 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.0 -24.1 66.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.561 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -60.84 -40.39 92.66 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.654 -0.418 . . . . 1.0 109.973 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 -30.58 60.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.8 p -69.51 -46.94 65.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.534 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 68' ' ' ALA . 38.2 t -57.55 -40.96 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.883 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 78.7 mm-40 -72.64 -36.7 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.96 -55.15 24.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.767 -0.651 . . . . 1.0 112.023 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.8 p -59.67 -44.09 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 tmm_? -51.91 -45.47 64.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.817 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.7 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.839 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -81.26 -47.23 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.821 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -77.21 -6.08 51.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.971 0.415 . . . . 1.0 110.124 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.59 17.6 0.5 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.464 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -76.28 143.4 40.93 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.053 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 70' ' ' GLY . 50.0 p30 -65.96 -21.95 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.886 0.699 . . . . 1.0 112.886 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.703 HH21 ' CD2' ' A' ' 169' ' ' HIS . 44.4 ttp180 -155.12 119.29 4.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 119.221 -0.992 . . . . 1.0 113.579 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.3 t -137.54 133.67 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -147.22 160.11 42.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.432 -0.507 . . . . 1.0 111.625 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.94 137.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.002 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 165' ' ' LEU . 38.7 t80 -121.36 119.33 31.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.074 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -100.11 167.83 10.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.33 134.19 46.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 1.0 112.102 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -103.52 129.26 25.75 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.357 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.72 -23.88 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.698 2.265 . . . . 1.0 112.953 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.69 -8.58 58.84 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.994 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.2 39.75 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.836 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -90.49 140.96 29.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.33 0.565 . . . . 1.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 81' ' ' THR . . . -118.24 135.57 11.7 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.9 p -124.0 144.05 50.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 1.0 112.278 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.6 t -100.53 122.87 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.95 -1.129 . . . . 1.0 107.95 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.3 3.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.572 0.582 . . . . 1.0 112.572 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -158.96 149.41 19.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.454 -0.572 . . . . 1.0 109.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -166.19 126.84 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.167 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.88 144.38 33.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -134.57 141.28 46.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.52 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.76 110.34 3.66 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.444 -1.063 . . . . 1.0 110.444 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.1 15.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.8 tt0 72.6 21.6 3.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.116 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -52.27 -57.03 10.96 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.7 146.93 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 107.791 -1.188 . . . . 1.0 107.791 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.25 162.81 40.95 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.068 1.845 . . . . 1.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 p -86.93 132.16 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.609 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 31.5 mt -105.83 -5.69 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.647 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.475 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.1 tp -48.26 134.34 14.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 1.0 112.259 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.05 -40.48 3.07 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 81' ' ' THR . 2.1 tt -59.87 112.57 1.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.39 . . . . 1.0 110.739 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 80' ' ' LEU . 27.9 m -74.77 124.25 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.455 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.26 132.64 20.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.274 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.64 149.16 26.56 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.155 1.904 . . . . 1.0 111.713 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.87 68.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -22.75 0.64 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -54.89 -33.64 62.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 1.0 110.672 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.6 132.4 21.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.264 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 61.8 Cg_endo -80.22 -120.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.601 2.2 . . . . 1.0 112.292 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 95.5 mt-10 -141.72 -71.93 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.904 0.383 . . . . 1.0 111.828 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 22.2 pt-20 -42.8 -42.86 3.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.781 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -65.05 -52.64 54.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.75 -29.49 59.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.548 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LEU . 66.6 mtp85 -60.07 -47.38 86.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.319 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 94' ' ' LEU . 57.4 mt -51.7 -44.95 63.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.589 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 27.7 m-85 -59.64 -30.21 68.56 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -90.87 -13.05 34.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.126 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' ARG . 1.5 tp -105.61 -45.97 4.29 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -112.82 0.89 15.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.462 0.912 . . . . 1.0 113.462 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.9 mt-30 28.1 66.39 0.09 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.131 1.16 . . . . 1.0 114.131 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 101' ' ' ARG . 8.2 p -119.32 -47.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 173.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.547 ' N ' HG13 ' A' ' 100' ' ' VAL . 1.6 mtt180 64.79 -22.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.272 170.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 176' ' ' TYR . 8.7 t -56.33 129.64 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.768 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 28.3 mt -107.11 132.68 53.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 104' ' ' VAL . 22.9 m -80.64 166.76 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -51.36 120.38 5.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.233 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -56.07 -10.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.823 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.8 pt-20 -88.61 -37.33 15.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.905 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.8 -15.09 10.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.395 0.617 . . . . 1.0 110.088 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.443 ' HG3' HH11 ' A' ' 111' ' ' ARG . 40.9 tp60 51.58 59.91 4.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.019 -0.991 . . . . 1.0 113.437 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.6 m -91.68 138.0 31.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 105.447 -2.057 . . . . 1.0 105.447 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 109' ' ' GLN . 67.3 mtm-85 -130.98 139.1 49.97 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.455 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 11.9 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.391 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.555 HH21 ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.683 0.278 . . . . 1.0 110.338 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.6 149.8 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.62 2.213 . . . . 1.0 111.777 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.866 HG23 HG12 ' A' ' 140' ' ' VAL . 18.9 m -99.97 149.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.036 0.445 . . . . 1.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -89.65 144.21 31.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.947 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -38.92 -21.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.236 1.957 . . . . 1.0 111.258 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.5 t -78.49 -46.27 20.04 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.624 ' CE1' HD13 ' A' ' 143' ' ' LEU . 40.1 t-80 -77.66 -38.78 46.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.639 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 135' ' ' VAL . 2.6 m -51.82 -43.09 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.342 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.497 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 85.9 t60 -66.2 -43.44 86.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.225 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -46.98 -50.11 19.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.555 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.624 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.9 mp -68.32 -50.98 49.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.456 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' GLY . 45.4 tptt -55.56 -40.66 72.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.8 m -54.82 -33.32 61.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 45.3 mtt -84.2 -2.87 57.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.218 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.67 24.61 75.36 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.221 -0.899 . . . . 1.0 112.341 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.6 p -108.46 124.12 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.93 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -119.34 153.89 34.42 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.564 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -147.13 128.49 14.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.173 -0.467 . . . . 1.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.97 105.36 8.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 m -110.93 164.75 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.423 0.63 . . . . 1.0 111.838 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 154' ' ' VAL . 3.0 p -161.08 110.44 1.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.331 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.85 139.66 44.06 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.54 2.827 . . . . 1.0 113.865 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.45 105.91 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.766 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.55 142.92 50.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.239 0.543 . . . . 1.0 111.899 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 51.8 t60 -114.09 115.52 27.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 17.5 m-70 60.33 -123.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -93.49 7.03 46.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.884 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -116.28 151.99 34.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.6 115.43 29.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.807 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.3 m95 -95.41 -28.12 15.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.87 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.34 -168.35 23.09 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.167 -1.016 . . . . 1.0 111.963 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -142.95 140.49 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 1.0 111.122 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.1 tp -110.07 145.46 37.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -149.07 128.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.58 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.4 m -117.59 142.64 46.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.0 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.703 ' CD2' HH21 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -149.82 144.04 25.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.135 0.493 . . . . 1.0 111.016 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -152.84 150.99 29.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.685 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.85 69.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.467 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 120.398 -0.521 . . . . 1.0 112.34 179.404 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.803 0.335 . . . . 1.0 110.788 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.2 m -95.78 140.01 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.47 -35.23 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.595 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.25 -52.06 67.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.0 111.428 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -68.14 -33.73 75.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.937 0.399 . . . . 1.0 110.667 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.16 -50.77 68.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.516 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.535 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 61.3 tp60 -59.11 -54.48 46.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.424 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.36 -46.93 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.31 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.89 -37.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.535 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 42.8 tt0 -48.0 -38.78 17.84 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.79 -41.95 67.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.34 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.407 ' CD2' HG23 ' A' ' 42' ' ' VAL . 11.5 tp -54.84 -32.8 60.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.666 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.0 -39.3 61.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.685 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.84 -37.92 71.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.754 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -54.66 -52.9 60.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.54 -44.82 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.906 . . . . 1.0 109.91 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 m -51.87 -38.52 56.36 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 76.7 mt -77.76 -32.18 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.061 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.82 67.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -67.37 -24.09 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.16 -56.06 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.868 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -57.45 -26.37 61.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.917 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.93 -34.93 57.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -58.52 -39.3 79.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.91 -59.23 3.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.123 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.6 p -58.25 -43.61 87.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 1.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.42 179.851 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 31' ' ' LEU . 46.1 tp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.883 0.373 . . . . 1.0 110.529 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 42.9 p-10 -55.62 -38.36 69.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.246 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.4 mt-30 -72.32 -51.33 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -57.4 -45.54 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.73 -27.19 64.76 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.558 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -55.08 -38.02 67.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.023 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.81 -31.89 57.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.374 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.7 p -68.26 -45.78 72.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.481 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 68' ' ' ALA . 52.9 t -57.07 -38.98 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.902 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -77.75 -37.73 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -59.8 -53.68 55.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 43' ' ' ARG . 13.3 p -60.15 -44.61 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.867 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.4 ttp180 -49.87 -44.91 50.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.847 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.87 74.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.772 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -81.33 -50.45 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.96 -6.7 55.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.976 0.417 . . . . 1.0 110.123 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.35 18.85 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.703 -0.68 . . . . 1.0 112.478 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.41 141.05 43.29 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.028 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 70' ' ' GLY . 96.0 m-20 -66.74 -23.9 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 48' ' ' THR . 43.2 ttt85 -152.76 121.41 6.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 119.186 -1.006 . . . . 1.0 113.551 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.17 135.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -146.52 162.55 38.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.427 -0.509 . . . . 1.0 111.549 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.33 135.77 31.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.024 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 165' ' ' LEU . 62.1 t80 -118.36 118.53 32.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -99.83 168.31 9.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 67.6 t80 -134.97 138.93 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.071 0.462 . . . . 1.0 112.133 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.8 m-20 -103.06 147.87 34.77 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.378 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.51 -19.9 65.45 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.69 2.26 . . . . 1.0 112.948 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -82.3 -1.73 50.47 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.41 -11.37 54.42 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.824 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -89.3 144.82 25.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.361 0.58 . . . . 1.0 110.961 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.23 144.01 15.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.7 p -128.47 146.98 50.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.23 0.538 . . . . 1.0 112.3 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.89 118.65 52.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.15 6.61 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.12 146.68 23.12 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 37.1 tt0 -166.44 128.68 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.369 -0.933 . . . . 1.0 113.13 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -109.89 138.22 46.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 44.0 ptt85 -131.19 141.28 50.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.498 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.33 109.05 3.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 49.32 -85.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.6 pt-20 178.2 31.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.135 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -68.71 -25.62 64.86 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 mt -122.85 148.47 53.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 11.8 Cg_exo -74.03 164.55 34.16 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.016 1.81 . . . . 1.0 112.428 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -85.99 134.21 33.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' H ' HH22 ' A' ' 50' ' ' ARG . 91.6 mt -109.53 -3.02 17.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.641 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.21 139.01 57.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.603 . . . . 1.0 112.191 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.28 -3.24 84.03 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.351 -0.84 . . . . 1.0 111.015 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 tp -101.2 128.43 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 1.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 81' ' ' THR . 9.6 t -85.88 125.19 33.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.444 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -103.15 128.63 27.21 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.36 161.15 25.78 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.126 1.884 . . . . 1.0 111.666 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.12 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.776 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.53 -29.3 0.71 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.141 -0.784 . . . . 1.0 111.141 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.99 -28.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.798 0.332 . . . . 1.0 110.62 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.8 mt -137.93 99.54 9.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.258 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' ILE . 42.4 Cg_exo -40.63 -103.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.534 2.156 . . . . 1.0 112.325 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 92.7 mt-10 -135.65 -71.34 0.47 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.797 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' HA ' HH11 ' A' ' 93' ' ' ARG . 22.7 pt-20 -42.67 -38.77 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.775 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.45 -53.14 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.97 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -57.2 -31.8 65.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.542 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 97' ' ' LEU . 77.3 mtt85 -60.47 -47.29 86.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.565 -0.289 . . . . 1.0 111.213 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.0 mt -50.23 -43.89 53.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.52 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 68.1 m-85 -59.29 -33.23 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -92.34 -21.0 20.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.061 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tp -106.63 -50.45 3.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.82 -5.81 12.07 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 101' ' ' ARG . 95.1 mt-30 53.13 71.96 0.46 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 100' ' ' VAL . 1.9 p -63.28 59.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.825 ' N ' ' O ' ' A' ' 99' ' ' GLN . 40.6 ptt85 -56.41 -1.62 0.06 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.07 -1.423 . . . . 1.0 114.31 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.9 p -152.68 131.81 3.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.458 -0.497 . . . . 1.0 111.732 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mt -112.11 131.02 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.1 t -83.22 168.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.697 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.3 m-20 -55.15 119.07 4.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.758 -1.11 . . . . 1.0 112.267 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.02 -11.62 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.718 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 2.1 pp20? -84.87 -39.87 17.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.902 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.68 -12.91 4.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 1.0 110.075 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 49.9 59.08 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.433 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -93.41 136.26 33.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.361 -2.088 . . . . 1.0 105.361 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -125.57 136.72 53.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 93.6 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.358 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HB2' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.693 0.282 . . . . 1.0 110.24 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.24 154.29 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.598 2.199 . . . . 1.0 111.817 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 16.0 m -98.85 148.05 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.117 0.485 . . . . 1.0 111.294 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.6 OUTLIER -92.28 143.58 27.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.439 -0.8 . . . . 1.0 110.898 -178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -38.67 -22.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.236 1.958 . . . . 1.0 111.227 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -74.9 -46.72 34.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.604 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 45.6 t-80 -78.39 -29.22 47.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.734 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.15 -55.01 16.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.321 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.448 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 86.7 t60 -63.79 -46.61 84.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.273 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -44.14 -48.61 9.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.488 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.71 -46.53 58.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.43 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 147' ' ' GLY . 18.1 tptm -59.3 -40.08 85.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.49 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.448 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 17.9 m -54.27 -32.91 57.38 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.9 mtt -84.26 -2.2 56.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.208 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.87 22.51 75.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.287 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 169' ' ' HIS . 43.0 t -105.65 123.59 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -35.39 30.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.4 p -130.88 168.53 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.534 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 p -161.44 139.69 9.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.038 0.447 . . . . 1.0 112.16 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.0 tp -116.84 136.49 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 m -131.6 158.72 43.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.651 . . . . 1.0 111.821 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 153' ' ' VAL . 55.3 t -159.01 90.81 2.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.327 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.52 114.61 1.65 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.559 2.839 . . . . 1.0 113.936 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.4 mt -71.86 105.37 3.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.8 ptm -135.1 147.04 49.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 1.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 79.4 t60 -118.22 115.12 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.517 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 32.0 t-80 59.9 -123.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.517 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 30.7 tt0 -93.04 8.44 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -114.94 143.87 44.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.4 115.55 30.4 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.489 -1.232 . . . . 1.0 108.853 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 76.0 m95 -100.63 -27.93 13.13 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.725 -0.39 . . . . 1.0 111.852 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.1 -171.73 24.38 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.283 -0.96 . . . . 1.0 112.031 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -139.99 131.26 26.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.803 0.335 . . . . 1.0 111.193 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -96.75 136.86 36.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -149.61 129.98 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.574 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -116.43 146.83 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.017 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.718 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -145.09 142.75 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 1.0 111.029 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 11.7 t60 -150.86 151.42 32.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 1.0 109.752 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.433 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.76 69.73 9.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.471 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 N--CA 1.466 0.334 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.3 179.305 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 1.0 110.819 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.0 m -67.37 133.54 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.307 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.42 -35.61 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.616 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.74 -54.82 40.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.63 -0.259 . . . . 1.0 111.333 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.63 -32.13 73.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 1.0 110.682 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 tp -62.24 -41.27 98.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.481 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.32 -56.3 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.543 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -45.0 -45.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.574 -0.451 . . . . 1.0 110.27 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -75.44 -36.72 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -47.68 -36.79 11.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.02 -40.38 68.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.386 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.5 tp -55.61 -31.76 62.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.692 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.438 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.95 -39.34 56.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.641 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -57.12 -39.03 74.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.732 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -53.21 -52.64 58.24 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.2 -40.55 65.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.82 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.5 p -51.54 -33.61 32.86 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.02 -36.62 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.062 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -46.45 65.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.114 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 196' ' ' ALA . 8.8 tp -61.57 -36.14 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.164 0.507 . . . . 1.0 109.666 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -74.84 -53.46 9.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.93 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.56 -28.84 57.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.73 -33.93 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.216 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.38 -41.14 84.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.2 -58.59 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.5 p -57.75 -43.97 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 1.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.457 179.739 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.8 tp . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.853 0.359 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 25.2 p-10 -63.09 -51.02 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.261 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 98.8 mt-30 -61.32 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.684 ' O ' HG23 ' A' ' 38' ' ' THR . 4.4 mm -57.8 -37.94 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.591 0.589 . . . . 1.0 112.591 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.34 -23.32 61.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -64.97 -42.32 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.011 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.12 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.374 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.4 p -69.41 -46.66 66.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 68' ' ' ALA . 13.0 t -55.2 -37.16 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.835 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.35 -38.7 85.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.777 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -62.22 -41.77 98.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.973 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.0 -40.97 84.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.879 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.2 tmm_? -57.95 -50.16 74.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.871 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.76 86.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.9 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -77.48 -52.88 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.824 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.67 -3.64 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 1.0 110.14 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.24 17.11 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.487 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.623 HG21 HG13 ' A' ' 51' ' ' VAL . 6.2 t -77.89 147.56 35.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 70' ' ' GLY . 33.2 p-10 -69.02 -11.6 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 1.0 112.895 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.603 ' NH2' ' CD2' ' A' ' 169' ' ' HIS . 30.7 ttp180 -163.73 122.0 1.91 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 119.115 -1.034 . . . . 1.0 113.487 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.96 133.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 176.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -145.36 159.65 42.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.556 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.65 135.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.015 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.5 t80 -118.32 118.28 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.054 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -99.24 166.97 10.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -132.22 134.05 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.569 -0.452 . . . . 1.0 112.15 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.48 129.56 25.79 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.727 -0.669 . . . . 1.0 109.283 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.86 -26.91 2.19 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.675 2.25 . . . . 1.0 112.976 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.21 -7.83 55.72 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.996 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.52 -11.61 42.85 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.048 -0.596 . . . . 1.0 112.832 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -88.46 142.75 27.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.363 0.582 . . . . 1.0 110.941 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -122.37 141.57 14.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 78.7 p -127.21 146.56 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.267 0.556 . . . . 1.0 112.374 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.3 t -95.75 118.82 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.03 -1.59 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.37 150.5 21.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -168.65 131.31 1.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.35 -0.94 . . . . 1.0 113.125 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -114.46 144.92 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -133.25 144.52 49.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.574 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.04 113.17 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.59 19.07 0.13 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 70' ' ' GLY . 38.6 tt0 68.72 28.9 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.194 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -58.2 -55.52 33.96 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt -95.43 149.87 36.74 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.31 170.01 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.066 1.844 . . . . 1.0 112.506 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -89.92 127.71 36.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.143 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 mt -98.88 -1.31 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.655 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 67' ' ' GLU . 9.4 tp -61.39 135.3 57.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.359 0.599 . . . . 1.0 112.179 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.61 -8.11 74.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.1 mp -98.11 131.79 44.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.399 . . . . 1.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.0 m -90.56 120.83 31.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.383 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 62' ' ' GLY . 8.7 m-85 -106.39 135.69 19.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.34 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.53 154.24 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.192 1.928 . . . . 1.0 111.672 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -69.44 -24.44 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.796 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.58 -20.09 0.19 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ALA . 88.8 m-20 -58.46 -30.76 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 1.0 110.659 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.0 mt -111.91 132.73 21.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.75 -111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.536 2.157 . . . . 1.0 112.27 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 13.2 tm-20 -150.99 -66.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.804 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 21.1 pt-20 -44.56 -43.7 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.743 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.38 98.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.916 0.389 . . . . 1.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HD22 ' A' ' 162' ' ' LEU . 59.8 ttt180 -64.34 -28.01 69.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.9 mtp85 -56.95 -49.85 74.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.272 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.03 -38.1 62.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.581 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 8.4 m-85 -64.24 -29.85 70.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -90.31 -13.66 34.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.128 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.16 -43.78 4.31 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.57 -3.73 13.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.541 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.8 mt-30 27.24 70.69 0.05 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.112 1.153 . . . . 1.0 114.112 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.2 p -112.64 -48.36 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.43 -2.434 . . . . 1.0 104.43 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.572 ' N ' HG13 ' A' ' 100' ' ' VAL . 12.1 mtm180 63.42 74.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.077 -1.42 . . . . 1.0 114.24 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.54 135.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.761 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 135' ' ' VAL . 3.0 mt -107.86 125.9 64.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 105' ' ' ASP . 7.5 p -82.79 166.28 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.621 ' N ' HG22 ' A' ' 104' ' ' VAL . 23.7 t0 -54.33 120.25 6.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.713 -1.131 . . . . 1.0 112.336 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.7 m -56.72 -9.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -87.27 -35.83 18.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.831 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -16.83 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.363 0.601 . . . . 1.0 110.076 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 51.38 53.05 13.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.086 -0.961 . . . . 1.0 113.45 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.03 135.6 34.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.385 -2.08 . . . . 1.0 105.385 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -129.46 142.8 50.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 81.9 p . . . . . 0 N--CA 1.453 -0.3 0 CA-C-N 114.11 -1.405 . . . . 1.0 107.322 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.609 ' NH2' HG22 ' A' ' 135' ' ' VAL . 63.2 ttp85 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 110.309 -0.256 . . . . 1.0 110.309 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.91 142.65 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.515 2.143 . . . . 1.0 111.896 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.609 HG22 ' NH2' ' A' ' 133' ' ' ARG . 16.7 t -133.35 140.1 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 1.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.552 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -39.76 156.17 0.16 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.883 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.21 -7.33 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.196 1.93 . . . . 1.0 111.308 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 m -56.45 -51.47 68.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.47 ' CE1' HG23 ' A' ' 140' ' ' VAL . 5.1 p-80 -71.7 -25.74 62.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.591 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.47 HG23 ' CE1' ' A' ' 139' ' ' HIS . 27.9 t -56.91 -64.13 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.364 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.25 -50.69 44.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.202 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.446 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' CD2' ' NE2' ' A' ' 169' ' ' HIS . 85.1 mt -73.56 -45.32 54.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.508 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 41.9 tptt -60.18 -41.7 93.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.2 m -53.42 -31.11 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.5 mtt -89.82 -2.04 58.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.199 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.11 26.16 71.53 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.251 -0.886 . . . . 1.0 112.348 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.37 120.7 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.971 0.386 . . . . 1.0 109.962 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.14 -34.47 32.46 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -134.92 170.06 16.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.595 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.561 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 39.1 m -163.68 139.82 6.7 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.037 0.446 . . . . 1.0 112.124 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.424 HD13 ' CG ' ' A' ' 176' ' ' TYR . 21.9 tp -114.03 139.26 49.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.5 m -132.46 156.78 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.437 0.637 . . . . 1.0 111.82 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.489 HG11 ' CB ' ' A' ' 188' ' ' ALA . 74.4 t -156.84 91.6 2.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.818 -1.083 . . . . 1.0 109.262 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.45 130.58 39.3 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 123.694 2.929 . . . . 1.0 113.893 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.89 104.83 16.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.795 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.8 mtp -119.2 144.63 46.61 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.871 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 86.1 t60 -124.73 113.3 17.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.951 -1.129 . . . . 1.0 107.951 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.488 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 11.8 t-80 65.17 -127.17 0.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.488 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 91.8 mm-40 -95.15 12.21 29.55 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -120.72 157.47 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.9 OUTLIER -110.95 115.53 29.64 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 114.493 -1.231 . . . . 1.0 108.848 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.5 m95 -93.44 -25.78 17.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.958 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.58 -167.94 22.75 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.152 -1.023 . . . . 1.0 111.941 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.6 tp -144.21 129.78 19.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.767 0.317 . . . . 1.0 111.231 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.56 138.31 31.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.33 133.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.597 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.679 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 25.1 p -114.47 142.91 45.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.029 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.679 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -133.92 139.51 46.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 1.0 111.08 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.426 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.7 p-80 -156.09 155.07 31.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.747 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.24 69.51 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.469 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.349 179.635 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 5.9 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.784 0.326 . . . . 1.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -99.21 150.88 21.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.81 -38.76 89.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.654 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 179' ' ' GLU . 47.6 mp0 -65.59 -55.34 18.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.289 . . . . 1.0 111.333 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.53 -34.23 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.942 0.401 . . . . 1.0 110.717 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.89 -39.48 94.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.467 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -58.73 -53.66 55.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.415 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -46.4 -45.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 187' ' ' LEU . 40.0 t -74.75 -37.96 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 7.5 tp-100 -47.84 -35.33 10.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.44 -40.08 64.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.734 -1.121 . . . . 1.0 109.367 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 184' ' ' VAL . 42.5 tp -55.07 -31.79 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.715 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.51 -38.07 62.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.64 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -55.54 -39.53 70.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.73 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -52.09 -52.39 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.07 -41.17 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.9 m -52.45 -36.17 54.1 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.62 -41.54 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.082 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.23 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.099 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.466 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.1 tp -61.49 -35.85 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.07 -53.91 11.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.904 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -55.66 -26.43 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.921 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -34.92 58.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.286 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.73 -38.98 76.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -66.99 -58.44 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.131 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.5 t -50.54 -40.85 52.92 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.312 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.369 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.923 0.392 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.18 -41.11 94.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.252 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -71.1 -54.13 12.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.848 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -58.33 -32.44 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -75.53 -25.12 56.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.729 -0.389 . . . . 1.0 111.555 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.34 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.616 -0.434 . . . . 1.0 109.974 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.24 -30.12 43.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.407 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 34' ' ' ILE . 37.5 p -74.77 -49.02 22.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.553 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 36' ' ' ARG . 5.2 p -53.43 -33.9 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.833 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -72.94 -35.52 67.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.38 -43.18 91.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.972 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.21 -51.74 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.89 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.2 ttp180 -49.95 -43.84 50.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.868 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.41 75.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -80.73 -50.73 9.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.32 -6.84 54.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.0 110.072 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.51 18.94 1.06 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.682 -0.69 . . . . 1.0 112.445 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.87 142.29 42.18 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' GLY . 90.5 m-20 -58.32 -32.88 68.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 48' ' ' THR . 58.8 ttp180 -152.45 120.8 6.33 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.595 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.89 135.53 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -144.77 161.0 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.551 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.33 137.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.011 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.7 t80 -122.27 118.48 28.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.014 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -99.57 170.59 8.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 27.8 t80 -134.57 136.74 43.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.039 0.447 . . . . 1.0 112.166 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 m-20 -102.17 148.53 35.53 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.299 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.61 -22.96 70.35 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.681 2.254 . . . . 1.0 112.971 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -79.39 -2.07 40.06 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.029 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.18 -10.5 56.77 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.894 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 148.03 22.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.344 0.572 . . . . 1.0 110.95 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.87 149.7 18.53 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.424 -1.07 . . . . 1.0 110.424 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 1.0 112.347 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.67 116.67 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -112.36 5.23 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.07 145.89 23.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.0 tt0 -166.2 126.97 1.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.378 -0.929 . . . . 1.0 113.216 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.06 138.07 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.9 ptt180 -129.61 142.43 50.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.544 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.49 106.23 2.99 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.84 -87.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLY . 19.5 pt-20 -179.27 31.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.115 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 49' ' ' ASP . 7.1 ttp180 -70.11 -51.2 33.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.52 124.63 47.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.33 169.44 3.93 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.133 1.889 . . . . 1.0 112.49 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 141.47 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.151 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.592 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 33.3 mt -113.28 -2.14 14.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.623 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.0 tp -56.83 138.17 53.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.329 0.585 . . . . 1.0 112.279 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -4.04 84.49 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.425 -0.807 . . . . 1.0 111.088 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -100.47 117.72 35.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 1.0 110.82 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.654 ' N ' HD23 ' A' ' 80' ' ' LEU . 76.9 p -76.88 123.55 26.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.447 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 80' ' ' LEU . 10.0 m-85 -107.17 135.07 19.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.92 150.97 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.128 1.885 . . . . 1.0 111.649 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.55 -25.78 66.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.849 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.45 -21.2 0.25 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 m-20 -54.84 -32.65 60.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 1.0 110.592 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 HH21 ' A' ' 92' ' ' ARG . 3.5 pt -121.0 99.49 46.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.244 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 87' ' ' ILE . 51.2 Cg_exo -42.11 -107.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.5 2.134 . . . . 1.0 112.317 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 19.7 pt-20 -152.4 -46.14 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 1.0 111.83 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 24.4 pt-20 -60.66 -39.09 87.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.71 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.9 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.554 HH21 HD12 ' A' ' 87' ' ' ILE . 29.4 ttm105 -66.34 -29.88 70.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.556 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -55.92 -55.29 34.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.318 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD22 ' NE ' ' A' ' 133' ' ' ARG . 5.5 tp -53.04 -43.42 66.59 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.543 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.35 -32.64 70.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.566 ' NH2' ' SD ' ' A' ' 157' ' ' MET . 9.6 mmp_? -87.34 -11.03 50.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.136 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 tp -106.85 -44.96 4.3 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.31 0.856 . . . . 1.0 113.31 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.57 -1.96 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.587 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 97.6 mt-30 26.15 69.03 0.05 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.093 1.146 . . . . 1.0 114.093 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.659 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 31.4 m -113.04 -50.96 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.405 -2.443 . . . . 1.0 104.405 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.659 ' HE ' ' N ' ' A' ' 100' ' ' VAL . 3.5 mtm180 63.66 72.38 0.47 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.052 -1.431 . . . . 1.0 114.256 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 102' ' ' VAL . 15.0 p -148.87 133.0 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.477 -0.489 . . . . 1.0 111.735 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.515 HG21 ' OG ' ' A' ' 151' ' ' SER . 2.4 mt -109.2 124.67 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 108.331 -0.989 . . . . 1.0 108.331 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.6 p -83.16 167.71 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.274 0.842 . . . . 1.0 113.274 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.665 ' N ' HG22 ' A' ' 104' ' ' VAL . 9.5 m-20 -55.54 119.18 5.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.711 -1.131 . . . . 1.0 112.268 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.67 -10.34 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.754 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.46 -36.93 16.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.906 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -16.79 37.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.416 0.626 . . . . 1.0 110.145 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 51.8 58.35 5.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.982 -1.008 . . . . 1.0 113.455 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -94.1 137.82 32.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.82 133.21 49.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-N 114.195 -1.366 . . . . 1.0 107.382 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.638 ' NE ' HD22 ' A' ' 94' ' ' LEU . 10.7 tpp180 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.708 0.29 . . . . 1.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.33 147.6 28.24 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.512 2.142 . . . . 1.0 111.791 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 139' ' ' HIS . 6.9 m -97.75 153.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.042 0.449 . . . . 1.0 111.373 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -89.09 155.81 49.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.891 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.23 -20.42 24.75 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.267 1.978 . . . . 1.0 111.164 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.0 t -69.89 -51.97 28.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.729 ' ND1' ' C ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -73.38 -27.28 61.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.634 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 25.4 t -52.9 -53.13 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.322 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.544 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 72.1 t60 -66.05 -44.09 85.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -42.02 -48.56 4.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.467 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.2 mt -74.19 -43.74 56.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.502 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' GLY . 40.1 tptt -61.02 -42.55 98.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.544 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 16.2 m -54.26 -32.29 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 42.9 mtt -88.18 -0.98 57.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.217 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.14 24.93 76.26 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.197 -0.911 . . . . 1.0 112.31 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.0 t -106.84 120.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.47 -30.88 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.54 ' OG ' ' CD2' ' A' ' 170' ' ' HIS . 98.7 p -139.46 171.76 13.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.137 -0.625 . . . . 1.0 111.563 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 103' ' ' ILE . 8.3 p -161.93 140.44 9.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.211 -0.45 . . . . 1.0 112.171 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.4 139.42 50.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -133.22 154.41 39.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.479 0.657 . . . . 1.0 111.821 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 153' ' ' VAL . 54.8 t -158.19 91.29 2.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.72 134.7 54.82 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.521 2.814 . . . . 1.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.9 mt -94.76 107.89 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.772 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.566 ' SD ' ' NH2' ' A' ' 96' ' ' ARG . 15.8 ptm -128.7 146.89 50.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.906 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 65.7 t60 -117.79 115.41 24.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 60.5 t60 61.52 -124.61 0.83 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.789 -0.449 . . . . 1.0 109.789 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 74.2 mt-30 -93.24 5.01 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.43 150.74 32.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.85 116.35 31.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.831 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.455 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 83.7 m95 -93.85 -24.87 17.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.898 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.79 -165.32 21.88 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.979 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.6 tp -143.55 133.31 23.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 1.0 111.179 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 3.5 tp -95.11 140.66 29.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.02 135.23 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.608 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.784 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 0.9 OUTLIER -120.02 139.95 51.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.049 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.784 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -136.51 142.15 43.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 1.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.54 ' CD2' ' OG ' ' A' ' 150' ' ' SER . 4.2 p-80 -156.48 153.75 29.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.712 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.69 72.2 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.418 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 N--CA 1.465 0.291 0 C-N-CA 120.396 -0.522 . . . . 1.0 112.359 179.623 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 9.4 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.719 0.295 . . . . 1.0 110.847 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.3 p -100.19 146.59 26.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.75 -35.67 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 58.0 mp0 -65.67 -55.59 16.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.302 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.43 -34.95 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 1.0 110.683 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.25 -34.66 74.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.49 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 185' ' ' GLN . 51.0 tt0 -66.88 -51.8 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.36 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.4 t -45.2 -48.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.317 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.1 p -74.59 -37.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 182' ' ' GLN . 6.9 tt0 -48.06 -37.15 14.42 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.54 -40.22 70.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 184' ' ' VAL . 34.5 tp -55.2 -30.97 61.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.738 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.448 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -73.74 -39.01 64.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.618 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.59 -40.23 71.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.76 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -51.05 -52.94 38.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.05 -41.14 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.839 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -36.17 57.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.15 -37.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.001 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.24 68.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.068 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.6 tp -62.42 -33.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -73.74 -53.75 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.895 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -55.73 -27.65 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.95 -34.5 57.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.291 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -58.35 -40.27 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.117 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.36 -58.55 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.46 -0.337 . . . . 1.0 111.084 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.0 p -46.22 -38.35 8.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 1.0 110.355 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.429 179.832 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.904 0.383 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -69.8 -52.42 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.275 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.6 -50.04 74.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.76 -32.35 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -176.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.5 -25.77 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.535 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.89 -42.22 94.98 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.003 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.88 -26.62 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.364 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 34' ' ' ILE . 71.3 p -73.66 -45.4 52.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.534 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 68' ' ' ALA . 20.4 t -55.05 -37.7 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.873 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.39 -34.8 70.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.9 -43.36 96.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.99 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.58 -45.87 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.916 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.9 ttp180 -52.89 -47.46 67.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.884 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.808 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.65 -51.63 9.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.24 -6.08 49.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 1.0 110.111 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 16.83 0.37 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.459 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.649 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -76.48 144.86 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.036 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -61.75 -29.3 70.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.947 0.721 . . . . 1.0 112.947 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 48' ' ' THR . 18.7 ttt85 -149.19 122.0 8.71 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.187 -1.005 . . . . 1.0 113.522 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.6 t -137.71 130.64 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -145.23 156.22 43.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.556 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.8 139.65 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.045 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.6 t80 -124.75 120.34 31.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -100.35 171.43 7.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.896 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 8.8 t80 -133.52 138.17 45.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 1.0 112.142 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.7 m-20 -103.59 147.71 34.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.386 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.71 -26.44 75.3 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.797 2.331 . . . . 1.0 112.906 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -76.32 -5.9 49.16 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.976 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.16 -11.55 51.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.923 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -86.48 142.85 28.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.343 0.572 . . . . 1.0 110.962 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -123.22 143.24 15.0 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -126.59 147.01 49.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.229 0.538 . . . . 1.0 112.282 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.53 115.26 31.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.12 -1.56 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -157.09 147.25 20.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 40.3 tt0 -164.68 125.51 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.409 -0.917 . . . . 1.0 113.214 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.44 134.75 49.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.524 HH11 ' CB ' ' A' ' 76' ' ' SER . 15.3 mtm180 -121.93 138.93 54.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.531 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.51 107.0 2.97 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.364 -1.094 . . . . 1.0 110.364 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.5 30.12 1.32 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.255 -1.138 . . . . 1.0 110.255 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 58.89 27.18 15.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.119 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -57.63 -58.83 6.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.25 147.61 38.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 52.3 Cg_endo -68.69 160.69 48.46 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.089 1.859 . . . . 1.0 112.552 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.524 ' CB ' HH11 ' A' ' 69' ' ' ARG . 5.4 p -80.84 126.02 30.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.181 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -101.0 -8.62 22.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.59 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 tp -53.61 138.24 35.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 -2.65 79.58 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -99.88 128.33 45.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 1.0 110.77 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.8 122.17 29.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.45 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.42 132.73 20.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.25 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.59 151.95 25.71 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.096 1.864 . . . . 1.0 111.629 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' C ' ' OD1' ' A' ' 86' ' ' ASP . . . -60.12 -25.02 65.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.812 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.84 -24.29 1.25 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 17.9 p-10 -54.68 -26.57 34.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 1.0 110.619 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.562 HD12 HH21 ' A' ' 92' ' ' ARG . 51.9 mt -127.84 132.88 24.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.297 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.87 -104.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.563 2.176 . . . . 1.0 112.277 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -161.28 -43.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 1.0 111.845 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.4 -42.83 88.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.757 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.36 76.31 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.947 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.562 HH21 HD12 ' A' ' 87' ' ' ILE . 90.0 mtt-85 -66.2 -27.5 68.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' LEU . 30.3 mmt180 -54.54 -58.93 5.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.275 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.09 -37.66 67.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.549 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.7 m-85 -66.69 -39.13 87.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.409 HH12 HD13 ' A' ' 162' ' ' LEU . 5.7 tpp180 -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.549 -0.751 . . . . 1.0 110.137 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ARG . 4.4 tp -107.13 -43.32 4.64 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.99 -3.66 12.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 97.1 mt-30 27.42 70.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.066 1.136 . . . . 1.0 114.066 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.66 ' H ' HH22 ' A' ' 133' ' ' ARG . 14.3 t -110.72 -50.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.516 HH22 ' CD ' ' A' ' 185' ' ' GLN . 12.4 mtm180 64.81 72.75 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.053 -1.431 . . . . 1.0 114.248 172.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.43 ' C ' HD12 ' A' ' 103' ' ' ILE . 70.3 t -149.37 131.42 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.67 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.06 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 105' ' ' ASP . 41.4 t -81.29 165.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.194 0.813 . . . . 1.0 113.194 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 104' ' ' VAL . 22.5 t0 -51.7 120.77 5.56 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.664 -1.153 . . . . 1.0 112.315 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 106' ' ' VAL . 16.9 t -57.13 -12.7 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.702 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 12.6 pt-20 -80.22 -38.73 30.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.96 -16.54 59.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 1.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 51.19 60.08 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.991 -1.004 . . . . 1.0 113.39 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.6 p -94.56 138.88 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.16 146.49 51.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.48 . . . . 1.0 114.997 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 114.1 -1.409 . . . . 1.0 107.337 176.671 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.66 HH22 ' H ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.767 0.318 . . . . 1.0 110.288 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.96 145.45 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.586 2.191 . . . . 1.0 111.746 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.4 m -113.01 122.42 67.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 1.0 111.346 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -39.34 155.92 0.14 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.883 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 140' ' ' VAL . 43.3 Cg_endo -63.0 -13.82 37.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.221 1.947 . . . . 1.0 111.317 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.76 -29.94 58.99 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.591 ' CE1' HD13 ' A' ' 143' ' ' LEU . 40.2 t-80 -86.4 -38.05 17.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.351 -0.84 . . . . 1.0 110.679 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 137' ' ' PRO . 4.0 m -52.16 -47.23 44.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.351 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.597 ' N ' HG23 ' A' ' 140' ' ' VAL . 82.3 t60 -65.49 -44.04 88.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.273 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -45.24 -48.75 12.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.5 mp -70.96 -48.47 53.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.45 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 16.4 tptp -58.08 -41.71 84.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.484 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.4 m -54.41 -30.6 52.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.3 mtt -87.28 -1.34 57.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.158 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.38 28.15 71.7 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.292 -0.867 . . . . 1.0 112.337 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -109.93 123.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.77 -32.51 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 8.6 t -137.18 169.54 17.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.551 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -158.6 139.45 12.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.045 0.45 . . . . 1.0 112.162 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.81 136.73 52.72 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 101' ' ' ARG . 2.7 m -135.8 159.39 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.458 0.647 . . . . 1.0 111.824 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 188' ' ' ALA . 79.0 t -157.04 91.79 2.41 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.869 -1.06 . . . . 1.0 109.346 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.02 126.35 19.91 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.617 2.878 . . . . 1.0 113.904 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.8 mt -81.55 106.17 13.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.839 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.428 ' O ' ' OG ' ' A' ' 192' ' ' SER . 73.8 mtp -123.91 144.9 49.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.793 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 81.2 t60 -120.89 113.39 20.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.501 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.4 t-80 61.35 -121.11 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.501 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 30.1 tt0 -95.94 6.31 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.873 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 161' ' ' GLU . 43.8 mp0 -115.79 154.09 30.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.409 HD13 HH12 ' A' ' 96' ' ' ARG . 5.9 tt -111.14 116.57 31.32 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.557 -1.201 . . . . 1.0 108.88 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.7 m95 -94.93 -25.79 16.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.922 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.84 20.52 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.237 -0.982 . . . . 1.0 111.953 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.8 tp -143.05 130.69 21.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.766 0.317 . . . . 1.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -95.33 132.5 40.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.71 137.47 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.597 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -122.22 144.12 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.094 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.487 ' ND1' HG21 ' A' ' 148' ' ' VAL . 89.7 m-70 -139.68 143.72 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.139 0.495 . . . . 1.0 110.974 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -159.43 155.42 26.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.707 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.55 67.51 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.436 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 N--CA 1.466 0.328 0 C-N-CA 120.429 -0.509 . . . . 1.0 112.314 -179.483 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.806 0.336 . . . . 1.0 110.767 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.9 t -92.22 145.69 24.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.288 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -63.61 -43.34 97.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.588 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 179' ' ' GLU . 46.8 mp0 -60.92 -55.64 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.044 -0.262 . . . . 1.0 111.394 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.66 -29.09 69.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 1.0 110.651 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.93 -35.17 77.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.523 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -69.5 -53.52 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.388 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.1 t -43.47 -47.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.296 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.8 m -74.69 -36.81 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.516 ' CD ' HH22 ' A' ' 101' ' ' ARG . 6.7 tt0 -48.4 -38.18 18.89 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.14 -40.75 71.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.356 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.4 tt -54.81 -31.83 59.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.725 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.485 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -71.93 -33.86 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.605 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -57.68 -40.82 80.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.716 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -51.35 -53.5 35.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.63 -40.83 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.92 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 157' ' ' MET . 5.8 t -52.09 -36.54 51.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.02 -34.84 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.035 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.87 -46.52 62.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.056 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.43 -33.53 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.67 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.911 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.49 -29.41 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.918 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.55 53.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.287 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.413 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.1 tt0 -57.64 -39.36 76.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.01 -57.98 4.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.125 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -56.41 -44.35 80.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 1.0 110.339 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.413 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 5.2 tp . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 35' ' ' LEU . 60.2 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.875 0.369 . . . . 1.0 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -52.38 -52.69 52.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.307 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -60.15 -48.43 81.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 1.0 112.254 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 38' ' ' THR . 57.3 mt -57.68 -40.47 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.592 0.59 . . . . 1.0 112.592 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 31' ' ' LEU . 51.7 mt -69.89 -22.52 63.22 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.531 -177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 39' ' ' VAL . 93.4 mtt-85 -65.3 -35.29 80.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.706 -0.397 . . . . 1.0 109.975 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.98 -28.66 39.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.343 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.5 p -74.17 -48.96 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.56 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -53.47 -36.28 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.3 mt-10 -75.51 -32.83 60.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -66.64 -51.45 56.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.04 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.8 p -64.96 -48.24 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.811 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.632 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.5 tmt_? -51.65 -44.13 62.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.886 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.15 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.867 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -79.76 -48.91 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.45 -5.64 48.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.101 0.477 . . . . 1.0 110.198 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.65 17.39 0.26 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.433 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.63 144.78 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.1 m-20 -55.86 -34.6 65.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 48' ' ' THR . 35.0 ttm180 -149.53 126.14 10.99 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.184 -1.006 . . . . 1.0 113.521 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 t -135.93 130.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.032 -1.099 . . . . 1.0 108.032 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 54.5 pttt -144.34 157.54 44.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.519 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' A' ' 66' ' ' ALA . 9.4 p -99.35 138.68 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.03 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.2 t80 -122.57 120.73 34.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.083 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.553 ' NH1' HD11 ' A' ' 195' ' ' ILE . 65.9 mtp85 -99.72 169.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -133.6 134.71 43.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.031 0.444 . . . . 1.0 112.165 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.54 129.1 26.66 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.343 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -25.77 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.739 2.293 . . . . 1.0 112.888 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.6 -6.15 52.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.015 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.45 -11.5 43.08 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.051 -0.595 . . . . 1.0 112.92 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -88.71 142.76 27.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.361 0.581 . . . . 1.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -123.13 142.63 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.43 -1.068 . . . . 1.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.7 p -128.05 146.01 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.217 0.532 . . . . 1.0 112.269 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.96 111.3 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.66 8.0 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB3' HG12 ' A' ' 53' ' ' VAL . . . -155.19 147.13 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 72.5 tt0 -167.34 128.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.352 -0.939 . . . . 1.0 113.184 -177.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.18 131.17 54.93 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -117.4 136.65 53.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.55 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.04 88.84 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.39 -87.88 0.05 OUTLIER Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.266 -1.133 . . . . 1.0 110.266 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -175.76 34.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.884 -0.326 . . . . 1.0 111.147 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -70.11 -55.71 8.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.572 ' C ' HH22 ' A' ' 50' ' ' ARG . 12.5 mt -94.97 157.85 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 176.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 3.3 Cg_exo -78.51 165.32 25.29 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.154 1.903 . . . . 1.0 112.476 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 p -87.01 127.98 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.177 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 44.7 mt -101.13 1.06 38.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.58 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.549 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -65.25 138.65 58.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.346 0.593 . . . . 1.0 112.264 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.549 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 91.6 -2.85 77.92 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.111 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.5 mp -100.76 128.96 46.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.866 0.365 . . . . 1.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.23 121.81 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.411 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 62' ' ' GLY . 7.5 m-85 -107.68 136.77 19.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.39 157.79 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.166 1.91 . . . . 1.0 111.664 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -66.18 -25.59 67.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.78 -19.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 84' ' ' ALA . 85.3 m-20 -54.87 -34.16 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.359 . . . . 1.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 ' HE ' ' A' ' 92' ' ' ARG . 21.7 mm -109.12 133.71 20.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.258 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 58.7 Cg_endo -80.89 -120.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.491 2.127 . . . . 1.0 112.335 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.5 mm-40 -138.87 -56.58 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.759 -0.376 . . . . 1.0 111.849 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -59.46 -39.57 84.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.733 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.62 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.963 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 87' ' ' ILE . 39.7 ttm180 -63.22 -30.32 71.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.508 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -58.21 -50.48 73.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.0 111.26 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' NE ' ' A' ' 133' ' ' ARG . 95.6 mt -55.13 -36.25 65.56 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.604 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.24 -32.05 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 96' ' ' ARG . 9.2 mmm180 -83.62 -15.12 50.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.157 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.84 -42.72 4.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.74 -4.97 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.549 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 26.27 69.96 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 101' ' ' ARG . 1.7 m -110.63 -49.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 9.3 mtm180 63.09 68.86 0.6 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.066 -1.425 . . . . 1.0 114.335 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -148.77 133.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.849 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 3.4 mt -106.12 124.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.0 p -82.57 167.59 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.627 ' N ' HG22 ' A' ' 104' ' ' VAL . 3.0 m-20 -51.61 115.06 1.44 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.327 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 106' ' ' VAL . 54.7 t -54.81 -11.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.722 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.45 -33.57 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.08 -16.97 36.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.438 0.637 . . . . 1.0 110.143 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 53.28 59.97 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.969 -1.014 . . . . 1.0 113.435 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -92.37 134.34 35.01 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -124.86 138.23 54.26 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.481 . . . . 1.0 114.997 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 114.209 -1.36 . . . . 1.0 107.342 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' CG ' HH11 ' A' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.7 0.286 . . . . 1.0 110.299 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.13 149.75 17.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.573 2.182 . . . . 1.0 111.783 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.531 HG11 ' CE1' ' A' ' 139' ' ' HIS . 5.7 m -101.42 153.53 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 1.0 111.375 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 12.2 m-20 -88.98 146.2 36.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.903 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -42.62 -23.76 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.278 1.985 . . . . 1.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.1 p -67.66 -40.36 84.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.679 ' CE1' HD12 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -78.97 -26.69 43.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.641 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -51.33 -53.16 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 1.0 110.38 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' SER . 51.1 t-80 -68.25 -43.35 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.261 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -47.1 -57.19 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.455 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.679 HD12 ' CE1' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -68.46 -50.0 55.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.481 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.7 tptm -56.33 -39.53 72.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.407 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 141' ' ' HIS . 29.4 t -54.47 -32.48 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.4 mtt -83.45 -2.04 54.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.196 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.67 24.22 74.01 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.34 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 170' ' ' HIS . 24.0 t -109.27 124.55 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.2 -31.98 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.743 0.645 . . . . 1.0 112.743 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -135.13 169.73 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 1.0 111.565 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 5.0 p -161.56 139.48 9.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.163 0.431 . . . . 1.0 112.163 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.1 tp -114.83 139.25 49.9 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -135.68 156.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.423 0.63 . . . . 1.0 111.845 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 153' ' ' VAL . 71.5 t -157.8 93.13 2.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.851 -1.068 . . . . 1.0 109.341 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.32 115.84 2.66 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.581 2.854 . . . . 1.0 113.973 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.08 105.07 4.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.794 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 75.5 mtp -121.78 146.14 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.168 0.508 . . . . 1.0 111.846 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 80.2 t60 -123.18 112.88 18.22 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.9 t-80 64.89 -125.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.413 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 87.4 mt-30 -95.19 8.56 42.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.868 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 44.8 mp0 -118.42 155.08 31.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.897 1.073 . . . . 1.0 113.897 -177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.09 118.0 35.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.504 -1.225 . . . . 1.0 108.885 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CD2' ' OE2' ' A' ' 199' ' ' GLU . 77.9 m95 -97.51 -27.73 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.736 -0.386 . . . . 1.0 111.981 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.06 -173.45 25.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.189 -1.005 . . . . 1.0 111.965 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.0 tp -139.15 131.33 28.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.849 0.357 . . . . 1.0 111.149 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.94 137.86 34.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.9 p -150.91 132.76 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.572 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 p -116.02 145.55 42.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.0 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.402 ' HB3' HG11 ' A' ' 148' ' ' VAL . 99.7 m-70 -132.54 140.31 48.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 1.0 110.975 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 6.5 t60 -147.44 142.75 27.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.757 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.79 67.42 9.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.441 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 120.43 -0.508 . . . . 1.0 112.349 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.826 0.346 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -101.45 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.314 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -68.96 -34.98 76.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.683 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.91 -55.92 16.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.401 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 38.9 mp0 -67.75 -34.1 76.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.0 110.734 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.8 tp -62.28 -31.43 72.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.484 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.93 -52.73 22.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.458 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.0 t -44.86 -45.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.282 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.3 p -75.06 -37.32 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -47.58 -38.1 13.75 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.34 -40.15 74.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.727 -1.124 . . . . 1.0 109.437 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.9 tt -54.34 -30.91 53.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.64 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.66 -36.02 67.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.637 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -55.31 -39.57 70.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.717 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -53.75 -53.9 45.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 82.2 t -58.42 -42.28 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.861 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.5 p -51.35 -36.62 43.8 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -77.68 -34.97 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.031 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.5 -46.36 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.047 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 55' ' ' ARG . 14.9 tt -64.08 -33.15 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.19 -55.83 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.875 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.28 -25.72 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.21 59.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.263 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.545 ' OE2' ' CD2' ' A' ' 163' ' ' TRP . 92.0 mt-10 -58.65 -39.96 82.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.198 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.38 -60.06 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.101 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 92.8 p -54.22 -40.72 67.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.348 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.042 -0.98 . . . . 1.0 110.442 179.554 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.916 0.389 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -65.21 -40.57 94.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.321 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.72 -53.7 14.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.846 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -59.23 -34.04 52.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.581 0.585 . . . . 1.0 112.581 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.59 -25.48 59.29 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.553 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -60.08 -54.11 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.951 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.78 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.32 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.2 p -65.71 -46.96 77.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.655 HG12 ' HB2' ' A' ' 68' ' ' ALA . 7.2 t -52.3 -31.45 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.848 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.36 -36.23 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 1.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -58.9 -43.24 90.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.953 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG22 HD22 ' A' ' 187' ' ' LEU . 74.0 t -66.33 -38.77 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.876 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.5 ttt180 -57.31 -52.54 64.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.06 87.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.745 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -79.43 -53.98 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.716 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -76.94 -4.76 45.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.0 110.176 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.12 16.74 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.397 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 51' ' ' VAL . 14.6 t -77.41 145.9 36.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.106 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 70' ' ' GLY . 49.2 p30 -68.46 -10.5 55.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.946 0.721 . . . . 1.0 112.946 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.697 HH21 ' CD2' ' A' ' 169' ' ' HIS . 46.1 ttp180 -164.39 120.59 1.56 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.137 -1.025 . . . . 1.0 113.579 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -140.74 132.52 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 176.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 53.3 pttt -145.69 158.82 43.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.56 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.76 137.56 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.994 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 165' ' ' LEU . 28.4 t80 -119.8 119.1 32.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.07 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -99.52 166.22 11.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.87 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 79.6 t80 -131.55 137.05 48.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 1.0 112.159 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.27 126.39 33.51 Favored Pre-proline 0 C--N 1.334 -0.104 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.07 -25.59 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.737 2.291 . . . . 1.0 112.901 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -76.71 -6.28 51.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.977 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.15 38.0 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.997 -0.62 . . . . 1.0 112.831 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -89.58 143.0 27.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.421 0.611 . . . . 1.0 110.919 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.74 140.95 14.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -128.64 146.86 50.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.248 0.547 . . . . 1.0 112.243 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.02 111.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -100.52 6.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.601 0.593 . . . . 1.0 112.601 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.41 146.99 23.02 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 42.5 tt0 -166.92 128.16 1.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.336 -0.946 . . . . 1.0 113.235 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.12 140.73 43.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.55 HH12 ' C ' ' A' ' 75' ' ' PRO . 5.2 ptm85 -131.37 142.67 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.25 110.4 3.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.456 -1.057 . . . . 1.0 110.456 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.54 -87.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.239 -1.145 . . . . 1.0 110.239 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.9 pt-20 -179.99 26.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.152 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.33 -32.24 73.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 69' ' ' ARG . 12.2 mt -118.23 142.74 31.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' C ' HH12 ' A' ' 69' ' ' ARG . 68.4 Cg_endo -73.85 170.57 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.072 1.848 . . . . 1.0 112.457 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.5 p -93.92 139.35 31.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.176 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -110.34 -3.37 16.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.633 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.17 137.89 55.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.307 0.575 . . . . 1.0 112.282 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.91 82.78 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.5 tp -101.49 122.72 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.887 0.375 . . . . 1.0 110.782 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 81' ' ' THR . 10.1 t -79.05 122.43 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.515 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -105.38 131.11 22.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.37 150.07 22.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.185 1.923 . . . . 1.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -62.62 -23.69 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.828 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.22 -22.68 0.58 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.51 -31.16 63.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 1.0 110.659 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 88' ' ' PRO . 3.5 pt -118.47 100.42 51.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.316 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.3 Cg_exo -44.29 -110.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.487 2.124 . . . . 1.0 112.347 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 84.2 tt0 -149.53 -58.45 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.751 -0.38 . . . . 1.0 111.784 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.56 -40.93 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.77 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.84 90.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.014 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -68.56 -29.7 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.572 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -55.3 -55.63 29.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.226 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.89 -40.16 72.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -57.9 -34.03 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -88.5 -9.8 51.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.103 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tp -107.18 -45.6 4.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.373 0.879 . . . . 1.0 113.373 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -115.39 -1.75 12.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.2 mt-30 28.44 71.64 0.05 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.116 1.154 . . . . 1.0 114.116 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 101' ' ' ARG . 35.4 m -117.53 -47.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.731 HH21 HG22 ' A' ' 154' ' ' VAL . 2.4 mpp_? 62.52 -26.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.143 -1.389 . . . . 1.0 114.354 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 100' ' ' VAL . 11.8 p -56.14 129.48 17.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.445 -0.502 . . . . 1.0 111.788 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.7 mt -105.37 129.94 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.8 p -81.34 168.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -50.08 120.57 4.55 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.289 -177.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 106' ' ' VAL . 24.0 t -57.6 -14.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.741 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.23 -36.56 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.914 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.79 -14.44 8.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.393 0.616 . . . . 1.0 110.101 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 51.5 59.8 4.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 1.0 113.409 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 m -92.09 137.57 32.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -126.63 135.45 51.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 45.6 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-N 114.126 -1.397 . . . . 1.0 107.402 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.487 HH21 ' HB3' ' A' ' 98' ' ' ALA . 19.9 mmt-85 . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.691 0.282 . . . . 1.0 110.28 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.26 149.45 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.495 2.13 . . . . 1.0 111.864 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 140' ' ' VAL . 19.0 m -100.8 148.76 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 1.0 111.416 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -87.73 154.89 53.39 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.909 -178.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -50.38 -21.28 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.268 1.979 . . . . 1.0 111.279 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.63 -39.8 30.68 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.524 ' ND1' ' CG1' ' A' ' 135' ' ' VAL . 51.4 t-80 -81.52 -40.48 23.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.666 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 135' ' ' VAL . 3.1 m -52.07 -43.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.357 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 140' ' ' VAL . 79.8 t60 -67.48 -43.99 79.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.256 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -43.3 -46.77 6.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.488 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 143' ' ' LEU . 83.5 mt -72.74 -43.84 62.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.574 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.1 tmtm? -60.69 -42.67 97.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.441 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 98.5 p -54.46 -31.32 55.4 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.6 mtt -89.47 -2.03 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.199 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.48 23.41 77.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.256 -0.884 . . . . 1.0 112.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 169' ' ' HIS . 11.5 t -104.09 121.14 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.889 -0.411 . . . . 1.0 109.889 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.87 44.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 t -131.45 167.48 19.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.156 -0.618 . . . . 1.0 111.545 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.2 p -162.47 141.92 9.34 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.137 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 38.3 tp -127.72 110.21 12.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.08 157.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.461 0.648 . . . . 1.0 111.849 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.731 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -153.39 93.95 3.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.311 -176.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.26 120.33 8.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.527 2.818 . . . . 1.0 113.957 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.4 mt -74.79 104.54 5.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.787 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.7 mtp -122.62 146.42 47.46 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.337 -0.545 . . . . 1.0 111.83 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 159' ' ' HIS . 72.0 t60 -126.42 114.17 17.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.019 -1.104 . . . . 1.0 108.019 175.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 158' ' ' HIS . 8.0 m-70 63.29 -125.97 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -95.6 10.73 35.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.876 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 55.3 mt-10 -119.71 153.56 35.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.923 1.082 . . . . 1.0 113.923 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.68 113.91 27.51 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.513 -1.221 . . . . 1.0 108.925 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 89.1 m95 -98.06 -28.64 13.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.916 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.37 -174.38 23.61 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.4 tp -142.46 130.41 21.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 1.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -96.25 140.7 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.4 t -146.2 111.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.394 -0.523 . . . . 1.0 111.531 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.5 t -100.17 139.23 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.013 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.698 ' ND1' ' N ' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -148.79 144.66 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.193 0.521 . . . . 1.0 110.944 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.48 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.8 p-80 -153.97 151.81 29.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.66 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.02 66.68 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.345 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 120.355 -0.538 . . . . 1.0 112.303 179.539 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.48 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 33.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.839 0.352 . . . . 1.0 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.5 t -99.68 146.49 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.272 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.35 -37.69 88.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.655 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.62 -56.16 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.327 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 33.3 mp0 -65.69 -34.09 77.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 1.0 110.639 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.48 -40.01 89.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.463 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.13 -51.0 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.423 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.5 t -46.99 -49.38 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.331 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.2 -37.63 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 43.4 tt0 -45.4 -36.43 4.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.82 -41.7 74.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.383 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.855 HD23 ' O ' ' A' ' 187' ' ' LEU . 5.4 tt -54.73 -33.16 60.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.638 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.16 -40.23 59.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.633 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.5 -38.33 71.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.684 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.94 -53.44 52.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.53 -43.83 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.838 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -51.94 -37.63 53.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.3 mt -78.71 -32.02 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.91 62.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.01 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.8 pp -65.49 -26.47 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.714 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.06 -55.72 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 1.0 109.925 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -56.56 -27.86 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.919 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.64 56.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.301 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.36 -37.41 72.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.13 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.1 mt -68.34 -58.2 4.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.108 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 m -55.15 -42.18 72.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.293 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.402 179.771 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD11 HD12 ' A' ' 195' ' ' ILE . 8.5 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.918 0.39 . . . . 1.0 110.572 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.66 -50.74 42.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.303 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.16 -44.49 95.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -62.59 -36.09 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -77.69 -20.82 53.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.446 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.505 ' O ' HG12 ' A' ' 39' ' ' VAL . 77.4 mtp180 -73.05 -33.71 65.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.639 -0.424 . . . . 1.0 109.972 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -33.62 28.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.36 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 2.1 t -70.74 -45.11 65.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.573 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.1 p -56.72 -36.55 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.839 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.1 mt-10 -75.46 -38.05 59.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 1.0 110.81 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.24 -51.12 65.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.966 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.28 -50.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.6 tmm_? -49.68 -41.63 43.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.9 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -35.79 73.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -79.64 -47.37 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 mt -76.53 -6.37 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.027 0.441 . . . . 1.0 110.177 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.62 16.46 0.19 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.462 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.5 m -74.92 144.82 43.1 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.4 m-20 -62.4 -27.47 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.759 ' H ' HG22 ' A' ' 48' ' ' THR . 59.9 ttt85 -153.54 121.56 6.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 119.127 -1.029 . . . . 1.0 113.562 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.34 134.43 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -146.01 160.26 42.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.577 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.9 134.97 32.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.004 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.9 t80 -119.15 118.55 31.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.021 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -99.03 165.72 11.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -132.08 136.17 46.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 1.0 112.155 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.69 129.68 24.89 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.714 -0.675 . . . . 1.0 109.341 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.59 -29.31 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.684 2.256 . . . . 1.0 112.933 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -72.72 -17.66 61.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.948 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.89 -15.24 12.49 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.839 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -84.93 141.85 30.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.375 0.588 . . . . 1.0 110.957 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.73 139.69 13.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.3 p -125.3 144.87 50.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.207 0.527 . . . . 1.0 112.312 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.33 116.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 p -110.09 2.75 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.98 145.91 24.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' CD ' HH22 ' A' ' 50' ' ' ARG . 35.0 tt0 -165.78 127.48 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.37 -0.932 . . . . 1.0 113.233 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -110.06 135.21 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.502 HH22 ' CB ' ' A' ' 72' ' ' GLU . 7.6 ptm180 -125.49 142.15 51.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.533 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.36 104.36 2.71 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.469 -1.052 . . . . 1.0 110.469 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.51 -89.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' CB ' HH22 ' A' ' 69' ' ' ARG . 22.2 pt-20 -177.31 29.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.153 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -66.61 -54.26 25.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.47 144.68 28.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.804 -1.184 . . . . 1.0 107.804 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.03 166.83 28.97 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.019 1.813 . . . . 1.0 112.58 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 t -92.21 136.7 32.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.096 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.751 ' H ' HH22 ' A' ' 50' ' ' ARG . 59.0 mt -111.24 -3.24 15.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.618 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.6 tp -55.77 139.83 44.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.287 0.565 . . . . 1.0 112.335 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -3.2 84.59 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.6 tp -101.48 128.62 47.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 1.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -85.16 122.79 29.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.491 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -104.82 132.88 20.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.283 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.74 151.21 28.08 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.134 1.889 . . . . 1.0 111.714 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.4 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.799 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.64 -22.73 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -55.26 -31.08 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.51 132.88 21.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.246 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 60.0 Cg_endo -80.55 -119.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.54 2.16 . . . . 1.0 112.313 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 86.4 tt0 -139.78 -69.0 0.42 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.823 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.62 -40.49 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.804 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.53 62.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -62.29 -31.24 71.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.572 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.4 -48.08 81.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 133' ' ' ARG . 63.9 mt -54.69 -39.1 67.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.824 -0.351 . . . . 1.0 110.529 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -61.1 -32.86 72.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -88.19 -12.59 43.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.109 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 tp -105.54 -46.97 4.04 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.336 0.865 . . . . 1.0 113.336 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.72 -1.15 13.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' ALA . 91.8 mt-30 27.58 65.61 0.09 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.97 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 33.8 m -97.48 -46.37 12.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.374 -2.454 . . . . 1.0 104.374 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.97 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 0.4 OUTLIER 57.83 55.36 5.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.139 -1.392 . . . . 1.0 114.208 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' C ' HD12 ' A' ' 103' ' ' ILE . 62.9 t -148.88 133.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.833 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.22 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.43 168.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' OD2' ' OE2' ' A' ' 107' ' ' GLU . 13.2 t0 -53.28 118.38 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.326 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 140' ' ' VAL . 24.4 t -55.46 -12.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.76 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 14.0 pt-20 -87.59 -38.36 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.846 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -57.56 -13.62 4.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.513 0.673 . . . . 1.0 110.211 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 50.84 56.31 8.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.958 -1.019 . . . . 1.0 113.399 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 m -94.51 134.15 37.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.34 -2.096 . . . . 1.0 105.34 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -129.44 142.21 50.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 114.963 1.468 . . . . 1.0 114.963 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.8 t . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 114.125 -1.398 . . . . 1.0 107.306 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 134' ' ' PRO . 8.3 mmm180 . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 110.306 -0.257 . . . . 1.0 110.306 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.456 ' C ' ' O ' ' A' ' 133' ' ' ARG . 2.8 Cg_exo -30.73 147.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.564 2.176 . . . . 1.0 111.753 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 135' ' ' VAL . 29.3 m -94.4 147.8 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 1.0 111.362 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -91.08 144.07 29.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.873 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.38 -27.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.196 1.93 . . . . 1.0 111.279 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.6 t -71.99 -57.5 4.24 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.726 ' CE1' HD13 ' A' ' 143' ' ' LEU . 42.0 t-80 -68.21 -27.83 66.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.688 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 106' ' ' VAL . 37.7 t -51.62 -52.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.323 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.541 ' CD2' ' HG ' ' A' ' 145' ' ' SER . 76.3 t60 -63.58 -41.28 98.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.256 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -45.43 -51.82 10.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.497 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.5 mp -72.07 -49.13 39.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 2.4 tmtt? -57.32 -42.62 82.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.446 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.541 ' HG ' ' CD2' ' A' ' 141' ' ' HIS . 20.9 m -53.65 -32.01 49.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.4 mtt -85.61 -2.48 58.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 1.0 109.188 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.88 24.24 74.29 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.314 -0.857 . . . . 1.0 112.353 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.553 HG21 ' ND1' ' A' ' 169' ' ' HIS . 3.2 m -106.66 123.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.27 -35.18 55.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -132.75 170.71 14.86 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.545 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.528 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.1 t -162.0 139.71 8.72 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.062 0.458 . . . . 1.0 112.158 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.32 138.96 50.4 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.8 m -133.61 157.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.496 0.665 . . . . 1.0 111.828 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.575 HG11 ' CB ' ' A' ' 188' ' ' ALA . 73.0 t -157.56 91.57 2.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.268 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.14 115.73 2.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.575 2.85 . . . . 1.0 113.931 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.98 105.7 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.825 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.6 ptm -131.15 147.43 52.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.22 0.533 . . . . 1.0 111.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.436 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.2 t60 -122.67 115.66 22.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 8.9 t60 64.77 -128.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.466 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 11.8 mm100 -92.48 9.12 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -117.58 152.19 35.64 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.002 1.112 . . . . 1.0 114.002 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.96 116.92 32.84 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 114.498 -1.228 . . . . 1.0 108.873 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.436 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.5 m95 -95.94 -27.81 14.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.06 -170.42 27.91 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.247 -0.978 . . . . 1.0 112.029 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -141.38 131.91 25.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 1.0 111.19 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -96.02 141.55 29.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.92 135.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.566 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.6 m -121.15 150.61 41.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.027 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.553 ' ND1' HG21 ' A' ' 148' ' ' VAL . 92.5 m-70 -147.74 146.82 29.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.121 0.486 . . . . 1.0 111.005 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 17.0 t60 -156.36 152.46 27.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.408 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -84.66 65.02 8.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 1.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.314 -179.54 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.829 0.347 . . . . 1.0 110.758 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.2 m -95.22 150.35 20.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.19 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.6 -40.81 96.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.666 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.02 -54.9 35.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.405 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -66.97 -32.25 73.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 1.0 110.709 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.29 -38.22 76.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.507 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.23 -51.52 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.406 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.7 t -43.17 -48.79 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.8 m -74.63 -37.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.51 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 56.2 tt0 -47.76 -37.44 13.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.76 -40.2 63.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.393 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 48.8 tp -54.69 -32.88 60.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.682 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.575 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.26 -34.93 68.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.645 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.24 -39.15 69.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.794 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.96 -53.76 44.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -58.21 -41.86 81.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.176 -0.92 . . . . 1.0 109.825 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.0 p -51.71 -35.76 44.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 84.3 mt -78.29 -34.26 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.038 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.98 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.127 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.562 HD12 HD11 ' A' ' 31' ' ' LEU . 8.3 tp -63.56 -31.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.46 -56.96 4.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.873 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -55.41 -27.14 45.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.64 -34.53 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.301 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.402 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.7 tt0 -57.15 -39.98 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.101 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.2 mp -67.82 -56.07 10.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.05 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.9 m -51.53 -41.49 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 1.0 110.311 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.472 ' CD2' HD12 ' A' ' 195' ' ' ILE . 5.8 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 1.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.3 -43.17 99.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.256 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -69.1 -53.74 18.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . 28.4 mm -55.83 -46.74 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.7 -23.36 66.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.526 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.9 ttm180 -61.42 -36.02 79.16 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.639 -0.425 . . . . 1.0 109.993 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.44 -25.18 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.302 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.9 p -76.54 -47.0 24.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.546 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -52.79 -37.95 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.883 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 pt-20 -79.08 -32.36 44.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.91 -52.9 62.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.952 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.7 p -64.22 -44.4 97.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.902 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.6 tmm_? -48.98 -44.47 40.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.74 75.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -80.64 -50.66 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.751 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' THR . 1.9 tp -77.13 -8.16 57.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.081 0.467 . . . . 1.0 110.208 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 45.39 17.46 0.13 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.402 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 HG13 ' A' ' 51' ' ' VAL . 9.3 t -75.71 145.39 40.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.029 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.2 m-20 -56.47 -34.75 67.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.891 0.701 . . . . 1.0 112.891 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -150.66 126.83 10.57 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.204 -0.998 . . . . 1.0 113.523 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.534 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -141.77 130.43 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.939 -1.134 . . . . 1.0 107.939 176.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -144.35 161.26 39.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.58 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.81 133.45 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.055 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 72.1 t80 -118.14 117.42 29.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.019 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -100.81 169.07 9.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.5 t80 -133.9 138.66 45.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.161 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.4 m-20 -102.23 126.66 32.74 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.283 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.6 -27.09 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.722 2.281 . . . . 1.0 112.89 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.3 -9.68 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.004 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.79 21.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.868 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.53 139.77 32.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.308 0.554 . . . . 1.0 110.932 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -116.1 134.09 11.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.379 -1.088 . . . . 1.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -125.89 144.84 50.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.282 0.563 . . . . 1.0 112.229 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.09 126.2 61.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -113.1 4.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.31 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.7 tt0 -166.29 127.98 1.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.347 -0.941 . . . . 1.0 113.16 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.98 131.2 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -118.5 138.39 52.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.544 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.9 95.08 1.12 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.61 -89.21 0.05 OUTLIER Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.194 -1.162 . . . . 1.0 110.194 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.66 36.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.77 -0.372 . . . . 1.0 111.116 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -73.96 -54.38 8.04 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.0 mt -93.74 146.42 31.71 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.0 167.18 27.82 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.004 1.803 . . . . 1.0 112.518 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.5 p -88.14 139.51 30.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.108 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.606 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 34.8 mt -113.21 -2.45 14.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.593 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 45.1 tp -60.18 140.61 56.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.346 0.593 . . . . 1.0 112.25 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -4.27 86.23 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.391 -0.822 . . . . 1.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.6 mt -99.89 140.0 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 1.0 110.737 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -97.59 121.79 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.458 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 7.4 m-85 -106.74 131.41 21.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.26 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.68 152.55 29.35 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.145 1.897 . . . . 1.0 111.658 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.57 -20.98 66.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.773 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.62 -24.24 0.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.8 m-20 -53.39 -27.79 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 1.0 110.551 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.9 mt -120.98 132.34 24.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.59 -116.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.538 2.159 . . . . 1.0 112.329 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -126.09 -75.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.815 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -42.65 -37.1 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.775 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.9 -48.63 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -60.27 -32.09 70.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.519 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' LEU . 79.9 mtp180 -58.5 -46.2 87.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' GLN . 68.2 mt -56.26 -35.99 68.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.584 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 100' ' ' VAL . 8.7 m-85 -63.22 -42.8 99.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -87.43 -17.18 32.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.076 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.0 tp -106.7 -48.1 3.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -119.18 -7.47 10.29 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.583 0.957 . . . . 1.0 113.583 -175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 101' ' ' ARG . 92.2 mt-30 51.74 67.26 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 133' ' ' ARG . 35.2 m -69.2 63.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 99' ' ' GLN . 32.2 ptt180 -66.08 14.76 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.026 -1.443 . . . . 1.0 114.29 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' C ' HD12 ' A' ' 103' ' ' ILE . 2.0 t -147.63 128.08 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.488 -0.485 . . . . 1.0 111.758 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.6 mp -112.38 129.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.97 169.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.263 0.838 . . . . 1.0 113.263 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.69 120.85 5.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.304 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 106' ' ' VAL . 82.3 t -59.68 -15.39 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.806 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' GLN . 18.5 pt-20 -84.87 -38.25 19.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.866 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.89 3.03 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.378 0.609 . . . . 1.0 110.096 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.607 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 35.89 59.49 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.046 -0.979 . . . . 1.0 113.384 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 t -92.66 134.76 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -126.09 139.74 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.104 -1.407 . . . . 1.0 107.377 177.447 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.547 ' HB2' HG11 ' A' ' 100' ' ' VAL . 35.4 ttt85 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.699 0.285 . . . . 1.0 110.27 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.6 156.35 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 C-N-CA 122.601 2.201 . . . . 1.0 111.758 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 139' ' ' HIS . 27.1 m -99.39 140.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.027 0.442 . . . . 1.0 111.341 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 139' ' ' HIS . 3.5 m-20 -94.93 148.2 34.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.913 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -38.36 -26.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.215 1.943 . . . . 1.0 111.237 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -76.19 -47.22 24.91 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.3 t-80 -76.12 -28.81 57.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.653 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -50.56 -47.9 27.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.403 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 145' ' ' SER . 80.2 t60 -65.59 -42.16 92.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -45.93 -56.07 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.453 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 143' ' ' LEU . 50.7 mt -72.12 -50.44 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 44.3 tptt -57.56 -43.32 84.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.415 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' HIS . 33.9 t -53.78 -34.18 58.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.238 -0.652 . . . . 1.0 109.238 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.1 mtt -84.3 -7.33 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.2 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.45 23.87 76.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.9 122.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.97 31.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 151' ' ' SER . 1.5 t -142.98 170.42 15.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.573 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 30.9 t -162.04 140.31 9.04 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.205 -0.452 . . . . 1.0 112.173 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 152' ' ' LEU . 62.2 tp -114.64 116.36 28.61 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -117.07 158.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.447 0.641 . . . . 1.0 111.791 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 79.5 t -155.65 95.24 2.47 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.363 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.02 113.46 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.558 2.839 . . . . 1.0 113.928 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.2 106.62 5.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 17.1 ptm -133.57 146.41 50.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.917 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 78.5 t60 -117.68 115.64 25.46 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 34.0 m-70 59.1 -123.53 1.25 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -93.48 8.56 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.63 149.71 39.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.983 1.105 . . . . 1.0 113.983 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.0 tp -107.54 115.92 31.01 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.545 -1.207 . . . . 1.0 108.857 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 95.4 m95 -96.65 -30.41 13.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.965 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.56 -170.14 24.77 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.205 -0.998 . . . . 1.0 111.937 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -138.18 128.49 26.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 1.0 111.16 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -92.09 138.01 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 10.8 p -149.58 135.3 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.593 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 48' ' ' THR . 12.3 t -117.36 146.15 43.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.049 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.508 ' CE1' ' OG ' ' A' ' 151' ' ' SER . 78.1 m-70 -143.68 141.43 30.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 1.0 111.043 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -152.72 151.88 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.69 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.94 9.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.583 -0.28 . . . . 1.0 111.489 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.467 0.388 0 C-N-CA 120.319 -0.552 . . . . 1.0 112.302 179.307 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 1.0 110.748 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -93.19 143.12 26.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.284 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -62.14 -39.51 92.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.33 -54.95 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.61 -0.268 . . . . 1.0 111.366 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.63 -32.39 73.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.974 0.416 . . . . 1.0 110.765 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.64 -42.71 88.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.86 -50.85 70.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.45 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.19 -48.42 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.24 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -74.03 -39.23 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.422 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 7.3 tt0 -46.18 -35.57 5.22 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.3 tp -71.44 -38.37 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.685 -1.143 . . . . 1.0 109.35 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 9.8 tp -56.28 -31.04 63.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.686 . . . . 1.0 109.631 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.402 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.28 -36.41 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.602 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -59.57 -38.75 81.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.747 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -52.74 -55.15 24.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.82 -40.5 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.904 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 157' ' ' MET . 6.1 t -52.02 -35.53 47.24 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.2 mt -79.12 -36.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.081 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -47.22 63.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.062 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 31' ' ' LEU . 2.8 tp -61.0 -33.48 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -75.51 -53.9 7.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.967 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -55.34 -28.31 52.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -34.86 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.294 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -56.51 -40.25 74.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.198 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.6 mp -68.29 -56.59 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.172 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.4 m -58.32 -45.59 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 1.0 110.292 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.427 179.638 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 202' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.912 0.386 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.46 -50.55 73.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.317 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.77 -48.6 79.95 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.675 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -62.54 -29.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' THR . 96.6 mt -77.85 -20.93 52.2 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.4 mtp180 -72.44 -34.16 67.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.032 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.19 31.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.349 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 35' ' ' LEU . 2.5 t -74.29 -44.87 50.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.55 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.2 p -55.69 -36.02 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.59 -36.86 68.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.021 0.438 . . . . 1.0 110.872 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.55 -52.15 48.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.979 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.15 -51.22 75.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -49.17 -43.93 42.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.21 -47.43 14.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.91 -6.62 53.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.76 16.67 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.714 -0.676 . . . . 1.0 112.458 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -75.01 144.66 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.391 -0.524 . . . . 1.0 110.083 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.0 m-20 -57.21 -34.29 68.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.651 ' H ' HG22 ' A' ' 48' ' ' THR . 29.5 ttm180 -149.55 124.14 9.75 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.212 -0.995 . . . . 1.0 113.526 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 11.9 t -135.21 131.57 52.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -143.74 152.04 40.77 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.569 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.9 t -98.46 139.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.983 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.0 t80 -124.76 121.63 35.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.001 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -99.95 171.78 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.86 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -134.12 138.19 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.558 -0.457 . . . . 1.0 112.15 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 m-20 -104.81 149.33 37.39 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.269 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.21 -26.64 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.741 2.294 . . . . 1.0 112.946 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -76.54 -3.73 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.055 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.88 -10.29 57.13 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.032 -0.604 . . . . 1.0 112.811 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 95.9 m-70 -90.42 147.06 23.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.338 0.569 . . . . 1.0 110.941 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . -130.12 151.41 19.4 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -131.3 149.69 52.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.256 0.55 . . . . 1.0 112.274 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.73 115.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.023 -1.103 . . . . 1.0 108.023 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.69 -2.41 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.635 0.606 . . . . 1.0 112.635 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.15 20.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.7 tt0 -167.41 127.14 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.332 -0.947 . . . . 1.0 113.159 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 142.05 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.119 -1.067 . . . . 1.0 108.119 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' O ' ' NH2' ' A' ' 43' ' ' ARG . 35.9 ptt-85 -132.87 141.96 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.544 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.33 111.54 3.7 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.363 -1.095 . . . . 1.0 110.363 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.32 40.05 3.41 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.309 -1.116 . . . . 1.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 48.53 26.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.119 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -54.13 -56.34 19.05 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 10.7 mt -93.76 152.03 40.38 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.542 ' C ' HH22 ' A' ' 50' ' ' ARG . 56.4 Cg_endo -69.58 156.97 62.36 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.114 1.876 . . . . 1.0 112.573 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -76.44 113.98 14.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.611 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 56.5 mt -87.39 -6.76 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.595 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.2 tp -60.25 139.98 57.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.305 0.574 . . . . 1.0 112.209 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.82 -3.51 84.84 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.8 mt -99.58 136.61 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 1.0 110.737 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 81' ' ' THR . 15.4 t -94.3 120.62 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.482 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' GLY . 7.3 m-85 -108.73 133.26 20.71 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.283 178.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 149.29 34.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.147 1.898 . . . . 1.0 111.719 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.34 -25.63 64.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.779 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.01 -20.95 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ALA . 32.6 t70 -51.78 -23.38 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.0 110.608 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 87' ' ' ILE . 29.4 mt -127.15 132.73 24.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.58 -108.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.53 2.154 . . . . 1.0 112.319 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -142.58 -72.46 0.31 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.1 pt-20 -41.42 -43.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.721 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -63.65 -49.48 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -58.23 -29.08 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -55.81 -47.63 76.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.218 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 94' ' ' LEU . 8.4 mp -54.45 -38.68 66.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.572 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.637 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 7.4 m-85 -60.03 -24.99 64.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.227 0.537 . . . . 1.0 109.572 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 97' ' ' LEU . 60.5 mtp85 -94.74 -19.02 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.123 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.0 mp -109.5 -45.51 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.03 -11.08 15.37 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.581 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 82.7 mt-30 25.35 70.77 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.082 1.141 . . . . 1.0 114.082 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.711 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -141.77 -55.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 104.44 -2.43 . . . . 1.0 104.44 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.711 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.6 mmp_? 52.84 103.85 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.038 -1.437 . . . . 1.0 114.297 173.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.2 m -144.77 132.66 16.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.768 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 135' ' ' VAL . 58.3 mt -108.64 123.86 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.71 168.08 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.58 120.43 5.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.242 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -56.73 -10.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -86.61 -37.08 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.39 -17.84 55.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.372 0.606 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 53.44 60.43 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.056 -0.974 . . . . 1.0 113.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -93.51 135.16 35.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.0 mtp-105 -130.06 142.44 50.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 1.5 m . . . . . 0 N--CA 1.452 -0.326 0 CA-C-N 114.189 -1.368 . . . . 1.0 107.357 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 15.8 mmm180 . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.69 0.281 . . . . 1.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.479 ' O ' ' OG ' ' A' ' 112' ' ' SER . 73.7 Cg_exo -47.72 145.36 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.536 2.157 . . . . 1.0 111.774 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 139' ' ' HIS . 15.7 t -128.46 135.34 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.994 0.426 . . . . 1.0 111.354 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -44.2 154.73 0.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.883 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -56.32 -7.16 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.243 1.962 . . . . 1.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 136' ' ' ASP . 42.0 t -58.42 -50.58 73.2 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.569 ' ND1' HD12 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -73.32 -27.38 61.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.329 -0.851 . . . . 1.0 110.689 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.433 ' N ' ' CD2' ' A' ' 139' ' ' HIS . 22.3 t -52.01 -54.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 1.0 110.362 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 145' ' ' SER . 10.2 m80 -68.99 -46.06 69.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.215 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -47.43 -55.96 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.48 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.569 HD12 ' ND1' ' A' ' 139' ' ' HIS . 89.1 mt -66.83 -50.48 62.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.514 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 42.7 tptt -57.56 -42.09 82.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 m -54.28 -34.92 61.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mtt -84.73 -3.77 58.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.242 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.97 25.84 70.47 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.261 -0.881 . . . . 1.0 112.324 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 150' ' ' SER . 14.2 t -106.71 114.92 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.011 0.405 . . . . 1.0 109.945 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.78 -30.1 61.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 148' ' ' VAL . 97.4 p -138.67 170.14 16.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.615 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 p -161.85 130.86 4.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.46 114.97 29.23 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.7 p -113.42 157.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.455 0.645 . . . . 1.0 111.853 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.9 t -157.7 124.54 2.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.281 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.33 149.87 22.06 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.602 2.868 . . . . 1.0 113.906 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.52 107.43 15.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.409 -0.814 . . . . 1.0 109.799 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.581 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 81.5 mtp -121.23 140.63 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 111.834 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 71.2 t60 -118.15 113.9 22.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 10.6 t-80 68.08 -129.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 40.0 mt-30 -95.33 8.78 42.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -120.99 159.84 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.963 1.097 . . . . 1.0 113.963 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.71 117.97 34.91 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.543 -1.208 . . . . 1.0 108.896 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 94.0 m95 -96.24 -28.47 14.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.95 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.2 -173.95 26.29 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.215 -0.993 . . . . 1.0 112.006 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -140.99 126.38 18.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 1.0 111.278 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 167' ' ' VAL . 0.6 OUTLIER -95.14 135.61 36.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 1.011 ' N ' HD12 ' A' ' 166' ' ' LEU . 85.3 t -145.55 137.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.567 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.527 ' C ' ' ND1' ' A' ' 169' ' ' HIS . 20.6 m -125.26 144.49 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.608 ' ND1' ' N ' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.33 152.82 36.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 1.0 111.013 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.517 ' NE2' ' OG ' ' A' ' 150' ' ' SER . 1.1 p-80 -158.15 154.08 26.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.03 67.91 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.421 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.348 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.86 0.362 . . . . 1.0 110.789 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -92.31 150.04 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.304 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 179' ' ' GLU . 12.3 pt20 -67.34 -42.94 82.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.625 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.449 ' N ' ' CG ' ' A' ' 178' ' ' GLN . 79.1 mm-40 -61.74 -55.14 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 111.359 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.33 -30.69 71.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 1.0 110.698 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.3 tp -61.72 -34.83 76.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.499 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.49 -53.7 21.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.376 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 49.3 t -44.34 -47.39 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.226 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.24 -37.44 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -48.63 -37.14 17.44 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 21.1 tp -72.79 -40.62 65.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.71 -1.132 . . . . 1.0 109.3 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.22 -32.29 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.633 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.03 -37.24 64.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.671 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -56.8 -41.54 77.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.758 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -52.63 -54.31 34.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.69 -41.55 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.837 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.1 m -50.46 -29.67 10.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.2 mm -77.26 -42.35 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.049 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.05 88.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.1 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.09 -31.31 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.33 -56.29 4.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.864 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -55.04 -28.88 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.56 -34.2 53.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.304 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -58.42 -38.59 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 200' ' ' LEU . 2.4 tt -67.63 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.036 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.3 t -69.77 -55.57 9.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 1.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 31' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.435 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.502 HD23 ' NH1' ' A' ' 55' ' ' ARG . 61.0 tp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.903 0.382 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -51.86 -49.5 62.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.22 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.43 -46.56 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 mp -59.9 -40.03 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.97 -22.04 58.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.693 -0.403 . . . . 1.0 111.504 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.1 ttm-85 -68.57 -36.77 79.22 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.652 -0.419 . . . . 1.0 109.991 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.01 -29.3 39.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.369 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.1 p -71.14 -48.39 52.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 36' ' ' ARG . 2.8 p -54.05 -35.16 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.842 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.12 -39.89 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.88 -40.65 98.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.932 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.32 -51.21 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.867 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HD3' ' HB1' ' A' ' 68' ' ' ALA . 23.4 ttp85 -50.78 -44.94 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.909 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.4 79.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.848 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -79.56 -51.44 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.751 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.11 -6.51 53.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.009 0.433 . . . . 1.0 110.081 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.1 16.99 0.54 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.695 -0.684 . . . . 1.0 112.45 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -73.73 141.66 46.34 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 70' ' ' GLY . 78.9 m-20 -60.13 -29.21 68.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 48' ' ' THR . 59.8 ttp180 -154.4 119.07 4.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 119.17 -1.012 . . . . 1.0 113.578 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.85 136.09 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -145.63 160.87 41.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.41 -0.516 . . . . 1.0 111.579 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.9 t -97.76 137.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.999 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.9 t80 -121.29 119.35 31.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 1.0 111.031 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' NH1' HD23 ' A' ' 31' ' ' LEU . 63.8 mtm180 -99.97 170.47 8.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 6.7 t80 -134.96 137.61 43.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.061 0.458 . . . . 1.0 112.172 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -103.14 148.59 35.87 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.325 179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.92 -23.87 67.95 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.739 2.293 . . . . 1.0 112.902 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.61 -2.9 41.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.27 -12.71 51.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.954 -0.641 . . . . 1.0 112.876 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -88.79 146.2 25.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.326 0.563 . . . . 1.0 110.95 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -125.35 145.58 15.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.467 -1.053 . . . . 1.0 110.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -128.36 146.96 50.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.291 0.567 . . . . 1.0 112.341 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.1 118.2 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 65' ' ' VAL . 8.6 p -115.12 9.2 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.9 142.8 23.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 48.9 tt0 -165.99 126.67 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.368 -0.933 . . . . 1.0 113.181 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.66 140.66 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 36.4 ptt85 -132.2 143.38 49.91 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.203 -0.599 . . . . 1.0 111.539 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.84 106.94 3.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.366 -1.094 . . . . 1.0 110.366 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 55.2 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 70' ' ' GLY . 44.7 tt0 -176.94 35.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.089 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -72.94 -51.98 16.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -95.07 121.16 63.05 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 107.803 -1.184 . . . . 1.0 107.803 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.39 162.92 11.23 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.054 1.836 . . . . 1.0 112.557 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.1 t -83.83 135.16 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.3 mt -109.64 -7.66 15.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.592 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 tp -49.4 138.06 13.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.347 0.594 . . . . 1.0 112.288 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.54 -4.04 79.34 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.063 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -98.22 115.22 27.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 1.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.617 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -78.8 126.41 30.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.445 -178.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 80' ' ' LEU . 61.5 m-85 -108.26 139.82 21.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.82 152.28 19.28 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.131 1.887 . . . . 1.0 111.675 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -59.8 -26.45 65.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.819 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.05 -21.7 1.05 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 49.0 p-10 -58.0 -29.67 65.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.685 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.4 mm -110.17 99.8 41.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.228 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.7 Cg_exo -48.41 -126.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.091 . . . . 1.0 112.3 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.79 -60.64 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.811 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.59 -41.02 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.758 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.96 99.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 1.0 110.932 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.685 ' HE ' HG21 ' A' ' 87' ' ' ILE . 34.9 ttm180 -63.82 -28.86 70.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.591 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 97' ' ' LEU . 31.9 mmt180 -56.73 -53.77 53.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.286 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ALA . 32.3 mt -54.02 -36.01 62.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.651 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -66.49 -35.95 81.55 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -85.05 -16.15 41.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.114 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.1 mp -106.04 -42.84 4.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.25 -4.58 13.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.527 0.936 . . . . 1.0 113.527 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.1 mt-30 27.93 69.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.05 1.13 . . . . 1.0 114.05 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 58.3 t -110.73 -50.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.417 -2.438 . . . . 1.0 104.417 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.588 ' HE ' ' C ' ' A' ' 100' ' ' VAL . 10.5 mtm180 63.72 72.02 0.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.088 -1.414 . . . . 1.0 114.269 172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.597 ' C ' HD12 ' A' ' 103' ' ' ILE . 87.7 t -152.1 133.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.782 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -107.41 127.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 105' ' ' ASP . 12.7 p -83.01 167.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.266 0.839 . . . . 1.0 113.266 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.651 ' N ' HG22 ' A' ' 104' ' ' VAL . 5.9 m-20 -54.62 120.03 6.12 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.315 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.53 -10.99 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.771 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 17.4 pt-20 -85.38 -40.42 16.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.876 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.23 -12.61 3.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.433 0.635 . . . . 1.0 110.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 49.4 52.0 15.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.051 -0.977 . . . . 1.0 113.396 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.6 m -94.44 136.56 34.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -128.12 141.71 51.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.432 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 4.2 t . . . . . 0 N--CA 1.452 -0.338 0 CA-C-N 114.098 -1.41 . . . . 1.0 107.323 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.06 142.86 7.92 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.56 2.174 . . . . 1.0 111.768 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -107.26 117.54 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.016 0.436 . . . . 1.0 111.312 -177.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -39.85 153.95 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.947 177.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -56.96 -20.43 36.58 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.237 1.958 . . . . 1.0 111.233 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.6 t -65.79 -46.97 76.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.017 -0.734 . . . . 1.0 109.017 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.806 ' ND1' ' C ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -74.7 -27.94 60.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.632 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.48 -54.72 13.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.318 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -65.93 -44.48 84.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.279 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -44.49 -51.69 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.482 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.78 -47.03 50.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.522 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.8 OUTLIER -59.45 -42.06 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.503 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.0 p -53.77 -30.65 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.6 mtt -86.91 -0.47 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.238 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.97 24.41 76.48 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.22 -0.9 . . . . 1.0 112.36 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 150' ' ' SER . 11.4 t -106.9 122.57 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.15 -26.27 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.1 p -142.58 171.87 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.573 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.02 136.78 12.4 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.51 136.23 52.28 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -135.02 155.41 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.436 0.636 . . . . 1.0 111.845 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 153' ' ' VAL . 65.4 t -157.67 90.0 2.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.22 140.24 52.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.552 2.835 . . . . 1.0 113.923 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.1 mt -98.52 105.65 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.799 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 81.3 mtp -119.42 141.13 49.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.553 . . . . 1.0 111.818 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.442 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 84.5 t60 -116.61 112.03 20.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 175.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.431 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 4.9 t60 62.86 -123.7 0.63 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.431 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 17.2 pt20 -94.64 7.72 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 162' ' ' LEU . 26.4 tp10 -117.23 153.4 32.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 161' ' ' GLU . 6.5 tt -107.72 117.36 33.9 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 114.55 -1.205 . . . . 1.0 108.816 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.0 m95 -96.97 -27.87 14.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.858 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.06 23.53 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -141.59 127.81 19.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.0 111.263 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.3 tp -92.92 134.06 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.55 134.84 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.578 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.78 142.43 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.99 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -134.56 132.17 38.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 1.0 110.96 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 19.0 t60 -168.53 161.41 11.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.766 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.709 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -46.22 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.428 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.661 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 120.391 -0.523 . . . . 1.0 112.343 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.856 0.36 . . . . 1.0 110.795 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -106.43 143.95 33.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.254 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.79 -28.3 66.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.617 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.14 -54.58 27.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.594 -0.275 . . . . 1.0 111.325 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.58 -33.88 76.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.944 0.402 . . . . 1.0 110.688 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.66 -39.99 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.501 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.54 ' OE1' ' NE2' ' A' ' 185' ' ' GLN . 14.0 mm100 -61.98 -51.96 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.352 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.1 t -45.27 -48.95 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 187' ' ' LEU . 63.9 t -74.27 -38.71 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.542 ' CD ' HH12 ' A' ' 101' ' ' ARG . 7.2 tt0 -45.93 -36.02 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.59 -39.68 67.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.764 -1.107 . . . . 1.0 109.333 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 184' ' ' VAL . 35.0 tp -54.95 -32.92 61.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.85 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.655 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -56.91 -39.36 74.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.697 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -53.38 -53.91 44.37 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.2 t -56.7 -43.67 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.36 -0.836 . . . . 1.0 109.869 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -51.7 -37.43 50.73 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.2 mt -78.39 -32.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.025 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.36 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 1.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.6 pp -66.62 -26.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.52 -55.71 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.846 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.26 -26.88 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.95 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.48 -35.73 58.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -56.94 -39.34 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.221 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.5 tp -66.97 -56.31 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.119 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.9 m -47.16 -39.16 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 1.0 110.307 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.081 -0.961 . . . . 1.0 110.47 179.78 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD21 ' NH2' ' A' ' 55' ' ' ARG . 4.4 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.823 0.344 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 40.6 p-10 -65.33 -37.88 88.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.313 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.0 mt-30 -73.3 -53.71 10.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.799 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -57.2 -40.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 69.9 mt -71.29 -33.28 69.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.631 -0.427 . . . . 1.0 111.589 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -49.53 -37.96 28.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.634 -0.426 . . . . 1.0 109.993 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.16 -26.4 52.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.35 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.5 p -74.85 -44.33 49.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.557 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 53' ' ' VAL . 56.8 t -59.13 -38.89 76.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.548 . . . . 1.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.27 -38.22 56.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.55 -49.35 75.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.995 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.92 -47.99 90.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.942 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.2 ttp180 -49.71 -43.99 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.853 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -81.52 -47.95 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.804 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -78.0 -7.08 56.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 1.0 110.084 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 50.18 19.51 2.76 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.668 -0.696 . . . . 1.0 112.494 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.703 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.9 m -76.91 141.9 40.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.065 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.0 m-20 -62.6 -28.45 69.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.703 ' H ' HG22 ' A' ' 48' ' ' THR . 60.5 ttp180 -152.98 124.87 7.88 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.145 -1.022 . . . . 1.0 113.54 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -146.7 136.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -146.81 162.45 38.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.566 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 39' ' ' VAL . 70.6 t -97.71 136.47 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.035 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -122.89 121.67 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.024 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.854 ' NH2' HD11 ' A' ' 195' ' ' ILE . 36.6 ttm-85 -101.47 168.93 9.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.85 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' N ' ' CG ' ' A' ' 55' ' ' ARG . 71.0 t80 -131.2 136.7 48.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.053 0.454 . . . . 1.0 112.124 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.5 148.74 35.63 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.379 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.69 -22.53 64.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.728 2.286 . . . . 1.0 112.94 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -79.69 -3.09 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.544 -0.463 . . . . 1.0 111.041 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.7 -10.42 52.86 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.815 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -90.19 145.83 24.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.377 0.588 . . . . 1.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.61 142.92 14.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.3 p -128.39 147.5 50.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.152 0.501 . . . . 1.0 112.346 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.7 t -101.14 121.35 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 m -108.98 1.84 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.468 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.62 149.12 24.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.6 tt0 -166.83 127.18 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.394 -0.922 . . . . 1.0 113.248 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 133.89 54.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.549 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 58.6 mtm180 -117.45 139.74 50.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.22 107.05 2.56 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.32 18.17 0.06 OUTLIER Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.268 -1.133 . . . . 1.0 110.268 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' GLY . 43.6 tt0 70.57 30.91 3.01 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.115 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 36.7 ttm180 -57.83 -59.57 5.03 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.8 164.8 20.67 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.81 171.75 17.43 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.043 1.829 . . . . 1.0 112.533 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -90.42 121.37 32.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -92.76 -11.85 32.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.624 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 tp -50.4 137.23 19.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.17 82.37 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.384 -0.825 . . . . 1.0 111.051 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 81' ' ' THR . 4.3 tt -97.68 115.9 28.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 1.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.625 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.0 t -76.46 122.5 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.465 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.75 132.16 21.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.318 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.11 152.39 27.73 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.195 1.93 . . . . 1.0 111.698 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.36 -21.14 66.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.81 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.73 -22.29 0.14 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.3 m-20 -48.44 -23.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.331 . . . . 1.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.544 ' CD1' HH21 ' A' ' 92' ' ' ARG . 2.9 pt -133.67 142.04 42.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.55 -104.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.525 2.15 . . . . 1.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HA ' HH12 ' A' ' 92' ' ' ARG . 82.3 tt0 -147.64 -64.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 1.0 111.788 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.04 -41.12 46.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.716 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.63 99.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.96 0.41 . . . . 1.0 111.005 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.544 HH21 ' CD1' ' A' ' 87' ' ' ILE . 23.6 ttm105 -64.54 -27.93 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' LEU . 68.7 mtm180 -58.53 -53.56 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.327 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 94' ' ' LEU . 8.4 mp -52.73 -41.33 63.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.55 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 4.2 m-85 -64.1 -35.91 82.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -85.2 -8.96 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.072 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.4 tp -105.86 -43.34 4.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.42 -0.08 12.62 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 98' ' ' ALA . 93.6 mt-30 28.45 68.28 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 t -117.73 -48.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.381 -2.452 . . . . 1.0 104.381 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 101' ' ' ARG . 6.2 mtp180 50.57 76.5 0.15 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.26 171.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' C ' HD12 ' A' ' 103' ' ' ILE . 11.2 m -145.15 139.17 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.757 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.775 HD12 ' N ' ' A' ' 103' ' ' ILE . 2.8 mp -107.24 125.2 63.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 105' ' ' ASP . 24.3 t -83.49 166.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 113.256 0.835 . . . . 1.0 113.256 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.673 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.1 m-20 -48.85 120.32 3.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.252 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.1 m -57.77 -12.18 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.764 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -87.01 -37.33 17.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.46 -16.19 44.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.372 0.606 . . . . 1.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 53.06 60.32 3.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.002 -0.999 . . . . 1.0 113.427 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.1 m -92.89 133.98 35.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -128.35 141.67 51.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 114.073 -1.422 . . . . 1.0 107.298 176.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.487 ' NH1' ' CD2' ' A' ' 94' ' ' LEU . 2.5 mmp_? . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.711 0.291 . . . . 1.0 110.338 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' OG ' ' A' ' 112' ' ' SER . 88.2 Cg_exo -46.0 145.21 5.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.525 2.15 . . . . 1.0 111.797 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.777 HG21 ' ND1' ' A' ' 139' ' ' HIS . 6.5 m -118.1 127.01 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 1.0 111.361 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -43.12 139.39 2.29 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.9 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -39.91 -46.8 3.85 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.163 1.909 . . . . 1.0 111.24 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 9.9 p -43.83 -41.68 5.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.777 ' ND1' HG21 ' A' ' 135' ' ' VAL . 13.1 t-80 -79.94 -38.52 32.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.368 -0.833 . . . . 1.0 110.687 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.6 t -50.9 -50.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.3 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 77.0 t60 -64.13 -39.86 94.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.253 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -43.95 -47.48 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.447 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.78 -45.4 61.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.511 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -60.17 -42.49 95.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.492 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.8 m -54.17 -33.33 57.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.6 mtt -86.99 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.156 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.26 26.16 66.75 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.291 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 169' ' ' HIS . 48.0 t -106.74 120.87 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.33 33.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 172' ' ' GLU . 37.7 m -127.89 153.99 46.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.155 -0.618 . . . . 1.0 111.585 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -143.87 129.55 19.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.052 0.453 . . . . 1.0 112.178 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.96 141.78 50.97 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' CG2' ' A' ' 154' ' ' VAL . 2.3 m -129.65 155.42 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.845 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 2.1 t -150.72 97.82 3.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.891 -1.05 . . . . 1.0 109.287 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.84 139.52 36.65 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.536 2.824 . . . . 1.0 113.889 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.24 104.52 16.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.718 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 88.3 mtp -119.06 141.07 49.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.843 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 84.4 t60 -125.31 112.93 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 158' ' ' HIS . 7.9 t-80 75.08 -135.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.429 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 80.9 mt-30 -96.16 12.38 31.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.412 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 63.7 mt-10 -120.19 161.43 21.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.79 116.83 32.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.544 -1.207 . . . . 1.0 108.851 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.4 m95 -99.04 -29.3 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.847 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.96 179.7 28.31 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.217 -0.992 . . . . 1.0 111.927 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 tp -139.96 130.68 25.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 1.0 111.193 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.9 tp -99.6 145.27 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.1 p -151.62 125.81 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.556 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -110.51 143.25 41.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.049 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.763 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -141.95 143.53 33.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 19.2 t60 -153.29 153.24 32.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.657 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.445 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.59 68.46 9.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.433 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.1 tp10 . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 120.401 -0.52 . . . . 1.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 N--CA 1.461 0.081 0 CA-C-O 120.913 0.387 . . . . 1.0 110.804 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -91.21 143.44 26.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.234 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.57 -55.3 28.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.661 0.267 . . . . 1.0 111.388 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -65.07 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 1.0 110.653 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.71 -30.47 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.576 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -73.88 -52.67 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.406 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.94 -45.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.283 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' LEU . 5.4 p -73.18 -39.38 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -49.8 -36.59 26.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.5 tp -69.88 -31.22 68.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.704 -1.134 . . . . 1.0 109.41 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.6 tt -63.32 -28.17 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.72 70.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.664 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -53.36 -44.61 68.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -52.56 -55.53 21.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.047 -0.724 . . . . 1.0 109.047 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.66 -40.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.903 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.8 m -50.22 -29.13 8.8 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.451 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 11.2 mm -77.28 -48.53 24.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.064 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.63 87.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.084 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.854 HD11 ' NH2' ' A' ' 55' ' ' ARG . 4.0 tp -59.91 -37.48 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 195' ' ' ILE . . . -72.97 -51.64 17.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.848 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 193' ' ' ILE . 2.9 mp0 -55.61 -26.59 44.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.81 55.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -59.08 -41.37 87.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.05 -60.14 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.024 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.2 p -58.97 -43.84 91.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.422 179.793 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 198' ' ' ALA . 32.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.886 0.374 . . . . 1.0 110.555 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.8 p-10 -63.66 -44.63 93.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.251 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 93.8 mt-30 -67.0 -53.19 33.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mt -55.24 -48.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.0 112.629 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.81 -25.25 68.16 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.641 -0.423 . . . . 1.0 111.609 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.562 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -57.42 -36.63 71.59 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.636 -0.426 . . . . 1.0 110.036 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.68 41.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.391 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -73.57 -48.4 33.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.556 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.2 p -53.3 -35.12 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 95.4 mt-10 -77.76 -33.71 52.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.44 -50.51 71.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.978 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.4 p -64.24 -45.56 95.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.91 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' N ' HG13 ' A' ' 42' ' ' VAL . 18.3 ttt-85 -49.09 -46.42 44.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.05 82.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.782 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -78.31 -52.11 9.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.761 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.55 -5.61 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 1.0 110.167 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.75 18.0 0.33 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.599 -0.728 . . . . 1.0 112.399 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -75.86 144.0 41.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 1.0 110.14 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 70' ' ' GLY . 97.4 m-20 -64.29 -26.81 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.87 0.693 . . . . 1.0 112.87 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 48' ' ' THR . 24.4 ttt180 -149.98 121.27 7.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.103 -1.039 . . . . 1.0 113.476 -178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 3.2 t -140.32 130.53 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.957 -1.127 . . . . 1.0 107.957 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -143.33 155.32 44.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.626 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.79 137.44 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.009 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -121.36 119.7 32.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -99.76 170.29 8.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.871 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 48.9 t80 -135.05 141.66 46.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.155 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 4.0 m-20 -104.0 150.47 38.31 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.269 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.49 -29.18 53.31 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.699 2.266 . . . . 1.0 112.901 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.47 -4.99 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.586 -0.446 . . . . 1.0 110.935 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.36 -14.54 36.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.803 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 99.2 m-70 -84.65 143.79 29.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.398 0.599 . . . . 1.0 110.959 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -119.67 139.28 13.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -125.08 143.85 50.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.289 0.566 . . . . 1.0 112.25 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.27 120.16 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.61 3.47 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.52 149.87 24.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 79.2 tt0 -166.15 125.46 1.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.433 -0.907 . . . . 1.0 113.266 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.13 135.86 47.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 7.1 ptp85 -129.78 141.97 50.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.552 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.36 106.32 3.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.454 -1.058 . . . . 1.0 110.454 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.19 -88.55 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.261 -1.136 . . . . 1.0 110.261 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.7 tt0 -177.36 32.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.064 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.57 -33.94 73.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.73 142.63 29.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 64.0 Cg_endo -73.36 170.35 20.1 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.077 1.851 . . . . 1.0 112.535 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 14.9 m -93.53 137.93 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.189 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.536 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.8 mt -109.63 -3.9 16.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.641 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 14.2 tp -56.69 137.75 53.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.278 0.561 . . . . 1.0 112.286 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.97 86.03 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 81' ' ' THR . 2.8 tt -101.61 118.77 37.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.907 0.384 . . . . 1.0 110.746 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -76.69 122.43 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.463 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 m-85 -106.26 133.69 20.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.336 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.7 152.28 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.175 1.917 . . . . 1.0 111.71 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.9 -23.39 67.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.796 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.86 -22.93 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -54.05 -21.72 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.407 ' HB ' HH21 ' A' ' 92' ' ' ARG . 18.1 mt -129.0 132.83 24.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.302 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.17 -107.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.531 2.154 . . . . 1.0 112.341 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.11 -69.09 0.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.815 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -42.34 -42.38 3.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.96 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.407 HH21 ' HB ' ' A' ' 87' ' ' ILE . 35.4 ttm180 -56.44 -30.37 62.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.566 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -57.47 -45.11 85.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.231 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 98' ' ' ALA . 50.5 mt -54.96 -36.68 65.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.582 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.624 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 7.6 m-85 -61.17 -26.53 67.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 97' ' ' LEU . 48.0 mtp85 -93.87 -18.23 22.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.12 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.1 mp -109.44 -46.86 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.374 0.879 . . . . 1.0 113.374 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -107.96 -10.87 15.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -174.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 98' ' ' ALA . 22.3 mt-30 26.12 69.29 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.69 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -137.46 -54.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.69 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.4 mmp_? 49.57 101.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.111 -1.404 . . . . 1.0 114.288 171.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.61 136.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.464 -0.494 . . . . 1.0 111.743 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.8 mt -107.61 123.16 62.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.688 HG12 ' N ' ' A' ' 105' ' ' ASP . 23.4 t -84.17 168.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.688 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.0 m-20 -50.4 118.48 3.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.262 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.9 p -55.54 -11.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.313 -0.858 . . . . 1.0 110.75 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 109' ' ' GLN . 4.8 pt-20 -88.61 -35.86 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.915 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.59 0.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.4 0.619 . . . . 1.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 107' ' ' GLU . 10.1 pt20 35.35 60.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.106 -0.952 . . . . 1.0 113.504 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -93.96 134.99 35.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.384 -2.08 . . . . 1.0 105.384 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -131.09 141.85 50.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 114.184 -1.371 . . . . 1.0 107.354 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.514 HH21 HH22 ' A' ' 101' ' ' ARG . 11.3 tpp180 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.715 0.293 . . . . 1.0 110.336 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 133' ' ' ARG . 3.5 Cg_exo -30.36 143.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.615 2.21 . . . . 1.0 111.774 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.599 HG11 ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -104.8 115.69 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.107 0.479 . . . . 1.0 111.363 -178.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -40.27 147.14 0.38 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.912 178.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.7 Cg_endo -52.86 -12.41 1.94 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.221 1.947 . . . . 1.0 111.258 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.02 -39.32 50.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.599 ' CE1' HG11 ' A' ' 135' ' ' VAL . 3.3 t-80 -83.34 -34.2 25.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.366 -0.834 . . . . 1.0 110.633 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 137' ' ' PRO . 2.9 m -53.94 -45.88 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.299 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.553 ' N ' HG23 ' A' ' 140' ' ' VAL . 84.7 t60 -67.41 -44.92 77.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.197 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -46.59 -51.16 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.47 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.3 -49.22 57.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 147' ' ' GLY . 17.8 tptp -58.0 -40.25 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.449 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.9 m -53.73 -33.47 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.62 0.88 44.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.191 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.62 23.96 75.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.247 -0.888 . . . . 1.0 112.334 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 170' ' ' HIS . 25.3 t -107.46 121.8 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.913 -0.402 . . . . 1.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.72 49.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' HG12 ' A' ' 148' ' ' VAL . 32.4 t -135.53 170.12 16.45 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.112 -0.635 . . . . 1.0 111.593 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.7 t -162.05 139.82 8.72 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 35.9 tp -115.33 133.58 55.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.4 p -132.37 155.58 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.06 -0.656 . . . . 1.0 111.818 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 77.2 t -156.53 109.93 2.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.334 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.62 114.17 3.42 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.634 2.889 . . . . 1.0 113.87 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.51 107.02 7.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.808 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.456 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 17.0 ptm -132.15 144.19 50.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.824 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 70.8 t60 -114.31 114.73 26.33 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 46.8 t-80 61.48 -123.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.507 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 33.3 tt0 -94.04 6.16 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.901 0.334 . . . . 1.0 111.901 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 43.9 mp0 -115.65 149.82 37.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.991 1.108 . . . . 1.0 113.991 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.28 116.83 32.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.562 -1.199 . . . . 1.0 108.912 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -99.22 -30.47 12.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.917 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.26 -174.1 24.76 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.187 -1.006 . . . . 1.0 111.958 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 tp -141.09 131.11 24.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 1.0 111.201 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -93.7 136.21 34.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.56 ' CG1' ' NE2' ' A' ' 169' ' ' HIS . 31.0 t -148.52 122.74 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.527 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -108.09 143.27 37.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.971 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.56 ' NE2' ' CG1' ' A' ' 167' ' ' VAL . 54.3 m-70 -137.03 143.2 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.096 0.474 . . . . 1.0 111.048 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.539 ' O ' HG13 ' A' ' 148' ' ' VAL . 2.5 p-80 -152.95 151.92 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.703 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.56 68.97 9.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.403 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.465 0.324 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.102 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 1.0 110.799 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 t -96.26 139.2 32.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -63.17 -40.34 97.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.671 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -65.49 -55.73 16.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.31 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.89 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 1.0 110.64 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.2 tp -59.56 -40.23 86.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.539 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -60.76 -50.84 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.416 -0.357 . . . . 1.0 111.358 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.39 -47.16 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 75.3 t -73.39 -40.71 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -45.99 -34.83 4.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.67 -38.07 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.404 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 10.9 tp -54.84 -31.36 59.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.698 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.55 70.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.648 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -57.19 -42.1 80.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.72 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -52.7 -55.35 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.136 -0.69 . . . . 1.0 109.136 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.07 -43.17 84.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.826 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 p -52.0 -37.27 52.64 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.1 mt -78.11 -33.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.079 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.71 66.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.037 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.7 pp -67.13 -23.78 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.53 -56.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.794 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.2 -26.9 63.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.909 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -76.41 -36.27 58.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.263 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.2 -38.13 70.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.8 mt -68.08 -55.94 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.055 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.2 p -53.0 -41.16 64.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.281 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.02 -0.99 . . . . 1.0 110.423 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 1.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 65' ' ' VAL . 64.1 t0 -53.6 -53.07 56.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.02 -46.42 90.81 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 38' ' ' THR . 18.4 mm -60.63 -38.98 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.38 -21.15 60.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.555 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -70.32 -40.21 74.31 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.034 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.43 -33.56 62.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.349 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 34' ' ' ILE . 41.2 p -68.17 -46.39 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.573 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 68' ' ' ALA . 5.2 t -56.18 -38.89 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.874 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.64 -37.43 56.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -57.43 -53.14 61.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.951 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 43' ' ' ARG . 10.7 p -63.35 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.896 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.3 ttp-105 -51.13 -47.21 62.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.905 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.71 78.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.4 -50.93 10.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.26 -5.59 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 1.0 110.206 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.3 19.2 1.07 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.442 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.3 m -76.08 141.99 41.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.374 -0.531 . . . . 1.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 70' ' ' GLY . 37.3 p30 -67.8 -24.16 65.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 48' ' ' THR . 71.2 ttt-85 -153.98 120.31 5.44 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.176 -1.01 . . . . 1.0 113.538 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.21 139.18 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' ALA . 28.4 pttt -148.04 160.59 42.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.553 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -99.41 139.15 21.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.078 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 165' ' ' LEU . 16.0 t80 -121.58 120.47 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.01 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' A' ' 55' ' ' ARG . 20.2 ttp-105 -99.43 166.59 11.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 1.0 109.911 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 43.2 t80 -132.36 142.77 49.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.074 0.464 . . . . 1.0 112.117 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 m-20 -105.34 149.88 38.26 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.32 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.78 -30.32 58.95 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.735 2.29 . . . . 1.0 112.896 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.95 -5.43 34.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.607 -0.437 . . . . 1.0 111.022 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.77 -14.24 38.19 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.998 -0.62 . . . . 1.0 112.83 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.64 142.77 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.436 0.618 . . . . 1.0 110.896 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.35 140.17 14.25 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.0 p -127.1 145.71 50.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.242 0.544 . . . . 1.0 112.253 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.5 p -104.54 121.26 56.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 32' ' ' ASP . 1.3 p -115.97 9.01 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -155.71 145.52 21.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.2 tt0 -168.69 129.93 1.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.447 -0.901 . . . . 1.0 113.212 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.36 140.42 44.57 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.39 143.85 50.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.523 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.6 108.19 3.36 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.21 -84.92 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 70' ' ' GLY . 16.1 pt-20 177.89 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.859 -0.337 . . . . 1.0 111.15 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.591 ' NH1' ' NE2' ' A' ' 170' ' ' HIS . 10.4 ptp180 -65.76 -31.6 72.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 12.8 mt -116.3 150.28 45.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 4.8 Cg_exo -78.01 162.88 28.79 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.066 1.844 . . . . 1.0 112.494 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -90.79 113.62 25.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.98 -1.18 57.83 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.554 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.2 tp -52.8 135.63 35.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 1.0 112.216 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 90.89 -1.43 78.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 81' ' ' THR . 3.7 tt -95.22 120.31 35.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 1.0 110.743 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 80' ' ' LEU . 6.2 p -87.75 127.34 35.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.446 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -109.23 139.02 20.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.288 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.67 161.48 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.214 1.943 . . . . 1.0 111.608 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -68.27 -28.87 67.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.781 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.43 -23.43 3.08 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.68 -26.9 68.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 1.0 110.663 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 88' ' ' PRO . 60.8 mt -112.18 99.98 47.95 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.3 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 87' ' ' ILE . 84.2 Cg_exo -49.4 -121.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.584 2.189 . . . . 1.0 112.318 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -145.64 -58.32 0.32 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.8 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -51.3 -42.09 60.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.805 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.85 -49.87 66.61 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -29.92 68.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.534 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.18 -48.27 80.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.278 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HB2' ' HE ' ' A' ' 133' ' ' ARG . 74.2 mt -51.89 -40.2 60.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.652 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.7 -24.91 67.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.484 ' CA ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -90.98 -21.29 21.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.16 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -105.57 -45.94 4.3 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.404 0.89 . . . . 1.0 113.404 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.72 -5.83 16.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' ALA . 96.3 mt-30 24.68 66.87 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 101' ' ' ARG . 3.1 m -108.44 -50.78 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 1.0 104.43 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.832 ' H ' HH22 ' A' ' 133' ' ' ARG . 1.2 mtt180 65.67 68.03 0.48 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.069 -1.423 . . . . 1.0 114.233 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.538 ' H ' HH12 ' A' ' 133' ' ' ARG . 44.6 t -148.92 130.85 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.754 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 139' ' ' HIS . 89.8 mt -110.93 128.51 67.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 105' ' ' ASP . 12.9 t -82.39 168.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 113.307 0.854 . . . . 1.0 113.307 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.655 ' N ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -47.49 117.34 1.76 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.805 -1.088 . . . . 1.0 112.325 -178.52 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.08 -10.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.745 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -87.4 -35.41 18.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.872 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.03 48.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.367 0.603 . . . . 1.0 110.149 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 52.78 59.41 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.974 . . . . 1.0 113.456 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -93.79 138.61 31.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -133.82 144.12 48.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.003 1.483 . . . . 1.0 115.003 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-N 114.127 -1.397 . . . . 1.0 107.404 177.062 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.832 HH22 ' H ' ' A' ' 101' ' ' ARG . 17.8 ttm105 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.765 0.317 . . . . 1.0 110.28 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -44.23 145.79 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.512 2.141 . . . . 1.0 111.833 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 135' ' ' VAL . 12.5 m -122.38 130.07 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.014 0.435 . . . . 1.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -42.47 163.45 0.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.913 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.3 -11.07 17.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.226 1.951 . . . . 1.0 111.257 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.727 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -60.23 -55.42 33.98 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.976 -0.749 . . . . 1.0 108.976 178.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.727 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 18.0 t-80 -72.34 -27.16 62.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.631 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.05 -60.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.335 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -66.1 -41.98 89.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.24 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -42.51 -48.72 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.546 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.697 HD11 ' CE1' ' A' ' 139' ' ' HIS . 30.2 mt -72.08 -47.01 54.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.46 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 147' ' ' GLY . 38.7 tptt -55.99 -42.97 77.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -55.1 -30.2 59.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 41.7 mtt -90.02 -7.98 52.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.118 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 144' ' ' LYS . . . 75.96 28.96 59.7 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.337 -0.847 . . . . 1.0 112.327 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.589 HG11 ' CB ' ' A' ' 169' ' ' HIS . 14.4 t -108.94 124.36 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.03 -31.17 39.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.41 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.6 p -134.12 169.4 17.22 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.594 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -159.06 139.47 12.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.023 0.439 . . . . 1.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.02 141.89 48.3 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -132.96 156.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.418 0.628 . . . . 1.0 111.914 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 153' ' ' VAL . 53.3 t -157.62 98.53 1.91 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.337 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.24 117.74 4.83 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.571 2.848 . . . . 1.0 113.9 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.82 106.3 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.809 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.2 ptm -129.34 143.33 50.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.848 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 70.0 t60 -110.42 113.96 27.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 21.3 m-70 57.97 -119.67 1.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -93.63 2.55 56.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -112.56 150.69 30.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.959 1.096 . . . . 1.0 113.959 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.03 116.84 32.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.491 -1.231 . . . . 1.0 108.867 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -96.96 -28.52 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.921 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.41 -173.81 28.33 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.949 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.0 tp -138.18 133.54 33.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 1.0 111.214 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -99.45 140.03 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.9 p -149.44 111.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.512 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 142.04 31.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.106 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.589 ' CB ' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -146.71 148.51 32.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.141 0.496 . . . . 1.0 111.043 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' HIS . . . . . 0.591 ' NE2' ' NH1' ' A' ' 73' ' ' ARG . 7.0 t60 -152.63 148.57 27.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -72.74 69.11 0.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 120.345 -0.542 . . . . 1.0 112.293 179.603 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.324 . . . . 1.0 110.85 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -94.01 149.3 21.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.291 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -68.93 -40.78 78.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.678 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.87 -55.81 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.366 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.15 -31.34 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 1.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.2 tp -60.82 -38.12 84.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.456 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -63.42 -52.98 59.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.395 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.5 t -43.95 -49.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.317 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.7 m -75.06 -36.28 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLN . . . . . 0.472 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 7.1 tp-100 -46.89 -36.64 7.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.099 -1.075 . . . . 1.0 108.099 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.53 -40.76 66.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.374 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' VAL . 33.9 tp -54.76 -33.1 60.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.645 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.451 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.14 -35.94 61.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.603 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . 0.464 ' O ' ' OG ' ' A' ' 192' ' ' SER . 50.6 t0 -57.37 -41.15 79.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.661 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -52.33 -52.38 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.89 -43.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.888 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.6 p -51.92 -38.07 54.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.65 -32.64 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.027 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -46.13 64.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.117 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.6 pp -66.74 -26.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.43 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -77.03 -56.31 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.946 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.13 -26.77 63.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.869 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.84 -35.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.24 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -56.91 -38.98 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.8 -57.16 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.09 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 t -60.4 -46.08 91.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 1.0 110.321 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.427 179.768 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 195' ' ' ILE . 6.9 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.899 0.381 . . . . 1.0 110.581 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.18 -46.98 65.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -66.01 -47.31 74.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.222 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.87 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -59.68 -41.07 84.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -74.83 -22.33 58.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.586 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.3 ttp180 -66.72 -36.83 83.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.614 -0.434 . . . . 1.0 109.973 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.71 -30.98 41.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.317 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.87 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.0 p -72.39 -48.5 41.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.543 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.3 p -55.29 -33.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.858 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -72.23 -39.13 68.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.63 -40.63 97.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.988 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.25 -52.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 47' ' ' GLY . 31.2 ttp85 -52.2 -43.55 64.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.877 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.66 75.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 1.0 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -81.55 -50.35 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.77 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -77.39 -7.6 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 1.0 110.087 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.91 19.05 1.25 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.413 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.6 m -76.03 142.74 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.047 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.5 m-20 -57.69 -33.28 68.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 48' ' ' THR . 58.1 ttp180 -153.29 120.97 5.98 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 119.128 -1.029 . . . . 1.0 113.536 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.75 135.23 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 9.1 pttp -146.45 162.06 39.07 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.552 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.01 136.78 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.007 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' CD1' HBB2 ' A' ' 203' ' ' CYC . 79.5 t80 -123.4 120.56 33.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.052 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' OG1' ' A' ' 63' ' ' THR . 27.2 ptt180 -101.08 171.98 7.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -134.01 134.19 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 1.0 112.138 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.74 129.32 25.53 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.345 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.47 -25.93 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.739 2.293 . . . . 1.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 -9.82 59.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.984 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.4 36.35 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.816 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -86.72 141.76 28.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.38 0.59 . . . . 1.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.3 145.98 15.95 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.434 -1.067 . . . . 1.0 110.434 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' NE ' ' A' ' 55' ' ' ARG . 28.6 p -129.86 147.88 51.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.25 0.547 . . . . 1.0 112.303 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.06 101.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.36 3.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.18 147.26 24.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.1 tt0 -166.88 126.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.245 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.44 53.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -121.92 141.84 50.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.555 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.93 97.64 1.88 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.47 -90.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.02 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.83 -0.348 . . . . 1.0 111.101 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -70.72 -55.61 8.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.5 mt -92.95 154.48 41.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.92 167.82 23.1 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.099 1.866 . . . . 1.0 112.518 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 p -89.27 132.05 35.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.125 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.09 -4.41 20.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.618 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -59.36 139.89 56.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.35 0.595 . . . . 1.0 112.239 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.8 80.2 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 mt -101.23 131.73 47.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 1.0 110.76 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -88.14 119.41 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.485 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.9 m-85 -108.64 132.5 21.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.285 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.73 157.52 27.99 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.125 1.883 . . . . 1.0 111.702 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.14 66.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.76 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -23.72 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -55.53 -29.07 58.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 1.0 110.634 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.418 HG23 ' HHA' ' A' ' 203' ' ' CYC . 13.4 mt -121.35 133.43 24.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.297 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 71.8 Cg_endo -78.4 -106.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.538 2.159 . . . . 1.0 112.336 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -152.49 -64.71 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.832 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -43.02 -41.97 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.723 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.7 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -61.8 -41.02 97.22 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.958 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -65.57 -28.44 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.526 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -56.72 -55.31 35.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.267 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 94' ' ' LEU . 9.4 mp -54.13 -40.75 67.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.587 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.91 -40.19 92.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.09 -8.42 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.56 -0.746 . . . . 1.0 110.11 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tp -107.49 -43.58 4.5 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.389 0.885 . . . . 1.0 113.389 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.71 -1.52 12.08 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.53 0.937 . . . . 1.0 113.53 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 28.9 mp0 27.51 69.64 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.5 p -116.9 -49.67 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.437 -2.431 . . . . 1.0 104.437 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.595 ' N ' HG13 ' A' ' 100' ' ' VAL . 2.6 mtt180 61.55 78.96 0.27 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.058 -1.428 . . . . 1.0 114.35 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.79 132.32 5.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.76 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.5 mp -107.06 126.26 63.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 105' ' ' ASP . 27.3 t -82.85 167.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.249 0.833 . . . . 1.0 113.249 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.681 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.5 m-20 -50.84 118.22 3.0 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.692 -1.14 . . . . 1.0 112.261 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -57.66 -10.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.742 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.5 -36.25 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.889 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.5 -15.31 25.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 1.0 110.134 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 52.81 59.98 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.032 -0.986 . . . . 1.0 113.424 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -94.25 137.34 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 1.0 105.401 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -127.9 139.94 52.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.017 1.488 . . . . 1.0 115.017 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 t -105.05 154.2 20.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.154 -1.385 . . . . 1.0 107.338 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 114' ' ' SER . 11.0 tp -157.17 159.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 119.666 -0.814 . . . . 1.0 112.105 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.488 ' N ' HG13 ' A' ' 113' ' ' ILE . 73.5 m -85.78 167.84 14.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.241 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 116' ' ' PRO . 25.2 mt-30 -150.66 159.91 33.52 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.666 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' GLN . 48.1 Cg_exo -37.72 165.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.682 2.255 . . . . 1.0 112.238 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -46.09 140.87 3.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.532 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.8 p -149.85 160.85 43.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.623 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -148.65 172.33 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.57 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.01 1.75 61.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 121' ' ' LEU . 44.0 tp -69.51 -37.98 77.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 1.0 110.542 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.7 p -63.22 -20.63 65.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.614 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.2 -30.39 17.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.844 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.412 HH11 ' HB3' ' A' ' 124' ' ' ARG . 18.8 ttm105 69.16 59.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.861 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 125' ' ' VAL . 32.9 m -77.76 125.82 85.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.091 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.6 129.55 11.48 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.559 2.172 . . . . 1.0 111.195 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt 44.27 -117.08 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 3.1 84.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.616 -0.594 . . . . 1.0 111.616 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' OE1' HD21 ' A' ' 94' ' ' LEU . 22.1 mt-10 -148.36 158.49 40.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.672 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -50.56 166.31 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.417 2.078 . . . . 1.0 111.681 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.0 mp -79.07 12.36 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.301 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 131' ' ' LEU . 93.4 mm-40 -134.89 165.81 24.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.045 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mmt-85 -124.71 78.57 63.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.301 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.92 144.86 5.49 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.516 2.144 . . . . 1.0 111.801 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 135' ' ' VAL . 3.1 m -113.33 120.1 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 1.0 111.349 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.46 148.97 0.4 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.903 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 140' ' ' VAL . 93.2 Cg_exo -45.85 -48.16 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.212 1.941 . . . . 1.0 111.275 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.2 p -43.83 -34.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.692 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 53.0 t-80 -82.67 -32.62 28.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.715 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' PRO . 52.4 t -53.09 -51.01 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.32 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.13 -43.06 93.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 1.0 110.26 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -46.21 -50.42 15.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.4 mp -71.76 -49.44 38.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.537 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.1 tptm -58.94 -41.29 87.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.46 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.5 p -54.24 -30.3 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.3 mtt -87.01 -0.61 56.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.228 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.26 25.03 75.8 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.293 -0.867 . . . . 1.0 112.359 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 150' ' ' SER . 21.6 t -105.87 122.57 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.23 -33.14 49.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 148' ' ' VAL . 2.4 t -137.42 171.16 14.89 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.592 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 7.3 p -161.42 139.98 9.66 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.198 0.444 . . . . 1.0 112.198 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 65.1 tp -115.19 138.66 50.67 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.5 m -132.14 155.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.468 0.651 . . . . 1.0 111.828 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.9 t -158.12 90.46 2.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.83 -1.077 . . . . 1.0 109.313 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.76 133.4 54.11 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.562 2.842 . . . . 1.0 113.946 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.8 mt -89.79 106.34 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.776 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 20.6 ptm -127.39 144.91 50.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.0 111.864 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.498 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 75.6 t60 -114.15 114.06 25.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.43 ' CD2' ' NE2' ' A' ' 158' ' ' HIS . 22.2 m-70 59.01 -118.38 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.649 ' CD ' ' H ' ' A' ' 160' ' ' GLN . 0.1 OUTLIER -95.38 3.06 54.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -178.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.545 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.2 tt0 -112.06 149.49 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 162' ' ' LEU . 11.0 mp -107.37 117.28 33.66 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 114.532 -1.213 . . . . 1.0 108.841 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 81.7 m95 -97.2 -25.84 15.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.887 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.88 -168.19 23.42 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.971 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.488 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.7 tp -141.11 128.65 21.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.797 0.332 . . . . 1.0 111.239 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -93.9 137.91 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.571 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.0 p -150.87 133.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.541 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 p -115.77 145.4 42.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.009 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.07 140.62 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.157 0.503 . . . . 1.0 111.011 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -154.03 154.35 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.483 -0.781 . . . . 1.0 109.638 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.97 72.81 10.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.446 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -174.16 129.72 0.48 Allowed Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 120.399 -0.52 . . . . 1.0 112.323 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.93 78.52 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.667 2.245 . . . . 1.0 110.912 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -114.79 146.17 35.49 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.024 -0.989 . . . . 1.0 112.703 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.97 149.49 36.91 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.831 2.354 . . . . 1.0 111.123 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -108.14 154.04 22.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.809 0.338 . . . . 1.0 110.802 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.8 p -99.07 139.99 33.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.285 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.23 -36.01 76.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.65 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.7 -54.96 35.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.334 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.21 -32.05 73.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 1.0 110.643 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.54 -42.27 91.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.497 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.9 -52.71 63.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.455 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -44.77 -46.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.275 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.43 -37.85 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -48.68 -37.83 19.6 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.8 -40.92 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.383 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 42.3 tp -53.54 -32.65 51.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.68 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.57 -32.58 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.617 . . . . 1.0 109.616 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -58.68 -41.7 86.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -53.23 -52.85 57.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.4 -41.66 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.886 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.7 m -50.34 -29.78 10.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.7 mm -77.79 -38.52 25.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.023 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.67 67.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.108 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 31' ' ' LEU . 10.4 tp -64.24 -34.61 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.23 -55.91 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.881 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.79 -26.62 47.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.893 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.4 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.302 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.55 -39.38 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.154 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.1 mp -68.55 -56.43 8.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.107 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -55.56 -43.07 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.891 0.377 . . . . 1.0 110.357 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.419 179.708 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.7 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 195' ' ' ILE . 5.9 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.931 0.396 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.19 -32.65 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.245 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -78.39 -54.72 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.243 0.46 . . . . 1.0 112.243 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 38' ' ' THR . 4.7 tp -58.35 -37.42 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HG ' HG23 ' A' ' 34' ' ' ILE . 80.8 mt -74.36 -33.93 63.23 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -49.76 -37.93 31.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 1.0 109.993 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.39 -30.26 57.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.394 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 34' ' ' ILE . 52.9 p -70.58 -44.54 67.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.533 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 53' ' ' VAL . 49.8 t -59.15 -37.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.846 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.63 -39.53 84.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.13 -37.55 83.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.98 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.4 t -68.39 -43.56 84.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.4 ttp180 -57.03 -50.08 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.865 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.75 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.847 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -79.14 -51.88 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.781 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.95 -6.47 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.015 0.436 . . . . 1.0 110.089 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.96 17.65 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.0 112.393 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 51' ' ' VAL . 6.8 t -78.53 149.43 33.08 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.077 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.6 m-20 -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.705 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 51.2 ttp180 -155.01 131.86 10.75 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 119.124 -1.03 . . . . 1.0 113.499 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 48' ' ' THR . 0.3 OUTLIER -139.15 133.59 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HE3' HBB2 ' A' ' 203' ' ' CYC . 47.7 pttt -146.61 160.29 42.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.594 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 39' ' ' VAL . 71.2 t -99.11 135.08 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.975 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.7 t80 -117.38 120.27 37.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.058 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH2' HD21 ' A' ' 31' ' ' LEU . 46.4 ttm-85 -99.83 166.35 11.13 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 11.5 t80 -131.21 135.99 47.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.091 0.472 . . . . 1.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.9 m-20 -102.22 147.79 34.46 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.329 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.42 -21.59 71.26 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.726 2.284 . . . . 1.0 112.909 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.83 -2.44 47.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.044 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.54 -8.58 54.99 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.916 -0.659 . . . . 1.0 112.842 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -90.24 143.5 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.318 0.559 . . . . 1.0 111.005 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -120.47 137.88 12.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.6 p -124.31 145.36 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.197 0.522 . . . . 1.0 112.34 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -104.49 120.57 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.08 4.74 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -153.78 146.24 24.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.9 tt0 -166.38 127.36 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.398 -0.921 . . . . 1.0 113.222 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 129.5 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 6.8 ptp85 -116.85 140.61 49.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.216 -0.594 . . . . 1.0 111.524 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.47 98.53 1.89 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.78 -90.23 0.04 OUTLIER Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.188 -1.165 . . . . 1.0 110.188 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -176.38 33.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.116 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -71.38 -54.25 11.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.88 145.93 30.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.88 166.37 29.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.081 1.854 . . . . 1.0 112.564 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.521 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 16.2 m -88.86 135.94 33.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.108 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 45.6 mt -108.7 -0.99 19.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.615 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -60.59 138.95 57.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.588 . . . . 1.0 112.239 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.16 -4.95 85.37 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.338 -0.846 . . . . 1.0 111.05 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.62 130.14 45.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.861 0.362 . . . . 1.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -87.06 121.84 30.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.503 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 62' ' ' GLY . 28.7 m-85 -103.01 136.23 19.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.259 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.11 145.7 24.8 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.126 1.884 . . . . 1.0 111.708 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.37 69.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.15 -20.56 1.45 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 40.4 p30 -60.08 -30.67 69.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.792 0.329 . . . . 1.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.565 ' O ' ' O ' ' A' ' 88' ' ' PRO . 45.6 mt -113.74 101.0 53.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.262 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -45.57 -116.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.536 2.158 . . . . 1.0 112.351 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -154.3 -44.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.907 0.384 . . . . 1.0 111.832 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.4 -39.1 82.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.707 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.521 ' HB1' HAD2 ' A' ' 203' ' ' CYC . . . -61.93 -36.33 81.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 1.0 110.982 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -67.98 -28.63 67.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.562 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' LEU . 55.0 mtp180 -53.65 -57.71 9.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.244 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.7 mt -54.7 -38.29 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.556 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 6.6 m-85 -65.5 -30.71 71.51 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -93.62 -14.24 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.127 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' ARG . 11.8 tp -107.1 -46.16 3.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.99 -3.36 12.65 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.451 0.908 . . . . 1.0 113.451 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.619 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 13.0 mm-40 29.19 69.8 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -110.04 -51.06 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 175.046 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.619 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER 63.18 70.4 0.54 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.292 172.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.1 p -152.35 134.31 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.556 -0.457 . . . . 1.0 111.793 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.59 ' CD1' HMA2 ' A' ' 203' ' ' CYC . 22.8 mt -108.51 127.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.659 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.4 p -83.25 167.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.659 ' N ' HG22 ' A' ' 104' ' ' VAL . 15.7 t0 -53.55 119.41 4.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.312 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.88 -10.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.735 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 1.3 pp20? -86.47 -37.76 17.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.921 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.97 -13.91 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.405 0.622 . . . . 1.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 50.34 52.63 14.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.041 -0.981 . . . . 1.0 113.35 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -93.27 133.44 36.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -126.13 141.07 52.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 m -91.91 144.34 25.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.363 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.16 149.76 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.161 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.8 t -87.29 164.9 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.266 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.53 152.16 55.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.603 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -37.86 -37.84 0.61 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.659 2.24 . . . . 1.0 112.294 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.37 159.79 15.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.535 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.3 m -111.27 170.9 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -48.49 -41.32 29.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.502 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 93.95 3.24 64.03 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt 59.9 -69.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 1.0 110.546 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 120' ' ' GLY . 32.5 t -48.69 -28.83 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.601 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.687 ' O ' ' C ' ' A' ' 124' ' ' ARG . . . -50.0 -43.73 50.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.687 ' C ' ' O ' ' A' ' 123' ' ' ALA . 38.4 ttm180 1.62 90.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.815 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.29 107.02 54.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.054 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -47.28 146.24 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.509 2.14 . . . . 1.0 111.179 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.6 mt 44.44 -165.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.57 -0.529 . . . . 1.0 109.57 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.41 88.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.64 -0.584 . . . . 1.0 111.64 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.1 151.65 45.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 121.0 -0.28 . . . . 1.0 110.661 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.5 160.57 48.1 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.367 2.045 . . . . 1.0 111.68 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.665 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.8 mp -78.27 -5.17 51.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -139.24 165.59 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.654 -0.419 . . . . 1.0 111.084 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HE ' ' HD2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -125.2 114.93 25.93 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.275 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.462 ' HD2' ' HE ' ' A' ' 133' ' ' ARG . 91.0 Cg_endo -81.35 143.48 13.88 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.573 2.182 . . . . 1.0 111.745 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.54 HG21 ' ND1' ' A' ' 139' ' ' HIS . 1.5 m -112.99 123.34 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.073 0.463 . . . . 1.0 111.319 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.85 154.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.895 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.39 -26.94 79.76 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.221 1.947 . . . . 1.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.486 ' O ' HBC1 ' A' ' 203' ' ' CYC . 22.2 t -61.26 -43.0 99.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.797 ' CE1' HD13 ' A' ' 143' ' ' LEU . 46.8 t-80 -77.84 -29.65 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.0 -53.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.275 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.487 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 80.1 t60 -64.68 -42.78 95.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.268 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -44.29 -50.56 8.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.405 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.797 HD13 ' CE1' ' A' ' 139' ' ' HIS . 3.1 mp -71.59 -49.6 38.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.461 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.6 tptm -56.98 -40.83 77.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.487 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 30.9 m -54.2 -32.82 56.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 50.3 mtt -83.98 -2.01 55.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.164 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.68 26.43 74.48 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.277 -0.874 . . . . 1.0 112.353 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.1 p -109.01 127.04 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.08 -30.9 39.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -137.97 170.45 16.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.145 -0.622 . . . . 1.0 111.512 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -162.66 138.45 7.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.135 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 176' ' ' TYR . 18.3 tp -113.63 139.72 48.79 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -128.8 156.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.457 0.646 . . . . 1.0 111.783 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 153' ' ' VAL . 66.7 t -156.65 100.38 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.812 -1.085 . . . . 1.0 109.327 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.88 127.11 13.27 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.603 2.869 . . . . 1.0 113.899 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.51 106.08 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.812 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.2 ptm -130.73 146.65 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.834 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.528 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 30.5 t-80 -117.24 116.11 26.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.499 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 61.6 m170 57.66 -122.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -92.81 7.59 43.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -116.61 150.56 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.011 1.115 . . . . 1.0 114.011 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.93 116.27 31.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.547 -1.206 . . . . 1.0 108.851 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 82.7 m95 -95.27 -26.34 15.98 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.924 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.5 -168.7 24.8 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.158 -1.02 . . . . 1.0 111.972 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.8 tp -145.32 136.76 25.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.803 0.335 . . . . 1.0 111.142 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.2 tp -100.91 145.5 28.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 167' ' ' VAL . 14.7 p -150.9 129.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.6 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.8 p -112.96 145.84 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.077 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.705 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -148.01 138.54 22.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.219 0.533 . . . . 1.0 110.973 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 148' ' ' VAL . 21.3 t60 -150.64 151.73 32.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.702 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.441 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -79.7 67.46 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.424 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -177.08 135.38 0.39 Allowed Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 120.376 -0.53 . . . . 1.0 112.297 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 174' ' ' ARG . 23.7 Cg_exo -38.8 -53.36 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.672 2.248 . . . . 1.0 110.896 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 173' ' ' PRO . 68.1 ttt180 29.95 101.56 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.999 -1.001 . . . . 1.0 112.801 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.96 154.51 22.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.78 2.32 . . . . 1.0 111.162 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CG ' HD13 ' A' ' 152' ' ' LEU . 42.6 m-85 -113.82 140.27 48.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.804 0.335 . . . . 1.0 110.78 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.6 m -95.27 148.31 22.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.245 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -67.19 -37.33 83.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.692 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.19 -54.48 40.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.349 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.64 -31.59 72.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.846 0.355 . . . . 1.0 110.598 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.439 HD11 HH12 ' A' ' 101' ' ' ARG . 28.2 tp -60.14 -41.85 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' GLN . 24.7 mm100 -61.54 -52.86 62.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.377 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.6 t -43.06 -44.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.255 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.31 -36.88 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 36.6 tp60 -52.32 -37.86 56.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.58 -32.15 67.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.391 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.75 -27.85 69.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.53 -37.02 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.69 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -53.89 -42.33 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.717 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -52.35 -56.3 15.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.19 -41.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.902 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.9 p -51.82 -35.26 43.75 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.4 mt -78.97 -35.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.046 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.07 61.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.08 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 31' ' ' LEU . 9.0 tp -62.12 -36.7 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.181 0.515 . . . . 1.0 109.622 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -73.23 -53.63 10.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.958 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 197' ' ' GLN . 19.3 tm0? -55.3 -27.23 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.908 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.07 -33.91 57.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.298 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -58.0 -40.99 82.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.153 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.6 mp -64.96 -58.48 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.093 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.4 t -53.03 -42.22 65.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 1.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.4 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.59 HMA2 ' CD1' ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.6 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.885 0.374 . . . . 1.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.67 -52.28 27.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.231 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.87 -48.35 82.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.789 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.96 -30.95 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.598 0.592 . . . . 1.0 112.598 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -75.57 -24.16 56.61 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.595 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.1 mtp180 -66.83 -36.08 81.52 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.94 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.1 -25.16 43.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 34' ' ' ILE . 68.7 p -74.77 -50.68 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.577 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.4 p -53.52 -36.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.923 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 96.8 mt-10 -74.53 -37.37 63.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -64.79 -51.77 60.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 1.0 112.021 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.23 -50.39 79.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.9 tmm_? -51.36 -43.61 61.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.69 73.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -80.47 -47.17 14.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.17 -6.83 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.175 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.83 17.11 0.49 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.41 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -73.44 140.35 46.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.083 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.6 m-20 -61.99 -29.86 70.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 48' ' ' THR . 43.1 ttp180 -152.99 118.69 5.34 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 119.231 -0.988 . . . . 1.0 113.517 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.24 137.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.457 ' HZ1' HBB3 ' A' ' 203' ' ' CYC . 18.2 pttp -146.23 161.81 39.44 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.547 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.91 135.27 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.017 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.7 t80 -117.9 116.54 27.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.012 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 27.3 ttm180 -98.16 164.76 12.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.849 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -131.75 139.56 48.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 1.0 112.12 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -103.79 148.35 35.67 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.718 -0.673 . . . . 1.0 109.296 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.21 -21.85 72.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.732 2.288 . . . . 1.0 112.924 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -80.01 -4.47 52.76 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.974 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.86 46.5 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.871 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -89.13 146.07 25.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.335 0.567 . . . . 1.0 110.888 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.88 144.35 15.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 m -128.55 147.31 50.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.133 0.492 . . . . 1.0 112.309 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.67 119.09 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.05 0.14 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.64 150.46 23.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.1 tt0 -166.05 125.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.372 -0.931 . . . . 1.0 113.166 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -108.62 136.14 48.7 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.0 141.55 51.77 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.238 -0.585 . . . . 1.0 111.516 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.32 104.67 2.63 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.4 -89.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.8 tt0 -176.94 34.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.174 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -70.98 -53.57 14.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.2 mt -94.76 144.13 27.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 107.921 -1.141 . . . . 1.0 107.921 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.09 170.34 20.35 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.043 1.828 . . . . 1.0 112.504 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -92.32 136.22 33.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.173 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 38.5 mt -109.63 -2.35 17.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.543 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.7 tp -58.52 139.55 55.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.568 . . . . 1.0 112.289 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.38 84.36 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.058 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.1 133.97 43.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.863 0.364 . . . . 1.0 110.766 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -89.07 117.01 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.515 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -107.98 134.91 19.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.78 158.11 27.88 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.123 1.882 . . . . 1.0 111.663 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.76 -20.1 63.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.779 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.66 -22.46 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 10.3 p30 -55.54 -27.78 50.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.323 . . . . 1.0 110.649 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.565 HD11 HMB3 ' A' ' 203' ' ' CYC . 90.6 mt -127.96 99.58 25.34 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.279 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' ILE . 47.6 Cg_exo -41.71 -101.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.544 2.163 . . . . 1.0 112.312 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 43.7 tp10 -153.54 -59.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.809 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -43.46 -38.67 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.714 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -67.75 -50.92 54.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 1.0 110.947 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -61.64 -31.4 71.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -58.04 -49.58 76.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.284 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.0 mt -53.85 -36.97 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.7 -29.15 69.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -89.66 -15.38 32.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.092 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.82 -46.34 3.98 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.399 0.889 . . . . 1.0 113.399 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.99 -3.0 14.1 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 25.21 67.01 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.879 ' H ' HH21 ' A' ' 133' ' ' ARG . 13.0 t -107.24 -52.52 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.503 -2.406 . . . . 1.0 104.503 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.814 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 11.5 mtm180 64.38 65.57 0.65 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.312 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 103' ' ' ILE . 35.7 m -150.11 133.39 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.726 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -109.25 127.38 66.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 108.353 -0.981 . . . . 1.0 108.353 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.9 t -83.2 168.11 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.696 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.8 m-20 -51.33 114.52 1.25 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.268 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' VAL . 9.5 p -54.82 -10.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.789 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.5 -35.96 16.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.912 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -15.03 9.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.412 0.625 . . . . 1.0 110.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 49.97 51.5 16.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 1.0 113.396 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 m -94.2 138.2 32.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.405 -2.072 . . . . 1.0 105.405 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -128.27 137.93 52.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.05 1.5 . . . . 1.0 115.05 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 113' ' ' ILE . 54.2 m -100.34 153.03 19.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.307 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 112' ' ' SER . 14.6 pt -157.5 163.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.732 -0.787 . . . . 1.0 112.189 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.8 t -86.58 163.62 17.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.228 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -153.32 149.93 22.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.695 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 117' ' ' GLU . 48.2 Cg_exo -37.21 157.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.637 2.225 . . . . 1.0 112.254 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' PRO . 44.2 mt-10 55.89 158.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.8 m -145.02 152.81 40.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.641 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 0.3 OUTLIER -42.79 -76.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.517 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.83 3.59 73.64 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.675 HD12 ' N ' ' A' ' 121' ' ' LEU . 8.5 mp -93.26 125.12 37.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 1.0 110.555 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -64.69 -58.11 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -67.98 -29.26 68.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.82 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 123' ' ' ALA . 19.6 tpt180 57.84 145.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 125' ' ' VAL . 4.6 m -62.65 149.88 87.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.133 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.38 132.58 26.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.584 2.19 . . . . 1.0 111.177 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 129' ' ' GLU . 22.3 mt 43.49 -126.8 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.22 -6.63 3.03 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.642 -0.583 . . . . 1.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 127' ' ' LEU . 45.6 mm-40 -95.5 154.58 39.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.574 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -42.85 152.91 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.323 2.015 . . . . 1.0 111.738 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.0 mt -78.57 -7.51 57.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.344 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.52 166.25 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.087 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.879 HH21 ' H ' ' A' ' 100' ' ' VAL . 26.1 mtt-85 -119.99 77.58 23.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.286 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.07 150.29 5.08 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.515 2.143 . . . . 1.0 111.837 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.406 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -97.44 145.69 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.027 0.442 . . . . 1.0 111.382 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.4 m-20 -91.1 147.02 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.553 -0.749 . . . . 1.0 110.913 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -38.75 -28.69 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.199 1.933 . . . . 1.0 111.288 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.654 ' O ' HBC1 ' A' ' 203' ' ' CYC . 47.9 t -67.6 -53.15 30.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.671 ' CE1' HD11 ' A' ' 143' ' ' LEU . 19.4 t-80 -73.54 -24.99 60.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.4 t -50.99 -55.94 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.353 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.14 -41.46 94.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -43.17 -50.4 6.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 139' ' ' HIS . 77.4 mt -72.51 -48.1 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.525 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.3 tmtm? -57.27 -43.07 82.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.511 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.8 p -55.2 -27.34 45.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 39.4 mtt -92.25 -3.48 55.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.186 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.12 22.77 72.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.357 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.648 HG11 ' HB2' ' A' ' 169' ' ' HIS . 10.2 m -104.83 122.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.72 -0.392 . . . . 1.0 109.953 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.36 -37.22 57.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -130.22 170.57 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.579 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 3.4 p -158.92 139.64 12.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.02 0.438 . . . . 1.0 112.157 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 tp -116.31 140.02 49.77 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -134.33 154.54 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.463 0.649 . . . . 1.0 111.739 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 153' ' ' VAL . 74.6 t -157.21 108.21 1.89 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.767 -1.106 . . . . 1.0 109.267 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.78 113.88 3.9 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.659 2.906 . . . . 1.0 113.847 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.72 105.88 3.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.78 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.7 ptm -132.19 147.07 52.4 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.835 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.608 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 53.4 t60 -118.07 115.58 25.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.608 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 35.5 m80 59.32 -122.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -92.99 7.59 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.883 0.327 . . . . 1.0 111.883 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 44.3 mp0 -114.65 146.03 41.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 162' ' ' LEU . 6.5 mp -106.94 117.41 33.98 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 114.525 -1.216 . . . . 1.0 108.809 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.2 m95 -96.15 -26.67 15.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.899 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.27 -170.88 28.79 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.261 -0.971 . . . . 1.0 112.041 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.9 tp -141.67 137.29 31.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 1.0 111.216 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 5.1 tp -99.11 142.8 30.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.31 135.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.595 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 p -120.8 142.51 49.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.046 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.648 ' HB2' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -150.03 127.99 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.127 0.489 . . . . 1.0 111.021 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.561 ' O ' ' O ' ' A' ' 171' ' ' ALA . 15.2 p-80 -166.58 156.52 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.704 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 170' ' ' HIS . . . -46.14 -170.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.607 -0.269 . . . . 1.0 111.448 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -103.61 104.96 45.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.261 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.404 ' CD ' ' H ' ' A' ' 174' ' ' ARG . 36.2 Cg_endo -92.35 -48.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.676 2.251 . . . . 1.0 110.908 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 173' ' ' PRO . 9.6 ptp180 -179.43 156.83 0.84 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.065 -0.971 . . . . 1.0 112.691 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.89 162.89 2.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.848 2.365 . . . . 1.0 111.119 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -111.82 146.38 37.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 1.0 110.744 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 t -99.68 143.12 30.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.23 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.14 -31.93 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.646 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.05 -54.52 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.337 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.42 -30.64 71.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.904 0.383 . . . . 1.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.16 -35.1 74.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.538 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.58 -52.75 28.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.407 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -44.44 -47.38 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 187' ' ' LEU . 27.3 m -75.01 -36.81 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -46.94 -35.84 6.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.711 ' O ' HD23 ' A' ' 186' ' ' LEU . 3.6 tt -72.1 -43.46 64.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.412 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 184' ' ' VAL . 39.0 tp -53.96 -33.17 56.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.662 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.47 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.95 -37.27 62.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.618 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -56.21 -38.09 70.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.705 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -53.16 -51.83 60.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.12 -42.46 79.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.265 -0.879 . . . . 1.0 109.889 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.3 m -51.86 -37.12 50.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.61 -33.47 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.048 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.37 -47.13 58.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.101 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.0 tp -62.4 -33.12 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.96 -53.59 8.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.898 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -56.28 -28.36 58.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.68 -34.3 52.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.17 -39.98 80.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.86 -57.62 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.4 t -58.14 -44.17 87.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.059 -0.972 . . . . 1.0 110.373 179.657 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.654 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 198' ' ' ALA . 16.0 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.397 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.294 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.18 -52.7 45.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -55.05 -50.09 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.687 0.625 . . . . 1.0 112.687 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 mt -64.42 -23.97 67.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.541 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.553 ' O ' HG12 ' A' ' 39' ' ' VAL . 61.0 ttt180 -58.23 -36.1 72.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.651 -0.419 . . . . 1.0 109.925 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.35 38.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.3 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.413 ' HG1' ' H ' ' A' ' 39' ' ' VAL . 50.6 p -69.36 -49.87 51.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.507 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.9 p -53.08 -36.32 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 75.2 mm-40 -65.24 -38.41 90.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.841 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.15 -44.91 87.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.924 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.08 -44.08 95.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.3 tmm_? -62.43 -51.64 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.843 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' N ' ' HE ' ' A' ' 43' ' ' ARG . . . -58.49 -40.06 81.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.847 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.76 -51.49 9.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.794 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.51 -5.58 48.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.087 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.29 17.71 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.716 -0.675 . . . . 1.0 112.415 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -74.48 141.85 44.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.108 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -57.48 -33.39 67.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' H ' HG22 ' A' ' 48' ' ' THR . 46.2 ttp180 -152.28 119.82 6.03 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 119.18 -1.008 . . . . 1.0 113.577 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -139.14 134.88 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.716 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 29.3 pttt -145.62 161.9 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.377 -0.529 . . . . 1.0 111.566 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.44 136.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.006 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 165' ' ' LEU . 43.8 t80 -121.0 119.11 31.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.113 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -100.07 170.08 8.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.925 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 72.3 t80 -134.32 138.78 45.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.526 -0.47 . . . . 1.0 112.124 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -102.45 148.79 35.97 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.306 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.36 -21.22 66.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.729 2.286 . . . . 1.0 112.965 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.3 -0.57 41.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.563 -0.455 . . . . 1.0 111.038 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.33 -11.51 54.72 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.855 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.6 m-70 -89.34 146.44 24.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.383 0.592 . . . . 1.0 110.976 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.8 144.68 15.37 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 p -129.26 148.21 51.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.184 0.516 . . . . 1.0 112.275 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.78 120.99 57.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.937 -1.134 . . . . 1.0 107.937 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' C ' HD11 ' A' ' 78' ' ' LEU . 4.3 m -112.04 8.1 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' N ' HD11 ' A' ' 78' ' ' LEU . . . -154.06 146.37 23.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -166.75 127.69 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.296 -0.962 . . . . 1.0 113.186 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.1 139.07 47.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -127.53 141.46 51.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.138 -0.625 . . . . 1.0 111.569 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.15 107.59 3.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.417 -1.073 . . . . 1.0 110.417 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.23 16.95 0.1 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.264 -1.134 . . . . 1.0 110.264 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.7 tt0 71.99 28.87 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.791 -0.364 . . . . 1.0 111.104 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -57.55 -58.24 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -90.65 158.63 42.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.31 162.49 33.69 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.09 1.86 . . . . 1.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -85.9 108.9 18.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.119 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' NH1' ' A' ' 50' ' ' ARG . 48.9 mt -84.1 -1.47 54.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.46 HD11 ' C ' ' A' ' 65' ' ' VAL . 8.4 tp -62.44 139.54 58.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.349 0.595 . . . . 1.0 112.289 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.567 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.0 -4.12 74.36 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.121 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.8 mp -102.41 131.04 49.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 1.0 110.774 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.01 119.81 25.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.447 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 7.8 m-85 -106.95 132.96 20.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.302 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -79.61 155.8 24.43 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.214 1.943 . . . . 1.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -67.9 -21.08 65.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.798 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.19 -22.07 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.03 -27.8 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 1.0 110.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.6 mt -107.86 106.28 58.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.332 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.5 Cg_exo -48.47 -125.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.505 2.136 . . . . 1.0 112.35 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.6 pt-20 -142.91 -43.08 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 22.7 pt-20 -68.83 -39.8 79.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.723 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.09 84.1 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.007 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.433 HH21 HD22 ' A' ' 162' ' ' LEU . 76.7 ttt180 -63.24 -30.62 71.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.553 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -56.66 -51.13 69.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.323 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.4 mp -55.71 -35.33 65.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 7.9 m-85 -63.36 -31.49 72.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 1.0 109.625 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -87.16 -15.16 39.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.042 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.48 -42.67 4.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.03 -4.78 13.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.517 0.932 . . . . 1.0 113.517 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.632 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 96.4 mt-30 27.06 69.65 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 6.8 t -109.76 -49.21 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.435 -2.431 . . . . 1.0 104.435 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.702 ' NH1' HE22 ' A' ' 185' ' ' GLN . 0.6 OUTLIER 63.06 70.56 0.54 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.137 -1.392 . . . . 1.0 114.311 172.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.566 ' C ' HD12 ' A' ' 103' ' ' ILE . 15.0 p -153.11 136.74 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.706 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.566 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -108.71 127.76 64.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 105' ' ' ASP . 34.3 t -83.53 166.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.675 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.1 m-20 -53.68 119.44 4.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.26 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.0 m -58.01 -13.2 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.876 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -87.61 -38.04 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.89 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.32 -13.72 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.384 0.611 . . . . 1.0 110.059 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 51.3 54.77 10.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 113.409 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -93.94 133.62 37.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -128.21 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 80.0 p -99.54 147.03 25.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.17 -1.377 . . . . 1.0 107.316 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.0 mt -146.9 152.27 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.681 -0.807 . . . . 1.0 112.135 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.1 t -91.5 171.36 9.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.21 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.4 OUTLIER -149.17 152.84 36.95 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.667 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.38 -13.65 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.635 2.223 . . . . 1.0 112.239 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.39 -28.12 69.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 119' ' ' TRP . 29.5 t 54.89 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.675 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.493 ' N ' ' OG ' ' A' ' 118' ' ' SER . 38.6 m95 53.8 170.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.502 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.94 29.69 45.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 121' ' ' LEU . 1.6 tt -150.69 -61.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 1.0 110.564 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.0 p -60.7 -22.79 64.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.14 -14.61 56.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 60.92 79.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.7 m -99.51 146.8 32.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.114 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.68 129.87 14.08 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.54 2.16 . . . . 1.0 111.202 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.7 mt 43.26 -134.25 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.67 11.64 76.8 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.689 -0.564 . . . . 1.0 111.689 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.81 148.35 17.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.661 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -43.48 157.55 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.354 2.036 . . . . 1.0 111.706 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.602 ' O ' ' NE2' ' A' ' 132' ' ' GLN . 25.3 mt -82.06 25.71 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.244 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.602 ' NE2' ' O ' ' A' ' 131' ' ' LEU . 88.2 mm-40 -134.08 163.96 28.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.096 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.475 ' NE ' ' HA ' ' A' ' 133' ' ' ARG . 1.6 mmp_? -122.39 80.37 45.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.286 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.75 147.63 6.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.494 2.129 . . . . 1.0 111.816 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.515 ' HB ' ' HD1' ' A' ' 139' ' ' HIS . 14.6 m -95.72 151.58 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 1.0 111.329 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.3 m-20 -84.89 156.32 61.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.909 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -56.34 -26.52 62.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.216 1.944 . . . . 1.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.6 OUTLIER -74.51 -34.81 63.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.06 -0.718 . . . . 1.0 109.06 176.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.515 ' HD1' ' HB ' ' A' ' 135' ' ' VAL . 46.2 t-80 -81.47 -31.56 32.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.657 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -52.29 -50.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.33 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -65.99 -43.88 86.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.28 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -44.19 -52.07 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -73.16 -46.2 52.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.501 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.0 OUTLIER -59.51 -42.76 92.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.52 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 t -53.83 -32.53 53.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 40.7 mtt -84.51 -1.89 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.113 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.1 23.85 76.03 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.352 -0.84 . . . . 1.0 112.233 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.9 t -105.03 124.92 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.52 24.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -131.5 169.37 16.18 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.565 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.0 m -162.61 139.47 7.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.106 0.479 . . . . 1.0 112.15 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.57 139.69 50.21 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.9 m -135.13 157.81 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.803 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.3 t -158.98 91.91 1.95 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.388 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.46 115.37 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.636 2.891 . . . . 1.0 113.922 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.29 105.87 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.859 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.442 ' O ' ' OG ' ' A' ' 192' ' ' SER . 16.7 ptm -130.92 146.43 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.0 111.836 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 84.5 t60 -119.51 115.68 24.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 10.6 t-80 64.02 -126.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.456 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 85.9 mt-30 -92.66 5.28 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.855 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 46.9 mp0 -115.09 150.69 35.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.433 HD22 HH21 ' A' ' 92' ' ' ARG . 13.1 tp -106.24 117.34 33.79 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 114.517 -1.219 . . . . 1.0 108.86 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.425 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 84.0 m95 -97.4 -28.83 13.83 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.864 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.65 -171.93 24.22 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.22 -0.99 . . . . 1.0 111.962 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.701 HD23 HMB2 ' A' ' 203' ' ' CYC . 3.9 tp -138.8 129.69 26.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.565 -0.318 . . . . 1.0 111.205 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -94.52 139.06 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 169' ' ' HIS . 9.7 p -151.19 132.83 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.532 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.739 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 1.5 m -115.22 140.57 48.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.05 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.739 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -135.5 141.48 45.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 1.0 110.992 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.44 ' O ' HG13 ' A' ' 148' ' ' VAL . 1.6 p-80 -158.2 154.27 27.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.5 -0.773 . . . . 1.0 109.742 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.94 67.94 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -178.79 134.75 0.3 Allowed Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.298 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 174' ' ' ARG . 20.0 Cg_exo -38.34 -38.39 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.726 2.284 . . . . 1.0 110.82 176.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' PRO . 59.2 ttm-85 26.88 78.8 0.24 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 114.983 -1.008 . . . . 1.0 112.678 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.55 148.2 83.22 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.861 2.374 . . . . 1.0 111.136 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -110.96 141.45 44.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.809 0.337 . . . . 1.0 110.721 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -96.17 153.93 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.641 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.99 -53.49 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.324 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 180' ' ' GLU . 37.4 mp0 -71.41 -24.22 62.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.884 0.373 . . . . 1.0 110.677 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -61.44 -45.65 93.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.505 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 10.9 pt20 -67.56 -48.66 66.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.417 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 46.4 t -43.68 -51.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.243 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.48 -36.05 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.702 HE22 ' NH1' ' A' ' 101' ' ' ARG . 63.0 tp60 -48.24 -37.95 17.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.89 -40.27 65.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.375 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.71 -32.42 63.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.687 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.54 -37.7 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.701 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -56.96 -40.36 76.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.741 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.66 -54.09 38.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.39 -40.69 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.923 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 157' ' ' MET . 3.5 t -50.1 -30.17 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.63 -39.43 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.056 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.67 67.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.133 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.01 -35.64 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -76.48 -54.77 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.863 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -55.94 -28.52 57.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.949 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.36 -35.23 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.336 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.43 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 83.6 tt0 -57.77 -39.76 78.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.133 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.9 tp -68.52 -58.04 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.047 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.7 m -56.86 -44.25 81.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.43 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 7.8 tp . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.425 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.716 HAB1 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 1.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.2 p-10 -61.96 -42.54 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.259 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 96.3 mt-30 -68.81 -52.0 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -60.78 -34.54 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.22 -23.67 60.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -62.56 -52.85 61.81 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.632 -0.427 . . . . 1.0 109.965 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.02 77.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.359 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.3 p -67.82 -46.5 71.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.526 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 68' ' ' ALA . 10.1 t -59.28 -38.42 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.903 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.31 -37.74 77.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.778 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.31 -43.98 80.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 1.0 112.01 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.44 -51.11 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.861 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.4 tmt_? -52.73 -44.6 66.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.834 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.82 68.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.806 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -83.21 -46.2 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.734 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.53 -8.5 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 1.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 49.56 17.88 1.44 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.632 -0.713 . . . . 1.0 112.405 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -77.07 144.85 38.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.159 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 94.1 m-20 -54.56 -34.16 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.597 ' H ' HG22 ' A' ' 48' ' ' THR . 9.0 ttm180 -152.61 122.62 7.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.168 -1.013 . . . . 1.0 113.595 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 t -130.42 132.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HE2' HBB2 ' A' ' 203' ' ' CYC . 19.5 pttm -146.64 155.74 42.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.576 -177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.66 138.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.97 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -122.43 119.81 32.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.058 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -100.21 170.64 8.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.436 . . . . 1.0 109.864 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.9 t80 -133.22 141.89 48.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.0 m-20 -105.52 149.42 37.82 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.371 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.35 -25.95 63.73 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.696 2.264 . . . . 1.0 112.961 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -76.52 -5.38 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.941 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.19 -12.69 44.46 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.839 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.03 144.64 26.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.388 0.594 . . . . 1.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 143.85 15.3 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.9 p -127.37 146.69 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.346 0.498 . . . . 1.0 112.346 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.19 118.34 46.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -111.9 4.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.38 21.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.9 tt0 -166.46 127.44 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.362 -0.935 . . . . 1.0 113.215 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -107.06 140.66 39.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -129.75 141.89 50.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.512 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.94 106.16 2.84 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.431 -1.068 . . . . 1.0 110.431 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.19 -88.72 0.01 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.294 -1.122 . . . . 1.0 110.294 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' GLY . 23.0 pt-20 -176.77 31.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.109 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -66.51 -54.12 27.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD13 HH21 ' A' ' 50' ' ' ARG . 28.6 mt -95.33 151.93 39.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 171.57 16.42 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.07 1.846 . . . . 1.0 112.504 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.4 m -92.73 135.29 34.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.148 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.58 -9.22 15.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.618 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.583 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 17.6 tp -50.73 138.79 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.363 0.601 . . . . 1.0 112.212 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -1.87 79.27 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 61.3 tp -100.51 125.92 46.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 1.0 110.757 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.543 ' O ' HG23 ' A' ' 81' ' ' THR . 8.9 t -84.08 122.23 28.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.488 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.659 ' CG ' HAB2 ' A' ' 203' ' ' CYC . 47.7 m-85 -108.07 138.81 20.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.25 155.06 16.74 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.136 1.89 . . . . 1.0 111.646 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.531 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -65.56 -21.11 66.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.827 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 87' ' ' ILE . . . -49.8 -24.82 6.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.6 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 19.1 p-10 -47.86 -13.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 1.0 110.663 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.479 ' N ' ' C ' ' A' ' 85' ' ' GLY . 3.5 pt -135.91 137.96 26.57 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.224 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 61.5 Cg_endo -80.68 -114.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 1.0 112.374 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -141.82 -66.12 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.91 0.386 . . . . 1.0 111.881 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -47.79 -43.09 27.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.682 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HB1' HBD1 ' A' ' 203' ' ' CYC . . . -67.78 -53.07 30.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.964 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.481 HH21 ' CD2' ' A' ' 162' ' ' LEU . 24.6 ttt180 -54.47 -27.86 40.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' LEU . 22.1 mmt180 -63.68 -46.15 86.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.297 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 98' ' ' ALA . 39.6 mt -49.99 -42.61 49.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.564 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 30.3 m-85 -64.99 -29.88 70.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -90.24 -18.96 24.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.102 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -104.76 -45.34 4.62 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.426 0.899 . . . . 1.0 113.426 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.1 -2.78 15.72 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.7 mt-30 28.29 67.2 0.08 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.014 1.116 . . . . 1.0 114.014 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.38 -50.51 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.385 -2.45 . . . . 1.0 104.385 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.692 HH21 HG13 ' A' ' 154' ' ' VAL . 3.0 mtp180 64.79 70.38 0.48 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.072 -1.422 . . . . 1.0 114.304 172.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.581 ' C ' HD12 ' A' ' 103' ' ' ILE . 64.1 t -150.67 130.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.784 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.581 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.64 126.58 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.636 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.9 p -81.81 166.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.224 0.824 . . . . 1.0 113.224 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 104' ' ' VAL . 13.6 m-20 -52.2 120.82 5.88 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.658 -1.156 . . . . 1.0 112.328 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 106' ' ' VAL . 37.1 t -57.6 -11.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.737 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 109' ' ' GLN . 17.0 pt-20 -83.04 -38.95 21.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.851 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.98 1.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.396 0.617 . . . . 1.0 110.114 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 107' ' ' GLU . 19.5 pt20 35.43 58.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.018 -0.992 . . . . 1.0 113.392 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -94.32 135.27 35.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.386 -2.079 . . . . 1.0 105.386 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -129.98 145.59 51.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.97 114.45 14.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.132 -1.394 . . . . 1.0 107.31 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 pt -119.21 -167.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 119.69 -0.804 . . . . 1.0 112.091 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 76.6 p -87.98 161.84 17.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.231 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -144.04 154.7 58.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.665 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.25 -6.62 15.76 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.681 2.254 . . . . 1.0 112.254 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.73 156.66 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -139.03 171.38 14.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.632 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 120' ' ' GLY . 50.8 t-105 62.96 179.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.553 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 119' ' ' TRP . . . 87.42 23.43 40.11 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.981 -0.847 . . . . 1.0 110.981 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -154.05 -18.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 1.0 110.587 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.8 m -59.93 -28.49 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.17 -17.49 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 57.98 91.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.3 144.64 30.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.075 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.2 140.98 31.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.553 2.169 . . . . 1.0 111.246 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 127' ' ' LEU . 9.1 mp 43.45 -113.24 0.27 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.1 21.39 67.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' PRO . 44.1 mt-10 -139.37 154.4 71.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.611 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 129' ' ' GLU . 79.6 Cg_exo -42.81 168.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.464 2.109 . . . . 1.0 111.654 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.08 9.87 6.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.288 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.488 ' O ' ' NH2' ' A' ' 133' ' ' ARG . 14.1 pt20 -139.62 163.44 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.678 -0.409 . . . . 1.0 111.063 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -118.43 108.62 41.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.327 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.9 145.98 16.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.587 2.191 . . . . 1.0 111.818 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.628 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.9 m -118.03 127.19 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.447 . . . . 1.0 111.389 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.776 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -39.94 163.74 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.888 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.94 -19.68 34.94 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.265 1.977 . . . . 1.0 111.234 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.2 p -66.22 -37.52 85.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.628 ' ND1' HG21 ' A' ' 135' ' ' VAL . 40.4 t-80 -80.69 -28.34 36.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.632 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 106' ' ' VAL . 29.3 t -52.31 -53.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.322 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 145' ' ' SER . 85.2 t60 -66.88 -42.15 86.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.296 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -47.66 -56.9 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.503 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.521 HD13 ' NE2' ' A' ' 139' ' ' HIS . 1.2 tp -68.49 -50.38 52.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.527 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 21.1 tptm -57.35 -40.08 77.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 t -54.06 -32.49 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.5 mtt -83.46 1.15 43.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.264 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.52 25.3 75.64 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.214 -0.903 . . . . 1.0 112.33 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 169' ' ' HIS . 12.0 t -109.17 122.91 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.835 -0.432 . . . . 1.0 109.835 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.09 -30.43 49.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 148' ' ' VAL . 9.0 t -140.11 172.89 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.09 -0.644 . . . . 1.0 111.551 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 p -162.84 139.96 7.77 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.081 0.467 . . . . 1.0 112.141 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.1 tp -118.3 138.79 52.14 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 HAA1 ' A' ' 203' ' ' CYC . 2.3 m -133.04 158.98 43.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.418 0.628 . . . . 1.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.692 HG13 HH21 ' A' ' 101' ' ' ARG . 88.5 t -154.32 96.44 2.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.849 -1.069 . . . . 1.0 109.313 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.97 139.23 66.65 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.571 2.847 . . . . 1.0 113.957 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.59 105.56 17.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.736 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.449 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.1 mtp -117.54 139.06 51.45 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.906 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' NE2' ' CE1' ' A' ' 159' ' ' HIS . 72.1 t60 -113.74 113.58 25.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.437 ' CE1' ' NE2' ' A' ' 158' ' ' HIS . 31.5 m170 57.6 -123.0 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -94.23 10.99 31.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 51.0 mp0 -119.87 153.64 35.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.047 1.129 . . . . 1.0 114.047 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.481 ' CD2' HH21 ' A' ' 92' ' ' ARG . 14.8 tp -108.83 112.25 24.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.882 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -95.5 -28.61 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.905 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -154.88 -175.9 26.5 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.21 -0.995 . . . . 1.0 111.944 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.45 133.6 24.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.812 0.339 . . . . 1.0 111.215 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.7 tp -99.93 135.78 40.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.2 t -148.17 120.87 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.381 -0.528 . . . . 1.0 111.538 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 p -108.89 148.74 30.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.692 ' ND1' ' N ' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.06 148.22 29.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 1.0 111.018 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.0 p-80 -158.92 155.41 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.678 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.74 69.95 4.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.552 -0.295 . . . . 1.0 111.43 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -175.07 172.13 1.18 Allowed Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 120.41 -0.516 . . . . 1.0 112.326 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 174' ' ' ARG . 42.3 Cg_endo -89.11 -47.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.697 2.265 . . . . 1.0 110.914 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 173' ' ' PRO . 7.3 tpp180 23.32 88.29 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.058 -0.974 . . . . 1.0 112.723 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.08 151.32 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.791 2.327 . . . . 1.0 111.112 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -109.99 144.21 38.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.756 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -96.5 146.69 24.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.05 -40.08 78.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.6 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.11 -54.48 37.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.419 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.05 -35.31 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.374 . . . . 1.0 110.738 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.61 -38.71 88.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.505 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.1 -55.67 32.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.2 t -43.87 -43.46 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 86.0 t -74.99 -37.64 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.496 ' CD ' HH12 ' A' ' 101' ' ' ARG . 60.9 tt0 -48.27 -37.21 15.66 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.92 -40.2 63.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.751 -1.113 . . . . 1.0 109.344 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 44.0 tp -54.99 -32.34 61.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.692 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.83 -35.25 67.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.679 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -56.28 -39.58 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.695 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -53.64 -54.58 35.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.67 -44.11 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.226 -0.897 . . . . 1.0 109.834 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 157' ' ' MET . 10.1 t -51.68 -37.72 51.87 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 71.6 mt -78.2 -32.2 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.082 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.4 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.074 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -68.18 -24.26 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -77.24 -57.14 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.862 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -59.9 -27.34 66.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.885 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.56 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.355 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.421 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 41.3 tp10 -55.66 -37.02 67.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.163 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 -55.34 12.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.075 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.3 p -54.83 -42.07 71.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 1.0 110.303 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.421 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 27.3 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.422 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.776 HMD2 ' OD2' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 198' ' ' ALA . 17.4 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.843 0.354 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.2 p-10 -64.04 -40.26 95.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.236 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.8 mt-30 -71.21 -54.24 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -56.41 -44.79 81.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.88 -26.38 65.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.522 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -56.43 -38.82 72.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.945 0.402 . . . . 1.0 109.998 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.66 58.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.2 p -70.04 -45.44 67.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.479 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 68' ' ' ALA . 55.2 t -57.61 -39.29 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.869 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -68.23 -37.89 81.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.817 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.2 -41.36 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.013 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.74 -45.91 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.866 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.0 tmm_? -53.74 -48.32 69.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.885 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.76 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.24 -52.49 7.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.776 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.86 -7.39 55.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.959 0.409 . . . . 1.0 110.114 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.14 17.79 0.38 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.457 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.642 HG21 HG13 ' A' ' 51' ' ' VAL . 15.1 t -77.37 146.77 36.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.1 m-20 -56.39 -33.08 65.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 41.7 ttm-85 -153.39 127.44 9.02 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 119.174 -1.01 . . . . 1.0 113.533 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.72 132.33 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.973 -1.121 . . . . 1.0 107.973 176.236 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -145.73 161.07 40.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.54 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.38 137.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.955 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 165' ' ' LEU . 67.3 t80 -122.26 119.85 32.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.074 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -100.07 171.11 8.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 67.0 t80 -133.96 136.68 44.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 1.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.42 126.45 33.14 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.353 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.94 -28.61 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.68 2.253 . . . . 1.0 112.923 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -74.29 -7.73 53.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.029 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.06 -13.57 34.11 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.014 -0.612 . . . . 1.0 112.825 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.94 145.94 25.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.352 0.576 . . . . 1.0 110.862 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.61 145.45 15.71 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.9 p -128.82 148.28 50.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 1.0 112.328 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.25 120.49 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 m -110.58 0.51 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -159.0 151.04 21.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 50' ' ' ARG . 1.9 pp20? -169.25 131.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.36 -0.936 . . . . 1.0 113.209 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -113.45 142.56 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' C ' HH12 ' A' ' 43' ' ' ARG . 10.0 ptt85 -133.22 143.96 49.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.481 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.53 112.87 3.9 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.22 34.04 2.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 54.57 31.52 15.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.14 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' NH1' ' HB3' ' A' ' 171' ' ' ALA . 26.6 ttm180 -60.65 -55.56 31.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.457 ' HB2' ' HE ' ' A' ' 50' ' ' ARG . 81.9 mt -95.86 147.21 32.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 57.9 Cg_endo -70.67 170.77 16.86 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.128 1.885 . . . . 1.0 112.528 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' HH22 ' A' ' 50' ' ' ARG . 23.1 t -89.08 130.11 35.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.158 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.8 mt -101.13 1.56 39.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.594 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.62 135.01 57.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.323 0.582 . . . . 1.0 112.24 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 92.63 -7.49 77.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.698 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.8 mp -96.99 132.04 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.885 0.374 . . . . 1.0 110.737 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 m -90.87 117.9 29.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.455 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 m-85 -109.42 135.82 20.27 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.293 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.98 157.35 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.12 1.88 . . . . 1.0 111.628 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.9 -17.78 63.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.823 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.51 -22.23 0.99 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.31 -29.82 64.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.86 0.362 . . . . 1.0 110.634 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.525 ' CG2' ' HE ' ' A' ' 92' ' ' ARG . 58.4 mt -98.66 146.74 32.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.228 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 5.0 Cg_endo -96.18 -142.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.465 2.11 . . . . 1.0 112.331 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 1.2 pt-20 -121.94 -76.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.794 -0.363 . . . . 1.0 111.825 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -45.84 -40.53 9.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.779 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -66.84 -48.61 68.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.657 -0.417 . . . . 1.0 111.014 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 21.3 ttm180 -59.82 -29.46 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.555 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' LEU . 35.1 mtp180 -58.91 -46.79 87.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.567 HD22 ' OE1' ' A' ' 129' ' ' GLU . 43.0 mt -55.12 -36.74 66.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.569 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' CZ ' ' O2A' ' A' ' 203' ' ' CYC . 9.9 m-85 -63.49 -35.18 79.6 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -91.32 -15.85 28.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 2.8 tp -105.8 -45.53 4.36 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.33 0.863 . . . . 1.0 113.33 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.31 -3.67 12.46 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.515 0.931 . . . . 1.0 113.515 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.3 mt-30 30.08 69.68 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.01 1.115 . . . . 1.0 114.01 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.9 -51.21 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.634 HH21 HG22 ' A' ' 154' ' ' VAL . 0.8 OUTLIER 62.82 74.09 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.997 -1.456 . . . . 1.0 114.286 172.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.85 132.42 5.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.72 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 103' ' ' ILE . 2.1 mp -107.84 128.15 63.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.664 HG12 ' N ' ' A' ' 105' ' ' ASP . 44.9 t -82.36 165.99 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.272 0.841 . . . . 1.0 113.272 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.664 ' N ' HG12 ' A' ' 104' ' ' VAL . 12.9 m-20 -52.74 123.28 10.9 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.772 -1.104 . . . . 1.0 112.308 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -58.96 -10.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.707 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.0 pt-20 -85.94 -39.48 16.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.867 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.434 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -60.68 -15.29 27.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.372 0.606 . . . . 1.0 110.066 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 50.86 57.72 6.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.047 -0.979 . . . . 1.0 113.345 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t -94.47 136.09 35.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.349 -2.093 . . . . 1.0 105.349 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -129.6 142.42 50.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.98 1.474 . . . . 1.0 114.98 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 2.8 m -108.3 161.57 14.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.181 -1.372 . . . . 1.0 107.341 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CG1' ' N ' ' A' ' 114' ' ' SER . 15.5 tt -166.9 168.64 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.708 -0.797 . . . . 1.0 112.153 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.429 ' N ' ' CG1' ' A' ' 113' ' ' ILE . 40.7 t -90.41 164.67 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.18 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -151.76 149.5 23.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.645 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -37.81 -41.02 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.679 2.253 . . . . 1.0 112.246 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CD ' ' CH2' ' A' ' 119' ' ' TRP . 93.0 mt-10 -74.47 -74.12 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.533 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 t 41.73 38.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.574 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.478 ' CH2' ' CD ' ' A' ' 117' ' ' GLU . 5.5 m-90 -53.97 -35.55 61.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.99 65.22 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.6 mp 46.0 69.56 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 1.0 110.598 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.4 m -60.67 -27.46 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.585 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.52 -19.17 3.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.811 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 59.52 85.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.84 108.27 59.2 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.111 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -46.12 133.49 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.536 2.157 . . . . 1.0 111.223 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 127' ' ' LEU . 8.5 mp 46.49 -117.7 0.76 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.46 -25.62 0.08 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.646 -0.582 . . . . 1.0 111.646 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.615 ' H ' ' C ' ' A' ' 127' ' ' LEU . 52.9 mt-10 -83.25 153.81 66.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 122.677 -0.307 . . . . 1.0 110.675 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 78.6 Cg_exo -42.28 164.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.431 2.088 . . . . 1.0 111.634 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 mt -80.11 1.88 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.261 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -138.25 160.33 39.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.056 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 130' ' ' PRO . 7.0 mpt_? -121.05 81.61 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.409 ' O ' ' OG ' ' A' ' 112' ' ' SER . 75.5 Cg_exo -49.23 144.46 17.04 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.508 2.139 . . . . 1.0 111.808 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 139' ' ' HIS . 27.0 m -112.8 123.39 68.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 1.0 111.322 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.02 154.55 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.907 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.5 -21.73 73.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 1.0 111.261 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 12.8 p -63.05 -37.07 85.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.658 ' CE1' HG21 ' A' ' 135' ' ' VAL . 1.1 t-80 -80.83 -28.96 35.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.7 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.7 t -52.94 -55.2 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.339 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -66.96 -44.98 79.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.257 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -44.21 -50.99 8.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.473 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.532 HD13 ' NE2' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -72.67 -46.44 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.454 179.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -57.76 -42.64 84.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.456 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.5 m -53.72 -34.34 58.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.2 mtt -82.35 -4.25 56.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.179 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 72.16 25.26 74.98 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.268 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.97 120.84 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.96 -33.16 34.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.4 t -138.48 170.49 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.199 -0.6 . . . . 1.0 111.569 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -163.01 139.82 7.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 1.0 112.185 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.9 tp -116.32 116.23 27.37 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.39 157.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.54 0.686 . . . . 1.0 111.79 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.634 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -156.02 95.73 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.295 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HD2' ' NE ' ' A' ' 101' ' ' ARG . 58.4 Cg_endo -65.81 139.74 58.51 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.536 2.824 . . . . 1.0 113.929 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.8 mt -98.15 107.47 19.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 83.1 mtp -121.12 143.37 49.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 1.0 111.775 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.431 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 84.0 t60 -121.81 114.41 21.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 160' ' ' GLN . 47.2 t60 65.05 -127.65 0.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 159' ' ' HIS . 0.5 OUTLIER -94.53 10.01 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -120.19 158.62 26.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.9 117.31 32.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.872 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 80.0 m95 -95.18 -26.55 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.61 -173.04 26.5 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.987 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.2 tp -142.33 131.44 23.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 1.0 111.251 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 1.9 tp -96.84 143.32 27.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.6 p -150.0 130.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.524 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.589 ' OG ' HG21 ' A' ' 48' ' ' THR . 18.2 t -112.1 141.77 45.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.011 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.401 ' NE2' ' CG2' ' A' ' 167' ' ' VAL . 68.0 m-70 -139.55 142.04 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.108 0.48 . . . . 1.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -155.98 152.27 27.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.778 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.452 ' HB3' ' NH1' ' A' ' 73' ' ' ARG . . . -82.33 71.01 9.39 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.034 -0.266 . . . . 1.0 111.418 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -174.91 168.05 1.86 Allowed Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.325 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -92.45 11.24 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.744 2.296 . . . . 1.0 110.908 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -30.95 113.35 0.32 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.032 -0.985 . . . . 1.0 112.692 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.13 152.28 21.25 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.867 2.378 . . . . 1.0 111.059 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.3 140.88 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.1 p -92.75 154.26 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 182' ' ' GLN . 13.8 pt20 -70.23 -39.01 75.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.624 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.23 -54.17 49.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.532 -0.303 . . . . 1.0 111.369 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -65.67 -30.04 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.378 . . . . 1.0 110.718 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.57 -31.89 71.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.494 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 178' ' ' GLN . 0.3 OUTLIER -71.91 -55.96 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.504 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 51.4 t -42.97 -45.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.257 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.41 -33.69 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 182' ' ' GLN . 59.6 tt0 -50.91 -42.17 59.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 186' ' ' LEU . 9.0 mp -67.66 -41.45 83.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.694 -1.139 . . . . 1.0 109.354 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.02 -28.87 59.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.697 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 191' ' ' VAL . . . -70.8 -26.44 63.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.615 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -70.99 -36.0 72.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.682 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -53.8 -58.62 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 188' ' ' ALA . 17.9 m -60.27 -38.17 76.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.891 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 15.8 m -52.39 -35.55 51.84 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.95 -36.08 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.518 -0.764 . . . . 1.0 110.127 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.91 -46.81 61.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.084 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.65 -34.56 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -75.69 -54.13 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.883 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -55.93 -28.56 57.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.955 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.05 -34.9 57.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.269 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -57.22 -38.57 73.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.183 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.35 -59.21 3.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.169 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 t -65.46 -50.91 63.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 1.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.417 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.577 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.81 0.338 . . . . 1.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -60.51 -49.2 78.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.267 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.51 -51.0 69.15 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 38' ' ' THR . 52.5 mt -56.67 -42.28 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.0 -24.1 66.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.561 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -60.84 -40.39 92.66 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.654 -0.418 . . . . 1.0 109.973 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 -30.58 60.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.8 p -69.51 -46.94 65.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.534 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 68' ' ' ALA . 38.2 t -57.55 -40.96 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.883 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 78.7 mm-40 -72.64 -36.7 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.96 -55.15 24.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.767 -0.651 . . . . 1.0 112.023 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.8 p -59.67 -44.09 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 tmm_? -51.91 -45.47 64.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.817 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.7 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.839 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -81.26 -47.23 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.821 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -77.21 -6.08 51.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.971 0.415 . . . . 1.0 110.124 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.59 17.6 0.5 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.464 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -76.28 143.4 40.93 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.053 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 70' ' ' GLY . 50.0 p30 -65.96 -21.95 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.886 0.699 . . . . 1.0 112.886 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.703 HH21 ' CD2' ' A' ' 169' ' ' HIS . 44.4 ttp180 -155.12 119.29 4.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 119.221 -0.992 . . . . 1.0 113.579 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.3 t -137.54 133.67 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -147.22 160.11 42.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.432 -0.507 . . . . 1.0 111.625 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.94 137.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.002 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 165' ' ' LEU . 38.7 t80 -121.36 119.33 31.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.074 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -100.11 167.83 10.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.33 134.19 46.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 1.0 112.102 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -103.52 129.26 25.75 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.357 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.72 -23.88 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.698 2.265 . . . . 1.0 112.953 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.69 -8.58 58.84 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.994 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.2 39.75 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.836 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -90.49 140.96 29.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.33 0.565 . . . . 1.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 81' ' ' THR . . . -118.24 135.57 11.7 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.9 p -124.0 144.05 50.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 1.0 112.278 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.6 t -100.53 122.87 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.95 -1.129 . . . . 1.0 107.95 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.3 3.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.572 0.582 . . . . 1.0 112.572 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -158.96 149.41 19.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.454 -0.572 . . . . 1.0 109.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -166.19 126.84 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.167 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.88 144.38 33.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -134.57 141.28 46.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.52 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.76 110.34 3.66 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.444 -1.063 . . . . 1.0 110.444 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.1 15.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.8 tt0 72.6 21.6 3.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.116 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -52.27 -57.03 10.96 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.7 146.93 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 107.791 -1.188 . . . . 1.0 107.791 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.25 162.81 40.95 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.068 1.845 . . . . 1.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 p -86.93 132.16 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.609 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 31.5 mt -105.83 -5.69 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.647 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.475 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.1 tp -48.26 134.34 14.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 1.0 112.259 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.05 -40.48 3.07 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 81' ' ' THR . 2.1 tt -59.87 112.57 1.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.39 . . . . 1.0 110.739 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 80' ' ' LEU . 27.9 m -74.77 124.25 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.455 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 6.2 m-85 -104.26 132.64 20.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.274 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.64 149.16 26.56 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.155 1.904 . . . . 1.0 111.713 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.87 68.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -22.75 0.64 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -54.89 -33.64 62.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 1.0 110.672 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.6 132.4 21.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.264 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 61.8 Cg_endo -80.22 -120.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.601 2.2 . . . . 1.0 112.292 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 95.5 mt-10 -141.72 -71.93 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.904 0.383 . . . . 1.0 111.828 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 22.2 pt-20 -42.8 -42.86 3.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.781 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -65.05 -52.64 54.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.75 -29.49 59.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.548 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LEU . 66.6 mtp85 -60.07 -47.38 86.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.319 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 94' ' ' LEU . 57.4 mt -51.7 -44.95 63.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.589 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 27.7 m-85 -59.64 -30.21 68.56 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -90.87 -13.05 34.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.126 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' ARG . 1.5 tp -105.61 -45.97 4.29 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -112.82 0.89 15.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.462 0.912 . . . . 1.0 113.462 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.9 mt-30 28.1 66.39 0.09 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.131 1.16 . . . . 1.0 114.131 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 101' ' ' ARG . 8.2 p -119.32 -47.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 173.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.547 ' N ' HG13 ' A' ' 100' ' ' VAL . 1.6 mtt180 64.79 -22.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.272 170.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 176' ' ' TYR . 8.7 t -56.33 129.64 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.768 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 28.3 mt -107.11 132.68 53.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 104' ' ' VAL . 22.9 m -80.64 166.76 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -51.36 120.38 5.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.233 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -56.07 -10.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.823 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.8 pt-20 -88.61 -37.33 15.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.905 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.8 -15.09 10.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.395 0.617 . . . . 1.0 110.088 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.443 ' HG3' HH11 ' A' ' 111' ' ' ARG . 40.9 tp60 51.58 59.91 4.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.019 -0.991 . . . . 1.0 113.437 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.6 m -91.68 138.0 31.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 105.447 -2.057 . . . . 1.0 105.447 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 109' ' ' GLN . 67.3 mtm-85 -130.98 139.1 49.97 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.455 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 11.9 m -142.48 114.49 8.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.391 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 114' ' ' SER . 0.6 OUTLIER -119.68 -164.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.658 -0.817 . . . . 1.0 112.159 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.594 ' H ' HG22 ' A' ' 113' ' ' ILE . 71.2 m -88.96 166.21 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.264 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -141.3 157.71 65.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.655 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.29 -8.78 21.22 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.648 2.232 . . . . 1.0 112.307 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -140.55 130.08 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.553 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.2 t -146.93 132.83 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -154.17 174.51 14.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.72 70.78 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.014 -0.834 . . . . 1.0 111.014 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.2 mp -70.61 -46.9 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 1.0 110.575 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -69.55 -22.11 63.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.629 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.95 -39.53 71.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.808 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 49.01 93.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 125' ' ' VAL . 35.4 m -119.15 118.04 32.98 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.107 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' LEU . 90.1 Cg_exo -46.16 130.98 14.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.563 2.175 . . . . 1.0 111.157 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 127' ' ' LEU . 9.3 mp 43.79 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.95 -11.7 67.62 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 10.7 mp0 -79.71 153.64 75.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.939 -0.304 . . . . 1.0 110.663 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HB2' HH12 ' A' ' 133' ' ' ARG . 93.8 Cg_exo -45.06 152.15 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.351 2.034 . . . . 1.0 111.652 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 131' ' ' LEU . 7.8 mp -81.38 0.27 38.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.228 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.534 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 7.5 pt20 -150.61 161.55 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.095 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.555 HH21 ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -118.51 82.8 20.0 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.338 178.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.6 149.8 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.62 2.213 . . . . 1.0 111.777 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.866 HG23 HG12 ' A' ' 140' ' ' VAL . 18.9 m -99.97 149.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.036 0.445 . . . . 1.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -89.65 144.21 31.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.947 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -38.92 -21.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.236 1.957 . . . . 1.0 111.258 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.797 ' O ' HBC1 ' A' ' 203' ' ' CYC . 48.5 t -78.49 -46.27 20.04 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.624 ' CE1' HD13 ' A' ' 143' ' ' LEU . 40.1 t-80 -77.66 -38.78 46.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.639 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 135' ' ' VAL . 2.6 m -51.82 -43.09 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.342 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.497 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 85.9 t60 -66.2 -43.44 86.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.225 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -46.98 -50.11 19.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.555 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.624 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.9 mp -68.32 -50.98 49.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.456 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' GLY . 45.4 tptt -55.56 -40.66 72.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.8 m -54.82 -33.32 61.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 45.3 mtt -84.2 -2.87 57.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.218 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.67 24.61 75.36 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.221 -0.899 . . . . 1.0 112.341 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.6 p -108.46 124.12 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.93 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -119.34 153.89 34.42 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.564 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -147.13 128.49 14.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.173 -0.467 . . . . 1.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.97 105.36 8.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 m -110.93 164.75 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.423 0.63 . . . . 1.0 111.838 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 154' ' ' VAL . 3.0 p -161.08 110.44 1.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.331 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.85 139.66 44.06 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.54 2.827 . . . . 1.0 113.865 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.45 105.91 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.766 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.55 142.92 50.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.239 0.543 . . . . 1.0 111.899 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 51.8 t60 -114.09 115.52 27.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 17.5 m-70 60.33 -123.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -93.49 7.03 46.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.884 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -116.28 151.99 34.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.6 115.43 29.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.807 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.3 m95 -95.41 -28.12 15.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.87 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.34 -168.35 23.09 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.167 -1.016 . . . . 1.0 111.963 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -142.95 140.49 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 1.0 111.122 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.1 tp -110.07 145.46 37.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG21 HMB2 ' A' ' 203' ' ' CYC . 38.8 t -149.07 128.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.58 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.4 m -117.59 142.64 46.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.0 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.703 ' CD2' HH21 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -149.82 144.04 25.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.135 0.493 . . . . 1.0 111.016 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -152.84 150.99 29.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.685 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.85 69.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.467 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -147.3 118.49 4.58 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.398 -0.521 . . . . 1.0 112.34 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -89.76 71.93 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.714 2.276 . . . . 1.0 110.887 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -139.23 163.85 42.97 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.063 -0.972 . . . . 1.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.81 164.08 20.6 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.823 2.349 . . . . 1.0 111.086 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.53 154.74 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.803 0.335 . . . . 1.0 110.788 178.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.2 m -95.78 140.01 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.47 -35.23 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.595 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.25 -52.06 67.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.0 111.428 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -68.14 -33.73 75.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.937 0.399 . . . . 1.0 110.667 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.16 -50.77 68.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.516 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.535 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 61.3 tp60 -59.11 -54.48 46.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.424 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.36 -46.93 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.31 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.89 -37.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.535 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 42.8 tt0 -48.0 -38.78 17.84 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.79 -41.95 67.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.34 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.407 ' CD2' HG23 ' A' ' 42' ' ' VAL . 11.5 tp -54.84 -32.8 60.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.666 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.0 -39.3 61.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.685 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.84 -37.92 71.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.754 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -54.66 -52.9 60.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.54 -44.82 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.906 . . . . 1.0 109.91 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 m -51.87 -38.52 56.36 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 76.7 mt -77.76 -32.18 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.061 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.82 67.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -67.37 -24.09 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.16 -56.06 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.868 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -57.45 -26.37 61.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.917 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.93 -34.93 57.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -58.52 -39.3 79.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.91 -59.23 3.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.123 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.6 p -58.25 -43.61 87.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 1.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.42 179.851 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.797 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 31' ' ' LEU . 46.1 tp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.883 0.373 . . . . 1.0 110.529 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 42.9 p-10 -55.62 -38.36 69.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.246 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.4 mt-30 -72.32 -51.33 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -57.4 -45.54 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.73 -27.19 64.76 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.558 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -55.08 -38.02 67.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.023 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.81 -31.89 57.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.374 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.7 p -68.26 -45.78 72.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.481 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 68' ' ' ALA . 52.9 t -57.07 -38.98 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.902 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -77.75 -37.73 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -59.8 -53.68 55.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 43' ' ' ARG . 13.3 p -60.15 -44.61 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.867 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.4 ttp180 -49.87 -44.91 50.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.847 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.87 74.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.772 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -81.33 -50.45 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.96 -6.7 55.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.976 0.417 . . . . 1.0 110.123 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.35 18.85 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.703 -0.68 . . . . 1.0 112.478 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.41 141.05 43.29 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.028 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 70' ' ' GLY . 96.0 m-20 -66.74 -23.9 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 48' ' ' THR . 43.2 ttt85 -152.76 121.41 6.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 119.186 -1.006 . . . . 1.0 113.551 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.17 135.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -146.52 162.55 38.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.427 -0.509 . . . . 1.0 111.549 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.33 135.77 31.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.024 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 62.1 t80 -118.36 118.53 32.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -99.83 168.31 9.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 67.6 t80 -134.97 138.93 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.071 0.462 . . . . 1.0 112.133 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.8 m-20 -103.06 147.87 34.77 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.378 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.51 -19.9 65.45 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.69 2.26 . . . . 1.0 112.948 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -82.3 -1.73 50.47 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.41 -11.37 54.42 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.824 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -89.3 144.82 25.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.361 0.58 . . . . 1.0 110.961 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.23 144.01 15.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.7 p -128.47 146.98 50.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.23 0.538 . . . . 1.0 112.3 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.89 118.65 52.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.15 6.61 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.12 146.68 23.12 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 37.1 tt0 -166.44 128.68 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.369 -0.933 . . . . 1.0 113.13 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -109.89 138.22 46.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 44.0 ptt85 -131.19 141.28 50.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.498 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.33 109.05 3.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 49.32 -85.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.6 pt-20 178.2 31.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.135 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -68.71 -25.62 64.86 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 mt -122.85 148.47 53.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 11.8 Cg_exo -74.03 164.55 34.16 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.016 1.81 . . . . 1.0 112.428 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -85.99 134.21 33.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' H ' HH22 ' A' ' 50' ' ' ARG . 91.6 mt -109.53 -3.02 17.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.641 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.21 139.01 57.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.603 . . . . 1.0 112.191 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.28 -3.24 84.03 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.351 -0.84 . . . . 1.0 111.015 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 tp -101.2 128.43 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 1.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 81' ' ' THR . 9.6 t -85.88 125.19 33.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.444 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' CB ' HAB2 ' A' ' 203' ' ' CYC . 18.7 m-85 -103.15 128.63 27.21 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.282 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.36 161.15 25.78 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.126 1.884 . . . . 1.0 111.666 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.12 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.776 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.53 -29.3 0.71 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.141 -0.784 . . . . 1.0 111.141 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.99 -28.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.798 0.332 . . . . 1.0 110.62 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.8 mt -137.93 99.54 9.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.258 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' ILE . 42.4 Cg_exo -40.63 -103.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.534 2.156 . . . . 1.0 112.325 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 92.7 mt-10 -135.65 -71.34 0.47 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.797 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' HA ' HH11 ' A' ' 93' ' ' ARG . 22.7 pt-20 -42.67 -38.77 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.775 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.45 -53.14 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.97 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -57.2 -31.8 65.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.542 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 97' ' ' LEU . 77.3 mtt85 -60.47 -47.29 86.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.565 -0.289 . . . . 1.0 111.213 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.0 mt -50.23 -43.89 53.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.52 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 68.1 m-85 -59.29 -33.23 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -92.34 -21.0 20.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.061 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tp -106.63 -50.45 3.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.82 -5.81 12.07 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 101' ' ' ARG . 95.1 mt-30 53.13 71.96 0.46 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 100' ' ' VAL . 1.9 p -63.28 59.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.825 ' N ' ' O ' ' A' ' 99' ' ' GLN . 40.6 ptt85 -56.41 -1.62 0.06 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.07 -1.423 . . . . 1.0 114.31 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.9 p -152.68 131.81 3.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.458 -0.497 . . . . 1.0 111.732 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mt -112.11 131.02 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.1 t -83.22 168.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.697 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.3 m-20 -55.15 119.07 4.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.758 -1.11 . . . . 1.0 112.267 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.02 -11.62 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.718 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 2.1 pp20? -84.87 -39.87 17.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.902 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.68 -12.91 4.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 1.0 110.075 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 49.9 59.08 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.433 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -93.41 136.26 33.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.361 -2.088 . . . . 1.0 105.361 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -125.57 136.72 53.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 113' ' ' ILE . 93.6 p -102.81 150.07 23.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.358 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 112' ' ' SER . 19.4 pt -155.19 159.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.696 -0.802 . . . . 1.0 112.113 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.7 t -86.4 164.01 17.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.185 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -149.28 157.17 39.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.722 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.93 -1.58 11.58 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.708 2.272 . . . . 1.0 112.262 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 118' ' ' SER . 84.7 tt0 -57.02 -23.89 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.524 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.3 p 82.29 142.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.627 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -49.35 -98.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.487 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.27 4.94 68.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -90.99 4.31 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.367 . . . . 1.0 110.595 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 124' ' ' ARG . 88.5 p -60.39 -21.46 62.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.542 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.79 1.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.826 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 122' ' ' SER . 12.1 tpt180 55.62 90.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.885 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 125' ' ' VAL . 7.9 p -104.96 132.26 21.03 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 127' ' ' LEU . 85.6 Cg_endo -74.16 125.98 10.17 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.553 2.169 . . . . 1.0 111.143 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLU . 61.1 mt 40.38 -111.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.3 20.41 0.11 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.681 -0.567 . . . . 1.0 111.681 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' LEU . 37.0 mm-40 -114.25 156.51 44.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.679 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -41.55 148.72 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.384 2.056 . . . . 1.0 111.711 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 40.7 mt -76.08 -20.3 57.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.484 ' O ' ' NE ' ' A' ' 133' ' ' ARG . 87.7 mt-30 -133.65 165.44 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.066 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' NE ' ' O ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -133.46 87.26 38.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.24 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.24 154.29 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.598 2.199 . . . . 1.0 111.817 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 16.0 m -98.85 148.05 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.117 0.485 . . . . 1.0 111.294 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.6 OUTLIER -92.28 143.58 27.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.439 -0.8 . . . . 1.0 110.898 -178.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -38.67 -22.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.236 1.958 . . . . 1.0 111.227 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -74.9 -46.72 34.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.604 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 45.6 t-80 -78.39 -29.22 47.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.734 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.15 -55.01 16.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.321 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.448 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 86.7 t60 -63.79 -46.61 84.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.273 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CD1' ' OC ' ' A' ' 203' ' ' CYC . 21.2 t80 -44.14 -48.61 9.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.488 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.713 ' CD1' HMA2 ' A' ' 203' ' ' CYC . 1.0 OUTLIER -71.71 -46.53 58.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.43 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 147' ' ' GLY . 18.1 tptm -59.3 -40.08 85.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.49 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.448 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 17.9 m -54.27 -32.91 57.38 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.9 mtt -84.26 -2.2 56.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.208 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.87 22.51 75.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.287 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 169' ' ' HIS . 43.0 t -105.65 123.59 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -35.39 30.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.4 p -130.88 168.53 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.534 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 p -161.44 139.69 9.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.038 0.447 . . . . 1.0 112.16 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.0 tp -116.84 136.49 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 m -131.6 158.72 43.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.651 . . . . 1.0 111.821 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 153' ' ' VAL . 55.3 t -159.01 90.81 2.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.327 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.52 114.61 1.65 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.559 2.839 . . . . 1.0 113.936 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.4 mt -71.86 105.37 3.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.8 ptm -135.1 147.04 49.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 1.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 79.4 t60 -118.22 115.12 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.517 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 32.0 t-80 59.9 -123.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.517 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 30.7 tt0 -93.04 8.44 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -114.94 143.87 44.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.4 115.55 30.4 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.489 -1.232 . . . . 1.0 108.853 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 76.0 m95 -100.63 -27.93 13.13 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.725 -0.39 . . . . 1.0 111.852 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.1 -171.73 24.38 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.283 -0.96 . . . . 1.0 112.031 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -139.99 131.26 26.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.803 0.335 . . . . 1.0 111.193 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -96.75 136.86 36.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -149.61 129.98 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.574 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -116.43 146.83 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.017 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.718 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -145.09 142.75 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 1.0 111.029 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 11.7 t60 -150.86 151.42 32.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 1.0 109.752 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.433 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.76 69.73 9.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.471 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -173.25 126.72 0.48 Allowed Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.3 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -88.54 111.13 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.582 2.188 . . . . 1.0 110.889 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -157.38 163.42 24.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.694 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.85 152.4 22.11 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.786 2.324 . . . . 1.0 111.098 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.88 127.0 53.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.805 0.336 . . . . 1.0 110.819 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.0 m -67.37 133.54 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.307 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.42 -35.61 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.616 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.74 -54.82 40.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.63 -0.259 . . . . 1.0 111.333 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.63 -32.13 73.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 1.0 110.682 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 tp -62.24 -41.27 98.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.481 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.32 -56.3 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.543 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -45.0 -45.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.574 -0.451 . . . . 1.0 110.27 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -75.44 -36.72 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -47.68 -36.79 11.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.02 -40.38 68.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.386 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.5 tp -55.61 -31.76 62.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.692 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.438 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.95 -39.34 56.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.641 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -57.12 -39.03 74.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.732 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -53.21 -52.64 58.24 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.2 -40.55 65.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.82 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.5 p -51.54 -33.61 32.86 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.02 -36.62 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.062 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -46.45 65.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.114 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 196' ' ' ALA . 8.8 tp -61.57 -36.14 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.164 0.507 . . . . 1.0 109.666 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 158' ' ' HIS . . . -74.84 -53.46 9.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.93 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.56 -28.84 57.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.73 -33.93 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.216 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.38 -41.14 84.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.2 -58.59 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.5 p -57.75 -43.97 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 1.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.457 179.739 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.713 HMA2 ' CD1' ' A' ' 143' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.8 tp . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.853 0.359 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 25.2 p-10 -63.09 -51.02 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.261 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 98.8 mt-30 -61.32 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.684 ' O ' HG23 ' A' ' 38' ' ' THR . 4.4 mm -57.8 -37.94 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.591 0.589 . . . . 1.0 112.591 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.34 -23.32 61.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -64.97 -42.32 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.011 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.12 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.374 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.4 p -69.41 -46.66 66.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 68' ' ' ALA . 13.0 t -55.2 -37.16 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.835 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.35 -38.7 85.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.777 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -62.22 -41.77 98.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.973 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.0 -40.97 84.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.879 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.2 tmm_? -57.95 -50.16 74.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.871 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.76 86.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.9 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -77.48 -52.88 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.824 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.67 -3.64 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 1.0 110.14 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.24 17.11 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.487 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.623 HG21 HG13 ' A' ' 51' ' ' VAL . 6.2 t -77.89 147.56 35.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 70' ' ' GLY . 33.2 p-10 -69.02 -11.6 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 1.0 112.895 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.603 ' NH2' ' CD2' ' A' ' 169' ' ' HIS . 30.7 ttp180 -163.73 122.0 1.91 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 119.115 -1.034 . . . . 1.0 113.487 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.96 133.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 176.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -145.36 159.65 42.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.556 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.65 135.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.015 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' CD1' HBB3 ' A' ' 203' ' ' CYC . 75.5 t80 -118.32 118.28 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.054 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -99.24 166.97 10.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -132.22 134.05 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.569 -0.452 . . . . 1.0 112.15 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.48 129.56 25.79 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.727 -0.669 . . . . 1.0 109.283 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.86 -26.91 2.19 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.675 2.25 . . . . 1.0 112.976 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.21 -7.83 55.72 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.996 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.52 -11.61 42.85 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.048 -0.596 . . . . 1.0 112.832 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -88.46 142.75 27.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.363 0.582 . . . . 1.0 110.941 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -122.37 141.57 14.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 78.7 p -127.21 146.56 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.267 0.556 . . . . 1.0 112.374 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.3 t -95.75 118.82 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.03 -1.59 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.37 150.5 21.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -168.65 131.31 1.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.35 -0.94 . . . . 1.0 113.125 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -114.46 144.92 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -133.25 144.52 49.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.574 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.04 113.17 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.59 19.07 0.13 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 70' ' ' GLY . 38.6 tt0 68.72 28.9 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.194 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -58.2 -55.52 33.96 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt -95.43 149.87 36.74 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.31 170.01 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.066 1.844 . . . . 1.0 112.506 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -89.92 127.71 36.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.143 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 mt -98.88 -1.31 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.655 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 67' ' ' GLU . 9.4 tp -61.39 135.3 57.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.359 0.599 . . . . 1.0 112.179 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.61 -8.11 74.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.1 mp -98.11 131.79 44.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.399 . . . . 1.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.0 m -90.56 120.83 31.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.383 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 62' ' ' GLY . 8.7 m-85 -106.39 135.69 19.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.34 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.53 154.24 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.192 1.928 . . . . 1.0 111.672 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -69.44 -24.44 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.796 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.58 -20.09 0.19 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ALA . 88.8 m-20 -58.46 -30.76 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 1.0 110.659 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.408 ' HA ' ' HHA' ' A' ' 203' ' ' CYC . 23.0 mt -111.91 132.73 21.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.265 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.75 -111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.536 2.157 . . . . 1.0 112.27 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 13.2 tm-20 -150.99 -66.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.804 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 21.1 pt-20 -44.56 -43.7 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.743 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.668 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -63.19 -43.38 98.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.916 0.389 . . . . 1.0 110.974 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HD22 ' A' ' 162' ' ' LEU . 59.8 ttt180 -64.34 -28.01 69.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.585 ' HE ' HD23 ' A' ' 121' ' ' LEU . 66.9 mtp85 -56.95 -49.85 74.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.272 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.03 -38.1 62.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.581 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 8.4 m-85 -64.24 -29.85 70.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -90.31 -13.66 34.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.128 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.16 -43.78 4.31 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.57 -3.73 13.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.541 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.8 mt-30 27.24 70.69 0.05 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.112 1.153 . . . . 1.0 114.112 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.2 p -112.64 -48.36 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.43 -2.434 . . . . 1.0 104.43 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.572 ' N ' HG13 ' A' ' 100' ' ' VAL . 12.1 mtm180 63.42 74.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.077 -1.42 . . . . 1.0 114.24 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.54 135.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.761 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 135' ' ' VAL . 3.0 mt -107.86 125.9 64.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 105' ' ' ASP . 7.5 p -82.79 166.28 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.621 ' N ' HG22 ' A' ' 104' ' ' VAL . 23.7 t0 -54.33 120.25 6.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.713 -1.131 . . . . 1.0 112.336 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.7 m -56.72 -9.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -87.27 -35.83 18.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.831 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -16.83 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.363 0.601 . . . . 1.0 110.076 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 51.38 53.05 13.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.086 -0.961 . . . . 1.0 113.45 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.03 135.6 34.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.385 -2.08 . . . . 1.0 105.385 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -129.46 142.8 50.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 81.9 p -101.43 154.06 19.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.11 -1.405 . . . . 1.0 107.322 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 112' ' ' SER . 20.4 pt -154.92 158.28 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 119.649 -0.821 . . . . 1.0 112.164 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.0 p -89.67 172.3 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.189 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 150.09 53.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -35.85 -74.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.614 2.21 . . . . 1.0 112.297 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -86.27 -44.25 12.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.506 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 t 60.02 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.596 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.56 -173.24 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.576 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.86 57.85 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.1 mp -83.87 -50.13 8.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 1.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 124' ' ' ARG . 19.7 m -63.68 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.01 0.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.788 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 122' ' ' SER . 54.0 ttp180 62.38 102.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.906 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.15 126.78 49.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' O ' ' C ' ' A' ' 127' ' ' LEU . 84.6 Cg_endo -76.5 178.48 7.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.549 2.166 . . . . 1.0 111.204 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 126' ' ' PRO . 45.5 mt -28.59 -72.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.467 -0.493 . . . . 1.0 109.676 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 41.26 33.91 0.88 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.591 -0.604 . . . . 1.0 111.591 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 130' ' ' PRO . 2.7 pt-20 -115.29 83.75 10.7 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.68 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 129' ' ' GLU . 83.4 Cg_exo -45.6 179.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.392 2.062 . . . . 1.0 111.685 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.83 16.81 0.19 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.304 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 130' ' ' PRO . 21.0 pt20 -164.81 168.37 17.86 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.104 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.609 ' NH2' HG22 ' A' ' 135' ' ' VAL . 63.2 ttp85 -143.89 132.43 11.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.309 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.91 142.65 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.515 2.143 . . . . 1.0 111.896 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.609 HG22 ' NH2' ' A' ' 133' ' ' ARG . 16.7 t -133.35 140.1 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 1.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.552 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -39.76 156.17 0.16 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.883 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.21 -7.33 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.196 1.93 . . . . 1.0 111.308 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 m -56.45 -51.47 68.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.47 ' CE1' HG23 ' A' ' 140' ' ' VAL . 5.1 p-80 -71.7 -25.74 62.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.591 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.47 HG23 ' CE1' ' A' ' 139' ' ' HIS . 27.9 t -56.91 -64.13 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.364 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -69.25 -50.69 44.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.202 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.881 ' CD2' HBA1 ' A' ' 203' ' ' CYC . 68.0 t80 -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.446 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' CD2' ' NE2' ' A' ' 169' ' ' HIS . 85.1 mt -73.56 -45.32 54.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.508 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 41.9 tptt -60.18 -41.7 93.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 15.2 m -53.42 -31.11 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.5 mtt -89.82 -2.04 58.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.199 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.11 26.16 71.53 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.251 -0.886 . . . . 1.0 112.348 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.37 120.7 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.971 0.386 . . . . 1.0 109.962 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.14 -34.47 32.46 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -134.92 170.06 16.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.595 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.561 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 39.1 m -163.68 139.82 6.7 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.037 0.446 . . . . 1.0 112.124 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.424 HD13 ' CG ' ' A' ' 176' ' ' TYR . 21.9 tp -114.03 139.26 49.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.5 m -132.46 156.78 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.437 0.637 . . . . 1.0 111.82 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.489 HG11 ' CB ' ' A' ' 188' ' ' ALA . 74.4 t -156.84 91.6 2.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.818 -1.083 . . . . 1.0 109.262 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.45 130.58 39.3 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 123.694 2.929 . . . . 1.0 113.893 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.89 104.83 16.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.795 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.8 mtp -119.2 144.63 46.61 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.871 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 86.1 t60 -124.73 113.3 17.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.951 -1.129 . . . . 1.0 107.951 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.488 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 11.8 t-80 65.17 -127.17 0.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.488 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 91.8 mm-40 -95.15 12.21 29.55 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -120.72 157.47 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 162' ' ' LEU . 0.9 OUTLIER -110.95 115.53 29.64 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 114.493 -1.231 . . . . 1.0 108.848 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.5 m95 -93.44 -25.78 17.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.958 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.58 -167.94 22.75 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.152 -1.023 . . . . 1.0 111.941 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.52 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.6 tp -144.21 129.78 19.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.767 0.317 . . . . 1.0 111.231 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.56 138.31 31.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.33 133.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.597 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.679 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 25.1 p -114.47 142.91 45.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.029 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.679 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -133.92 139.51 46.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 1.0 111.08 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.426 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.7 p-80 -156.09 155.07 31.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.747 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.24 69.51 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.469 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 177.15 153.57 0.42 Allowed Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.349 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -44.34 -58.68 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.713 2.276 . . . . 1.0 110.831 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 43.72 72.41 1.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.696 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.61 149.41 89.88 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.798 2.332 . . . . 1.0 111.044 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 5.9 m-85 -114.36 141.53 47.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 1.0 110.82 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -99.21 150.88 21.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.81 -38.76 89.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.654 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 179' ' ' GLU . 47.6 mp0 -65.59 -55.34 18.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.289 . . . . 1.0 111.333 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.53 -34.23 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.942 0.401 . . . . 1.0 110.717 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.89 -39.48 94.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.467 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -58.73 -53.66 55.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.415 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -46.4 -45.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 187' ' ' LEU . 40.0 t -74.75 -37.96 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.466 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 7.5 tp-100 -47.84 -35.33 10.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.44 -40.08 64.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.734 -1.121 . . . . 1.0 109.367 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 184' ' ' VAL . 42.5 tp -55.07 -31.79 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.715 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.51 -38.07 62.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.64 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -55.54 -39.53 70.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.73 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -52.09 -52.39 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.07 -41.17 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.9 m -52.45 -36.17 54.1 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.62 -41.54 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.082 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.23 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.099 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.466 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.1 tp -61.49 -35.85 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.07 -53.91 11.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.904 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -55.66 -26.43 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.921 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -34.92 58.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.286 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.73 -38.98 76.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -66.99 -58.44 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.131 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.5 t -50.54 -40.85 52.92 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.312 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.369 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.881 HBA1 ' CD2' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.923 0.392 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.18 -41.11 94.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.252 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -71.1 -54.13 12.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.848 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -58.33 -32.44 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -75.53 -25.12 56.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.729 -0.389 . . . . 1.0 111.555 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.34 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.616 -0.434 . . . . 1.0 109.974 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.24 -30.12 43.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.407 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 34' ' ' ILE . 37.5 p -74.77 -49.02 22.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.553 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 36' ' ' ARG . 5.2 p -53.43 -33.9 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.833 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -72.94 -35.52 67.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.38 -43.18 91.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.972 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.21 -51.74 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.89 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.2 ttp180 -49.95 -43.84 50.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.868 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.41 75.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -80.73 -50.73 9.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.32 -6.84 54.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.0 110.072 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.51 18.94 1.06 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.682 -0.69 . . . . 1.0 112.445 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.87 142.29 42.18 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' GLY . 90.5 m-20 -58.32 -32.88 68.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 48' ' ' THR . 58.8 ttp180 -152.45 120.8 6.33 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.595 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.89 135.53 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.673 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 20.8 pttp -144.77 161.0 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.551 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.33 137.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.011 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.7 t80 -122.27 118.48 28.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.014 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -99.57 170.59 8.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 27.8 t80 -134.57 136.74 43.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.039 0.447 . . . . 1.0 112.166 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 m-20 -102.17 148.53 35.53 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.299 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.61 -22.96 70.35 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.681 2.254 . . . . 1.0 112.971 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -79.39 -2.07 40.06 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.029 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.18 -10.5 56.77 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.894 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 148.03 22.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.344 0.572 . . . . 1.0 110.95 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.87 149.7 18.53 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.424 -1.07 . . . . 1.0 110.424 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 1.0 112.347 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.67 116.67 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -112.36 5.23 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.07 145.89 23.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.0 tt0 -166.2 126.97 1.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.378 -0.929 . . . . 1.0 113.216 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.06 138.07 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.9 ptt180 -129.61 142.43 50.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.544 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.49 106.23 2.99 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.84 -87.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLY . 19.5 pt-20 -179.27 31.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.115 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 49' ' ' ASP . 7.1 ttp180 -70.11 -51.2 33.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.52 124.63 47.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.33 169.44 3.93 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.133 1.889 . . . . 1.0 112.49 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 141.47 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.151 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.592 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 33.3 mt -113.28 -2.14 14.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.623 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.0 tp -56.83 138.17 53.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.329 0.585 . . . . 1.0 112.279 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -4.04 84.49 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.425 -0.807 . . . . 1.0 111.088 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -100.47 117.72 35.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 1.0 110.82 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.654 ' N ' HD23 ' A' ' 80' ' ' LEU . 76.9 p -76.88 123.55 26.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.447 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 80' ' ' LEU . 10.0 m-85 -107.17 135.07 19.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.92 150.97 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.128 1.885 . . . . 1.0 111.649 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.55 -25.78 66.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.849 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.45 -21.2 0.25 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 m-20 -54.84 -32.65 60.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 1.0 110.592 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 HH21 ' A' ' 92' ' ' ARG . 3.5 pt -121.0 99.49 46.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.244 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 87' ' ' ILE . 51.2 Cg_exo -42.11 -107.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.5 2.134 . . . . 1.0 112.317 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 19.7 pt-20 -152.4 -46.14 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 1.0 111.83 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 24.4 pt-20 -60.66 -39.09 87.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.71 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.9 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.554 HH21 HD12 ' A' ' 87' ' ' ILE . 29.4 ttm105 -66.34 -29.88 70.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.556 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -55.92 -55.29 34.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.318 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.638 HD22 ' NE ' ' A' ' 133' ' ' ARG . 5.5 tp -53.04 -43.42 66.59 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.543 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.35 -32.64 70.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' NH2' ' SD ' ' A' ' 157' ' ' MET . 9.6 mmp_? -87.34 -11.03 50.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.136 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 tp -106.85 -44.96 4.3 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.31 0.856 . . . . 1.0 113.31 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.57 -1.96 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.587 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 97.6 mt-30 26.15 69.03 0.05 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.093 1.146 . . . . 1.0 114.093 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.659 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 31.4 m -113.04 -50.96 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.405 -2.443 . . . . 1.0 104.405 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.659 ' HE ' ' N ' ' A' ' 100' ' ' VAL . 3.5 mtm180 63.66 72.38 0.47 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.052 -1.431 . . . . 1.0 114.256 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 102' ' ' VAL . 15.0 p -148.87 133.0 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.477 -0.489 . . . . 1.0 111.735 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.515 HG21 ' OG ' ' A' ' 151' ' ' SER . 2.4 mt -109.2 124.67 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 108.331 -0.989 . . . . 1.0 108.331 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.6 p -83.16 167.71 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.274 0.842 . . . . 1.0 113.274 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.665 ' N ' HG22 ' A' ' 104' ' ' VAL . 9.5 m-20 -55.54 119.18 5.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.711 -1.131 . . . . 1.0 112.268 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.67 -10.34 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.754 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.46 -36.93 16.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.906 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -16.79 37.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.416 0.626 . . . . 1.0 110.145 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 51.8 58.35 5.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.982 -1.008 . . . . 1.0 113.455 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -94.1 137.82 32.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -127.82 133.21 49.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 113' ' ' ILE . 23.6 m -103.58 152.43 21.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.195 -1.366 . . . . 1.0 107.382 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 112' ' ' SER . 17.3 pt -156.53 160.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 119.689 -0.804 . . . . 1.0 112.189 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.0 m -89.18 165.94 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.229 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 117' ' ' GLU . 36.1 mt-30 -153.05 150.88 25.05 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.639 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -41.37 74.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.651 2.234 . . . . 1.0 112.243 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' A' ' 115' ' ' GLN . 6.3 pt-20 178.36 55.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.55 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 t -57.41 -33.95 68.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.645 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.32 -168.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.593 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.27 60.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 40.4 mt -74.45 -24.76 59.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 1.0 110.565 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 m -54.59 -28.4 45.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.602 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.93 51.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 56.48 86.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.26 109.27 59.89 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.097 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.55 130.95 15.32 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.568 2.179 . . . . 1.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.2 mt 43.63 -124.83 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.77 15.12 5.93 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 98' ' ' ALA . 23.1 mt-10 -112.1 152.11 44.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.683 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.56 156.32 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.407 2.072 . . . . 1.0 111.663 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.66 -0.67 34.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.284 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.61 162.09 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.111 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.638 ' NE ' HD22 ' A' ' 94' ' ' LEU . 10.7 tpp180 -120.8 86.65 41.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.258 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.33 147.6 28.24 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.512 2.142 . . . . 1.0 111.791 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 139' ' ' HIS . 6.9 m -97.75 153.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.042 0.449 . . . . 1.0 111.373 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -89.09 155.81 49.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.891 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.23 -20.42 24.75 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.267 1.978 . . . . 1.0 111.164 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.717 ' O ' HBC1 ' A' ' 203' ' ' CYC . 45.0 t -69.89 -51.97 28.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.729 ' ND1' ' C ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -73.38 -27.28 61.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.634 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 25.4 t -52.9 -53.13 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.322 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.544 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 72.1 t60 -66.05 -44.09 85.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.661 ' CD2' HAA2 ' A' ' 203' ' ' CYC . 52.6 t80 -42.02 -48.56 4.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.467 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.2 mt -74.19 -43.74 56.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.502 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' GLY . 40.1 tptt -61.02 -42.55 98.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.544 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 16.2 m -54.26 -32.29 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 42.9 mtt -88.18 -0.98 57.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.217 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.14 24.93 76.26 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.197 -0.911 . . . . 1.0 112.31 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.0 t -106.84 120.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.47 -30.88 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.54 ' OG ' ' CD2' ' A' ' 170' ' ' HIS . 98.7 p -139.46 171.76 13.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.137 -0.625 . . . . 1.0 111.563 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 103' ' ' ILE . 8.3 p -161.93 140.44 9.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.211 -0.45 . . . . 1.0 112.171 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.4 139.42 50.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -133.22 154.41 39.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.479 0.657 . . . . 1.0 111.821 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 153' ' ' VAL . 54.8 t -158.19 91.29 2.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.72 134.7 54.82 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.521 2.814 . . . . 1.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.9 mt -94.76 107.89 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.772 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.566 ' SD ' ' NH2' ' A' ' 96' ' ' ARG . 15.8 ptm -128.7 146.89 50.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.906 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 65.7 t60 -117.79 115.41 24.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 60.5 t60 61.52 -124.61 0.83 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.789 -0.449 . . . . 1.0 109.789 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 74.2 mt-30 -93.24 5.01 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.43 150.74 32.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.85 116.35 31.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.831 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.455 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 83.7 m95 -93.85 -24.87 17.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.898 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.79 -165.32 21.88 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.979 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.6 tp -143.55 133.31 23.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 1.0 111.179 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 3.5 tp -95.11 140.66 29.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.02 135.23 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.608 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.784 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 0.9 OUTLIER -120.02 139.95 51.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.049 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.784 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -136.51 142.15 43.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 1.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.54 ' CD2' ' OG ' ' A' ' 150' ' ' SER . 4.2 p-80 -156.48 153.75 29.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.712 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.69 72.2 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.418 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -173.2 135.16 0.69 Allowed Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.396 -0.522 . . . . 1.0 112.359 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -84.72 47.44 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.681 2.254 . . . . 1.0 110.885 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -78.65 131.77 66.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.031 -0.986 . . . . 1.0 112.756 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.55 149.97 35.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.856 2.37 . . . . 1.0 111.079 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 9.4 m-85 -108.77 150.07 28.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.847 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.3 p -100.19 146.59 26.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.75 -35.67 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 58.0 mp0 -65.67 -55.59 16.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.302 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.43 -34.95 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 1.0 110.683 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.25 -34.66 74.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.49 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 185' ' ' GLN . 51.0 tt0 -66.88 -51.8 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.36 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.4 t -45.2 -48.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.317 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.1 p -74.59 -37.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 182' ' ' GLN . 6.9 tt0 -48.06 -37.15 14.42 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.54 -40.22 70.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 184' ' ' VAL . 34.5 tp -55.2 -30.97 61.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.738 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.448 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -73.74 -39.01 64.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.618 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.59 -40.23 71.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.76 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -51.05 -52.94 38.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.05 -41.14 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.839 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -36.17 57.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.15 -37.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.001 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.24 68.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.068 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.6 tp -62.42 -33.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -73.74 -53.75 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.895 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -55.73 -27.65 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.95 -34.5 57.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.291 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -58.35 -40.27 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.117 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.36 -58.55 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.46 -0.337 . . . . 1.0 111.084 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.0 p -46.22 -38.35 8.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 1.0 110.355 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.429 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.963 HBA2 HBC2 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.904 0.383 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -69.8 -52.42 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.275 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.6 -50.04 74.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.76 -32.35 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -176.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.5 -25.77 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.535 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.89 -42.22 94.98 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.003 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.88 -26.62 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.364 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 34' ' ' ILE . 71.3 p -73.66 -45.4 52.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.534 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 68' ' ' ALA . 20.4 t -55.05 -37.7 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.873 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.39 -34.8 70.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.9 -43.36 96.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.99 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.58 -45.87 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.916 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.9 ttp180 -52.89 -47.46 67.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.884 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.808 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.65 -51.63 9.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.24 -6.08 49.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 1.0 110.111 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 16.83 0.37 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.459 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.649 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -76.48 144.86 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.036 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -61.75 -29.3 70.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.947 0.721 . . . . 1.0 112.947 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 48' ' ' THR . 18.7 ttt85 -149.19 122.0 8.71 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.187 -1.005 . . . . 1.0 113.522 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.6 t -137.71 130.64 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.526 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 36.7 pttt -145.23 156.22 43.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.556 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.8 139.65 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.045 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.6 t80 -124.75 120.34 31.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -100.35 171.43 7.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.896 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 8.8 t80 -133.52 138.17 45.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 1.0 112.142 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.7 m-20 -103.59 147.71 34.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.386 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.71 -26.44 75.3 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.797 2.331 . . . . 1.0 112.906 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -76.32 -5.9 49.16 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.976 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.16 -11.55 51.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.923 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -86.48 142.85 28.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.343 0.572 . . . . 1.0 110.962 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -123.22 143.24 15.0 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -126.59 147.01 49.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.229 0.538 . . . . 1.0 112.282 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.53 115.26 31.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.12 -1.56 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -157.09 147.25 20.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 40.3 tt0 -164.68 125.51 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.409 -0.917 . . . . 1.0 113.214 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.44 134.75 49.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.524 HH11 ' CB ' ' A' ' 76' ' ' SER . 15.3 mtm180 -121.93 138.93 54.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.531 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.51 107.0 2.97 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.364 -1.094 . . . . 1.0 110.364 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.5 30.12 1.32 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.255 -1.138 . . . . 1.0 110.255 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 58.89 27.18 15.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.119 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -57.63 -58.83 6.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.25 147.61 38.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 52.3 Cg_endo -68.69 160.69 48.46 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.089 1.859 . . . . 1.0 112.552 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.524 ' CB ' HH11 ' A' ' 69' ' ' ARG . 5.4 p -80.84 126.02 30.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.181 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.424 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 33.7 mt -101.0 -8.62 22.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.59 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 tp -53.61 138.24 35.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 -2.65 79.58 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -99.88 128.33 45.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 1.0 110.77 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.8 122.17 29.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.45 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.42 132.73 20.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.25 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.59 151.95 25.71 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.096 1.864 . . . . 1.0 111.629 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' C ' ' OD1' ' A' ' 86' ' ' ASP . . . -60.12 -25.02 65.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.812 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.84 -24.29 1.25 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 17.9 p-10 -54.68 -26.57 34.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 1.0 110.619 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.562 HD12 HH21 ' A' ' 92' ' ' ARG . 51.9 mt -127.84 132.88 24.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.297 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 89.3 Cg_endo -76.87 -104.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.563 2.176 . . . . 1.0 112.277 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -161.28 -43.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 1.0 111.845 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.4 -42.83 88.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.757 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.791 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -59.67 -36.36 76.31 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.562 HH21 HD12 ' A' ' 87' ' ' ILE . 90.0 mtt-85 -66.2 -27.5 68.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' LEU . 30.3 mmt180 -54.54 -58.93 5.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.275 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.09 -37.66 67.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.549 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.7 m-85 -66.69 -39.13 87.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.409 HH12 HD13 ' A' ' 162' ' ' LEU . 5.7 tpp180 -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.549 -0.751 . . . . 1.0 110.137 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ARG . 4.4 tp -107.13 -43.32 4.64 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.99 -3.66 12.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 97.1 mt-30 27.42 70.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.066 1.136 . . . . 1.0 114.066 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.66 ' H ' HH22 ' A' ' 133' ' ' ARG . 14.3 t -110.72 -50.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.516 HH22 ' CD ' ' A' ' 185' ' ' GLN . 12.4 mtm180 64.81 72.75 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.053 -1.431 . . . . 1.0 114.248 172.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.43 ' C ' HD12 ' A' ' 103' ' ' ILE . 70.3 t -149.37 131.42 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.67 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.06 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 105' ' ' ASP . 41.4 t -81.29 165.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.194 0.813 . . . . 1.0 113.194 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 104' ' ' VAL . 22.5 t0 -51.7 120.77 5.56 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.664 -1.153 . . . . 1.0 112.315 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 106' ' ' VAL . 16.9 t -57.13 -12.7 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.702 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 12.6 pt-20 -80.22 -38.73 30.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.96 -16.54 59.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 1.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 51.19 60.08 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.991 -1.004 . . . . 1.0 113.39 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.6 p -94.56 138.88 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.16 146.49 51.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.48 . . . . 1.0 114.997 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 t -134.4 115.39 13.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.1 -1.409 . . . . 1.0 107.337 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.83 ' H ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -120.07 -165.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.686 -0.806 . . . . 1.0 112.114 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.593 ' H ' HG22 ' A' ' 113' ' ' ILE . 33.3 t -85.06 161.2 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.45 -0.796 . . . . 1.0 110.201 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 113' ' ' ILE . 0.0 OUTLIER -140.74 159.94 60.66 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.685 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.84 -158.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.621 2.214 . . . . 1.0 112.296 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -47.0 138.96 6.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.572 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t 169.48 -60.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.592 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.423 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 36.9 t-105 47.0 -131.86 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.569 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 91.38 2.67 70.27 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.5 mt -68.87 -35.19 76.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 1.0 110.544 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.6 m -58.74 -27.87 65.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.61 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.799 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 56.9 86.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.1 m -104.33 110.08 63.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.129 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 127' ' ' LEU . 95.3 Cg_exo -46.39 138.97 13.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.529 2.153 . . . . 1.0 111.211 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.7 tp 43.26 -164.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.407 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 87.31 -5.03 85.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.57 -0.612 . . . . 1.0 111.57 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.54 155.2 68.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.689 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.38 158.98 52.49 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.431 2.087 . . . . 1.0 111.636 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.4 mt -78.76 -10.47 59.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.278 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -134.58 159.12 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.634 -0.427 . . . . 1.0 111.061 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.66 HH22 ' H ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -122.97 81.24 50.6 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.288 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.96 145.45 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.586 2.191 . . . . 1.0 111.746 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.4 m -113.01 122.42 67.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 1.0 111.346 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.605 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.1 OUTLIER -39.34 155.92 0.14 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.883 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 140' ' ' VAL . 43.3 Cg_endo -63.0 -13.82 37.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.221 1.947 . . . . 1.0 111.317 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.76 -29.94 58.99 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.769 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 40.2 t-80 -86.4 -38.05 17.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.351 -0.84 . . . . 1.0 110.679 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 137' ' ' PRO . 4.0 m -52.16 -47.23 44.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.351 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.597 ' N ' HG23 ' A' ' 140' ' ' VAL . 82.3 t60 -65.49 -44.04 88.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.273 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -45.24 -48.75 12.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.5 mp -70.96 -48.47 53.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.45 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 16.4 tptp -58.08 -41.71 84.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.484 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.4 m -54.41 -30.6 52.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.3 mtt -87.28 -1.34 57.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.158 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.38 28.15 71.7 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.292 -0.867 . . . . 1.0 112.337 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -109.93 123.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.77 -32.51 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 8.6 t -137.18 169.54 17.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.551 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -158.6 139.45 12.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.045 0.45 . . . . 1.0 112.162 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.81 136.73 52.72 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 101' ' ' ARG . 2.7 m -135.8 159.39 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.458 0.647 . . . . 1.0 111.824 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 188' ' ' ALA . 79.0 t -157.04 91.79 2.41 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.869 -1.06 . . . . 1.0 109.346 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.02 126.35 19.91 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.617 2.878 . . . . 1.0 113.904 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.8 mt -81.55 106.17 13.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.839 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.428 ' O ' ' OG ' ' A' ' 192' ' ' SER . 73.8 mtp -123.91 144.9 49.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.793 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 81.2 t60 -120.89 113.39 20.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.501 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 26.4 t-80 61.35 -121.11 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.501 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 30.1 tt0 -95.94 6.31 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.873 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' N ' ' CD ' ' A' ' 161' ' ' GLU . 43.8 mp0 -115.79 154.09 30.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.409 HD13 HH12 ' A' ' 96' ' ' ARG . 5.9 tt -111.14 116.57 31.32 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.557 -1.201 . . . . 1.0 108.88 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.7 m95 -94.93 -25.79 16.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.922 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.84 20.52 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.237 -0.982 . . . . 1.0 111.953 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.8 tp -143.05 130.69 21.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.766 0.317 . . . . 1.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -95.33 132.5 40.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.71 137.47 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.597 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -122.22 144.12 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.094 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.487 ' ND1' HG21 ' A' ' 148' ' ' VAL . 89.7 m-70 -139.68 143.72 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.139 0.495 . . . . 1.0 110.974 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -159.43 155.42 26.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.707 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.55 67.51 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.436 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -176.22 131.99 0.4 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 120.429 -0.509 . . . . 1.0 112.314 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 174' ' ' ARG . 24.9 Cg_exo -39.02 -48.6 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.649 2.232 . . . . 1.0 110.91 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 173' ' ' PRO . 23.6 ttm180 29.1 81.45 0.22 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.009 -0.996 . . . . 1.0 112.733 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.34 150.38 88.71 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.796 2.331 . . . . 1.0 111.195 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.83 139.26 46.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.806 0.336 . . . . 1.0 110.767 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.9 t -92.22 145.69 24.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.288 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -63.61 -43.34 97.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.588 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 179' ' ' GLU . 46.8 mp0 -60.92 -55.64 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.044 -0.262 . . . . 1.0 111.394 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.66 -29.09 69.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 1.0 110.651 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.93 -35.17 77.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.523 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -69.5 -53.52 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.388 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.1 t -43.47 -47.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.296 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.8 m -74.69 -36.81 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.516 ' CD ' HH22 ' A' ' 101' ' ' ARG . 6.7 tt0 -48.4 -38.18 18.89 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.14 -40.75 71.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.356 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.4 tt -54.81 -31.83 59.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.725 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.485 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -71.93 -33.86 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.605 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -57.68 -40.82 80.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.716 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -51.35 -53.5 35.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.63 -40.83 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.92 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 157' ' ' MET . 5.8 t -52.09 -36.54 51.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.02 -34.84 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.035 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.87 -46.52 62.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.056 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.43 -33.53 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.67 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.911 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -55.49 -29.41 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.918 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.55 53.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.287 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.413 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.1 tt0 -57.64 -39.36 76.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.01 -57.98 4.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.125 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -56.41 -44.35 80.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 1.0 110.339 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.413 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 5.2 tp . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.791 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 35' ' ' LEU . 60.2 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.875 0.369 . . . . 1.0 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -52.38 -52.69 52.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.307 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -60.15 -48.43 81.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 1.0 112.254 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 38' ' ' THR . 57.3 mt -57.68 -40.47 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.592 0.59 . . . . 1.0 112.592 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 31' ' ' LEU . 51.7 mt -69.89 -22.52 63.22 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.531 -177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 39' ' ' VAL . 93.4 mtt-85 -65.3 -35.29 80.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.706 -0.397 . . . . 1.0 109.975 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.98 -28.66 39.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.343 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.5 p -74.17 -48.96 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.56 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -53.47 -36.28 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.3 mt-10 -75.51 -32.83 60.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -66.64 -51.45 56.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.04 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.8 p -64.96 -48.24 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.811 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.632 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.5 tmt_? -51.65 -44.13 62.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.886 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.15 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.867 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -79.76 -48.91 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.45 -5.64 48.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.101 0.477 . . . . 1.0 110.198 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.65 17.39 0.26 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.433 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.63 144.78 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.1 m-20 -55.86 -34.6 65.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 48' ' ' THR . 35.0 ttm180 -149.53 126.14 10.99 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.184 -1.006 . . . . 1.0 113.521 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 t -135.93 130.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.032 -1.099 . . . . 1.0 108.032 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 54.5 pttt -144.34 157.54 44.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.519 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' A' ' 66' ' ' ALA . 9.4 p -99.35 138.68 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.03 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.2 t80 -122.57 120.73 34.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.083 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.553 ' NH1' HD11 ' A' ' 195' ' ' ILE . 65.9 mtp85 -99.72 169.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -133.6 134.71 43.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.031 0.444 . . . . 1.0 112.165 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.54 129.1 26.66 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.343 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -25.77 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.739 2.293 . . . . 1.0 112.888 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.6 -6.15 52.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.015 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.45 -11.5 43.08 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.051 -0.595 . . . . 1.0 112.92 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -88.71 142.76 27.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.361 0.581 . . . . 1.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -123.13 142.63 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.43 -1.068 . . . . 1.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.7 p -128.05 146.01 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.217 0.532 . . . . 1.0 112.269 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.96 111.3 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.66 8.0 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB3' HG12 ' A' ' 53' ' ' VAL . . . -155.19 147.13 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 72.5 tt0 -167.34 128.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.352 -0.939 . . . . 1.0 113.184 -177.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.18 131.17 54.93 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -117.4 136.65 53.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.55 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.04 88.84 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.39 -87.88 0.05 OUTLIER Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.266 -1.133 . . . . 1.0 110.266 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -175.76 34.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.884 -0.326 . . . . 1.0 111.147 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -70.11 -55.71 8.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.572 ' C ' HH22 ' A' ' 50' ' ' ARG . 12.5 mt -94.97 157.85 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 176.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 3.3 Cg_exo -78.51 165.32 25.29 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.154 1.903 . . . . 1.0 112.476 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 p -87.01 127.98 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.177 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 44.7 mt -101.13 1.06 38.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.58 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.549 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -65.25 138.65 58.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.346 0.593 . . . . 1.0 112.264 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.549 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 91.6 -2.85 77.92 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.111 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.5 mp -100.76 128.96 46.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.866 0.365 . . . . 1.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.23 121.81 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.411 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 62' ' ' GLY . 7.5 m-85 -107.68 136.77 19.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.39 157.79 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.166 1.91 . . . . 1.0 111.664 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -66.18 -25.59 67.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.78 -19.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 84' ' ' ALA . 85.3 m-20 -54.87 -34.16 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.359 . . . . 1.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 ' HE ' ' A' ' 92' ' ' ARG . 21.7 mm -109.12 133.71 20.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.258 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.53 ' HD3' HMC3 ' A' ' 203' ' ' CYC . 58.7 Cg_endo -80.89 -120.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.491 2.127 . . . . 1.0 112.335 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.5 mm-40 -138.87 -56.58 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.759 -0.376 . . . . 1.0 111.849 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -59.46 -39.57 84.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.733 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.62 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.963 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 87' ' ' ILE . 39.7 ttm180 -63.22 -30.32 71.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.508 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -58.21 -50.48 73.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.0 111.26 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' NE ' ' A' ' 133' ' ' ARG . 95.6 mt -55.13 -36.25 65.56 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.604 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.625 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 6.6 m-85 -64.24 -32.05 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 96' ' ' ARG . 9.2 mmm180 -83.62 -15.12 50.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.157 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.84 -42.72 4.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.74 -4.97 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.549 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 26.27 69.96 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 101' ' ' ARG . 1.7 m -110.63 -49.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 9.3 mtm180 63.09 68.86 0.6 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.066 -1.425 . . . . 1.0 114.335 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -148.77 133.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.849 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.507 HD11 HAA2 ' A' ' 203' ' ' CYC . 3.4 mt -106.12 124.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.0 p -82.57 167.59 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.627 ' N ' HG22 ' A' ' 104' ' ' VAL . 3.0 m-20 -51.61 115.06 1.44 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.327 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 106' ' ' VAL . 54.7 t -54.81 -11.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.722 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.45 -33.57 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.08 -16.97 36.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.438 0.637 . . . . 1.0 110.143 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 53.28 59.97 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.969 -1.014 . . . . 1.0 113.435 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -92.37 134.34 35.01 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -124.86 138.23 54.26 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.481 . . . . 1.0 114.997 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.11 158.15 20.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.209 -1.36 . . . . 1.0 107.342 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 14.9 tt -165.86 167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.67 -0.812 . . . . 1.0 112.143 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.422 ' N ' ' CG1' ' A' ' 113' ' ' ILE . 28.4 t -89.38 164.67 14.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 118' ' ' SER . 24.3 mp0 -136.96 149.95 68.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.648 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -35.29 -40.18 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.663 2.242 . . . . 1.0 112.212 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 118' ' ' SER . 45.0 mt-10 -64.84 -37.48 87.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.0 t 58.27 149.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.631 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 5.5 m0 42.39 -139.6 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.5 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 3.16 64.08 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.42 -7.46 59.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 1.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.6 t -58.23 -26.81 63.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.619 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.16 -33.4 62.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.807 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 60.32 79.26 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.884 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 m -98.41 144.22 27.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.107 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 127' ' ' LEU . 73.6 Cg_endo -72.73 130.07 15.33 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.531 2.154 . . . . 1.0 111.186 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 126' ' ' PRO . 35.0 mt 41.77 -122.64 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.89 10.17 64.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.644 -0.582 . . . . 1.0 111.644 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -157.61 144.7 13.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.722 -0.281 . . . . 1.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.06 150.65 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.378 2.052 . . . . 1.0 111.676 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.7 mt -80.02 24.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.271 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -130.98 163.75 26.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.039 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' CG ' HH11 ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.97 117.17 24.01 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.299 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.13 149.75 17.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.573 2.182 . . . . 1.0 111.783 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.564 HG12 HBD2 ' A' ' 203' ' ' CYC . 5.7 m -101.42 153.53 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 1.0 111.375 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.675 ' H ' HMD2 ' A' ' 203' ' ' CYC . 12.2 m-20 -88.98 146.2 36.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.903 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -42.62 -23.76 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.278 1.985 . . . . 1.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.1 p -67.66 -40.36 84.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.679 ' CE1' HD12 ' A' ' 143' ' ' LEU . 0.2 OUTLIER -78.97 -26.69 43.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.641 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -51.33 -53.16 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 1.0 110.38 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' SER . 51.1 t-80 -68.25 -43.35 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.261 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -47.1 -57.19 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.455 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.679 HD12 ' CE1' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -68.46 -50.0 55.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.481 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.7 tptm -56.33 -39.53 72.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.407 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 141' ' ' HIS . 29.4 t -54.47 -32.48 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.4 mtt -83.45 -2.04 54.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.196 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.67 24.22 74.01 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.34 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 170' ' ' HIS . 24.0 t -109.27 124.55 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.2 -31.98 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.743 0.645 . . . . 1.0 112.743 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -135.13 169.73 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 1.0 111.565 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 5.0 p -161.56 139.48 9.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.163 0.431 . . . . 1.0 112.163 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.1 tp -114.83 139.25 49.9 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -135.68 156.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.423 0.63 . . . . 1.0 111.845 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 153' ' ' VAL . 71.5 t -157.8 93.13 2.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.851 -1.068 . . . . 1.0 109.341 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.32 115.84 2.66 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.581 2.854 . . . . 1.0 113.973 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.08 105.07 4.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.794 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 75.5 mtp -121.78 146.14 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.168 0.508 . . . . 1.0 111.846 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.454 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 80.2 t60 -123.18 112.88 18.22 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.9 t-80 64.89 -125.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.413 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 87.4 mt-30 -95.19 8.56 42.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.868 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 44.8 mp0 -118.42 155.08 31.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.897 1.073 . . . . 1.0 113.897 -177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.09 118.0 35.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.504 -1.225 . . . . 1.0 108.885 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CD2' ' OE2' ' A' ' 199' ' ' GLU . 77.9 m95 -97.51 -27.73 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.736 -0.386 . . . . 1.0 111.981 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.06 -173.45 25.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.189 -1.005 . . . . 1.0 111.965 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.529 ' CD2' HMB2 ' A' ' 203' ' ' CYC . 5.0 tp -139.15 131.33 28.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.849 0.357 . . . . 1.0 111.149 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.94 137.86 34.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.9 p -150.91 132.76 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.572 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 p -116.02 145.55 42.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.0 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.402 ' HB3' HG11 ' A' ' 148' ' ' VAL . 99.7 m-70 -132.54 140.31 48.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 1.0 110.975 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 6.5 t60 -147.44 142.75 27.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.757 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.79 67.42 9.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.441 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -177.04 133.45 0.37 Allowed Pre-proline 0 N--CA 1.466 0.342 0 C-N-CA 120.43 -0.508 . . . . 1.0 112.349 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -85.23 112.05 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.654 2.236 . . . . 1.0 110.85 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -146.37 146.68 28.41 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.021 -0.99 . . . . 1.0 112.698 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.07 149.57 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.873 2.382 . . . . 1.0 111.118 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.66 151.38 25.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.826 0.346 . . . . 1.0 110.831 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -101.45 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.314 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -68.96 -34.98 76.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.683 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.91 -55.92 16.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.401 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 38.9 mp0 -67.75 -34.1 76.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.0 110.734 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.8 tp -62.28 -31.43 72.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.484 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.93 -52.73 22.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.458 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.0 t -44.86 -45.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.282 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.3 p -75.06 -37.32 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -47.58 -38.1 13.75 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.34 -40.15 74.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.727 -1.124 . . . . 1.0 109.437 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.9 tt -54.34 -30.91 53.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.64 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.66 -36.02 67.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.637 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -55.31 -39.57 70.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.717 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -53.75 -53.9 45.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 82.2 t -58.42 -42.28 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.861 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.5 p -51.35 -36.62 43.8 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -77.68 -34.97 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.031 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.5 -46.36 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.047 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 55' ' ' ARG . 14.9 tt -64.08 -33.15 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -74.19 -55.83 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.875 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.28 -25.72 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.21 59.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.263 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.545 ' OE2' ' CD2' ' A' ' 163' ' ' TRP . 92.0 mt-10 -58.65 -39.96 82.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.198 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.38 -60.06 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.101 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 92.8 p -54.22 -40.72 67.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.348 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.042 -0.98 . . . . 1.0 110.442 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.675 HMD2 ' H ' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.916 0.389 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -65.21 -40.57 94.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.321 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.72 -53.7 14.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.846 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -59.23 -34.04 52.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.581 0.585 . . . . 1.0 112.581 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.59 -25.48 59.29 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.553 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -60.08 -54.11 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.951 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.78 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.32 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.2 p -65.71 -46.96 77.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.655 HG12 ' HB2' ' A' ' 68' ' ' ALA . 7.2 t -52.3 -31.45 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.848 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.36 -36.23 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 1.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -58.9 -43.24 90.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.953 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG22 HD22 ' A' ' 187' ' ' LEU . 74.0 t -66.33 -38.77 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.876 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.5 ttt180 -57.31 -52.54 64.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.06 87.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.745 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -79.43 -53.98 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.716 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -76.94 -4.76 45.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.0 110.176 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.12 16.74 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.397 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 51' ' ' VAL . 14.6 t -77.41 145.9 36.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.106 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 70' ' ' GLY . 49.2 p30 -68.46 -10.5 55.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.946 0.721 . . . . 1.0 112.946 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.697 HH21 ' CD2' ' A' ' 169' ' ' HIS . 46.1 ttp180 -164.39 120.59 1.56 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.137 -1.025 . . . . 1.0 113.579 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -140.74 132.52 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 176.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 53.3 pttt -145.69 158.82 43.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.56 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.76 137.56 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.994 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 165' ' ' LEU . 28.4 t80 -119.8 119.1 32.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.07 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -99.52 166.22 11.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.87 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 79.6 t80 -131.55 137.05 48.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 1.0 112.159 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.27 126.39 33.51 Favored Pre-proline 0 C--N 1.334 -0.104 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.07 -25.59 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.737 2.291 . . . . 1.0 112.901 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -76.71 -6.28 51.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.977 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.15 38.0 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.997 -0.62 . . . . 1.0 112.831 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -89.58 143.0 27.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.421 0.611 . . . . 1.0 110.919 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.74 140.95 14.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -128.64 146.86 50.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.248 0.547 . . . . 1.0 112.243 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.02 111.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -100.52 6.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.601 0.593 . . . . 1.0 112.601 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.41 146.99 23.02 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 42.5 tt0 -166.92 128.16 1.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.336 -0.946 . . . . 1.0 113.235 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.12 140.73 43.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.55 HH12 ' C ' ' A' ' 75' ' ' PRO . 5.2 ptm85 -131.37 142.67 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.25 110.4 3.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.456 -1.057 . . . . 1.0 110.456 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.54 -87.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.239 -1.145 . . . . 1.0 110.239 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.9 pt-20 -179.99 26.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.152 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.33 -32.24 73.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 69' ' ' ARG . 12.2 mt -118.23 142.74 31.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' C ' HH12 ' A' ' 69' ' ' ARG . 68.4 Cg_endo -73.85 170.57 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.072 1.848 . . . . 1.0 112.457 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.5 p -93.92 139.35 31.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.176 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -110.34 -3.37 16.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.633 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.17 137.89 55.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.307 0.575 . . . . 1.0 112.282 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.91 82.78 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.5 tp -101.49 122.72 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.887 0.375 . . . . 1.0 110.782 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 81' ' ' THR . 10.1 t -79.05 122.43 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.515 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -105.38 131.11 22.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.37 150.07 22.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.185 1.923 . . . . 1.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -62.62 -23.69 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.828 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.22 -22.68 0.58 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' ' NC ' ' A' ' 203' ' ' CYC . 90.7 m-20 -56.51 -31.16 63.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 1.0 110.659 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 88' ' ' PRO . 3.5 pt -118.47 100.42 51.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.316 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.3 Cg_exo -44.29 -110.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.487 2.124 . . . . 1.0 112.347 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 84.2 tt0 -149.53 -58.45 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.751 -0.38 . . . . 1.0 111.784 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.56 -40.93 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.77 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.84 90.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.014 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -68.56 -29.7 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.572 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -55.3 -55.63 29.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.226 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.89 -40.16 72.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.622 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 6.0 m-85 -57.9 -34.03 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -88.5 -9.8 51.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.103 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tp -107.18 -45.6 4.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.373 0.879 . . . . 1.0 113.373 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -115.39 -1.75 12.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.2 mt-30 28.44 71.64 0.05 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.116 1.154 . . . . 1.0 114.116 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 101' ' ' ARG . 35.4 m -117.53 -47.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.731 HH21 HG22 ' A' ' 154' ' ' VAL . 2.4 mpp_? 62.52 -26.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.143 -1.389 . . . . 1.0 114.354 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 100' ' ' VAL . 11.8 p -56.14 129.48 17.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.445 -0.502 . . . . 1.0 111.788 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.956 HD11 HAA2 ' A' ' 203' ' ' CYC . 16.7 mt -105.37 129.94 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.8 p -81.34 168.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -50.08 120.57 4.55 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.289 -177.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 106' ' ' VAL . 24.0 t -57.6 -14.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.741 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.23 -36.56 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.914 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.79 -14.44 8.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.393 0.616 . . . . 1.0 110.101 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 51.5 59.8 4.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 1.0 113.409 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 m -92.09 137.57 32.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -126.63 135.45 51.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 113' ' ' ILE . 45.6 t -104.33 150.02 24.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.126 -1.397 . . . . 1.0 107.402 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 112' ' ' SER . 20.2 pt -154.08 157.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.705 -0.798 . . . . 1.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 t -89.35 167.42 13.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.492 -0.777 . . . . 1.0 110.243 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -131.85 154.44 81.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.62 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.6 -6.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.691 2.261 . . . . 1.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 118' ' ' SER . 22.5 pt-20 -158.03 -162.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.564 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 119' ' ' TRP . 8.8 p 62.59 127.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.417 ' CG ' ' O ' ' A' ' 118' ' ' SER . 94.2 m95 -154.24 -129.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.28 14.03 67.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.6 mt -60.32 -35.23 75.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 1.0 110.52 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.1 m -59.39 -29.85 68.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.15 54.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 64.91 62.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.27 143.81 73.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.124 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.42 132.26 18.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.556 2.171 . . . . 1.0 111.249 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.4 mt 43.52 -119.57 0.61 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.39 -0.76 67.84 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' CD ' HH22 ' A' ' 133' ' ' ARG . 1.3 pp20? -156.76 149.53 18.25 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.667 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 91.7 Cg_exo -43.51 149.13 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.467 2.111 . . . . 1.0 111.697 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.69 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.3 mp -78.85 27.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 89.0 mt-30 -131.25 164.04 26.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.121 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.548 HH22 ' CD ' ' A' ' 129' ' ' GLU . 19.9 mmt-85 -122.43 78.92 45.84 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.26 149.45 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.495 2.13 . . . . 1.0 111.864 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 140' ' ' VAL . 19.0 m -100.8 148.76 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 1.0 111.416 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -87.73 154.89 53.39 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.909 -178.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -50.38 -21.28 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.268 1.979 . . . . 1.0 111.279 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.716 ' O ' HBC1 ' A' ' 203' ' ' CYC . 42.1 t -79.63 -39.8 30.68 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.524 ' ND1' ' CG1' ' A' ' 135' ' ' VAL . 51.4 t-80 -81.52 -40.48 23.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.666 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 135' ' ' VAL . 3.1 m -52.07 -43.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.357 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 140' ' ' VAL . 79.8 t60 -67.48 -43.99 79.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.256 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -43.3 -46.77 6.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.488 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 143' ' ' LEU . 83.5 mt -72.74 -43.84 62.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.574 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.1 tmtm? -60.69 -42.67 97.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.441 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 98.5 p -54.46 -31.32 55.4 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.6 mtt -89.47 -2.03 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.199 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.48 23.41 77.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.256 -0.884 . . . . 1.0 112.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 169' ' ' HIS . 11.5 t -104.09 121.14 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.889 -0.411 . . . . 1.0 109.889 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.87 44.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 t -131.45 167.48 19.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.156 -0.618 . . . . 1.0 111.545 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.2 p -162.47 141.92 9.34 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.137 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 38.3 tp -127.72 110.21 12.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.08 157.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.461 0.648 . . . . 1.0 111.849 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.731 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -153.39 93.95 3.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.311 -176.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.26 120.33 8.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.527 2.818 . . . . 1.0 113.957 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.4 mt -74.79 104.54 5.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.787 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.7 mtp -122.62 146.42 47.46 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.337 -0.545 . . . . 1.0 111.83 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 159' ' ' HIS . 72.0 t60 -126.42 114.17 17.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.019 -1.104 . . . . 1.0 108.019 175.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 158' ' ' HIS . 8.0 m-70 63.29 -125.97 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -95.6 10.73 35.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.876 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 55.3 mt-10 -119.71 153.56 35.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.923 1.082 . . . . 1.0 113.923 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.68 113.91 27.51 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.513 -1.221 . . . . 1.0 108.925 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 89.1 m95 -98.06 -28.64 13.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.916 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.37 -174.38 23.61 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.4 tp -142.46 130.41 21.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 1.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -96.25 140.7 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.4 t -146.2 111.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.394 -0.523 . . . . 1.0 111.531 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.5 t -100.17 139.23 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.013 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.698 ' ND1' ' N ' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -148.79 144.66 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.193 0.521 . . . . 1.0 110.944 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.48 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.8 p-80 -153.97 151.81 29.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.66 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.02 66.68 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.345 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -176.02 134.68 0.45 Allowed Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.355 -0.538 . . . . 1.0 112.303 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.489 ' O ' ' C ' ' A' ' 174' ' ' ARG . 34.6 Cg_exo -41.95 -45.7 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.669 2.246 . . . . 1.0 110.823 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 173' ' ' PRO . 30.4 ttm180 21.75 84.32 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.099 -0.955 . . . . 1.0 112.711 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.11 154.36 57.93 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.844 2.362 . . . . 1.0 111.103 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.48 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 33.6 m-85 -110.94 138.33 47.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.803 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.5 t -99.68 146.49 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.272 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.35 -37.69 88.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.655 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.62 -56.16 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.327 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 33.3 mp0 -65.69 -34.09 77.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 1.0 110.639 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.48 -40.01 89.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.463 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.13 -51.0 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.423 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.5 t -46.99 -49.38 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.331 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.2 -37.63 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 43.4 tt0 -45.4 -36.43 4.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.82 -41.7 74.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.383 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.855 HD23 ' O ' ' A' ' 187' ' ' LEU . 5.4 tt -54.73 -33.16 60.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.638 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.16 -40.23 59.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.633 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.5 -38.33 71.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.684 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.94 -53.44 52.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.53 -43.83 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.838 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -51.94 -37.63 53.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.3 mt -78.71 -32.02 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.91 62.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.01 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.8 pp -65.49 -26.47 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.714 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.06 -55.72 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 1.0 109.925 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -56.56 -27.86 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.919 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.64 56.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.301 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.36 -37.41 72.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.13 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.1 mt -68.34 -58.2 4.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.108 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 m -55.15 -42.18 72.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.293 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.402 179.771 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.956 HAA2 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD11 HD12 ' A' ' 195' ' ' ILE . 8.5 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.918 0.39 . . . . 1.0 110.572 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.66 -50.74 42.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.303 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.16 -44.49 95.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -62.59 -36.09 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -77.69 -20.82 53.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.446 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.505 ' O ' HG12 ' A' ' 39' ' ' VAL . 77.4 mtp180 -73.05 -33.71 65.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.639 -0.424 . . . . 1.0 109.972 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -33.62 28.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.36 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 2.1 t -70.74 -45.11 65.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.573 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.1 p -56.72 -36.55 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.839 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.1 mt-10 -75.46 -38.05 59.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 1.0 110.81 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.24 -51.12 65.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.966 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.28 -50.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.6 tmm_? -49.68 -41.63 43.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.9 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -35.79 73.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -79.64 -47.37 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 mt -76.53 -6.37 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.027 0.441 . . . . 1.0 110.177 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.62 16.46 0.19 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.462 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.5 m -74.92 144.82 43.1 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.4 m-20 -62.4 -27.47 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.759 ' H ' HG22 ' A' ' 48' ' ' THR . 59.9 ttt85 -153.54 121.56 6.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 119.127 -1.029 . . . . 1.0 113.562 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.34 134.43 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.788 ' HZ3' HD12 ' A' ' 77' ' ' LEU . 32.8 pttt -146.01 160.26 42.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.577 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.9 134.97 32.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.004 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.9 t80 -119.15 118.55 31.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.021 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -99.03 165.72 11.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -132.08 136.17 46.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 1.0 112.155 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.69 129.68 24.89 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.714 -0.675 . . . . 1.0 109.341 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.59 -29.31 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.684 2.256 . . . . 1.0 112.933 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -72.72 -17.66 61.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.948 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.89 -15.24 12.49 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.839 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -84.93 141.85 30.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.375 0.588 . . . . 1.0 110.957 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.73 139.69 13.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.3 p -125.3 144.87 50.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.207 0.527 . . . . 1.0 112.312 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.33 116.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 65' ' ' VAL . 10.7 p -110.09 2.75 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.98 145.91 24.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' CD ' HH22 ' A' ' 50' ' ' ARG . 35.0 tt0 -165.78 127.48 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.37 -0.932 . . . . 1.0 113.233 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -110.06 135.21 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.502 HH22 ' CB ' ' A' ' 72' ' ' GLU . 7.6 ptm180 -125.49 142.15 51.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.533 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.36 104.36 2.71 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.469 -1.052 . . . . 1.0 110.469 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.51 -89.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' CB ' HH22 ' A' ' 69' ' ' ARG . 22.2 pt-20 -177.31 29.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.153 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -66.61 -54.26 25.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.47 144.68 28.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.804 -1.184 . . . . 1.0 107.804 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.03 166.83 28.97 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.019 1.813 . . . . 1.0 112.58 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 t -92.21 136.7 32.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.096 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.788 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 59.0 mt -111.24 -3.24 15.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.618 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.6 tp -55.77 139.83 44.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.287 0.565 . . . . 1.0 112.335 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -3.2 84.59 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.6 tp -101.48 128.62 47.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 1.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -85.16 122.79 29.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.491 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -104.82 132.88 20.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.283 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.74 151.21 28.08 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.134 1.889 . . . . 1.0 111.714 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.4 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.799 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.64 -22.73 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -55.26 -31.08 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.51 132.88 21.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.246 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 60.0 Cg_endo -80.55 -119.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.54 2.16 . . . . 1.0 112.313 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 86.4 tt0 -139.78 -69.0 0.42 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.823 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.62 -40.49 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.804 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.53 62.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -62.29 -31.24 71.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.572 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.4 -48.08 81.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 133' ' ' ARG . 63.9 mt -54.69 -39.1 67.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.824 -0.351 . . . . 1.0 110.529 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CZ ' ' O1A' ' A' ' 203' ' ' CYC . 11.4 m-85 -61.1 -32.86 72.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -88.19 -12.59 43.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.109 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 tp -105.54 -46.97 4.04 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.336 0.865 . . . . 1.0 113.336 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.72 -1.15 13.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' ALA . 91.8 mt-30 27.58 65.61 0.09 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.97 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 33.8 m -97.48 -46.37 12.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.374 -2.454 . . . . 1.0 104.374 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.97 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 0.4 OUTLIER 57.83 55.36 5.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.139 -1.392 . . . . 1.0 114.208 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' C ' HD12 ' A' ' 103' ' ' ILE . 62.9 t -148.88 133.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.833 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.22 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.43 168.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' OD2' ' OE2' ' A' ' 107' ' ' GLU . 13.2 t0 -53.28 118.38 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.326 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 140' ' ' VAL . 24.4 t -55.46 -12.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.76 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 14.0 pt-20 -87.59 -38.36 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.846 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -57.56 -13.62 4.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.513 0.673 . . . . 1.0 110.211 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 50.84 56.31 8.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.958 -1.019 . . . . 1.0 113.399 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 m -94.51 134.15 37.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.34 -2.096 . . . . 1.0 105.34 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -129.44 142.21 50.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 114.963 1.468 . . . . 1.0 114.963 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.8 t -139.53 113.41 8.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.125 -1.398 . . . . 1.0 107.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.868 ' H ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -119.57 -167.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.676 -0.81 . . . . 1.0 112.12 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -92.98 160.62 14.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.43 -0.804 . . . . 1.0 110.247 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 117' ' ' GLU . 53.2 mt-30 -140.25 152.34 66.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.603 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -36.14 -30.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.636 2.224 . . . . 1.0 112.238 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' GLN . 94.6 mt-10 -114.45 152.77 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.6 p -168.79 60.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.501 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 76.8 t-105 -143.61 166.77 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.489 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 96.51 3.55 59.73 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.643 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.2 mp -64.26 -29.77 70.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.809 0.338 . . . . 1.0 110.542 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 m -54.15 -24.78 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.7 -40.5 40.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 61.69 75.2 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.914 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 125' ' ' VAL . 33.4 m -95.56 118.91 65.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.095 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.58 131.4 12.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.525 2.15 . . . . 1.0 111.125 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 mt 44.1 -131.88 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 0.91 85.37 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.648 -0.581 . . . . 1.0 111.648 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -155.51 146.44 16.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.964 -0.295 . . . . 1.0 110.662 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.54 153.6 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.357 2.038 . . . . 1.0 111.66 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.6 mp -80.72 27.77 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.291 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -133.55 167.52 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.077 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 134' ' ' PRO . 8.3 mmm180 -126.24 67.34 63.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.306 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.456 ' C ' ' O ' ' A' ' 133' ' ' ARG . 2.8 Cg_exo -30.73 147.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.564 2.176 . . . . 1.0 111.753 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 135' ' ' VAL . 29.3 m -94.4 147.8 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 1.0 111.362 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -91.08 144.07 29.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.873 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.38 -27.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.196 1.93 . . . . 1.0 111.279 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.752 ' O ' HBC1 ' A' ' 203' ' ' CYC . 48.6 t -71.99 -57.5 4.24 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.726 ' CE1' HD13 ' A' ' 143' ' ' LEU . 42.0 t-80 -68.21 -27.83 66.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.688 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 106' ' ' VAL . 37.7 t -51.62 -52.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.323 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.541 ' CD2' ' HG ' ' A' ' 145' ' ' SER . 76.3 t60 -63.58 -41.28 98.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.256 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -45.43 -51.82 10.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.497 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.5 mp -72.07 -49.13 39.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 2.4 tmtt? -57.32 -42.62 82.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.446 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.541 ' HG ' ' CD2' ' A' ' 141' ' ' HIS . 20.9 m -53.65 -32.01 49.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.4 mtt -85.61 -2.48 58.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 1.0 109.188 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.88 24.24 74.29 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.314 -0.857 . . . . 1.0 112.353 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.553 HG21 ' ND1' ' A' ' 169' ' ' HIS . 3.2 m -106.66 123.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.27 -35.18 55.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -132.75 170.71 14.86 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.545 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.528 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.1 t -162.0 139.71 8.72 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.062 0.458 . . . . 1.0 112.158 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.32 138.96 50.4 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.8 m -133.61 157.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.496 0.665 . . . . 1.0 111.828 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.575 HG11 ' CB ' ' A' ' 188' ' ' ALA . 73.0 t -157.56 91.57 2.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.268 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.14 115.73 2.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.575 2.85 . . . . 1.0 113.931 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.98 105.7 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.825 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.6 ptm -131.15 147.43 52.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.22 0.533 . . . . 1.0 111.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.436 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.2 t60 -122.67 115.66 22.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 8.9 t60 64.77 -128.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.466 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 11.8 mm100 -92.48 9.12 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -117.58 152.19 35.64 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.002 1.112 . . . . 1.0 114.002 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.96 116.92 32.84 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 114.498 -1.228 . . . . 1.0 108.873 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.436 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.5 m95 -95.94 -27.81 14.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.06 -170.42 27.91 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.247 -0.978 . . . . 1.0 112.029 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -141.38 131.91 25.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 1.0 111.19 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -96.02 141.55 29.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.92 135.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.566 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.6 m -121.15 150.61 41.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.027 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.553 ' ND1' HG21 ' A' ' 148' ' ' VAL . 92.5 m-70 -147.74 146.82 29.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.121 0.486 . . . . 1.0 111.005 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 17.0 t60 -156.36 152.46 27.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.408 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -84.66 65.02 8.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 1.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -178.29 136.6 0.35 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.314 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -36.63 -51.79 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.686 2.257 . . . . 1.0 110.884 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 30.94 77.11 0.34 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.076 -0.965 . . . . 1.0 112.74 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.88 150.58 85.53 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.849 2.366 . . . . 1.0 111.103 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -111.55 140.03 46.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 1.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.2 m -95.22 150.35 20.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.19 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.6 -40.81 96.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.666 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.02 -54.9 35.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.405 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -66.97 -32.25 73.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 1.0 110.709 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.29 -38.22 76.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.507 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.23 -51.52 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.406 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.7 t -43.17 -48.79 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.8 m -74.63 -37.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.51 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 56.2 tt0 -47.76 -37.44 13.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.76 -40.2 63.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.393 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 48.8 tp -54.69 -32.88 60.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.682 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.575 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.26 -34.93 68.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.645 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.24 -39.15 69.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.794 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.96 -53.76 44.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -58.21 -41.86 81.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.176 -0.92 . . . . 1.0 109.825 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.0 p -51.71 -35.76 44.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 84.3 mt -78.29 -34.26 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.038 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.98 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.127 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.562 HD12 HD11 ' A' ' 31' ' ' LEU . 8.3 tp -63.56 -31.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.46 -56.96 4.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.873 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -55.41 -27.14 45.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.64 -34.53 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.301 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.402 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.7 tt0 -57.15 -39.98 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.101 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.2 mp -67.82 -56.07 10.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.05 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.9 m -51.53 -41.49 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 1.0 110.311 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.752 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' CD2' HD12 ' A' ' 195' ' ' ILE . 5.8 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 1.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.3 -43.17 99.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.256 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -69.1 -53.74 18.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . 28.4 mm -55.83 -46.74 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.7 -23.36 66.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.526 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.9 ttm180 -61.42 -36.02 79.16 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.639 -0.425 . . . . 1.0 109.993 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.44 -25.18 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.302 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.9 p -76.54 -47.0 24.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.546 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -52.79 -37.95 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.883 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 pt-20 -79.08 -32.36 44.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.91 -52.9 62.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.952 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.7 p -64.22 -44.4 97.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.902 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.6 tmm_? -48.98 -44.47 40.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.74 75.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -80.64 -50.66 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.751 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' THR . 1.9 tp -77.13 -8.16 57.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.081 0.467 . . . . 1.0 110.208 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 45.39 17.46 0.13 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.402 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 HG13 ' A' ' 51' ' ' VAL . 9.3 t -75.71 145.39 40.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.029 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.2 m-20 -56.47 -34.75 67.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.891 0.701 . . . . 1.0 112.891 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -150.66 126.83 10.57 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.204 -0.998 . . . . 1.0 113.523 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.534 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -141.77 130.43 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.939 -1.134 . . . . 1.0 107.939 176.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' NZ ' ' OB ' ' A' ' 203' ' ' CYC . 20.4 pttm -144.35 161.26 39.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.58 -177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.81 133.45 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.055 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 72.1 t80 -118.14 117.42 29.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.019 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -100.81 169.07 9.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.5 t80 -133.9 138.66 45.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.161 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.4 m-20 -102.23 126.66 32.74 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.283 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.6 -27.09 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.722 2.281 . . . . 1.0 112.89 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.3 -9.68 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.004 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.79 21.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.868 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.53 139.77 32.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.308 0.554 . . . . 1.0 110.932 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -116.1 134.09 11.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.379 -1.088 . . . . 1.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -125.89 144.84 50.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.282 0.563 . . . . 1.0 112.229 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.09 126.2 61.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -113.1 4.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.31 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.7 tt0 -166.29 127.98 1.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.347 -0.941 . . . . 1.0 113.16 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.98 131.2 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -118.5 138.39 52.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.544 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.9 95.08 1.12 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.61 -89.21 0.05 OUTLIER Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.194 -1.162 . . . . 1.0 110.194 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.66 36.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.77 -0.372 . . . . 1.0 111.116 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -73.96 -54.38 8.04 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.0 mt -93.74 146.42 31.71 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.0 167.18 27.82 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.004 1.803 . . . . 1.0 112.518 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.5 p -88.14 139.51 30.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.108 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.606 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 34.8 mt -113.21 -2.45 14.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.593 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 45.1 tp -60.18 140.61 56.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.346 0.593 . . . . 1.0 112.25 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -4.27 86.23 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.391 -0.822 . . . . 1.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.6 mt -99.89 140.0 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 1.0 110.737 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -97.59 121.79 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.458 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 7.4 m-85 -106.74 131.41 21.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.26 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.68 152.55 29.35 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.145 1.897 . . . . 1.0 111.658 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.57 -20.98 66.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.773 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.62 -24.24 0.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.8 m-20 -53.39 -27.79 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 1.0 110.551 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.42 HG23 HAD2 ' A' ' 203' ' ' CYC . 33.9 mt -120.98 132.34 24.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD3' HMC3 ' A' ' 203' ' ' CYC . 52.5 Cg_endo -80.59 -116.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.538 2.159 . . . . 1.0 112.329 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -126.09 -75.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.815 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -42.65 -37.1 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.775 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.909 ' HB1' HBD2 ' A' ' 203' ' ' CYC . . . -69.9 -48.63 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.937 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -60.27 -32.09 70.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.519 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' LEU . 79.9 mtp180 -58.5 -46.2 87.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' GLN . 68.2 mt -56.26 -35.99 68.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.584 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 100' ' ' VAL . 8.7 m-85 -63.22 -42.8 99.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -87.43 -17.18 32.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.076 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.0 tp -106.7 -48.1 3.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -119.18 -7.47 10.29 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.583 0.957 . . . . 1.0 113.583 -175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 101' ' ' ARG . 92.2 mt-30 51.74 67.26 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 133' ' ' ARG . 35.2 m -69.2 63.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 99' ' ' GLN . 32.2 ptt180 -66.08 14.76 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.026 -1.443 . . . . 1.0 114.29 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' C ' HD12 ' A' ' 103' ' ' ILE . 2.0 t -147.63 128.08 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.488 -0.485 . . . . 1.0 111.758 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.6 mp -112.38 129.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.97 169.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.263 0.838 . . . . 1.0 113.263 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 173' ' ' PRO . 0.4 OUTLIER -51.69 120.85 5.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.304 -178.14 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 106' ' ' VAL . 82.3 t -59.68 -15.39 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.806 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' GLN . 18.5 pt-20 -84.87 -38.25 19.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.866 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.89 3.03 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.378 0.609 . . . . 1.0 110.096 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.607 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 35.89 59.49 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.046 -0.979 . . . . 1.0 113.384 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 t -92.66 134.76 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -126.09 139.74 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 113' ' ' ILE . 28.5 t -104.57 150.28 24.77 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.104 -1.407 . . . . 1.0 107.377 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 112' ' ' SER . 18.9 pt -154.62 158.15 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.676 -0.809 . . . . 1.0 112.136 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 t -88.06 165.64 15.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.28 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.12 156.05 37.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.665 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -34.92 145.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.709 2.272 . . . . 1.0 112.26 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -52.76 140.43 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.491 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.5 t -163.15 -125.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -56.69 -43.32 80.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 122' ' ' SER . . . 69.57 9.95 62.7 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.8 mt 56.11 4.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 1.0 110.608 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 120' ' ' GLY . 34.8 t -59.85 -29.4 68.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.606 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.85 -11.57 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.808 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 58.33 86.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.65 109.93 60.6 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.11 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.69 135.51 16.85 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.551 2.168 . . . . 1.0 111.167 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 129' ' ' GLU . 7.7 tp 42.88 -117.19 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 1.0 109.603 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.76 14.47 0.08 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.639 -0.584 . . . . 1.0 111.639 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 127' ' ' LEU . 75.8 mt-10 -148.13 152.16 39.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.63 141.55 55.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.438 2.092 . . . . 1.0 111.69 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.76 19.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.308 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -131.93 168.38 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.049 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.547 ' HB2' HG11 ' A' ' 100' ' ' VAL . 35.4 ttt85 -134.97 96.47 14.45 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.27 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.6 156.35 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 C-N-CA 122.601 2.201 . . . . 1.0 111.758 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 139' ' ' HIS . 27.1 m -99.39 140.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.027 0.442 . . . . 1.0 111.341 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 139' ' ' HIS . 3.5 m-20 -94.93 148.2 34.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.913 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -38.36 -26.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.215 1.943 . . . . 1.0 111.237 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -76.19 -47.22 24.91 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.3 t-80 -76.12 -28.81 57.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.653 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -50.56 -47.9 27.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.403 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 145' ' ' SER . 80.2 t60 -65.59 -42.16 92.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -45.93 -56.07 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.453 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.762 HD21 HMA2 ' A' ' 203' ' ' CYC . 50.7 mt -72.12 -50.44 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 44.3 tptt -57.56 -43.32 84.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.415 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' HIS . 33.9 t -53.78 -34.18 58.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.238 -0.652 . . . . 1.0 109.238 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.1 mtt -84.3 -7.33 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.2 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.45 23.87 76.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.9 122.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.97 31.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 151' ' ' SER . 1.5 t -142.98 170.42 15.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.573 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 30.9 t -162.04 140.31 9.04 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.205 -0.452 . . . . 1.0 112.173 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 152' ' ' LEU . 62.2 tp -114.64 116.36 28.61 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -117.07 158.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.447 0.641 . . . . 1.0 111.791 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 79.5 t -155.65 95.24 2.47 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.363 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.02 113.46 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.558 2.839 . . . . 1.0 113.928 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.2 106.62 5.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 17.1 ptm -133.57 146.41 50.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.917 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 78.5 t60 -117.68 115.64 25.46 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 34.0 m-70 59.1 -123.53 1.25 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -93.48 8.56 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.63 149.71 39.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.983 1.105 . . . . 1.0 113.983 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.0 tp -107.54 115.92 31.01 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.545 -1.207 . . . . 1.0 108.857 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 95.4 m95 -96.65 -30.41 13.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.965 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.56 -170.14 24.77 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.205 -0.998 . . . . 1.0 111.937 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.778 HD23 HMB2 ' A' ' 203' ' ' CYC . 5.4 tp -138.18 128.49 26.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 1.0 111.16 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -92.09 138.01 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 10.8 p -149.58 135.3 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.593 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 48' ' ' THR . 12.3 t -117.36 146.15 43.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.049 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.508 ' CE1' ' OG ' ' A' ' 151' ' ' SER . 78.1 m-70 -143.68 141.43 30.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 1.0 111.043 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -152.72 151.88 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.69 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.94 9.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.583 -0.28 . . . . 1.0 111.489 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -176.37 164.66 1.72 Allowed Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 120.319 -0.552 . . . . 1.0 112.302 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.494 ' CB ' ' OD2' ' A' ' 105' ' ' ASP . 31.5 Cg_endo -95.35 89.61 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.703 2.269 . . . . 1.0 110.928 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -115.45 92.91 34.53 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.755 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.16 152.78 29.37 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.813 2.342 . . . . 1.0 111.086 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -111.01 140.93 45.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 1.0 110.748 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -93.19 143.12 26.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.284 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -62.14 -39.51 92.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.33 -54.95 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.61 -0.268 . . . . 1.0 111.366 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.63 -32.39 73.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.974 0.416 . . . . 1.0 110.765 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.64 -42.71 88.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.86 -50.85 70.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.45 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.19 -48.42 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.24 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -74.03 -39.23 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.422 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 7.3 tt0 -46.18 -35.57 5.22 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.3 tp -71.44 -38.37 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.685 -1.143 . . . . 1.0 109.35 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 9.8 tp -56.28 -31.04 63.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.686 . . . . 1.0 109.631 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.402 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.28 -36.41 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.602 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -59.57 -38.75 81.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.747 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -52.74 -55.15 24.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.82 -40.5 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.904 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 157' ' ' MET . 6.1 t -52.02 -35.53 47.24 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.2 mt -79.12 -36.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.081 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -47.22 63.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.062 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 31' ' ' LEU . 2.8 tp -61.0 -33.48 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -75.51 -53.9 7.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.967 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -55.34 -28.31 52.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -34.86 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.294 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -56.51 -40.25 74.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.198 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.6 mp -68.29 -56.59 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.172 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.4 m -58.32 -45.59 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 1.0 110.292 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.427 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.909 HBD2 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 202' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.912 0.386 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.46 -50.55 73.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.317 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.77 -48.6 79.95 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.675 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -62.54 -29.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' THR . 96.6 mt -77.85 -20.93 52.2 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.4 mtp180 -72.44 -34.16 67.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.032 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.19 31.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.349 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 35' ' ' LEU . 2.5 t -74.29 -44.87 50.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.55 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.2 p -55.69 -36.02 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.59 -36.86 68.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.021 0.438 . . . . 1.0 110.872 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.55 -52.15 48.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.979 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.15 -51.22 75.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -49.17 -43.93 42.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.21 -47.43 14.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.91 -6.62 53.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.76 16.67 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.714 -0.676 . . . . 1.0 112.458 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -75.01 144.66 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.391 -0.524 . . . . 1.0 110.083 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.0 m-20 -57.21 -34.29 68.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.651 ' H ' HG22 ' A' ' 48' ' ' THR . 29.5 ttm180 -149.55 124.14 9.75 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.212 -0.995 . . . . 1.0 113.526 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 11.9 t -135.21 131.57 52.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -143.74 152.04 40.77 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.569 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.9 t -98.46 139.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.983 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.0 t80 -124.76 121.63 35.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.001 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -99.95 171.78 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.86 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -134.12 138.19 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.558 -0.457 . . . . 1.0 112.15 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 m-20 -104.81 149.33 37.39 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.269 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.21 -26.64 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.741 2.294 . . . . 1.0 112.946 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -76.54 -3.73 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.055 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.88 -10.29 57.13 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.032 -0.604 . . . . 1.0 112.811 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 95.9 m-70 -90.42 147.06 23.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.338 0.569 . . . . 1.0 110.941 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . -130.12 151.41 19.4 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -131.3 149.69 52.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.256 0.55 . . . . 1.0 112.274 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.73 115.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.023 -1.103 . . . . 1.0 108.023 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.69 -2.41 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.635 0.606 . . . . 1.0 112.635 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.15 20.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.7 tt0 -167.41 127.14 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.332 -0.947 . . . . 1.0 113.159 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 142.05 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.119 -1.067 . . . . 1.0 108.119 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' O ' ' NH2' ' A' ' 43' ' ' ARG . 35.9 ptt-85 -132.87 141.96 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.544 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.33 111.54 3.7 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.363 -1.095 . . . . 1.0 110.363 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.32 40.05 3.41 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.309 -1.116 . . . . 1.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 48.53 26.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.119 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -54.13 -56.34 19.05 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 10.7 mt -93.76 152.03 40.38 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.542 ' C ' HH22 ' A' ' 50' ' ' ARG . 56.4 Cg_endo -69.58 156.97 62.36 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.114 1.876 . . . . 1.0 112.573 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -76.44 113.98 14.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.611 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 56.5 mt -87.39 -6.76 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.595 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.2 tp -60.25 139.98 57.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.305 0.574 . . . . 1.0 112.209 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.82 -3.51 84.84 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.8 mt -99.58 136.61 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 1.0 110.737 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.598 ' O ' HG23 ' A' ' 81' ' ' THR . 15.4 t -94.3 120.62 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.482 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' GLY . 7.3 m-85 -108.73 133.26 20.71 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.283 178.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 149.29 34.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.147 1.898 . . . . 1.0 111.719 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.34 -25.63 64.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.779 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.01 -20.95 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' NC ' ' A' ' 203' ' ' CYC . 32.6 t70 -51.78 -23.38 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.0 110.608 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 87' ' ' ILE . 29.4 mt -127.15 132.73 24.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.58 -108.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.53 2.154 . . . . 1.0 112.319 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -142.58 -72.46 0.31 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.1 pt-20 -41.42 -43.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.721 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.854 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -63.65 -49.48 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -58.23 -29.08 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' NH2' ' CD2' ' A' ' 121' ' ' LEU . 33.2 mtm180 -55.81 -47.63 76.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.218 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 94' ' ' LEU . 8.4 mp -54.45 -38.68 66.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.572 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.637 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 7.4 m-85 -60.03 -24.99 64.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.227 0.537 . . . . 1.0 109.572 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 97' ' ' LEU . 60.5 mtp85 -94.74 -19.02 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.123 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.0 mp -109.5 -45.51 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.03 -11.08 15.37 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.581 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 82.7 mt-30 25.35 70.77 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.082 1.141 . . . . 1.0 114.082 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.711 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -141.77 -55.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 104.44 -2.43 . . . . 1.0 104.44 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.711 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.6 mmp_? 52.84 103.85 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.038 -1.437 . . . . 1.0 114.297 173.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 102' ' ' VAL . 19.2 m -144.77 132.66 16.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.768 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 135' ' ' VAL . 58.3 mt -108.64 123.86 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.71 168.08 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.58 120.43 5.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.242 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -56.73 -10.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -86.61 -37.08 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.39 -17.84 55.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.372 0.606 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 53.44 60.43 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.056 -0.974 . . . . 1.0 113.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -93.51 135.16 35.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.0 mtp-105 -130.06 142.44 50.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 113' ' ' ILE . 1.5 m -106.96 155.78 19.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.189 -1.368 . . . . 1.0 107.357 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 112' ' ' SER . 17.7 pt -156.31 159.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.769 -0.772 . . . . 1.0 112.223 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.405 ' C ' ' NE2' ' A' ' 115' ' ' GLN . 86.4 p -86.51 163.64 17.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.214 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' NE2' ' C ' ' A' ' 114' ' ' SER . 1.6 mp0 -137.2 158.76 71.9 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.47 -12.3 18.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.662 2.241 . . . . 1.0 112.239 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -152.24 125.98 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.458 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.4 t 175.08 114.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.655 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -150.6 -173.64 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.479 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.86 4.5 56.81 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.648 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.0 mp -63.11 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 1.0 110.559 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.4 m -54.23 -26.77 30.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.61 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.97 -27.48 19.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.827 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 58.56 90.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.896 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.03 104.52 52.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.16 129.35 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.498 2.132 . . . . 1.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.1 tp 43.15 -110.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.44 12.94 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.599 -0.6 . . . . 1.0 111.599 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 130' ' ' PRO . 33.7 mt-10 -134.78 154.26 79.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 1.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 129' ' ' GLU . 78.4 Cg_exo -42.0 167.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.41 2.073 . . . . 1.0 111.658 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.9 mt -78.55 -6.95 56.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.254 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -134.06 168.51 18.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 15.8 mmm180 -133.85 86.58 37.93 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.294 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.479 ' O ' ' OG ' ' A' ' 112' ' ' SER . 73.7 Cg_exo -47.72 145.36 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.536 2.157 . . . . 1.0 111.774 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.615 HG13 HBD2 ' A' ' 203' ' ' CYC . 15.7 t -128.46 135.34 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.994 0.426 . . . . 1.0 111.354 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -44.2 154.73 0.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.883 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -56.32 -7.16 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.243 1.962 . . . . 1.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 136' ' ' ASP . 42.0 t -58.42 -50.58 73.2 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.569 ' ND1' HD12 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -73.32 -27.38 61.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.329 -0.851 . . . . 1.0 110.689 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.433 ' N ' ' CD2' ' A' ' 139' ' ' HIS . 22.3 t -52.01 -54.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 1.0 110.362 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 145' ' ' SER . 10.2 m80 -68.99 -46.06 69.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.215 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' CD2' HBA1 ' A' ' 203' ' ' CYC . 6.3 t80 -47.43 -55.96 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.48 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.569 HD12 ' ND1' ' A' ' 139' ' ' HIS . 89.1 mt -66.83 -50.48 62.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.514 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 42.7 tptt -57.56 -42.09 82.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 m -54.28 -34.92 61.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mtt -84.73 -3.77 58.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.242 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.97 25.84 70.47 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.261 -0.881 . . . . 1.0 112.324 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 150' ' ' SER . 14.2 t -106.71 114.92 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.011 0.405 . . . . 1.0 109.945 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.78 -30.1 61.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 148' ' ' VAL . 97.4 p -138.67 170.14 16.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.615 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 p -161.85 130.86 4.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.46 114.97 29.23 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.7 p -113.42 157.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.455 0.645 . . . . 1.0 111.853 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.9 t -157.7 124.54 2.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.281 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.33 149.87 22.06 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.602 2.868 . . . . 1.0 113.906 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.52 107.43 15.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.409 -0.814 . . . . 1.0 109.799 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.581 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 81.5 mtp -121.23 140.63 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 111.834 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 71.2 t60 -118.15 113.9 22.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 10.6 t-80 68.08 -129.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 40.0 mt-30 -95.33 8.78 42.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -120.99 159.84 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.963 1.097 . . . . 1.0 113.963 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.71 117.97 34.91 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.543 -1.208 . . . . 1.0 108.896 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 94.0 m95 -96.24 -28.47 14.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.95 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.2 -173.95 26.29 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.215 -0.993 . . . . 1.0 112.006 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -140.99 126.38 18.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 1.0 111.278 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 167' ' ' VAL . 0.6 OUTLIER -95.14 135.61 36.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 1.011 ' N ' HD12 ' A' ' 166' ' ' LEU . 85.3 t -145.55 137.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.567 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.527 ' C ' ' ND1' ' A' ' 169' ' ' HIS . 20.6 m -125.26 144.49 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.608 ' ND1' ' N ' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.33 152.82 36.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 1.0 111.013 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.517 ' NE2' ' OG ' ' A' ' 150' ' ' SER . 1.1 p-80 -158.15 154.08 26.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.03 67.91 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.421 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -177.62 131.43 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.348 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -38.16 -51.22 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.695 2.263 . . . . 1.0 110.918 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 31.41 84.44 0.17 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.033 -0.985 . . . . 1.0 112.691 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.69 151.09 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.773 2.315 . . . . 1.0 111.114 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -114.49 137.85 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -92.31 150.04 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.304 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 179' ' ' GLU . 12.3 pt20 -67.34 -42.94 82.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.625 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.449 ' N ' ' CG ' ' A' ' 178' ' ' GLN . 79.1 mm-40 -61.74 -55.14 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 111.359 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.33 -30.69 71.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 1.0 110.698 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.3 tp -61.72 -34.83 76.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.499 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.49 -53.7 21.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.376 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 49.3 t -44.34 -47.39 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.226 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.24 -37.44 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -48.63 -37.14 17.44 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 21.1 tp -72.79 -40.62 65.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.71 -1.132 . . . . 1.0 109.3 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.22 -32.29 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.633 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.03 -37.24 64.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.671 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -56.8 -41.54 77.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.758 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -52.63 -54.31 34.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.69 -41.55 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.837 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.1 m -50.46 -29.67 10.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.2 mm -77.26 -42.35 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.049 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.05 88.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.1 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.09 -31.31 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.33 -56.29 4.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.864 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -55.04 -28.88 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.56 -34.2 53.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.304 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -58.42 -38.59 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 200' ' ' LEU . 2.4 tt -67.63 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.036 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.3 t -69.77 -55.57 9.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 1.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 31' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.435 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.854 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.502 HD23 ' NH1' ' A' ' 55' ' ' ARG . 61.0 tp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.903 0.382 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -51.86 -49.5 62.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.22 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.43 -46.56 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 mp -59.9 -40.03 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.97 -22.04 58.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.693 -0.403 . . . . 1.0 111.504 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.1 ttm-85 -68.57 -36.77 79.22 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.652 -0.419 . . . . 1.0 109.991 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.01 -29.3 39.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.369 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.1 p -71.14 -48.39 52.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 36' ' ' ARG . 2.8 p -54.05 -35.16 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.842 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.12 -39.89 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.88 -40.65 98.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.932 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.32 -51.21 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.867 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HD3' ' HB1' ' A' ' 68' ' ' ALA . 23.4 ttp85 -50.78 -44.94 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.909 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.4 79.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.848 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -79.56 -51.44 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.751 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.11 -6.51 53.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.009 0.433 . . . . 1.0 110.081 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.1 16.99 0.54 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.695 -0.684 . . . . 1.0 112.45 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -73.73 141.66 46.34 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 70' ' ' GLY . 78.9 m-20 -60.13 -29.21 68.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 48' ' ' THR . 59.8 ttp180 -154.4 119.07 4.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 119.17 -1.012 . . . . 1.0 113.578 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.85 136.09 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.694 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 18.0 pttp -145.63 160.87 41.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.41 -0.516 . . . . 1.0 111.579 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.9 t -97.76 137.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.999 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CD1' HAB1 ' A' ' 203' ' ' CYC . 60.9 t80 -121.29 119.35 31.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 1.0 111.031 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' NH1' HD23 ' A' ' 31' ' ' LEU . 63.8 mtm180 -99.97 170.47 8.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 6.7 t80 -134.96 137.61 43.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.061 0.458 . . . . 1.0 112.172 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -103.14 148.59 35.87 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.325 179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.92 -23.87 67.95 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.739 2.293 . . . . 1.0 112.902 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.61 -2.9 41.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.27 -12.71 51.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.954 -0.641 . . . . 1.0 112.876 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -88.79 146.2 25.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.326 0.563 . . . . 1.0 110.95 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -125.35 145.58 15.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.467 -1.053 . . . . 1.0 110.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -128.36 146.96 50.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.291 0.567 . . . . 1.0 112.341 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.1 118.2 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 65' ' ' VAL . 8.6 p -115.12 9.2 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.9 142.8 23.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 48.9 tt0 -165.99 126.67 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.368 -0.933 . . . . 1.0 113.181 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.66 140.66 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 36.4 ptt85 -132.2 143.38 49.91 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.203 -0.599 . . . . 1.0 111.539 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.84 106.94 3.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.366 -1.094 . . . . 1.0 110.366 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 55.2 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 70' ' ' GLY . 44.7 tt0 -176.94 35.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.089 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -72.94 -51.98 16.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -95.07 121.16 63.05 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 107.803 -1.184 . . . . 1.0 107.803 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.39 162.92 11.23 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.054 1.836 . . . . 1.0 112.557 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.1 t -83.83 135.16 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.3 mt -109.64 -7.66 15.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.592 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 tp -49.4 138.06 13.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.347 0.594 . . . . 1.0 112.288 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.54 -4.04 79.34 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.063 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -98.22 115.22 27.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 1.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.617 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -78.8 126.41 30.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.445 -178.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 80' ' ' LEU . 61.5 m-85 -108.26 139.82 21.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.82 152.28 19.28 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.131 1.887 . . . . 1.0 111.675 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -59.8 -26.45 65.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.819 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.05 -21.7 1.05 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 49.0 p-10 -58.0 -29.67 65.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.685 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.4 mm -110.17 99.8 41.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.228 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.7 Cg_exo -48.41 -126.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.091 . . . . 1.0 112.3 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.79 -60.64 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.811 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.59 -41.02 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.758 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.725 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -63.18 -42.96 99.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 1.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.685 ' HE ' HG21 ' A' ' 87' ' ' ILE . 34.9 ttm180 -63.82 -28.86 70.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.591 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 97' ' ' LEU . 31.9 mmt180 -56.73 -53.77 53.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.286 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ALA . 32.3 mt -54.02 -36.01 62.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.651 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -66.49 -35.95 81.55 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -85.05 -16.15 41.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.114 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.1 mp -106.04 -42.84 4.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.25 -4.58 13.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.527 0.936 . . . . 1.0 113.527 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.1 mt-30 27.93 69.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.05 1.13 . . . . 1.0 114.05 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 58.3 t -110.73 -50.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.417 -2.438 . . . . 1.0 104.417 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.588 ' HE ' ' C ' ' A' ' 100' ' ' VAL . 10.5 mtm180 63.72 72.02 0.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.088 -1.414 . . . . 1.0 114.269 172.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.597 ' C ' HD12 ' A' ' 103' ' ' ILE . 87.7 t -152.1 133.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.782 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -107.41 127.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 105' ' ' ASP . 12.7 p -83.01 167.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.266 0.839 . . . . 1.0 113.266 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.651 ' N ' HG22 ' A' ' 104' ' ' VAL . 5.9 m-20 -54.62 120.03 6.12 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.315 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.53 -10.99 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.771 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 17.4 pt-20 -85.38 -40.42 16.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.876 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.23 -12.61 3.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.433 0.635 . . . . 1.0 110.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 49.4 52.0 15.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.051 -0.977 . . . . 1.0 113.396 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.6 m -94.44 136.56 34.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -128.12 141.71 51.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 113' ' ' ILE . 4.2 t -99.33 153.66 18.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.098 -1.41 . . . . 1.0 107.323 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 112' ' ' SER . 19.7 pt -155.03 159.52 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 119.663 -0.815 . . . . 1.0 112.164 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.8 p -87.15 167.84 13.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.254 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -146.06 154.11 50.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.689 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.54 -39.81 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.637 2.225 . . . . 1.0 112.264 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.62 -33.74 74.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.3 t -71.69 162.27 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.481 ' CG ' ' O ' ' A' ' 119' ' ' TRP . 73.8 t-105 -146.21 27.79 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.548 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.67 64.91 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.996 -0.841 . . . . 1.0 110.996 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.4 mt 44.52 47.5 8.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.372 . . . . 1.0 110.562 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.1 t -56.53 -26.69 55.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.604 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.96 -16.95 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.828 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 61.59 79.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.858 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.2 t -85.19 131.0 49.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.081 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 127' ' ' LEU . 97.6 Cg_endo -75.56 141.61 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.562 2.175 . . . . 1.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.428 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 21.0 mt 41.42 -160.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.09 27.69 57.66 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 127' ' ' LEU . 8.3 mp0 -118.13 152.33 50.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.635 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.538 ' CG ' ' NH2' ' A' ' 133' ' ' ARG . 61.1 Cg_endo -70.69 164.95 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.404 2.069 . . . . 1.0 111.65 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.7 mp -77.99 -7.26 56.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.316 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -134.42 168.26 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.068 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.538 ' NH2' ' CG ' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -129.88 84.44 60.84 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.284 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.06 142.86 7.92 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.56 2.174 . . . . 1.0 111.768 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -107.26 117.54 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.016 0.436 . . . . 1.0 111.312 -177.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -39.85 153.95 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.947 177.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -56.96 -20.43 36.58 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.237 1.958 . . . . 1.0 111.233 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.6 t -65.79 -46.97 76.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.017 -0.734 . . . . 1.0 109.017 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.806 ' ND1' ' C ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -74.7 -27.94 60.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.632 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.48 -54.72 13.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.318 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -65.93 -44.48 84.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.279 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -44.49 -51.69 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.482 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.78 -47.03 50.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.522 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.8 OUTLIER -59.45 -42.06 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.503 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.0 p -53.77 -30.65 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.6 mtt -86.91 -0.47 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.238 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.97 24.41 76.48 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.22 -0.9 . . . . 1.0 112.36 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 150' ' ' SER . 11.4 t -106.9 122.57 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.15 -26.27 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.1 p -142.58 171.87 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.573 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.02 136.78 12.4 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.51 136.23 52.28 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -135.02 155.41 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.436 0.636 . . . . 1.0 111.845 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 153' ' ' VAL . 65.4 t -157.67 90.0 2.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.22 140.24 52.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.552 2.835 . . . . 1.0 113.923 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.1 mt -98.52 105.65 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.799 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 81.3 mtp -119.42 141.13 49.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.553 . . . . 1.0 111.818 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.442 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 84.5 t60 -116.61 112.03 20.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 175.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.431 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 4.9 t60 62.86 -123.7 0.63 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.431 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 17.2 pt20 -94.64 7.72 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 162' ' ' LEU . 26.4 tp10 -117.23 153.4 32.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 161' ' ' GLU . 6.5 tt -107.72 117.36 33.9 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 114.55 -1.205 . . . . 1.0 108.816 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.0 m95 -96.97 -27.87 14.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.858 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.06 23.53 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.63 HD23 HMB3 ' A' ' 203' ' ' CYC . 3.1 tp -141.59 127.81 19.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.0 111.263 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.3 tp -92.92 134.06 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.55 134.84 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.578 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.78 142.43 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.99 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -134.56 132.17 38.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 1.0 110.96 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 19.0 t60 -168.53 161.41 11.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.766 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.709 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -46.22 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.428 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.661 ' OE1' ' N ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -91.78 107.29 21.34 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 120.391 -0.523 . . . . 1.0 112.343 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 171' ' ' ALA . 26.7 Cg_endo -92.61 -156.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.67 2.247 . . . . 1.0 110.849 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -91.0 173.83 5.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.046 -0.979 . . . . 1.0 112.698 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.34 155.96 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.876 2.384 . . . . 1.0 111.108 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -108.23 150.19 27.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.856 0.36 . . . . 1.0 110.795 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -106.43 143.95 33.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.254 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.79 -28.3 66.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.617 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.14 -54.58 27.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.594 -0.275 . . . . 1.0 111.325 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.58 -33.88 76.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.944 0.402 . . . . 1.0 110.688 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.66 -39.99 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.501 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.54 ' OE1' ' NE2' ' A' ' 185' ' ' GLN . 14.0 mm100 -61.98 -51.96 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.352 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.1 t -45.27 -48.95 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 187' ' ' LEU . 63.9 t -74.27 -38.71 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.542 ' CD ' HH12 ' A' ' 101' ' ' ARG . 7.2 tt0 -45.93 -36.02 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.59 -39.68 67.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.764 -1.107 . . . . 1.0 109.333 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 184' ' ' VAL . 35.0 tp -54.95 -32.92 61.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.85 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.655 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -56.91 -39.36 74.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.697 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -53.38 -53.91 44.37 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.2 t -56.7 -43.67 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.36 -0.836 . . . . 1.0 109.869 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -51.7 -37.43 50.73 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.2 mt -78.39 -32.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.025 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.36 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 1.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.6 pp -66.62 -26.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.52 -55.71 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.846 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.26 -26.88 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.95 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.48 -35.73 58.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -56.94 -39.34 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.221 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.5 tp -66.97 -56.31 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.119 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.9 m -47.16 -39.16 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 1.0 110.307 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.081 -0.961 . . . . 1.0 110.47 179.78 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 1.008 HBA2 HBC2 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD21 ' NH2' ' A' ' 55' ' ' ARG . 4.4 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.823 0.344 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 40.6 p-10 -65.33 -37.88 88.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.313 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.0 mt-30 -73.3 -53.71 10.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.799 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -57.2 -40.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 69.9 mt -71.29 -33.28 69.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.631 -0.427 . . . . 1.0 111.589 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -49.53 -37.96 28.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.634 -0.426 . . . . 1.0 109.993 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.16 -26.4 52.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.35 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.5 p -74.85 -44.33 49.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.557 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 53' ' ' VAL . 56.8 t -59.13 -38.89 76.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.548 . . . . 1.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.27 -38.22 56.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.55 -49.35 75.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.995 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.92 -47.99 90.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.942 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.2 ttp180 -49.71 -43.99 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.853 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -81.52 -47.95 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.804 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -78.0 -7.08 56.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 1.0 110.084 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 50.18 19.51 2.76 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.668 -0.696 . . . . 1.0 112.494 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.703 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.9 m -76.91 141.9 40.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.065 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.0 m-20 -62.6 -28.45 69.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.703 ' H ' HG22 ' A' ' 48' ' ' THR . 60.5 ttp180 -152.98 124.87 7.88 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.145 -1.022 . . . . 1.0 113.54 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -146.7 136.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -146.81 162.45 38.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.566 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 39' ' ' VAL . 70.6 t -97.71 136.47 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.035 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -122.89 121.67 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.024 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.854 ' NH2' HD11 ' A' ' 195' ' ' ILE . 36.6 ttm-85 -101.47 168.93 9.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.85 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' N ' ' CG ' ' A' ' 55' ' ' ARG . 71.0 t80 -131.2 136.7 48.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.053 0.454 . . . . 1.0 112.124 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.5 148.74 35.63 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.379 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.69 -22.53 64.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.728 2.286 . . . . 1.0 112.94 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -79.69 -3.09 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.544 -0.463 . . . . 1.0 111.041 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.7 -10.42 52.86 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.815 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -90.19 145.83 24.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.377 0.588 . . . . 1.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.61 142.92 14.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.3 p -128.39 147.5 50.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.152 0.501 . . . . 1.0 112.346 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.7 t -101.14 121.35 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 m -108.98 1.84 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.468 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.62 149.12 24.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.6 tt0 -166.83 127.18 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.394 -0.922 . . . . 1.0 113.248 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 133.89 54.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.549 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 58.6 mtm180 -117.45 139.74 50.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.22 107.05 2.56 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.32 18.17 0.06 OUTLIER Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.268 -1.133 . . . . 1.0 110.268 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' GLY . 43.6 tt0 70.57 30.91 3.01 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.115 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 36.7 ttm180 -57.83 -59.57 5.03 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.8 164.8 20.67 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.81 171.75 17.43 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.043 1.829 . . . . 1.0 112.533 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -90.42 121.37 32.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -92.76 -11.85 32.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.624 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 tp -50.4 137.23 19.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.17 82.37 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.384 -0.825 . . . . 1.0 111.051 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 81' ' ' THR . 4.3 tt -97.68 115.9 28.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 1.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.625 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.0 t -76.46 122.5 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.465 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.75 132.16 21.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.318 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.11 152.39 27.73 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.195 1.93 . . . . 1.0 111.698 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.36 -21.14 66.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.81 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.73 -22.29 0.14 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' HB3' ' HHB' ' A' ' 203' ' ' CYC . 91.3 m-20 -48.44 -23.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.331 . . . . 1.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.544 ' CD1' HH21 ' A' ' 92' ' ' ARG . 2.9 pt -133.67 142.04 42.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HD3' HMC3 ' A' ' 203' ' ' CYC . 43.1 Cg_endo -83.55 -104.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.525 2.15 . . . . 1.0 112.346 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HA ' HH12 ' A' ' 92' ' ' ARG . 82.3 tt0 -147.64 -64.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 1.0 111.788 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.04 -41.12 46.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.716 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.035 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -63.15 -41.63 99.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.96 0.41 . . . . 1.0 111.005 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.544 HH21 ' CD1' ' A' ' 87' ' ' ILE . 23.6 ttm105 -64.54 -27.93 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' LEU . 68.7 mtm180 -58.53 -53.56 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.327 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.665 HD12 ' N ' ' A' ' 94' ' ' LEU . 8.4 mp -52.73 -41.33 63.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.55 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 4.2 m-85 -64.1 -35.91 82.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -85.2 -8.96 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.072 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.4 tp -105.86 -43.34 4.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.42 -0.08 12.62 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 98' ' ' ALA . 93.6 mt-30 28.45 68.28 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 t -117.73 -48.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.381 -2.452 . . . . 1.0 104.381 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 101' ' ' ARG . 6.2 mtp180 50.57 76.5 0.15 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.26 171.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' C ' HD12 ' A' ' 103' ' ' ILE . 11.2 m -145.15 139.17 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.757 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.775 HD12 ' N ' ' A' ' 103' ' ' ILE . 2.8 mp -107.24 125.2 63.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 105' ' ' ASP . 24.3 t -83.49 166.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 113.256 0.835 . . . . 1.0 113.256 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.673 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.1 m-20 -48.85 120.32 3.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.252 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.1 m -57.77 -12.18 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.764 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -87.01 -37.33 17.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.46 -16.19 44.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.372 0.606 . . . . 1.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 53.06 60.32 3.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.002 -0.999 . . . . 1.0 113.427 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.1 m -92.89 133.98 35.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -128.35 141.67 51.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -101.81 150.74 22.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.073 -1.422 . . . . 1.0 107.298 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 112' ' ' SER . 22.4 pt -155.12 159.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.678 -0.809 . . . . 1.0 112.162 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.2 t -88.11 162.03 16.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.186 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -150.21 154.54 36.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.668 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.11 165.18 24.14 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.626 2.217 . . . . 1.0 112.236 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 119' ' ' TRP . 85.0 tt0 46.22 -100.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.586 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 119' ' ' TRP . 34.3 t 41.96 -93.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.59 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.529 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 51.9 t-105 45.87 -174.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.566 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 92.2 1.68 69.31 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.9 tp -70.86 -33.19 70.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 1.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.8 p -55.95 -20.01 14.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.57 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.77 -23.04 4.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.816 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 58.8 84.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -98.54 140.77 22.03 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.53 137.65 23.17 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.525 2.15 . . . . 1.0 111.205 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt 43.66 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.02 -24.87 13.65 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.641 -0.584 . . . . 1.0 111.641 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.76 152.85 89.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.627 ' CG ' HH21 ' A' ' 133' ' ' ARG . 55.6 Cg_endo -67.05 166.28 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 1.0 111.686 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.35 0.15 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.309 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -137.99 168.72 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.627 HH21 ' CG ' ' A' ' 130' ' ' PRO . 2.5 mmp_? -133.09 83.63 50.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.338 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 112' ' ' SER . 88.2 Cg_exo -46.0 145.21 5.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.525 2.15 . . . . 1.0 111.797 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.777 HG21 ' ND1' ' A' ' 139' ' ' HIS . 6.5 m -118.1 127.01 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 1.0 111.361 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.86 ' H ' HMD2 ' A' ' 203' ' ' CYC . 2.7 m-20 -43.12 139.39 2.29 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.9 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -39.91 -46.8 3.85 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.163 1.909 . . . . 1.0 111.24 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 9.9 p -43.83 -41.68 5.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.777 ' ND1' HG21 ' A' ' 135' ' ' VAL . 13.1 t-80 -79.94 -38.52 32.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.368 -0.833 . . . . 1.0 110.687 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.6 t -50.9 -50.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.3 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 77.0 t60 -64.13 -39.86 94.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.253 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -43.95 -47.48 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.447 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.78 -45.4 61.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.511 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -60.17 -42.49 95.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.492 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.8 m -54.17 -33.33 57.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.6 mtt -86.99 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.156 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.26 26.16 66.75 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.291 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 169' ' ' HIS . 48.0 t -106.74 120.87 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.33 33.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 173' ' ' PRO . 37.7 m -127.89 153.99 46.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.155 -0.618 . . . . 1.0 111.585 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -143.87 129.55 19.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.052 0.453 . . . . 1.0 112.178 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.96 141.78 50.97 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' CG2' ' A' ' 154' ' ' VAL . 2.3 m -129.65 155.42 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.845 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 2.1 t -150.72 97.82 3.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.891 -1.05 . . . . 1.0 109.287 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.84 139.52 36.65 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.536 2.824 . . . . 1.0 113.889 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.24 104.52 16.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.718 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 88.3 mtp -119.06 141.07 49.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.843 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 84.4 t60 -125.31 112.93 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 158' ' ' HIS . 7.9 t-80 75.08 -135.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.429 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 80.9 mt-30 -96.16 12.38 31.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 63.7 mt-10 -120.19 161.43 21.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.79 116.83 32.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.544 -1.207 . . . . 1.0 108.851 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.4 m95 -99.04 -29.3 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.847 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.96 179.7 28.31 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.217 -0.992 . . . . 1.0 111.927 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.401 ' CD2' HMB2 ' A' ' 203' ' ' CYC . 5.1 tp -139.96 130.68 25.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 1.0 111.193 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.9 tp -99.6 145.27 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 167' ' ' VAL . 7.1 p -151.62 125.81 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.556 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -110.51 143.25 41.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.049 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.763 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -141.95 143.53 33.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 19.2 t60 -153.29 153.24 32.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.657 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.445 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.59 68.46 9.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.433 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.431 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.1 tp10 -177.04 131.41 0.35 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 120.401 -0.52 . . . . 1.0 112.302 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 174' ' ' ARG . 21.4 Cg_exo -39.08 -44.73 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.68 2.253 . . . . 1.0 110.885 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 173' ' ' PRO . 42.3 ttm180 23.17 104.6 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.009 -0.996 . . . . 1.0 112.689 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.72 156.18 24.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.793 2.329 . . . . 1.0 111.1 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -115.18 137.67 51.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 1.0 110.804 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -91.21 143.44 26.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.234 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.57 -55.3 28.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.661 0.267 . . . . 1.0 111.388 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -65.07 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 1.0 110.653 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.71 -30.47 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.576 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -73.88 -52.67 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.406 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.94 -45.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.283 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' LEU . 5.4 p -73.18 -39.38 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -49.8 -36.59 26.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.5 tp -69.88 -31.22 68.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.704 -1.134 . . . . 1.0 109.41 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.6 tt -63.32 -28.17 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.72 70.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.664 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -53.36 -44.61 68.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -52.56 -55.53 21.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.047 -0.724 . . . . 1.0 109.047 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.66 -40.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.903 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.8 m -50.22 -29.13 8.8 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.451 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 11.2 mm -77.28 -48.53 24.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.064 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.63 87.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.084 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.854 HD11 ' NH2' ' A' ' 55' ' ' ARG . 4.0 tp -59.91 -37.48 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 195' ' ' ILE . . . -72.97 -51.64 17.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.848 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 193' ' ' ILE . 2.9 mp0 -55.61 -26.59 44.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.81 55.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -59.08 -41.37 87.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.05 -60.14 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.024 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.2 p -58.97 -43.84 91.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.422 179.793 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 1.035 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 198' ' ' ALA . 32.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.886 0.374 . . . . 1.0 110.555 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.8 p-10 -63.66 -44.63 93.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.251 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 93.8 mt-30 -67.0 -53.19 33.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mt -55.24 -48.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.0 112.629 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.81 -25.25 68.16 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.641 -0.423 . . . . 1.0 111.609 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -57.42 -36.63 71.59 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.636 -0.426 . . . . 1.0 110.036 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.68 41.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.391 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -73.57 -48.4 33.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.556 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.2 p -53.3 -35.12 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 95.4 mt-10 -77.76 -33.71 52.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.44 -50.51 71.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.978 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.4 p -64.24 -45.56 95.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.91 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' N ' HG13 ' A' ' 42' ' ' VAL . 18.3 ttt-85 -49.09 -46.42 44.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.05 82.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.782 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -78.31 -52.11 9.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.761 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.55 -5.61 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 1.0 110.167 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.75 18.0 0.33 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.599 -0.728 . . . . 1.0 112.399 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -75.86 144.0 41.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 1.0 110.14 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 70' ' ' GLY . 97.4 m-20 -64.29 -26.81 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.87 0.693 . . . . 1.0 112.87 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 48' ' ' THR . 24.4 ttt180 -149.98 121.27 7.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.103 -1.039 . . . . 1.0 113.476 -178.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 3.2 t -140.32 130.53 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.957 -1.127 . . . . 1.0 107.957 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -143.33 155.32 44.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.626 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.79 137.44 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.009 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -121.36 119.7 32.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -99.76 170.29 8.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.871 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 48.9 t80 -135.05 141.66 46.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.155 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 4.0 m-20 -104.0 150.47 38.31 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.269 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.49 -29.18 53.31 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.699 2.266 . . . . 1.0 112.901 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.47 -4.99 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.586 -0.446 . . . . 1.0 110.935 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.36 -14.54 36.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.803 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 99.2 m-70 -84.65 143.79 29.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.398 0.599 . . . . 1.0 110.959 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -119.67 139.28 13.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -125.08 143.85 50.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.289 0.566 . . . . 1.0 112.25 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.27 120.16 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.61 3.47 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.52 149.87 24.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 79.2 tt0 -166.15 125.46 1.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.433 -0.907 . . . . 1.0 113.266 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.13 135.86 47.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 7.1 ptp85 -129.78 141.97 50.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.552 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.36 106.32 3.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.454 -1.058 . . . . 1.0 110.454 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.19 -88.55 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.261 -1.136 . . . . 1.0 110.261 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.7 tt0 -177.36 32.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.064 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.57 -33.94 73.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.73 142.63 29.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 64.0 Cg_endo -73.36 170.35 20.1 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.077 1.851 . . . . 1.0 112.535 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 14.9 m -93.53 137.93 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.189 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.8 mt -109.63 -3.9 16.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.641 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 14.2 tp -56.69 137.75 53.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.278 0.561 . . . . 1.0 112.286 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.97 86.03 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 81' ' ' THR . 2.8 tt -101.61 118.77 37.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.907 0.384 . . . . 1.0 110.746 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -76.69 122.43 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.463 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 m-85 -106.26 133.69 20.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.336 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.7 152.28 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.175 1.917 . . . . 1.0 111.71 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.9 -23.39 67.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.796 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.86 -22.93 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -54.05 -21.72 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.407 ' HB ' HH21 ' A' ' 92' ' ' ARG . 18.1 mt -129.0 132.83 24.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.302 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 89.8 Cg_endo -77.17 -107.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.531 2.154 . . . . 1.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.11 -69.09 0.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.815 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -42.34 -42.38 3.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -66.14 -52.96 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.976 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.407 HH21 ' HB ' ' A' ' 87' ' ' ILE . 35.4 ttm180 -56.44 -30.37 62.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.566 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -57.47 -45.11 85.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.231 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 98' ' ' ALA . 50.5 mt -54.96 -36.68 65.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.582 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.624 ' HD1' ' H ' ' A' ' 95' ' ' PHE . 7.6 m-85 -61.17 -26.53 67.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 97' ' ' LEU . 48.0 mtp85 -93.87 -18.23 22.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.12 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.1 mp -109.44 -46.86 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.374 0.879 . . . . 1.0 113.374 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -107.96 -10.87 15.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -174.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 98' ' ' ALA . 22.3 mt-30 26.12 69.29 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.69 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -137.46 -54.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.69 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.4 mmp_? 49.57 101.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.111 -1.404 . . . . 1.0 114.288 171.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.61 136.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.464 -0.494 . . . . 1.0 111.743 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.454 ' CD1' HMA2 ' A' ' 203' ' ' CYC . 70.8 mt -107.61 123.16 62.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.688 HG12 ' N ' ' A' ' 105' ' ' ASP . 23.4 t -84.17 168.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.688 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.0 m-20 -50.4 118.48 3.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.262 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.9 p -55.54 -11.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.313 -0.858 . . . . 1.0 110.75 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 109' ' ' GLN . 4.8 pt-20 -88.61 -35.86 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.915 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.59 0.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.4 0.619 . . . . 1.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 107' ' ' GLU . 10.1 pt20 35.35 60.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.106 -0.952 . . . . 1.0 113.504 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -93.96 134.99 35.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.384 -2.08 . . . . 1.0 105.384 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -131.09 141.85 50.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 1.9 t -142.89 116.56 9.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.184 -1.371 . . . . 1.0 107.354 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -119.34 -163.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 119.673 -0.811 . . . . 1.0 112.181 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.663 ' H ' HG22 ' A' ' 113' ' ' ILE . 49.0 m -88.02 164.43 15.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 116' ' ' PRO . 39.2 mt-30 -143.12 151.29 55.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.651 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 115' ' ' GLN . 41.5 Cg_exo -35.09 -40.7 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.686 2.257 . . . . 1.0 112.241 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -145.76 147.68 32.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.538 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.2 p -130.19 152.79 49.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.577 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 87.4 t90 -153.01 171.74 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.537 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.545 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 92.73 6.32 63.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 121' ' ' LEU . 10.1 mp -81.63 -72.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 1.0 110.595 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.9 p -65.25 -20.43 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.6 75.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 56.23 86.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.8 142.94 25.6 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.29 130.31 13.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.597 2.198 . . . . 1.0 111.151 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 5.3 tp 47.66 -134.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 55.06 16.47 8.34 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.678 -0.569 . . . . 1.0 111.678 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -102.05 152.23 38.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.929 -0.309 . . . . 1.0 110.599 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.92 160.0 50.75 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.408 2.072 . . . . 1.0 111.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.94 -14.47 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.297 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -134.57 169.41 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.514 HH21 HH22 ' A' ' 101' ' ' ARG . 11.3 tpp180 -138.72 73.46 40.67 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.336 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 133' ' ' ARG . 3.5 Cg_exo -30.36 143.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.615 2.21 . . . . 1.0 111.774 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.599 HG11 ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -104.8 115.69 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.107 0.479 . . . . 1.0 111.363 -178.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -40.27 147.14 0.38 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.912 178.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.7 Cg_endo -52.86 -12.41 1.94 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.221 1.947 . . . . 1.0 111.258 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.607 ' O ' HBC1 ' A' ' 203' ' ' CYC . 36.0 t -77.02 -39.32 50.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.599 ' CE1' HG11 ' A' ' 135' ' ' VAL . 3.3 t-80 -83.34 -34.2 25.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.366 -0.834 . . . . 1.0 110.633 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 137' ' ' PRO . 2.9 m -53.94 -45.88 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.299 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.553 ' N ' HG23 ' A' ' 140' ' ' VAL . 84.7 t60 -67.41 -44.92 77.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.197 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -46.59 -51.16 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.47 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.3 -49.22 57.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 147' ' ' GLY . 17.8 tptp -58.0 -40.25 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.449 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.9 m -53.73 -33.47 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.62 0.88 44.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.191 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.62 23.96 75.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.247 -0.888 . . . . 1.0 112.334 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 170' ' ' HIS . 25.3 t -107.46 121.8 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.913 -0.402 . . . . 1.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.72 49.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' HG12 ' A' ' 148' ' ' VAL . 32.4 t -135.53 170.12 16.45 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.112 -0.635 . . . . 1.0 111.593 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.7 t -162.05 139.82 8.72 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 35.9 tp -115.33 133.58 55.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.4 p -132.37 155.58 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.06 -0.656 . . . . 1.0 111.818 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 77.2 t -156.53 109.93 2.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.334 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.62 114.17 3.42 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.634 2.889 . . . . 1.0 113.87 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.51 107.02 7.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.808 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.456 ' SD ' ' OE1' ' A' ' 99' ' ' GLN . 17.0 ptm -132.15 144.19 50.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.824 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 70.8 t60 -114.31 114.73 26.33 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 46.8 t-80 61.48 -123.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.507 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 33.3 tt0 -94.04 6.16 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.901 0.334 . . . . 1.0 111.901 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.497 ' N ' ' OE1' ' A' ' 161' ' ' GLU . 43.9 mp0 -115.65 149.82 37.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.991 1.108 . . . . 1.0 113.991 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.28 116.83 32.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.562 -1.199 . . . . 1.0 108.912 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -99.22 -30.47 12.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.917 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.26 -174.1 24.76 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.187 -1.006 . . . . 1.0 111.958 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 tp -141.09 131.11 24.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 1.0 111.201 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -93.7 136.21 34.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.56 ' CG1' ' NE2' ' A' ' 169' ' ' HIS . 31.0 t -148.52 122.74 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.527 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -108.09 143.27 37.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.971 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.56 ' NE2' ' CG1' ' A' ' 167' ' ' VAL . 54.3 m-70 -137.03 143.2 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.096 0.474 . . . . 1.0 111.048 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.732 ' CG ' ' HE ' ' A' ' 174' ' ' ARG . 2.5 p-80 -152.95 151.92 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.703 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.56 68.97 9.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.403 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 179.67 153.91 0.62 Allowed Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -89.54 101.76 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.695 2.263 . . . . 1.0 110.934 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.732 ' HE ' ' CG ' ' A' ' 170' ' ' HIS . 6.9 ptt85 -128.62 100.11 22.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.068 -0.969 . . . . 1.0 112.686 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.99 152.65 17.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.89 2.394 . . . . 1.0 111.089 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -110.53 145.8 37.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.864 -0.335 . . . . 1.0 110.799 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 t -96.26 139.2 32.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -63.17 -40.34 97.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.671 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -65.49 -55.73 16.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.31 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.89 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 1.0 110.64 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.2 tp -59.56 -40.23 86.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.539 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -60.76 -50.84 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.416 -0.357 . . . . 1.0 111.358 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.39 -47.16 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 75.3 t -73.39 -40.71 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -45.99 -34.83 4.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 177.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.67 -38.07 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.404 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 10.9 tp -54.84 -31.36 59.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.698 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.55 70.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.648 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -57.19 -42.1 80.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.72 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -52.7 -55.35 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.136 -0.69 . . . . 1.0 109.136 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.07 -43.17 84.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.826 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 p -52.0 -37.27 52.64 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.1 mt -78.11 -33.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.079 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.71 66.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.037 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.7 pp -67.13 -23.78 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.53 -56.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.794 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.2 -26.9 63.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.909 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -76.41 -36.27 58.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.263 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.2 -38.13 70.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.8 mt -68.08 -55.94 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.055 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.2 p -53.0 -41.16 64.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.281 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.02 -0.99 . . . . 1.0 110.423 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.607 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 1.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 65' ' ' VAL . 64.1 t0 -53.6 -53.07 56.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.02 -46.42 90.81 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 38' ' ' THR . 18.4 mm -60.63 -38.98 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.38 -21.15 60.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.555 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -70.32 -40.21 74.31 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.034 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.43 -33.56 62.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.349 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 34' ' ' ILE . 41.2 p -68.17 -46.39 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.573 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 68' ' ' ALA . 5.2 t -56.18 -38.89 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.874 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.64 -37.43 56.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -57.43 -53.14 61.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.951 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 43' ' ' ARG . 10.7 p -63.35 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.896 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.3 ttp-105 -51.13 -47.21 62.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.905 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.71 78.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.4 -50.93 10.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.26 -5.59 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 1.0 110.206 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.3 19.2 1.07 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.442 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.3 m -76.08 141.99 41.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.374 -0.531 . . . . 1.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 70' ' ' GLY . 37.3 p30 -67.8 -24.16 65.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 48' ' ' THR . 71.2 ttt-85 -153.98 120.31 5.44 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.176 -1.01 . . . . 1.0 113.538 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.21 139.18 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.674 ' CE ' HAB1 ' A' ' 203' ' ' CYC . 28.4 pttt -148.04 160.59 42.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.553 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -99.41 139.15 21.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.078 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 165' ' ' LEU . 16.0 t80 -121.58 120.47 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.01 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' A' ' 55' ' ' ARG . 20.2 ttp-105 -99.43 166.59 11.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 1.0 109.911 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 43.2 t80 -132.36 142.77 49.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.074 0.464 . . . . 1.0 112.117 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 m-20 -105.34 149.88 38.26 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.32 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.78 -30.32 58.95 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.735 2.29 . . . . 1.0 112.896 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.95 -5.43 34.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.607 -0.437 . . . . 1.0 111.022 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.77 -14.24 38.19 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.998 -0.62 . . . . 1.0 112.83 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.64 142.77 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.436 0.618 . . . . 1.0 110.896 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.35 140.17 14.25 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.0 p -127.1 145.71 50.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.242 0.544 . . . . 1.0 112.253 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 64' ' ' VAL . 7.5 p -104.54 121.26 56.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 32' ' ' ASP . 1.3 p -115.97 9.01 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -155.71 145.52 21.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.2 tt0 -168.69 129.93 1.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.447 -0.901 . . . . 1.0 113.212 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.36 140.42 44.57 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.39 143.85 50.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.523 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.6 108.19 3.36 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.21 -84.92 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 70' ' ' GLY . 16.1 pt-20 177.89 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.859 -0.337 . . . . 1.0 111.15 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.591 ' NH1' ' NE2' ' A' ' 170' ' ' HIS . 10.4 ptp180 -65.76 -31.6 72.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 12.8 mt -116.3 150.28 45.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 4.8 Cg_exo -78.01 162.88 28.79 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.066 1.844 . . . . 1.0 112.494 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -90.79 113.62 25.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.98 -1.18 57.83 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.554 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.2 tp -52.8 135.63 35.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 1.0 112.216 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 90.89 -1.43 78.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 81' ' ' THR . 3.7 tt -95.22 120.31 35.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 1.0 110.743 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 80' ' ' LEU . 6.2 p -87.75 127.34 35.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.446 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.429 ' CG ' HBB3 ' A' ' 203' ' ' CYC . 35.1 m-85 -109.23 139.02 20.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.288 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.67 161.48 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.214 1.943 . . . . 1.0 111.608 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -68.27 -28.87 67.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.781 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.43 -23.43 3.08 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.68 -26.9 68.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 1.0 110.663 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 88' ' ' PRO . 60.8 mt -112.18 99.98 47.95 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.3 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 87' ' ' ILE . 84.2 Cg_exo -49.4 -121.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.584 2.189 . . . . 1.0 112.318 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -145.64 -58.32 0.32 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.8 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -51.3 -42.09 60.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.805 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -65.85 -49.87 66.61 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -29.92 68.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.534 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.18 -48.27 80.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.278 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HB2' ' HE ' ' A' ' 133' ' ' ARG . 74.2 mt -51.89 -40.2 60.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.652 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.7 -24.91 67.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.484 ' CA ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -90.98 -21.29 21.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.16 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 125' ' ' VAL . 9.4 mp -105.57 -45.94 4.3 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.404 0.89 . . . . 1.0 113.404 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.72 -5.83 16.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' ALA . 96.3 mt-30 24.68 66.87 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 101' ' ' ARG . 3.1 m -108.44 -50.78 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 1.0 104.43 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.832 ' H ' HH22 ' A' ' 133' ' ' ARG . 1.2 mtt180 65.67 68.03 0.48 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.069 -1.423 . . . . 1.0 114.233 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.538 ' H ' HH12 ' A' ' 133' ' ' ARG . 44.6 t -148.92 130.85 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.754 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 139' ' ' HIS . 89.8 mt -110.93 128.51 67.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 105' ' ' ASP . 12.9 t -82.39 168.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 113.307 0.854 . . . . 1.0 113.307 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.655 ' N ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -47.49 117.34 1.76 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.805 -1.088 . . . . 1.0 112.325 -178.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.08 -10.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.745 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -87.4 -35.41 18.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.872 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.03 48.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.367 0.603 . . . . 1.0 110.149 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 52.78 59.41 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.974 . . . . 1.0 113.456 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -93.79 138.61 31.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -133.82 144.12 48.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.003 1.483 . . . . 1.0 115.003 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -129.49 113.99 15.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.127 -1.397 . . . . 1.0 107.404 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.858 ' H ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -119.93 -168.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.745 -0.782 . . . . 1.0 112.214 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.401 ' O ' HG12 ' A' ' 113' ' ' ILE . 40.2 t -88.25 154.65 20.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.482 -0.781 . . . . 1.0 110.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -151.37 153.61 32.62 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.578 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 115' ' ' GLN . 39.5 Cg_exo -35.44 157.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.635 2.223 . . . . 1.0 112.27 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.66 142.0 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.515 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.8 t -150.69 146.84 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -56.92 -44.57 82.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.48 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.92 32.32 62.2 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.639 HD12 ' N ' ' A' ' 121' ' ' LEU . 9.3 mp 50.83 78.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 1.0 110.559 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.4 m -58.39 -33.95 70.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.76 -53.46 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.826 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -171.94 143.91 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.974 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 97' ' ' LEU . 3.0 m -114.35 84.18 9.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.073 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' C ' ' A' ' 127' ' ' LEU . 78.9 Cg_endo -84.35 126.67 3.71 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.529 2.153 . . . . 1.0 111.208 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 126' ' ' PRO . 69.5 mt 36.63 -108.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.51 8.17 18.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.609 -0.597 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -153.96 149.91 21.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.662 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.25 168.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.446 2.097 . . . . 1.0 111.675 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.29 19.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.286 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -133.47 171.38 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.036 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.832 HH22 ' H ' ' A' ' 101' ' ' ARG . 17.8 ttm105 -131.41 80.53 67.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.28 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -44.23 145.79 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.512 2.141 . . . . 1.0 111.833 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.447 HG12 HBD2 ' A' ' 203' ' ' CYC . 12.5 m -122.38 130.07 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.014 0.435 . . . . 1.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.685 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -42.47 163.45 0.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.913 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.3 -11.07 17.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.226 1.951 . . . . 1.0 111.257 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.727 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -60.23 -55.42 33.98 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.976 -0.749 . . . . 1.0 108.976 178.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.727 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 18.0 t-80 -72.34 -27.16 62.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.631 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.05 -60.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.335 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -66.1 -41.98 89.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.24 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -42.51 -48.72 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.546 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.697 HD11 ' CE1' ' A' ' 139' ' ' HIS . 30.2 mt -72.08 -47.01 54.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.46 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 147' ' ' GLY . 38.7 tptt -55.99 -42.97 77.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -55.1 -30.2 59.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 41.7 mtt -90.02 -7.98 52.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.118 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 144' ' ' LYS . . . 75.96 28.96 59.7 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.337 -0.847 . . . . 1.0 112.327 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.589 HG11 ' CB ' ' A' ' 169' ' ' HIS . 14.4 t -108.94 124.36 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.03 -31.17 39.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.41 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.6 p -134.12 169.4 17.22 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.594 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -159.06 139.47 12.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.023 0.439 . . . . 1.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.02 141.89 48.3 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -132.96 156.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.418 0.628 . . . . 1.0 111.914 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 153' ' ' VAL . 53.3 t -157.62 98.53 1.91 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.337 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.24 117.74 4.83 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.571 2.848 . . . . 1.0 113.9 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.82 106.3 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.809 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.2 ptm -129.34 143.33 50.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.848 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 70.0 t60 -110.42 113.96 27.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 21.3 m-70 57.97 -119.67 1.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -93.63 2.55 56.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -112.56 150.69 30.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.959 1.096 . . . . 1.0 113.959 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.03 116.84 32.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.491 -1.231 . . . . 1.0 108.867 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -96.96 -28.52 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.921 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.41 -173.81 28.33 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.949 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.528 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.0 tp -138.18 133.54 33.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 1.0 111.214 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -99.45 140.03 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.628 ' O ' HG13 ' A' ' 167' ' ' VAL . 8.9 p -149.44 111.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.512 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 142.04 31.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.106 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.589 ' CB ' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -146.71 148.51 32.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.141 0.496 . . . . 1.0 111.043 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.591 ' NE2' ' NH1' ' A' ' 73' ' ' ARG . 7.0 t60 -152.63 148.57 27.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -72.74 69.11 0.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -173.22 167.09 2.82 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.345 -0.542 . . . . 1.0 112.293 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -89.74 6.75 4.21 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.64 2.227 . . . . 1.0 110.831 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -34.25 115.12 0.48 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.104 -0.953 . . . . 1.0 112.669 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.26 155.28 22.17 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.804 2.336 . . . . 1.0 111.056 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -108.83 141.75 40.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.779 0.324 . . . . 1.0 110.85 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -94.01 149.3 21.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.291 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.93 -40.78 78.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.678 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.87 -55.81 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.366 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.15 -31.34 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 1.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.2 tp -60.82 -38.12 84.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.456 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -63.42 -52.98 59.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.395 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.5 t -43.95 -49.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.317 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.7 m -75.06 -36.28 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.472 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 7.1 tp-100 -46.89 -36.64 7.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.099 -1.075 . . . . 1.0 108.099 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.53 -40.76 66.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.374 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' VAL . 33.9 tp -54.76 -33.1 60.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.645 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.451 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.14 -35.94 61.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.603 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . 0.464 ' O ' ' OG ' ' A' ' 192' ' ' SER . 50.6 t0 -57.37 -41.15 79.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.661 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -52.33 -52.38 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.89 -43.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.888 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.6 p -51.92 -38.07 54.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.65 -32.64 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.027 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -46.13 64.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.117 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.6 pp -66.74 -26.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.43 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -77.03 -56.31 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.946 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.13 -26.77 63.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.869 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.84 -35.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.24 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -56.91 -38.98 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.8 -57.16 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.09 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 t -60.4 -46.08 91.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 1.0 110.321 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.427 179.768 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 203' ' ' CYC . . . . . 0.685 HMD2 ' OD1' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 195' ' ' ILE . 6.9 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.899 0.381 . . . . 1.0 110.581 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.18 -46.98 65.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -66.01 -47.31 74.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.222 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.87 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -59.68 -41.07 84.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -74.83 -22.33 58.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.586 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.3 ttp180 -66.72 -36.83 83.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.614 -0.434 . . . . 1.0 109.973 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.71 -30.98 41.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.317 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.87 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.0 p -72.39 -48.5 41.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.543 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.3 p -55.29 -33.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.858 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -72.23 -39.13 68.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.63 -40.63 97.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.988 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.25 -52.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 47' ' ' GLY . 31.2 ttp85 -52.2 -43.55 64.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.877 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.66 75.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 1.0 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -81.55 -50.35 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.77 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -77.39 -7.6 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 1.0 110.087 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.91 19.05 1.25 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.413 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.6 m -76.03 142.74 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.047 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.5 m-20 -57.69 -33.28 68.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 48' ' ' THR . 58.1 ttp180 -153.29 120.97 5.98 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 119.128 -1.029 . . . . 1.0 113.536 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.75 135.23 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.584 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 9.1 pttp -146.45 162.06 39.07 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.552 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.01 136.78 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.007 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 165' ' ' LEU . 79.5 t80 -123.4 120.56 33.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.052 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' OG1' ' A' ' 63' ' ' THR . 27.2 ptt180 -101.08 171.98 7.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -134.01 134.19 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 1.0 112.138 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.74 129.32 25.53 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.345 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.47 -25.93 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.739 2.293 . . . . 1.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 -9.82 59.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.984 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.4 36.35 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.816 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -86.72 141.76 28.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.38 0.59 . . . . 1.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.3 145.98 15.95 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.434 -1.067 . . . . 1.0 110.434 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' NE ' ' A' ' 55' ' ' ARG . 28.6 p -129.86 147.88 51.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.25 0.547 . . . . 1.0 112.303 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.06 101.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.36 3.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.18 147.26 24.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.1 tt0 -166.88 126.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.245 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.44 53.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -121.92 141.84 50.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.555 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.93 97.64 1.88 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.47 -90.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.02 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.83 -0.348 . . . . 1.0 111.101 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -70.72 -55.61 8.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.5 mt -92.95 154.48 41.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.92 167.82 23.1 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.099 1.866 . . . . 1.0 112.518 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 p -89.27 132.05 35.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.125 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.09 -4.41 20.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.618 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -59.36 139.89 56.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.35 0.595 . . . . 1.0 112.239 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.8 80.2 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 mt -101.23 131.73 47.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 1.0 110.76 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -88.14 119.41 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.485 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.9 m-85 -108.64 132.5 21.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.285 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.73 157.52 27.99 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.125 1.883 . . . . 1.0 111.702 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.14 66.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.76 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -23.72 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -55.53 -29.07 58.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 1.0 110.634 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.4 mt -121.35 133.43 24.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.297 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.4 -106.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.538 2.159 . . . . 1.0 112.336 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -152.49 -64.71 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.832 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -43.02 -41.97 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.723 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.02 97.22 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.958 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -65.57 -28.44 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.526 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -56.72 -55.31 35.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.267 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 94' ' ' LEU . 9.4 mp -54.13 -40.75 67.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.587 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.91 -40.19 92.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.09 -8.42 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.56 -0.746 . . . . 1.0 110.11 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tp -107.49 -43.58 4.5 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.389 0.885 . . . . 1.0 113.389 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.71 -1.52 12.08 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.53 0.937 . . . . 1.0 113.53 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 28.9 mp0 27.51 69.64 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.5 p -116.9 -49.67 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.437 -2.431 . . . . 1.0 104.437 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.595 ' N ' HG13 ' A' ' 100' ' ' VAL . 2.6 mtt180 61.55 78.96 0.27 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.058 -1.428 . . . . 1.0 114.35 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.79 132.32 5.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.76 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.5 mp -107.06 126.26 63.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 105' ' ' ASP . 27.3 t -82.85 167.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.249 0.833 . . . . 1.0 113.249 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.681 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.5 m-20 -50.84 118.22 3.0 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.692 -1.14 . . . . 1.0 112.261 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -57.66 -10.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.742 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.5 -36.25 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.889 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.5 -15.31 25.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 1.0 110.134 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 52.81 59.98 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.032 -0.986 . . . . 1.0 113.424 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -94.25 137.34 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 1.0 105.401 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -127.9 139.94 52.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.017 1.488 . . . . 1.0 115.017 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-N 114.154 -1.385 . . . . 1.0 107.338 176.934 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mmt-85 . . . . . 0 CA--C 1.527 0.091 0 CA-C-O 120.722 0.296 . . . . 1.0 110.301 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.92 144.86 5.49 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.516 2.144 . . . . 1.0 111.801 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 135' ' ' VAL . 3.1 m -113.33 120.1 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 1.0 111.349 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.46 148.97 0.4 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.903 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 140' ' ' VAL . 93.2 Cg_exo -45.85 -48.16 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.212 1.941 . . . . 1.0 111.275 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.2 p -43.83 -34.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.672 ' CE1' HD13 ' A' ' 143' ' ' LEU . 53.0 t-80 -82.67 -32.62 28.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.715 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' PRO . 52.4 t -53.09 -51.01 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.32 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.13 -43.06 93.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 1.0 110.26 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -46.21 -50.42 15.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.4 mp -71.76 -49.44 38.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.537 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.1 tptm -58.94 -41.29 87.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.46 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.5 p -54.24 -30.3 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.3 mtt -87.01 -0.61 56.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.228 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.26 25.03 75.8 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.293 -0.867 . . . . 1.0 112.359 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 150' ' ' SER . 21.6 t -105.87 122.57 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.23 -33.14 49.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 148' ' ' VAL . 2.4 t -137.42 171.16 14.89 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.592 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 7.3 p -161.42 139.98 9.66 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.198 0.444 . . . . 1.0 112.198 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 65.1 tp -115.19 138.66 50.67 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.5 m -132.14 155.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.468 0.651 . . . . 1.0 111.828 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.9 t -158.12 90.46 2.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.83 -1.077 . . . . 1.0 109.313 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.76 133.4 54.11 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.562 2.842 . . . . 1.0 113.946 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.8 mt -89.79 106.34 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.776 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 20.6 ptm -127.39 144.91 50.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.0 111.864 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.631 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 22.9 t-80 -114.15 114.06 25.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.631 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 22.2 m-70 59.01 -118.38 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.649 ' H ' ' CD ' ' A' ' 160' ' ' GLN . 2.3 pm0 -95.38 3.06 54.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.545 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.2 tt0 -112.06 149.49 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 162' ' ' LEU . 11.0 mp -107.37 117.28 33.66 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 114.532 -1.213 . . . . 1.0 108.841 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 81.7 m95 -97.2 -25.84 15.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.887 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.88 -168.19 23.42 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.971 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.7 tp -141.11 128.65 21.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.797 0.332 . . . . 1.0 111.239 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -93.9 137.91 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.584 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.0 p -150.87 133.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.541 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 p -115.77 145.4 42.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.009 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.07 140.62 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.157 0.503 . . . . 1.0 111.011 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -154.03 154.35 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.483 -0.781 . . . . 1.0 109.638 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.97 72.81 10.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.446 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.465 0.29 0 C-N-CA 120.399 -0.52 . . . . 1.0 112.323 179.344 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.809 0.338 . . . . 1.0 110.802 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.8 p -99.07 139.99 33.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.285 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.23 -36.01 76.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.65 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.7 -54.96 35.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.334 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.21 -32.05 73.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 1.0 110.643 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.54 -42.27 91.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.497 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.9 -52.71 63.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.455 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -44.77 -46.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.275 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.43 -37.85 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -48.68 -37.83 19.6 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.8 -40.92 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.383 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 42.3 tp -53.54 -32.65 51.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.68 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.57 -32.58 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.617 . . . . 1.0 109.616 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -58.68 -41.7 86.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -53.23 -52.85 57.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.4 -41.66 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.886 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.7 m -50.34 -29.78 10.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.7 mm -77.79 -38.52 25.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.023 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.67 67.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.108 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 31' ' ' LEU . 10.4 tp -64.24 -34.61 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -75.23 -55.91 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.881 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.79 -26.62 47.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.893 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.4 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.302 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.55 -39.38 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.154 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.1 mp -68.55 -56.43 8.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.107 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -55.56 -43.07 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.891 0.377 . . . . 1.0 110.357 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.419 179.708 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 195' ' ' ILE . 5.9 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.931 0.396 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.19 -32.65 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.245 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -78.39 -54.72 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.243 0.46 . . . . 1.0 112.243 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 38' ' ' THR . 4.7 tp -58.35 -37.42 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HG ' HG23 ' A' ' 34' ' ' ILE . 80.8 mt -74.36 -33.93 63.23 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -49.76 -37.93 31.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 1.0 109.993 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.39 -30.26 57.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.394 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 34' ' ' ILE . 52.9 p -70.58 -44.54 67.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.533 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 53' ' ' VAL . 49.8 t -59.15 -37.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.846 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.63 -39.53 84.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.13 -37.55 83.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.98 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.4 t -68.39 -43.56 84.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.4 ttp180 -57.03 -50.08 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.865 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.75 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.847 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -79.14 -51.88 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.781 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.95 -6.47 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.015 0.436 . . . . 1.0 110.089 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.96 17.65 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.0 112.393 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 51' ' ' VAL . 6.8 t -78.53 149.43 33.08 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.077 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.6 m-20 -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.705 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 51.2 ttp180 -155.01 131.86 10.75 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 119.124 -1.03 . . . . 1.0 113.499 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 48' ' ' THR . 0.3 OUTLIER -139.15 133.59 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.504 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 47.7 pttt -146.61 160.29 42.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.594 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 39' ' ' VAL . 71.2 t -99.11 135.08 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.975 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.7 t80 -117.38 120.27 37.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.058 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH2' HD21 ' A' ' 31' ' ' LEU . 46.4 ttm-85 -99.83 166.35 11.13 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 11.5 t80 -131.21 135.99 47.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.091 0.472 . . . . 1.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.9 m-20 -102.22 147.79 34.46 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.329 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.42 -21.59 71.26 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.726 2.284 . . . . 1.0 112.909 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.83 -2.44 47.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.044 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.54 -8.58 54.99 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.916 -0.659 . . . . 1.0 112.842 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -90.24 143.5 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.318 0.559 . . . . 1.0 111.005 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -120.47 137.88 12.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.6 p -124.31 145.36 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.197 0.522 . . . . 1.0 112.34 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -104.49 120.57 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.08 4.74 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.459 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -153.78 146.24 24.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.9 tt0 -166.38 127.36 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.398 -0.921 . . . . 1.0 113.222 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 129.5 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.521 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 6.8 ptp85 -116.85 140.61 49.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.216 -0.594 . . . . 1.0 111.524 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.47 98.53 1.89 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.78 -90.23 0.04 OUTLIER Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.188 -1.165 . . . . 1.0 110.188 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -176.38 33.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.116 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -71.38 -54.25 11.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.88 145.93 30.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.88 166.37 29.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.081 1.854 . . . . 1.0 112.564 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.521 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 16.2 m -88.86 135.94 33.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.108 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 45.6 mt -108.7 -0.99 19.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.615 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -60.59 138.95 57.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.588 . . . . 1.0 112.239 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.16 -4.95 85.37 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.338 -0.846 . . . . 1.0 111.05 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.62 130.14 45.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.861 0.362 . . . . 1.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -87.06 121.84 30.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.503 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 62' ' ' GLY . 28.7 m-85 -103.01 136.23 19.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.259 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.11 145.7 24.8 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.126 1.884 . . . . 1.0 111.708 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.37 69.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.15 -20.56 1.45 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 40.4 p30 -60.08 -30.67 69.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.792 0.329 . . . . 1.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.565 ' O ' ' O ' ' A' ' 88' ' ' PRO . 45.6 mt -113.74 101.0 53.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.262 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -45.57 -116.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.536 2.158 . . . . 1.0 112.351 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -154.3 -44.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.907 0.384 . . . . 1.0 111.832 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.4 -39.1 82.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.707 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.33 81.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 1.0 110.982 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -67.98 -28.63 67.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.562 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' LEU . 55.0 mtp180 -53.65 -57.71 9.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.244 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.7 mt -54.7 -38.29 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.556 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 6.6 m-85 -65.5 -30.71 71.51 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -93.62 -14.24 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.127 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' ARG . 11.8 tp -107.1 -46.16 3.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.99 -3.36 12.65 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.451 0.908 . . . . 1.0 113.451 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.619 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 13.0 mm-40 29.19 69.8 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -110.04 -51.06 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 175.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.619 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER 63.18 70.4 0.54 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.292 172.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.1 p -152.35 134.31 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.556 -0.457 . . . . 1.0 111.793 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 22.8 mt -108.51 127.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.659 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.4 p -83.25 167.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.659 ' N ' HG22 ' A' ' 104' ' ' VAL . 15.7 t0 -53.55 119.41 4.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.312 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.88 -10.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.735 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 1.3 pp20? -86.47 -37.76 17.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.921 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.97 -13.91 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.405 0.622 . . . . 1.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 50.34 52.63 14.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.041 -0.981 . . . . 1.0 113.35 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -93.27 133.44 36.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -126.13 141.07 52.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 m . . . . . 0 N--CA 1.452 -0.335 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.363 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HE ' ' HD2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.777 0.323 . . . . 1.0 110.275 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.462 ' HD2' ' HE ' ' A' ' 133' ' ' ARG . 91.0 Cg_endo -81.35 143.48 13.88 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.573 2.182 . . . . 1.0 111.745 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.54 HG21 ' ND1' ' A' ' 139' ' ' HIS . 1.5 m -112.99 123.34 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.073 0.463 . . . . 1.0 111.319 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.85 154.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.895 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.39 -26.94 79.76 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.221 1.947 . . . . 1.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 22.2 t -61.26 -43.0 99.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.797 ' CE1' HD13 ' A' ' 143' ' ' LEU . 46.8 t-80 -77.84 -29.65 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.0 -53.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.275 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.487 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 80.1 t60 -64.68 -42.78 95.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.268 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -44.29 -50.56 8.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.405 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.797 HD13 ' CE1' ' A' ' 139' ' ' HIS . 3.1 mp -71.59 -49.6 38.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.461 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.6 tptm -56.98 -40.83 77.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.487 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 30.9 m -54.2 -32.82 56.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 50.3 mtt -83.98 -2.01 55.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.164 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.68 26.43 74.48 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.277 -0.874 . . . . 1.0 112.353 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.1 p -109.01 127.04 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.08 -30.9 39.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -137.97 170.45 16.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.145 -0.622 . . . . 1.0 111.512 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -162.66 138.45 7.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.135 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 176' ' ' TYR . 18.3 tp -113.63 139.72 48.79 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -128.8 156.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.457 0.646 . . . . 1.0 111.783 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 153' ' ' VAL . 66.7 t -156.65 100.38 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.812 -1.085 . . . . 1.0 109.327 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.88 127.11 13.27 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.603 2.869 . . . . 1.0 113.899 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.51 106.08 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.812 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.2 ptm -130.73 146.65 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.834 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.615 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 30.5 t-80 -117.24 116.11 26.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.615 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 3.7 m-70 57.66 -122.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -92.81 7.59 43.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -116.61 150.56 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.011 1.115 . . . . 1.0 114.011 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.93 116.27 31.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.547 -1.206 . . . . 1.0 108.851 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 82.7 m95 -95.27 -26.34 15.98 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.924 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.5 -168.7 24.8 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.158 -1.02 . . . . 1.0 111.972 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.8 tp -145.32 136.76 25.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.803 0.335 . . . . 1.0 111.142 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.2 tp -100.91 145.5 28.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 167' ' ' VAL . 14.7 p -150.9 129.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.6 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.8 p -112.96 145.84 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.077 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.705 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -148.01 138.54 22.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.219 0.533 . . . . 1.0 110.973 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 148' ' ' VAL . 21.3 t60 -150.64 151.73 32.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.702 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.441 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -79.7 67.46 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.424 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 120.376 -0.53 . . . . 1.0 112.297 -179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CG ' HD13 ' A' ' 152' ' ' LEU . 42.6 m-85 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.804 0.335 . . . . 1.0 110.78 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.6 m -95.27 148.31 22.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.245 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.4 HE21 HE21 ' A' ' 182' ' ' GLN . 59.0 tp60 -67.19 -37.33 83.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.692 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.19 -54.48 40.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.349 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.64 -31.59 72.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.846 0.355 . . . . 1.0 110.598 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.439 HD11 HH12 ' A' ' 101' ' ' ARG . 28.2 tp -60.14 -41.85 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' GLN . 94.5 mm-40 -61.54 -52.86 62.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.377 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.6 t -43.06 -44.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.255 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.31 -36.88 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 36.6 tp60 -52.32 -37.86 56.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.58 -32.15 67.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.391 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.75 -27.85 69.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.53 -37.02 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.69 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -53.89 -42.33 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.717 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -52.35 -56.3 15.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.19 -41.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.902 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.9 p -51.82 -35.26 43.75 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.4 mt -78.97 -35.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.046 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.07 61.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.08 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 31' ' ' LEU . 9.0 tp -62.12 -36.7 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.181 0.515 . . . . 1.0 109.622 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -73.23 -53.63 10.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.958 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 197' ' ' GLN . 19.3 tm0? -55.3 -27.23 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.908 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.07 -33.91 57.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.298 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -58.0 -40.99 82.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.153 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.6 mp -64.96 -58.48 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.093 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.4 t -53.03 -42.22 65.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 1.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.4 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.6 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.885 0.374 . . . . 1.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.67 -52.28 27.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.231 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.87 -48.35 82.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.789 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.96 -30.95 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.598 0.592 . . . . 1.0 112.598 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -75.57 -24.16 56.61 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.595 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.1 mtp180 -66.83 -36.08 81.52 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.94 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.1 -25.16 43.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 34' ' ' ILE . 68.7 p -74.77 -50.68 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.577 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.4 p -53.52 -36.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.923 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 96.8 mt-10 -74.53 -37.37 63.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -64.79 -51.77 60.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 1.0 112.021 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.23 -50.39 79.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.9 tmm_? -51.36 -43.61 61.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.69 73.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -80.47 -47.17 14.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.17 -6.83 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.175 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.83 17.11 0.49 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.41 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -73.44 140.35 46.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.083 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.6 m-20 -61.99 -29.86 70.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 48' ' ' THR . 43.1 ttp180 -152.99 118.69 5.34 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 119.231 -0.988 . . . . 1.0 113.517 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.24 137.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -146.23 161.81 39.44 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.547 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.91 135.27 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.017 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.7 t80 -117.9 116.54 27.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.012 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 27.3 ttm180 -98.16 164.76 12.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.849 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -131.75 139.56 48.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 1.0 112.12 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -103.79 148.35 35.67 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.718 -0.673 . . . . 1.0 109.296 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.21 -21.85 72.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.732 2.288 . . . . 1.0 112.924 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -80.01 -4.47 52.76 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.974 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.86 46.5 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.871 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -89.13 146.07 25.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.335 0.567 . . . . 1.0 110.888 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.88 144.35 15.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 m -128.55 147.31 50.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.133 0.492 . . . . 1.0 112.309 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.67 119.09 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.05 0.14 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.64 150.46 23.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.1 tt0 -166.05 125.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.372 -0.931 . . . . 1.0 113.166 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -108.62 136.14 48.7 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.0 141.55 51.77 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.238 -0.585 . . . . 1.0 111.516 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.32 104.67 2.63 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.4 -89.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.8 tt0 -176.94 34.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.174 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -70.98 -53.57 14.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.2 mt -94.76 144.13 27.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 107.921 -1.141 . . . . 1.0 107.921 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.09 170.34 20.35 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.043 1.828 . . . . 1.0 112.504 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -92.32 136.22 33.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.173 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 38.5 mt -109.63 -2.35 17.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.543 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.526 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.7 tp -58.52 139.55 55.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.568 . . . . 1.0 112.289 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.38 84.36 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.058 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.1 133.97 43.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.863 0.364 . . . . 1.0 110.766 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -89.07 117.01 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.515 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -107.98 134.91 19.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.78 158.11 27.88 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.123 1.882 . . . . 1.0 111.663 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.76 -20.1 63.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.779 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.66 -22.46 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 10.3 p30 -55.54 -27.78 50.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.323 . . . . 1.0 110.649 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.535 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 90.6 mt -127.96 99.58 25.34 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.279 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' ILE . 47.6 Cg_exo -41.71 -101.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.544 2.163 . . . . 1.0 112.312 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 43.7 tp10 -153.54 -59.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.809 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -43.46 -38.67 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.714 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.92 54.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 1.0 110.947 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -61.64 -31.4 71.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -58.04 -49.58 76.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.284 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.0 mt -53.85 -36.97 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.7 -29.15 69.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -89.66 -15.38 32.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.092 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.82 -46.34 3.98 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.399 0.889 . . . . 1.0 113.399 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.99 -3.0 14.1 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 25.21 67.01 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.879 ' H ' HH21 ' A' ' 133' ' ' ARG . 13.0 t -107.24 -52.52 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.503 -2.406 . . . . 1.0 104.503 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.814 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 11.5 mtm180 64.38 65.57 0.65 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.312 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 103' ' ' ILE . 35.7 m -150.11 133.39 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.726 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -109.25 127.38 66.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 108.353 -0.981 . . . . 1.0 108.353 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.9 t -83.2 168.11 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.696 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.8 m-20 -51.33 114.52 1.25 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.268 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' VAL . 9.5 p -54.82 -10.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.789 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.5 -35.96 16.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.912 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -15.03 9.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.412 0.625 . . . . 1.0 110.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 49.97 51.5 16.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 1.0 113.396 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 m -94.2 138.2 32.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.405 -2.072 . . . . 1.0 105.405 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -128.27 137.93 52.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.05 1.5 . . . . 1.0 115.05 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.452 -0.33 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.307 177.35 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.879 HH21 ' H ' ' A' ' 100' ' ' VAL . 26.1 mtt-85 . . . . . 0 CA--C 1.527 0.082 0 CA-C-O 120.671 0.272 . . . . 1.0 110.286 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.07 150.29 5.08 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.515 2.143 . . . . 1.0 111.837 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.406 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -97.44 145.69 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.027 0.442 . . . . 1.0 111.382 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.4 m-20 -91.1 147.02 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.553 -0.749 . . . . 1.0 110.913 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -38.75 -28.69 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.199 1.933 . . . . 1.0 111.288 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.45 ' N ' ' O ' ' A' ' 136' ' ' ASP . 47.9 t -67.6 -53.15 30.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.671 ' CE1' HD11 ' A' ' 143' ' ' LEU . 19.4 t-80 -73.54 -24.99 60.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.4 t -50.99 -55.94 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.353 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.14 -41.46 94.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -43.17 -50.4 6.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 139' ' ' HIS . 77.4 mt -72.51 -48.1 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.525 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.3 tmtm? -57.27 -43.07 82.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.511 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.8 p -55.2 -27.34 45.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 39.4 mtt -92.25 -3.48 55.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.186 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.12 22.77 72.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.357 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.648 HG11 ' HB2' ' A' ' 169' ' ' HIS . 10.2 m -104.83 122.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.72 -0.392 . . . . 1.0 109.953 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.36 -37.22 57.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -130.22 170.57 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.579 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 3.4 p -158.92 139.64 12.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.02 0.438 . . . . 1.0 112.157 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 tp -116.31 140.02 49.77 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -134.33 154.54 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.463 0.649 . . . . 1.0 111.739 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 153' ' ' VAL . 74.6 t -157.21 108.21 1.89 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.767 -1.106 . . . . 1.0 109.267 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.78 113.88 3.9 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.659 2.906 . . . . 1.0 113.847 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.72 105.88 3.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.78 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.7 ptm -132.19 147.07 52.4 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.835 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.628 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 11.7 t-80 -118.07 115.58 25.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.628 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 79.8 m-70 59.32 -122.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.99 7.59 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.883 0.327 . . . . 1.0 111.883 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.3 mp0 -114.65 146.03 41.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 162' ' ' LEU . 6.5 mp -106.94 117.41 33.98 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 114.525 -1.216 . . . . 1.0 108.809 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.2 m95 -96.15 -26.67 15.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.899 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.27 -170.88 28.79 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.261 -0.971 . . . . 1.0 112.041 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.9 tp -141.67 137.29 31.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 1.0 111.216 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 5.1 tp -99.11 142.8 30.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.31 135.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.595 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 p -120.8 142.51 49.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.046 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.648 ' HB2' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -150.03 127.99 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.127 0.489 . . . . 1.0 111.021 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.561 ' O ' ' O ' ' A' ' 171' ' ' ALA . 3.8 p80 -166.58 156.52 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.704 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 170' ' ' HIS . . . -46.14 -170.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.607 -0.269 . . . . 1.0 111.448 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 . . . . . 0 N--CA 1.466 0.355 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.261 179.599 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.4 p90 . . . . . 0 N--CA 1.46 0.066 0 CA-C-O 120.822 0.344 . . . . 1.0 110.744 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 t -99.68 143.12 30.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.23 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.14 -31.93 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.646 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.05 -54.52 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.337 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.42 -30.64 71.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.904 0.383 . . . . 1.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.16 -35.1 74.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.538 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.58 -52.75 28.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.407 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -44.44 -47.38 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 187' ' ' LEU . 27.3 m -75.01 -36.81 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.69 ' NE2' HH22 ' A' ' 101' ' ' ARG . 58.7 tt0 -46.94 -35.84 6.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 186' ' ' LEU . 3.6 tt -72.1 -43.46 64.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.412 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 184' ' ' VAL . 39.0 tp -53.96 -33.17 56.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.662 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.47 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.95 -37.27 62.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.618 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -56.21 -38.09 70.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.705 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -53.16 -51.83 60.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.12 -42.46 79.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.265 -0.879 . . . . 1.0 109.889 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.3 m -51.86 -37.12 50.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.61 -33.47 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.048 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.37 -47.13 58.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.101 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.0 tp -62.4 -33.12 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.527 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.96 -53.59 8.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.898 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -56.28 -28.36 58.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.68 -34.3 52.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.17 -39.98 80.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.86 -57.62 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.4 t -58.14 -44.17 87.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.059 -0.972 . . . . 1.0 110.373 179.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 198' ' ' ALA . 16.0 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.397 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.294 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.18 -52.7 45.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -55.05 -50.09 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.687 0.625 . . . . 1.0 112.687 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 mt -64.42 -23.97 67.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.541 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.553 ' O ' HG12 ' A' ' 39' ' ' VAL . 61.0 ttt180 -58.23 -36.1 72.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.651 -0.419 . . . . 1.0 109.925 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.35 38.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.3 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.413 ' HG1' ' H ' ' A' ' 39' ' ' VAL . 50.6 p -69.36 -49.87 51.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.507 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.9 p -53.08 -36.32 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 75.2 mm-40 -65.24 -38.41 90.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.841 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.15 -44.91 87.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.924 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.08 -44.08 95.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.3 tmm_? -62.43 -51.64 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.843 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' N ' ' HE ' ' A' ' 43' ' ' ARG . . . -58.49 -40.06 81.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.847 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.76 -51.49 9.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.794 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.51 -5.58 48.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.087 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.29 17.71 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.716 -0.675 . . . . 1.0 112.415 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -74.48 141.85 44.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.108 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -57.48 -33.39 67.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.531 ' H ' HG22 ' A' ' 48' ' ' THR . 46.2 ttp180 -152.28 119.82 6.03 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 119.18 -1.008 . . . . 1.0 113.577 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -139.14 134.88 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -145.62 161.9 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.377 -0.529 . . . . 1.0 111.566 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.44 136.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.006 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 165' ' ' LEU . 43.8 t80 -121.0 119.11 31.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.113 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -100.07 170.08 8.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.925 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 72.3 t80 -134.32 138.78 45.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.526 -0.47 . . . . 1.0 112.124 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -102.45 148.79 35.97 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.306 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.36 -21.22 66.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.729 2.286 . . . . 1.0 112.965 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.3 -0.57 41.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.563 -0.455 . . . . 1.0 111.038 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.33 -11.51 54.72 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.855 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.6 m-70 -89.34 146.44 24.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.383 0.592 . . . . 1.0 110.976 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.8 144.68 15.37 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 p -129.26 148.21 51.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.184 0.516 . . . . 1.0 112.275 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.78 120.99 57.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.937 -1.134 . . . . 1.0 107.937 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.46 ' C ' HD11 ' A' ' 78' ' ' LEU . 4.3 m -112.04 8.1 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' N ' HD11 ' A' ' 78' ' ' LEU . . . -154.06 146.37 23.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -166.75 127.69 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.296 -0.962 . . . . 1.0 113.186 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.1 139.07 47.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -127.53 141.46 51.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.138 -0.625 . . . . 1.0 111.569 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.15 107.59 3.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.417 -1.073 . . . . 1.0 110.417 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.23 16.95 0.1 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.264 -1.134 . . . . 1.0 110.264 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.7 tt0 71.99 28.87 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.791 -0.364 . . . . 1.0 111.104 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -57.55 -58.24 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -90.65 158.63 42.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.31 162.49 33.69 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.09 1.86 . . . . 1.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -85.9 108.9 18.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.119 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' NH1' ' A' ' 50' ' ' ARG . 48.9 mt -84.1 -1.47 54.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.46 HD11 ' C ' ' A' ' 65' ' ' VAL . 8.4 tp -62.44 139.54 58.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.349 0.595 . . . . 1.0 112.289 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.567 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.0 -4.12 74.36 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.121 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.8 mp -102.41 131.04 49.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 1.0 110.774 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.01 119.81 25.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -106.95 132.96 20.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.302 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -79.61 155.8 24.43 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.214 1.943 . . . . 1.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -67.9 -21.08 65.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.798 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.19 -22.07 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.03 -27.8 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 1.0 110.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.6 mt -107.86 106.28 58.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.332 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.5 Cg_exo -48.47 -125.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.505 2.136 . . . . 1.0 112.35 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.6 pt-20 -142.91 -43.08 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 22.7 pt-20 -68.83 -39.8 79.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.723 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.09 84.1 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.007 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.433 HH21 HD22 ' A' ' 162' ' ' LEU . 76.7 ttt180 -63.24 -30.62 71.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.553 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -56.66 -51.13 69.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.323 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 94' ' ' LEU . 10.4 mp -55.71 -35.33 65.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -63.36 -31.49 72.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 1.0 109.625 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -87.16 -15.16 39.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.042 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.48 -42.67 4.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.03 -4.78 13.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.517 0.932 . . . . 1.0 113.517 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.632 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 96.4 mt-30 27.06 69.65 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 6.8 t -109.76 -49.21 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.435 -2.431 . . . . 1.0 104.435 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.702 ' NH1' HE22 ' A' ' 185' ' ' GLN . 0.6 OUTLIER 63.06 70.56 0.54 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.137 -1.392 . . . . 1.0 114.311 172.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.566 ' C ' HD12 ' A' ' 103' ' ' ILE . 15.0 p -153.11 136.74 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.706 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.566 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -108.71 127.76 64.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 105' ' ' ASP . 34.3 t -83.53 166.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.675 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.1 m-20 -53.68 119.44 4.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.26 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.0 m -58.01 -13.2 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.876 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -87.61 -38.04 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.89 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.32 -13.72 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.384 0.611 . . . . 1.0 110.059 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 51.3 54.77 10.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 113.409 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -93.94 133.62 37.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -128.21 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 80.0 p . . . . . 0 N--CA 1.453 -0.282 0 CA-C-N 114.17 -1.377 . . . . 1.0 107.316 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 1.6 mmp_? . . . . . 0 N--CA 1.461 0.087 0 N-CA-C 110.286 -0.265 . . . . 1.0 110.286 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.75 147.63 6.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.494 2.129 . . . . 1.0 111.816 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.6 m -95.72 151.58 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 1.0 111.329 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.3 m-20 -84.89 156.32 61.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.909 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -56.34 -26.52 62.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.216 1.944 . . . . 1.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.6 OUTLIER -74.51 -34.81 63.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.06 -0.718 . . . . 1.0 109.06 176.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.504 ' CE1' HD13 ' A' ' 143' ' ' LEU . 46.2 t-80 -81.47 -31.56 32.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.657 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -52.29 -50.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.33 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -65.99 -43.88 86.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.28 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -44.19 -52.07 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -73.16 -46.2 52.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.501 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.0 OUTLIER -59.51 -42.76 92.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.52 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 t -53.83 -32.53 53.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 40.7 mtt -84.51 -1.89 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.113 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.1 23.85 76.03 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.352 -0.84 . . . . 1.0 112.233 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.9 t -105.03 124.92 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.52 24.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -131.5 169.37 16.18 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.565 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.0 m -162.61 139.47 7.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.106 0.479 . . . . 1.0 112.15 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.57 139.69 50.21 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.9 m -135.13 157.81 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.803 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.3 t -158.98 91.91 1.95 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.388 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.46 115.37 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.636 2.891 . . . . 1.0 113.922 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.29 105.87 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.859 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.442 ' O ' ' OG ' ' A' ' 192' ' ' SER . 16.7 ptm -130.92 146.43 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.0 111.836 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 84.5 t60 -119.51 115.68 24.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 49.1 t60 64.02 -126.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.456 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.5 mt-30 -92.66 5.28 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.855 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 46.9 mp0 -115.09 150.69 35.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.433 HD22 HH21 ' A' ' 92' ' ' ARG . 13.1 tp -106.24 117.34 33.79 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 114.517 -1.219 . . . . 1.0 108.86 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.425 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 84.0 m95 -97.4 -28.83 13.83 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.864 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.65 -171.93 24.22 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.22 -0.99 . . . . 1.0 111.962 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.9 tp -138.8 129.69 26.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.565 -0.318 . . . . 1.0 111.205 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -94.52 139.06 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 169' ' ' HIS . 9.7 p -151.19 132.83 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.532 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.739 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 1.5 m -115.22 140.57 48.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.05 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.739 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -135.5 141.48 45.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 1.0 110.992 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.44 ' O ' HG13 ' A' ' 148' ' ' VAL . 1.6 p-80 -158.2 154.27 27.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.5 -0.773 . . . . 1.0 109.742 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.94 67.94 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.466 0.338 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.298 -179.267 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.809 0.337 . . . . 1.0 110.721 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -96.17 153.93 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.641 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.99 -53.49 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.324 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 37.4 mp0 -71.41 -24.22 62.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.884 0.373 . . . . 1.0 110.677 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -61.44 -45.65 93.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.505 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 10.9 pt20 -67.56 -48.66 66.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.417 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 46.4 t -43.68 -51.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.243 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.48 -36.05 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.702 HE22 ' NH1' ' A' ' 101' ' ' ARG . 63.0 tp60 -48.24 -37.95 17.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.89 -40.27 65.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.375 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.71 -32.42 63.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.687 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.54 -37.7 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.701 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -56.96 -40.36 76.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.741 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.66 -54.09 38.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.39 -40.69 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.923 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 157' ' ' MET . 3.5 t -50.1 -30.17 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.63 -39.43 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.056 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.67 67.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.133 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.01 -35.64 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.465 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -76.48 -54.77 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.863 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -55.94 -28.52 57.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.949 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.36 -35.23 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.336 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.43 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 83.6 tt0 -57.77 -39.76 78.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.133 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.9 tp -68.52 -58.04 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.047 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.7 m -56.86 -44.25 81.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.43 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 7.8 tp . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.425 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 1.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.2 p-10 -61.96 -42.54 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.259 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 96.3 mt-30 -68.81 -52.0 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -60.78 -34.54 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.22 -23.67 60.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -62.56 -52.85 61.81 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.632 -0.427 . . . . 1.0 109.965 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.02 77.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.359 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.3 p -67.82 -46.5 71.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.526 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 68' ' ' ALA . 10.1 t -59.28 -38.42 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.903 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.31 -37.74 77.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.778 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.31 -43.98 80.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 1.0 112.01 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.44 -51.11 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.861 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.4 tmt_? -52.73 -44.6 66.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.834 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.82 68.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.806 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -83.21 -46.2 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.734 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.53 -8.5 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 1.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 49.56 17.88 1.44 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.632 -0.713 . . . . 1.0 112.405 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -77.07 144.85 38.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.159 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 94.1 m-20 -54.56 -34.16 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.597 ' H ' HG22 ' A' ' 48' ' ' THR . 9.0 ttm180 -152.61 122.62 7.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.168 -1.013 . . . . 1.0 113.595 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 t -130.42 132.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 19.5 pttm -146.64 155.74 42.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.576 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.66 138.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.97 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -122.43 119.81 32.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.058 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -100.21 170.64 8.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.436 . . . . 1.0 109.864 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.9 t80 -133.22 141.89 48.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.0 m-20 -105.52 149.42 37.82 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.371 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.35 -25.95 63.73 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.696 2.264 . . . . 1.0 112.961 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -76.52 -5.38 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.941 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.19 -12.69 44.46 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.839 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.03 144.64 26.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.388 0.594 . . . . 1.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 143.85 15.3 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.9 p -127.37 146.69 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.346 0.498 . . . . 1.0 112.346 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.19 118.34 46.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -111.9 4.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.38 21.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.9 tt0 -166.46 127.44 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.362 -0.935 . . . . 1.0 113.215 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -107.06 140.66 39.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -129.75 141.89 50.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.512 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.94 106.16 2.84 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.431 -1.068 . . . . 1.0 110.431 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.19 -88.72 0.01 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.294 -1.122 . . . . 1.0 110.294 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' GLY . 23.0 pt-20 -176.77 31.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.109 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -66.51 -54.12 27.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD13 HH21 ' A' ' 50' ' ' ARG . 28.6 mt -95.33 151.93 39.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 171.57 16.42 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.07 1.846 . . . . 1.0 112.504 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.4 m -92.73 135.29 34.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.148 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.58 -9.22 15.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.618 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.583 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 17.6 tp -50.73 138.79 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.363 0.601 . . . . 1.0 112.212 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -1.87 79.27 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.471 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 61.3 tp -100.51 125.92 46.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 1.0 110.757 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 81' ' ' THR . 8.9 t -84.08 122.23 28.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.488 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CZ ' HD23 ' A' ' 80' ' ' LEU . 47.7 m-85 -108.07 138.81 20.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.25 155.06 16.74 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.136 1.89 . . . . 1.0 111.646 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.531 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -65.56 -21.11 66.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.827 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 87' ' ' ILE . . . -49.8 -24.82 6.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' ALA . 19.1 p-10 -47.86 -13.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 1.0 110.663 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.479 ' N ' ' C ' ' A' ' 85' ' ' GLY . 3.5 pt -135.91 137.96 26.57 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.224 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -80.68 -114.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 1.0 112.374 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -141.82 -66.12 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.91 0.386 . . . . 1.0 111.881 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -47.79 -43.09 27.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.682 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -67.78 -53.07 30.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.964 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.481 HH21 ' CD2' ' A' ' 162' ' ' LEU . 24.6 ttt180 -54.47 -27.86 40.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' LEU . 22.1 mmt180 -63.68 -46.15 86.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.297 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 98' ' ' ALA . 39.6 mt -49.99 -42.61 49.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.564 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 30.3 m-85 -64.99 -29.88 70.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -90.24 -18.96 24.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.102 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -104.76 -45.34 4.62 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.426 0.899 . . . . 1.0 113.426 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.1 -2.78 15.72 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.7 mt-30 28.29 67.2 0.08 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.014 1.116 . . . . 1.0 114.014 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.38 -50.51 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.385 -2.45 . . . . 1.0 104.385 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.692 HH21 HG13 ' A' ' 154' ' ' VAL . 3.0 mtp180 64.79 70.38 0.48 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.072 -1.422 . . . . 1.0 114.304 172.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.581 ' C ' HD12 ' A' ' 103' ' ' ILE . 64.1 t -150.67 130.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.784 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.581 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.64 126.58 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.636 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.9 p -81.81 166.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.224 0.824 . . . . 1.0 113.224 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 104' ' ' VAL . 13.6 m-20 -52.2 120.82 5.88 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.658 -1.156 . . . . 1.0 112.328 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 106' ' ' VAL . 37.1 t -57.6 -11.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.737 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 109' ' ' GLN . 17.0 pt-20 -83.04 -38.95 21.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.851 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.98 1.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.396 0.617 . . . . 1.0 110.114 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 107' ' ' GLU . 19.5 pt20 35.43 58.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.018 -0.992 . . . . 1.0 113.392 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -94.32 135.27 35.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.386 -2.079 . . . . 1.0 105.386 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -129.98 145.59 51.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 CA-C-N 114.132 -1.394 . . . . 1.0 107.31 177.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.106 0 CA-C-O 120.636 0.255 . . . . 1.0 110.327 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.9 145.98 16.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.587 2.191 . . . . 1.0 111.818 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.628 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.9 m -118.03 127.19 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.447 . . . . 1.0 111.389 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -39.94 163.74 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.888 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.94 -19.68 34.94 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.265 1.977 . . . . 1.0 111.234 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.2 p -66.22 -37.52 85.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.628 ' ND1' HG21 ' A' ' 135' ' ' VAL . 40.4 t-80 -80.69 -28.34 36.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.632 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 106' ' ' VAL . 29.3 t -52.31 -53.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.322 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 145' ' ' SER . 85.2 t60 -66.88 -42.15 86.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.296 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -47.66 -56.9 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.503 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.521 HD13 ' NE2' ' A' ' 139' ' ' HIS . 1.2 tp -68.49 -50.38 52.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.527 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 21.1 tptm -57.35 -40.08 77.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 t -54.06 -32.49 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.5 mtt -83.46 1.15 43.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.264 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.52 25.3 75.64 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.214 -0.903 . . . . 1.0 112.33 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 169' ' ' HIS . 12.0 t -109.17 122.91 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.835 -0.432 . . . . 1.0 109.835 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.09 -30.43 49.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 148' ' ' VAL . 9.0 t -140.11 172.89 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.09 -0.644 . . . . 1.0 111.551 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 p -162.84 139.96 7.77 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.081 0.467 . . . . 1.0 112.141 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.1 tp -118.3 138.79 52.14 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.424 ' C ' HG23 ' A' ' 154' ' ' VAL . 2.3 m -133.04 158.98 43.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.418 0.628 . . . . 1.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.692 HG13 HH21 ' A' ' 101' ' ' ARG . 88.5 t -154.32 96.44 2.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.849 -1.069 . . . . 1.0 109.313 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.97 139.23 66.65 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.571 2.847 . . . . 1.0 113.957 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.59 105.56 17.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.736 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.449 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.1 mtp -117.54 139.06 51.45 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.906 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.632 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 26.6 t-80 -113.74 113.58 25.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.632 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 46.5 m-70 57.6 -123.0 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -94.23 10.99 31.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 51.0 mp0 -119.87 153.64 35.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.047 1.129 . . . . 1.0 114.047 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.481 ' CD2' HH21 ' A' ' 92' ' ' ARG . 14.8 tp -108.83 112.25 24.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.882 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -95.5 -28.61 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.905 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -154.88 -175.9 26.5 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.21 -0.995 . . . . 1.0 111.944 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.45 133.6 24.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.812 0.339 . . . . 1.0 111.215 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.7 tp -99.93 135.78 40.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.2 t -148.17 120.87 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.381 -0.528 . . . . 1.0 111.538 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 p -108.89 148.74 30.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.692 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.06 148.22 29.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 1.0 111.018 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.0 p-80 -158.92 155.41 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.678 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.74 69.95 4.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.552 -0.295 . . . . 1.0 111.43 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 . . . . . 0 N--CA 1.466 0.371 0 C-N-CA 120.41 -0.516 . . . . 1.0 112.326 -179.526 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 120.832 0.349 . . . . 1.0 110.756 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -96.5 146.69 24.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.05 -40.08 78.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.6 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.11 -54.48 37.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.419 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.05 -35.31 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.374 . . . . 1.0 110.738 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.61 -38.71 88.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.505 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.1 -55.67 32.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.2 t -43.87 -43.46 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 86.0 t -74.99 -37.64 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.496 ' CD ' HH12 ' A' ' 101' ' ' ARG . 60.9 tt0 -48.27 -37.21 15.66 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.92 -40.2 63.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.751 -1.113 . . . . 1.0 109.344 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 44.0 tp -54.99 -32.34 61.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.692 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.83 -35.25 67.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.679 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -56.28 -39.58 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.695 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -53.64 -54.58 35.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.67 -44.11 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.226 -0.897 . . . . 1.0 109.834 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 157' ' ' MET . 10.1 t -51.68 -37.72 51.87 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 71.6 mt -78.2 -32.2 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.082 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.4 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.074 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -68.18 -24.26 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -77.24 -57.14 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.862 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.9 -27.34 66.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.885 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.56 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.355 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.421 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 41.3 tp10 -55.66 -37.02 67.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.163 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 -55.34 12.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.075 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.3 p -54.83 -42.07 71.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 1.0 110.303 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.421 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 27.3 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.422 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 198' ' ' ALA . 17.4 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.843 0.354 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.2 p-10 -64.04 -40.26 95.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.236 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.8 mt-30 -71.21 -54.24 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -56.41 -44.79 81.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.88 -26.38 65.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.522 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -56.43 -38.82 72.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.945 0.402 . . . . 1.0 109.998 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.66 58.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.2 p -70.04 -45.44 67.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.479 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 68' ' ' ALA . 55.2 t -57.61 -39.29 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.869 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -68.23 -37.89 81.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.817 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.2 -41.36 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.013 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.74 -45.91 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.866 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.0 tmm_? -53.74 -48.32 69.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.885 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.76 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.24 -52.49 7.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.776 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.86 -7.39 55.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.959 0.409 . . . . 1.0 110.114 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.14 17.79 0.38 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.457 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.642 HG21 HG13 ' A' ' 51' ' ' VAL . 15.1 t -77.37 146.77 36.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.1 m-20 -56.39 -33.08 65.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 41.7 ttm-85 -153.39 127.44 9.02 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 119.174 -1.01 . . . . 1.0 113.533 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.72 132.33 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.973 -1.121 . . . . 1.0 107.973 176.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -145.73 161.07 40.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.54 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.38 137.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.955 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 165' ' ' LEU . 67.3 t80 -122.26 119.85 32.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.074 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -100.07 171.11 8.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 67.0 t80 -133.96 136.68 44.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 1.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.42 126.45 33.14 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.353 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.94 -28.61 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.68 2.253 . . . . 1.0 112.923 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -74.29 -7.73 53.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.029 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.06 -13.57 34.11 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.014 -0.612 . . . . 1.0 112.825 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.94 145.94 25.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.352 0.576 . . . . 1.0 110.862 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.61 145.45 15.71 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.9 p -128.82 148.28 50.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 1.0 112.328 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.25 120.49 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 m -110.58 0.51 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -159.0 151.04 21.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 50' ' ' ARG . 1.9 pp20? -169.25 131.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.36 -0.936 . . . . 1.0 113.209 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -113.45 142.56 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' C ' HH12 ' A' ' 43' ' ' ARG . 10.0 ptt85 -133.22 143.96 49.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.481 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.53 112.87 3.9 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.22 34.04 2.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 54.57 31.52 15.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.14 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.452 ' NH1' ' HB3' ' A' ' 171' ' ' ALA . 26.6 ttm180 -60.65 -55.56 31.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.457 ' HB2' ' HE ' ' A' ' 50' ' ' ARG . 81.9 mt -95.86 147.21 32.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 57.9 Cg_endo -70.67 170.77 16.86 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.128 1.885 . . . . 1.0 112.528 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' HH22 ' A' ' 50' ' ' ARG . 23.1 t -89.08 130.11 35.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.158 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.8 mt -101.13 1.56 39.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.594 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.62 135.01 57.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.323 0.582 . . . . 1.0 112.24 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 92.63 -7.49 77.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.698 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.8 mp -96.99 132.04 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.885 0.374 . . . . 1.0 110.737 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 m -90.87 117.9 29.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.455 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 m-85 -109.42 135.82 20.27 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.293 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.98 157.35 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.12 1.88 . . . . 1.0 111.628 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.9 -17.78 63.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.823 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.51 -22.23 0.99 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.31 -29.82 64.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.86 0.362 . . . . 1.0 110.634 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.525 ' CG2' ' HE ' ' A' ' 92' ' ' ARG . 58.4 mt -98.66 146.74 32.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.228 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 5.0 Cg_endo -96.18 -142.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.465 2.11 . . . . 1.0 112.331 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 1.2 pt-20 -121.94 -76.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.794 -0.363 . . . . 1.0 111.825 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -45.84 -40.53 9.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.779 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.84 -48.61 68.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.657 -0.417 . . . . 1.0 111.014 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 21.3 ttm180 -59.82 -29.46 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.555 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' LEU . 35.1 mtp180 -58.91 -46.79 87.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.54 ' O ' ' N ' ' A' ' 98' ' ' ALA . 43.0 mt -55.12 -36.74 66.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.569 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -63.49 -35.18 79.6 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -91.32 -15.85 28.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 2.8 tp -105.8 -45.53 4.36 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.33 0.863 . . . . 1.0 113.33 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.31 -3.67 12.46 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.515 0.931 . . . . 1.0 113.515 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.3 mt-30 30.08 69.68 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.01 1.115 . . . . 1.0 114.01 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.9 -51.21 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.634 HH21 HG22 ' A' ' 154' ' ' VAL . 0.8 OUTLIER 62.82 74.09 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.997 -1.456 . . . . 1.0 114.286 172.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.85 132.42 5.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.72 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 103' ' ' ILE . 2.1 mp -107.84 128.15 63.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.664 HG12 ' N ' ' A' ' 105' ' ' ASP . 44.9 t -82.36 165.99 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.272 0.841 . . . . 1.0 113.272 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.664 ' N ' HG12 ' A' ' 104' ' ' VAL . 12.9 m-20 -52.74 123.28 10.9 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.772 -1.104 . . . . 1.0 112.308 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -58.96 -10.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.707 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.0 pt-20 -85.94 -39.48 16.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.867 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.434 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -60.68 -15.29 27.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.372 0.606 . . . . 1.0 110.066 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 50.86 57.72 6.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.047 -0.979 . . . . 1.0 113.345 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t -94.47 136.09 35.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.349 -2.093 . . . . 1.0 105.349 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -129.6 142.42 50.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.98 1.474 . . . . 1.0 114.98 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 2.8 m . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 114.181 -1.372 . . . . 1.0 107.341 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.737 0.303 . . . . 1.0 110.254 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.409 ' O ' ' OG ' ' A' ' 112' ' ' SER . 75.5 Cg_exo -49.23 144.46 17.04 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.508 2.139 . . . . 1.0 111.808 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 139' ' ' HIS . 27.0 m -112.8 123.39 68.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 1.0 111.322 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.02 154.55 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.907 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.5 -21.73 73.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 1.0 111.261 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 12.8 p -63.05 -37.07 85.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.658 ' CE1' HG21 ' A' ' 135' ' ' VAL . 1.1 t-80 -80.83 -28.96 35.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.7 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.7 t -52.94 -55.2 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.339 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -66.96 -44.98 79.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.257 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -44.21 -50.99 8.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.473 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.532 HD13 ' NE2' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -72.67 -46.44 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.454 179.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -57.76 -42.64 84.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.456 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.5 m -53.72 -34.34 58.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.2 mtt -82.35 -4.25 56.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.179 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 72.16 25.26 74.98 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.268 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.97 120.84 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.96 -33.16 34.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.4 t -138.48 170.49 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.199 -0.6 . . . . 1.0 111.569 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -163.01 139.82 7.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 1.0 112.185 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.9 tp -116.32 116.23 27.37 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.39 157.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.54 0.686 . . . . 1.0 111.79 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.634 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -156.02 95.73 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.295 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HD2' ' NE ' ' A' ' 101' ' ' ARG . 58.4 Cg_endo -65.81 139.74 58.51 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.536 2.824 . . . . 1.0 113.929 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.8 mt -98.15 107.47 19.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 83.1 mtp -121.12 143.37 49.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 1.0 111.775 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 41.6 t-80 -121.81 114.41 21.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 160' ' ' GLN . 47.2 t60 65.05 -127.65 0.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 159' ' ' HIS . 0.5 OUTLIER -94.53 10.01 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -120.19 158.62 26.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.9 117.31 32.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.872 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 80.0 m95 -95.18 -26.55 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.61 -173.04 26.5 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.987 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.2 tp -142.33 131.44 23.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 1.0 111.251 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 1.9 tp -96.84 143.32 27.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 167' ' ' VAL . 8.6 p -150.0 130.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.524 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.589 ' OG ' HG21 ' A' ' 48' ' ' THR . 18.2 t -112.1 141.77 45.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.011 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.401 ' NE2' ' CG2' ' A' ' 167' ' ' VAL . 68.0 m-70 -139.55 142.04 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.108 0.48 . . . . 1.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -155.98 152.27 27.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.778 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.452 ' HB3' ' NH1' ' A' ' 73' ' ' ARG . . . -82.33 71.01 9.39 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.034 -0.266 . . . . 1.0 111.418 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.466 0.356 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.325 179.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.779 0.323 . . . . 1.0 110.818 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.1 p -92.75 154.26 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 182' ' ' GLN . 13.8 pt20 -70.23 -39.01 75.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.624 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.23 -54.17 49.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.532 -0.303 . . . . 1.0 111.369 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -65.67 -30.04 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.378 . . . . 1.0 110.718 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.57 -31.89 71.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.494 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 178' ' ' GLN . 0.3 OUTLIER -71.91 -55.96 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.504 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 51.4 t -42.97 -45.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.257 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.41 -33.69 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 182' ' ' GLN . 7.4 tt0 -50.91 -42.17 59.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 186' ' ' LEU . 9.0 mp -67.66 -41.45 83.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.694 -1.139 . . . . 1.0 109.354 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.02 -28.87 59.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.697 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 191' ' ' VAL . . . -70.8 -26.44 63.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.615 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -70.99 -36.0 72.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.682 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -53.8 -58.62 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 188' ' ' ALA . 17.9 m -60.27 -38.17 76.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.891 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 15.8 m -52.39 -35.55 51.84 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.95 -36.08 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.518 -0.764 . . . . 1.0 110.127 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.91 -46.81 61.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.084 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.65 -34.56 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -75.69 -54.13 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.883 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -55.93 -28.56 57.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.955 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.05 -34.9 57.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.269 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -57.22 -38.57 73.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.183 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.35 -59.21 3.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.169 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 t -65.46 -50.91 63.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 1.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.417 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.81 0.338 . . . . 1.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -60.51 -49.2 78.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.267 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.51 -51.0 69.15 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 38' ' ' THR . 52.5 mt -56.67 -42.28 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.0 -24.1 66.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.561 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -60.84 -40.39 92.66 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.654 -0.418 . . . . 1.0 109.973 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 -30.58 60.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.8 p -69.51 -46.94 65.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.534 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 68' ' ' ALA . 38.2 t -57.55 -40.96 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.883 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 78.7 mm-40 -72.64 -36.7 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.96 -55.15 24.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.767 -0.651 . . . . 1.0 112.023 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.8 p -59.67 -44.09 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 tmm_? -51.91 -45.47 64.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.817 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.7 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.839 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -81.26 -47.23 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.821 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -77.21 -6.08 51.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.971 0.415 . . . . 1.0 110.124 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.59 17.6 0.5 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.464 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -76.28 143.4 40.93 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.053 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 70' ' ' GLY . 50.0 p30 -65.96 -21.95 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.886 0.699 . . . . 1.0 112.886 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.703 HH21 ' CD2' ' A' ' 169' ' ' HIS . 44.4 ttp180 -155.12 119.29 4.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 119.221 -0.992 . . . . 1.0 113.579 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.3 t -137.54 133.67 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -147.22 160.11 42.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.432 -0.507 . . . . 1.0 111.625 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.94 137.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.002 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 165' ' ' LEU . 38.7 t80 -121.36 119.33 31.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.074 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -100.11 167.83 10.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.33 134.19 46.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 1.0 112.102 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -103.52 129.26 25.75 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.357 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.72 -23.88 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.698 2.265 . . . . 1.0 112.953 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.69 -8.58 58.84 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.994 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.2 39.75 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.836 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -90.49 140.96 29.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.33 0.565 . . . . 1.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 81' ' ' THR . . . -118.24 135.57 11.7 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.9 p -124.0 144.05 50.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 1.0 112.278 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.6 t -100.53 122.87 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.95 -1.129 . . . . 1.0 107.95 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.3 3.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.572 0.582 . . . . 1.0 112.572 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -158.96 149.41 19.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.454 -0.572 . . . . 1.0 109.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -166.19 126.84 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.167 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.88 144.38 33.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -134.57 141.28 46.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.52 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.76 110.34 3.66 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.444 -1.063 . . . . 1.0 110.444 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.1 15.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.8 tt0 72.6 21.6 3.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.116 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -52.27 -57.03 10.96 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.7 146.93 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 107.791 -1.188 . . . . 1.0 107.791 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.25 162.81 40.95 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.068 1.845 . . . . 1.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 p -86.93 132.16 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.609 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 31.5 mt -105.83 -5.69 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.647 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.475 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.1 tp -48.26 134.34 14.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 1.0 112.259 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.05 -40.48 3.07 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 81' ' ' THR . 2.1 tt -59.87 112.57 1.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.39 . . . . 1.0 110.739 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 80' ' ' LEU . 27.9 m -74.77 124.25 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.455 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -104.26 132.64 20.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.274 177.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.64 149.16 26.56 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.155 1.904 . . . . 1.0 111.713 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.87 68.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -22.75 0.64 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -54.89 -33.64 62.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 1.0 110.672 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.6 132.4 21.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.264 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 61.8 Cg_endo -80.22 -120.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.601 2.2 . . . . 1.0 112.292 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 95.5 mt-10 -141.72 -71.93 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.904 0.383 . . . . 1.0 111.828 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 22.2 pt-20 -42.8 -42.86 3.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.781 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -65.05 -52.64 54.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.75 -29.49 59.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.548 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LEU . 66.6 mtp85 -60.07 -47.38 86.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.319 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 94' ' ' LEU . 57.4 mt -51.7 -44.95 63.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.589 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 27.7 m-85 -59.64 -30.21 68.56 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -90.87 -13.05 34.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.126 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' ARG . 1.5 tp -105.61 -45.97 4.29 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -112.82 0.89 15.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.462 0.912 . . . . 1.0 113.462 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.9 mt-30 28.1 66.39 0.09 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.131 1.16 . . . . 1.0 114.131 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 101' ' ' ARG . 8.2 p -119.32 -47.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 173.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.547 ' N ' HG13 ' A' ' 100' ' ' VAL . 1.6 mtt180 64.79 -22.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.272 170.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 176' ' ' TYR . 8.7 t -56.33 129.64 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.768 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 28.3 mt -107.11 132.68 53.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 104' ' ' VAL . 22.9 m -80.64 166.76 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -51.36 120.38 5.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.233 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -56.07 -10.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.823 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.8 pt-20 -88.61 -37.33 15.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.905 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.8 -15.09 10.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.395 0.617 . . . . 1.0 110.088 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.443 ' HG3' HH11 ' A' ' 111' ' ' ARG . 40.9 tp60 51.58 59.91 4.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.019 -0.991 . . . . 1.0 113.437 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.6 m -91.68 138.0 31.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 105.447 -2.057 . . . . 1.0 105.447 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 109' ' ' GLN . 67.3 mtm-85 -130.98 139.1 49.97 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.455 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 11.9 m . . . . . 0 N--CA 1.453 -0.304 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.391 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.555 HH21 ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.683 0.278 . . . . 1.0 110.338 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.6 149.8 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.62 2.213 . . . . 1.0 111.777 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.866 HG23 HG12 ' A' ' 140' ' ' VAL . 18.9 m -99.97 149.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.036 0.445 . . . . 1.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -89.65 144.21 31.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.947 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -38.92 -21.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.236 1.957 . . . . 1.0 111.258 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.557 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.5 t -78.49 -46.27 20.04 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.624 ' CE1' HD13 ' A' ' 143' ' ' LEU . 40.1 t-80 -77.66 -38.78 46.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.639 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 135' ' ' VAL . 2.6 m -51.82 -43.09 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.342 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.497 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 47.1 t-80 -66.2 -43.44 86.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.225 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -46.98 -50.11 19.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.555 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.624 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.9 mp -68.32 -50.98 49.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.456 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' GLY . 45.4 tptt -55.56 -40.66 72.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 27.8 m -54.82 -33.32 61.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 45.3 mtt -84.2 -2.87 57.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.218 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.67 24.61 75.36 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.221 -0.899 . . . . 1.0 112.341 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.6 p -108.46 124.12 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.93 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -119.34 153.89 34.42 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.564 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -147.13 128.49 14.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.173 -0.467 . . . . 1.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.97 105.36 8.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 m -110.93 164.75 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.423 0.63 . . . . 1.0 111.838 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 154' ' ' VAL . 3.0 p -161.08 110.44 1.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.331 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.85 139.66 44.06 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.54 2.827 . . . . 1.0 113.865 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.45 105.91 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.766 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.55 142.92 50.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.239 0.543 . . . . 1.0 111.899 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 51.8 t60 -114.09 115.52 27.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 17.5 m-70 60.33 -123.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -93.49 7.03 46.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.884 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -116.28 151.99 34.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.6 115.43 29.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.807 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.3 m95 -95.41 -28.12 15.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.87 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.34 -168.35 23.09 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.167 -1.016 . . . . 1.0 111.963 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -142.95 140.49 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 1.0 111.122 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.1 tp -110.07 145.46 37.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -149.07 128.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.58 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.4 m -117.59 142.64 46.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.0 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.703 ' CD2' HH21 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -149.82 144.04 25.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.135 0.493 . . . . 1.0 111.016 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -152.84 150.99 29.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.685 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.85 69.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.467 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 120.398 -0.521 . . . . 1.0 112.34 179.404 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.803 0.335 . . . . 1.0 110.788 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.2 m -95.78 140.01 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.47 -35.23 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.595 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.25 -52.06 67.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.0 111.428 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -68.14 -33.73 75.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.937 0.399 . . . . 1.0 110.667 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.16 -50.77 68.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.516 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.535 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 61.3 tp60 -59.11 -54.48 46.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.424 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.36 -46.93 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.31 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.89 -37.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.535 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 42.8 tt0 -48.0 -38.78 17.84 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.79 -41.95 67.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.34 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.407 ' CD2' HG23 ' A' ' 42' ' ' VAL . 11.5 tp -54.84 -32.8 60.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.666 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.0 -39.3 61.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.685 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.84 -37.92 71.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.754 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -54.66 -52.9 60.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.54 -44.82 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.906 . . . . 1.0 109.91 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 m -51.87 -38.52 56.36 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 76.7 mt -77.76 -32.18 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.061 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.82 67.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -67.37 -24.09 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.16 -56.06 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.868 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -57.45 -26.37 61.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.917 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.93 -34.93 57.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -58.52 -39.3 79.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.91 -59.23 3.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.123 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.6 p -58.25 -43.61 87.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 1.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.42 179.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 31' ' ' LEU . 46.1 tp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.883 0.373 . . . . 1.0 110.529 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 42.9 p-10 -55.62 -38.36 69.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.246 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.4 mt-30 -72.32 -51.33 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -57.4 -45.54 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.73 -27.19 64.76 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.558 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -55.08 -38.02 67.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.023 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.81 -31.89 57.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.374 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.7 p -68.26 -45.78 72.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.481 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 68' ' ' ALA . 52.9 t -57.07 -38.98 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.902 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -77.75 -37.73 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -59.8 -53.68 55.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 43' ' ' ARG . 13.3 p -60.15 -44.61 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.867 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.4 ttp180 -49.87 -44.91 50.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.847 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.87 74.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.772 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -81.33 -50.45 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.96 -6.7 55.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.976 0.417 . . . . 1.0 110.123 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.35 18.85 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.703 -0.68 . . . . 1.0 112.478 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.41 141.05 43.29 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.028 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 70' ' ' GLY . 96.0 m-20 -66.74 -23.9 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 48' ' ' THR . 43.2 ttt85 -152.76 121.41 6.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 119.186 -1.006 . . . . 1.0 113.551 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.17 135.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -146.52 162.55 38.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.427 -0.509 . . . . 1.0 111.549 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.33 135.77 31.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.024 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.43 ' O ' ' N ' ' A' ' 165' ' ' LEU . 62.1 t80 -118.36 118.53 32.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -99.83 168.31 9.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 67.6 t80 -134.97 138.93 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.071 0.462 . . . . 1.0 112.133 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.8 m-20 -103.06 147.87 34.77 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.378 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.51 -19.9 65.45 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.69 2.26 . . . . 1.0 112.948 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -82.3 -1.73 50.47 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.41 -11.37 54.42 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.824 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -89.3 144.82 25.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.361 0.58 . . . . 1.0 110.961 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.23 144.01 15.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.7 p -128.47 146.98 50.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.23 0.538 . . . . 1.0 112.3 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.89 118.65 52.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.15 6.61 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.12 146.68 23.12 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 37.1 tt0 -166.44 128.68 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.369 -0.933 . . . . 1.0 113.13 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -109.89 138.22 46.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 44.0 ptt85 -131.19 141.28 50.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.498 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.33 109.05 3.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 49.32 -85.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.6 pt-20 178.2 31.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.135 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -68.71 -25.62 64.86 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 mt -122.85 148.47 53.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 11.8 Cg_exo -74.03 164.55 34.16 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.016 1.81 . . . . 1.0 112.428 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -85.99 134.21 33.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' H ' HH22 ' A' ' 50' ' ' ARG . 91.6 mt -109.53 -3.02 17.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.641 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.21 139.01 57.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.603 . . . . 1.0 112.191 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.28 -3.24 84.03 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.351 -0.84 . . . . 1.0 111.015 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 tp -101.2 128.43 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 1.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 81' ' ' THR . 9.6 t -85.88 125.19 33.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.444 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -103.15 128.63 27.21 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.36 161.15 25.78 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.126 1.884 . . . . 1.0 111.666 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.12 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.776 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.53 -29.3 0.71 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.141 -0.784 . . . . 1.0 111.141 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.99 -28.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.798 0.332 . . . . 1.0 110.62 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.8 mt -137.93 99.54 9.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.258 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' ILE . 42.4 Cg_exo -40.63 -103.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.534 2.156 . . . . 1.0 112.325 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 92.7 mt-10 -135.65 -71.34 0.47 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.797 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' HA ' HH11 ' A' ' 93' ' ' ARG . 22.7 pt-20 -42.67 -38.77 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.775 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.45 -53.14 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.97 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -57.2 -31.8 65.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.542 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 97' ' ' LEU . 77.3 mtt85 -60.47 -47.29 86.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.565 -0.289 . . . . 1.0 111.213 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.0 mt -50.23 -43.89 53.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.52 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 68.1 m-85 -59.29 -33.23 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -92.34 -21.0 20.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.061 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tp -106.63 -50.45 3.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.82 -5.81 12.07 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 101' ' ' ARG . 95.1 mt-30 53.13 71.96 0.46 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 100' ' ' VAL . 1.9 p -63.28 59.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.825 ' N ' ' O ' ' A' ' 99' ' ' GLN . 40.6 ptt85 -56.41 -1.62 0.06 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.07 -1.423 . . . . 1.0 114.31 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.9 p -152.68 131.81 3.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.458 -0.497 . . . . 1.0 111.732 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mt -112.11 131.02 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.1 t -83.22 168.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.697 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.3 m-20 -55.15 119.07 4.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.758 -1.11 . . . . 1.0 112.267 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.02 -11.62 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.718 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 2.1 pp20? -84.87 -39.87 17.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.902 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.68 -12.91 4.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 1.0 110.075 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 49.9 59.08 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.433 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -93.41 136.26 33.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.361 -2.088 . . . . 1.0 105.361 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -125.57 136.72 53.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 93.6 p . . . . . 0 N--CA 1.452 -0.36 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.358 177.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' HB2' HG23 ' A' ' 100' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.693 0.282 . . . . 1.0 110.24 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.24 154.29 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.598 2.199 . . . . 1.0 111.817 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 16.0 m -98.85 148.05 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.117 0.485 . . . . 1.0 111.294 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.6 OUTLIER -92.28 143.58 27.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.439 -0.8 . . . . 1.0 110.898 -178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -38.67 -22.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.236 1.958 . . . . 1.0 111.227 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -74.9 -46.72 34.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.604 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 45.6 t-80 -78.39 -29.22 47.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.734 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.15 -55.01 16.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.321 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.448 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 86.7 t60 -63.79 -46.61 84.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.273 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -44.14 -48.61 9.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.488 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.71 -46.53 58.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.43 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 147' ' ' GLY . 18.1 tptm -59.3 -40.08 85.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.49 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.448 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 17.9 m -54.27 -32.91 57.38 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.9 mtt -84.26 -2.2 56.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.208 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.87 22.51 75.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.287 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 169' ' ' HIS . 43.0 t -105.65 123.59 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -35.39 30.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.4 p -130.88 168.53 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.534 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 p -161.44 139.69 9.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.038 0.447 . . . . 1.0 112.16 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.0 tp -116.84 136.49 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 m -131.6 158.72 43.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.651 . . . . 1.0 111.821 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 153' ' ' VAL . 55.3 t -159.01 90.81 2.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.327 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.52 114.61 1.65 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.559 2.839 . . . . 1.0 113.936 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.4 mt -71.86 105.37 3.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.8 ptm -135.1 147.04 49.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 1.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 30.3 t-80 -118.22 115.12 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 77.9 t60 59.9 -123.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.614 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 30.7 tt0 -93.04 8.44 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -114.94 143.87 44.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.4 115.55 30.4 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.489 -1.232 . . . . 1.0 108.853 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 76.0 m95 -100.63 -27.93 13.13 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.725 -0.39 . . . . 1.0 111.852 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.1 -171.73 24.38 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.283 -0.96 . . . . 1.0 112.031 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -139.99 131.26 26.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.803 0.335 . . . . 1.0 111.193 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -96.75 136.86 36.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -149.61 129.98 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.574 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -116.43 146.83 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.017 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.718 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -145.09 142.75 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 1.0 111.029 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 11.7 t60 -150.86 151.42 32.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 1.0 109.752 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.433 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.76 69.73 9.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.471 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 N--CA 1.466 0.334 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.3 179.305 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.805 0.336 . . . . 1.0 110.819 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.0 m -67.37 133.54 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.307 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.42 -35.61 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.616 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.74 -54.82 40.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.63 -0.259 . . . . 1.0 111.333 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.63 -32.13 73.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 1.0 110.682 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 tp -62.24 -41.27 98.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.481 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.32 -56.3 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.543 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -45.0 -45.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.574 -0.451 . . . . 1.0 110.27 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -75.44 -36.72 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -47.68 -36.79 11.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.02 -40.38 68.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.386 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.5 tp -55.61 -31.76 62.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.692 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.438 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.95 -39.34 56.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.641 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -57.12 -39.03 74.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.732 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -53.21 -52.64 58.24 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.2 -40.55 65.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.82 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.5 p -51.54 -33.61 32.86 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.02 -36.62 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.062 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -46.45 65.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.114 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 196' ' ' ALA . 8.8 tp -61.57 -36.14 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.164 0.507 . . . . 1.0 109.666 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -74.84 -53.46 9.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.93 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.56 -28.84 57.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.73 -33.93 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.216 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.38 -41.14 84.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.2 -58.59 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.5 p -57.75 -43.97 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 1.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.457 179.739 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.8 tp . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.853 0.359 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 25.2 p-10 -63.09 -51.02 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.261 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 98.8 mt-30 -61.32 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.684 ' O ' HG23 ' A' ' 38' ' ' THR . 4.4 mm -57.8 -37.94 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.591 0.589 . . . . 1.0 112.591 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.34 -23.32 61.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -64.97 -42.32 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.011 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.12 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.374 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.4 p -69.41 -46.66 66.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 68' ' ' ALA . 13.0 t -55.2 -37.16 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.835 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.35 -38.7 85.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.777 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -62.22 -41.77 98.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.973 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.0 -40.97 84.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.879 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.2 tmm_? -57.95 -50.16 74.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.871 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.76 86.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.9 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -77.48 -52.88 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.824 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.67 -3.64 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 1.0 110.14 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.24 17.11 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.487 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.623 HG21 HG13 ' A' ' 51' ' ' VAL . 6.2 t -77.89 147.56 35.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 70' ' ' GLY . 33.2 p-10 -69.02 -11.6 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 1.0 112.895 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.603 ' NH2' ' CD2' ' A' ' 169' ' ' HIS . 30.7 ttp180 -163.73 122.0 1.91 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 119.115 -1.034 . . . . 1.0 113.487 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.96 133.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 176.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -145.36 159.65 42.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.556 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.65 135.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.015 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.437 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.5 t80 -118.32 118.28 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.054 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -99.24 166.97 10.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -132.22 134.05 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.569 -0.452 . . . . 1.0 112.15 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.48 129.56 25.79 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.727 -0.669 . . . . 1.0 109.283 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.86 -26.91 2.19 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.675 2.25 . . . . 1.0 112.976 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.21 -7.83 55.72 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.996 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.52 -11.61 42.85 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.048 -0.596 . . . . 1.0 112.832 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -88.46 142.75 27.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.363 0.582 . . . . 1.0 110.941 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -122.37 141.57 14.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 78.7 p -127.21 146.56 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.267 0.556 . . . . 1.0 112.374 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.3 t -95.75 118.82 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.03 -1.59 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.37 150.5 21.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -168.65 131.31 1.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.35 -0.94 . . . . 1.0 113.125 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -114.46 144.92 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -133.25 144.52 49.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.574 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.04 113.17 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.59 19.07 0.13 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 70' ' ' GLY . 38.6 tt0 68.72 28.9 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.194 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -58.2 -55.52 33.96 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt -95.43 149.87 36.74 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.31 170.01 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.066 1.844 . . . . 1.0 112.506 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -89.92 127.71 36.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.143 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 mt -98.88 -1.31 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.655 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 67' ' ' GLU . 9.4 tp -61.39 135.3 57.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.359 0.599 . . . . 1.0 112.179 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.61 -8.11 74.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.1 mp -98.11 131.79 44.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.399 . . . . 1.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.0 m -90.56 120.83 31.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.383 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 62' ' ' GLY . 8.7 m-85 -106.39 135.69 19.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.34 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.53 154.24 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.192 1.928 . . . . 1.0 111.672 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -69.44 -24.44 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.796 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.58 -20.09 0.19 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ALA . 88.8 m-20 -58.46 -30.76 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 1.0 110.659 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.0 mt -111.91 132.73 21.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.265 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.75 -111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.536 2.157 . . . . 1.0 112.27 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 13.2 tm-20 -150.99 -66.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.804 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 21.1 pt-20 -44.56 -43.7 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.743 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.38 98.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.916 0.389 . . . . 1.0 110.974 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HD22 ' A' ' 162' ' ' LEU . 59.8 ttt180 -64.34 -28.01 69.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 66.9 mtp85 -56.95 -49.85 74.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.272 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.03 -38.1 62.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.581 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 8.4 m-85 -64.24 -29.85 70.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -90.31 -13.66 34.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.128 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.16 -43.78 4.31 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.57 -3.73 13.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.541 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.8 mt-30 27.24 70.69 0.05 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.112 1.153 . . . . 1.0 114.112 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.2 p -112.64 -48.36 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.43 -2.434 . . . . 1.0 104.43 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.617 ' NH1' ' NE2' ' A' ' 185' ' ' GLN . 12.1 mtm180 63.42 74.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.077 -1.42 . . . . 1.0 114.24 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.54 135.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.761 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 135' ' ' VAL . 3.0 mt -107.86 125.9 64.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 105' ' ' ASP . 7.5 p -82.79 166.28 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.621 ' N ' HG22 ' A' ' 104' ' ' VAL . 23.7 t0 -54.33 120.25 6.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.713 -1.131 . . . . 1.0 112.336 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.7 m -56.72 -9.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -87.27 -35.83 18.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.831 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -16.83 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.363 0.601 . . . . 1.0 110.076 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 51.38 53.05 13.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.086 -0.961 . . . . 1.0 113.45 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.03 135.6 34.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.385 -2.08 . . . . 1.0 105.385 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -129.46 142.8 50.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 81.9 p . . . . . 0 N--CA 1.453 -0.3 0 CA-C-N 114.11 -1.405 . . . . 1.0 107.322 176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.609 ' NH2' HG22 ' A' ' 135' ' ' VAL . 63.2 ttp85 . . . . . 0 CA--C 1.529 0.147 0 N-CA-C 110.309 -0.256 . . . . 1.0 110.309 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.91 142.65 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.515 2.143 . . . . 1.0 111.896 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.609 HG22 ' NH2' ' A' ' 133' ' ' ARG . 16.7 t -133.35 140.1 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 1.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.552 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -39.76 156.17 0.16 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.883 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.21 -7.33 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.196 1.93 . . . . 1.0 111.308 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 m -56.45 -51.47 68.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.47 ' CE1' HG23 ' A' ' 140' ' ' VAL . 5.1 p-80 -71.7 -25.74 62.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.591 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.47 HG23 ' CE1' ' A' ' 139' ' ' HIS . 27.9 t -56.91 -64.13 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.364 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.541 ' CE1' ' OG ' ' A' ' 145' ' ' SER . 31.7 t-80 -69.25 -50.69 44.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.202 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.446 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' CD2' ' NE2' ' A' ' 169' ' ' HIS . 85.1 mt -73.56 -45.32 54.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.508 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 41.9 tptt -60.18 -41.7 93.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.541 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 15.2 m -53.42 -31.11 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.5 mtt -89.82 -2.04 58.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.199 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.11 26.16 71.53 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.251 -0.886 . . . . 1.0 112.348 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.37 120.7 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.971 0.386 . . . . 1.0 109.962 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.14 -34.47 32.46 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -134.92 170.06 16.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.595 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.561 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 39.1 m -163.68 139.82 6.7 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.037 0.446 . . . . 1.0 112.124 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.424 HD13 ' CG ' ' A' ' 176' ' ' TYR . 21.9 tp -114.03 139.26 49.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.5 m -132.46 156.78 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.437 0.637 . . . . 1.0 111.82 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.527 HG13 ' NE2' ' A' ' 185' ' ' GLN . 74.4 t -156.84 91.6 2.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.818 -1.083 . . . . 1.0 109.262 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.45 130.58 39.3 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 123.694 2.929 . . . . 1.0 113.893 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.89 104.83 16.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.795 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.8 mtp -119.2 144.63 46.61 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.871 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 86.1 t60 -124.73 113.3 17.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.951 -1.129 . . . . 1.0 107.951 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.488 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 53.3 t60 65.17 -127.17 0.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.488 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.8 mm100 -95.15 12.21 29.55 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -120.72 157.47 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.9 OUTLIER -110.95 115.53 29.64 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 114.493 -1.231 . . . . 1.0 108.848 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.5 m95 -93.44 -25.78 17.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.958 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.58 -167.94 22.75 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.152 -1.023 . . . . 1.0 111.941 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.6 tp -144.21 129.78 19.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.767 0.317 . . . . 1.0 111.231 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.56 138.31 31.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.33 133.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.597 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.679 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 25.1 p -114.47 142.91 45.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.029 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.679 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -133.92 139.51 46.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 1.0 111.08 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.426 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.7 p-80 -156.09 155.07 31.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.747 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.24 69.51 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.469 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 N--CA 1.466 0.362 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.349 179.635 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 5.9 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.784 0.326 . . . . 1.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -99.21 150.88 21.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.81 -38.76 89.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.654 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 47.6 mp0 -65.59 -55.34 18.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.289 . . . . 1.0 111.333 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.53 -34.23 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.942 0.401 . . . . 1.0 110.717 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.89 -39.48 94.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.467 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -58.73 -53.66 55.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.415 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -46.4 -45.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 187' ' ' LEU . 40.0 t -74.75 -37.96 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.617 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 49.4 tp60 -47.84 -35.33 10.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.44 -40.08 64.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.734 -1.121 . . . . 1.0 109.367 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 184' ' ' VAL . 42.5 tp -55.07 -31.79 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.715 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.51 -38.07 62.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.64 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -55.54 -39.53 70.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.73 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -52.09 -52.39 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.07 -41.17 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.9 m -52.45 -36.17 54.1 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.62 -41.54 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.082 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.23 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.099 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.466 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.1 tp -61.49 -35.85 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.07 -53.91 11.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.904 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -55.66 -26.43 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.921 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -34.92 58.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.286 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.73 -38.98 76.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -66.99 -58.44 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.131 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.5 t -50.54 -40.85 52.92 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.312 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.369 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.923 0.392 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.18 -41.11 94.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.252 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -71.1 -54.13 12.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.848 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -58.33 -32.44 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -75.53 -25.12 56.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.729 -0.389 . . . . 1.0 111.555 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.34 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.616 -0.434 . . . . 1.0 109.974 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.24 -30.12 43.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.407 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 34' ' ' ILE . 37.5 p -74.77 -49.02 22.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.553 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 36' ' ' ARG . 5.2 p -53.43 -33.9 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.833 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -72.94 -35.52 67.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.38 -43.18 91.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.972 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.21 -51.74 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.89 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.2 ttp180 -49.95 -43.84 50.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.868 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.41 75.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -80.73 -50.73 9.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.32 -6.84 54.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.0 110.072 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.51 18.94 1.06 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.682 -0.69 . . . . 1.0 112.445 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.87 142.29 42.18 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' GLY . 90.5 m-20 -58.32 -32.88 68.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 48' ' ' THR . 58.8 ttp180 -152.45 120.8 6.33 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.595 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.89 135.53 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -144.77 161.0 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.551 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.33 137.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.011 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.7 t80 -122.27 118.48 28.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.014 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -99.57 170.59 8.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 27.8 t80 -134.57 136.74 43.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.039 0.447 . . . . 1.0 112.166 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 m-20 -102.17 148.53 35.53 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.299 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.61 -22.96 70.35 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.681 2.254 . . . . 1.0 112.971 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -79.39 -2.07 40.06 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.029 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.18 -10.5 56.77 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.894 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 148.03 22.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.344 0.572 . . . . 1.0 110.95 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.87 149.7 18.53 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.424 -1.07 . . . . 1.0 110.424 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 1.0 112.347 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.67 116.67 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -112.36 5.23 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.07 145.89 23.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.0 tt0 -166.2 126.97 1.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.378 -0.929 . . . . 1.0 113.216 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.06 138.07 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.9 ptt180 -129.61 142.43 50.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.544 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.49 106.23 2.99 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.84 -87.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLY . 19.5 pt-20 -179.27 31.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.115 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 49' ' ' ASP . 7.1 ttp180 -70.11 -51.2 33.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.52 124.63 47.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.33 169.44 3.93 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.133 1.889 . . . . 1.0 112.49 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 141.47 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.151 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.592 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 33.3 mt -113.28 -2.14 14.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.623 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.0 tp -56.83 138.17 53.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.329 0.585 . . . . 1.0 112.279 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -4.04 84.49 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.425 -0.807 . . . . 1.0 111.088 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -100.47 117.72 35.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 1.0 110.82 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.654 ' N ' HD23 ' A' ' 80' ' ' LEU . 76.9 p -76.88 123.55 26.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.447 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 80' ' ' LEU . 10.0 m-85 -107.17 135.07 19.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.92 150.97 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.128 1.885 . . . . 1.0 111.649 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.55 -25.78 66.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.849 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.45 -21.2 0.25 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 m-20 -54.84 -32.65 60.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 1.0 110.592 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 HH21 ' A' ' 92' ' ' ARG . 3.5 pt -121.0 99.49 46.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.244 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 87' ' ' ILE . 51.2 Cg_exo -42.11 -107.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.5 2.134 . . . . 1.0 112.317 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 19.7 pt-20 -152.4 -46.14 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 1.0 111.83 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 24.4 pt-20 -60.66 -39.09 87.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.71 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.9 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.554 HH21 HD12 ' A' ' 87' ' ' ILE . 29.4 ttm105 -66.34 -29.88 70.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.556 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -55.92 -55.29 34.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.318 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD22 ' NE ' ' A' ' 133' ' ' ARG . 5.5 tp -53.04 -43.42 66.59 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.543 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.35 -32.64 70.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.566 ' NH2' ' SD ' ' A' ' 157' ' ' MET . 9.6 mmp_? -87.34 -11.03 50.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.136 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 tp -106.85 -44.96 4.3 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.31 0.856 . . . . 1.0 113.31 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.57 -1.96 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.587 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 97.6 mt-30 26.15 69.03 0.05 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.093 1.146 . . . . 1.0 114.093 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.659 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 31.4 m -113.04 -50.96 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.405 -2.443 . . . . 1.0 104.405 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.659 ' HE ' ' N ' ' A' ' 100' ' ' VAL . 3.5 mtm180 63.66 72.38 0.47 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.052 -1.431 . . . . 1.0 114.256 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 102' ' ' VAL . 15.0 p -148.87 133.0 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.477 -0.489 . . . . 1.0 111.735 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.515 HG21 ' OG ' ' A' ' 151' ' ' SER . 2.4 mt -109.2 124.67 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 108.331 -0.989 . . . . 1.0 108.331 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.6 p -83.16 167.71 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.274 0.842 . . . . 1.0 113.274 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.665 ' N ' HG22 ' A' ' 104' ' ' VAL . 9.5 m-20 -55.54 119.18 5.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.711 -1.131 . . . . 1.0 112.268 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.67 -10.34 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.754 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.46 -36.93 16.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.906 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -16.79 37.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.416 0.626 . . . . 1.0 110.145 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.499 HE21 ' HE ' ' A' ' 111' ' ' ARG . 44.8 tp60 51.8 58.35 5.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.982 -1.008 . . . . 1.0 113.455 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -94.1 137.82 32.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.499 ' HE ' HE21 ' A' ' 109' ' ' GLN . 98.3 mtt180 -127.82 133.21 49.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 23.6 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-N 114.195 -1.366 . . . . 1.0 107.382 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.638 ' NE ' HD22 ' A' ' 94' ' ' LEU . 10.7 tpp180 . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.708 0.29 . . . . 1.0 110.258 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.33 147.6 28.24 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.512 2.142 . . . . 1.0 111.791 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 139' ' ' HIS . 6.9 m -97.75 153.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.042 0.449 . . . . 1.0 111.373 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -89.09 155.81 49.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.891 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.23 -20.42 24.75 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.267 1.978 . . . . 1.0 111.164 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 45.0 t -69.89 -51.97 28.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.729 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -73.38 -27.28 61.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.634 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 25.4 t -52.9 -53.13 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.322 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.544 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 72.1 t60 -66.05 -44.09 85.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -42.02 -48.56 4.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.467 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.2 mt -74.19 -43.74 56.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.502 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' GLY . 40.1 tptt -61.02 -42.55 98.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.544 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 16.2 m -54.26 -32.29 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 42.9 mtt -88.18 -0.98 57.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.217 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.14 24.93 76.26 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.197 -0.911 . . . . 1.0 112.31 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.0 t -106.84 120.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.47 -30.88 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.54 ' OG ' ' CD2' ' A' ' 170' ' ' HIS . 98.7 p -139.46 171.76 13.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.137 -0.625 . . . . 1.0 111.563 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 103' ' ' ILE . 8.3 p -161.93 140.44 9.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.211 -0.45 . . . . 1.0 112.171 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.4 139.42 50.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -133.22 154.41 39.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.479 0.657 . . . . 1.0 111.821 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 153' ' ' VAL . 54.8 t -158.19 91.29 2.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.72 134.7 54.82 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.521 2.814 . . . . 1.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.9 mt -94.76 107.89 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.772 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.566 ' SD ' ' NH2' ' A' ' 96' ' ' ARG . 15.8 ptm -128.7 146.89 50.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.906 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 65.7 t60 -117.79 115.41 24.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 60.5 t60 61.52 -124.61 0.83 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.789 -0.449 . . . . 1.0 109.789 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.486 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 36.5 mt-30 -93.24 5.01 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.43 150.74 32.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.85 116.35 31.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.831 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.455 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 83.7 m95 -93.85 -24.87 17.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.898 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.79 -165.32 21.88 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.979 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.6 tp -143.55 133.31 23.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 1.0 111.179 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 3.5 tp -95.11 140.66 29.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.02 135.23 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.608 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.784 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 0.9 OUTLIER -120.02 139.95 51.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.049 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.784 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -136.51 142.15 43.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 1.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.54 ' CD2' ' OG ' ' A' ' 150' ' ' SER . 4.2 p-80 -156.48 153.75 29.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.712 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.69 72.2 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.418 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 . . . . . 0 N--CA 1.465 0.291 0 C-N-CA 120.396 -0.522 . . . . 1.0 112.359 179.623 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 9.4 m-85 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.719 0.295 . . . . 1.0 110.847 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.3 p -100.19 146.59 26.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.75 -35.67 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 58.0 mp0 -65.67 -55.59 16.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.302 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.43 -34.95 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 1.0 110.683 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.25 -34.66 74.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.49 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 185' ' ' GLN . 51.0 tt0 -66.88 -51.8 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.36 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.4 t -45.2 -48.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.317 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.1 p -74.59 -37.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 182' ' ' GLN . 6.9 tt0 -48.06 -37.15 14.42 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.54 -40.22 70.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 184' ' ' VAL . 34.5 tp -55.2 -30.97 61.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.738 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.448 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -73.74 -39.01 64.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.618 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.59 -40.23 71.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.76 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -51.05 -52.94 38.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.05 -41.14 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.839 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -36.17 57.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.15 -37.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.001 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.24 68.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.068 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.6 tp -62.42 -33.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -73.74 -53.75 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.895 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -55.73 -27.65 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.95 -34.5 57.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.291 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -58.35 -40.27 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.117 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.36 -58.55 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.46 -0.337 . . . . 1.0 111.084 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.0 p -46.22 -38.35 8.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 1.0 110.355 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.429 179.832 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.904 0.383 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -69.8 -52.42 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.275 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.6 -50.04 74.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.76 -32.35 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -176.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.5 -25.77 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.535 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.89 -42.22 94.98 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.003 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.88 -26.62 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.364 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 34' ' ' ILE . 71.3 p -73.66 -45.4 52.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.534 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 68' ' ' ALA . 20.4 t -55.05 -37.7 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.873 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.39 -34.8 70.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.9 -43.36 96.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.99 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.58 -45.87 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.916 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.9 ttp180 -52.89 -47.46 67.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.884 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.808 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.65 -51.63 9.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.24 -6.08 49.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 1.0 110.111 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 16.83 0.37 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.459 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.649 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -76.48 144.86 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.036 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -61.75 -29.3 70.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.947 0.721 . . . . 1.0 112.947 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 48' ' ' THR . 18.7 ttt85 -149.19 122.0 8.71 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.187 -1.005 . . . . 1.0 113.522 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.6 t -137.71 130.64 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -145.23 156.22 43.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.556 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.8 139.65 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.045 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.6 t80 -124.75 120.34 31.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -100.35 171.43 7.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.896 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 8.8 t80 -133.52 138.17 45.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 1.0 112.142 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.7 m-20 -103.59 147.71 34.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.386 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.71 -26.44 75.3 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.797 2.331 . . . . 1.0 112.906 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -76.32 -5.9 49.16 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.976 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.16 -11.55 51.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.923 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -86.48 142.85 28.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.343 0.572 . . . . 1.0 110.962 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -123.22 143.24 15.0 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -126.59 147.01 49.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.229 0.538 . . . . 1.0 112.282 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.53 115.26 31.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.12 -1.56 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -157.09 147.25 20.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 40.3 tt0 -164.68 125.51 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.409 -0.917 . . . . 1.0 113.214 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.44 134.75 49.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.524 HH11 ' CB ' ' A' ' 76' ' ' SER . 15.3 mtm180 -121.93 138.93 54.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.531 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.51 107.0 2.97 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.364 -1.094 . . . . 1.0 110.364 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.5 30.12 1.32 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.255 -1.138 . . . . 1.0 110.255 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 58.89 27.18 15.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.119 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -57.63 -58.83 6.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.25 147.61 38.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 52.3 Cg_endo -68.69 160.69 48.46 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.089 1.859 . . . . 1.0 112.552 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.524 ' CB ' HH11 ' A' ' 69' ' ' ARG . 5.4 p -80.84 126.02 30.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.181 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -101.0 -8.62 22.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.59 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 tp -53.61 138.24 35.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 -2.65 79.58 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -99.88 128.33 45.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 1.0 110.77 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.8 122.17 29.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.45 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.42 132.73 20.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.25 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.59 151.95 25.71 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.096 1.864 . . . . 1.0 111.629 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.424 ' C ' ' OD1' ' A' ' 86' ' ' ASP . . . -60.12 -25.02 65.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.812 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.84 -24.29 1.25 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 17.9 p-10 -54.68 -26.57 34.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 1.0 110.619 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.562 HD12 HH21 ' A' ' 92' ' ' ARG . 51.9 mt -127.84 132.88 24.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.297 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.87 -104.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.563 2.176 . . . . 1.0 112.277 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -161.28 -43.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 1.0 111.845 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.4 -42.83 88.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.757 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.67 -36.36 76.31 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.947 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.562 HH21 HD12 ' A' ' 87' ' ' ILE . 90.0 mtt-85 -66.2 -27.5 68.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' LEU . 30.3 mmt180 -54.54 -58.93 5.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.275 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.09 -37.66 67.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.549 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.7 m-85 -66.69 -39.13 87.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.409 HH12 HD13 ' A' ' 162' ' ' LEU . 5.7 tpp180 -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.549 -0.751 . . . . 1.0 110.137 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ARG . 4.4 tp -107.13 -43.32 4.64 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.99 -3.66 12.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 97.1 mt-30 27.42 70.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.066 1.136 . . . . 1.0 114.066 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.66 ' H ' HH22 ' A' ' 133' ' ' ARG . 14.3 t -110.72 -50.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.715 HH22 ' NE2' ' A' ' 185' ' ' GLN . 12.4 mtm180 64.81 72.75 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.053 -1.431 . . . . 1.0 114.248 172.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.43 ' C ' HD12 ' A' ' 103' ' ' ILE . 70.3 t -149.37 131.42 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.67 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.06 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 105' ' ' ASP . 41.4 t -81.29 165.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.194 0.813 . . . . 1.0 113.194 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 104' ' ' VAL . 22.5 t0 -51.7 120.77 5.56 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.664 -1.153 . . . . 1.0 112.315 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 106' ' ' VAL . 16.9 t -57.13 -12.7 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.702 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 12.6 pt-20 -80.22 -38.73 30.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.96 -16.54 59.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 1.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 51.19 60.08 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.991 -1.004 . . . . 1.0 113.39 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.6 p -94.56 138.88 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.16 146.49 51.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.48 . . . . 1.0 114.997 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.453 -0.318 0 CA-C-N 114.1 -1.409 . . . . 1.0 107.337 176.671 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.66 HH22 ' H ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.767 0.318 . . . . 1.0 110.288 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.96 145.45 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.586 2.191 . . . . 1.0 111.746 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.4 m -113.01 122.42 67.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 1.0 111.346 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.494 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -39.34 155.92 0.14 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.883 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 140' ' ' VAL . 43.3 Cg_endo -63.0 -13.82 37.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.221 1.947 . . . . 1.0 111.317 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.76 -29.94 58.99 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.591 ' CE1' HD13 ' A' ' 143' ' ' LEU . 40.2 t-80 -86.4 -38.05 17.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.351 -0.84 . . . . 1.0 110.679 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 137' ' ' PRO . 4.0 m -52.16 -47.23 44.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.351 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.597 ' N ' HG23 ' A' ' 140' ' ' VAL . 32.1 t-80 -65.49 -44.04 88.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.273 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -45.24 -48.75 12.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.5 mp -70.96 -48.47 53.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.45 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 16.4 tptp -58.08 -41.71 84.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.484 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 32.4 m -54.41 -30.6 52.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.3 mtt -87.28 -1.34 57.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.158 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.38 28.15 71.7 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.292 -0.867 . . . . 1.0 112.337 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -109.93 123.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.77 -32.51 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 8.6 t -137.18 169.54 17.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.551 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -158.6 139.45 12.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.045 0.45 . . . . 1.0 112.162 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.81 136.73 52.72 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 101' ' ' ARG . 2.7 m -135.8 159.39 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.458 0.647 . . . . 1.0 111.824 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 188' ' ' ALA . 79.0 t -157.04 91.79 2.41 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.869 -1.06 . . . . 1.0 109.346 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.02 126.35 19.91 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.617 2.878 . . . . 1.0 113.904 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.8 mt -81.55 106.17 13.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.839 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.428 ' O ' ' OG ' ' A' ' 192' ' ' SER . 73.8 mtp -123.91 144.9 49.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.793 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 81.2 t60 -120.89 113.39 20.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.518 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 77.7 t60 61.35 -121.11 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.518 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 4.7 tt0 -95.94 6.31 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.873 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 161' ' ' GLU . 43.8 mp0 -115.79 154.09 30.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.409 HD13 HH12 ' A' ' 96' ' ' ARG . 5.9 tt -111.14 116.57 31.32 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.557 -1.201 . . . . 1.0 108.88 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.7 m95 -94.93 -25.79 16.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.922 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.84 20.52 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.237 -0.982 . . . . 1.0 111.953 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.8 tp -143.05 130.69 21.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.766 0.317 . . . . 1.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -95.33 132.5 40.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.71 137.47 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.597 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -122.22 144.12 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.094 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.487 ' ND1' HG21 ' A' ' 148' ' ' VAL . 89.7 m-70 -139.68 143.72 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.139 0.495 . . . . 1.0 110.974 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -159.43 155.42 26.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.707 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.55 67.51 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.436 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 . . . . . 0 N--CA 1.466 0.328 0 C-N-CA 120.429 -0.509 . . . . 1.0 112.314 -179.483 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.806 0.336 . . . . 1.0 110.767 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.9 t -92.22 145.69 24.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.288 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -63.61 -43.34 97.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.588 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 46.8 mp0 -60.92 -55.64 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.044 -0.262 . . . . 1.0 111.394 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.66 -29.09 69.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 1.0 110.651 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.93 -35.17 77.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.523 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -69.5 -53.52 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.388 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.1 t -43.47 -47.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.296 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.8 m -74.69 -36.81 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.715 ' NE2' HH22 ' A' ' 101' ' ' ARG . 53.9 tt0 -48.4 -38.18 18.89 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.14 -40.75 71.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.356 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.4 tt -54.81 -31.83 59.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.725 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.485 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -71.93 -33.86 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.605 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -57.68 -40.82 80.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.716 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -51.35 -53.5 35.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.63 -40.83 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.92 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 157' ' ' MET . 5.8 t -52.09 -36.54 51.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.02 -34.84 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.035 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.87 -46.52 62.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.056 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.43 -33.53 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.67 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.911 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 197' ' ' GLN . 9.7 tm0? -55.49 -29.41 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.918 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.55 53.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.287 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.413 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.1 tt0 -57.64 -39.36 76.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.01 -57.98 4.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.125 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -56.41 -44.35 80.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 1.0 110.339 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.413 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 5.2 tp . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 35' ' ' LEU . 60.2 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.875 0.369 . . . . 1.0 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -52.38 -52.69 52.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.307 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -60.15 -48.43 81.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 1.0 112.254 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 38' ' ' THR . 57.3 mt -57.68 -40.47 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.592 0.59 . . . . 1.0 112.592 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 31' ' ' LEU . 51.7 mt -69.89 -22.52 63.22 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.531 -177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 39' ' ' VAL . 93.4 mtt-85 -65.3 -35.29 80.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.706 -0.397 . . . . 1.0 109.975 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.98 -28.66 39.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.343 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.5 p -74.17 -48.96 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.56 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -53.47 -36.28 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.3 mt-10 -75.51 -32.83 60.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -66.64 -51.45 56.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.04 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.8 p -64.96 -48.24 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.811 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.632 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.5 tmt_? -51.65 -44.13 62.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.886 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.15 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.867 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -79.76 -48.91 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.45 -5.64 48.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.101 0.477 . . . . 1.0 110.198 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.65 17.39 0.26 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.433 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.63 144.78 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.1 m-20 -55.86 -34.6 65.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 48' ' ' THR . 35.0 ttm180 -149.53 126.14 10.99 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.184 -1.006 . . . . 1.0 113.521 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 t -135.93 130.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.032 -1.099 . . . . 1.0 108.032 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 54.5 pttt -144.34 157.54 44.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.519 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' A' ' 66' ' ' ALA . 9.4 p -99.35 138.68 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.03 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.2 t80 -122.57 120.73 34.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.083 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.553 ' NH1' HD11 ' A' ' 195' ' ' ILE . 65.9 mtp85 -99.72 169.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -133.6 134.71 43.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.031 0.444 . . . . 1.0 112.165 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.54 129.1 26.66 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.343 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -25.77 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.739 2.293 . . . . 1.0 112.888 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.6 -6.15 52.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.015 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.45 -11.5 43.08 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.051 -0.595 . . . . 1.0 112.92 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -88.71 142.76 27.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.361 0.581 . . . . 1.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -123.13 142.63 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.43 -1.068 . . . . 1.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.7 p -128.05 146.01 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.217 0.532 . . . . 1.0 112.269 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.96 111.3 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.66 8.0 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB3' HG12 ' A' ' 53' ' ' VAL . . . -155.19 147.13 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 72.5 tt0 -167.34 128.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.352 -0.939 . . . . 1.0 113.184 -177.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.18 131.17 54.93 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -117.4 136.65 53.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.55 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.04 88.84 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.39 -87.88 0.05 OUTLIER Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.266 -1.133 . . . . 1.0 110.266 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -175.76 34.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.884 -0.326 . . . . 1.0 111.147 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -70.11 -55.71 8.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.572 ' C ' HH22 ' A' ' 50' ' ' ARG . 12.5 mt -94.97 157.85 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 176.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 3.3 Cg_exo -78.51 165.32 25.29 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.154 1.903 . . . . 1.0 112.476 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 p -87.01 127.98 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.177 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.406 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 44.7 mt -101.13 1.06 38.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.58 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.549 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -65.25 138.65 58.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.346 0.593 . . . . 1.0 112.264 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.549 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 91.6 -2.85 77.92 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.111 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.5 mp -100.76 128.96 46.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.866 0.365 . . . . 1.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.23 121.81 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.411 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 62' ' ' GLY . 7.5 m-85 -107.68 136.77 19.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.39 157.79 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.166 1.91 . . . . 1.0 111.664 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -66.18 -25.59 67.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.78 -19.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 84' ' ' ALA . 85.3 m-20 -54.87 -34.16 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.359 . . . . 1.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 ' HE ' ' A' ' 92' ' ' ARG . 21.7 mm -109.12 133.71 20.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.258 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.428 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 58.7 Cg_endo -80.89 -120.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.491 2.127 . . . . 1.0 112.335 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.5 mm-40 -138.87 -56.58 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.759 -0.376 . . . . 1.0 111.849 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -59.46 -39.57 84.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.733 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.62 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.963 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 87' ' ' ILE . 39.7 ttm180 -63.22 -30.32 71.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.508 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -58.21 -50.48 73.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.0 111.26 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' NE ' ' A' ' 133' ' ' ARG . 95.6 mt -55.13 -36.25 65.56 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.604 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -64.24 -32.05 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 96' ' ' ARG . 9.2 mmm180 -83.62 -15.12 50.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.157 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.84 -42.72 4.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.74 -4.97 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.549 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 26.27 69.96 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 101' ' ' ARG . 1.7 m -110.63 -49.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 9.3 mtm180 63.09 68.86 0.6 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.066 -1.425 . . . . 1.0 114.335 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -148.77 133.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.849 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 3.4 mt -106.12 124.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.0 p -82.57 167.59 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.627 ' N ' HG22 ' A' ' 104' ' ' VAL . 3.0 m-20 -51.61 115.06 1.44 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.327 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 106' ' ' VAL . 54.7 t -54.81 -11.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.722 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.45 -33.57 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.08 -16.97 36.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.438 0.637 . . . . 1.0 110.143 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 53.28 59.97 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.969 -1.014 . . . . 1.0 113.435 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -92.37 134.34 35.01 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -124.86 138.23 54.26 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.481 . . . . 1.0 114.997 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.35 0 CA-C-N 114.209 -1.36 . . . . 1.0 107.342 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' CG ' HH11 ' A' ' 133' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.7 0.286 . . . . 1.0 110.299 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.13 149.75 17.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.573 2.182 . . . . 1.0 111.783 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.532 ' HB ' ' CD2' ' A' ' 139' ' ' HIS . 5.7 m -101.42 153.53 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 1.0 111.375 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 12.2 m-20 -88.98 146.2 36.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.903 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -42.62 -23.76 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.278 1.985 . . . . 1.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.1 p -67.66 -40.36 84.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.643 ' CE1' HD12 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -78.97 -26.69 43.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.641 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -51.33 -53.16 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 1.0 110.38 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' SER . 51.1 t-80 -68.25 -43.35 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.261 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -47.1 -57.19 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.455 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.643 HD12 ' CE1' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -68.46 -50.0 55.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.481 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.7 tptm -56.33 -39.53 72.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.407 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 141' ' ' HIS . 29.4 t -54.47 -32.48 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.4 mtt -83.45 -2.04 54.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.196 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.67 24.22 74.01 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.34 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 170' ' ' HIS . 24.0 t -109.27 124.55 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.2 -31.98 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.743 0.645 . . . . 1.0 112.743 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -135.13 169.73 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 1.0 111.565 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 5.0 p -161.56 139.48 9.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.163 0.431 . . . . 1.0 112.163 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.1 tp -114.83 139.25 49.9 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -135.68 156.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.423 0.63 . . . . 1.0 111.845 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 153' ' ' VAL . 71.5 t -157.8 93.13 2.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.851 -1.068 . . . . 1.0 109.341 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.32 115.84 2.66 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.581 2.854 . . . . 1.0 113.973 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.08 105.07 4.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.794 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 75.5 mtp -121.78 146.14 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.168 0.508 . . . . 1.0 111.846 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 25.6 t-80 -123.18 112.88 18.22 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.9 t-80 64.89 -125.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.413 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.7 mt-30 -95.19 8.56 42.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.868 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.8 mp0 -118.42 155.08 31.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.897 1.073 . . . . 1.0 113.897 -177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.09 118.0 35.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.504 -1.225 . . . . 1.0 108.885 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CD2' ' OE2' ' A' ' 199' ' ' GLU . 77.9 m95 -97.51 -27.73 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.736 -0.386 . . . . 1.0 111.981 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.06 -173.45 25.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.189 -1.005 . . . . 1.0 111.965 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.0 tp -139.15 131.33 28.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.849 0.357 . . . . 1.0 111.149 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.94 137.86 34.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.9 p -150.91 132.76 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.572 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 p -116.02 145.55 42.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.0 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.431 ' CE1' HG22 ' A' ' 167' ' ' VAL . 59.3 m80 -132.54 140.31 48.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 1.0 110.975 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 6.5 t60 -147.44 142.75 27.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.757 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.79 67.42 9.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.441 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 120.43 -0.508 . . . . 1.0 112.349 179.794 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.826 0.346 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -101.45 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.314 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -68.96 -34.98 76.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.683 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.91 -55.92 16.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.401 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 38.9 mp0 -67.75 -34.1 76.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.0 110.734 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.8 tp -62.28 -31.43 72.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.484 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.93 -52.73 22.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.458 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.0 t -44.86 -45.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.282 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.3 p -75.06 -37.32 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -47.58 -38.1 13.75 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.34 -40.15 74.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.727 -1.124 . . . . 1.0 109.437 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.9 tt -54.34 -30.91 53.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.64 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.66 -36.02 67.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.637 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -55.31 -39.57 70.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.717 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -53.75 -53.9 45.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 82.2 t -58.42 -42.28 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.861 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.5 p -51.35 -36.62 43.8 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -77.68 -34.97 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.031 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.5 -46.36 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.047 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 55' ' ' ARG . 14.9 tt -64.08 -33.15 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.19 -55.83 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.875 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.28 -25.72 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.21 59.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.263 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.545 ' OE2' ' CD2' ' A' ' 163' ' ' TRP . 92.0 mt-10 -58.65 -39.96 82.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.198 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.38 -60.06 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.101 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 92.8 p -54.22 -40.72 67.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.348 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.042 -0.98 . . . . 1.0 110.442 179.554 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.916 0.389 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -65.21 -40.57 94.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.321 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.72 -53.7 14.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.846 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -59.23 -34.04 52.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.581 0.585 . . . . 1.0 112.581 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.59 -25.48 59.29 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.553 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -60.08 -54.11 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.951 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.78 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.32 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.2 p -65.71 -46.96 77.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.655 HG12 ' HB2' ' A' ' 68' ' ' ALA . 7.2 t -52.3 -31.45 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.848 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.36 -36.23 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 1.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -58.9 -43.24 90.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.953 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG22 HD22 ' A' ' 187' ' ' LEU . 74.0 t -66.33 -38.77 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.876 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.5 ttt180 -57.31 -52.54 64.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.06 87.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.745 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -79.43 -53.98 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.716 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -76.94 -4.76 45.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.0 110.176 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.12 16.74 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.397 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 51' ' ' VAL . 14.6 t -77.41 145.9 36.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.106 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 70' ' ' GLY . 49.2 p30 -68.46 -10.5 55.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.946 0.721 . . . . 1.0 112.946 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.697 HH21 ' CD2' ' A' ' 169' ' ' HIS . 46.1 ttp180 -164.39 120.59 1.56 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.137 -1.025 . . . . 1.0 113.579 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -140.74 132.52 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 176.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.436 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 53.3 pttt -145.69 158.82 43.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.56 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.76 137.56 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.994 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 165' ' ' LEU . 28.4 t80 -119.8 119.1 32.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.07 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -99.52 166.22 11.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.87 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 79.6 t80 -131.55 137.05 48.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 1.0 112.159 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.27 126.39 33.51 Favored Pre-proline 0 C--N 1.334 -0.104 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.07 -25.59 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.737 2.291 . . . . 1.0 112.901 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -76.71 -6.28 51.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.977 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.15 38.0 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.997 -0.62 . . . . 1.0 112.831 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -89.58 143.0 27.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.421 0.611 . . . . 1.0 110.919 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.74 140.95 14.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -128.64 146.86 50.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.248 0.547 . . . . 1.0 112.243 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.02 111.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -100.52 6.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.601 0.593 . . . . 1.0 112.601 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.41 146.99 23.02 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 42.5 tt0 -166.92 128.16 1.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.336 -0.946 . . . . 1.0 113.235 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.12 140.73 43.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.55 HH12 ' C ' ' A' ' 75' ' ' PRO . 5.2 ptm85 -131.37 142.67 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.25 110.4 3.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.456 -1.057 . . . . 1.0 110.456 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.54 -87.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.239 -1.145 . . . . 1.0 110.239 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.9 pt-20 -179.99 26.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.152 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.33 -32.24 73.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 69' ' ' ARG . 12.2 mt -118.23 142.74 31.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' C ' HH12 ' A' ' 69' ' ' ARG . 68.4 Cg_endo -73.85 170.57 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.072 1.848 . . . . 1.0 112.457 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.5 p -93.92 139.35 31.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.176 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -110.34 -3.37 16.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.633 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.17 137.89 55.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.307 0.575 . . . . 1.0 112.282 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.91 82.78 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.5 tp -101.49 122.72 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.887 0.375 . . . . 1.0 110.782 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 81' ' ' THR . 10.1 t -79.05 122.43 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.515 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -105.38 131.11 22.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.37 150.07 22.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.185 1.923 . . . . 1.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -62.62 -23.69 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.828 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.22 -22.68 0.58 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -56.51 -31.16 63.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 1.0 110.659 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 88' ' ' PRO . 3.5 pt -118.47 100.42 51.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.316 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.3 Cg_exo -44.29 -110.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.487 2.124 . . . . 1.0 112.347 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 84.2 tt0 -149.53 -58.45 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.751 -0.38 . . . . 1.0 111.784 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.56 -40.93 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.77 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.84 90.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.014 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -68.56 -29.7 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.572 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -55.3 -55.63 29.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.226 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.89 -40.16 72.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -57.9 -34.03 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -88.5 -9.8 51.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.103 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tp -107.18 -45.6 4.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.373 0.879 . . . . 1.0 113.373 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -115.39 -1.75 12.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.2 mt-30 28.44 71.64 0.05 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.116 1.154 . . . . 1.0 114.116 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 101' ' ' ARG . 35.4 m -117.53 -47.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.731 HH21 HG22 ' A' ' 154' ' ' VAL . 2.4 mpp_? 62.52 -26.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.143 -1.389 . . . . 1.0 114.354 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 100' ' ' VAL . 11.8 p -56.14 129.48 17.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.445 -0.502 . . . . 1.0 111.788 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 16.7 mt -105.37 129.94 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.8 p -81.34 168.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -50.08 120.57 4.55 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.289 -177.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 106' ' ' VAL . 24.0 t -57.6 -14.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.741 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.23 -36.56 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.914 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.79 -14.44 8.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.393 0.616 . . . . 1.0 110.101 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 51.5 59.8 4.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 1.0 113.409 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 m -92.09 137.57 32.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -126.63 135.45 51.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 45.6 t . . . . . 0 N--CA 1.452 -0.347 0 CA-C-N 114.126 -1.397 . . . . 1.0 107.402 176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.487 HH21 ' HB3' ' A' ' 98' ' ' ALA . 19.9 mmt-85 . . . . . 0 CA--C 1.528 0.124 0 CA-C-O 120.691 0.282 . . . . 1.0 110.28 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.26 149.45 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.495 2.13 . . . . 1.0 111.864 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 140' ' ' VAL . 19.0 m -100.8 148.76 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 1.0 111.416 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -87.73 154.89 53.39 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.909 -178.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -50.38 -21.28 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.268 1.979 . . . . 1.0 111.279 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.63 -39.8 30.68 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.524 ' ND1' ' CG1' ' A' ' 135' ' ' VAL . 51.4 t-80 -81.52 -40.48 23.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.666 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 135' ' ' VAL . 3.1 m -52.07 -43.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.357 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 140' ' ' VAL . 79.8 t60 -67.48 -43.99 79.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.256 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -43.3 -46.77 6.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.488 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 143' ' ' LEU . 83.5 mt -72.74 -43.84 62.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.574 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.1 tmtm? -60.69 -42.67 97.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.441 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 98.5 p -54.46 -31.32 55.4 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.6 mtt -89.47 -2.03 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.199 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.48 23.41 77.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.256 -0.884 . . . . 1.0 112.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 169' ' ' HIS . 11.5 t -104.09 121.14 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.889 -0.411 . . . . 1.0 109.889 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.87 44.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 t -131.45 167.48 19.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.156 -0.618 . . . . 1.0 111.545 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.2 p -162.47 141.92 9.34 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.137 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 38.3 tp -127.72 110.21 12.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.08 157.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.461 0.648 . . . . 1.0 111.849 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.731 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -153.39 93.95 3.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.311 -176.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.26 120.33 8.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.527 2.818 . . . . 1.0 113.957 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.4 mt -74.79 104.54 5.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.787 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.7 mtp -122.62 146.42 47.46 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.337 -0.545 . . . . 1.0 111.83 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 159' ' ' HIS . 72.0 t60 -126.42 114.17 17.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.019 -1.104 . . . . 1.0 108.019 175.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 158' ' ' HIS . 8.0 m-70 63.29 -125.97 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -95.6 10.73 35.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.876 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 55.3 mt-10 -119.71 153.56 35.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.923 1.082 . . . . 1.0 113.923 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.68 113.91 27.51 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.513 -1.221 . . . . 1.0 108.925 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 89.1 m95 -98.06 -28.64 13.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.916 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.37 -174.38 23.61 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.4 tp -142.46 130.41 21.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 1.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -96.25 140.7 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.4 t -146.2 111.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.394 -0.523 . . . . 1.0 111.531 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.5 t -100.17 139.23 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.013 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.698 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -148.79 144.66 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.193 0.521 . . . . 1.0 110.944 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.48 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.8 p-80 -153.97 151.81 29.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.66 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.02 66.68 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.345 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 120.355 -0.538 . . . . 1.0 112.303 179.539 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.48 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 33.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.839 0.352 . . . . 1.0 110.803 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.5 t -99.68 146.49 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.272 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.35 -37.69 88.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.655 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.62 -56.16 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.327 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 33.3 mp0 -65.69 -34.09 77.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 1.0 110.639 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.48 -40.01 89.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.463 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.13 -51.0 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.423 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.5 t -46.99 -49.38 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.331 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.2 -37.63 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 43.4 tt0 -45.4 -36.43 4.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.82 -41.7 74.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.383 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.855 HD23 ' O ' ' A' ' 187' ' ' LEU . 5.4 tt -54.73 -33.16 60.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.638 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.16 -40.23 59.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.633 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.5 -38.33 71.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.684 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.94 -53.44 52.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.53 -43.83 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.838 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -51.94 -37.63 53.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.3 mt -78.71 -32.02 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.91 62.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.01 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.8 pp -65.49 -26.47 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.714 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.06 -55.72 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 1.0 109.925 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 -27.86 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.919 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.64 56.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.301 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.36 -37.41 72.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.13 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.1 mt -68.34 -58.2 4.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.108 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 m -55.15 -42.18 72.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.293 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.402 179.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.562 HD11 HD12 ' A' ' 195' ' ' ILE . 8.5 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.918 0.39 . . . . 1.0 110.572 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.66 -50.74 42.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.303 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.16 -44.49 95.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -62.59 -36.09 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -77.69 -20.82 53.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.446 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.505 ' O ' HG12 ' A' ' 39' ' ' VAL . 77.4 mtp180 -73.05 -33.71 65.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.639 -0.424 . . . . 1.0 109.972 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -33.62 28.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.36 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 2.1 t -70.74 -45.11 65.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.573 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.1 p -56.72 -36.55 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.839 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.1 mt-10 -75.46 -38.05 59.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 1.0 110.81 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.24 -51.12 65.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.966 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.28 -50.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.6 tmm_? -49.68 -41.63 43.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.9 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -35.79 73.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -79.64 -47.37 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 mt -76.53 -6.37 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.027 0.441 . . . . 1.0 110.177 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.62 16.46 0.19 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.462 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.5 m -74.92 144.82 43.1 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.4 m-20 -62.4 -27.47 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.759 ' H ' HG22 ' A' ' 48' ' ' THR . 59.9 ttt85 -153.54 121.56 6.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 119.127 -1.029 . . . . 1.0 113.562 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.34 134.43 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -146.01 160.26 42.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.577 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.9 134.97 32.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.004 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.9 t80 -119.15 118.55 31.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.021 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -99.03 165.72 11.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -132.08 136.17 46.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 1.0 112.155 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.69 129.68 24.89 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.714 -0.675 . . . . 1.0 109.341 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.59 -29.31 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.684 2.256 . . . . 1.0 112.933 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -72.72 -17.66 61.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.948 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.89 -15.24 12.49 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.839 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -84.93 141.85 30.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.375 0.588 . . . . 1.0 110.957 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.73 139.69 13.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.3 p -125.3 144.87 50.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.207 0.527 . . . . 1.0 112.312 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.33 116.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.681 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.7 p -110.09 2.75 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.98 145.91 24.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' CD ' HH22 ' A' ' 50' ' ' ARG . 35.0 tt0 -165.78 127.48 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.37 -0.932 . . . . 1.0 113.233 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -110.06 135.21 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.502 HH22 ' CB ' ' A' ' 72' ' ' GLU . 7.6 ptm180 -125.49 142.15 51.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.533 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.36 104.36 2.71 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.469 -1.052 . . . . 1.0 110.469 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.51 -89.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.502 ' CB ' HH22 ' A' ' 69' ' ' ARG . 22.2 pt-20 -177.31 29.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.153 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -66.61 -54.26 25.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.47 144.68 28.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.804 -1.184 . . . . 1.0 107.804 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.03 166.83 28.97 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.019 1.813 . . . . 1.0 112.58 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 t -92.21 136.7 32.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.096 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.751 ' H ' HH22 ' A' ' 50' ' ' ARG . 59.0 mt -111.24 -3.24 15.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.618 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.6 tp -55.77 139.83 44.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.287 0.565 . . . . 1.0 112.335 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -3.2 84.59 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.6 tp -101.48 128.62 47.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 1.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -85.16 122.79 29.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.491 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -104.82 132.88 20.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.283 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.74 151.21 28.08 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.134 1.889 . . . . 1.0 111.714 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.4 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.799 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.64 -22.73 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -55.26 -31.08 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.51 132.88 21.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.246 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 60.0 Cg_endo -80.55 -119.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.54 2.16 . . . . 1.0 112.313 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 86.4 tt0 -139.78 -69.0 0.42 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.823 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.62 -40.49 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.804 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.53 62.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -62.29 -31.24 71.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.572 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.4 -48.08 81.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 133' ' ' ARG . 63.9 mt -54.69 -39.1 67.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.824 -0.351 . . . . 1.0 110.529 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -61.1 -32.86 72.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -88.19 -12.59 43.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.109 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 tp -105.54 -46.97 4.04 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.336 0.865 . . . . 1.0 113.336 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.72 -1.15 13.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' ALA . 91.8 mt-30 27.58 65.61 0.09 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.97 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 33.8 m -97.48 -46.37 12.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.374 -2.454 . . . . 1.0 104.374 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.97 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 0.4 OUTLIER 57.83 55.36 5.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.139 -1.392 . . . . 1.0 114.208 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.506 ' C ' HD12 ' A' ' 103' ' ' ILE . 62.9 t -148.88 133.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.833 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.22 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.43 168.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' OD2' ' OE2' ' A' ' 107' ' ' GLU . 13.2 t0 -53.28 118.38 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.326 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 140' ' ' VAL . 24.4 t -55.46 -12.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.76 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 14.0 pt-20 -87.59 -38.36 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.846 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -57.56 -13.62 4.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.513 0.673 . . . . 1.0 110.211 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 50.84 56.31 8.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.958 -1.019 . . . . 1.0 113.399 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 m -94.51 134.15 37.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.34 -2.096 . . . . 1.0 105.34 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -129.44 142.21 50.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 114.963 1.468 . . . . 1.0 114.963 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.8 t . . . . . 0 N--CA 1.452 -0.366 0 CA-C-N 114.125 -1.398 . . . . 1.0 107.306 176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 134' ' ' PRO . 8.3 mmm180 . . . . . 0 CA--C 1.527 0.094 0 N-CA-C 110.306 -0.257 . . . . 1.0 110.306 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.456 ' C ' ' O ' ' A' ' 133' ' ' ARG . 2.8 Cg_exo -30.73 147.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.564 2.176 . . . . 1.0 111.753 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 135' ' ' VAL . 29.3 m -94.4 147.8 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 1.0 111.362 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.614 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -91.08 144.07 29.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.873 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.38 -27.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.196 1.93 . . . . 1.0 111.279 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.478 ' N ' ' O ' ' A' ' 136' ' ' ASP . 48.6 t -71.99 -57.5 4.24 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.726 ' CE1' HD13 ' A' ' 143' ' ' LEU . 42.0 t-80 -68.21 -27.83 66.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.688 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 106' ' ' VAL . 37.7 t -51.62 -52.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.323 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.541 ' CD2' ' HG ' ' A' ' 145' ' ' SER . 76.3 t60 -63.58 -41.28 98.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.256 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -45.43 -51.82 10.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.497 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.5 mp -72.07 -49.13 39.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 2.4 tmtt? -57.32 -42.62 82.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.446 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.541 ' HG ' ' CD2' ' A' ' 141' ' ' HIS . 20.9 m -53.65 -32.01 49.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.4 mtt -85.61 -2.48 58.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 1.0 109.188 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.88 24.24 74.29 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.314 -0.857 . . . . 1.0 112.353 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.553 HG21 ' ND1' ' A' ' 169' ' ' HIS . 3.2 m -106.66 123.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.27 -35.18 55.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -132.75 170.71 14.86 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.545 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.528 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.1 t -162.0 139.71 8.72 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.062 0.458 . . . . 1.0 112.158 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.32 138.96 50.4 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.8 m -133.61 157.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.496 0.665 . . . . 1.0 111.828 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.575 HG11 ' CB ' ' A' ' 188' ' ' ALA . 73.0 t -157.56 91.57 2.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.268 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.14 115.73 2.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.575 2.85 . . . . 1.0 113.931 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.98 105.7 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.825 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.6 ptm -131.15 147.43 52.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.22 0.533 . . . . 1.0 111.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.436 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.2 t60 -122.67 115.66 22.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 8.9 t60 64.77 -128.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.466 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.5 mm-40 -92.48 9.12 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -117.58 152.19 35.64 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.002 1.112 . . . . 1.0 114.002 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.96 116.92 32.84 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 114.498 -1.228 . . . . 1.0 108.873 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.436 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.5 m95 -95.94 -27.81 14.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.06 -170.42 27.91 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.247 -0.978 . . . . 1.0 112.029 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -141.38 131.91 25.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 1.0 111.19 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -96.02 141.55 29.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.92 135.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.566 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.6 m -121.15 150.61 41.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.027 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.553 ' ND1' HG21 ' A' ' 148' ' ' VAL . 92.5 m-70 -147.74 146.82 29.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.121 0.486 . . . . 1.0 111.005 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 17.0 t60 -156.36 152.46 27.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.408 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -84.66 65.02 8.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 1.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.314 -179.54 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.829 0.347 . . . . 1.0 110.758 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.2 m -95.22 150.35 20.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.19 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.6 -40.81 96.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.666 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.02 -54.9 35.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.405 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -66.97 -32.25 73.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 1.0 110.709 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.29 -38.22 76.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.507 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.23 -51.52 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.406 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.7 t -43.17 -48.79 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.8 m -74.63 -37.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.51 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 56.2 tt0 -47.76 -37.44 13.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.76 -40.2 63.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.393 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 48.8 tp -54.69 -32.88 60.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.682 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.575 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.26 -34.93 68.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.645 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.24 -39.15 69.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.794 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.96 -53.76 44.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -58.21 -41.86 81.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.176 -0.92 . . . . 1.0 109.825 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.0 p -51.71 -35.76 44.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 84.3 mt -78.29 -34.26 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.038 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.98 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.127 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.562 HD12 HD11 ' A' ' 31' ' ' LEU . 8.3 tp -63.56 -31.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.46 -56.96 4.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.873 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -55.41 -27.14 45.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.64 -34.53 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.301 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.402 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.7 tt0 -57.15 -39.98 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.101 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.2 mp -67.82 -56.07 10.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.05 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.9 m -51.53 -41.49 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 1.0 110.311 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.472 ' CD2' HD12 ' A' ' 195' ' ' ILE . 5.8 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 1.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.3 -43.17 99.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.256 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -69.1 -53.74 18.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . 28.4 mm -55.83 -46.74 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.7 -23.36 66.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.526 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.9 ttm180 -61.42 -36.02 79.16 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.639 -0.425 . . . . 1.0 109.993 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.44 -25.18 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.302 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.9 p -76.54 -47.0 24.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.546 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -52.79 -37.95 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.883 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 pt-20 -79.08 -32.36 44.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.91 -52.9 62.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.952 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.7 p -64.22 -44.4 97.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.902 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.6 tmm_? -48.98 -44.47 40.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.74 75.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -80.64 -50.66 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.751 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' THR . 1.9 tp -77.13 -8.16 57.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.081 0.467 . . . . 1.0 110.208 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 45.39 17.46 0.13 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.402 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 HG13 ' A' ' 51' ' ' VAL . 9.3 t -75.71 145.39 40.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.029 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.2 m-20 -56.47 -34.75 67.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.891 0.701 . . . . 1.0 112.891 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -150.66 126.83 10.57 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.204 -0.998 . . . . 1.0 113.523 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.534 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -141.77 130.43 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.939 -1.134 . . . . 1.0 107.939 176.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -144.35 161.26 39.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.58 -177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.81 133.45 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.055 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 72.1 t80 -118.14 117.42 29.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.019 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -100.81 169.07 9.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.5 t80 -133.9 138.66 45.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.161 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-20 -102.23 126.66 32.74 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.283 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.6 -27.09 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.722 2.281 . . . . 1.0 112.89 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.3 -9.68 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.004 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.79 21.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.868 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.53 139.77 32.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.308 0.554 . . . . 1.0 110.932 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -116.1 134.09 11.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.379 -1.088 . . . . 1.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -125.89 144.84 50.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.282 0.563 . . . . 1.0 112.229 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.09 126.2 61.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -113.1 4.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.31 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.7 tt0 -166.29 127.98 1.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.347 -0.941 . . . . 1.0 113.16 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.98 131.2 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -118.5 138.39 52.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.544 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.9 95.08 1.12 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.61 -89.21 0.05 OUTLIER Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.194 -1.162 . . . . 1.0 110.194 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.66 36.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.77 -0.372 . . . . 1.0 111.116 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -73.96 -54.38 8.04 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.0 mt -93.74 146.42 31.71 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.0 167.18 27.82 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.004 1.803 . . . . 1.0 112.518 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.5 p -88.14 139.51 30.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.108 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.606 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 34.8 mt -113.21 -2.45 14.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.593 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 45.1 tp -60.18 140.61 56.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.346 0.593 . . . . 1.0 112.25 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -4.27 86.23 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.391 -0.822 . . . . 1.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.6 mt -99.89 140.0 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 1.0 110.737 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -97.59 121.79 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.458 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 7.4 m-85 -106.74 131.41 21.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.26 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.68 152.55 29.35 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.145 1.897 . . . . 1.0 111.658 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.57 -20.98 66.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.773 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.62 -24.24 0.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.8 m-20 -53.39 -27.79 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 1.0 110.551 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 33.9 mt -120.98 132.34 24.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.243 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -80.59 -116.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.538 2.159 . . . . 1.0 112.329 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -126.09 -75.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.815 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -42.65 -37.1 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.775 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.9 -48.63 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.937 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -60.27 -32.09 70.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.519 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' LEU . 79.9 mtp180 -58.5 -46.2 87.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' GLN . 68.2 mt -56.26 -35.99 68.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.584 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 100' ' ' VAL . 8.7 m-85 -63.22 -42.8 99.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -87.43 -17.18 32.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.076 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.0 tp -106.7 -48.1 3.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -119.18 -7.47 10.29 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.583 0.957 . . . . 1.0 113.583 -175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 101' ' ' ARG . 92.2 mt-30 51.74 67.26 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 133' ' ' ARG . 35.2 m -69.2 63.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 99' ' ' GLN . 32.2 ptt180 -66.08 14.76 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.026 -1.443 . . . . 1.0 114.29 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.507 ' C ' HD12 ' A' ' 103' ' ' ILE . 2.0 t -147.63 128.08 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.488 -0.485 . . . . 1.0 111.758 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.6 mp -112.38 129.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.97 169.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.263 0.838 . . . . 1.0 113.263 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.69 120.85 5.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.304 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 106' ' ' VAL . 82.3 t -59.68 -15.39 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.806 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' GLN . 18.5 pt-20 -84.87 -38.25 19.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.866 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.89 3.03 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.378 0.609 . . . . 1.0 110.096 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.607 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 35.89 59.49 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.046 -0.979 . . . . 1.0 113.384 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 t -92.66 134.76 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -126.09 139.74 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.453 -0.316 0 CA-C-N 114.104 -1.407 . . . . 1.0 107.377 177.447 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.547 ' HB2' HG11 ' A' ' 100' ' ' VAL . 35.4 ttt85 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.699 0.285 . . . . 1.0 110.27 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.6 156.35 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 C-N-CA 122.601 2.201 . . . . 1.0 111.758 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 139' ' ' HIS . 27.1 m -99.39 140.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.027 0.442 . . . . 1.0 111.341 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 139' ' ' HIS . 3.5 m-20 -94.93 148.2 34.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.913 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -38.36 -26.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.215 1.943 . . . . 1.0 111.237 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -76.19 -47.22 24.91 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.3 t-80 -76.12 -28.81 57.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.653 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -50.56 -47.9 27.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.403 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 145' ' ' SER . 80.2 t60 -65.59 -42.16 92.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -45.93 -56.07 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.453 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 143' ' ' LEU . 50.7 mt -72.12 -50.44 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 44.3 tptt -57.56 -43.32 84.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.415 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' HIS . 33.9 t -53.78 -34.18 58.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.238 -0.652 . . . . 1.0 109.238 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.1 mtt -84.3 -7.33 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.2 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.45 23.87 76.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.9 122.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.97 31.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 151' ' ' SER . 1.5 t -142.98 170.42 15.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.573 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 30.9 t -162.04 140.31 9.04 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.205 -0.452 . . . . 1.0 112.173 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 152' ' ' LEU . 62.2 tp -114.64 116.36 28.61 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -117.07 158.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.447 0.641 . . . . 1.0 111.791 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 79.5 t -155.65 95.24 2.47 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.363 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.02 113.46 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.558 2.839 . . . . 1.0 113.928 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.2 106.62 5.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 17.1 ptm -133.57 146.41 50.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.917 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 78.5 t60 -117.68 115.64 25.46 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 34.0 m-70 59.1 -123.53 1.25 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.48 8.56 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.63 149.71 39.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.983 1.105 . . . . 1.0 113.983 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.0 tp -107.54 115.92 31.01 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.545 -1.207 . . . . 1.0 108.857 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 95.4 m95 -96.65 -30.41 13.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.965 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.56 -170.14 24.77 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.205 -0.998 . . . . 1.0 111.937 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -138.18 128.49 26.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 1.0 111.16 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -92.09 138.01 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.414 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 10.8 p -149.58 135.3 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.593 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 48' ' ' THR . 12.3 t -117.36 146.15 43.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.049 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.508 ' CE1' ' OG ' ' A' ' 151' ' ' SER . 78.1 m-70 -143.68 141.43 30.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 1.0 111.043 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -152.72 151.88 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.69 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.94 9.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.583 -0.28 . . . . 1.0 111.489 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 N--CA 1.467 0.388 0 C-N-CA 120.319 -0.552 . . . . 1.0 112.302 179.307 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.856 0.36 . . . . 1.0 110.748 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -93.19 143.12 26.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.284 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -62.14 -39.51 92.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.33 -54.95 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.61 -0.268 . . . . 1.0 111.366 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.63 -32.39 73.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.974 0.416 . . . . 1.0 110.765 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.64 -42.71 88.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.86 -50.85 70.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.45 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.19 -48.42 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.24 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -74.03 -39.23 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.571 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 57.3 tt0 -46.18 -35.57 5.22 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.3 tp -71.44 -38.37 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.685 -1.143 . . . . 1.0 109.35 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 9.8 tp -56.28 -31.04 63.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.686 . . . . 1.0 109.631 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.402 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.28 -36.41 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.602 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -59.57 -38.75 81.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.747 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -52.74 -55.15 24.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.82 -40.5 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.904 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 157' ' ' MET . 6.1 t -52.02 -35.53 47.24 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.2 mt -79.12 -36.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.081 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -47.22 63.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.062 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 31' ' ' LEU . 2.8 tp -61.0 -33.48 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -75.51 -53.9 7.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.967 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -55.34 -28.31 52.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -34.86 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.294 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -56.51 -40.25 74.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.198 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.6 mp -68.29 -56.59 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.172 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.4 m -58.32 -45.59 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 1.0 110.292 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.427 179.638 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 202' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.912 0.386 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.46 -50.55 73.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.317 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.77 -48.6 79.95 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.675 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -62.54 -29.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' THR . 96.6 mt -77.85 -20.93 52.2 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.4 mtp180 -72.44 -34.16 67.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.032 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.19 31.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.349 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 35' ' ' LEU . 2.5 t -74.29 -44.87 50.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.55 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.2 p -55.69 -36.02 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.59 -36.86 68.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.021 0.438 . . . . 1.0 110.872 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.55 -52.15 48.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.979 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.15 -51.22 75.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -49.17 -43.93 42.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.21 -47.43 14.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.91 -6.62 53.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.76 16.67 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.714 -0.676 . . . . 1.0 112.458 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -75.01 144.66 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.391 -0.524 . . . . 1.0 110.083 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.0 m-20 -57.21 -34.29 68.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.651 ' H ' HG22 ' A' ' 48' ' ' THR . 29.5 ttm180 -149.55 124.14 9.75 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.212 -0.995 . . . . 1.0 113.526 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 11.9 t -135.21 131.57 52.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -143.74 152.04 40.77 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.569 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.9 t -98.46 139.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.983 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.0 t80 -124.76 121.63 35.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.001 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -99.95 171.78 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.86 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -134.12 138.19 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.558 -0.457 . . . . 1.0 112.15 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 m-20 -104.81 149.33 37.39 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.269 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.21 -26.64 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.741 2.294 . . . . 1.0 112.946 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -76.54 -3.73 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.055 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.88 -10.29 57.13 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.032 -0.604 . . . . 1.0 112.811 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 95.9 m-70 -90.42 147.06 23.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.338 0.569 . . . . 1.0 110.941 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . -130.12 151.41 19.4 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -131.3 149.69 52.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.256 0.55 . . . . 1.0 112.274 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.73 115.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.023 -1.103 . . . . 1.0 108.023 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.69 -2.41 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.635 0.606 . . . . 1.0 112.635 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.15 20.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.7 tt0 -167.41 127.14 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.332 -0.947 . . . . 1.0 113.159 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 142.05 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.119 -1.067 . . . . 1.0 108.119 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' O ' ' NH2' ' A' ' 43' ' ' ARG . 35.9 ptt-85 -132.87 141.96 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.544 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.33 111.54 3.7 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.363 -1.095 . . . . 1.0 110.363 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.32 40.05 3.41 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.309 -1.116 . . . . 1.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 48.53 26.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.119 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -54.13 -56.34 19.05 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 10.7 mt -93.76 152.03 40.38 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.542 ' C ' HH22 ' A' ' 50' ' ' ARG . 56.4 Cg_endo -69.58 156.97 62.36 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.114 1.876 . . . . 1.0 112.573 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -76.44 113.98 14.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.611 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 56.5 mt -87.39 -6.76 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.595 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.2 tp -60.25 139.98 57.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.305 0.574 . . . . 1.0 112.209 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.82 -3.51 84.84 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.8 mt -99.58 136.61 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 1.0 110.737 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 81' ' ' THR . 15.4 t -94.3 120.62 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.482 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' GLY . 7.3 m-85 -108.73 133.26 20.71 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.283 178.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 149.29 34.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.147 1.898 . . . . 1.0 111.719 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.34 -25.63 64.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.779 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.01 -20.95 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 84' ' ' ALA . 32.6 t70 -51.78 -23.38 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.0 110.608 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 87' ' ' ILE . 29.4 mt -127.15 132.73 24.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.58 -108.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.53 2.154 . . . . 1.0 112.319 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -142.58 -72.46 0.31 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.1 pt-20 -41.42 -43.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.721 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 90' ' ' GLU . . . -63.65 -49.48 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -58.23 -29.08 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.2 mtm180 -55.81 -47.63 76.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.218 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 94' ' ' LEU . 8.4 mp -54.45 -38.68 66.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.572 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.637 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.4 m-85 -60.03 -24.99 64.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.227 0.537 . . . . 1.0 109.572 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 97' ' ' LEU . 60.5 mtp85 -94.74 -19.02 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.123 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.0 mp -109.5 -45.51 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.03 -11.08 15.37 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.581 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 82.7 mt-30 25.35 70.77 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.082 1.141 . . . . 1.0 114.082 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.711 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -141.77 -55.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 104.44 -2.43 . . . . 1.0 104.44 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.711 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.6 mmp_? 52.84 103.85 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.038 -1.437 . . . . 1.0 114.297 173.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 102' ' ' VAL . 19.2 m -144.77 132.66 16.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.768 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 135' ' ' VAL . 58.3 mt -108.64 123.86 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.71 168.08 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.58 120.43 5.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.242 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -56.73 -10.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -86.61 -37.08 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.39 -17.84 55.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.372 0.606 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 53.44 60.43 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.056 -0.974 . . . . 1.0 113.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -93.51 135.16 35.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.0 mtp-105 -130.06 142.44 50.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.479 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 1.5 m . . . . . 0 N--CA 1.452 -0.326 0 CA-C-N 114.189 -1.368 . . . . 1.0 107.357 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 15.8 mmm180 . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.69 0.281 . . . . 1.0 110.294 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.479 ' O ' ' OG ' ' A' ' 112' ' ' SER . 73.7 Cg_exo -47.72 145.36 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.536 2.157 . . . . 1.0 111.774 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 139' ' ' HIS . 15.7 t -128.46 135.34 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.994 0.426 . . . . 1.0 111.354 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -44.2 154.73 0.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.883 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -56.32 -7.16 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.243 1.962 . . . . 1.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 136' ' ' ASP . 42.0 t -58.42 -50.58 73.2 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.569 ' ND1' HD12 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -73.32 -27.38 61.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.329 -0.851 . . . . 1.0 110.689 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.433 ' N ' ' CD2' ' A' ' 139' ' ' HIS . 22.3 t -52.01 -54.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 1.0 110.362 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 145' ' ' SER . 10.2 m80 -68.99 -46.06 69.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.215 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -47.43 -55.96 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.48 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.569 HD12 ' ND1' ' A' ' 139' ' ' HIS . 89.1 mt -66.83 -50.48 62.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.514 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 42.7 tptt -57.56 -42.09 82.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 m -54.28 -34.92 61.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mtt -84.73 -3.77 58.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.242 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.97 25.84 70.47 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.261 -0.881 . . . . 1.0 112.324 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 150' ' ' SER . 14.2 t -106.71 114.92 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.011 0.405 . . . . 1.0 109.945 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.78 -30.1 61.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 148' ' ' VAL . 97.4 p -138.67 170.14 16.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.615 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 p -161.85 130.86 4.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.46 114.97 29.23 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.7 p -113.42 157.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.455 0.645 . . . . 1.0 111.853 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.9 t -157.7 124.54 2.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.281 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.33 149.87 22.06 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.602 2.868 . . . . 1.0 113.906 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.52 107.43 15.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.409 -0.814 . . . . 1.0 109.799 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.581 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 81.5 mtp -121.23 140.63 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 111.834 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 22.2 t-80 -118.15 113.9 22.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 46.9 t60 68.08 -129.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 58.8 mt-30 -95.33 8.78 42.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -120.99 159.84 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.963 1.097 . . . . 1.0 113.963 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.71 117.97 34.91 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.543 -1.208 . . . . 1.0 108.896 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 94.0 m95 -96.24 -28.47 14.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.95 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.2 -173.95 26.29 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.215 -0.993 . . . . 1.0 112.006 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -140.99 126.38 18.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 1.0 111.278 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 167' ' ' VAL . 0.6 OUTLIER -95.14 135.61 36.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 1.011 ' N ' HD12 ' A' ' 166' ' ' LEU . 85.3 t -145.55 137.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.567 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.527 ' C ' ' ND1' ' A' ' 169' ' ' HIS . 20.6 m -125.26 144.49 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.33 152.82 36.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 1.0 111.013 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.517 ' NE2' ' OG ' ' A' ' 150' ' ' SER . 1.1 p-80 -158.15 154.08 26.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.03 67.91 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.421 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.348 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.86 0.362 . . . . 1.0 110.789 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -92.31 150.04 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.304 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 179' ' ' GLU . 12.3 pt20 -67.34 -42.94 82.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.625 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.449 ' N ' ' CG ' ' A' ' 178' ' ' GLN . 79.1 mm-40 -61.74 -55.14 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 111.359 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.33 -30.69 71.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 1.0 110.698 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.3 tp -61.72 -34.83 76.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.499 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.49 -53.7 21.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.376 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 49.3 t -44.34 -47.39 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.226 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.24 -37.44 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -48.63 -37.14 17.44 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 21.1 tp -72.79 -40.62 65.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.71 -1.132 . . . . 1.0 109.3 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.22 -32.29 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.633 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.03 -37.24 64.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.671 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -56.8 -41.54 77.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.758 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -52.63 -54.31 34.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.69 -41.55 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.837 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.1 m -50.46 -29.67 10.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.2 mm -77.26 -42.35 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.049 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.05 88.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.1 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.09 -31.31 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.485 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.33 -56.29 4.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -55.04 -28.88 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.56 -34.2 53.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.304 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -58.42 -38.59 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 200' ' ' LEU . 2.4 tt -67.63 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.036 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.3 t -69.77 -55.57 9.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 1.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 31' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.435 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.502 HD23 ' NH1' ' A' ' 55' ' ' ARG . 61.0 tp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.903 0.382 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -51.86 -49.5 62.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.22 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.43 -46.56 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 mp -59.9 -40.03 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.97 -22.04 58.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.693 -0.403 . . . . 1.0 111.504 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.1 ttm-85 -68.57 -36.77 79.22 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.652 -0.419 . . . . 1.0 109.991 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.01 -29.3 39.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.369 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.1 p -71.14 -48.39 52.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 36' ' ' ARG . 2.8 p -54.05 -35.16 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.842 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.12 -39.89 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.88 -40.65 98.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.932 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.32 -51.21 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.867 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HD3' ' HB1' ' A' ' 68' ' ' ALA . 23.4 ttp85 -50.78 -44.94 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.909 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.4 79.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.848 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -79.56 -51.44 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.751 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.11 -6.51 53.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.009 0.433 . . . . 1.0 110.081 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.1 16.99 0.54 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.695 -0.684 . . . . 1.0 112.45 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -73.73 141.66 46.34 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 70' ' ' GLY . 78.9 m-20 -60.13 -29.21 68.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 48' ' ' THR . 59.8 ttp180 -154.4 119.07 4.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 119.17 -1.012 . . . . 1.0 113.578 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.85 136.09 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -145.63 160.87 41.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.41 -0.516 . . . . 1.0 111.579 -177.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.9 t -97.76 137.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.999 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.402 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.9 t80 -121.29 119.35 31.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 1.0 111.031 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' NH1' HD23 ' A' ' 31' ' ' LEU . 63.8 mtm180 -99.97 170.47 8.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 6.7 t80 -134.96 137.61 43.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.061 0.458 . . . . 1.0 112.172 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -103.14 148.59 35.87 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.325 179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.92 -23.87 67.95 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.739 2.293 . . . . 1.0 112.902 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.61 -2.9 41.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.27 -12.71 51.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.954 -0.641 . . . . 1.0 112.876 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -88.79 146.2 25.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.326 0.563 . . . . 1.0 110.95 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -125.35 145.58 15.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.467 -1.053 . . . . 1.0 110.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -128.36 146.96 50.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.291 0.567 . . . . 1.0 112.341 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.1 118.2 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 65' ' ' VAL . 8.6 p -115.12 9.2 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.9 142.8 23.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 48.9 tt0 -165.99 126.67 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.368 -0.933 . . . . 1.0 113.181 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.66 140.66 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 36.4 ptt85 -132.2 143.38 49.91 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.203 -0.599 . . . . 1.0 111.539 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.84 106.94 3.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.366 -1.094 . . . . 1.0 110.366 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 55.2 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 70' ' ' GLY . 44.7 tt0 -176.94 35.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.089 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -72.94 -51.98 16.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -95.07 121.16 63.05 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 107.803 -1.184 . . . . 1.0 107.803 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.39 162.92 11.23 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.054 1.836 . . . . 1.0 112.557 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.1 t -83.83 135.16 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.454 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.3 mt -109.64 -7.66 15.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.592 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 tp -49.4 138.06 13.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.347 0.594 . . . . 1.0 112.288 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.54 -4.04 79.34 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.063 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -98.22 115.22 27.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 1.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.617 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -78.8 126.41 30.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.445 -178.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 80' ' ' LEU . 61.5 m-85 -108.26 139.82 21.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.82 152.28 19.28 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.131 1.887 . . . . 1.0 111.675 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -59.8 -26.45 65.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.819 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.05 -21.7 1.05 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 49.0 p-10 -58.0 -29.67 65.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.685 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.4 mm -110.17 99.8 41.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.228 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.7 Cg_exo -48.41 -126.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.091 . . . . 1.0 112.3 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.79 -60.64 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.811 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.59 -41.02 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.758 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.18 -42.96 99.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 1.0 110.932 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.685 ' HE ' HG21 ' A' ' 87' ' ' ILE . 34.9 ttm180 -63.82 -28.86 70.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.591 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 97' ' ' LEU . 31.9 mmt180 -56.73 -53.77 53.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.286 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ALA . 32.3 mt -54.02 -36.01 62.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.651 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -66.49 -35.95 81.55 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -85.05 -16.15 41.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.114 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.1 mp -106.04 -42.84 4.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.25 -4.58 13.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.527 0.936 . . . . 1.0 113.527 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.1 mt-30 27.93 69.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.05 1.13 . . . . 1.0 114.05 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 58.3 t -110.73 -50.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.417 -2.438 . . . . 1.0 104.417 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.693 HH12 ' NE2' ' A' ' 185' ' ' GLN . 10.5 mtm180 63.72 72.02 0.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.088 -1.414 . . . . 1.0 114.269 172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.597 ' C ' HD12 ' A' ' 103' ' ' ILE . 87.7 t -152.1 133.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.782 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -107.41 127.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 105' ' ' ASP . 12.7 p -83.01 167.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.266 0.839 . . . . 1.0 113.266 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.651 ' N ' HG22 ' A' ' 104' ' ' VAL . 5.9 m-20 -54.62 120.03 6.12 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.315 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.53 -10.99 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.771 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 17.4 pt-20 -85.38 -40.42 16.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.876 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.23 -12.61 3.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.433 0.635 . . . . 1.0 110.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 49.4 52.0 15.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.051 -0.977 . . . . 1.0 113.396 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.6 m -94.44 136.56 34.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -128.12 141.71 51.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.432 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 4.2 t . . . . . 0 N--CA 1.452 -0.338 0 CA-C-N 114.098 -1.41 . . . . 1.0 107.323 177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.06 142.86 7.92 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.56 2.174 . . . . 1.0 111.768 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -107.26 117.54 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.016 0.436 . . . . 1.0 111.312 -177.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -39.85 153.95 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.947 177.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -56.96 -20.43 36.58 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.237 1.958 . . . . 1.0 111.233 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.6 t -65.79 -46.97 76.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.017 -0.734 . . . . 1.0 109.017 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.806 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -74.7 -27.94 60.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.632 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.48 -54.72 13.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.318 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.93 -44.48 84.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.279 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -44.49 -51.69 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.482 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.78 -47.03 50.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.522 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.8 OUTLIER -59.45 -42.06 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.503 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.0 p -53.77 -30.65 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.6 mtt -86.91 -0.47 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.238 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.97 24.41 76.48 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.22 -0.9 . . . . 1.0 112.36 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 150' ' ' SER . 11.4 t -106.9 122.57 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.15 -26.27 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.1 p -142.58 171.87 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.573 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.02 136.78 12.4 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.51 136.23 52.28 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -135.02 155.41 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.436 0.636 . . . . 1.0 111.845 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 153' ' ' VAL . 65.4 t -157.67 90.0 2.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.22 140.24 52.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.552 2.835 . . . . 1.0 113.923 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.1 mt -98.52 105.65 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.799 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 81.3 mtp -119.42 141.13 49.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.553 . . . . 1.0 111.818 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.45 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 42.0 t-80 -116.61 112.03 20.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.431 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 4.9 t60 62.86 -123.7 0.63 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.431 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 17.2 pt20 -94.64 7.72 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 162' ' ' LEU . 26.4 tp10 -117.23 153.4 32.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 161' ' ' GLU . 6.5 tt -107.72 117.36 33.9 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 114.55 -1.205 . . . . 1.0 108.816 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.0 m95 -96.97 -27.87 14.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.858 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.06 23.53 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -141.59 127.81 19.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.0 111.263 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.3 tp -92.92 134.06 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.55 134.84 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.578 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.78 142.43 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.99 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -134.56 132.17 38.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 1.0 110.96 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 19.0 t60 -168.53 161.41 11.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.766 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.709 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -46.22 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.428 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.661 ' N ' ' OE1' ' A' ' 172' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 120.391 -0.523 . . . . 1.0 112.343 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.856 0.36 . . . . 1.0 110.795 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -106.43 143.95 33.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.254 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.79 -28.3 66.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.617 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.14 -54.58 27.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.594 -0.275 . . . . 1.0 111.325 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.58 -33.88 76.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.944 0.402 . . . . 1.0 110.688 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.66 -39.99 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.501 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.548 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 78.5 mm-40 -61.98 -51.96 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.352 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.1 t -45.27 -48.95 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 187' ' ' LEU . 63.9 t -74.27 -38.71 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.693 ' NE2' HH12 ' A' ' 101' ' ' ARG . 56.9 tt0 -45.93 -36.02 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.59 -39.68 67.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.764 -1.107 . . . . 1.0 109.333 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 184' ' ' VAL . 35.0 tp -54.95 -32.92 61.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.85 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.655 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -56.91 -39.36 74.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.697 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -53.38 -53.91 44.37 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.2 t -56.7 -43.67 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.36 -0.836 . . . . 1.0 109.869 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -51.7 -37.43 50.73 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.2 mt -78.39 -32.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.025 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.36 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 1.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.6 pp -66.62 -26.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.52 -55.71 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.846 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.26 -26.88 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.95 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.48 -35.73 58.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -56.94 -39.34 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.221 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.5 tp -66.97 -56.31 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.119 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.9 m -47.16 -39.16 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 1.0 110.307 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.081 -0.961 . . . . 1.0 110.47 179.78 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD21 ' NH2' ' A' ' 55' ' ' ARG . 4.4 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.823 0.344 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 40.6 p-10 -65.33 -37.88 88.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.313 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.0 mt-30 -73.3 -53.71 10.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.799 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -57.2 -40.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 69.9 mt -71.29 -33.28 69.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.631 -0.427 . . . . 1.0 111.589 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -49.53 -37.96 28.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.634 -0.426 . . . . 1.0 109.993 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.16 -26.4 52.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.35 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.5 p -74.85 -44.33 49.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.557 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 53' ' ' VAL . 56.8 t -59.13 -38.89 76.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.548 . . . . 1.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.27 -38.22 56.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.55 -49.35 75.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.995 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.92 -47.99 90.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.942 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.2 ttp180 -49.71 -43.99 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.853 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -81.52 -47.95 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.804 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -78.0 -7.08 56.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 1.0 110.084 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 50.18 19.51 2.76 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.668 -0.696 . . . . 1.0 112.494 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.703 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.9 m -76.91 141.9 40.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.065 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.0 m-20 -62.6 -28.45 69.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.703 ' H ' HG22 ' A' ' 48' ' ' THR . 60.5 ttp180 -152.98 124.87 7.88 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.145 -1.022 . . . . 1.0 113.54 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -146.7 136.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -146.81 162.45 38.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.566 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 39' ' ' VAL . 70.6 t -97.71 136.47 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.035 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -122.89 121.67 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.024 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.854 ' NH2' HD11 ' A' ' 195' ' ' ILE . 36.6 ttm-85 -101.47 168.93 9.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.85 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.457 ' N ' ' CG ' ' A' ' 55' ' ' ARG . 71.0 t80 -131.2 136.7 48.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.053 0.454 . . . . 1.0 112.124 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.5 148.74 35.63 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.379 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.69 -22.53 64.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.728 2.286 . . . . 1.0 112.94 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -79.69 -3.09 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.544 -0.463 . . . . 1.0 111.041 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.7 -10.42 52.86 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.815 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -90.19 145.83 24.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.377 0.588 . . . . 1.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.61 142.92 14.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.3 p -128.39 147.5 50.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.152 0.501 . . . . 1.0 112.346 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.7 t -101.14 121.35 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 m -108.98 1.84 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.468 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.62 149.12 24.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.6 tt0 -166.83 127.18 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.394 -0.922 . . . . 1.0 113.248 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 133.89 54.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.549 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 58.6 mtm180 -117.45 139.74 50.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.22 107.05 2.56 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.32 18.17 0.06 OUTLIER Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.268 -1.133 . . . . 1.0 110.268 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' GLY . 43.6 tt0 70.57 30.91 3.01 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.115 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 36.7 ttm180 -57.83 -59.57 5.03 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.8 164.8 20.67 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.81 171.75 17.43 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.043 1.829 . . . . 1.0 112.533 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -90.42 121.37 32.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -92.76 -11.85 32.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.624 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 tp -50.4 137.23 19.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.17 82.37 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.384 -0.825 . . . . 1.0 111.051 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 81' ' ' THR . 4.3 tt -97.68 115.9 28.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 1.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.625 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.0 t -76.46 122.5 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.465 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.75 132.16 21.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.318 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.11 152.39 27.73 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.195 1.93 . . . . 1.0 111.698 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.36 -21.14 66.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.81 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.73 -22.29 0.14 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.3 m-20 -48.44 -23.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.331 . . . . 1.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.544 ' CD1' HH21 ' A' ' 92' ' ' ARG . 2.9 pt -133.67 142.04 42.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -83.55 -104.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.525 2.15 . . . . 1.0 112.346 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HA ' HH12 ' A' ' 92' ' ' ARG . 82.3 tt0 -147.64 -64.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 1.0 111.788 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.04 -41.12 46.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.716 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.63 99.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.96 0.41 . . . . 1.0 111.005 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.544 HH21 ' CD1' ' A' ' 87' ' ' ILE . 23.6 ttm105 -64.54 -27.93 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' LEU . 68.7 mtm180 -58.53 -53.56 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.327 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.665 ' N ' HD12 ' A' ' 94' ' ' LEU . 8.4 mp -52.73 -41.33 63.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.55 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 4.2 m-85 -64.1 -35.91 82.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -85.2 -8.96 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.072 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.4 tp -105.86 -43.34 4.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.42 -0.08 12.62 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 98' ' ' ALA . 93.6 mt-30 28.45 68.28 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 t -117.73 -48.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.381 -2.452 . . . . 1.0 104.381 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HD2' HH11 ' A' ' 101' ' ' ARG . 6.2 mtp180 50.57 76.5 0.15 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.26 171.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.537 ' C ' HD12 ' A' ' 103' ' ' ILE . 11.2 m -145.15 139.17 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.757 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 103' ' ' ILE . 2.8 mp -107.24 125.2 63.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 105' ' ' ASP . 24.3 t -83.49 166.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 113.256 0.835 . . . . 1.0 113.256 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.673 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.1 m-20 -48.85 120.32 3.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.252 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.1 m -57.77 -12.18 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.764 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -87.01 -37.33 17.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.46 -16.19 44.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.372 0.606 . . . . 1.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 53.06 60.32 3.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.002 -0.999 . . . . 1.0 113.427 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.1 m -92.89 133.98 35.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -128.35 141.67 51.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.311 0 CA-C-N 114.073 -1.422 . . . . 1.0 107.298 176.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.487 ' NH1' ' CD2' ' A' ' 94' ' ' LEU . 2.5 mmp_? . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.711 0.291 . . . . 1.0 110.338 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' O ' ' OG ' ' A' ' 112' ' ' SER . 88.2 Cg_exo -46.0 145.21 5.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.525 2.15 . . . . 1.0 111.797 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.777 HG21 ' ND1' ' A' ' 139' ' ' HIS . 6.5 m -118.1 127.01 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 1.0 111.361 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -43.12 139.39 2.29 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.9 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -39.91 -46.8 3.85 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.163 1.909 . . . . 1.0 111.24 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 9.9 p -43.83 -41.68 5.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.777 ' ND1' HG21 ' A' ' 135' ' ' VAL . 13.1 t-80 -79.94 -38.52 32.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.368 -0.833 . . . . 1.0 110.687 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.6 t -50.9 -50.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.3 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 77.0 t60 -64.13 -39.86 94.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.253 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -43.95 -47.48 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.447 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.78 -45.4 61.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.511 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -60.17 -42.49 95.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.492 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.8 m -54.17 -33.33 57.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.6 mtt -86.99 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.156 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.26 26.16 66.75 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.291 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 169' ' ' HIS . 48.0 t -106.74 120.87 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.33 33.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 172' ' ' GLU . 37.7 m -127.89 153.99 46.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.155 -0.618 . . . . 1.0 111.585 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -143.87 129.55 19.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.052 0.453 . . . . 1.0 112.178 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.96 141.78 50.97 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' CG2' ' A' ' 154' ' ' VAL . 2.3 m -129.65 155.42 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.845 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 2.1 t -150.72 97.82 3.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.891 -1.05 . . . . 1.0 109.287 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.84 139.52 36.65 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.536 2.824 . . . . 1.0 113.889 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.24 104.52 16.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.718 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 88.3 mtp -119.06 141.07 49.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.843 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 39.3 t-80 -125.31 112.93 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.495 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 26.4 t60 75.08 -135.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.495 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 25.4 mt-30 -96.16 12.38 31.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.412 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 63.7 mt-10 -120.19 161.43 21.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.79 116.83 32.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.544 -1.207 . . . . 1.0 108.851 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.4 m95 -99.04 -29.3 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.847 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.96 179.7 28.31 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.217 -0.992 . . . . 1.0 111.927 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.1 tp -139.96 130.68 25.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 1.0 111.193 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.9 tp -99.6 145.27 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 167' ' ' VAL . 7.1 p -151.62 125.81 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.556 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -110.51 143.25 41.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.049 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.763 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -141.95 143.53 33.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 19.2 t60 -153.29 153.24 32.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.657 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.445 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.59 68.46 9.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.433 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.1 tp10 . . . . . 0 N--CA 1.466 0.359 0 C-N-CA 120.401 -0.52 . . . . 1.0 112.302 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 . . . . . 0 N--CA 1.461 0.081 0 CA-C-O 120.913 0.387 . . . . 1.0 110.804 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -91.21 143.44 26.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.234 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.57 -55.3 28.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.661 0.267 . . . . 1.0 111.388 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -65.07 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 1.0 110.653 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.71 -30.47 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.576 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -73.88 -52.67 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.406 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.94 -45.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.283 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' LEU . 5.4 p -73.18 -39.38 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -49.8 -36.59 26.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.5 tp -69.88 -31.22 68.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.704 -1.134 . . . . 1.0 109.41 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.6 tt -63.32 -28.17 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.72 70.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.664 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -53.36 -44.61 68.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -52.56 -55.53 21.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.047 -0.724 . . . . 1.0 109.047 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.66 -40.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.903 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.8 m -50.22 -29.13 8.8 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.451 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 11.2 mm -77.28 -48.53 24.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.064 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.63 87.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.084 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.854 HD11 ' NH2' ' A' ' 55' ' ' ARG . 4.0 tp -59.91 -37.48 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 195' ' ' ILE . . . -72.97 -51.64 17.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.848 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 193' ' ' ILE . 2.9 mp0 -55.61 -26.59 44.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.81 55.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -59.08 -41.37 87.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.05 -60.14 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.024 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.2 p -58.97 -43.84 91.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.422 179.793 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 198' ' ' ALA . 32.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.886 0.374 . . . . 1.0 110.555 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.8 p-10 -63.66 -44.63 93.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.251 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 93.8 mt-30 -67.0 -53.19 33.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mt -55.24 -48.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.0 112.629 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.81 -25.25 68.16 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.641 -0.423 . . . . 1.0 111.609 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.562 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -57.42 -36.63 71.59 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.636 -0.426 . . . . 1.0 110.036 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.68 41.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.391 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -73.57 -48.4 33.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.556 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.2 p -53.3 -35.12 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 95.4 mt-10 -77.76 -33.71 52.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.44 -50.51 71.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.978 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.4 p -64.24 -45.56 95.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.91 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' N ' HG13 ' A' ' 42' ' ' VAL . 18.3 ttt-85 -49.09 -46.42 44.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.05 82.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.782 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -78.31 -52.11 9.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.761 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.55 -5.61 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 1.0 110.167 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.75 18.0 0.33 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.599 -0.728 . . . . 1.0 112.399 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -75.86 144.0 41.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 1.0 110.14 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 70' ' ' GLY . 97.4 m-20 -64.29 -26.81 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.87 0.693 . . . . 1.0 112.87 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 48' ' ' THR . 24.4 ttt180 -149.98 121.27 7.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.103 -1.039 . . . . 1.0 113.476 -178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 3.2 t -140.32 130.53 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.957 -1.127 . . . . 1.0 107.957 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -143.33 155.32 44.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.626 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.79 137.44 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.009 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -121.36 119.7 32.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -99.76 170.29 8.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.871 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 48.9 t80 -135.05 141.66 46.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.155 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.52 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 4.0 m-20 -104.0 150.47 38.31 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.269 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.49 -29.18 53.31 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.699 2.266 . . . . 1.0 112.901 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.47 -4.99 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.586 -0.446 . . . . 1.0 110.935 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.36 -14.54 36.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.803 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 99.2 m-70 -84.65 143.79 29.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.398 0.599 . . . . 1.0 110.959 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -119.67 139.28 13.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -125.08 143.85 50.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.289 0.566 . . . . 1.0 112.25 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.27 120.16 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.61 3.47 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.52 149.87 24.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 79.2 tt0 -166.15 125.46 1.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.433 -0.907 . . . . 1.0 113.266 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.13 135.86 47.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 7.1 ptp85 -129.78 141.97 50.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.552 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.36 106.32 3.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.454 -1.058 . . . . 1.0 110.454 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.19 -88.55 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.261 -1.136 . . . . 1.0 110.261 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.7 tt0 -177.36 32.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.064 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.57 -33.94 73.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.73 142.63 29.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 64.0 Cg_endo -73.36 170.35 20.1 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.077 1.851 . . . . 1.0 112.535 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 14.9 m -93.53 137.93 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.189 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.536 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.8 mt -109.63 -3.9 16.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.641 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 14.2 tp -56.69 137.75 53.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.278 0.561 . . . . 1.0 112.286 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.97 86.03 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 81' ' ' THR . 2.8 tt -101.61 118.77 37.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.907 0.384 . . . . 1.0 110.746 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -76.69 122.43 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.463 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 m-85 -106.26 133.69 20.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.336 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.7 152.28 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.175 1.917 . . . . 1.0 111.71 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.9 -23.39 67.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.796 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.86 -22.93 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -54.05 -21.72 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.407 ' HB ' HH21 ' A' ' 92' ' ' ARG . 18.1 mt -129.0 132.83 24.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.302 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.17 -107.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.531 2.154 . . . . 1.0 112.341 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.11 -69.09 0.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.815 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -42.34 -42.38 3.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.14 -52.96 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.976 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.407 HH21 ' HB ' ' A' ' 87' ' ' ILE . 35.4 ttm180 -56.44 -30.37 62.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.566 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -57.47 -45.11 85.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.231 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 98' ' ' ALA . 50.5 mt -54.96 -36.68 65.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.582 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.624 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.6 m-85 -61.17 -26.53 67.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 97' ' ' LEU . 48.0 mtp85 -93.87 -18.23 22.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.12 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.1 mp -109.44 -46.86 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.374 0.879 . . . . 1.0 113.374 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -107.96 -10.87 15.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -174.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.596 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 79.8 mt-30 26.12 69.29 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.69 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -137.46 -54.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.69 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.4 mmp_? 49.57 101.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.111 -1.404 . . . . 1.0 114.288 171.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.61 136.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.464 -0.494 . . . . 1.0 111.743 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 70.8 mt -107.61 123.16 62.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.688 HG12 ' N ' ' A' ' 105' ' ' ASP . 23.4 t -84.17 168.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.688 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.0 m-20 -50.4 118.48 3.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.262 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.9 p -55.54 -11.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.313 -0.858 . . . . 1.0 110.75 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 109' ' ' GLN . 4.8 pt-20 -88.61 -35.86 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.915 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.59 0.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.4 0.619 . . . . 1.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 107' ' ' GLU . 10.1 pt20 35.35 60.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.106 -0.952 . . . . 1.0 113.504 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -93.96 134.99 35.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.384 -2.08 . . . . 1.0 105.384 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -131.09 141.85 50.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-N 114.184 -1.371 . . . . 1.0 107.354 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.514 HH21 HH22 ' A' ' 101' ' ' ARG . 11.3 tpp180 . . . . . 0 CA--C 1.526 0.057 0 CA-C-O 120.715 0.293 . . . . 1.0 110.336 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 133' ' ' ARG . 3.5 Cg_exo -30.36 143.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.615 2.21 . . . . 1.0 111.774 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.599 HG11 ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -104.8 115.69 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.107 0.479 . . . . 1.0 111.363 -178.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -40.27 147.14 0.38 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.912 178.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.7 Cg_endo -52.86 -12.41 1.94 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.221 1.947 . . . . 1.0 111.258 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.0 t -77.02 -39.32 50.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.599 ' CE1' HG11 ' A' ' 135' ' ' VAL . 3.3 t-80 -83.34 -34.2 25.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.366 -0.834 . . . . 1.0 110.633 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 137' ' ' PRO . 2.9 m -53.94 -45.88 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.299 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.553 ' N ' HG23 ' A' ' 140' ' ' VAL . 42.7 t-80 -67.41 -44.92 77.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.197 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -46.59 -51.16 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.47 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.3 -49.22 57.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 147' ' ' GLY . 17.8 tptp -58.0 -40.25 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.449 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 34.9 m -53.73 -33.47 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.62 0.88 44.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.191 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.62 23.96 75.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.247 -0.888 . . . . 1.0 112.334 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 170' ' ' HIS . 25.3 t -107.46 121.8 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.913 -0.402 . . . . 1.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.72 49.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' HG12 ' A' ' 148' ' ' VAL . 32.4 t -135.53 170.12 16.45 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.112 -0.635 . . . . 1.0 111.593 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.7 t -162.05 139.82 8.72 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 35.9 tp -115.33 133.58 55.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.4 p -132.37 155.58 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.06 -0.656 . . . . 1.0 111.818 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 77.2 t -156.53 109.93 2.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.334 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.62 114.17 3.42 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.634 2.889 . . . . 1.0 113.87 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.51 107.02 7.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.808 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.596 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 17.0 ptm -132.15 144.19 50.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.824 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 70.8 t60 -114.31 114.73 26.33 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 46.8 t-80 61.48 -123.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.507 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.2 tt0 -94.04 6.16 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.901 0.334 . . . . 1.0 111.901 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 43.9 mp0 -115.65 149.82 37.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.991 1.108 . . . . 1.0 113.991 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.28 116.83 32.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.562 -1.199 . . . . 1.0 108.912 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -99.22 -30.47 12.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.917 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.26 -174.1 24.76 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.187 -1.006 . . . . 1.0 111.958 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 tp -141.09 131.11 24.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 1.0 111.201 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -93.7 136.21 34.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.56 ' CG1' ' NE2' ' A' ' 169' ' ' HIS . 31.0 t -148.52 122.74 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.527 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -108.09 143.27 37.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.971 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.56 ' NE2' ' CG1' ' A' ' 167' ' ' VAL . 54.3 m-70 -137.03 143.2 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.096 0.474 . . . . 1.0 111.048 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.539 ' O ' HG13 ' A' ' 148' ' ' VAL . 2.5 p-80 -152.95 151.92 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.703 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.56 68.97 9.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.403 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 . . . . . 0 N--CA 1.465 0.324 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.102 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 1.0 110.799 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 t -96.26 139.2 32.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -63.17 -40.34 97.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.671 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -65.49 -55.73 16.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.31 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.89 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 1.0 110.64 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.2 tp -59.56 -40.23 86.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.539 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.76 -50.84 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.416 -0.357 . . . . 1.0 111.358 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.39 -47.16 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 75.3 t -73.39 -40.71 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 57.0 tt0 -45.99 -34.83 4.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.67 -38.07 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.404 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 10.9 tp -54.84 -31.36 59.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.698 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.55 70.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.648 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -57.19 -42.1 80.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.72 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -52.7 -55.35 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.136 -0.69 . . . . 1.0 109.136 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.07 -43.17 84.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.826 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 p -52.0 -37.27 52.64 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.1 mt -78.11 -33.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.079 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.71 66.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.037 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.7 pp -67.13 -23.78 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.53 -56.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.794 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.2 -26.9 63.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.909 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -76.41 -36.27 58.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.263 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.2 -38.13 70.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.8 mt -68.08 -55.94 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.055 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.2 p -53.0 -41.16 64.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.281 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.02 -0.99 . . . . 1.0 110.423 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 1.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 65' ' ' VAL . 64.1 t0 -53.6 -53.07 56.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.02 -46.42 90.81 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 38' ' ' THR . 18.4 mm -60.63 -38.98 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.38 -21.15 60.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.555 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -70.32 -40.21 74.31 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.034 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.43 -33.56 62.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.349 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 34' ' ' ILE . 41.2 p -68.17 -46.39 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.573 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 68' ' ' ALA . 5.2 t -56.18 -38.89 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.874 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.64 -37.43 56.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -57.43 -53.14 61.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.951 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 43' ' ' ARG . 10.7 p -63.35 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.896 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.3 ttp-105 -51.13 -47.21 62.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.905 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.71 78.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.4 -50.93 10.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.26 -5.59 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 1.0 110.206 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.3 19.2 1.07 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.442 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.3 m -76.08 141.99 41.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.374 -0.531 . . . . 1.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 70' ' ' GLY . 37.3 p30 -67.8 -24.16 65.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 48' ' ' THR . 71.2 ttt-85 -153.98 120.31 5.44 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.176 -1.01 . . . . 1.0 113.538 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.21 139.18 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 66' ' ' ALA . 28.4 pttt -148.04 160.59 42.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.553 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -99.41 139.15 21.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.078 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 165' ' ' LEU . 16.0 t80 -121.58 120.47 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.01 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' A' ' 55' ' ' ARG . 20.2 ttp-105 -99.43 166.59 11.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 1.0 109.911 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 43.2 t80 -132.36 142.77 49.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.074 0.464 . . . . 1.0 112.117 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.535 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 m-20 -105.34 149.88 38.26 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.32 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.78 -30.32 58.95 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.735 2.29 . . . . 1.0 112.896 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.95 -5.43 34.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.607 -0.437 . . . . 1.0 111.022 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.77 -14.24 38.19 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.998 -0.62 . . . . 1.0 112.83 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.64 142.77 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.436 0.618 . . . . 1.0 110.896 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.35 140.17 14.25 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.0 p -127.1 145.71 50.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.242 0.544 . . . . 1.0 112.253 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.5 p -104.54 121.26 56.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 32' ' ' ASP . 1.3 p -115.97 9.01 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -155.71 145.52 21.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.2 tt0 -168.69 129.93 1.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.447 -0.901 . . . . 1.0 113.212 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.36 140.42 44.57 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.39 143.85 50.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.523 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.6 108.19 3.36 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.21 -84.92 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 70' ' ' GLY . 16.1 pt-20 177.89 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.859 -0.337 . . . . 1.0 111.15 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.591 ' NH1' ' NE2' ' A' ' 170' ' ' HIS . 10.4 ptp180 -65.76 -31.6 72.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 12.8 mt -116.3 150.28 45.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 4.8 Cg_exo -78.01 162.88 28.79 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.066 1.844 . . . . 1.0 112.494 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -90.79 113.62 25.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.98 -1.18 57.83 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.554 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.2 tp -52.8 135.63 35.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 1.0 112.216 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 90.89 -1.43 78.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 81' ' ' THR . 3.7 tt -95.22 120.31 35.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 1.0 110.743 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 80' ' ' LEU . 6.2 p -87.75 127.34 35.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.446 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -109.23 139.02 20.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.288 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.67 161.48 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.214 1.943 . . . . 1.0 111.608 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -68.27 -28.87 67.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.781 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.43 -23.43 3.08 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.68 -26.9 68.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 1.0 110.663 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 88' ' ' PRO . 60.8 mt -112.18 99.98 47.95 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.3 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 87' ' ' ILE . 84.2 Cg_exo -49.4 -121.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.584 2.189 . . . . 1.0 112.318 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -145.64 -58.32 0.32 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.8 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -51.3 -42.09 60.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.805 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.85 -49.87 66.61 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.968 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -29.92 68.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.534 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.18 -48.27 80.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.278 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HB2' ' HE ' ' A' ' 133' ' ' ARG . 74.2 mt -51.89 -40.2 60.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.652 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.7 -24.91 67.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.484 ' HE ' ' CA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -90.98 -21.29 21.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.16 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.4 mp -105.57 -45.94 4.3 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.404 0.89 . . . . 1.0 113.404 -177.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.72 -5.83 16.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' ALA . 96.3 mt-30 24.68 66.87 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 101' ' ' ARG . 3.1 m -108.44 -50.78 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 1.0 104.43 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.832 ' H ' HH22 ' A' ' 133' ' ' ARG . 1.2 mtt180 65.67 68.03 0.48 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.069 -1.423 . . . . 1.0 114.233 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.538 ' H ' HH12 ' A' ' 133' ' ' ARG . 44.6 t -148.92 130.85 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.754 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 139' ' ' HIS . 89.8 mt -110.93 128.51 67.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 105' ' ' ASP . 12.9 t -82.39 168.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 113.307 0.854 . . . . 1.0 113.307 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.655 ' N ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -47.49 117.34 1.76 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.805 -1.088 . . . . 1.0 112.325 -178.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.08 -10.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.745 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -87.4 -35.41 18.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.872 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.03 48.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.367 0.603 . . . . 1.0 110.149 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 52.78 59.41 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.974 . . . . 1.0 113.456 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -93.79 138.61 31.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -133.82 144.12 48.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.003 1.483 . . . . 1.0 115.003 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-N 114.127 -1.397 . . . . 1.0 107.404 177.062 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.832 HH22 ' H ' ' A' ' 101' ' ' ARG . 17.8 ttm105 . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.765 0.317 . . . . 1.0 110.28 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -44.23 145.79 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.512 2.141 . . . . 1.0 111.833 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 135' ' ' VAL . 12.5 m -122.38 130.07 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.014 0.435 . . . . 1.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.0 OUTLIER -42.47 163.45 0.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.913 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.3 -11.07 17.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.226 1.951 . . . . 1.0 111.257 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.727 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -60.23 -55.42 33.98 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.976 -0.749 . . . . 1.0 108.976 178.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.727 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 18.0 t-80 -72.34 -27.16 62.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.631 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.05 -60.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.335 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -66.1 -41.98 89.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.24 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -42.51 -48.72 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.546 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.697 HD11 ' CE1' ' A' ' 139' ' ' HIS . 30.2 mt -72.08 -47.01 54.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.46 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 147' ' ' GLY . 38.7 tptt -55.99 -42.97 77.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -55.1 -30.2 59.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 41.7 mtt -90.02 -7.98 52.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.118 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 144' ' ' LYS . . . 75.96 28.96 59.7 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.337 -0.847 . . . . 1.0 112.327 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.589 HG11 ' CB ' ' A' ' 169' ' ' HIS . 14.4 t -108.94 124.36 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.03 -31.17 39.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.41 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.6 p -134.12 169.4 17.22 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.594 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -159.06 139.47 12.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.023 0.439 . . . . 1.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.02 141.89 48.3 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -132.96 156.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.418 0.628 . . . . 1.0 111.914 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.563 HG13 ' NE2' ' A' ' 185' ' ' GLN . 53.3 t -157.62 98.53 1.91 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.337 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.24 117.74 4.83 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.571 2.848 . . . . 1.0 113.9 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.82 106.3 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.809 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.2 ptm -129.34 143.33 50.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.848 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 70.0 t60 -110.42 113.96 27.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 21.3 m-70 57.97 -119.67 1.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -93.63 2.55 56.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -112.56 150.69 30.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.959 1.096 . . . . 1.0 113.959 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.03 116.84 32.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.491 -1.231 . . . . 1.0 108.867 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -96.96 -28.52 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.921 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.41 -173.81 28.33 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.949 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.0 tp -138.18 133.54 33.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 1.0 111.214 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -99.45 140.03 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 167' ' ' VAL . 8.9 p -149.44 111.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.512 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 142.04 31.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.106 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.589 ' CB ' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -146.71 148.51 32.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.141 0.496 . . . . 1.0 111.043 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' HIS . . . . . 0.591 ' NE2' ' NH1' ' A' ' 73' ' ' ARG . 7.0 t60 -152.63 148.57 27.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -72.74 69.11 0.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 120.345 -0.542 . . . . 1.0 112.293 179.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.779 0.324 . . . . 1.0 110.85 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -94.01 149.3 21.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.291 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.93 -40.78 78.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.678 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.87 -55.81 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.366 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.15 -31.34 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 1.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.2 tp -60.82 -38.12 84.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.456 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -63.42 -52.98 59.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.395 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.5 t -43.95 -49.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.317 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.7 m -75.06 -36.28 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLN . . . . . 0.635 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 47.6 tp60 -46.89 -36.64 7.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.099 -1.075 . . . . 1.0 108.099 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.53 -40.76 66.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.374 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' VAL . 33.9 tp -54.76 -33.1 60.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.645 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.451 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.14 -35.94 61.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.603 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . 0.464 ' O ' ' OG ' ' A' ' 192' ' ' SER . 50.6 t0 -57.37 -41.15 79.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.661 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -52.33 -52.38 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.89 -43.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.888 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.6 p -51.92 -38.07 54.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.65 -32.64 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.027 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -46.13 64.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.117 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.6 pp -66.74 -26.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.43 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -77.03 -56.31 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.946 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.13 -26.77 63.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.869 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.84 -35.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.24 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -56.91 -38.98 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.8 -57.16 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.09 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 t -60.4 -46.08 91.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 1.0 110.321 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.427 179.768 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.649 HD11 HD12 ' A' ' 195' ' ' ILE . 6.9 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.899 0.381 . . . . 1.0 110.581 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.18 -46.98 65.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.294 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -66.01 -47.31 74.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 1.0 112.222 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.87 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -59.68 -41.07 84.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 112.665 0.617 . . . . 1.0 112.665 -177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 73.6 mt -74.83 -22.33 58.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.586 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.466 ' O ' HG12 ' A' ' 39' ' ' VAL . 41.3 ttp180 -66.72 -36.83 83.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.614 -0.434 . . . . 1.0 109.973 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.71 -30.98 41.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.317 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.87 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.0 p -72.39 -48.5 41.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.543 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.3 p -55.29 -33.86 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.858 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -72.23 -39.13 68.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.809 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.63 -40.63 97.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.988 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.25 -52.4 53.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.592 -0.443 . . . . 1.0 110.894 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' O ' ' N ' ' A' ' 47' ' ' GLY . 31.2 ttp85 -52.2 -43.55 64.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.877 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -36.66 75.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.323 -0.398 . . . . 1.0 110.803 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -81.55 -50.35 9.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.77 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -77.39 -7.6 56.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.978 0.418 . . . . 1.0 110.087 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.91 19.05 1.25 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 115.667 -0.697 . . . . 1.0 112.413 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.6 m -76.03 142.74 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.047 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.5 m-20 -57.69 -33.28 68.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.913 0.708 . . . . 1.0 112.913 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 48' ' ' THR . 58.1 ttp180 -153.29 120.97 5.98 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 119.128 -1.029 . . . . 1.0 113.536 -179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.2 p -138.75 135.23 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.955 -1.128 . . . . 1.0 107.955 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.571 ' HZ2' ' CG1' ' A' ' 167' ' ' VAL . 9.1 pttp -146.45 162.06 39.07 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.552 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -97.01 136.78 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.007 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.444 ' CD1' HBB2 ' A' ' 203' ' ' CYC . 79.5 t80 -123.4 120.56 33.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.052 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.589 ' NE ' ' OG1' ' A' ' 63' ' ' THR . 27.2 ptt180 -101.08 171.98 7.29 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -134.01 134.19 42.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.067 0.46 . . . . 1.0 112.138 -178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -103.74 129.32 25.53 Favored Pre-proline 0 C--N 1.333 -0.127 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.345 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.47 -25.93 1.54 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.739 2.293 . . . . 1.0 112.913 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -77.5 -9.82 59.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.984 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.4 -13.4 36.35 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.816 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.2 m80 -86.72 141.76 28.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 117.38 0.59 . . . . 1.0 110.944 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.3 145.98 15.95 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.434 -1.067 . . . . 1.0 110.434 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.589 ' OG1' ' NE ' ' A' ' 55' ' ' ARG . 28.6 p -129.86 147.88 51.67 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.25 0.547 . . . . 1.0 112.303 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.06 101.72 12.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 p -93.36 3.01 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 -176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.18 147.26 24.62 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.432 -0.581 . . . . 1.0 109.432 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 81.1 tt0 -166.88 126.89 1.52 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.245 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.79 133.44 53.14 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.5 mtm-85 -121.92 141.84 50.88 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.555 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.93 97.64 1.88 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.47 -90.56 0.03 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.02 36.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.83 -0.348 . . . . 1.0 111.101 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -70.72 -55.61 8.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.5 mt -92.95 154.48 41.83 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 107.858 -1.164 . . . . 1.0 107.858 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -77.92 167.82 23.1 Favored 'Trans proline' 0 C--N 1.302 -1.887 0 C-N-CA 122.099 1.866 . . . . 1.0 112.518 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 60.5 p -89.27 132.05 35.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.125 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.09 -4.41 20.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.09 -0.504 . . . . 1.0 111.618 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -59.36 139.89 56.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.35 0.595 . . . . 1.0 112.239 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.8 80.2 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.5 mt -101.23 131.73 47.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.904 0.383 . . . . 1.0 110.76 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -88.14 119.41 28.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.485 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.9 m-85 -108.64 132.5 21.1 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.285 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -78.73 157.52 27.99 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.125 1.883 . . . . 1.0 111.702 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.37 -21.14 66.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.76 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -23.72 0.83 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -55.53 -29.07 58.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.794 0.331 . . . . 1.0 110.634 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.418 HG23 ' HHA' ' A' ' 203' ' ' CYC . 13.4 mt -121.35 133.43 24.2 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.297 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 71.8 Cg_endo -78.4 -106.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.538 2.159 . . . . 1.0 112.336 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -152.49 -64.71 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.832 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -43.02 -41.97 3.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.723 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.7 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -61.8 -41.02 97.22 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.724 -0.39 . . . . 1.0 110.958 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.8 mtp-105 -65.57 -28.44 69.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.526 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.6 mmm-85 -56.72 -55.31 35.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.267 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 94' ' ' LEU . 9.4 mp -54.13 -40.75 67.66 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.587 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -60.91 -40.19 92.2 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -80.09 -8.42 59.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.56 -0.746 . . . . 1.0 110.11 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 tp -107.49 -43.58 4.5 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 113.389 0.885 . . . . 1.0 113.389 -178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.71 -1.52 12.08 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.53 0.937 . . . . 1.0 113.53 -175.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 28.9 mp0 27.51 69.64 0.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 114.077 1.14 . . . . 1.0 114.077 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.595 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.5 p -116.9 -49.67 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 104.437 -2.431 . . . . 1.0 104.437 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.595 ' N ' HG13 ' A' ' 100' ' ' VAL . 2.6 mtt180 61.55 78.96 0.27 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.058 -1.428 . . . . 1.0 114.35 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.79 132.32 5.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 120.476 -0.49 . . . . 1.0 111.76 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 151' ' ' SER . 1.5 mp -107.06 126.26 63.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.681 HG12 ' N ' ' A' ' 105' ' ' ASP . 27.3 t -82.85 167.05 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.249 0.833 . . . . 1.0 113.249 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.681 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.5 m-20 -50.84 118.22 3.0 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 114.692 -1.14 . . . . 1.0 112.261 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.1 m -57.66 -10.91 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.742 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -87.5 -36.25 17.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.889 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.5 -15.31 25.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 1.0 110.134 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 52.81 59.98 4.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.032 -0.986 . . . . 1.0 113.424 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.0 t -94.25 137.34 33.53 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 1.0 105.401 175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -127.9 139.94 52.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.017 1.488 . . . . 1.0 115.017 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 t -105.05 154.2 20.45 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.154 -1.385 . . . . 1.0 107.338 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 114' ' ' SER . 11.0 tp -157.17 159.06 2.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 119.666 -0.814 . . . . 1.0 112.105 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.488 ' N ' HG13 ' A' ' 113' ' ' ILE . 73.5 m -85.78 167.84 14.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.241 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.459 ' O ' ' O ' ' A' ' 116' ' ' PRO . 9.0 mt-30 -150.66 159.91 33.52 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.666 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' GLN . 48.1 Cg_exo -37.72 165.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.682 2.255 . . . . 1.0 112.238 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -46.09 140.87 3.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.532 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.8 p -149.85 160.85 43.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.623 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -148.65 172.33 14.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.57 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.01 1.75 61.24 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 121' ' ' LEU . 44.0 tp -69.51 -37.98 77.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.792 0.33 . . . . 1.0 110.542 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.7 p -63.22 -20.63 65.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.614 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.2 -30.39 17.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.844 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.412 HH11 ' HB3' ' A' ' 124' ' ' ARG . 18.8 ttm105 69.16 59.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.861 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 125' ' ' VAL . 32.9 m -77.76 125.82 85.14 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.091 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -45.6 129.55 11.48 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.559 2.172 . . . . 1.0 111.195 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.9 mt 44.27 -117.08 0.52 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.45 3.1 84.57 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.616 -0.594 . . . . 1.0 111.616 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' OE1' HD21 ' A' ' 94' ' ' LEU . 22.1 mt-10 -148.36 158.49 40.82 Favored Pre-proline 0 C--N 1.328 -0.341 0 C-N-CA 120.957 -0.297 . . . . 1.0 110.672 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -50.56 166.31 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.417 2.078 . . . . 1.0 111.681 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.0 mp -79.07 12.36 2.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.301 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 131' ' ' LEU . 93.4 mm-40 -134.89 165.81 24.45 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.045 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 68.2 mmt-85 -124.71 78.57 63.89 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.301 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -45.92 144.86 5.49 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.516 2.144 . . . . 1.0 111.801 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 135' ' ' VAL . 3.1 m -113.33 120.1 62.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.987 0.422 . . . . 1.0 111.349 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.46 148.97 0.4 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.903 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 140' ' ' VAL . 93.2 Cg_exo -45.85 -48.16 12.89 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.212 1.941 . . . . 1.0 111.275 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 1.2 p -43.83 -34.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.692 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 53.0 t-80 -82.67 -32.62 28.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.715 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 137' ' ' PRO . 52.4 t -53.09 -51.01 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.32 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -65.13 -43.06 93.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.922 0.391 . . . . 1.0 110.26 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -46.21 -50.42 15.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.672 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.4 mp -71.76 -49.44 38.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.537 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.1 tptm -58.94 -41.29 87.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.46 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 93.5 p -54.24 -30.3 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.153 -0.684 . . . . 1.0 109.153 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.3 mtt -87.01 -0.61 56.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.228 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.26 25.03 75.8 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.293 -0.867 . . . . 1.0 112.359 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 150' ' ' SER . 21.6 t -105.87 122.57 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.23 -33.14 49.99 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.75 0.648 . . . . 1.0 112.75 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 148' ' ' VAL . 2.4 t -137.42 171.16 14.89 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.592 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.405 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 7.3 p -161.42 139.98 9.66 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.198 0.444 . . . . 1.0 112.198 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 65.1 tp -115.19 138.66 50.67 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.5 m -132.14 155.13 41.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.468 0.651 . . . . 1.0 111.828 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.9 t -158.12 90.46 2.24 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 114.83 -1.077 . . . . 1.0 109.313 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.76 133.4 54.11 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.562 2.842 . . . . 1.0 113.946 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.8 mt -89.79 106.34 18.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.776 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 20.6 ptm -127.39 144.91 50.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.23 0.538 . . . . 1.0 111.864 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.631 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 22.9 t-80 -114.15 114.06 25.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.631 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 22.2 m-70 59.01 -118.38 0.95 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.707 -0.479 . . . . 1.0 109.707 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.649 ' H ' ' CD ' ' A' ' 160' ' ' GLN . 2.3 pm0 -95.38 3.06 54.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.545 ' OE2' ' CH2' ' A' ' 163' ' ' TRP . 87.2 tt0 -112.06 149.49 32.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 162' ' ' LEU . 11.0 mp -107.37 117.28 33.66 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 114.532 -1.213 . . . . 1.0 108.841 178.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CH2' ' OE2' ' A' ' 161' ' ' GLU . 81.7 m95 -97.2 -25.84 15.15 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.887 -178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -161.88 -168.19 23.42 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.971 -178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.488 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.7 tp -141.11 128.65 21.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.797 0.332 . . . . 1.0 111.239 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -93.9 137.91 32.62 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.571 ' CG1' ' HZ2' ' A' ' 52' ' ' LYS . 9.0 p -150.87 133.83 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.397 -0.521 . . . . 1.0 111.541 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 p -115.77 145.4 42.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.009 178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.07 140.62 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.157 0.503 . . . . 1.0 111.011 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 148' ' ' VAL . 0.3 OUTLIER -154.03 154.35 33.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.483 -0.781 . . . . 1.0 109.638 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.97 72.81 10.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.446 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -174.16 129.72 0.48 Allowed Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 120.399 -0.52 . . . . 1.0 112.323 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.93 78.52 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.667 2.245 . . . . 1.0 110.912 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -114.79 146.17 35.49 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.024 -0.989 . . . . 1.0 112.703 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.97 149.49 36.91 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.831 2.354 . . . . 1.0 111.123 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -108.14 154.04 22.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.809 0.338 . . . . 1.0 110.802 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 95.8 p -99.07 139.99 33.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.285 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.23 -36.01 76.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.118 -0.492 . . . . 1.0 111.65 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.7 -54.96 35.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.334 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.21 -32.05 73.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.878 0.37 . . . . 1.0 110.643 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.54 -42.27 91.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.497 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -60.9 -52.71 63.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.455 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -44.77 -46.86 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.275 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 87.4 t -74.43 -37.85 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.498 -0.556 . . . . 1.0 109.498 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -48.68 -37.83 19.6 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.055 -1.091 . . . . 1.0 108.055 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.8 -40.92 63.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.73 -1.123 . . . . 1.0 109.383 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 42.3 tp -53.54 -32.65 51.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.68 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.57 -32.58 60.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.844 -0.617 . . . . 1.0 109.616 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -58.68 -41.7 86.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 1.0 109.69 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -53.23 -52.85 57.62 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.4 -41.66 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.267 -0.879 . . . . 1.0 109.886 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.7 m -50.34 -29.78 10.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.7 mm -77.79 -38.52 25.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.023 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.75 -45.67 67.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.108 -178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.649 HD12 HD11 ' A' ' 31' ' ' LEU . 10.4 tp -64.24 -34.61 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.619 -0.512 . . . . 1.0 109.619 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -75.23 -55.91 5.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.881 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -55.79 -26.62 47.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.893 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.79 -34.4 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.302 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -57.55 -39.38 76.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.154 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.1 mp -68.55 -56.43 8.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.48 -0.327 . . . . 1.0 111.107 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.3 m -55.56 -43.07 75.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.891 0.377 . . . . 1.0 110.357 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.014 -0.994 . . . . 1.0 110.419 179.708 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.7 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.807 HD11 HD12 ' A' ' 195' ' ' ILE . 5.9 tp . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.931 0.396 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.19 -32.65 74.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.533 . . . . 1.0 111.245 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -78.39 -54.72 5.88 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.243 0.46 . . . . 1.0 112.243 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 38' ' ' THR . 4.7 tp -58.35 -37.42 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.607 0.595 . . . . 1.0 112.607 -177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.46 ' HG ' HG23 ' A' ' 34' ' ' ILE . 80.8 mt -74.36 -33.93 63.23 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.519 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -49.76 -37.93 31.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.66 -0.416 . . . . 1.0 109.993 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.39 -30.26 57.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.394 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 34' ' ' ILE . 52.9 p -70.58 -44.54 67.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.533 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 53' ' ' VAL . 49.8 t -59.15 -37.93 71.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.846 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -67.63 -39.53 84.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.902 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.13 -37.55 83.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.98 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.4 t -68.39 -43.56 84.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLY . 49.4 ttp180 -57.03 -50.08 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.865 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -37.75 79.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.847 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -79.14 -51.88 8.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.781 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tp -76.95 -6.47 52.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.015 0.436 . . . . 1.0 110.089 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.96 17.65 0.32 Allowed Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.689 -0.687 . . . . 1.0 112.393 178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.547 HG21 HG13 ' A' ' 51' ' ' VAL . 6.8 t -78.53 149.43 33.08 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.405 -0.518 . . . . 1.0 110.077 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.6 m-20 -55.56 -35.09 65.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.705 ' HE ' ' CE1' ' A' ' 169' ' ' HIS . 51.2 ttp180 -155.01 131.86 10.75 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 119.124 -1.03 . . . . 1.0 113.499 -178.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG13 HG21 ' A' ' 48' ' ' THR . 0.3 OUTLIER -139.15 133.59 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HE3' HBB2 ' A' ' 203' ' ' CYC . 47.7 pttt -146.61 160.29 42.36 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.402 -0.519 . . . . 1.0 111.594 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 39' ' ' VAL . 71.2 t -99.11 135.08 35.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.75 -0.659 . . . . 1.0 109.975 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.7 t80 -117.38 120.27 37.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 1.0 111.058 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.618 ' NH2' HD21 ' A' ' 31' ' ' LEU . 46.4 ttm-85 -99.83 166.35 11.13 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 11.5 t80 -131.21 135.99 47.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.091 0.472 . . . . 1.0 112.109 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.9 m-20 -102.22 147.79 34.46 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 115.708 -0.678 . . . . 1.0 109.329 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -63.42 -21.59 71.26 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.726 2.284 . . . . 1.0 112.909 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -80.83 -2.44 47.29 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.044 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.54 -8.58 54.99 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.916 -0.659 . . . . 1.0 112.842 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -90.24 143.5 26.71 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.318 0.559 . . . . 1.0 111.005 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -120.47 137.88 12.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.6 p -124.31 145.36 49.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.197 0.522 . . . . 1.0 112.34 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -104.49 120.57 55.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.999 -1.112 . . . . 1.0 107.999 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 m -112.08 4.74 8.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.459 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -153.78 146.24 24.03 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.9 tt0 -166.38 127.36 1.73 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.398 -0.921 . . . . 1.0 113.222 -178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 129.5 56.25 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.521 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 6.8 ptp85 -116.85 140.61 49.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.216 -0.594 . . . . 1.0 111.524 -178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -81.47 98.53 1.89 Allowed Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.428 -1.069 . . . . 1.0 110.428 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.78 -90.23 0.04 OUTLIER Glycine 0 CA--C 1.52 0.359 0 N-CA-C 110.188 -1.165 . . . . 1.0 110.188 -177.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -176.38 33.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.116 177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -71.38 -54.25 11.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.802 -1.184 . . . . 1.0 107.802 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.88 145.93 30.77 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 107.856 -1.165 . . . . 1.0 107.856 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.88 166.37 29.4 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.081 1.854 . . . . 1.0 112.564 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.521 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 16.2 m -88.86 135.94 33.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.108 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 45.6 mt -108.7 -0.99 19.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.615 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.556 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 22.9 tp -60.59 138.95 57.99 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.334 0.588 . . . . 1.0 112.239 -176.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.16 -4.95 85.37 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.338 -0.846 . . . . 1.0 111.05 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.2 tp -99.62 130.14 45.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.861 0.362 . . . . 1.0 110.766 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.9 m -87.06 121.84 30.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.503 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 62' ' ' GLY . 28.7 m-85 -103.01 136.23 19.27 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.259 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -77.11 145.7 24.8 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.126 1.884 . . . . 1.0 111.708 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.04 -29.37 69.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.15 -20.56 1.45 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 40.4 p30 -60.08 -30.67 69.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.792 0.329 . . . . 1.0 110.59 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.565 ' O ' ' O ' ' A' ' 88' ' ' PRO . 45.6 mt -113.74 101.0 53.35 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.262 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.565 ' O ' ' O ' ' A' ' 87' ' ' ILE . 83.1 Cg_exo -45.57 -116.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.536 2.158 . . . . 1.0 112.351 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -154.3 -44.61 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.907 0.384 . . . . 1.0 111.832 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -59.4 -39.1 82.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.707 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.521 ' HB1' HAD2 ' A' ' 203' ' ' CYC . . . -61.93 -36.33 81.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.873 0.368 . . . . 1.0 110.982 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -67.98 -28.63 67.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.562 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 97' ' ' LEU . 55.0 mtp180 -53.65 -57.71 9.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.244 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.7 mt -54.7 -38.29 66.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.556 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' O ' ' OE1' ' A' ' 99' ' ' GLN . 6.6 m-85 -65.5 -30.71 71.51 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.1 mtp180 -93.62 -14.24 26.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.127 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 93' ' ' ARG . 11.8 tp -107.1 -46.16 3.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.294 0.85 . . . . 1.0 113.294 -178.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.99 -3.36 12.65 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.451 0.908 . . . . 1.0 113.451 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.619 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 13.0 mm-40 29.19 69.8 0.07 Allowed 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 114.091 1.145 . . . . 1.0 114.091 178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 101' ' ' ARG . 0.2 OUTLIER -110.04 -51.06 6.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 175.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.619 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER 63.18 70.4 0.54 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.292 172.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.1 p -152.35 134.31 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.556 -0.457 . . . . 1.0 111.793 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.59 ' CD1' HMA2 ' A' ' 203' ' ' CYC . 22.8 mt -108.51 127.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.406 -0.961 . . . . 1.0 108.406 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.659 HG22 ' N ' ' A' ' 105' ' ' ASP . 10.4 p -83.25 167.93 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 113.28 0.845 . . . . 1.0 113.28 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.659 ' N ' HG22 ' A' ' 104' ' ' VAL . 15.7 t0 -53.55 119.41 4.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.312 -178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.3 m -57.88 -10.44 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.412 -0.813 . . . . 1.0 110.735 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 1.3 pp20? -86.47 -37.76 17.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.921 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.97 -13.91 7.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.405 0.622 . . . . 1.0 110.132 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 50.34 52.63 14.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.041 -0.981 . . . . 1.0 113.35 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.9 m -93.27 133.44 36.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.343 -2.095 . . . . 1.0 105.343 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.1 mtm-85 -126.13 141.07 52.09 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 115.03 1.492 . . . . 1.0 115.03 -175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.437 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.5 m -91.91 144.34 25.57 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.171 -1.377 . . . . 1.0 107.363 176.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.16 149.76 16.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 119.697 -0.801 . . . . 1.0 112.161 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.8 t -87.29 164.9 16.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.266 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -143.53 152.16 55.96 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.603 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -37.86 -37.84 0.61 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.659 2.24 . . . . 1.0 112.294 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -104.37 159.79 15.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.535 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.3 m -111.27 170.9 7.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -48.49 -41.32 29.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.502 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 122' ' ' SER . . . 93.95 3.24 64.03 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt 59.9 -69.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 1.0 110.546 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 120' ' ' GLY . 32.5 t -48.69 -28.83 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.601 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.687 ' O ' ' C ' ' A' ' 124' ' ' ARG . . . -50.0 -43.73 50.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.825 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.687 ' C ' ' O ' ' A' ' 123' ' ' ALA . 38.4 ttm180 1.62 90.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.815 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.29 107.02 54.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.054 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -47.28 146.24 7.11 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.509 2.14 . . . . 1.0 111.179 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.6 mt 44.44 -165.36 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.57 -0.529 . . . . 1.0 109.57 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.16 7.41 88.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.64 -0.584 . . . . 1.0 111.64 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -90.1 151.65 45.18 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 121.0 -0.28 . . . . 1.0 110.661 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.5 160.57 48.1 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.367 2.045 . . . . 1.0 111.68 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.665 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.8 mp -78.27 -5.17 51.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -139.24 165.59 26.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.654 -0.419 . . . . 1.0 111.084 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' HE ' ' HD2' ' A' ' 134' ' ' PRO . 0.8 OUTLIER -125.2 114.93 25.93 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.275 -179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.462 ' HD2' ' HE ' ' A' ' 133' ' ' ARG . 91.0 Cg_endo -81.35 143.48 13.88 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.573 2.182 . . . . 1.0 111.745 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.54 HG21 ' ND1' ' A' ' 139' ' ' HIS . 1.5 m -112.99 123.34 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.073 0.463 . . . . 1.0 111.319 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.85 154.18 0.12 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.895 178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -58.39 -26.94 79.76 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.221 1.947 . . . . 1.0 111.275 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.486 ' O ' HBC1 ' A' ' 203' ' ' CYC . 22.2 t -61.26 -43.0 99.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 109.076 -0.713 . . . . 1.0 109.076 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.797 ' CE1' HD13 ' A' ' 143' ' ' LEU . 46.8 t-80 -77.84 -29.65 50.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.0 -53.1 19.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.275 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.487 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 80.1 t60 -64.68 -42.78 95.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.268 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -44.29 -50.56 8.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.405 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.797 HD13 ' CE1' ' A' ' 139' ' ' HIS . 3.1 mp -71.59 -49.6 38.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.461 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.524 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.6 tptm -56.98 -40.83 77.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.487 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 30.9 m -54.2 -32.82 56.68 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.254 -0.647 . . . . 1.0 109.254 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 50.3 mtt -83.98 -2.01 55.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.164 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.68 26.43 74.48 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 115.277 -0.874 . . . . 1.0 112.353 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.1 p -109.01 127.04 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.08 -30.9 39.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.76 0.652 . . . . 1.0 112.76 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.8 t -137.97 170.45 16.03 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.145 -0.622 . . . . 1.0 111.512 -178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -162.66 138.45 7.2 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.215 -0.448 . . . . 1.0 112.135 -178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 176' ' ' TYR . 18.3 tp -113.63 139.72 48.79 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -128.8 156.76 41.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.457 0.646 . . . . 1.0 111.783 -178.421 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 153' ' ' VAL . 66.7 t -156.65 100.38 2.03 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.812 -1.085 . . . . 1.0 109.327 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.88 127.11 13.27 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.603 2.869 . . . . 1.0 113.899 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.2 mt -85.51 106.08 16.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.372 -0.831 . . . . 1.0 109.812 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 22.2 ptm -130.73 146.65 52.26 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.834 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.615 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 30.5 t-80 -117.24 116.11 26.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.615 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 3.7 m-70 57.66 -122.42 1.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -92.81 7.59 43.06 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.91 0.337 . . . . 1.0 111.91 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -116.61 150.56 37.87 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.011 1.115 . . . . 1.0 114.011 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.93 116.27 31.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.547 -1.206 . . . . 1.0 108.851 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.404 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 82.7 m95 -95.27 -26.34 15.98 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.699 -0.401 . . . . 1.0 111.924 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.5 -168.7 24.8 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.158 -1.02 . . . . 1.0 111.972 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.8 tp -145.32 136.76 25.14 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.803 0.335 . . . . 1.0 111.142 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.428 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 3.2 tp -100.91 145.5 28.55 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 167' ' ' VAL . 14.7 p -150.9 129.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.373 -0.531 . . . . 1.0 111.6 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.8 p -112.96 145.84 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.077 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.705 ' CE1' ' HE ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -148.01 138.54 22.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.219 0.533 . . . . 1.0 110.973 179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.49 ' O ' HG23 ' A' ' 148' ' ' VAL . 21.3 t60 -150.64 151.73 32.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.702 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.441 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -79.7 67.46 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.521 -0.309 . . . . 1.0 111.424 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -177.08 135.38 0.39 Allowed Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 120.376 -0.53 . . . . 1.0 112.297 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 174' ' ' ARG . 23.7 Cg_exo -38.8 -53.36 1.91 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.672 2.248 . . . . 1.0 110.896 176.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 173' ' ' PRO . 68.1 ttt180 29.95 101.56 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 114.999 -1.001 . . . . 1.0 112.801 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.96 154.51 22.79 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.78 2.32 . . . . 1.0 111.162 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' CG ' HD13 ' A' ' 152' ' ' LEU . 42.6 m-85 -113.82 140.27 48.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.804 0.335 . . . . 1.0 110.78 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.6 m -95.27 148.31 22.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.245 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.4 HE21 HE21 ' A' ' 182' ' ' GLN . 59.0 tp60 -67.19 -37.33 83.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.692 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -62.19 -54.48 40.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.581 -0.281 . . . . 1.0 111.349 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.64 -31.59 72.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.846 0.355 . . . . 1.0 110.598 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.439 HD11 HH12 ' A' ' 101' ' ' ARG . 28.2 tp -60.14 -41.85 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.509 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 185' ' ' GLN . 94.5 mm-40 -61.54 -52.86 62.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.377 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.6 t -43.06 -44.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.255 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 95.4 t -74.31 -36.88 44.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 101' ' ' ARG . 36.6 tp60 -52.32 -37.86 56.99 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.3 mp -71.58 -32.15 67.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.391 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 21.4 tp -63.75 -27.85 69.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -70.53 -37.02 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.69 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -53.89 -42.33 68.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.805 -0.634 . . . . 1.0 109.717 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -52.35 -56.3 15.83 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.032 -0.729 . . . . 1.0 109.032 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.19 -41.07 82.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.902 178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.9 p -51.82 -35.26 43.75 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.4 mt -78.97 -35.25 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.046 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.07 61.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.08 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.807 HD12 HD11 ' A' ' 31' ' ' LEU . 9.0 tp -62.12 -36.7 75.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.181 0.515 . . . . 1.0 109.622 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.528 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -73.23 -53.63 10.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.958 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 197' ' ' GLN . 19.3 tm0? -55.3 -27.23 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.908 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.07 -33.91 57.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.298 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -58.0 -40.99 82.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.153 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 200' ' ' LEU . 9.6 mp -64.96 -58.48 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.093 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.4 t -53.03 -42.22 65.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 1.0 110.281 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.5 mp . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.4 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.59 HMA2 ' CD1' ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.6 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.885 0.374 . . . . 1.0 110.565 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -69.67 -52.28 27.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.231 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -60.87 -48.35 82.23 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.789 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.96 -30.95 48.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 112.598 0.592 . . . . 1.0 112.598 -176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 65.2 mt -75.57 -24.16 56.61 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.595 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.1 mtp180 -66.83 -36.08 81.52 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.94 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.1 -25.16 43.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 34' ' ' ILE . 68.7 p -74.77 -50.68 16.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.577 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.4 p -53.52 -36.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.923 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 96.8 mt-10 -74.53 -37.37 63.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -64.79 -51.77 60.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.85 -0.614 . . . . 1.0 112.021 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.23 -50.39 79.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.901 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 47' ' ' GLY . 4.9 tmm_? -51.36 -43.61 61.87 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.85 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.07 -36.69 73.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -80.47 -47.17 14.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.821 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.17 -6.83 53.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.175 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.83 17.11 0.49 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.591 -0.731 . . . . 1.0 112.41 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -73.44 140.35 46.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.083 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.639 ' O ' ' N ' ' A' ' 70' ' ' GLY . 88.6 m-20 -61.99 -29.86 70.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.899 0.703 . . . . 1.0 112.899 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.575 ' H ' HG22 ' A' ' 48' ' ' THR . 43.1 ttp180 -152.99 118.69 5.34 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 119.231 -0.988 . . . . 1.0 113.517 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 8.6 p -144.24 137.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 107.938 -1.134 . . . . 1.0 107.938 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.457 ' HZ1' HBB3 ' A' ' 203' ' ' CYC . 18.2 pttp -146.23 161.81 39.44 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.376 -0.53 . . . . 1.0 111.547 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.91 135.27 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.017 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 165' ' ' LEU . 75.7 t80 -117.9 116.54 27.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.012 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 56' ' ' PHE . 27.3 ttm180 -98.16 164.76 12.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.849 178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.41 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 78.9 t80 -131.75 139.56 48.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 1.0 112.12 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.4 OUTLIER -103.79 148.35 35.67 Favored Pre-proline 0 C--N 1.333 -0.143 0 CA-C-N 115.718 -0.673 . . . . 1.0 109.296 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.21 -21.85 72.4 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.732 2.288 . . . . 1.0 112.924 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -80.01 -4.47 52.76 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.974 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.51 -10.86 46.5 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.058 -0.591 . . . . 1.0 112.871 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.4 m80 -89.13 146.07 25.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.335 0.567 . . . . 1.0 110.888 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.88 144.35 15.14 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.1 m -128.55 147.31 50.69 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.133 0.492 . . . . 1.0 112.309 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.67 119.09 44.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -108.05 0.14 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.64 150.46 23.05 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.1 tt0 -166.05 125.98 1.69 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.372 -0.931 . . . . 1.0 113.166 -178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -108.62 136.14 48.7 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -127.0 141.55 51.77 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.238 -0.585 . . . . 1.0 111.516 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.32 104.67 2.63 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.419 -1.072 . . . . 1.0 110.419 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.4 -89.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.395 0 N-CA-C 110.262 -1.135 . . . . 1.0 110.262 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.8 tt0 -176.94 34.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.833 -0.347 . . . . 1.0 111.174 177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ttm105 -70.98 -53.57 14.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.851 -1.166 . . . . 1.0 107.851 177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 36.2 mt -94.76 144.13 27.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 N-CA-C 107.921 -1.141 . . . . 1.0 107.921 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.09 170.34 20.35 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 122.043 1.828 . . . . 1.0 112.504 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 t -92.32 136.22 33.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.173 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 38.5 mt -109.63 -2.35 17.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.543 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.526 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 18.7 tp -58.52 139.55 55.51 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.294 0.568 . . . . 1.0 112.289 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.38 84.36 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.38 -0.827 . . . . 1.0 111.058 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 45.6 mt -100.1 133.97 43.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.863 0.364 . . . . 1.0 110.766 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.5 m -89.07 117.01 27.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.515 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -107.98 134.91 19.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.78 158.11 27.88 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.123 1.882 . . . . 1.0 111.663 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.76 -20.1 63.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.779 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.66 -22.46 0.72 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 10.3 p30 -55.54 -27.78 50.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.323 . . . . 1.0 110.649 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.565 HD11 HMB3 ' A' ' 203' ' ' CYC . 90.6 mt -127.96 99.58 25.34 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.279 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' ILE . 47.6 Cg_exo -41.71 -101.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.544 2.163 . . . . 1.0 112.312 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 43.7 tp10 -153.54 -59.22 0.13 Allowed 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.809 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -43.46 -38.67 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.714 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -67.75 -50.92 54.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 1.0 110.947 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.8 ttt-85 -61.64 -31.4 71.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -58.04 -49.58 76.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.495 -0.321 . . . . 1.0 111.284 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.0 mt -53.85 -36.97 63.16 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.809 -0.357 . . . . 1.0 110.578 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.7 -29.15 69.91 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.554 -0.535 . . . . 1.0 109.554 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -89.66 -15.38 32.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.092 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.7 mp -106.82 -46.34 3.98 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.399 0.889 . . . . 1.0 113.399 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -112.99 -3.0 14.1 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 25.21 67.01 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 114.096 1.147 . . . . 1.0 114.096 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.879 ' H ' HH21 ' A' ' 133' ' ' ARG . 13.0 t -107.24 -52.52 6.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 104.503 -2.406 . . . . 1.0 104.503 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.814 ' H ' ' HE ' ' A' ' 133' ' ' ARG . 11.5 mtm180 64.38 65.57 0.65 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.024 -1.444 . . . . 1.0 114.312 172.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.524 ' C ' HD12 ' A' ' 103' ' ' ILE . 35.7 m -150.11 133.39 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 C-N-CA 120.456 -0.498 . . . . 1.0 111.726 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.524 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -109.25 127.38 66.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 N-CA-C 108.353 -0.981 . . . . 1.0 108.353 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.9 t -83.2 168.11 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 113.297 0.851 . . . . 1.0 113.297 -177.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.696 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.8 m-20 -51.33 114.52 1.25 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.268 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 106' ' ' VAL . 9.5 p -54.82 -10.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.789 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -88.5 -35.96 16.7 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.912 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.61 -15.03 9.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.412 0.625 . . . . 1.0 110.065 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 49.97 51.5 16.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 1.0 113.396 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.7 m -94.2 138.2 32.5 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.405 -2.072 . . . . 1.0 105.405 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -128.27 137.93 52.2 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 115.05 1.5 . . . . 1.0 115.05 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.588 ' O ' HG23 ' A' ' 113' ' ' ILE . 54.2 m -100.34 153.03 19.64 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.152 -1.385 . . . . 1.0 107.307 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 112' ' ' SER . 14.6 pt -157.5 163.17 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.732 -0.787 . . . . 1.0 112.189 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.8 t -86.58 163.62 17.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.477 -0.783 . . . . 1.0 110.228 178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -153.32 149.93 22.58 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.695 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 117' ' ' GLU . 48.2 Cg_exo -37.21 157.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.637 2.225 . . . . 1.0 112.254 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 116' ' ' PRO . 44.2 mt-10 55.89 158.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.602 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.8 m -145.02 152.81 40.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.641 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.489 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 0.3 OUTLIER -42.79 -76.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.517 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.83 3.59 73.64 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 121' ' ' LEU . 8.5 mp -93.26 125.12 37.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.839 0.352 . . . . 1.0 110.555 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -64.69 -58.11 7.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 124' ' ' ARG . . . -67.98 -29.26 68.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.82 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 123' ' ' ALA . 19.6 tpt180 57.84 145.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.861 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 125' ' ' VAL . 4.6 m -62.65 149.88 87.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.133 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.38 132.58 26.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.584 2.19 . . . . 1.0 111.177 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 129' ' ' GLU . 22.3 mt 43.49 -126.8 0.85 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.22 -6.63 3.03 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.642 -0.583 . . . . 1.0 111.642 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 127' ' ' LEU . 45.6 mm-40 -95.5 154.58 39.25 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.574 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -42.85 152.91 0.18 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.323 2.015 . . . . 1.0 111.738 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.0 mt -78.57 -7.51 57.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.344 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.52 166.25 25.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.721 -0.392 . . . . 1.0 111.087 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.879 HH21 ' H ' ' A' ' 100' ' ' VAL . 26.1 mtt-85 -119.99 77.58 23.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.286 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.07 150.29 5.08 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.515 2.143 . . . . 1.0 111.837 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.406 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 27.0 m -97.44 145.69 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.027 0.442 . . . . 1.0 111.382 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 139' ' ' HIS . 4.4 m-20 -91.1 147.02 34.74 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.553 -0.749 . . . . 1.0 110.913 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -38.75 -28.69 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.199 1.933 . . . . 1.0 111.288 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.654 ' O ' HBC1 ' A' ' 203' ' ' CYC . 47.9 t -67.6 -53.15 30.58 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.671 ' CE1' HD11 ' A' ' 143' ' ' LEU . 19.4 t-80 -73.54 -24.99 60.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.316 -0.856 . . . . 1.0 110.602 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 30.4 t -50.99 -55.94 5.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.353 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -65.14 -41.46 94.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -43.17 -50.4 6.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.534 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.671 HD11 ' CE1' ' A' ' 139' ' ' HIS . 77.4 mt -72.51 -48.1 43.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.525 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.3 tmtm? -57.27 -43.07 82.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.511 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 87.8 p -55.2 -27.34 45.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 39.4 mtt -92.25 -3.48 55.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.536 -0.756 . . . . 1.0 109.186 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.12 22.77 72.75 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.357 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.648 HG11 ' HB2' ' A' ' 169' ' ' HIS . 10.2 m -104.83 122.73 58.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.72 -0.392 . . . . 1.0 109.953 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -76.36 -37.22 57.56 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -130.22 170.57 13.91 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.185 -0.606 . . . . 1.0 111.579 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.473 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 3.4 p -158.92 139.64 12.65 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.02 0.438 . . . . 1.0 112.157 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 tp -116.31 140.02 49.77 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -134.33 154.54 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.463 0.649 . . . . 1.0 111.739 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 153' ' ' VAL . 74.6 t -157.21 108.21 1.89 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 114.767 -1.106 . . . . 1.0 109.267 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.78 113.88 3.9 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 123.659 2.906 . . . . 1.0 113.847 -175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.72 105.88 3.9 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.78 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.7 ptm -132.19 147.07 52.4 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.334 -0.546 . . . . 1.0 111.835 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.628 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 11.7 t-80 -118.07 115.58 25.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.628 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 79.8 m-70 59.32 -122.98 1.19 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.761 -0.459 . . . . 1.0 109.761 -177.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -92.99 7.59 43.44 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.883 0.327 . . . . 1.0 111.883 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.3 mp0 -114.65 146.03 41.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 162' ' ' LEU . 6.5 mp -106.94 117.41 33.98 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 114.525 -1.216 . . . . 1.0 108.809 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.42 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.2 m95 -96.15 -26.67 15.38 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.899 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.27 -170.88 28.79 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.261 -0.971 . . . . 1.0 112.041 -178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.9 tp -141.67 137.29 31.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 1.0 111.216 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.417 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 5.1 tp -99.11 142.8 30.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.31 135.88 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.595 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.3 p -120.8 142.51 49.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.718 -0.674 . . . . 1.0 110.046 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.648 ' HB2' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -150.03 127.99 11.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.127 0.489 . . . . 1.0 111.021 179.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.561 ' O ' ' O ' ' A' ' 171' ' ' ALA . 3.8 p80 -166.58 156.52 11.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.704 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 170' ' ' HIS . . . -46.14 -170.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.607 -0.269 . . . . 1.0 111.448 178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -103.61 104.96 45.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.261 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.404 ' CD ' ' H ' ' A' ' 174' ' ' ARG . 36.2 Cg_endo -92.35 -48.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.676 2.251 . . . . 1.0 110.908 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.404 ' H ' ' CD ' ' A' ' 173' ' ' PRO . 9.6 ptp180 -179.43 156.83 0.84 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.065 -0.971 . . . . 1.0 112.691 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.89 162.89 2.3 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.848 2.365 . . . . 1.0 111.119 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -111.82 146.38 37.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.822 0.344 . . . . 1.0 110.744 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.0 t -99.68 143.12 30.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.23 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.14 -31.93 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.646 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.05 -54.52 43.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.337 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.42 -30.64 71.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.904 0.383 . . . . 1.0 110.743 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.16 -35.1 74.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.538 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -68.58 -52.75 28.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.407 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.0 t -44.44 -47.38 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.259 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 187' ' ' LEU . 27.3 m -75.01 -36.81 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.69 ' NE2' HH22 ' A' ' 101' ' ' ARG . 58.7 tt0 -46.94 -35.84 6.98 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.098 -1.075 . . . . 1.0 108.098 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 186' ' ' LEU . 3.6 tt -72.1 -43.46 64.73 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 114.641 -1.163 . . . . 1.0 109.412 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' A' ' 184' ' ' VAL . 39.0 tp -53.96 -33.17 56.17 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.662 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.47 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.95 -37.27 62.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.618 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -56.21 -38.09 70.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.705 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -53.16 -51.83 60.74 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.12 -42.46 79.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.265 -0.879 . . . . 1.0 109.889 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.3 m -51.86 -37.12 50.86 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.61 -33.47 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.048 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.37 -47.13 58.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.101 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.0 tp -62.4 -33.12 57.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.527 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.96 -53.59 8.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.898 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -56.28 -28.36 58.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.893 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.68 -34.3 52.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.253 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -58.17 -39.98 80.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.188 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.86 -57.62 5.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.155 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.4 t -58.14 -44.17 87.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 1.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.0 tp . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 118.059 -0.972 . . . . 1.0 110.373 179.657 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.654 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 198' ' ' ALA . 16.0 mt . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.397 . . . . 1.0 110.579 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -63.12 -46.67 86.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.294 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.18 -52.7 45.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.244 0.461 . . . . 1.0 112.244 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -55.05 -50.09 66.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.687 0.625 . . . . 1.0 112.687 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.8 mt -64.42 -23.97 67.47 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.541 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.553 ' O ' HG12 ' A' ' 39' ' ' VAL . 61.0 ttt180 -58.23 -36.1 72.68 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.651 -0.419 . . . . 1.0 109.925 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.3 -28.35 38.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.3 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.413 ' HG1' ' H ' ' A' ' 39' ' ' VAL . 50.6 p -69.36 -49.87 51.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.507 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.553 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.9 p -53.08 -36.32 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.838 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 75.2 mm-40 -65.24 -38.41 90.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.841 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.15 -44.91 87.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.924 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.08 -44.08 95.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 47' ' ' GLY . 1.3 tmm_? -62.43 -51.64 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.843 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' N ' ' HE ' ' A' ' 43' ' ' ARG . . . -58.49 -40.06 81.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.847 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -78.76 -51.49 9.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.794 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.0 tp -76.51 -5.58 48.13 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.087 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.29 17.71 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-N 115.716 -0.675 . . . . 1.0 112.415 178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -74.48 141.85 44.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.431 -0.508 . . . . 1.0 110.108 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.581 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.7 m-20 -57.48 -33.39 67.94 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.911 0.708 . . . . 1.0 112.911 -178.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.531 ' H ' HG22 ' A' ' 48' ' ' THR . 46.2 ttp180 -152.28 119.82 6.03 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 119.18 -1.008 . . . . 1.0 113.577 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 13.3 p -139.14 134.88 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.716 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 29.3 pttt -145.62 161.9 38.74 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.377 -0.529 . . . . 1.0 111.566 -177.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.5 t -98.44 136.77 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.006 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.418 ' O ' ' N ' ' A' ' 165' ' ' LEU . 43.8 t80 -121.0 119.11 31.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.113 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -100.07 170.08 8.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.21 -0.45 . . . . 1.0 109.925 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 72.3 t80 -134.32 138.78 45.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.526 -0.47 . . . . 1.0 112.124 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -102.45 148.79 35.97 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.761 -0.654 . . . . 1.0 109.306 178.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -64.36 -21.22 66.81 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.729 2.286 . . . . 1.0 112.965 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -81.3 -0.57 41.57 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.563 -0.455 . . . . 1.0 111.038 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.33 -11.51 54.72 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.855 177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.6 m-70 -89.34 146.44 24.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.383 0.592 . . . . 1.0 110.976 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.8 144.68 15.37 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.461 -1.056 . . . . 1.0 110.461 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 53.8 p -129.26 148.21 51.17 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.184 0.516 . . . . 1.0 112.275 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.78 120.99 57.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.937 -1.134 . . . . 1.0 107.937 176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.46 ' C ' HD11 ' A' ' 78' ' ' LEU . 4.3 m -112.04 8.1 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.688 0.625 . . . . 1.0 112.688 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' N ' HD11 ' A' ' 78' ' ' LEU . . . -154.06 146.37 23.88 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -166.75 127.69 1.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 119.296 -0.962 . . . . 1.0 113.186 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.1 139.07 47.92 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -127.53 141.46 51.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.138 -0.625 . . . . 1.0 111.569 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.15 107.59 3.1 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.417 -1.073 . . . . 1.0 110.417 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.23 16.95 0.1 OUTLIER Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.264 -1.134 . . . . 1.0 110.264 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.7 tt0 71.99 28.87 2.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.791 -0.364 . . . . 1.0 111.104 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.8 ttm180 -57.55 -58.24 9.16 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.722 -1.214 . . . . 1.0 107.722 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.8 mt -90.65 158.63 42.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.31 162.49 33.69 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 C-N-CA 122.09 1.86 . . . . 1.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -85.9 108.9 18.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.119 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD11 ' NH1' ' A' ' 50' ' ' ARG . 48.9 mt -84.1 -1.47 54.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 1.0 111.56 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.46 HD11 ' C ' ' A' ' 65' ' ' VAL . 8.4 tp -62.44 139.54 58.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.349 0.595 . . . . 1.0 112.289 -177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.567 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.0 -4.12 74.36 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-N 115.343 -0.844 . . . . 1.0 111.121 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.8 mp -102.41 131.04 49.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.913 0.387 . . . . 1.0 110.774 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.01 119.81 25.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.508 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.447 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 7.8 m-85 -106.95 132.96 20.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.302 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -79.61 155.8 24.43 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.214 1.943 . . . . 1.0 111.72 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -67.9 -21.08 65.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.798 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.19 -22.07 0.84 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.036 -0.826 . . . . 1.0 111.036 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -59.03 -27.8 65.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.82 0.343 . . . . 1.0 110.619 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.573 ' O ' ' O ' ' A' ' 88' ' ' PRO . 8.6 mt -107.86 106.28 58.16 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.332 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.5 Cg_exo -48.47 -125.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.505 2.136 . . . . 1.0 112.35 178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 20.6 pt-20 -142.91 -43.08 0.3 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 22.7 pt-20 -68.83 -39.8 79.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.062 -0.517 . . . . 1.0 111.723 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.62 -46.09 84.1 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.007 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.433 HH21 HD22 ' A' ' 162' ' ' LEU . 76.7 ttt180 -63.24 -30.62 71.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.553 -178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -56.66 -51.13 69.93 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.323 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 94' ' ' LEU . 10.4 mp -55.71 -35.33 65.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.849 -0.341 . . . . 1.0 110.571 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.405 ' CE2' ' O2A' ' A' ' 203' ' ' CYC . 7.9 m-85 -63.36 -31.49 72.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.207 0.527 . . . . 1.0 109.625 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 tpp85 -87.16 -15.16 39.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.518 -0.765 . . . . 1.0 110.042 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.48 -42.67 4.73 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.03 -4.78 13.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.517 0.932 . . . . 1.0 113.517 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.632 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 96.4 mt-30 27.06 69.65 0.05 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 101' ' ' ARG . 6.8 t -109.76 -49.21 6.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 104.435 -2.431 . . . . 1.0 104.435 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.702 ' NH1' HE22 ' A' ' 185' ' ' GLN . 0.6 OUTLIER 63.06 70.56 0.54 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.137 -1.392 . . . . 1.0 114.311 172.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.566 ' C ' HD12 ' A' ' 103' ' ' ILE . 15.0 p -153.11 136.74 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.706 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.566 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -108.71 127.76 64.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG12 ' N ' ' A' ' 105' ' ' ASP . 34.3 t -83.53 166.89 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.29 0.848 . . . . 1.0 113.29 -177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.675 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.1 m-20 -53.68 119.44 4.93 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.26 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.0 m -58.01 -13.2 2.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.404 -0.816 . . . . 1.0 110.876 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -87.61 -38.04 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.89 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.32 -13.72 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.384 0.611 . . . . 1.0 110.059 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 51.3 54.77 10.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.066 -0.97 . . . . 1.0 113.409 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.8 t -93.94 133.62 37.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 105.381 -2.081 . . . . 1.0 105.381 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -128.21 140.92 51.64 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.025 1.491 . . . . 1.0 115.025 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 136' ' ' ASP . 80.0 p -99.54 147.03 25.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.17 -1.377 . . . . 1.0 107.316 176.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 6.0 mt -146.9 152.27 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.681 -0.807 . . . . 1.0 112.135 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.1 t -91.5 171.36 9.24 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.21 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.4 OUTLIER -149.17 152.84 36.95 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.667 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.38 -13.65 12.18 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.635 2.223 . . . . 1.0 112.239 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.39 -28.12 69.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.509 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 119' ' ' TRP . 29.5 t 54.89 -171.26 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.675 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.493 ' N ' ' OG ' ' A' ' 118' ' ' SER . 38.6 m95 53.8 170.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.502 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.94 29.69 45.85 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 121' ' ' LEU . 1.6 tt -150.69 -61.17 0.19 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.787 0.327 . . . . 1.0 110.564 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 85.0 p -60.7 -22.79 64.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.14 -14.61 56.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 60.92 79.55 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.871 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.7 m -99.51 146.8 32.41 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.114 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.68 129.87 14.08 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.54 2.16 . . . . 1.0 111.202 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.7 mt 43.26 -134.25 0.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.67 11.64 76.8 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.689 -0.564 . . . . 1.0 111.689 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -156.81 148.35 17.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.661 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -43.48 157.55 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.354 2.036 . . . . 1.0 111.706 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.446 ' O ' ' OE1' ' A' ' 132' ' ' GLN . 25.3 mt -82.06 25.71 0.56 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.244 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 131' ' ' LEU . 25.7 mm100 -134.08 163.96 28.41 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.096 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 1.6 mmp_? -122.39 80.37 45.84 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.286 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -47.75 147.63 6.88 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.494 2.129 . . . . 1.0 111.816 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.515 ' HB ' ' HD1' ' A' ' 139' ' ' HIS . 14.6 m -95.72 151.58 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.063 0.459 . . . . 1.0 111.329 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.468 ' OD1' ' OG ' ' A' ' 112' ' ' SER . 1.3 m-20 -84.89 156.32 61.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.527 -0.761 . . . . 1.0 110.909 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -56.34 -26.52 62.57 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.216 1.944 . . . . 1.0 111.234 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.6 OUTLIER -74.51 -34.81 63.14 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.06 -0.718 . . . . 1.0 109.06 176.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.515 ' HD1' ' HB ' ' A' ' 135' ' ' VAL . 46.2 t-80 -81.47 -31.56 32.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.657 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.0 t -52.29 -50.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.33 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -65.99 -43.88 86.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.28 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -44.19 -52.07 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.508 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -73.16 -46.2 52.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.501 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.0 OUTLIER -59.51 -42.76 92.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.52 -179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 t -53.83 -32.53 53.18 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.189 -0.671 . . . . 1.0 109.189 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 40.7 mtt -84.51 -1.89 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.113 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.1 23.85 76.03 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.352 -0.84 . . . . 1.0 112.233 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.9 t -105.03 124.92 60.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -83.53 -35.52 24.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.808 0.67 . . . . 1.0 112.808 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -131.5 169.37 16.18 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.102 -0.639 . . . . 1.0 111.565 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.58 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.0 m -162.61 139.47 7.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.106 0.479 . . . . 1.0 112.15 -177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.57 139.69 50.21 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.561 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.9 m -135.13 157.81 40.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.803 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.3 t -158.98 91.91 1.95 Allowed Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.388 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.46 115.37 2.04 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.636 2.891 . . . . 1.0 113.922 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 44.9 mt -73.29 105.87 4.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.859 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.442 ' O ' ' OG ' ' A' ' 192' ' ' SER . 16.7 ptm -130.92 146.43 52.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.235 0.54 . . . . 1.0 111.836 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' ND1' ' CB ' ' A' ' 196' ' ' ALA . 84.5 t60 -119.51 115.68 24.53 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 49.1 t60 64.02 -126.71 0.48 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.722 -0.473 . . . . 1.0 109.722 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.456 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.5 mt-30 -92.66 5.28 51.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.855 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 46.9 mp0 -115.09 150.69 35.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.433 HD22 HH21 ' A' ' 92' ' ' ARG . 13.1 tp -106.24 117.34 33.79 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 114.517 -1.219 . . . . 1.0 108.86 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.425 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 84.0 m95 -97.4 -28.83 13.83 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.731 -0.388 . . . . 1.0 111.864 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.65 -171.93 24.22 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.22 -0.99 . . . . 1.0 111.962 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.701 HD23 HMB2 ' A' ' 203' ' ' CYC . 3.9 tp -138.8 129.69 26.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.565 -0.318 . . . . 1.0 111.205 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -94.52 139.06 31.66 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.412 ' CG2' ' CE1' ' A' ' 169' ' ' HIS . 9.7 p -151.19 132.83 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.532 -179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.739 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 1.5 m -115.22 140.57 48.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.75 -0.659 . . . . 1.0 110.05 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.739 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -135.5 141.48 45.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.114 0.483 . . . . 1.0 110.992 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.44 ' O ' HG13 ' A' ' 148' ' ' VAL . 1.6 p-80 -158.2 154.27 27.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.5 -0.773 . . . . 1.0 109.742 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.94 67.94 10.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.415 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -178.79 134.75 0.3 Allowed Pre-proline 0 N--CA 1.466 0.338 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.298 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 174' ' ' ARG . 20.0 Cg_exo -38.34 -38.39 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.726 2.284 . . . . 1.0 110.82 176.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 173' ' ' PRO . 59.2 ttm-85 26.88 78.8 0.24 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 114.983 -1.008 . . . . 1.0 112.678 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.55 148.2 83.22 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.861 2.374 . . . . 1.0 111.136 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -110.96 141.45 44.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.809 0.337 . . . . 1.0 110.721 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 75.1 m -96.17 153.93 17.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.267 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -64.29 -41.22 96.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 1.0 111.641 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.99 -53.49 54.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.583 -0.281 . . . . 1.0 111.324 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 37.4 mp0 -71.41 -24.22 62.01 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.884 0.373 . . . . 1.0 110.677 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -61.44 -45.65 93.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.934 -0.576 . . . . 1.0 111.505 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HG3' ' H ' ' A' ' 183' ' ' VAL . 10.9 pt20 -67.56 -48.66 66.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.417 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 46.4 t -43.68 -51.16 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.243 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 7.5 p -74.48 -36.05 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.702 HE22 ' NH1' ' A' ' 101' ' ' ARG . 63.0 tp60 -48.24 -37.95 17.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.084 -1.08 . . . . 1.0 108.084 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.89 -40.27 65.72 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.375 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.1 tt -55.71 -32.42 63.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.687 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.517 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.54 -37.7 62.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.701 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -56.96 -40.36 76.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.85 -0.614 . . . . 1.0 109.741 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -52.66 -54.09 38.27 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 75.5 t -54.39 -40.69 49.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.923 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 157' ' ' MET . 3.5 t -50.1 -30.17 10.51 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 109.222 -0.658 . . . . 1.0 109.222 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.4 mm -77.63 -39.43 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.056 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.69 -45.67 67.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.133 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 17.7 tt -62.01 -35.64 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -76.48 -54.77 6.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.863 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -55.94 -28.52 57.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.781 -0.645 . . . . 1.0 110.949 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.461 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.36 -35.23 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.336 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.43 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 83.6 tt0 -57.77 -39.76 78.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.133 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 16.9 tp -68.52 -58.04 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.047 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.7 m -56.86 -44.25 81.99 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.786 -0.366 . . . . 1.0 110.403 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.43 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 7.8 tp . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.984 -1.007 . . . . 1.0 110.425 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.716 HAB1 ' NZ ' ' A' ' 52' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.2 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.358 . . . . 1.0 110.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.2 p-10 -61.96 -42.54 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.259 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 96.3 mt-30 -68.81 -52.0 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.197 0.443 . . . . 1.0 112.197 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 ' O ' HG23 ' A' ' 38' ' ' THR . 1.4 mp -60.78 -34.54 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.22 -23.67 60.4 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.748 -0.381 . . . . 1.0 111.512 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -62.56 -52.85 61.81 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.632 -0.427 . . . . 1.0 109.965 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.22 -35.02 77.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.359 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.8 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.3 p -67.82 -46.5 71.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.526 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 68' ' ' ALA . 10.1 t -59.28 -38.42 74.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.903 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -69.31 -37.74 77.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.778 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -67.31 -43.98 80.31 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 1.0 112.01 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.1 t -65.44 -51.11 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.861 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.4 tmt_? -52.73 -44.6 66.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.834 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.82 68.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.806 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -83.21 -46.2 12.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.734 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -77.53 -8.5 57.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.072 0.463 . . . . 1.0 110.144 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 49.56 17.88 1.44 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.632 -0.713 . . . . 1.0 112.405 178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -77.07 144.85 38.26 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.159 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' O ' ' N ' ' A' ' 70' ' ' GLY . 94.1 m-20 -54.56 -34.16 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.597 ' H ' HG22 ' A' ' 48' ' ' THR . 9.0 ttm180 -152.61 122.62 7.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 119.168 -1.013 . . . . 1.0 113.595 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.1 t -130.42 132.09 64.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HE2' HBB2 ' A' ' 203' ' ' CYC . 19.5 pttm -146.64 155.74 42.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.576 -177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.66 138.98 20.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.97 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -122.43 119.81 32.09 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.058 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -100.21 170.64 8.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.242 -0.436 . . . . 1.0 109.864 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.9 t80 -133.22 141.89 48.29 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.191 0.441 . . . . 1.0 112.191 -178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.0 m-20 -105.52 149.42 37.82 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.371 178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.35 -25.95 63.73 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.696 2.264 . . . . 1.0 112.961 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -76.52 -5.38 47.32 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.941 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.19 -12.69 44.46 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.839 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -88.03 144.64 26.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.388 0.594 . . . . 1.0 110.967 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 143.85 15.3 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.9 p -127.37 146.69 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.346 0.498 . . . . 1.0 112.346 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.19 118.34 46.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -111.9 4.52 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.73 145.38 21.16 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 88.9 tt0 -166.46 127.44 1.71 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.362 -0.935 . . . . 1.0 113.215 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -107.06 140.66 39.53 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.178 -1.045 . . . . 1.0 108.178 176.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ptt-85 -129.75 141.89 50.79 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.512 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.94 106.16 2.84 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.431 -1.068 . . . . 1.0 110.431 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.19 -88.72 0.01 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.294 -1.122 . . . . 1.0 110.294 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' GLY . 23.0 pt-20 -176.77 31.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.109 178.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -66.51 -54.12 27.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD13 HH21 ' A' ' 50' ' ' ARG . 28.6 mt -95.33 151.93 39.0 Favored Pre-proline 0 C--N 1.329 -0.284 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.76 171.57 16.42 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.07 1.846 . . . . 1.0 112.504 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.4 m -92.73 135.29 34.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.055 -0.521 . . . . 1.0 110.148 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.58 -9.22 15.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 1.0 111.618 -178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.583 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 17.6 tp -50.73 138.79 17.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.363 0.601 . . . . 1.0 112.212 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.69 -1.87 79.27 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.993 -0.843 . . . . 1.0 110.993 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.471 HD23 ' CZ ' ' A' ' 82' ' ' PHE . 61.3 tp -100.51 125.92 46.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.836 0.35 . . . . 1.0 110.757 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.543 HG23 ' O ' ' A' ' 81' ' ' THR . 8.9 t -84.08 122.23 28.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.488 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.659 ' CG ' HAB2 ' A' ' 203' ' ' CYC . 47.7 m-85 -108.07 138.81 20.21 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -82.25 155.06 16.74 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.136 1.89 . . . . 1.0 111.646 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.531 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -65.56 -21.11 66.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.827 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 87' ' ' ILE . . . -49.8 -24.82 6.44 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.6 ' OD2' ' HHB' ' A' ' 203' ' ' CYC . 19.1 p-10 -47.86 -13.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.817 0.341 . . . . 1.0 110.663 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.479 ' N ' ' C ' ' A' ' 85' ' ' GLY . 3.5 pt -135.91 137.96 26.57 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.224 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.522 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 61.5 Cg_endo -80.68 -114.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.534 2.156 . . . . 1.0 112.374 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -141.82 -66.12 0.41 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.91 0.386 . . . . 1.0 111.881 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -47.79 -43.09 27.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.682 -178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HB1' HBD1 ' A' ' 203' ' ' CYC . . . -67.78 -53.07 30.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.964 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.481 HH21 ' CD2' ' A' ' 162' ' ' LEU . 24.6 ttt180 -54.47 -27.86 40.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.053 -0.521 . . . . 1.0 111.57 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.566 ' O ' ' N ' ' A' ' 97' ' ' LEU . 22.1 mmt180 -63.68 -46.15 86.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.493 -0.321 . . . . 1.0 111.297 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 98' ' ' ALA . 39.6 mt -49.99 -42.61 49.42 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.564 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 30.3 m-85 -64.99 -29.88 70.83 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -90.24 -18.96 24.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.558 -0.746 . . . . 1.0 110.102 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tt -104.76 -45.34 4.62 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.426 0.899 . . . . 1.0 113.426 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -111.1 -2.78 15.72 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.7 mt-30 28.29 67.2 0.08 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 114.014 1.116 . . . . 1.0 114.014 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -109.38 -50.51 6.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 104.385 -2.45 . . . . 1.0 104.385 174.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.692 HH21 HG13 ' A' ' 154' ' ' VAL . 3.0 mtp180 64.79 70.38 0.48 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.072 -1.422 . . . . 1.0 114.304 172.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.581 ' C ' HD12 ' A' ' 103' ' ' ILE . 64.1 t -150.67 130.61 3.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.516 -0.474 . . . . 1.0 111.784 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.581 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.64 126.58 62.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.387 -0.968 . . . . 1.0 108.387 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.636 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.9 p -81.81 166.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.224 0.824 . . . . 1.0 113.224 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 104' ' ' VAL . 13.6 m-20 -52.2 120.82 5.88 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 114.658 -1.156 . . . . 1.0 112.328 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.475 ' O ' HG12 ' A' ' 106' ' ' VAL . 37.1 t -57.6 -11.53 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.333 -0.849 . . . . 1.0 110.737 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 109' ' ' GLN . 17.0 pt-20 -83.04 -38.95 21.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.851 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.98 1.11 0.46 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.396 0.617 . . . . 1.0 110.114 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.537 ' H ' ' C ' ' A' ' 107' ' ' GLU . 19.5 pt20 35.43 58.56 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.018 -0.992 . . . . 1.0 113.392 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 m -94.32 135.27 35.91 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.386 -2.079 . . . . 1.0 105.386 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.3 mtt85 -129.98 145.59 51.65 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.97 114.45 14.62 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 114.132 -1.394 . . . . 1.0 107.31 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 pt -119.21 -167.93 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 119.69 -0.804 . . . . 1.0 112.091 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 76.6 p -87.98 161.84 17.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.446 -0.797 . . . . 1.0 110.231 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -144.04 154.7 58.46 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.665 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.25 -6.62 15.76 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.681 2.254 . . . . 1.0 112.254 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.73 156.66 21.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.542 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -139.03 171.38 14.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.632 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 120' ' ' GLY . 50.8 t-105 62.96 179.93 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.553 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' CD1' ' A' ' 119' ' ' TRP . . . 87.42 23.43 40.11 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.981 -0.847 . . . . 1.0 110.981 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -154.05 -18.41 0.13 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.864 0.364 . . . . 1.0 110.587 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.8 m -59.93 -28.49 67.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.17 -17.49 19.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 57.98 91.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.3 144.64 30.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.075 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.2 140.98 31.67 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.553 2.169 . . . . 1.0 111.246 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.1 mp 43.45 -113.24 0.27 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 65.1 21.39 67.96 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' O ' ' O ' ' A' ' 130' ' ' PRO . 44.1 mt-10 -139.37 154.4 71.74 Favored Pre-proline 0 C--N 1.329 -0.321 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.611 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.407 ' O ' ' O ' ' A' ' 129' ' ' GLU . 79.6 Cg_exo -42.81 168.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.464 2.109 . . . . 1.0 111.654 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 32.7 mt -81.08 9.87 6.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.288 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.488 ' O ' ' NH2' ' A' ' 133' ' ' ARG . 14.1 pt20 -139.62 163.44 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.678 -0.409 . . . . 1.0 111.063 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.603 ' CA ' ' HE ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -118.43 108.62 41.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.327 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -80.9 145.98 16.08 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.587 2.191 . . . . 1.0 111.818 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.628 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.9 m -118.03 127.19 75.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.04 0.447 . . . . 1.0 111.389 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.776 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -39.94 163.74 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.888 179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.94 -19.68 34.94 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.265 1.977 . . . . 1.0 111.234 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 4.2 p -66.22 -37.52 85.75 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.628 ' ND1' HG21 ' A' ' 135' ' ' VAL . 40.4 t-80 -80.69 -28.34 36.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.632 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 106' ' ' VAL . 29.3 t -52.31 -53.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.444 -0.343 . . . . 1.0 110.322 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.512 ' O ' ' N ' ' A' ' 145' ' ' SER . 85.2 t60 -66.88 -42.15 86.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.296 178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -47.66 -56.9 6.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.503 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.521 HD13 ' NE2' ' A' ' 139' ' ' HIS . 1.2 tp -68.49 -50.38 52.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.527 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 21.1 tptm -57.35 -40.08 77.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 t -54.06 -32.49 54.73 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.193 -0.669 . . . . 1.0 109.193 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.5 mtt -83.46 1.15 43.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.706 -0.679 . . . . 1.0 109.264 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.52 25.3 75.64 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.214 -0.903 . . . . 1.0 112.33 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 169' ' ' HIS . 12.0 t -109.17 122.91 64.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.835 -0.432 . . . . 1.0 109.835 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.09 -30.43 49.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.446 ' O ' HG12 ' A' ' 148' ' ' VAL . 9.0 t -140.11 172.89 12.12 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.09 -0.644 . . . . 1.0 111.551 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 9.2 p -162.84 139.96 7.77 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.081 0.467 . . . . 1.0 112.141 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 57.1 tp -118.3 138.79 52.14 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.474 HG11 HAA1 ' A' ' 203' ' ' CYC . 2.3 m -133.04 158.98 43.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.418 0.628 . . . . 1.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.692 HG13 HH21 ' A' ' 101' ' ' ARG . 88.5 t -154.32 96.44 2.65 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.849 -1.069 . . . . 1.0 109.313 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -63.97 139.23 66.65 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 123.571 2.847 . . . . 1.0 113.957 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.59 105.56 17.72 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.736 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.449 ' O ' ' OG ' ' A' ' 192' ' ' SER . 89.1 mtp -117.54 139.06 51.45 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.322 -0.551 . . . . 1.0 111.906 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.632 ' CE1' ' CD2' ' A' ' 159' ' ' HIS . 26.6 t-80 -113.74 113.58 25.16 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.98 -1.118 . . . . 1.0 107.98 175.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.632 ' CD2' ' CE1' ' A' ' 158' ' ' HIS . 46.5 m-70 57.6 -123.0 1.55 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.764 -0.458 . . . . 1.0 109.764 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -94.23 10.99 31.8 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.923 0.342 . . . . 1.0 111.923 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 51.0 mp0 -119.87 153.64 35.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.047 1.129 . . . . 1.0 114.047 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.481 ' CD2' HH21 ' A' ' 92' ' ' ARG . 14.8 tp -108.83 112.25 24.41 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.882 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.432 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -95.5 -28.61 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.667 -0.413 . . . . 1.0 111.905 -178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -154.88 -175.9 26.5 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.21 -0.995 . . . . 1.0 111.944 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.45 133.6 24.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.812 0.339 . . . . 1.0 111.215 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.439 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.7 tp -99.93 135.78 40.85 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.155 -0.683 . . . . 1.0 109.155 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.2 t -148.17 120.87 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.381 -0.528 . . . . 1.0 111.538 -178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 p -108.89 148.74 30.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.021 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.692 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.06 148.22 29.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.058 0.456 . . . . 1.0 111.018 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 148' ' ' VAL . 3.0 p-80 -158.92 155.41 27.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.678 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.74 69.95 4.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.552 -0.295 . . . . 1.0 111.43 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -175.07 172.13 1.18 Allowed Pre-proline 0 N--CA 1.466 0.371 0 C-N-CA 120.41 -0.516 . . . . 1.0 112.326 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.467 ' O ' ' C ' ' A' ' 174' ' ' ARG . 42.3 Cg_endo -89.11 -47.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.697 2.265 . . . . 1.0 110.914 176.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' C ' ' O ' ' A' ' 173' ' ' PRO . 7.3 tpp180 23.32 88.29 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.058 -0.974 . . . . 1.0 112.723 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.08 151.32 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.791 2.327 . . . . 1.0 111.112 177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -109.99 144.21 38.86 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.756 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -96.5 146.69 24.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.314 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.05 -40.08 78.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.6 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -63.11 -54.48 37.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.575 -0.284 . . . . 1.0 111.419 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.05 -35.31 80.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.374 . . . . 1.0 110.738 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -61.61 -38.71 88.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.505 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -59.1 -55.67 32.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 92.2 t -43.87 -43.46 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.289 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 86.0 t -74.99 -37.64 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.464 -0.569 . . . . 1.0 109.464 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.496 ' CD ' HH12 ' A' ' 101' ' ' ARG . 60.9 tt0 -48.27 -37.21 15.66 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.92 -40.2 63.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.751 -1.113 . . . . 1.0 109.344 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 44.0 tp -54.99 -32.34 61.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.692 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.83 -35.25 67.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.679 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -56.28 -39.58 72.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.695 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? -53.64 -54.58 35.7 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.67 -44.11 84.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.226 -0.897 . . . . 1.0 109.834 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 157' ' ' MET . 10.1 t -51.68 -37.72 51.87 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 71.6 mt -78.2 -32.2 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.082 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.4 66.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.074 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -68.18 -24.26 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.66 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -77.24 -57.14 4.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.862 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -59.9 -27.34 66.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.885 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.56 58.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.355 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.421 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 41.3 tp10 -55.66 -37.02 67.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.163 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.25 -55.34 12.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.075 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.3 p -54.83 -42.07 71.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 1.0 110.303 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.421 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 27.3 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.422 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.776 HMD2 ' OD2' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 198' ' ' ALA . 17.4 mt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.843 0.354 . . . . 1.0 110.515 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 37.2 p-10 -64.04 -40.26 95.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.236 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.8 mt-30 -71.21 -54.24 11.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.205 0.446 . . . . 1.0 112.205 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -56.41 -44.79 81.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.3 mt -68.88 -26.38 65.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.522 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -56.43 -38.82 72.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.945 0.402 . . . . 1.0 109.998 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.97 -30.66 58.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.291 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.2 p -70.04 -45.44 67.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.479 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.536 HG12 ' HB2' ' A' ' 68' ' ' ALA . 55.2 t -57.61 -39.29 68.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.869 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -68.23 -37.89 81.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.817 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.2 -41.36 99.15 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.892 -0.595 . . . . 1.0 112.013 -179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.2 t -67.74 -45.91 83.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.866 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.533 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.0 tmm_? -53.74 -48.32 69.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.885 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.11 -36.76 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.854 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -80.24 -52.49 7.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.776 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.86 -7.39 55.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.959 0.409 . . . . 1.0 110.114 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.14 17.79 0.38 Allowed Glycine 0 CA--C 1.527 0.825 0 CA-C-N 115.713 -0.676 . . . . 1.0 112.457 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.642 HG21 HG13 ' A' ' 51' ' ' VAL . 15.1 t -77.37 146.77 36.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.096 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.1 m-20 -56.39 -33.08 65.42 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 75' ' ' PRO . 41.7 ttm-85 -153.39 127.44 9.02 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 119.174 -1.01 . . . . 1.0 113.533 -178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.642 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.72 132.33 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 107.973 -1.121 . . . . 1.0 107.973 176.236 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -145.73 161.07 40.75 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.365 -0.534 . . . . 1.0 111.54 -177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.5 t -99.38 137.49 26.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.955 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 165' ' ' LEU . 67.3 t80 -122.26 119.85 32.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.074 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.3 mtp-105 -100.07 171.11 8.03 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.473 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 67.0 t80 -133.96 136.68 44.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 1.0 112.084 -178.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -102.42 126.45 33.14 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.353 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -42.94 -28.61 1.26 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.68 2.253 . . . . 1.0 112.923 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -74.29 -7.73 53.8 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.029 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.06 -13.57 34.11 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.014 -0.612 . . . . 1.0 112.825 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -88.94 145.94 25.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.352 0.576 . . . . 1.0 110.862 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -125.61 145.45 15.71 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.9 p -128.82 148.28 50.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.223 0.535 . . . . 1.0 112.328 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 49.4 t -97.25 120.49 46.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.8 m -110.58 0.51 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -159.0 151.04 21.02 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.374 -0.602 . . . . 1.0 109.374 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE1' ' NH2' ' A' ' 50' ' ' ARG . 1.9 pp20? -169.25 131.79 1.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 119.36 -0.936 . . . . 1.0 113.209 -178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -113.45 142.56 45.76 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' C ' HH12 ' A' ' 43' ' ' ARG . 10.0 ptt85 -133.22 143.96 49.48 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.481 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.53 112.87 3.9 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.422 -1.071 . . . . 1.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.22 34.04 2.12 Favored Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.203 -1.159 . . . . 1.0 110.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.0 mt-10 54.57 31.52 15.16 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.892 -0.323 . . . . 1.0 111.14 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' NH1' ' HB3' ' A' ' 171' ' ' ALA . 26.6 ttm180 -60.65 -55.56 31.79 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.844 -1.169 . . . . 1.0 107.844 178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.457 ' HB2' ' HE ' ' A' ' 50' ' ' ARG . 81.9 mt -95.86 147.21 32.63 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.863 -1.162 . . . . 1.0 107.863 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 57.9 Cg_endo -70.67 170.77 16.86 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 C-N-CA 122.128 1.885 . . . . 1.0 112.528 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.43 ' HA ' HH22 ' A' ' 50' ' ' ARG . 23.1 t -89.08 130.11 35.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.158 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 46.8 mt -101.13 1.56 39.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 1.0 111.594 -178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.62 135.01 57.17 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.323 0.582 . . . . 1.0 112.24 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 92.63 -7.49 77.35 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.698 ' N ' HD12 ' A' ' 80' ' ' LEU . 7.8 mp -96.99 132.04 43.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.885 0.374 . . . . 1.0 110.737 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 23.8 m -90.87 117.9 29.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.455 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.0 m-85 -109.42 135.82 20.27 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.293 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -79.98 157.35 23.78 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.12 1.88 . . . . 1.0 111.628 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.473 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -69.9 -17.78 63.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.823 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -46.51 -22.23 0.99 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -57.31 -29.82 64.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.86 0.362 . . . . 1.0 110.634 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.525 ' CG2' ' HE ' ' A' ' 92' ' ' ARG . 58.4 mt -98.66 146.74 32.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.228 -178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' ' H ' ' A' ' 89' ' ' GLU . 5.0 Cg_endo -96.18 -142.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.465 2.11 . . . . 1.0 112.331 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 1.2 pt-20 -121.94 -76.54 0.59 Allowed 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.794 -0.363 . . . . 1.0 111.825 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -45.84 -40.53 9.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.779 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.577 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -66.84 -48.61 68.32 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.657 -0.417 . . . . 1.0 111.014 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.525 ' HE ' ' CG2' ' A' ' 87' ' ' ILE . 21.3 ttm180 -59.82 -29.46 68.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.555 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 97' ' ' LEU . 35.1 mtp180 -58.91 -46.79 87.07 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.537 -0.301 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.567 HD22 ' OE1' ' A' ' 129' ' ' GLU . 43.0 mt -55.12 -36.74 66.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.569 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' CZ ' ' O2A' ' A' ' 203' ' ' CYC . 9.9 m-85 -63.49 -35.18 79.6 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -91.32 -15.85 28.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.098 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 93' ' ' ARG . 2.8 tp -105.8 -45.53 4.36 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.33 0.863 . . . . 1.0 113.33 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.31 -3.67 12.46 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.515 0.931 . . . . 1.0 113.515 -176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 98' ' ' ALA . 94.3 mt-30 30.08 69.68 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 114.01 1.115 . . . . 1.0 114.01 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.4 t -112.9 -51.21 5.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.634 HH21 HG22 ' A' ' 154' ' ' VAL . 0.8 OUTLIER 62.82 74.09 0.44 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 113.997 -1.456 . . . . 1.0 114.286 172.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.7 m -150.85 132.42 5.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.72 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 103' ' ' ILE . 2.1 mp -107.84 128.15 63.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.432 -0.951 . . . . 1.0 108.432 177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.664 HG12 ' N ' ' A' ' 105' ' ' ASP . 44.9 t -82.36 165.99 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.272 0.841 . . . . 1.0 113.272 -176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.664 ' N ' HG12 ' A' ' 104' ' ' VAL . 12.9 m-20 -52.74 123.28 10.9 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-N 114.772 -1.104 . . . . 1.0 112.308 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -58.96 -10.47 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.395 -0.82 . . . . 1.0 110.707 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.0 pt-20 -85.94 -39.48 16.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.867 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.434 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -60.68 -15.29 27.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.372 0.606 . . . . 1.0 110.066 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 50.86 57.72 6.33 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.047 -0.979 . . . . 1.0 113.345 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.7 t -94.47 136.09 35.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.349 -2.093 . . . . 1.0 105.349 175.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -129.6 142.42 50.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 114.98 1.474 . . . . 1.0 114.98 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 136' ' ' ASP . 2.8 m -108.3 161.57 14.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.181 -1.372 . . . . 1.0 107.341 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.429 ' CG1' ' N ' ' A' ' 114' ' ' SER . 15.5 tt -166.9 168.64 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 119.708 -0.797 . . . . 1.0 112.153 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.429 ' N ' ' CG1' ' A' ' 113' ' ' ILE . 40.7 t -90.41 164.67 14.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.18 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -151.76 149.5 23.99 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.645 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -37.81 -41.02 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.679 2.253 . . . . 1.0 112.246 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.478 ' CD ' ' CH2' ' A' ' 119' ' ' TRP . 93.0 mt-10 -74.47 -74.12 0.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.533 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.1 t 41.73 38.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.574 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.478 ' CH2' ' CD ' ' A' ' 117' ' ' GLU . 5.5 m-90 -53.97 -35.55 61.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.547 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.55 8.99 65.22 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.6 mp 46.0 69.56 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 1.0 110.598 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.4 m -60.67 -27.46 67.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.585 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.52 -19.17 3.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.811 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 59.52 85.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.874 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.84 108.27 59.2 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.111 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -46.12 133.49 15.0 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.536 2.157 . . . . 1.0 111.223 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.657 ' N ' HD12 ' A' ' 127' ' ' LEU . 8.5 mp 46.49 -117.7 0.76 Allowed 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.591 -0.522 . . . . 1.0 109.591 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 63.46 -25.62 0.08 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.646 -0.582 . . . . 1.0 111.646 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.615 ' H ' ' C ' ' A' ' 127' ' ' LEU . 52.9 mt-10 -83.25 153.81 66.22 Favored Pre-proline 0 C--N 1.329 -0.293 0 O-C-N 122.677 -0.307 . . . . 1.0 110.675 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.53 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 78.6 Cg_exo -42.28 164.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.431 2.088 . . . . 1.0 111.634 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 43.4 mt -80.11 1.88 26.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.261 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -138.25 160.33 39.73 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.412 . . . . 1.0 111.056 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 130' ' ' PRO . 7.0 mpt_? -121.05 81.61 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.409 ' O ' ' OG ' ' A' ' 112' ' ' SER . 75.5 Cg_exo -49.23 144.46 17.04 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.508 2.139 . . . . 1.0 111.808 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.658 HG21 ' CE1' ' A' ' 139' ' ' HIS . 27.0 m -112.8 123.39 68.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 1.0 111.322 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 112' ' ' SER . 0.7 OUTLIER -37.02 154.55 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.907 178.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.5 -21.73 73.16 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.174 1.916 . . . . 1.0 111.261 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.493 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 12.8 p -63.05 -37.07 85.75 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 108.979 -0.749 . . . . 1.0 108.979 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.658 ' CE1' HG21 ' A' ' 135' ' ' VAL . 1.1 t-80 -80.83 -28.96 35.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.7 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 38.7 t -52.94 -55.2 13.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.339 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -66.96 -44.98 79.14 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.257 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -44.21 -50.99 8.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.473 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.532 HD13 ' NE2' ' A' ' 139' ' ' HIS . 0.8 OUTLIER -72.67 -46.44 53.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.454 179.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -57.76 -42.64 84.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.456 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 24.5 m -53.72 -34.34 58.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.192 -0.67 . . . . 1.0 109.192 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 43.2 mtt -82.35 -4.25 56.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.179 178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 72.16 25.26 74.98 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-N 115.25 -0.886 . . . . 1.0 112.268 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.97 120.84 57.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.96 -33.16 34.09 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.759 0.651 . . . . 1.0 112.759 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.4 t -138.48 170.49 15.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.199 -0.6 . . . . 1.0 111.569 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.9 t -163.01 139.82 7.47 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.204 -0.453 . . . . 1.0 112.185 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 61.9 tp -116.32 116.23 27.37 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 108.648 -0.871 . . . . 1.0 108.648 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.457 ' C ' HG23 ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.39 157.7 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.54 0.686 . . . . 1.0 111.79 -178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.634 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -156.02 95.73 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 114.815 -1.084 . . . . 1.0 109.295 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.425 ' HD2' ' NE ' ' A' ' 101' ' ' ARG . 58.4 Cg_endo -65.81 139.74 58.51 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 123.536 2.824 . . . . 1.0 113.929 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 42.8 mt -98.15 107.47 19.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.762 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 83.1 mtp -121.12 143.37 49.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.276 0.56 . . . . 1.0 111.775 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.487 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 41.6 t-80 -121.81 114.41 21.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.534 ' NE2' ' OE1' ' A' ' 160' ' ' GLN . 47.2 t60 65.05 -127.65 0.35 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.534 ' OE1' ' NE2' ' A' ' 159' ' ' HIS . 0.5 OUTLIER -94.53 10.01 36.3 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -120.19 158.62 26.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.007 1.114 . . . . 1.0 114.007 -177.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.9 117.31 32.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 114.55 -1.204 . . . . 1.0 108.872 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.431 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 80.0 m95 -95.18 -26.55 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.759 -0.377 . . . . 1.0 111.832 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.61 -173.04 26.5 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.249 -0.977 . . . . 1.0 111.987 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.2 tp -142.33 131.44 23.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.744 0.307 . . . . 1.0 111.251 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 1.9 tp -96.84 143.32 27.86 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 167' ' ' VAL . 8.6 p -150.0 130.41 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.409 -0.516 . . . . 1.0 111.524 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.589 ' OG ' HG21 ' A' ' 48' ' ' THR . 18.2 t -112.1 141.77 45.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.011 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.401 ' NE2' ' CG2' ' A' ' 167' ' ' VAL . 68.0 m-70 -139.55 142.04 37.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.108 0.48 . . . . 1.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -155.98 152.27 27.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.778 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.452 ' HB3' ' NH1' ' A' ' 73' ' ' ARG . . . -82.33 71.01 9.39 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 121.034 -0.266 . . . . 1.0 111.418 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -174.91 168.05 1.86 Allowed Pre-proline 0 N--CA 1.466 0.356 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.325 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -92.45 11.24 2.26 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.744 2.296 . . . . 1.0 110.908 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -30.95 113.35 0.32 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.032 -0.985 . . . . 1.0 112.692 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.13 152.28 21.25 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 122.867 2.378 . . . . 1.0 111.059 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.3 140.88 48.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.818 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 83.1 p -92.75 154.26 18.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.296 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 182' ' ' GLN . 13.8 pt20 -70.23 -39.01 75.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.624 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.23 -54.17 49.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.532 -0.303 . . . . 1.0 111.369 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -65.67 -30.04 70.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.895 0.378 . . . . 1.0 110.718 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.5 tp -61.57 -31.89 71.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.494 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 178' ' ' GLN . 0.3 OUTLIER -71.91 -55.96 6.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.366 . . . . 1.0 111.504 -178.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 51.4 t -42.97 -45.23 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.257 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 34.9 m -75.41 -33.69 28.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 182' ' ' GLN . 7.4 tt0 -50.91 -42.17 59.17 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.071 -1.085 . . . . 1.0 108.071 178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 186' ' ' LEU . 9.0 mp -67.66 -41.45 83.76 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 114.694 -1.139 . . . . 1.0 109.354 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.02 -28.87 59.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.697 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' A' ' 191' ' ' VAL . . . -70.8 -26.44 63.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.615 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -70.99 -36.0 72.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.682 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -53.8 -58.62 6.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 188' ' ' ALA . 17.9 m -60.27 -38.17 76.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.891 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 188' ' ' ALA . 15.8 m -52.39 -35.55 51.84 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 63.4 mt -78.95 -36.08 18.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.518 -0.764 . . . . 1.0 110.127 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.91 -46.81 61.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.727 -0.669 . . . . 1.0 111.084 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.1 tp -61.65 -34.56 62.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -75.69 -54.13 7.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.883 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -55.93 -28.56 57.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.955 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -77.05 -34.9 57.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.269 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -57.22 -38.57 73.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.183 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.35 -59.21 3.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.169 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 27.5 t -65.46 -50.91 63.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.938 0.399 . . . . 1.0 110.351 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.023 . . . . 1.0 110.417 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.577 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.81 0.338 . . . . 1.0 110.526 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -60.51 -49.2 78.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.267 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -62.51 -51.0 69.15 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 38' ' ' THR . 52.5 mt -56.67 -42.28 76.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.636 0.606 . . . . 1.0 112.636 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.6 mt -67.0 -24.1 66.0 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.561 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -60.84 -40.39 92.66 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.654 -0.418 . . . . 1.0 109.973 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.32 -30.58 60.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.365 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.8 p -69.51 -46.94 65.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.534 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 68' ' ' ALA . 38.2 t -57.55 -40.96 77.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.883 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' OE1' ' NH2' ' A' ' 43' ' ' ARG . 78.7 mm-40 -72.64 -36.7 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.809 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -63.96 -55.15 24.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.767 -0.651 . . . . 1.0 112.023 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 43' ' ' ARG . 8.8 p -59.67 -44.09 92.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.827 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 tmm_? -51.91 -45.47 64.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.817 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.85 -35.7 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.839 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -81.26 -47.23 13.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.821 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -77.21 -6.08 51.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.971 0.415 . . . . 1.0 110.124 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.59 17.6 0.5 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.464 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -76.28 143.4 40.93 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.439 -0.504 . . . . 1.0 110.053 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 70' ' ' GLY . 50.0 p30 -65.96 -21.95 66.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.886 0.699 . . . . 1.0 112.886 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.703 HH21 ' CD2' ' A' ' 169' ' ' HIS . 44.4 ttp180 -155.12 119.29 4.65 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 119.221 -0.992 . . . . 1.0 113.579 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 39' ' ' VAL . 3.3 t -137.54 133.67 46.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.963 -1.125 . . . . 1.0 107.963 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -147.22 160.11 42.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.432 -0.507 . . . . 1.0 111.625 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.94 137.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.002 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.507 ' O ' ' N ' ' A' ' 165' ' ' LEU . 38.7 t80 -121.36 119.33 31.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.074 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.6 mtm180 -100.11 167.83 10.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.815 -0.439 . . . . 1.0 109.815 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.33 134.19 46.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.098 0.475 . . . . 1.0 112.102 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -103.52 129.26 25.75 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.743 -0.662 . . . . 1.0 109.357 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -44.72 -23.88 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.698 2.265 . . . . 1.0 112.953 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -78.69 -8.58 58.84 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.994 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.69 -8.2 39.75 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.836 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -90.49 140.96 29.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.33 0.565 . . . . 1.0 110.938 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 81' ' ' THR . . . -118.24 135.57 11.7 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.504 -1.038 . . . . 1.0 110.504 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.9 p -124.0 144.05 50.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.268 0.556 . . . . 1.0 112.278 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.6 t -100.53 122.87 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.95 -1.129 . . . . 1.0 107.95 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.0 m -109.3 3.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.572 0.582 . . . . 1.0 112.572 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -158.96 149.41 19.66 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.454 -0.572 . . . . 1.0 109.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 84.5 tt0 -166.19 126.84 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.413 -0.915 . . . . 1.0 113.167 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.88 144.38 33.61 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.105 -1.072 . . . . 1.0 108.105 177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.4 ptt85 -134.57 141.28 46.62 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.52 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.76 110.34 3.66 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.444 -1.063 . . . . 1.0 110.444 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.1 15.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.326 0 N-CA-C 110.303 -1.119 . . . . 1.0 110.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.541 ' N ' ' O ' ' A' ' 70' ' ' GLY . 33.8 tt0 72.6 21.6 3.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.845 -0.342 . . . . 1.0 111.116 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -52.27 -57.03 10.96 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 68.4 mt -92.7 146.93 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 N-CA-C 107.791 -1.188 . . . . 1.0 107.791 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.25 162.81 40.95 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 122.068 1.845 . . . . 1.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.2 p -86.93 132.16 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.139 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.609 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 31.5 mt -105.83 -5.69 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.134 -0.485 . . . . 1.0 111.647 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.475 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 16.1 tp -48.26 134.34 14.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.307 0.575 . . . . 1.0 112.259 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.05 -40.48 3.07 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.007 -0.837 . . . . 1.0 111.007 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 81' ' ' THR . 2.1 tt -59.87 112.57 1.9 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.92 0.39 . . . . 1.0 110.739 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.51 ' N ' HD23 ' A' ' 80' ' ' LEU . 27.9 m -74.77 124.25 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.455 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.635 ' CD2' HBB3 ' A' ' 203' ' ' CYC . 6.2 m-85 -104.26 132.64 20.79 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.758 -0.655 . . . . 1.0 109.274 177.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.64 149.16 26.56 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.155 1.904 . . . . 1.0 111.713 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.59 -27.87 68.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.755 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.33 -22.75 0.64 Allowed Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -54.89 -33.64 62.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.817 0.342 . . . . 1.0 110.672 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.6 132.4 21.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.046 -0.524 . . . . 1.0 111.264 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.493 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 61.8 Cg_endo -80.22 -120.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.601 2.2 . . . . 1.0 112.292 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 95.5 mt-10 -141.72 -71.93 0.34 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.904 0.383 . . . . 1.0 111.828 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 22.2 pt-20 -42.8 -42.86 3.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.781 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -65.05 -52.64 54.71 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.732 -0.387 . . . . 1.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -55.75 -29.49 59.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.548 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.45 ' O ' ' N ' ' A' ' 97' ' ' LEU . 66.6 mtp85 -60.07 -47.38 86.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.319 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 94' ' ' LEU . 57.4 mt -51.7 -44.95 63.35 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.868 -0.333 . . . . 1.0 110.589 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 27.7 m-85 -59.64 -30.21 68.56 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -90.87 -13.05 34.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.618 -0.719 . . . . 1.0 110.126 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 93' ' ' ARG . 1.5 tp -105.61 -45.97 4.29 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.555 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -112.82 0.89 15.36 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.462 0.912 . . . . 1.0 113.462 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.9 mt-30 28.1 66.39 0.09 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 114.131 1.16 . . . . 1.0 114.131 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG13 ' N ' ' A' ' 101' ' ' ARG . 8.2 p -119.32 -47.61 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 104.379 -2.452 . . . . 1.0 104.379 173.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.547 ' N ' HG13 ' A' ' 100' ' ' VAL . 1.6 mtt180 64.79 -22.39 0.08 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.272 170.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.473 ' CG1' ' CD1' ' A' ' 176' ' ' TYR . 8.7 t -56.33 129.64 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.569 -0.452 . . . . 1.0 111.768 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 28.3 mt -107.11 132.68 53.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.411 ' H ' HG22 ' A' ' 104' ' ' VAL . 22.9 m -80.64 166.76 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 113.335 0.865 . . . . 1.0 113.335 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -51.36 120.38 5.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.233 -178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.0 p -56.07 -10.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.823 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 16.8 pt-20 -88.61 -37.33 15.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.905 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.8 -15.09 10.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.395 0.617 . . . . 1.0 110.088 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.443 ' HG3' HH11 ' A' ' 111' ' ' ARG . 40.9 tp60 51.58 59.91 4.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.019 -0.991 . . . . 1.0 113.437 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.6 m -91.68 138.0 31.91 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 105.447 -2.057 . . . . 1.0 105.447 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.443 HH11 ' HG3' ' A' ' 109' ' ' GLN . 67.3 mtm-85 -130.98 139.1 49.97 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -176.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.455 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 11.9 m -142.48 114.49 8.19 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.391 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 114' ' ' SER . 0.6 OUTLIER -119.68 -164.47 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 119.658 -0.817 . . . . 1.0 112.159 -179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.594 ' H ' HG22 ' A' ' 113' ' ' ILE . 71.2 m -88.96 166.21 14.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.264 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -141.3 157.71 65.6 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.655 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.29 -8.78 21.22 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.648 2.232 . . . . 1.0 112.307 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -140.55 130.08 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.553 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.2 t -146.93 132.83 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.56 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -154.17 174.51 14.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.72 70.78 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 111.014 -0.834 . . . . 1.0 111.014 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.2 mp -70.61 -46.9 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 1.0 110.575 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.4 t -69.55 -22.11 63.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.629 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.95 -39.53 71.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.808 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 55.4 ttt85 49.01 93.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 125' ' ' VAL . 35.4 m -119.15 118.04 32.98 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.107 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' LEU . 90.1 Cg_exo -46.16 130.98 14.15 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.563 2.175 . . . . 1.0 111.157 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.629 ' N ' HD12 ' A' ' 127' ' ' LEU . 9.3 mp 43.79 -166.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.598 -0.519 . . . . 1.0 109.598 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.95 -11.7 67.62 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 111.583 -0.607 . . . . 1.0 111.583 179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.418 ' CB ' ' HB2' ' A' ' 98' ' ' ALA . 10.7 mp0 -79.71 153.64 75.73 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.939 -0.304 . . . . 1.0 110.663 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HB2' HH12 ' A' ' 133' ' ' ARG . 93.8 Cg_exo -45.06 152.15 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.351 2.034 . . . . 1.0 111.652 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 131' ' ' LEU . 7.8 mp -81.38 0.27 38.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.228 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.534 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 14.7 pt20 -150.61 161.55 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.688 -0.405 . . . . 1.0 111.095 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.555 HH21 ' HB3' ' A' ' 98' ' ' ALA . 0.0 OUTLIER -118.51 82.8 20.0 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.338 178.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -50.6 149.8 13.05 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.62 2.213 . . . . 1.0 111.777 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.866 HG23 HG12 ' A' ' 140' ' ' VAL . 18.9 m -99.97 149.7 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.036 0.445 . . . . 1.0 111.332 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.683 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -89.65 144.21 31.53 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.522 -0.763 . . . . 1.0 110.947 -178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -38.92 -21.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.236 1.957 . . . . 1.0 111.258 177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.797 ' O ' HBC1 ' A' ' 203' ' ' CYC . 48.5 t -78.49 -46.27 20.04 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.624 ' CE1' HD13 ' A' ' 143' ' ' LEU . 40.1 t-80 -77.66 -38.78 46.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.381 -0.827 . . . . 1.0 110.639 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.866 HG12 HG23 ' A' ' 135' ' ' VAL . 2.6 m -51.82 -43.09 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.444 -0.344 . . . . 1.0 110.342 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.497 ' N ' ' CG2' ' A' ' 140' ' ' VAL . 47.1 t-80 -66.2 -43.44 86.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.225 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -46.98 -50.11 19.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.555 179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.624 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.9 mp -68.32 -50.98 49.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.456 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 147' ' ' GLY . 45.4 tptt -55.56 -40.66 72.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.46 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 27.8 m -54.82 -33.32 61.46 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 45.3 mtt -84.2 -2.87 57.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.218 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.67 24.61 75.36 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-N 115.221 -0.899 . . . . 1.0 112.341 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.67 HG21 ' CB ' ' A' ' 169' ' ' HIS . 9.6 p -108.46 124.12 64.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.31 -29.93 30.8 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.9 t -119.34 153.89 34.42 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.564 -177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.7 t -147.13 128.49 14.88 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.173 -0.467 . . . . 1.0 112.106 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -126.97 105.36 8.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 1.6 m -110.93 164.75 6.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.423 0.63 . . . . 1.0 111.838 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 154' ' ' VAL . 3.0 p -161.08 110.44 1.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 114.844 -1.071 . . . . 1.0 109.331 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -68.85 139.66 44.06 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.54 2.827 . . . . 1.0 113.865 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 28.8 mt -94.45 105.91 17.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.766 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 21.6 ptm -128.55 142.92 50.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.239 0.543 . . . . 1.0 111.899 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 51.8 t60 -114.09 115.52 27.67 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.601 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 17.5 m-70 60.33 -123.5 1.02 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 -177.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -93.49 7.03 46.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.884 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -116.28 151.99 34.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.939 1.089 . . . . 1.0 113.939 -176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.6 115.43 29.89 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.807 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.3 m95 -95.41 -28.12 15.09 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.701 -0.4 . . . . 1.0 111.87 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.34 -168.35 23.09 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 120.167 -1.016 . . . . 1.0 111.963 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 54' ' ' TYR . 5.4 tp -142.95 140.49 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 1.0 111.122 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.1 tp -110.07 145.46 37.05 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.555 HG21 HMB2 ' A' ' 203' ' ' CYC . 38.8 t -149.07 128.96 3.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.58 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 20.4 m -117.59 142.64 46.97 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.0 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.703 ' CD2' HH21 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -149.82 144.04 25.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.135 0.493 . . . . 1.0 111.016 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -152.84 150.99 29.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.544 -0.753 . . . . 1.0 109.685 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.85 69.66 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.572 -0.286 . . . . 1.0 111.467 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -147.3 118.49 4.58 Favored Pre-proline 0 N--CA 1.466 0.36 0 C-N-CA 120.398 -0.521 . . . . 1.0 112.34 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -89.76 71.93 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.714 2.276 . . . . 1.0 110.887 176.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -139.23 163.85 42.97 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 115.063 -0.972 . . . . 1.0 112.719 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -80.81 164.08 20.6 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.823 2.349 . . . . 1.0 111.086 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.585 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -106.53 154.74 20.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.803 0.335 . . . . 1.0 110.788 178.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.2 m -95.78 140.01 31.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.316 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -68.47 -35.23 77.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 1.0 111.595 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -58.25 -52.06 67.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.603 -0.271 . . . . 1.0 111.428 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -68.14 -33.73 75.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.937 0.399 . . . . 1.0 110.667 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 23.4 tp -55.16 -50.77 68.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.516 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.535 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 61.3 tp60 -59.11 -54.48 46.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.424 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.36 -46.93 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.31 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.89 -37.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.535 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 42.8 tt0 -48.0 -38.78 17.84 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.045 -1.094 . . . . 1.0 108.045 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.4 tt -71.79 -41.95 67.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.34 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.407 ' CD2' HG23 ' A' ' 42' ' ' VAL . 11.5 tp -54.84 -32.8 60.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.666 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.0 -39.3 61.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.685 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -56.84 -37.92 71.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.754 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -54.66 -52.9 60.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.2 t -56.54 -44.82 81.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.207 -0.906 . . . . 1.0 109.91 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.6 m -51.87 -38.52 56.36 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.26 -0.644 . . . . 1.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 76.7 mt -77.76 -32.18 17.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.061 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.82 67.02 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.7 pp -67.37 -24.09 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.695 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.16 -56.06 5.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 1.0 109.868 178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -57.45 -26.37 61.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.917 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.93 -34.93 57.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.334 -0.393 . . . . 1.0 111.357 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -58.52 -39.3 79.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.165 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.91 -59.23 3.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.123 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 86.6 p -58.25 -43.61 87.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.847 0.356 . . . . 1.0 110.323 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.42 179.851 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.797 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 31' ' ' LEU . 46.1 tp . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.883 0.373 . . . . 1.0 110.529 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 42.9 p-10 -55.62 -38.36 69.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.246 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.54 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 95.4 mt-30 -72.32 -51.33 21.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.192 0.442 . . . . 1.0 112.192 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.594 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -57.4 -45.54 85.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 112.615 0.598 . . . . 1.0 112.615 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 66.6 mt -69.73 -27.19 64.76 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.639 -0.424 . . . . 1.0 111.558 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -55.08 -38.02 67.54 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.619 -0.432 . . . . 1.0 110.023 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.81 -31.89 57.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.374 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.7 p -68.26 -45.78 72.22 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.481 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG12 ' HB2' ' A' ' 68' ' ' ALA . 52.9 t -57.07 -38.98 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.902 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -77.75 -37.73 48.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -59.8 -53.68 55.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.802 -0.635 . . . . 1.0 111.947 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 43' ' ' ARG . 13.3 p -60.15 -44.61 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.664 -0.414 . . . . 1.0 110.867 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.4 ttp180 -49.87 -44.91 50.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.847 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.87 74.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.772 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -81.33 -50.45 9.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.747 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.96 -6.7 55.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.976 0.417 . . . . 1.0 110.123 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.35 18.85 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 115.703 -0.68 . . . . 1.0 112.478 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.592 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.41 141.05 43.29 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.375 -0.53 . . . . 1.0 110.028 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.643 ' O ' ' N ' ' A' ' 70' ' ' GLY . 96.0 m-20 -66.74 -23.9 66.16 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.916 0.71 . . . . 1.0 112.916 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.592 ' H ' HG22 ' A' ' 48' ' ' THR . 43.2 ttt85 -152.76 121.41 6.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 119.186 -1.006 . . . . 1.0 113.551 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.17 135.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.97 -1.122 . . . . 1.0 107.97 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -146.52 162.55 38.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.427 -0.509 . . . . 1.0 111.549 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -98.33 135.77 31.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.024 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' CD1' HBB1 ' A' ' 203' ' ' CYC . 62.1 t80 -118.36 118.53 32.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.046 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 34.1 mtm105 -99.83 168.31 9.98 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 67.6 t80 -134.97 138.93 44.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.071 0.462 . . . . 1.0 112.133 -178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.8 m-20 -103.06 147.87 34.77 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.753 -0.658 . . . . 1.0 109.378 178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.51 -19.9 65.45 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.69 2.26 . . . . 1.0 112.948 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.9 mp0 -82.3 -1.73 50.47 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.597 -0.441 . . . . 1.0 111.022 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.41 -11.37 54.42 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.995 -0.621 . . . . 1.0 112.824 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -89.3 144.82 25.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.361 0.58 . . . . 1.0 110.961 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -124.23 144.01 15.13 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.449 -1.06 . . . . 1.0 110.449 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.7 p -128.47 146.98 50.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.23 0.538 . . . . 1.0 112.3 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.89 118.65 52.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.15 6.61 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.626 0.602 . . . . 1.0 112.626 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.12 146.68 23.12 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.423 -0.584 . . . . 1.0 109.423 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 37.1 tt0 -166.44 128.68 1.85 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.369 -0.933 . . . . 1.0 113.13 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.616 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -109.89 138.22 46.57 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 44.0 ptt85 -131.19 141.28 50.04 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.197 -0.601 . . . . 1.0 111.498 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -83.33 109.05 3.09 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.407 -1.077 . . . . 1.0 110.407 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 49.32 -85.35 0.01 OUTLIER Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.6 pt-20 178.2 31.28 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.135 178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -68.71 -25.62 64.86 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 6.9 mt -122.85 148.47 53.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 11.8 Cg_exo -74.03 164.55 34.16 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 122.016 1.81 . . . . 1.0 112.428 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -85.99 134.21 33.87 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.205 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' H ' HH22 ' A' ' 50' ' ' ARG . 91.6 mt -109.53 -3.02 17.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.147 -0.479 . . . . 1.0 111.641 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.21 139.01 57.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.367 0.603 . . . . 1.0 112.191 -177.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.28 -3.24 84.03 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.351 -0.84 . . . . 1.0 111.015 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 tp -101.2 128.43 47.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.894 0.378 . . . . 1.0 110.835 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 81' ' ' THR . 9.6 t -85.88 125.19 33.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.444 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.423 ' CB ' HAB2 ' A' ' 203' ' ' CYC . 18.7 m-85 -103.15 128.63 27.21 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.721 -0.672 . . . . 1.0 109.282 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.36 161.15 25.78 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.126 1.884 . . . . 1.0 111.666 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.12 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.776 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.53 -29.3 0.71 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.141 -0.784 . . . . 1.0 111.141 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -45.99 -28.64 1.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.798 0.332 . . . . 1.0 110.62 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' PRO . 6.8 mt -137.93 99.54 9.16 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.258 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' ILE . 42.4 Cg_exo -40.63 -103.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.534 2.156 . . . . 1.0 112.325 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 92.7 mt-10 -135.65 -71.34 0.47 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.7 -0.4 . . . . 1.0 111.797 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' HA ' HH11 ' A' ' 93' ' ' ARG . 22.7 pt-20 -42.67 -38.77 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.775 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -69.45 -53.14 20.72 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.697 -0.401 . . . . 1.0 110.97 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -57.2 -31.8 65.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 1.0 111.542 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.561 ' O ' ' N ' ' A' ' 97' ' ' LEU . 77.3 mtt85 -60.47 -47.29 86.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.565 -0.289 . . . . 1.0 111.213 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.6 ' O ' ' N ' ' A' ' 98' ' ' ALA . 57.0 mt -50.23 -43.89 53.1 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.52 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' CE2' ' CG1' ' A' ' 100' ' ' VAL . 68.1 m-85 -59.29 -33.23 70.83 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.626 -0.509 . . . . 1.0 109.626 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.9 mtm180 -92.34 -21.0 20.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.061 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.561 ' N ' ' O ' ' A' ' 93' ' ' ARG . 5.5 tp -106.63 -50.45 3.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.349 0.87 . . . . 1.0 113.349 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -115.82 -5.81 12.07 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.457 0.91 . . . . 1.0 113.457 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 101' ' ' ARG . 95.1 mt-30 53.13 71.96 0.46 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.792 HG22 ' O ' ' A' ' 100' ' ' VAL . 1.9 p -63.28 59.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.825 ' N ' ' O ' ' A' ' 99' ' ' GLN . 40.6 ptt85 -56.41 -1.62 0.06 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 114.07 -1.423 . . . . 1.0 114.31 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 102' ' ' VAL . 14.9 p -152.68 131.81 3.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.458 -0.497 . . . . 1.0 111.732 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.9 mt -112.11 131.02 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.697 HG12 ' N ' ' A' ' 105' ' ' ASP . 25.1 t -83.22 168.39 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.697 ' N ' HG12 ' A' ' 104' ' ' VAL . 1.3 m-20 -55.15 119.07 4.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 114.758 -1.11 . . . . 1.0 112.267 -178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 m -58.02 -11.62 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.718 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.408 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 2.1 pp20? -84.87 -39.87 17.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.902 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.68 -12.91 4.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.366 0.603 . . . . 1.0 110.075 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 49.9 59.08 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.072 -0.967 . . . . 1.0 113.433 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.6 t -93.41 136.26 33.85 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 105.361 -2.088 . . . . 1.0 105.361 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -125.57 136.72 53.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.508 ' O ' HG23 ' A' ' 113' ' ' ILE . 93.6 p -102.81 150.07 23.85 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.135 -1.393 . . . . 1.0 107.358 177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 112' ' ' SER . 19.4 pt -155.19 159.47 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.696 -0.802 . . . . 1.0 112.113 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.7 t -86.4 164.01 17.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.185 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -149.28 157.17 39.7 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.722 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.93 -1.58 11.58 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.708 2.272 . . . . 1.0 112.262 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 118' ' ' SER . 84.7 tt0 -57.02 -23.89 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.524 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.3 p 82.29 142.07 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.627 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -49.35 -98.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.487 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.27 4.94 68.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.972 -0.851 . . . . 1.0 110.972 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 36.6 mt -90.99 4.31 52.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.872 0.367 . . . . 1.0 110.595 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 124' ' ' ARG . 88.5 p -60.39 -21.46 62.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.542 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -62.79 1.4 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.826 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 122' ' ' SER . 12.1 tpt180 55.62 90.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.885 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 125' ' ' VAL . 7.9 p -104.96 132.26 21.03 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.105 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 127' ' ' LEU . 85.6 Cg_endo -74.16 125.98 10.17 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.553 2.169 . . . . 1.0 111.143 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLU . 61.1 mt 40.38 -111.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 43.3 20.41 0.11 Allowed Glycine 0 CA--C 1.527 0.792 0 N-CA-C 111.681 -0.567 . . . . 1.0 111.681 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' LEU . 37.0 mm-40 -114.25 156.51 44.21 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.679 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -41.55 148.72 0.27 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.384 2.056 . . . . 1.0 111.711 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 40.7 mt -76.08 -20.3 57.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.276 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.484 ' O ' ' NE ' ' A' ' 133' ' ' ARG . 87.7 mt-30 -133.65 165.44 24.92 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.066 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.484 ' NE ' ' O ' ' A' ' 132' ' ' GLN . 0.0 OUTLIER -133.46 87.26 38.07 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.24 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.24 154.29 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.598 2.199 . . . . 1.0 111.817 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' ND1' ' A' ' 139' ' ' HIS . 16.0 m -98.85 148.05 6.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.117 0.485 . . . . 1.0 111.294 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 138' ' ' CYS . 0.6 OUTLIER -92.28 143.58 27.66 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.439 -0.8 . . . . 1.0 110.898 -178.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -38.67 -22.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.236 1.958 . . . . 1.0 111.227 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -74.9 -46.72 34.06 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.604 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 45.6 t-80 -78.39 -29.22 47.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.378 -0.828 . . . . 1.0 110.734 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.15 -55.01 16.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.321 -179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.448 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 86.7 t60 -63.79 -46.61 84.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.273 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.452 ' CD1' ' OC ' ' A' ' 203' ' ' CYC . 21.2 t80 -44.14 -48.61 9.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.488 -179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.713 ' CD1' HMA2 ' A' ' 203' ' ' CYC . 1.0 OUTLIER -71.71 -46.53 58.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.43 179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 147' ' ' GLY . 18.1 tptm -59.3 -40.08 85.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.49 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.448 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 17.9 m -54.27 -32.91 57.38 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.9 mtt -84.26 -2.2 56.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.674 -0.694 . . . . 1.0 109.208 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.87 22.51 75.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.287 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.718 HG11 ' HB3' ' A' ' 169' ' ' HIS . 43.0 t -105.65 123.59 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -35.39 30.31 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.741 0.645 . . . . 1.0 112.741 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.4 p -130.88 168.53 17.14 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.121 -0.632 . . . . 1.0 111.534 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 p -161.44 139.69 9.45 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.038 0.447 . . . . 1.0 112.16 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 24.0 tp -116.84 136.49 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.776 -0.824 . . . . 1.0 108.776 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.2 m -131.6 158.72 43.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.468 0.651 . . . . 1.0 111.821 -178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 153' ' ' VAL . 55.3 t -159.01 90.81 2.01 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 114.876 -1.056 . . . . 1.0 109.327 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.52 114.61 1.65 Allowed 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 123.559 2.839 . . . . 1.0 113.936 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 46.4 mt -71.86 105.37 3.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.42 -0.809 . . . . 1.0 109.788 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.8 ptm -135.1 147.04 49.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 1.0 111.869 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 30.3 t-80 -118.22 115.12 24.11 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 77.9 t60 59.9 -123.31 1.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -177.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.614 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 30.7 tt0 -93.04 8.44 39.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -114.94 143.87 44.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.982 1.104 . . . . 1.0 113.982 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.3 tp -106.4 115.55 30.4 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 114.489 -1.232 . . . . 1.0 108.853 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 76.0 m95 -100.63 -27.93 13.13 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.725 -0.39 . . . . 1.0 111.852 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.1 -171.73 24.38 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.283 -0.96 . . . . 1.0 112.031 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -139.99 131.26 26.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.803 0.335 . . . . 1.0 111.193 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -96.75 136.86 36.7 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.195 -0.669 . . . . 1.0 109.195 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.6 t -149.61 129.98 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.385 -0.526 . . . . 1.0 111.574 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.3 m -116.43 146.83 42.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.017 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.718 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -145.09 142.75 29.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 1.0 111.029 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 11.7 t60 -150.86 151.42 32.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.488 -0.778 . . . . 1.0 109.752 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.433 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.76 69.73 9.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.471 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -173.25 126.72 0.48 Allowed Pre-proline 0 N--CA 1.466 0.334 0 C-N-CA 120.375 -0.53 . . . . 1.0 112.3 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -88.54 111.13 0.62 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.582 2.188 . . . . 1.0 110.889 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 36.0 ptt85 -157.38 163.42 24.96 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 114.99 -1.004 . . . . 1.0 112.694 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.85 152.4 22.11 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.786 2.324 . . . . 1.0 111.098 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -106.88 127.0 53.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.805 0.336 . . . . 1.0 110.819 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.0 m -67.37 133.54 49.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.307 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -69.42 -35.61 75.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.616 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -60.74 -54.82 40.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.63 -0.259 . . . . 1.0 111.333 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.63 -32.13 73.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.925 0.393 . . . . 1.0 110.682 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.6 tp -62.24 -41.27 98.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.481 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.32 -56.3 23.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.543 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -45.0 -45.03 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.574 -0.451 . . . . 1.0 110.27 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -75.44 -36.72 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -47.68 -36.79 11.71 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.014 -1.106 . . . . 1.0 108.014 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.9 mt -72.02 -40.38 68.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.386 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.5 tp -55.61 -31.76 62.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.755 -0.657 . . . . 1.0 109.692 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.438 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.95 -39.34 56.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 1.0 109.641 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -57.12 -39.03 74.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.936 -0.575 . . . . 1.0 109.732 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -53.21 -52.64 58.24 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.9 t -56.2 -40.55 65.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.82 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.5 p -51.54 -33.61 32.86 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 60.1 mt -79.02 -36.62 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.062 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -46.45 65.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.642 -0.708 . . . . 1.0 111.114 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 196' ' ' ALA . 8.8 tp -61.57 -36.14 71.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.164 0.507 . . . . 1.0 109.666 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.465 ' HB2' ' CD2' ' A' ' 158' ' ' HIS . . . -74.84 -53.46 9.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.52 -0.763 . . . . 1.0 109.93 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -55.56 -28.84 57.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.891 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.73 -33.93 52.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 1.0 111.216 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.38 -41.14 84.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 1.0 111.14 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 30.6 mt -66.2 -58.59 5.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.092 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.5 p -57.75 -43.97 85.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.884 0.373 . . . . 1.0 110.358 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.938 -1.03 . . . . 1.0 110.457 179.739 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.713 HMA2 ' CD1' ' A' ' 143' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.466 HD11 ' CD1' ' A' ' 195' ' ' ILE . 12.8 tp . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.853 0.359 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 25.2 p-10 -63.09 -51.02 68.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.261 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 98.8 mt-30 -61.32 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.238 0.459 . . . . 1.0 112.238 -178.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.684 ' O ' HG23 ' A' ' 38' ' ' THR . 4.4 mm -57.8 -37.94 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.591 0.589 . . . . 1.0 112.591 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.2 mt -71.34 -23.32 61.9 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.526 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -64.97 -42.32 94.66 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.011 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.32 -30.12 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.374 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.4 p -69.41 -46.66 66.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.572 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 68' ' ' ALA . 13.0 t -55.2 -37.16 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.835 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.35 -38.7 85.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.777 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -62.22 -41.77 98.69 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.87 -0.605 . . . . 1.0 111.973 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -68.0 -40.97 84.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.879 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLY . 5.2 tmm_? -57.95 -50.16 74.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.871 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.76 86.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.9 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -77.48 -52.88 8.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.824 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.1 tp -76.67 -3.64 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.042 0.449 . . . . 1.0 110.14 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.24 17.11 0.19 Allowed Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.487 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.623 HG21 HG13 ' A' ' 51' ' ' VAL . 6.2 t -77.89 147.56 35.02 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.44 -0.504 . . . . 1.0 110.058 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.604 ' O ' ' N ' ' A' ' 70' ' ' GLY . 33.2 p-10 -69.02 -11.6 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.895 0.702 . . . . 1.0 112.895 -177.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.603 ' NH2' ' CD2' ' A' ' 169' ' ' HIS . 30.7 ttp180 -163.73 122.0 1.91 Allowed 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 119.115 -1.034 . . . . 1.0 113.487 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -139.96 133.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.003 -1.11 . . . . 1.0 108.003 176.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -145.36 159.65 42.74 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.556 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -99.65 135.83 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.015 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' CD1' HBB3 ' A' ' 203' ' ' CYC . 75.5 t80 -118.32 118.28 31.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 1.0 111.054 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -99.24 166.97 10.96 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -132.22 134.05 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.569 -0.452 . . . . 1.0 112.15 -178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.48 129.56 25.79 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.727 -0.669 . . . . 1.0 109.283 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -44.86 -26.91 2.19 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.675 2.25 . . . . 1.0 112.976 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -76.21 -7.83 55.72 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.996 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.52 -11.61 42.85 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.048 -0.596 . . . . 1.0 112.832 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -88.46 142.75 27.46 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.363 0.582 . . . . 1.0 110.941 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -122.37 141.57 14.26 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.421 -1.072 . . . . 1.0 110.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 78.7 p -127.21 146.56 50.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.267 0.556 . . . . 1.0 112.374 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 78' ' ' LEU . 25.3 t -95.75 118.82 42.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.997 -1.112 . . . . 1.0 107.997 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.03 -1.59 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.37 150.5 21.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.43 -0.582 . . . . 1.0 109.43 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 67' ' ' GLU . 0.5 OUTLIER -168.65 131.31 1.37 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 119.35 -0.94 . . . . 1.0 113.125 -178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -114.46 144.92 42.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -133.25 144.52 49.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.247 -0.581 . . . . 1.0 111.574 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -88.04 113.17 3.99 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.488 -1.045 . . . . 1.0 110.488 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.59 19.07 0.13 Allowed Glycine 0 CA--C 1.521 0.407 0 N-CA-C 110.244 -1.143 . . . . 1.0 110.244 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 70' ' ' GLY . 38.6 tt0 68.72 28.9 5.45 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.194 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.8 ttm-85 -58.2 -55.52 33.96 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mt -95.43 149.87 36.74 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.31 170.01 20.92 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.066 1.844 . . . . 1.0 112.506 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.1 t -89.92 127.71 36.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.143 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 mt -98.88 -1.31 40.43 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.655 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 67' ' ' GLU . 9.4 tp -61.39 135.3 57.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.359 0.599 . . . . 1.0 112.179 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.51 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 93.61 -8.11 74.39 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.696 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.1 mp -98.11 131.79 44.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.939 0.399 . . . . 1.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.0 m -90.56 120.83 31.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.383 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' A' ' 62' ' ' GLY . 8.7 m-85 -106.39 135.69 19.46 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.34 178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.53 154.24 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.192 1.928 . . . . 1.0 111.672 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -69.44 -24.44 63.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.796 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.58 -20.09 0.19 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 84' ' ' ALA . 88.8 m-20 -58.46 -30.76 67.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 1.0 110.659 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.408 ' HA ' ' HHA' ' A' ' 203' ' ' CYC . 23.0 mt -111.91 132.73 21.84 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.265 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.75 -111.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.536 2.157 . . . . 1.0 112.27 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 90' ' ' GLU . 13.2 tm-20 -150.99 -66.28 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.804 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 21.1 pt-20 -44.56 -43.7 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.743 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.668 ' CB ' HAD1 ' A' ' 203' ' ' CYC . . . -63.19 -43.38 98.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.916 0.389 . . . . 1.0 110.974 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HD22 ' A' ' 162' ' ' LEU . 59.8 ttt180 -64.34 -28.01 69.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.985 -0.552 . . . . 1.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.585 ' HE ' HD23 ' A' ' 121' ' ' LEU . 66.9 mtp85 -56.95 -49.85 74.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.272 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.03 -38.1 62.11 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.581 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 8.4 m-85 -64.24 -29.85 70.93 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -90.31 -13.66 34.77 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.575 -0.738 . . . . 1.0 110.128 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.16 -43.78 4.31 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.464 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.57 -3.73 13.6 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 -176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.541 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.8 mt-30 27.24 70.69 0.05 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.112 1.153 . . . . 1.0 114.112 178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.572 HG13 ' N ' ' A' ' 101' ' ' ARG . 11.2 p -112.64 -48.36 5.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 104.43 -2.434 . . . . 1.0 104.43 175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.617 ' NH1' ' NE2' ' A' ' 185' ' ' GLN . 12.1 mtm180 63.42 74.36 0.42 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.077 -1.42 . . . . 1.0 114.24 172.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.2 p -152.54 135.57 7.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.761 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 135' ' ' VAL . 3.0 mt -107.86 125.9 64.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 108.369 -0.974 . . . . 1.0 108.369 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.621 HG22 ' N ' ' A' ' 105' ' ' ASP . 7.5 p -82.79 166.28 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.621 ' N ' HG22 ' A' ' 104' ' ' VAL . 23.7 t0 -54.33 120.25 6.31 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 114.713 -1.131 . . . . 1.0 112.336 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.7 m -56.72 -9.42 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.738 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -87.27 -35.83 18.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.831 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.32 -16.83 49.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.363 0.601 . . . . 1.0 110.076 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 51.38 53.05 13.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.086 -0.961 . . . . 1.0 113.45 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.03 135.6 34.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.385 -2.08 . . . . 1.0 105.385 175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -129.46 142.8 50.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.552 ' OG ' ' N ' ' A' ' 136' ' ' ASP . 81.9 p -101.43 154.06 19.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.11 -1.405 . . . . 1.0 107.322 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 112' ' ' SER . 20.4 pt -154.92 158.28 3.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 119.649 -0.821 . . . . 1.0 112.164 -178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 84.0 p -89.67 172.3 9.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.496 -0.775 . . . . 1.0 110.189 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 150.09 53.53 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -35.85 -74.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.614 2.21 . . . . 1.0 112.297 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tm-20 -86.27 -44.25 12.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.506 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.0 t 60.02 107.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.596 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -139.56 -173.24 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.576 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.26 2.86 57.85 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.1 mp -83.87 -50.13 8.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.936 0.398 . . . . 1.0 110.619 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 124' ' ' ARG . 19.7 m -63.68 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.656 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -61.01 0.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.788 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.495 ' H ' ' C ' ' A' ' 122' ' ' SER . 54.0 ttp180 62.38 102.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.906 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.15 126.78 49.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.055 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' O ' ' C ' ' A' ' 127' ' ' LEU . 84.6 Cg_endo -76.5 178.48 7.5 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.549 2.166 . . . . 1.0 111.204 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.581 ' C ' ' O ' ' A' ' 126' ' ' PRO . 45.5 mt -28.59 -72.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.467 -0.493 . . . . 1.0 109.676 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 41.26 33.91 0.88 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.591 -0.604 . . . . 1.0 111.591 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 130' ' ' PRO . 2.7 pt-20 -115.29 83.75 10.7 Favored Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.68 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 129' ' ' GLU . 83.4 Cg_exo -45.6 179.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.392 2.062 . . . . 1.0 111.685 175.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.83 16.81 0.19 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.351 -0.386 . . . . 1.0 111.304 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 130' ' ' PRO . 2.8 pt20 -164.81 168.37 17.86 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.104 178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.609 ' NH2' HG22 ' A' ' 135' ' ' VAL . 63.2 ttp85 -143.89 132.43 11.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.309 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.91 142.65 14.03 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.515 2.143 . . . . 1.0 111.896 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.609 HG22 ' NH2' ' A' ' 133' ' ' ARG . 16.7 t -133.35 140.1 47.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.012 0.434 . . . . 1.0 111.355 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.552 ' N ' ' OG ' ' A' ' 112' ' ' SER . 0.5 OUTLIER -39.76 156.17 0.16 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.883 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -59.21 -7.33 4.86 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.196 1.93 . . . . 1.0 111.308 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 31.2 m -56.45 -51.47 68.31 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.47 ' CE1' HG23 ' A' ' 140' ' ' VAL . 5.1 p-80 -71.7 -25.74 62.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.329 -0.85 . . . . 1.0 110.591 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.47 HG23 ' CE1' ' A' ' 139' ' ' HIS . 27.9 t -56.91 -64.13 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.364 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.541 ' CE1' ' OG ' ' A' ' 145' ' ' SER . 31.7 t-80 -69.25 -50.69 44.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.202 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.881 ' CD2' HBA1 ' A' ' 203' ' ' CYC . 68.0 t80 -42.66 -48.06 5.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.446 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' CD2' ' NE2' ' A' ' 169' ' ' HIS . 85.1 mt -73.56 -45.32 54.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.508 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.552 ' O ' ' N ' ' A' ' 147' ' ' GLY . 41.9 tptt -60.18 -41.7 93.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.418 . . . . 1.0 110.42 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.541 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 15.2 m -53.42 -31.11 43.64 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.5 mtt -89.82 -2.04 58.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.199 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.11 26.16 71.53 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.251 -0.886 . . . . 1.0 112.348 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 t -106.37 120.7 57.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.971 0.386 . . . . 1.0 109.962 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.14 -34.47 32.46 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.792 0.664 . . . . 1.0 112.792 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -134.92 170.06 16.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.15 -0.62 . . . . 1.0 111.595 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.561 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 39.1 m -163.68 139.82 6.7 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.037 0.446 . . . . 1.0 112.124 -177.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.424 HD13 ' CG ' ' A' ' 176' ' ' TYR . 21.9 tp -114.03 139.26 49.42 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.5 m -132.46 156.78 42.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.437 0.637 . . . . 1.0 111.82 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.527 HG13 ' NE2' ' A' ' 185' ' ' GLN . 74.4 t -156.84 91.6 2.47 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 114.818 -1.083 . . . . 1.0 109.262 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.45 130.58 39.3 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 123.694 2.929 . . . . 1.0 113.893 -177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.1 mt -86.89 104.83 16.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.795 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.8 mtp -119.2 144.63 46.61 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.871 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.456 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 86.1 t60 -124.73 113.3 17.79 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.951 -1.129 . . . . 1.0 107.951 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.488 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 53.3 t60 65.17 -127.17 0.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.488 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.8 mm100 -95.15 12.21 29.55 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.905 0.335 . . . . 1.0 111.905 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -120.72 157.47 29.59 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.89 1.07 . . . . 1.0 113.89 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 162' ' ' LEU . 0.9 OUTLIER -110.95 115.53 29.64 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 114.493 -1.231 . . . . 1.0 108.848 177.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.456 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.5 m95 -93.44 -25.78 17.5 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.958 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -161.58 -167.94 22.75 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.152 -1.023 . . . . 1.0 111.941 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.52 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.6 tp -144.21 129.78 19.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.767 0.317 . . . . 1.0 111.231 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.7 tp -93.56 138.31 31.95 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.33 133.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.597 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.679 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 25.1 p -114.47 142.91 45.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.029 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.679 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.3 OUTLIER -133.92 139.51 46.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 1.0 111.08 179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.426 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.7 p-80 -156.09 155.07 31.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.747 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.24 69.51 10.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.469 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 177.15 153.57 0.42 Allowed Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 120.392 -0.523 . . . . 1.0 112.349 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_exo -44.34 -58.68 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.713 2.276 . . . . 1.0 110.831 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 50.5 ttt85 43.72 72.41 1.19 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.083 -0.962 . . . . 1.0 112.696 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.61 149.41 89.88 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.798 2.332 . . . . 1.0 111.044 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 5.9 m-85 -114.36 141.53 47.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 1.0 110.82 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -99.21 150.88 21.62 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.245 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.81 -38.76 89.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.654 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 47.6 mp0 -65.59 -55.34 18.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.708 0.289 . . . . 1.0 111.333 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.53 -34.23 77.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.942 0.401 . . . . 1.0 110.717 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.6 tp -63.89 -39.48 94.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.467 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -58.73 -53.66 55.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.508 -0.315 . . . . 1.0 111.415 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 98.2 t -46.4 -45.98 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 187' ' ' LEU . 40.0 t -74.75 -37.96 43.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.466 -0.568 . . . . 1.0 109.466 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.617 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 49.4 tp60 -47.84 -35.33 10.08 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 20.2 tp -73.44 -40.08 64.48 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.734 -1.121 . . . . 1.0 109.367 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 184' ' ' VAL . 42.5 tp -55.07 -31.79 61.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.715 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.489 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.51 -38.07 62.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.64 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -55.54 -39.53 70.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.853 -0.612 . . . . 1.0 109.73 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -52.09 -52.39 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.078 -0.712 . . . . 1.0 109.078 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.4 t -58.07 -41.17 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.854 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.9 m -52.45 -36.17 54.1 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.62 -41.54 24.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.082 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.23 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.099 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.466 ' CD1' HD11 ' A' ' 31' ' ' LEU . 3.1 tp -61.49 -35.85 69.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.607 -0.516 . . . . 1.0 109.607 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -72.07 -53.91 11.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.659 -0.7 . . . . 1.0 109.904 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -55.66 -26.43 44.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.921 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.41 -34.92 58.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.286 -178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -57.73 -38.98 76.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.138 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.61 ' N ' HD12 ' A' ' 200' ' ' LEU . 8.6 mp -66.99 -58.44 4.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.131 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 26.5 t -50.54 -40.85 52.92 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.312 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.369 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.881 HBA1 ' CD2' ' A' ' 142' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.923 0.392 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -65.18 -41.11 94.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.965 -0.562 . . . . 1.0 111.252 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -71.1 -54.13 12.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.848 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -58.33 -32.44 45.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 -177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -75.53 -25.12 56.92 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.729 -0.389 . . . . 1.0 111.555 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.484 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -64.34 -36.32 83.75 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.616 -0.434 . . . . 1.0 109.974 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.24 -30.12 43.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.407 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 34' ' ' ILE . 37.5 p -74.77 -49.02 22.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.553 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 36' ' ' ARG . 5.2 p -53.43 -33.9 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.833 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -72.94 -35.52 67.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.874 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -65.38 -43.18 91.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.972 -178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 56.1 t -65.21 -51.74 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.676 -0.41 . . . . 1.0 110.89 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' GLY . 20.2 ttp180 -49.95 -43.84 50.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.868 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 -36.41 75.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.806 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -80.73 -50.73 9.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.809 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.32 -6.84 54.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 1.0 110.072 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.51 18.94 1.06 Allowed Glycine 0 CA--C 1.528 0.848 0 CA-C-N 115.682 -0.69 . . . . 1.0 112.445 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.87 142.29 42.18 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.428 -0.509 . . . . 1.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 70' ' ' GLY . 90.5 m-20 -58.32 -32.88 68.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.587 ' H ' HG22 ' A' ' 48' ' ' THR . 58.8 ttp180 -152.45 120.8 6.33 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.148 -1.021 . . . . 1.0 113.595 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.89 135.53 42.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.673 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 20.8 pttp -144.77 161.0 40.33 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.376 -0.529 . . . . 1.0 111.551 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.33 137.07 25.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.011 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.7 t80 -122.27 118.48 28.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.014 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -99.57 170.59 8.48 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 27.8 t80 -134.57 136.74 43.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.039 0.447 . . . . 1.0 112.166 -177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 1.1 m-20 -102.17 148.53 35.53 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.299 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.61 -22.96 70.35 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.681 2.254 . . . . 1.0 112.971 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -79.39 -2.07 40.06 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.632 -0.427 . . . . 1.0 111.029 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 102.18 -10.5 56.77 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.894 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.84 148.03 22.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 117.344 0.572 . . . . 1.0 110.95 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.87 149.7 18.53 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.424 -1.07 . . . . 1.0 110.424 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 28.3 p -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.222 0.534 . . . . 1.0 112.347 -178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.2 t -102.67 116.67 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 107.977 -1.12 . . . . 1.0 107.977 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.1 m -112.36 5.23 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.672 0.619 . . . . 1.0 112.672 -177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.07 145.89 23.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.592 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.0 tt0 -166.2 126.97 1.74 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 119.378 -0.929 . . . . 1.0 113.216 -178.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.06 138.07 46.94 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.143 -1.058 . . . . 1.0 108.143 176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 36.9 ptt180 -129.61 142.43 50.74 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.544 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -85.49 106.23 2.99 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 55.84 -87.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.231 -1.148 . . . . 1.0 110.231 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 70' ' ' GLY . 19.5 pt-20 -179.27 31.36 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.783 -0.367 . . . . 1.0 111.115 177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 49' ' ' ASP . 7.1 ttp180 -70.11 -51.2 33.52 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.52 124.63 47.98 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 107.846 -1.168 . . . . 1.0 107.846 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -59.33 169.44 3.93 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 C-N-CA 122.133 1.889 . . . . 1.0 112.49 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.3 m -91.87 141.47 28.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.151 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.592 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 33.3 mt -113.28 -2.14 14.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.623 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.0 tp -56.83 138.17 53.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.329 0.585 . . . . 1.0 112.279 -177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.13 -4.04 84.49 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 115.425 -0.807 . . . . 1.0 111.088 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -100.47 117.72 35.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 1.0 110.82 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.654 ' N ' HD23 ' A' ' 80' ' ' LEU . 76.9 p -76.88 123.55 26.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.447 -178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE1' HD22 ' A' ' 80' ' ' LEU . 10.0 m-85 -107.17 135.07 19.66 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.724 -0.671 . . . . 1.0 109.288 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.92 150.97 23.95 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.128 1.885 . . . . 1.0 111.649 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -60.55 -25.78 66.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.849 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.45 -21.2 0.25 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 84' ' ' ALA . 84.5 m-20 -54.84 -32.65 60.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 1.0 110.592 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.554 HD12 HH21 ' A' ' 92' ' ' ARG . 3.5 pt -121.0 99.49 46.71 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.244 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.517 ' O ' ' O ' ' A' ' 87' ' ' ILE . 51.2 Cg_exo -42.11 -107.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.5 2.134 . . . . 1.0 112.317 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.436 ' CG ' ' N ' ' A' ' 90' ' ' GLU . 19.7 pt-20 -152.4 -46.14 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 1.0 111.83 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' N ' ' CG ' ' A' ' 89' ' ' GLU . 24.4 pt-20 -60.66 -39.09 87.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.71 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.18 98.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.9 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.554 HH21 HD12 ' A' ' 87' ' ' ILE . 29.4 ttm105 -66.34 -29.88 70.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.556 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -55.92 -55.29 34.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.318 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.638 HD22 ' NE ' ' A' ' 133' ' ' ARG . 5.5 tp -53.04 -43.42 66.59 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.543 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -59.35 -32.64 70.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.566 ' NH2' ' SD ' ' A' ' 157' ' ' MET . 9.6 mmp_? -87.34 -11.03 50.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.136 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 tp -106.85 -44.96 4.3 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.31 0.856 . . . . 1.0 113.31 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.57 -1.96 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.531 0.937 . . . . 1.0 113.531 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.587 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 97.6 mt-30 26.15 69.03 0.05 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.093 1.146 . . . . 1.0 114.093 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.659 ' N ' ' HE ' ' A' ' 101' ' ' ARG . 31.4 m -113.04 -50.96 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.405 -2.443 . . . . 1.0 104.405 175.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.659 ' HE ' ' N ' ' A' ' 100' ' ' VAL . 3.5 mtm180 63.66 72.38 0.47 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.052 -1.431 . . . . 1.0 114.256 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 102' ' ' VAL . 15.0 p -148.87 133.0 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 120.477 -0.489 . . . . 1.0 111.735 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.515 HG21 ' OG ' ' A' ' 151' ' ' SER . 2.4 mt -109.2 124.67 66.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 108.331 -0.989 . . . . 1.0 108.331 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.665 HG22 ' N ' ' A' ' 105' ' ' ASP . 11.6 p -83.16 167.71 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 113.274 0.842 . . . . 1.0 113.274 -176.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.665 ' N ' HG22 ' A' ' 104' ' ' VAL . 9.5 m-20 -55.54 119.18 5.26 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.711 -1.131 . . . . 1.0 112.268 -177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.67 -10.34 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.754 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.46 -36.93 16.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.906 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.28 -16.79 37.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.416 0.626 . . . . 1.0 110.145 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.499 HE21 ' HE ' ' A' ' 111' ' ' ARG . 44.8 tp60 51.8 58.35 5.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.982 -1.008 . . . . 1.0 113.455 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -94.1 137.82 32.86 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 175.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.499 ' HE ' HE21 ' A' ' 109' ' ' GLN . 98.3 mtt180 -127.82 133.21 49.4 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.547 ' O ' HG23 ' A' ' 113' ' ' ILE . 23.6 m -103.58 152.43 21.73 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.195 -1.366 . . . . 1.0 107.382 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 112' ' ' SER . 17.3 pt -156.53 160.35 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 119.689 -0.804 . . . . 1.0 112.189 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.0 m -89.18 165.94 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.229 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.718 ' O ' ' N ' ' A' ' 117' ' ' GLU . 36.1 mt-30 -153.05 150.88 25.05 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.639 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -41.37 74.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.651 2.234 . . . . 1.0 112.243 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.718 ' N ' ' O ' ' A' ' 115' ' ' GLN . 6.3 pt-20 178.36 55.87 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.55 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.0 t -57.41 -33.95 68.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.645 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -97.32 -168.78 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.593 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.39 3.27 60.02 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 40.4 mt -74.45 -24.76 59.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.85 0.357 . . . . 1.0 110.565 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.6 m -54.59 -28.4 45.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.602 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.9 -47.93 51.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.794 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 56.48 86.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.1 t -102.26 109.27 59.89 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.097 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -46.55 130.95 15.32 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.568 2.179 . . . . 1.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 21.2 mt 43.63 -124.83 0.86 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 54.77 15.12 5.93 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 98' ' ' ALA . 23.1 mt-10 -112.1 152.11 44.11 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.683 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.56 156.32 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.407 2.072 . . . . 1.0 111.663 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 31.1 mt -79.66 -0.67 34.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.284 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -145.61 162.09 38.29 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.714 -0.394 . . . . 1.0 111.111 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.638 ' NE ' HD22 ' A' ' 94' ' ' LEU . 10.7 tpp180 -120.8 86.65 41.36 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.258 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -52.33 147.6 28.24 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.512 2.142 . . . . 1.0 111.791 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.601 HG11 ' CE1' ' A' ' 139' ' ' HIS . 6.9 m -97.75 153.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.042 0.449 . . . . 1.0 111.373 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -89.09 155.81 49.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.497 -0.774 . . . . 1.0 110.891 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -55.23 -20.42 24.75 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.267 1.978 . . . . 1.0 111.164 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.717 ' O ' HBC1 ' A' ' 203' ' ' CYC . 45.0 t -69.89 -51.97 28.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 177.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.729 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -73.38 -27.28 61.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.325 -0.852 . . . . 1.0 110.634 -179.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' N ' ' ND1' ' A' ' 139' ' ' HIS . 25.4 t -52.9 -53.13 22.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.322 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.544 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 72.1 t60 -66.05 -44.09 85.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.209 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.661 ' CD2' HAA2 ' A' ' 203' ' ' CYC . 52.6 t80 -42.02 -48.56 4.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.467 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 143' ' ' LEU . 53.2 mt -74.19 -43.74 56.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.502 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 147' ' ' GLY . 40.1 tptt -61.02 -42.55 98.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.544 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 16.2 m -54.26 -32.29 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 42.9 mtt -88.18 -0.98 57.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.597 -0.729 . . . . 1.0 109.217 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.14 24.93 76.26 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-N 115.197 -0.911 . . . . 1.0 112.31 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 170' ' ' HIS . 11.0 t -106.84 120.41 58.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.912 -0.403 . . . . 1.0 109.912 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.47 -30.88 53.41 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.54 ' OG ' ' CD2' ' A' ' 170' ' ' HIS . 98.7 p -139.46 171.76 13.79 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.137 -0.625 . . . . 1.0 111.563 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.515 ' OG ' HG21 ' A' ' 103' ' ' ILE . 8.3 p -161.93 140.44 9.26 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.211 -0.45 . . . . 1.0 112.171 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 20.2 tp -115.4 139.42 50.03 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.3 OUTLIER -133.22 154.41 39.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.479 0.657 . . . . 1.0 111.821 -179.208 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 153' ' ' VAL . 54.8 t -158.19 91.29 2.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.295 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.72 134.7 54.82 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 123.521 2.814 . . . . 1.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 25.9 mt -94.76 107.89 19.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.772 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.566 ' SD ' ' NH2' ' A' ' 96' ' ' ARG . 15.8 ptm -128.7 146.89 50.76 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.403 -0.519 . . . . 1.0 111.906 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.455 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 65.7 t60 -117.79 115.41 24.93 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.486 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 60.5 t60 61.52 -124.61 0.83 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.789 -0.449 . . . . 1.0 109.789 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.486 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 36.5 mt-30 -93.24 5.01 53.01 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 1.0 111.92 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.43 150.74 32.32 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.1 tp -108.85 116.35 31.83 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 114.492 -1.231 . . . . 1.0 108.831 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.455 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 83.7 m95 -93.85 -24.87 17.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.79 -0.364 . . . . 1.0 111.898 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -164.79 -165.32 21.88 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.228 -0.987 . . . . 1.0 111.979 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.6 tp -143.55 133.31 23.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.804 0.335 . . . . 1.0 111.179 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 154' ' ' VAL . 3.5 tp -95.11 140.66 29.72 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.8 p -150.02 135.23 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.433 -0.507 . . . . 1.0 111.608 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.784 ' C ' ' HD1' ' A' ' 169' ' ' HIS . 0.9 OUTLIER -120.02 139.95 51.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.049 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.784 ' HD1' ' C ' ' A' ' 168' ' ' SER . 0.4 OUTLIER -136.51 142.15 43.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.133 0.492 . . . . 1.0 111.036 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.54 ' CD2' ' OG ' ' A' ' 150' ' ' SER . 4.2 p-80 -156.48 153.75 29.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.712 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -84.69 72.2 10.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.567 -0.288 . . . . 1.0 111.418 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 -173.2 135.16 0.69 Allowed Pre-proline 0 N--CA 1.465 0.291 0 C-N-CA 120.396 -0.522 . . . . 1.0 112.359 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -84.72 47.44 2.13 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.681 2.254 . . . . 1.0 110.885 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -78.65 131.77 66.92 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.031 -0.986 . . . . 1.0 112.756 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.55 149.97 35.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.856 2.37 . . . . 1.0 111.079 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 9.4 m-85 -108.77 150.07 28.13 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.847 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 80.3 p -100.19 146.59 26.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.75 -35.67 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 1.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 58.0 mp0 -65.67 -55.59 16.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.302 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.43 -34.95 79.08 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.919 0.39 . . . . 1.0 110.683 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -60.25 -34.66 74.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.937 -0.574 . . . . 1.0 111.49 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.436 ' HA ' HE21 ' A' ' 185' ' ' GLN . 51.0 tt0 -66.88 -51.8 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.36 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 59.4 t -45.2 -48.04 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.317 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.434 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.1 p -74.59 -37.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.436 HE21 ' HA ' ' A' ' 182' ' ' GLN . 6.9 tt0 -48.06 -37.15 14.42 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 36.8 tp -71.54 -40.22 70.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.353 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 184' ' ' VAL . 34.5 tp -55.2 -30.97 61.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.653 -0.703 . . . . 1.0 109.738 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.448 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -73.74 -39.01 64.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.618 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -55.59 -40.23 71.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.896 -0.593 . . . . 1.0 109.76 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -51.05 -52.94 38.26 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.05 -41.14 79.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.282 -0.872 . . . . 1.0 109.839 178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 4.7 m -52.73 -36.17 57.23 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.184 -0.672 . . . . 1.0 109.184 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.15 -37.75 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.001 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.96 -46.24 68.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.738 -0.665 . . . . 1.0 111.068 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.6 tp -62.42 -33.93 61.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' CB ' ' ND1' ' A' ' 158' ' ' HIS . . . -73.74 -53.75 9.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.895 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -55.73 -27.65 51.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.945 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.95 -34.5 57.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.291 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -58.35 -40.27 81.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.117 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 35.3 tp -65.36 -58.55 5.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.46 -0.337 . . . . 1.0 111.084 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.0 p -46.22 -38.35 8.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.848 0.356 . . . . 1.0 110.355 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.429 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.963 HBA2 HBC2 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.904 0.383 . . . . 1.0 110.551 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 26.0 p-10 -69.8 -52.42 25.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.275 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -61.6 -50.04 74.19 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.235 0.457 . . . . 1.0 112.235 -177.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.83 ' O ' HG23 ' A' ' 38' ' ' THR . 5.4 tp -60.76 -32.35 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.62 0.6 . . . . 1.0 112.62 -176.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.5 mt -76.5 -25.77 54.59 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.65 -0.42 . . . . 1.0 111.535 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.89 -42.22 94.98 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.003 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.88 -26.62 61.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.364 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 34' ' ' ILE . 71.3 p -73.66 -45.4 52.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.534 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HB2' ' A' ' 68' ' ' ALA . 20.4 t -55.05 -37.7 43.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.873 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.39 -34.8 70.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.922 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.9 -43.36 96.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.99 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.6 t -66.58 -45.87 87.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.634 -0.427 . . . . 1.0 110.916 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.9 ttp180 -52.89 -47.46 67.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.884 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.38 -39.57 83.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.808 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -79.65 -51.63 9.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.24 -6.08 49.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.967 0.413 . . . . 1.0 110.111 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 47.5 16.83 0.37 Allowed Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.684 -0.689 . . . . 1.0 112.459 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.649 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -76.48 144.86 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.036 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.5 m-20 -61.75 -29.3 70.03 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.947 0.721 . . . . 1.0 112.947 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.649 ' H ' HG22 ' A' ' 48' ' ' THR . 18.7 ttt85 -149.19 122.0 8.71 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 119.187 -1.005 . . . . 1.0 113.522 -178.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 39' ' ' VAL . 2.6 t -137.71 130.64 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.526 ' NZ ' HAB1 ' A' ' 203' ' ' CYC . 36.7 pttt -145.23 156.22 43.71 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.442 -0.503 . . . . 1.0 111.556 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.8 139.65 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.045 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 165' ' ' LEU . 55.6 t80 -124.75 120.34 31.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.069 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -100.35 171.43 7.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.896 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 8.8 t80 -133.52 138.17 45.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.09 0.471 . . . . 1.0 112.142 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.572 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.7 m-20 -103.59 147.71 34.64 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 115.794 -0.639 . . . . 1.0 109.386 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -62.71 -26.44 75.3 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.797 2.331 . . . . 1.0 112.906 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 -76.32 -5.9 49.16 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.976 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.16 -11.55 51.82 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.084 -0.579 . . . . 1.0 112.923 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -86.48 142.85 28.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.343 0.572 . . . . 1.0 110.962 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -123.22 143.24 15.0 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.453 -1.059 . . . . 1.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -126.59 147.01 49.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.229 0.538 . . . . 1.0 112.282 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.2 t -93.53 115.26 31.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 p -108.12 -1.56 9.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -157.09 147.25 20.98 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 50' ' ' ARG . 40.3 tt0 -164.68 125.51 2.07 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 119.409 -0.917 . . . . 1.0 113.214 -177.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -106.44 134.75 49.08 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.524 HH11 ' CB ' ' A' ' 76' ' ' SER . 15.3 mtm180 -121.93 138.93 54.22 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.242 -0.583 . . . . 1.0 111.531 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.51 107.0 2.97 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.364 -1.094 . . . . 1.0 110.364 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.5 30.12 1.32 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.255 -1.138 . . . . 1.0 110.255 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 58.89 27.18 15.84 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.119 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -57.63 -58.83 6.58 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.757 -1.201 . . . . 1.0 107.757 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.25 147.61 38.74 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 107.838 -1.171 . . . . 1.0 107.838 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 52.3 Cg_endo -68.69 160.69 48.46 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 C-N-CA 122.089 1.859 . . . . 1.0 112.552 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.524 ' CB ' HH11 ' A' ' 69' ' ' ARG . 5.4 p -80.84 126.02 30.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.478 . . . . 1.0 110.181 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.424 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 33.7 mt -101.0 -8.62 22.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.59 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.6 tp -53.61 138.24 35.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.06 -2.65 79.58 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.003 -0.839 . . . . 1.0 111.003 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -99.88 128.33 45.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 1.0 110.77 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.9 m -85.8 122.17 29.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.45 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.42 132.73 20.66 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.25 178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.59 151.95 25.71 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.096 1.864 . . . . 1.0 111.629 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.424 ' C ' ' OD1' ' A' ' 86' ' ' ASP . . . -60.12 -25.02 65.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.812 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.84 -24.29 1.25 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.814 . . . . 1.0 111.064 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 17.9 p-10 -54.68 -26.57 34.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.803 0.335 . . . . 1.0 110.619 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.562 HD12 HH21 ' A' ' 92' ' ' ARG . 51.9 mt -127.84 132.88 24.57 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.297 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.578 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 89.3 Cg_endo -76.87 -104.05 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.563 2.176 . . . . 1.0 112.277 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -161.28 -43.27 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.91 0.386 . . . . 1.0 111.845 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -58.4 -42.83 88.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.757 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.791 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -59.67 -36.36 76.31 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.688 -0.405 . . . . 1.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.562 HH21 HD12 ' A' ' 87' ' ' ILE . 90.0 mtt-85 -66.2 -27.5 68.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.546 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 97' ' ' LEU . 30.3 mmt180 -54.54 -58.93 5.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.275 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.6 mt -55.09 -37.66 67.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.549 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 4.7 m-85 -66.69 -39.13 87.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.577 -0.527 . . . . 1.0 109.577 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.409 HH12 HD13 ' A' ' 162' ' ' LEU . 5.7 tpp180 -78.45 -13.33 59.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.549 -0.751 . . . . 1.0 110.137 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 93' ' ' ARG . 4.4 tp -107.13 -43.32 4.64 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -115.99 -3.66 12.1 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.466 0.913 . . . . 1.0 113.466 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.509 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 97.1 mt-30 27.42 70.25 0.05 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.066 1.136 . . . . 1.0 114.066 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.66 ' H ' HH22 ' A' ' 133' ' ' ARG . 14.3 t -110.72 -50.42 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.452 -2.425 . . . . 1.0 104.452 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.715 HH22 ' NE2' ' A' ' 185' ' ' GLN . 12.4 mtm180 64.81 72.75 0.43 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.053 -1.431 . . . . 1.0 114.248 172.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.43 ' C ' HD12 ' A' ' 103' ' ' ILE . 70.3 t -149.37 131.42 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.45 -0.5 . . . . 1.0 111.67 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.06 62.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 105' ' ' ASP . 41.4 t -81.29 165.35 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.194 0.813 . . . . 1.0 113.194 -176.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.648 ' N ' HG12 ' A' ' 104' ' ' VAL . 22.5 t0 -51.7 120.77 5.56 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.664 -1.153 . . . . 1.0 112.315 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 106' ' ' VAL . 16.9 t -57.13 -12.7 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.702 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.447 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 12.6 pt-20 -80.22 -38.73 30.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -62.96 -16.54 59.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.458 0.647 . . . . 1.0 110.17 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 51.19 60.08 4.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.991 -1.004 . . . . 1.0 113.39 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.6 p -94.56 138.88 31.91 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.414 -2.069 . . . . 1.0 105.414 176.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -133.16 146.49 51.6 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.48 . . . . 1.0 114.997 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.0 t -134.4 115.39 13.96 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 114.1 -1.409 . . . . 1.0 107.337 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.83 ' H ' HD12 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -120.07 -165.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 119.686 -0.806 . . . . 1.0 112.114 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.593 ' H ' HG22 ' A' ' 113' ' ' ILE . 33.3 t -85.06 161.2 19.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.45 -0.796 . . . . 1.0 110.201 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.476 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.0 OUTLIER -140.74 159.94 60.66 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.685 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.84 -158.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.621 2.214 . . . . 1.0 112.296 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -47.0 138.96 6.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.572 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.5 t 169.48 -60.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.592 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.423 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 36.9 t-105 47.0 -131.86 1.28 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.569 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 91.38 2.67 70.27 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.5 mt -68.87 -35.19 76.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.869 0.366 . . . . 1.0 110.544 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.6 m -58.74 -27.87 65.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.583 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.61 63.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.799 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 56.9 86.9 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.1 m -104.33 110.08 63.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.129 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.419 ' O ' ' O ' ' A' ' 127' ' ' LEU . 95.3 Cg_exo -46.39 138.97 13.23 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.529 2.153 . . . . 1.0 111.211 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 126' ' ' PRO . 1.7 tp 43.26 -164.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.407 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 87.31 -5.03 85.79 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 111.57 -0.612 . . . . 1.0 111.57 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.54 155.2 68.83 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.966 -0.294 . . . . 1.0 110.689 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -66.38 158.98 52.49 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.431 2.087 . . . . 1.0 111.636 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 41.4 mt -78.76 -10.47 59.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.278 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -134.58 159.12 42.18 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.634 -0.427 . . . . 1.0 111.061 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.66 HH22 ' H ' ' A' ' 100' ' ' VAL . 0.0 OUTLIER -122.97 81.24 50.6 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.288 -179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -46.96 145.45 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.586 2.191 . . . . 1.0 111.746 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.588 HG21 ' ND1' ' A' ' 139' ' ' HIS . 2.4 m -113.01 122.42 67.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.981 0.42 . . . . 1.0 111.346 -177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.605 ' OD2' HMD2 ' A' ' 203' ' ' CYC . 0.1 OUTLIER -39.34 155.92 0.14 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.883 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.702 ' O ' HG22 ' A' ' 140' ' ' VAL . 43.3 Cg_endo -63.0 -13.82 37.64 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.221 1.947 . . . . 1.0 111.317 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 2.6 p -75.76 -29.94 58.99 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.769 ' HE2' HMA2 ' A' ' 203' ' ' CYC . 40.2 t-80 -86.4 -38.05 17.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.351 -0.84 . . . . 1.0 110.679 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 137' ' ' PRO . 4.0 m -52.16 -47.23 44.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.351 -178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.597 ' N ' HG23 ' A' ' 140' ' ' VAL . 32.1 t-80 -65.49 -44.04 88.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.273 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -45.24 -48.75 12.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.523 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.591 HD13 ' CE1' ' A' ' 139' ' ' HIS . 6.5 mp -70.96 -48.47 53.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.45 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 147' ' ' GLY . 16.4 tptp -58.08 -41.71 84.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.484 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.532 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 32.4 m -54.41 -30.6 52.87 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.3 mtt -87.28 -1.34 57.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.622 -0.717 . . . . 1.0 109.158 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.38 28.15 71.7 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 115.292 -0.867 . . . . 1.0 112.337 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 150' ' ' SER . 0.4 OUTLIER -109.93 123.49 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 178.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.77 -32.51 52.61 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.548 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 8.6 t -137.18 169.54 17.6 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.142 -0.623 . . . . 1.0 111.551 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.4 t -158.6 139.45 12.87 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.045 0.45 . . . . 1.0 112.162 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.81 136.73 52.72 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 101' ' ' ARG . 2.7 m -135.8 159.39 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.458 0.647 . . . . 1.0 111.824 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.485 HG11 ' CB ' ' A' ' 188' ' ' ALA . 79.0 t -157.04 91.79 2.41 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 114.869 -1.06 . . . . 1.0 109.346 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_exo -52.02 126.35 19.91 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.617 2.878 . . . . 1.0 113.904 -177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.8 mt -81.55 106.17 13.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.839 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.428 ' O ' ' OG ' ' A' ' 192' ' ' SER . 73.8 mtp -123.91 144.9 49.5 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.303 -0.559 . . . . 1.0 111.793 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 81.2 t60 -120.89 113.39 20.05 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.518 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 77.7 t60 61.35 -121.11 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.683 -0.488 . . . . 1.0 109.683 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.518 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 4.7 tt0 -95.94 6.31 49.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.873 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' CD ' ' N ' ' A' ' 161' ' ' GLU . 43.8 mp0 -115.79 154.09 30.26 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 114.012 1.116 . . . . 1.0 114.012 -176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.409 HD13 HH12 ' A' ' 96' ' ' ARG . 5.9 tt -111.14 116.57 31.32 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.557 -1.201 . . . . 1.0 108.88 177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.465 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.7 m95 -94.93 -25.79 16.4 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.72 -0.392 . . . . 1.0 111.922 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.84 20.52 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 120.237 -0.982 . . . . 1.0 111.953 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.8 tp -143.05 130.69 21.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.766 0.317 . . . . 1.0 111.193 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.9 tp -95.33 132.5 40.28 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -145.71 137.47 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.393 -0.523 . . . . 1.0 111.597 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -122.22 144.12 49.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 1.0 110.094 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.487 ' ND1' HG21 ' A' ' 148' ' ' VAL . 89.7 m-70 -139.68 143.72 37.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.139 0.495 . . . . 1.0 110.974 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -159.43 155.42 26.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.707 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -86.55 67.51 9.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.436 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -176.22 131.99 0.4 Allowed Pre-proline 0 N--CA 1.466 0.328 0 C-N-CA 120.429 -0.509 . . . . 1.0 112.314 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 174' ' ' ARG . 24.9 Cg_exo -39.02 -48.6 2.87 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.649 2.232 . . . . 1.0 110.91 176.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 173' ' ' PRO . 23.6 ttm180 29.1 81.45 0.22 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.009 -0.996 . . . . 1.0 112.733 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -63.34 150.38 88.71 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.796 2.331 . . . . 1.0 111.195 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -110.83 139.26 46.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.806 0.336 . . . . 1.0 110.767 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.9 t -92.22 145.69 24.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.288 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -63.61 -43.34 97.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.588 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.538 ' H ' ' CD ' ' A' ' 179' ' ' GLU . 46.8 mp0 -60.92 -55.64 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 121.044 -0.262 . . . . 1.0 111.394 -178.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.66 -29.09 69.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.882 0.373 . . . . 1.0 110.651 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.8 tp -61.93 -35.17 77.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.974 -0.557 . . . . 1.0 111.523 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -69.5 -53.52 18.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.388 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.1 t -43.47 -47.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.296 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.8 m -74.69 -36.81 41.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.457 -0.572 . . . . 1.0 109.457 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.715 ' NE2' HH22 ' A' ' 101' ' ' ARG . 53.9 tt0 -48.4 -38.18 18.89 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 40.9 tp -71.14 -40.75 71.18 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.76 -1.109 . . . . 1.0 109.356 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.4 tt -54.81 -31.83 59.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.725 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.485 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -71.93 -33.86 68.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.605 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -57.68 -40.82 80.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.716 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -51.35 -53.5 35.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.044 -0.725 . . . . 1.0 109.044 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.9 t -58.63 -40.83 80.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.333 -0.849 . . . . 1.0 109.92 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 157' ' ' MET . 5.8 t -52.09 -36.54 51.1 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.5 mp -78.02 -34.84 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.035 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.87 -46.52 62.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.751 -0.659 . . . . 1.0 111.056 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 3.4 tp -62.43 -33.53 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.08 -54.67 6.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.911 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' NE2' ' O ' ' A' ' 197' ' ' GLN . 9.7 tm0? -55.49 -29.41 58.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.77 -0.65 . . . . 1.0 110.918 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.53 -34.55 53.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.287 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.413 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.1 tt0 -57.64 -39.36 76.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.143 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 tp -69.01 -57.98 4.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.483 -0.326 . . . . 1.0 111.125 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 19.3 m -56.41 -44.35 80.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.85 0.357 . . . . 1.0 110.339 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.413 ' OXT' ' O ' ' A' ' 199' ' ' GLU . 5.2 tp . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.006 -0.997 . . . . 1.0 110.465 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.791 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 35' ' ' LEU . 60.2 tp . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.875 0.369 . . . . 1.0 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -52.38 -52.69 52.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.307 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -60.15 -48.43 81.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 1.0 112.254 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 38' ' ' THR . 57.3 mt -57.68 -40.47 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.592 0.59 . . . . 1.0 112.592 -177.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD11 HD11 ' A' ' 31' ' ' LEU . 51.7 mt -69.89 -22.52 63.22 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.531 -177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' O ' HG12 ' A' ' 39' ' ' VAL . 93.4 mtt-85 -65.3 -35.29 80.54 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.706 -0.397 . . . . 1.0 109.975 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.98 -28.66 39.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.343 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 34' ' ' ILE . 44.5 p -74.17 -48.96 25.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.56 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -53.47 -36.28 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.401 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.3 mt-10 -75.51 -32.83 60.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -66.64 -51.45 56.14 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 1.0 112.04 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.8 p -64.96 -48.24 84.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.811 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.632 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.5 tmt_? -51.65 -44.13 62.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.886 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.15 73.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.867 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -79.76 -48.91 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.774 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 tp -76.45 -5.64 48.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.101 0.477 . . . . 1.0 110.198 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.65 17.39 0.26 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.433 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.607 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.2 m -75.63 144.78 41.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.09 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 70' ' ' GLY . 89.1 m-20 -55.86 -34.6 65.6 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.607 ' H ' HG22 ' A' ' 48' ' ' THR . 35.0 ttm180 -149.53 126.14 10.99 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 119.184 -1.006 . . . . 1.0 113.521 -178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 2.4 t -135.93 130.35 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 108.032 -1.099 . . . . 1.0 108.032 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 54.5 pttt -144.34 157.54 44.21 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.349 -0.54 . . . . 1.0 111.519 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.67 HG12 ' HB3' ' A' ' 66' ' ' ALA . 9.4 p -99.35 138.68 23.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.03 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 29.2 t80 -122.57 120.73 34.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 1.0 111.083 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.553 ' NH1' HD11 ' A' ' 195' ' ' ILE . 65.9 mtp85 -99.72 169.26 9.38 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -133.6 134.71 43.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.031 0.444 . . . . 1.0 112.165 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -102.54 129.1 26.66 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.811 -0.631 . . . . 1.0 109.343 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -25.77 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.739 2.293 . . . . 1.0 112.888 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.8 mp0 -77.6 -6.15 52.76 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.538 -0.465 . . . . 1.0 111.015 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.45 -11.5 43.08 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.051 -0.595 . . . . 1.0 112.92 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -88.71 142.76 27.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.361 0.581 . . . . 1.0 110.875 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 82' ' ' PHE . . . -123.13 142.63 14.63 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.43 -1.068 . . . . 1.0 110.43 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.7 p -128.05 146.01 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.217 0.532 . . . . 1.0 112.269 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -104.96 111.3 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.954 -1.128 . . . . 1.0 107.954 177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.66 8.0 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.627 0.603 . . . . 1.0 112.627 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB3' HG12 ' A' ' 53' ' ' VAL . . . -155.19 147.13 23.47 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.407 -0.59 . . . . 1.0 109.407 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 72.5 tt0 -167.34 128.39 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 119.352 -0.939 . . . . 1.0 113.184 -177.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -108.18 131.17 54.93 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 108.113 -1.069 . . . . 1.0 108.113 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -117.4 136.65 53.02 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.55 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.04 88.84 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.39 -87.88 0.05 OUTLIER Glycine 0 CA--C 1.519 0.332 0 N-CA-C 110.266 -1.133 . . . . 1.0 110.266 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -175.76 34.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.884 -0.326 . . . . 1.0 111.147 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 ttm180 -70.11 -55.71 8.74 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.572 ' C ' HH22 ' A' ' 50' ' ' ARG . 12.5 mt -94.97 157.85 35.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 176.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 3.3 Cg_exo -78.51 165.32 25.29 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.154 1.903 . . . . 1.0 112.476 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.8 p -87.01 127.98 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.177 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.406 HD12 ' NZ ' ' A' ' 52' ' ' LYS . 44.7 mt -101.13 1.06 38.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.58 -178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.549 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 5.9 tp -65.25 138.65 58.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.346 0.593 . . . . 1.0 112.264 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.549 ' C ' HD12 ' A' ' 80' ' ' LEU . . . 91.6 -2.85 77.92 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.386 -0.825 . . . . 1.0 111.111 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.684 ' N ' HD12 ' A' ' 80' ' ' LEU . 8.5 mp -100.76 128.96 46.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.866 0.365 . . . . 1.0 110.788 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.23 121.81 29.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 111.411 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 62' ' ' GLY . 7.5 m-85 -107.68 136.77 19.62 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.39 157.79 25.77 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.166 1.91 . . . . 1.0 111.664 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -66.18 -25.59 67.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.808 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.78 -19.8 0.07 OUTLIER Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 84' ' ' ALA . 85.3 m-20 -54.87 -34.16 62.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.853 0.359 . . . . 1.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 ' HE ' ' A' ' 92' ' ' ARG . 21.7 mm -109.12 133.71 20.65 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 1.0 111.258 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.53 ' HD3' HMC3 ' A' ' 203' ' ' CYC . 58.7 Cg_endo -80.89 -120.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.491 2.127 . . . . 1.0 112.335 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.428 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 79.5 mm-40 -138.87 -56.58 0.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.759 -0.376 . . . . 1.0 111.849 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -59.46 -39.57 84.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.733 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -65.63 -46.62 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.963 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HE ' HG21 ' A' ' 87' ' ' ILE . 39.7 ttm180 -63.22 -30.32 71.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.508 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -58.21 -50.48 73.4 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.542 -0.299 . . . . 1.0 111.26 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.429 HD12 ' NE ' ' A' ' 133' ' ' ARG . 95.6 mt -55.13 -36.25 65.56 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.841 -0.344 . . . . 1.0 110.604 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.625 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 6.6 m-85 -64.24 -32.05 73.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 96' ' ' ARG . 9.2 mmm180 -83.62 -15.12 50.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.157 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.8 mp -107.84 -42.72 4.64 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.331 0.863 . . . . 1.0 113.331 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -113.74 -4.97 13.32 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.549 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 94.3 mt-30 26.27 69.96 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 101' ' ' ARG . 1.7 m -110.63 -49.1 6.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.396 -2.446 . . . . 1.0 104.396 175.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.549 ' HE ' ' C ' ' A' ' 99' ' ' GLN . 9.3 mtm180 63.09 68.86 0.6 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.066 -1.425 . . . . 1.0 114.335 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 43.1 t -148.77 133.26 9.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.6 -0.44 . . . . 1.0 111.849 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.507 HD11 HAA2 ' A' ' 203' ' ' CYC . 3.4 mt -106.12 124.17 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.356 -0.979 . . . . 1.0 108.356 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.0 p -82.57 167.59 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 113.247 0.832 . . . . 1.0 113.247 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.627 ' N ' HG22 ' A' ' 104' ' ' VAL . 3.0 m-20 -51.61 115.06 1.44 Allowed 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.327 -177.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.485 ' O ' HG12 ' A' ' 106' ' ' VAL . 54.7 t -54.81 -11.51 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.722 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.45 -33.57 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.08 -16.97 36.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.438 0.637 . . . . 1.0 110.143 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 53.28 59.97 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.969 -1.014 . . . . 1.0 113.435 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 m -92.37 134.34 35.01 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -124.86 138.23 54.26 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.997 1.481 . . . . 1.0 114.997 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.11 158.15 20.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.209 -1.36 . . . . 1.0 107.342 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.503 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 14.9 tt -165.86 167.21 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 119.67 -0.812 . . . . 1.0 112.143 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.422 ' N ' ' CG1' ' A' ' 113' ' ' ILE . 28.4 t -89.38 164.67 14.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.542 ' O ' ' N ' ' A' ' 118' ' ' SER . 24.3 mp0 -136.96 149.95 68.14 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.648 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -35.29 -40.18 0.28 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.663 2.242 . . . . 1.0 112.212 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 118' ' ' SER . 45.0 mt-10 -64.84 -37.48 87.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.59 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.542 ' N ' ' O ' ' A' ' 115' ' ' GLN . 11.0 t 58.27 149.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.631 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 119' ' ' TRP . 5.5 m0 42.39 -139.6 0.17 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.5 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.96 3.16 64.08 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.0 -0.84 . . . . 1.0 111.0 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.3 mt -83.42 -7.46 59.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 1.0 110.537 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.6 t -58.23 -26.81 63.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.619 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.16 -33.4 62.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.807 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 60.32 79.26 0.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.884 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.3 m -98.41 144.22 27.71 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.107 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 127' ' ' LEU . 73.6 Cg_endo -72.73 130.07 15.33 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.531 2.154 . . . . 1.0 111.186 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 126' ' ' PRO . 35.0 mt 41.77 -122.64 0.57 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.659 -0.497 . . . . 1.0 109.659 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.89 10.17 64.17 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.644 -0.582 . . . . 1.0 111.644 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -157.61 144.7 13.42 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.722 -0.281 . . . . 1.0 110.688 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.06 150.65 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.378 2.052 . . . . 1.0 111.676 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.7 mt -80.02 24.97 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.271 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -130.98 163.75 26.88 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.039 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' CG ' HH11 ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.97 117.17 24.01 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.299 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -81.13 149.75 17.5 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.573 2.182 . . . . 1.0 111.783 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.564 HG12 HBD2 ' A' ' 203' ' ' CYC . 5.7 m -101.42 153.53 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.054 0.454 . . . . 1.0 111.375 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.675 ' H ' HMD2 ' A' ' 203' ' ' CYC . 12.2 m-20 -88.98 146.2 36.07 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.903 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -42.62 -23.76 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.278 1.985 . . . . 1.0 111.252 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.575 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 2.1 p -67.66 -40.36 84.49 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 108.978 -0.749 . . . . 1.0 108.978 178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.643 ' CE1' HD12 ' A' ' 143' ' ' LEU . 0.3 OUTLIER -78.97 -26.69 43.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.641 178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 25.4 t -51.33 -53.16 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 1.0 110.38 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' SER . 51.1 t-80 -68.25 -43.35 78.07 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.261 178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -47.1 -57.19 5.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.455 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.643 HD12 ' CE1' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -68.46 -50.0 55.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.481 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 147' ' ' GLY . 19.7 tptm -56.33 -39.53 72.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.407 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 141' ' ' HIS . 29.4 t -54.47 -32.48 57.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.196 -0.668 . . . . 1.0 109.196 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 28.4 mtt -83.45 -2.04 54.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.196 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.67 24.22 74.01 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 115.279 -0.873 . . . . 1.0 112.34 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 170' ' ' HIS . 24.0 t -109.27 124.55 66.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.2 -31.98 43.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.743 0.645 . . . . 1.0 112.743 -177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 69.5 m -135.13 169.73 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 1.0 111.565 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 103' ' ' ILE . 5.0 p -161.56 139.48 9.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.163 0.431 . . . . 1.0 112.163 -178.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.1 tp -114.83 139.25 49.9 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.1 m -135.68 156.49 37.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.423 0.63 . . . . 1.0 111.845 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 153' ' ' VAL . 71.5 t -157.8 93.13 2.15 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 114.851 -1.068 . . . . 1.0 109.341 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.32 115.84 2.66 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.581 2.854 . . . . 1.0 113.973 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 38.9 mt -73.08 105.07 4.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.794 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 75.5 mtp -121.78 146.14 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.168 0.508 . . . . 1.0 111.846 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.477 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 25.6 t-80 -123.18 112.88 18.22 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 13.9 t-80 64.89 -125.23 0.41 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.413 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 27.7 mt-30 -95.19 8.56 42.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.868 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 44.8 mp0 -118.42 155.08 31.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.897 1.073 . . . . 1.0 113.897 -177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -110.09 118.0 35.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 114.504 -1.225 . . . . 1.0 108.885 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.545 ' CD2' ' OE2' ' A' ' 199' ' ' GLU . 77.9 m95 -97.51 -27.73 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.736 -0.386 . . . . 1.0 111.981 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.06 -173.45 25.51 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.189 -1.005 . . . . 1.0 111.965 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.529 ' CD2' HMB2 ' A' ' 203' ' ' CYC . 5.0 tp -139.15 131.33 28.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.849 0.357 . . . . 1.0 111.149 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.3 tp -95.94 137.86 34.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.234 -0.654 . . . . 1.0 109.234 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.445 ' O ' HG13 ' A' ' 167' ' ' VAL . 10.9 p -150.91 132.76 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.378 -0.529 . . . . 1.0 111.572 -179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.9 p -116.02 145.55 42.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.0 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.431 ' CE1' HG22 ' A' ' 167' ' ' VAL . 59.3 m80 -132.54 140.31 48.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.118 0.485 . . . . 1.0 110.975 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.541 ' O ' HG13 ' A' ' 148' ' ' VAL . 6.5 t60 -147.44 142.75 27.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.757 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.79 67.42 9.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.568 -0.287 . . . . 1.0 111.441 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -177.04 133.45 0.37 Allowed Pre-proline 0 N--CA 1.466 0.342 0 C-N-CA 120.43 -0.508 . . . . 1.0 112.349 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -85.23 112.05 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.654 2.236 . . . . 1.0 110.85 177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -146.37 146.68 28.41 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.021 -0.99 . . . . 1.0 112.698 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.07 149.57 32.63 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 122.873 2.382 . . . . 1.0 111.118 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -107.66 151.38 25.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.826 0.346 . . . . 1.0 110.831 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 31.3 t -101.45 140.97 35.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.314 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -68.96 -34.98 76.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.501 . . . . 1.0 111.683 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.91 -55.92 16.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.553 -0.294 . . . . 1.0 111.401 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 38.9 mp0 -67.75 -34.1 76.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.0 110.734 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 36.8 tp -62.28 -31.43 72.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.956 -0.565 . . . . 1.0 111.484 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -69.93 -52.73 22.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.458 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.0 t -44.86 -45.83 2.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.282 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 187' ' ' LEU . 6.3 p -75.06 -37.32 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -47.58 -38.1 13.75 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.5 mp -70.34 -40.15 74.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.727 -1.124 . . . . 1.0 109.437 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.9 tt -54.34 -30.91 53.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.64 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.66 -36.02 67.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.637 178.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -55.31 -39.57 70.09 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.824 -0.625 . . . . 1.0 109.717 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -53.75 -53.9 45.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.079 -0.712 . . . . 1.0 109.079 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 82.2 t -58.42 -42.28 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.209 -0.905 . . . . 1.0 109.861 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.5 p -51.35 -36.62 43.8 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 82.8 mt -77.68 -34.97 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.031 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.5 -46.36 63.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.047 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.553 HD11 ' NH1' ' A' ' 55' ' ' ARG . 14.9 tt -64.08 -33.15 60.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.477 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -74.19 -55.83 5.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.58 -0.736 . . . . 1.0 109.875 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -56.28 -25.72 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.762 -0.654 . . . . 1.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.89 -36.21 59.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.263 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.545 ' OE2' ' CD2' ' A' ' 163' ' ' TRP . 92.0 mt-10 -58.65 -39.96 82.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.198 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 32.2 tp -64.38 -60.06 3.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.101 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 92.8 p -54.22 -40.72 67.92 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.769 -0.372 . . . . 1.0 110.348 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.042 -0.98 . . . . 1.0 110.442 179.554 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.675 HMD2 ' H ' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.916 0.389 . . . . 1.0 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -65.21 -40.57 94.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.321 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -70.72 -53.7 14.62 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.223 0.453 . . . . 1.0 112.223 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.846 ' O ' HG23 ' A' ' 38' ' ' THR . 5.5 tp -59.23 -34.04 52.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.581 0.585 . . . . 1.0 112.581 -177.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.59 -25.48 59.29 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.553 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -60.08 -54.11 49.82 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.615 -0.434 . . . . 1.0 109.951 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.78 79.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.32 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.2 p -65.71 -46.96 77.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.546 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.655 HG12 ' HB2' ' A' ' 68' ' ' ALA . 7.2 t -52.3 -31.45 14.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.848 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -73.36 -36.23 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.032 0.444 . . . . 1.0 110.834 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -58.9 -43.24 90.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.953 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG22 HD22 ' A' ' 187' ' ' LEU . 74.0 t -66.33 -38.77 82.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.67 -0.412 . . . . 1.0 110.876 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.5 ttt180 -57.31 -52.54 64.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.918 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.06 87.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.745 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -79.43 -53.98 6.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.716 -178.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.5 tp -76.94 -4.76 45.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.027 0.441 . . . . 1.0 110.176 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.12 16.74 0.17 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.645 -0.707 . . . . 1.0 112.397 177.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 51' ' ' VAL . 14.6 t -77.41 145.9 36.9 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.347 -0.541 . . . . 1.0 110.106 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 70' ' ' GLY . 49.2 p30 -68.46 -10.5 55.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.946 0.721 . . . . 1.0 112.946 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.697 HH21 ' CD2' ' A' ' 169' ' ' HIS . 46.1 ttp180 -164.39 120.59 1.56 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 119.137 -1.025 . . . . 1.0 113.579 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -140.74 132.52 30.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 107.979 -1.119 . . . . 1.0 107.979 176.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.436 ' NZ ' HD12 ' A' ' 77' ' ' LEU . 53.3 pttt -145.69 158.82 43.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.56 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.76 137.56 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.994 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 165' ' ' LEU . 28.4 t80 -119.8 119.1 32.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.07 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -99.52 166.22 11.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.272 -0.422 . . . . 1.0 109.87 179.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 79.6 t80 -131.55 137.05 48.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.065 0.459 . . . . 1.0 112.159 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -102.27 126.39 33.51 Favored Pre-proline 0 C--N 1.334 -0.104 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.07 -25.59 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.737 2.291 . . . . 1.0 112.901 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -76.71 -6.28 51.52 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.977 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.88 -11.15 38.0 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.997 -0.62 . . . . 1.0 112.831 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -89.58 143.0 27.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.421 0.611 . . . . 1.0 110.919 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -121.74 140.95 14.14 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.3 p -128.64 146.86 50.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.248 0.547 . . . . 1.0 112.243 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -105.02 111.28 33.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.008 -1.108 . . . . 1.0 108.008 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.9 m -100.52 6.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.601 0.593 . . . . 1.0 112.601 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.41 146.99 23.02 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.388 -0.597 . . . . 1.0 109.388 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 42.5 tt0 -166.92 128.16 1.63 Allowed 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 119.336 -0.946 . . . . 1.0 113.235 -177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.12 140.73 43.9 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.16 -1.052 . . . . 1.0 108.16 176.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.55 HH12 ' C ' ' A' ' 75' ' ' PRO . 5.2 ptm85 -131.37 142.67 50.1 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.254 -0.578 . . . . 1.0 111.514 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.25 110.4 3.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.456 -1.057 . . . . 1.0 110.456 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.54 -87.28 0.01 OUTLIER Glycine 0 CA--C 1.52 0.377 0 N-CA-C 110.239 -1.145 . . . . 1.0 110.239 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' GLY . 18.9 pt-20 -179.99 26.86 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.152 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -67.33 -32.24 73.06 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.451 ' O ' ' NH2' ' A' ' 69' ' ' ARG . 12.2 mt -118.23 142.74 31.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 107.801 -1.185 . . . . 1.0 107.801 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' C ' HH12 ' A' ' 69' ' ' ARG . 68.4 Cg_endo -73.85 170.57 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.072 1.848 . . . . 1.0 112.457 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 82.5 p -93.92 139.35 31.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.176 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.2 mt -110.34 -3.37 16.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.633 -178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 tp -57.17 137.89 55.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.307 0.575 . . . . 1.0 112.282 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.91 82.78 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.034 -0.826 . . . . 1.0 111.034 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.5 tp -101.49 122.72 44.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.887 0.375 . . . . 1.0 110.782 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 81' ' ' THR . 10.1 t -79.05 122.43 26.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.515 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -105.38 131.11 22.05 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.37 150.07 22.07 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.185 1.923 . . . . 1.0 111.667 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.442 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -62.62 -23.69 67.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.828 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -45.22 -22.68 0.58 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.463 ' O ' ' NC ' ' A' ' 203' ' ' CYC . 90.7 m-20 -56.51 -31.16 63.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.806 0.336 . . . . 1.0 110.659 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.52 ' O ' ' O ' ' A' ' 88' ' ' PRO . 3.5 pt -118.47 100.42 51.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.316 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.52 ' O ' ' O ' ' A' ' 87' ' ' ILE . 71.3 Cg_exo -44.29 -110.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.487 2.124 . . . . 1.0 112.347 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 84.2 tt0 -149.53 -58.45 0.2 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.751 -0.38 . . . . 1.0 111.784 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -47.56 -40.93 20.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.77 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.17 -38.84 90.59 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.014 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -68.56 -29.7 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.572 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -55.3 -55.63 29.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.226 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.89 -40.16 72.59 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.616 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.622 ' CZ ' HBA1 ' A' ' 203' ' ' CYC . 6.0 m-85 -57.9 -34.03 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.606 -0.516 . . . . 1.0 109.606 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -88.5 -9.8 51.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.103 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 tp -107.18 -45.6 4.09 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.373 0.879 . . . . 1.0 113.373 -178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.487 ' HB3' HH21 ' A' ' 133' ' ' ARG . . . -115.39 -1.75 12.78 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.546 0.943 . . . . 1.0 113.546 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 98' ' ' ALA . 90.2 mt-30 28.44 71.64 0.05 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 114.116 1.154 . . . . 1.0 114.116 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 ' N ' ' A' ' 101' ' ' ARG . 35.4 m -117.53 -47.92 3.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 173.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.731 HH21 HG22 ' A' ' 154' ' ' VAL . 2.4 mpp_? 62.52 -26.24 0.06 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 114.143 -1.389 . . . . 1.0 114.354 171.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 100' ' ' VAL . 11.8 p -56.14 129.48 17.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 C-N-CA 120.445 -0.502 . . . . 1.0 111.788 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.956 HD11 HAA2 ' A' ' 203' ' ' CYC . 16.7 mt -105.37 129.94 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.36 -0.978 . . . . 1.0 108.36 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.626 HG22 ' N ' ' A' ' 105' ' ' ASP . 9.8 p -81.34 168.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -176.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.626 ' N ' HG22 ' A' ' 104' ' ' VAL . 0.3 OUTLIER -50.08 120.57 4.55 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.289 -177.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.412 ' O ' HG12 ' A' ' 106' ' ' VAL . 24.0 t -57.6 -14.57 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.383 -0.826 . . . . 1.0 110.741 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -87.23 -36.56 17.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.914 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.79 -14.44 8.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.393 0.616 . . . . 1.0 110.101 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 51.5 59.8 4.32 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.02 -0.991 . . . . 1.0 113.409 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.7 m -92.09 137.57 32.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -126.63 135.45 51.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 113' ' ' ILE . 45.6 t -104.33 150.02 24.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.126 -1.397 . . . . 1.0 107.402 176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 112' ' ' SER . 20.2 pt -154.08 157.49 4.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 119.705 -0.798 . . . . 1.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 t -89.35 167.42 13.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.492 -0.777 . . . . 1.0 110.243 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -131.85 154.44 81.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.62 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.6 -6.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.691 2.261 . . . . 1.0 112.247 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' O ' ' OG ' ' A' ' 118' ' ' SER . 22.5 pt-20 -158.03 -162.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.564 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.417 ' O ' ' CG ' ' A' ' 119' ' ' TRP . 8.8 p 62.59 127.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.611 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.417 ' CG ' ' O ' ' A' ' 118' ' ' SER . 94.2 m95 -154.24 -129.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.645 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.28 14.03 67.19 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.6 mt -60.32 -35.23 75.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.804 0.335 . . . . 1.0 110.52 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.1 m -59.39 -29.85 68.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.589 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -56.54 -26.15 54.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 64.91 62.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.27 143.81 73.73 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.124 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.42 132.26 18.88 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.556 2.171 . . . . 1.0 111.249 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.4 mt 43.52 -119.57 0.61 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.599 -0.519 . . . . 1.0 109.599 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.39 -0.76 67.84 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.548 ' CD ' HH22 ' A' ' 133' ' ' ARG . 1.3 pp20? -156.76 149.53 18.25 Favored Pre-proline 0 C--N 1.33 -0.259 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.667 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 91.7 Cg_exo -43.51 149.13 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.467 2.111 . . . . 1.0 111.697 179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.69 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.3 mp -78.85 27.71 0.22 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.314 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.52 ' O ' ' NH1' ' A' ' 133' ' ' ARG . 89.0 mt-30 -131.25 164.04 26.45 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.696 -0.402 . . . . 1.0 111.121 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.548 HH22 ' CD ' ' A' ' 129' ' ' GLU . 19.9 mmt-85 -122.43 78.92 45.84 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.28 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -45.26 149.45 1.48 Allowed 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.495 2.13 . . . . 1.0 111.864 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.915 HG23 HG12 ' A' ' 140' ' ' VAL . 19.0 m -100.8 148.76 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.981 0.42 . . . . 1.0 111.416 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -87.73 154.89 53.39 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.909 -178.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -50.38 -21.28 7.02 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.268 1.979 . . . . 1.0 111.279 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.716 ' O ' HBC1 ' A' ' 203' ' ' CYC . 42.1 t -79.63 -39.8 30.68 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.524 ' ND1' ' CG1' ' A' ' 135' ' ' VAL . 51.4 t-80 -81.52 -40.48 23.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.279 -0.873 . . . . 1.0 110.666 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.915 HG12 HG23 ' A' ' 135' ' ' VAL . 3.1 m -52.07 -43.55 37.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.357 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 140' ' ' VAL . 79.8 t60 -67.48 -43.99 79.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.256 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -43.3 -46.77 6.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.488 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 143' ' ' LEU . 83.5 mt -72.74 -43.84 62.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.574 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 147' ' ' GLY . 1.1 tmtm? -60.69 -42.67 97.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.441 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 98.5 p -54.46 -31.32 55.4 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 32.6 mtt -89.47 -2.03 58.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.199 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 70.48 23.41 77.58 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 115.256 -0.884 . . . . 1.0 112.304 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.601 HG11 ' CB ' ' A' ' 169' ' ' HIS . 11.5 t -104.09 121.14 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.889 -0.411 . . . . 1.0 109.889 179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.11 -32.87 44.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.781 0.66 . . . . 1.0 112.781 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.4 t -131.45 167.48 19.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.156 -0.618 . . . . 1.0 111.545 -177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.2 p -162.47 141.92 9.34 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.137 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 38.3 tp -127.72 110.21 12.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.685 -0.858 . . . . 1.0 108.685 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -105.08 157.17 6.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.461 0.648 . . . . 1.0 111.849 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.731 HG22 HH21 ' A' ' 101' ' ' ARG . 84.3 t -153.39 93.95 3.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.887 -1.051 . . . . 1.0 109.311 -176.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.26 120.33 8.02 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 123.527 2.818 . . . . 1.0 113.957 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.4 mt -74.79 104.54 5.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.41 -0.814 . . . . 1.0 109.787 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 91.7 mtp -122.62 146.42 47.46 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.337 -0.545 . . . . 1.0 111.83 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 159' ' ' HIS . 72.0 t60 -126.42 114.17 17.83 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.019 -1.104 . . . . 1.0 108.019 175.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.631 ' NE2' ' NE2' ' A' ' 158' ' ' HIS . 8.0 m-70 63.29 -125.97 0.57 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -95.6 10.73 35.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.876 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.523 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 55.3 mt-10 -119.71 153.56 35.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.923 1.082 . . . . 1.0 113.923 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.68 113.91 27.51 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 114.513 -1.221 . . . . 1.0 108.925 177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.523 ' CZ2' ' OE1' ' A' ' 161' ' ' GLU . 89.1 m95 -98.06 -28.64 13.67 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.916 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -153.37 -174.38 23.61 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.197 -1.001 . . . . 1.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.4 tp -142.46 130.41 21.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.77 0.319 . . . . 1.0 111.224 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -96.25 140.7 30.55 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.138 -0.689 . . . . 1.0 109.138 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.4 t -146.2 111.35 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.394 -0.523 . . . . 1.0 111.531 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 14.5 t -100.17 139.23 36.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.756 -0.656 . . . . 1.0 110.013 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.698 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -148.79 144.66 27.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.193 0.521 . . . . 1.0 110.944 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.48 ' NE2' ' OH ' ' A' ' 176' ' ' TYR . 1.8 p-80 -153.97 151.81 29.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.66 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.02 66.68 2.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.516 -0.311 . . . . 1.0 111.345 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -176.02 134.68 0.45 Allowed Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.355 -0.538 . . . . 1.0 112.303 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.489 ' O ' ' C ' ' A' ' 174' ' ' ARG . 34.6 Cg_exo -41.95 -45.7 6.99 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.669 2.246 . . . . 1.0 110.823 175.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.489 ' C ' ' O ' ' A' ' 173' ' ' PRO . 30.4 ttm180 21.75 84.32 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.099 -0.955 . . . . 1.0 112.711 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.11 154.36 57.93 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.844 2.362 . . . . 1.0 111.103 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.48 ' OH ' ' NE2' ' A' ' 170' ' ' HIS . 33.6 m-85 -110.94 138.33 47.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.803 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 26.5 t -99.68 146.49 26.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.272 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -63.35 -37.69 88.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.655 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.62 -56.16 11.98 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.327 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 180' ' ' GLU . 33.3 mp0 -65.69 -34.09 77.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.878 0.371 . . . . 1.0 110.639 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.6 tp -60.48 -40.01 89.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.992 -0.549 . . . . 1.0 111.463 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.537 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.13 -51.0 71.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.423 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 60.5 t -46.99 -49.38 7.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.331 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 187' ' ' LEU . 98.9 t -74.2 -37.63 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.537 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 43.4 tt0 -45.4 -36.43 4.3 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 30.3 tp -69.82 -41.7 74.63 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.655 -1.157 . . . . 1.0 109.383 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.855 HD23 ' O ' ' A' ' 187' ' ' LEU . 5.4 tt -54.73 -33.16 60.74 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.638 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.16 -40.23 59.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.633 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -56.5 -38.33 71.63 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.876 -0.602 . . . . 1.0 109.684 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.94 -53.44 52.72 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.53 -43.83 73.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.275 -0.875 . . . . 1.0 109.838 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -51.94 -37.63 53.45 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.201 -0.666 . . . . 1.0 109.201 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.3 mt -78.71 -32.02 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.05 -45.91 62.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.746 -0.661 . . . . 1.0 111.01 -178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.8 pp -65.49 -26.47 39.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.491 -0.559 . . . . 1.0 109.491 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.714 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.06 -55.72 5.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.748 -0.66 . . . . 1.0 109.925 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -56.56 -27.86 58.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.919 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.02 -35.64 56.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.301 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.36 -37.41 72.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.13 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 38.1 mt -68.34 -58.2 4.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.108 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.5 m -55.15 -42.18 72.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.293 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.402 179.771 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.956 HAA2 HD11 ' A' ' 103' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.562 HD11 HD12 ' A' ' 195' ' ' ILE . 8.5 tp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.918 0.39 . . . . 1.0 110.572 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -49.66 -50.74 42.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.303 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -63.16 -44.49 95.32 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.3 0.481 . . . . 1.0 112.3 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.5 mp -62.59 -36.09 73.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 112.619 0.6 . . . . 1.0 112.619 -177.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.486 ' O ' HG22 ' A' ' 38' ' ' THR . 82.4 mt -77.69 -20.82 53.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.446 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.505 ' O ' HG12 ' A' ' 39' ' ' VAL . 77.4 mtp180 -73.05 -33.71 65.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.639 -0.424 . . . . 1.0 109.972 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.56 -33.62 28.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.36 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.583 ' CG2' ' N ' ' A' ' 39' ' ' VAL . 2.1 t -70.74 -45.11 65.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.573 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.1 p -56.72 -36.55 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.839 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 97.1 mt-10 -75.46 -38.05 59.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.048 0.451 . . . . 1.0 110.81 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -64.24 -51.12 65.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.966 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.28 -50.85 78.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.713 -0.395 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.6 tmm_? -49.68 -41.63 43.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.9 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.65 -35.79 73.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.848 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -79.64 -47.37 15.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.1 mt -76.53 -6.37 51.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.027 0.441 . . . . 1.0 110.177 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.62 16.46 0.19 Allowed Glycine 0 CA--C 1.527 0.835 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.462 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.759 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.5 m -74.92 144.82 43.1 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.379 -0.528 . . . . 1.0 110.049 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.4 m-20 -62.4 -27.47 69.11 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.894 0.701 . . . . 1.0 112.894 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.759 ' H ' HG22 ' A' ' 48' ' ' THR . 59.9 ttt85 -153.54 121.56 6.09 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 119.127 -1.029 . . . . 1.0 113.562 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -141.34 134.43 30.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.927 -1.138 . . . . 1.0 107.927 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.788 ' HZ3' HD12 ' A' ' 77' ' ' LEU . 32.8 pttt -146.01 160.26 42.12 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.577 -178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.0 t -96.9 134.97 32.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.004 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.42 ' O ' ' N ' ' A' ' 165' ' ' LEU . 71.9 t80 -119.15 118.55 31.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.021 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -99.03 165.72 11.61 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -132.08 136.17 46.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.034 0.445 . . . . 1.0 112.155 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -103.69 129.68 24.89 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 115.714 -0.675 . . . . 1.0 109.341 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.59 -29.31 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.684 2.256 . . . . 1.0 112.933 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -72.72 -17.66 61.6 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.948 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.89 -15.24 12.49 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.021 -0.609 . . . . 1.0 112.839 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -84.93 141.85 30.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.375 0.588 . . . . 1.0 110.957 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.73 139.69 13.69 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.3 p -125.3 144.87 50.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.207 0.527 . . . . 1.0 112.312 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.33 116.71 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 107.948 -1.13 . . . . 1.0 107.948 177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.681 ' O ' HG22 ' A' ' 65' ' ' VAL . 10.7 p -110.09 2.75 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.693 0.627 . . . . 1.0 112.693 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.98 145.91 24.51 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' CD ' HH22 ' A' ' 50' ' ' ARG . 35.0 tt0 -165.78 127.48 1.94 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.37 -0.932 . . . . 1.0 113.233 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -110.06 135.21 51.23 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.083 -1.08 . . . . 1.0 108.083 175.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.502 HH22 ' CB ' ' A' ' 72' ' ' GLU . 7.6 ptm180 -125.49 142.15 51.66 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.533 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -84.36 104.36 2.71 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.469 -1.052 . . . . 1.0 110.469 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 54.51 -89.81 0.01 OUTLIER Glycine 0 CA--C 1.519 0.31 0 N-CA-C 110.29 -1.124 . . . . 1.0 110.29 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.502 ' CB ' HH22 ' A' ' 69' ' ' ARG . 22.2 pt-20 -177.31 29.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.153 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 39.9 ttm-85 -66.61 -54.26 25.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 107.766 -1.198 . . . . 1.0 107.766 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 28.5 mt -93.47 144.68 28.65 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.804 -1.184 . . . . 1.0 107.804 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.03 166.83 28.97 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 C-N-CA 122.019 1.813 . . . . 1.0 112.58 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.6 t -92.21 136.7 32.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.096 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.788 HD12 ' HZ3' ' A' ' 52' ' ' LYS . 59.0 mt -111.24 -3.24 15.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.618 -178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 30.6 tp -55.77 139.83 44.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.287 0.565 . . . . 1.0 112.335 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.99 -3.2 84.59 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD12 ' HA ' ' A' ' 80' ' ' LEU . 51.6 tp -101.48 128.62 47.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.879 0.371 . . . . 1.0 110.773 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -85.16 122.79 29.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.491 -178.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -104.82 132.88 20.49 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.283 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.74 151.21 28.08 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.134 1.889 . . . . 1.0 111.714 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.69 -25.4 67.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.799 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.64 -22.73 0.44 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -55.26 -31.08 61.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.861 0.362 . . . . 1.0 110.638 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.51 132.88 21.63 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.246 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 60.0 Cg_endo -80.55 -119.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.54 2.16 . . . . 1.0 112.313 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.429 ' H ' ' HB2' ' A' ' 88' ' ' PRO . 86.4 tt0 -139.78 -69.0 0.42 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.752 -0.379 . . . . 1.0 111.823 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.62 -40.49 9.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.804 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -66.53 -50.53 62.89 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.997 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -62.29 -31.24 71.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.572 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -58.4 -48.08 81.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.315 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' CD1' ' CZ ' ' A' ' 133' ' ' ARG . 63.9 mt -54.69 -39.1 67.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.824 -0.351 . . . . 1.0 110.529 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' CZ ' ' O1A' ' A' ' 203' ' ' CYC . 11.4 m-85 -61.1 -32.86 72.53 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -88.19 -12.59 43.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 1.0 110.109 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.7 tp -105.54 -46.97 4.04 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.336 0.865 . . . . 1.0 113.336 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.72 -1.15 13.35 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.503 0.927 . . . . 1.0 113.503 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' ALA . 91.8 mt-30 27.58 65.61 0.09 Allowed 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 114.092 1.145 . . . . 1.0 114.092 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.97 ' O ' ' HG2' ' A' ' 101' ' ' ARG . 33.8 m -97.48 -46.37 12.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 104.374 -2.454 . . . . 1.0 104.374 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.97 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 0.4 OUTLIER 57.83 55.36 5.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.139 -1.392 . . . . 1.0 114.208 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.506 ' C ' HD12 ' A' ' 103' ' ' ILE . 62.9 t -148.88 133.26 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.484 -0.486 . . . . 1.0 111.833 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.506 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -106.81 126.22 62.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.43 168.76 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 113.347 0.869 . . . . 1.0 113.347 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' OD2' ' OE2' ' A' ' 107' ' ' GLU . 13.2 t0 -53.28 118.38 3.76 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.81 -1.087 . . . . 1.0 112.326 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 140' ' ' VAL . 24.4 t -55.46 -12.89 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.76 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 14.0 pt-20 -87.59 -38.36 16.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.846 -178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -57.56 -13.62 4.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.513 0.673 . . . . 1.0 110.211 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 50.84 56.31 8.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.958 -1.019 . . . . 1.0 113.399 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.7 m -94.51 134.15 37.35 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.34 -2.096 . . . . 1.0 105.34 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -129.44 142.21 50.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 114.963 1.468 . . . . 1.0 114.963 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.454 ' O ' ' OD1' ' A' ' 136' ' ' ASP . 1.8 t -139.53 113.41 8.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.125 -1.398 . . . . 1.0 107.306 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.868 ' H ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -119.57 -167.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 119.676 -0.81 . . . . 1.0 112.12 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.1 t -92.98 160.62 14.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.43 -0.804 . . . . 1.0 110.247 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 117' ' ' GLU . 53.2 mt-30 -140.25 152.34 66.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.603 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -36.14 -30.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.636 2.224 . . . . 1.0 112.238 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' GLN . 94.6 mt-10 -114.45 152.77 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.6 p -168.79 60.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.637 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.501 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 76.8 t-105 -143.61 166.77 23.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.489 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.501 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 96.51 3.55 59.73 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.2 mp -64.26 -29.77 70.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.809 0.338 . . . . 1.0 110.542 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.9 m -54.15 -24.78 19.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.589 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -49.7 -40.5 40.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 61.69 75.2 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.914 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 125' ' ' VAL . 33.4 m -95.56 118.91 65.95 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.095 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.58 131.4 12.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.525 2.15 . . . . 1.0 111.125 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 24.0 mt 44.1 -131.88 0.76 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 0.91 85.37 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.648 -0.581 . . . . 1.0 111.648 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -155.51 146.44 16.41 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.964 -0.295 . . . . 1.0 110.662 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -43.54 153.6 0.23 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.357 2.038 . . . . 1.0 111.66 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.67 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.6 mp -80.72 27.77 0.36 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.291 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -133.55 167.52 20.33 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.077 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.456 ' O ' ' C ' ' A' ' 134' ' ' PRO . 8.3 mmm180 -126.24 67.34 63.42 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.306 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.456 ' C ' ' O ' ' A' ' 133' ' ' ARG . 2.8 Cg_exo -30.73 147.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.564 2.176 . . . . 1.0 111.753 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.412 ' H ' HG22 ' A' ' 135' ' ' VAL . 29.3 m -94.4 147.8 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 1.0 111.362 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.614 ' N ' ' OD1' ' A' ' 136' ' ' ASP . 0.4 OUTLIER -91.08 144.07 29.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.424 -0.807 . . . . 1.0 110.873 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -38.38 -27.05 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.196 1.93 . . . . 1.0 111.279 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.752 ' O ' HBC1 ' A' ' 203' ' ' CYC . 48.6 t -71.99 -57.5 4.24 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.028 -0.73 . . . . 1.0 109.028 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.726 ' CE1' HD13 ' A' ' 143' ' ' LEU . 42.0 t-80 -68.21 -27.83 66.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.29 -0.868 . . . . 1.0 110.688 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.507 HG13 HG13 ' A' ' 106' ' ' VAL . 37.7 t -51.62 -52.51 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.323 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.541 ' CD2' ' HG ' ' A' ' 145' ' ' SER . 76.3 t60 -63.58 -41.28 98.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.256 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -45.43 -51.82 10.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.497 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.726 HD13 ' CE1' ' A' ' 139' ' ' HIS . 4.5 mp -72.07 -49.13 39.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.469 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 147' ' ' GLY . 2.4 tmtt? -57.32 -42.62 82.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.446 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.541 ' HG ' ' CD2' ' A' ' 141' ' ' HIS . 20.9 m -53.65 -32.01 49.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 46.4 mtt -85.61 -2.48 58.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.595 -0.729 . . . . 1.0 109.188 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 67.88 24.24 74.29 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.314 -0.857 . . . . 1.0 112.353 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.553 HG21 ' ND1' ' A' ' 169' ' ' HIS . 3.2 m -106.66 123.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.919 -0.401 . . . . 1.0 109.919 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -77.27 -35.18 55.44 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -132.75 170.71 14.86 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.119 -0.632 . . . . 1.0 111.545 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.528 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 14.1 t -162.0 139.71 8.72 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.062 0.458 . . . . 1.0 112.158 -177.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.9 tp -115.32 138.96 50.4 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.755 -0.832 . . . . 1.0 108.755 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 154' ' ' VAL . 2.8 m -133.61 157.82 42.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.496 0.665 . . . . 1.0 111.828 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.575 HG11 ' CB ' ' A' ' 188' ' ' ALA . 73.0 t -157.56 91.57 2.3 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.268 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.14 115.73 2.48 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.575 2.85 . . . . 1.0 113.931 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.98 105.7 6.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.825 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 19.6 ptm -131.15 147.43 52.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.22 0.533 . . . . 1.0 111.862 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.436 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 74.2 t60 -122.67 115.66 22.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 8.9 t60 64.77 -128.59 0.36 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.466 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 20.5 mm-40 -92.48 9.12 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.885 0.328 . . . . 1.0 111.885 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -117.58 152.19 35.64 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.002 1.112 . . . . 1.0 114.002 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.3 tp -107.96 116.92 32.84 Favored 'General case' 0 C--O 1.23 0.051 0 CA-C-N 114.498 -1.228 . . . . 1.0 108.873 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.436 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 91.5 m95 -95.94 -27.81 14.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -163.06 -170.42 27.91 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 120.247 -0.978 . . . . 1.0 112.029 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 tp -141.38 131.91 25.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 1.0 111.19 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -96.02 141.55 29.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.92 135.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.372 -0.531 . . . . 1.0 111.566 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.6 m -121.15 150.61 41.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.027 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.553 ' ND1' HG21 ' A' ' 148' ' ' VAL . 92.5 m-70 -147.74 146.82 29.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.121 0.486 . . . . 1.0 111.005 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.508 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 17.0 t60 -156.36 152.46 27.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.718 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.408 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -84.66 65.02 8.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.55 -0.295 . . . . 1.0 111.41 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 70.7 tt0 -178.29 136.6 0.35 Allowed Pre-proline 0 N--CA 1.465 0.315 0 C-N-CA 120.389 -0.524 . . . . 1.0 112.314 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -36.63 -51.79 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.686 2.257 . . . . 1.0 110.884 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 30.94 77.11 0.34 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.076 -0.965 . . . . 1.0 112.74 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.88 150.58 85.53 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.849 2.366 . . . . 1.0 111.103 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -111.55 140.03 46.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 1.0 110.758 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 53.2 m -95.22 150.35 20.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.19 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -64.6 -40.81 96.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.666 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.02 -54.9 35.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.644 -0.253 . . . . 1.0 111.405 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -66.97 -32.25 73.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.925 0.393 . . . . 1.0 110.709 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.9 tp -58.29 -38.22 76.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.507 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -68.23 -51.52 44.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.406 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 55.7 t -43.17 -48.79 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.282 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 187' ' ' LEU . 30.8 m -74.63 -37.01 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.526 -0.546 . . . . 1.0 109.526 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.51 ' OE1' ' NH2' ' A' ' 101' ' ' ARG . 56.2 tt0 -47.76 -37.44 13.4 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 87.6 mt -73.76 -40.2 63.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 114.686 -1.143 . . . . 1.0 109.393 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 184' ' ' VAL . 48.8 tp -54.69 -32.88 60.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.681 -0.691 . . . . 1.0 109.682 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.575 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.26 -34.93 68.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.645 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -55.24 -39.15 69.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.882 -0.599 . . . . 1.0 109.794 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -52.96 -53.76 44.98 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -58.21 -41.86 81.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.176 -0.92 . . . . 1.0 109.825 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 7.0 p -51.71 -35.76 44.17 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 84.3 mt -78.29 -34.26 18.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.592 -0.731 . . . . 1.0 110.038 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.82 -45.98 66.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.127 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.562 HD12 HD11 ' A' ' 31' ' ' LEU . 8.3 tp -63.56 -31.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.652 -0.499 . . . . 1.0 109.652 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -76.46 -56.96 4.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.873 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -55.41 -27.14 45.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.64 -34.53 53.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.301 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.402 ' O ' ' OXT' ' A' ' 202' ' ' LEU . 85.7 tt0 -57.15 -39.98 76.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.101 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.2 mp -67.82 -56.07 10.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.05 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 21.9 m -51.53 -41.49 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 1.0 110.311 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.1 mp . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.032 -0.985 . . . . 1.0 110.455 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.752 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' CD2' HD12 ' A' ' 195' ' ' ILE . 5.8 mt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.865 0.364 . . . . 1.0 110.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -62.3 -43.17 99.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.256 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -69.1 -53.74 18.69 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.233 0.457 . . . . 1.0 112.233 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . 28.4 mm -55.83 -46.74 80.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.656 0.613 . . . . 1.0 112.656 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 mt -66.7 -23.36 66.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.683 -0.407 . . . . 1.0 111.526 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.585 ' O ' HG12 ' A' ' 39' ' ' VAL . 18.9 ttm180 -61.42 -36.02 79.16 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.639 -0.425 . . . . 1.0 109.993 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.44 -25.18 42.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.302 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 34' ' ' ILE . 43.9 p -76.54 -47.0 24.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.546 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 36' ' ' ARG . 4.0 p -52.79 -37.95 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.883 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.439 ' N ' ' CG1' ' A' ' 39' ' ' VAL . 23.4 pt-20 -79.08 -32.36 44.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.836 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -61.91 -52.9 62.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.844 -0.616 . . . . 1.0 111.952 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.577 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.7 p -64.22 -44.4 97.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.902 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.577 ' N ' HG13 ' A' ' 42' ' ' VAL . 6.6 tmm_? -48.98 -44.47 40.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.923 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.74 75.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -80.64 -50.66 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.751 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 48' ' ' THR . 1.9 tp -77.13 -8.16 57.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.081 0.467 . . . . 1.0 110.208 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 45.39 17.46 0.13 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.623 -0.717 . . . . 1.0 112.402 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.534 HG21 HG13 ' A' ' 51' ' ' VAL . 9.3 t -75.71 145.39 40.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.029 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' N ' ' A' ' 70' ' ' GLY . 91.2 m-20 -56.47 -34.75 67.2 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.891 0.701 . . . . 1.0 112.891 -177.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -150.66 126.83 10.57 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 119.204 -0.998 . . . . 1.0 113.523 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.534 HG13 HG21 ' A' ' 48' ' ' THR . 0.0 OUTLIER -141.77 130.43 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 107.939 -1.134 . . . . 1.0 107.939 176.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' NZ ' ' OB ' ' A' ' 203' ' ' CYC . 20.4 pttm -144.35 161.26 39.43 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.58 -177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.81 133.45 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.055 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' CA ' ' A' ' 164' ' ' GLY . 72.1 t80 -118.14 117.42 29.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 1.0 111.019 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -100.81 169.07 9.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 1.0 109.874 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 62.5 t80 -133.9 138.66 45.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.583 -0.447 . . . . 1.0 112.161 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 1.4 m-20 -102.23 126.66 32.74 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.777 -0.647 . . . . 1.0 109.283 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.6 -27.09 2.07 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.722 2.281 . . . . 1.0 112.89 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.3 -9.68 58.82 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.553 -0.459 . . . . 1.0 111.004 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.79 21.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.868 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -83.53 139.77 32.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.308 0.554 . . . . 1.0 110.932 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -116.1 134.09 11.22 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.379 -1.088 . . . . 1.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -125.89 144.84 50.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.282 0.563 . . . . 1.0 112.229 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.4 p -106.09 126.2 61.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -113.1 4.98 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.652 0.612 . . . . 1.0 112.652 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.31 25.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 83.7 tt0 -166.29 127.98 1.83 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 119.347 -0.941 . . . . 1.0 113.16 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.98 131.2 55.85 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.148 -1.056 . . . . 1.0 108.148 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 34.3 ptt-85 -118.5 138.39 52.54 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.317 -0.553 . . . . 1.0 111.544 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -76.9 95.08 1.12 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.61 -89.21 0.05 OUTLIER Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.194 -1.162 . . . . 1.0 110.194 -177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -175.66 36.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.77 -0.372 . . . . 1.0 111.116 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -73.96 -54.38 8.04 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.0 mt -93.74 146.42 31.71 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -74.0 167.18 27.82 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.004 1.803 . . . . 1.0 112.518 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.5 p -88.14 139.51 30.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.108 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.606 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 34.8 mt -113.21 -2.45 14.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.593 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 45.1 tp -60.18 140.61 56.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.346 0.593 . . . . 1.0 112.25 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -4.27 86.23 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.391 -0.822 . . . . 1.0 111.048 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.6 mt -99.89 140.0 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.902 0.382 . . . . 1.0 110.737 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.0 p -97.59 121.79 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.03 -0.532 . . . . 1.0 111.458 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' N ' ' O ' ' A' ' 62' ' ' GLY . 7.4 m-85 -106.74 131.41 21.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.26 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -77.68 152.55 29.35 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.145 1.897 . . . . 1.0 111.658 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.57 -20.98 66.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.773 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.62 -24.24 0.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 84' ' ' ALA . 91.8 m-20 -53.39 -27.79 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 1.0 110.551 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.42 HG23 HAD2 ' A' ' 203' ' ' CYC . 33.9 mt -120.98 132.34 24.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.243 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.459 ' HD3' HMC3 ' A' ' 203' ' ' CYC . 52.5 Cg_endo -80.59 -116.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.538 2.159 . . . . 1.0 112.329 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -126.09 -75.63 0.59 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.716 -0.393 . . . . 1.0 111.815 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -42.65 -37.1 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.775 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.909 ' HB1' HBD2 ' A' ' 203' ' ' CYC . . . -69.9 -48.63 57.89 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.937 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -60.27 -32.09 70.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.0 111.519 -178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' O ' ' N ' ' A' ' 97' ' ' LEU . 79.9 mtp180 -58.5 -46.2 87.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.309 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.619 ' O ' ' N ' ' A' ' 99' ' ' GLN . 68.2 mt -56.26 -35.99 68.05 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.584 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 100' ' ' VAL . 8.7 m-85 -63.22 -42.8 99.31 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.4 mtp180 -87.43 -17.18 32.83 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.076 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.0 tp -106.7 -48.1 3.6 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.351 0.871 . . . . 1.0 113.351 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 94' ' ' LEU . . . -119.18 -7.47 10.29 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.583 0.957 . . . . 1.0 113.583 -175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.669 ' O ' ' N ' ' A' ' 101' ' ' ARG . 92.2 mt-30 51.74 67.26 0.99 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.547 HG11 ' HB2' ' A' ' 133' ' ' ARG . 35.2 m -69.2 63.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 104.442 -2.429 . . . . 1.0 104.442 177.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 99' ' ' GLN . 32.2 ptt180 -66.08 14.76 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.026 -1.443 . . . . 1.0 114.29 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.507 ' C ' HD12 ' A' ' 103' ' ' ILE . 2.0 t -147.63 128.08 5.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.488 -0.485 . . . . 1.0 111.758 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.6 mp -112.38 129.53 67.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 108.418 -0.956 . . . . 1.0 108.418 177.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.0 m -82.97 169.62 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.263 0.838 . . . . 1.0 113.263 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.494 ' OD2' ' CB ' ' A' ' 173' ' ' PRO . 0.4 OUTLIER -51.69 120.85 5.64 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 114.73 -1.123 . . . . 1.0 112.304 -178.14 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 106' ' ' VAL . 82.3 t -59.68 -15.39 8.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.4 -0.818 . . . . 1.0 110.806 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' GLN . 18.5 pt-20 -84.87 -38.25 19.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.866 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -60.89 3.03 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.378 0.609 . . . . 1.0 110.096 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.607 ' H ' ' C ' ' A' ' 107' ' ' GLU . 14.0 pt20 35.89 59.49 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.046 -0.979 . . . . 1.0 113.384 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.1 t -92.66 134.76 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 105.323 -2.102 . . . . 1.0 105.323 174.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -126.09 139.74 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.493 ' O ' HG23 ' A' ' 113' ' ' ILE . 28.5 t -104.57 150.28 24.77 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.104 -1.407 . . . . 1.0 107.377 177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.493 HG23 ' O ' ' A' ' 112' ' ' SER . 18.9 pt -154.62 158.15 3.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 119.676 -0.809 . . . . 1.0 112.136 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.5 t -88.06 165.64 15.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.28 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.12 156.05 37.56 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.665 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -34.92 145.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.709 2.272 . . . . 1.0 112.26 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -52.76 140.43 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.491 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.5 t -163.15 -125.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.613 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -56.69 -43.32 80.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.533 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 122' ' ' SER . . . 69.57 9.95 62.7 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.8 mt 56.11 4.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 1.0 110.608 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 120' ' ' GLY . 34.8 t -59.85 -29.4 68.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.606 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.85 -11.57 8.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.808 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 58.33 86.13 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.4 t -101.65 109.93 60.6 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.11 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.69 135.51 16.85 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.551 2.168 . . . . 1.0 111.167 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 129' ' ' GLU . 7.7 tp 42.88 -117.19 0.44 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.603 -0.518 . . . . 1.0 109.603 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 45.76 14.47 0.08 OUTLIER Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.639 -0.584 . . . . 1.0 111.639 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 127' ' ' LEU . 75.8 mt-10 -148.13 152.16 39.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 C-N-CA 120.954 -0.298 . . . . 1.0 110.635 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.63 141.55 55.4 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.438 2.092 . . . . 1.0 111.69 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.2 mt -81.76 19.43 1.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.308 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -131.93 168.38 17.99 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.619 -0.433 . . . . 1.0 111.049 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.547 ' HB2' HG11 ' A' ' 100' ' ' VAL . 35.4 ttt85 -134.97 96.47 14.45 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.27 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.6 156.35 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.711 0 C-N-CA 122.601 2.201 . . . . 1.0 111.758 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.535 HG12 ' ND1' ' A' ' 139' ' ' HIS . 27.1 m -99.39 140.23 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.027 0.442 . . . . 1.0 111.341 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 139' ' ' HIS . 3.5 m-20 -94.93 148.2 34.33 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.913 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -38.36 -26.03 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.215 1.943 . . . . 1.0 111.237 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -76.19 -47.22 24.91 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 178.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.688 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 20.3 t-80 -76.12 -28.81 57.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.319 -0.855 . . . . 1.0 110.653 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 49.8 t -50.56 -47.9 27.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.403 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 145' ' ' SER . 80.2 t60 -65.59 -42.16 92.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -45.93 -56.07 5.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.453 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.762 HD21 HMA2 ' A' ' 203' ' ' CYC . 50.7 mt -72.12 -50.44 28.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.496 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 44.3 tptt -57.56 -43.32 84.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.415 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 141' ' ' HIS . 33.9 t -53.78 -34.18 58.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.238 -0.652 . . . . 1.0 109.238 178.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.1 mtt -84.3 -7.33 59.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.57 -0.741 . . . . 1.0 109.2 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.45 23.87 76.21 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 41.4 t -102.9 122.26 55.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.97 31.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.405 ' OG ' ' N ' ' A' ' 151' ' ' SER . 1.5 t -142.98 170.42 15.73 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.173 -0.611 . . . . 1.0 111.573 -178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 169' ' ' HIS . 30.9 t -162.04 140.31 9.04 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.205 -0.452 . . . . 1.0 112.173 -178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 152' ' ' LEU . 62.2 tp -114.64 116.36 28.61 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.731 -0.84 . . . . 1.0 108.731 177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.538 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -117.07 158.32 17.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.447 0.641 . . . . 1.0 111.791 -178.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.538 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 79.5 t -155.65 95.24 2.47 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.838 -1.074 . . . . 1.0 109.363 -177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -51.02 113.46 1.1 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 123.558 2.839 . . . . 1.0 113.928 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 70.4 mt -73.2 106.62 5.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.379 -0.828 . . . . 1.0 109.735 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.415 ' O ' ' OG ' ' A' ' 192' ' ' SER . 17.1 ptm -133.57 146.41 50.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.917 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 78.5 t60 -117.68 115.64 25.46 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.025 -1.102 . . . . 1.0 108.025 176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.614 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 34.0 m-70 59.1 -123.53 1.25 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.664 -0.495 . . . . 1.0 109.664 -176.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.48 8.56 40.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.914 0.339 . . . . 1.0 111.914 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -116.63 149.71 39.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.983 1.105 . . . . 1.0 113.983 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 10.0 tp -107.54 115.92 31.01 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 114.545 -1.207 . . . . 1.0 108.857 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.44 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 95.4 m95 -96.65 -30.41 13.27 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.965 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 54' ' ' TYR . . . -160.56 -170.14 24.77 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 120.205 -0.998 . . . . 1.0 111.937 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.778 HD23 HMB2 ' A' ' 203' ' ' CYC . 5.4 tp -138.18 128.49 26.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.819 0.342 . . . . 1.0 111.16 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.6 tp -92.09 138.01 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 ' CG2' ' NE2' ' A' ' 169' ' ' HIS . 10.8 p -149.58 135.3 11.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.593 -178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 48' ' ' THR . 12.3 t -117.36 146.15 43.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.049 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.508 ' CE1' ' OG ' ' A' ' 151' ' ' SER . 78.1 m-70 -143.68 141.43 30.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.134 0.492 . . . . 1.0 111.043 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -152.72 151.88 31.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.69 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 67.94 9.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.583 -0.28 . . . . 1.0 111.489 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -176.37 164.66 1.72 Allowed Pre-proline 0 N--CA 1.467 0.388 0 C-N-CA 120.319 -0.552 . . . . 1.0 112.302 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.494 ' CB ' ' OD2' ' A' ' 105' ' ' ASP . 31.5 Cg_endo -95.35 89.61 0.1 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.703 2.269 . . . . 1.0 110.928 176.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -115.45 92.91 34.53 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 114.98 -1.009 . . . . 1.0 112.755 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.16 152.78 29.37 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.813 2.342 . . . . 1.0 111.086 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -111.01 140.93 45.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 1.0 110.748 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 25.4 t -93.19 143.12 26.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.284 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -62.14 -39.51 92.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.605 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.33 -54.95 25.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.61 -0.268 . . . . 1.0 111.366 -178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -65.63 -32.39 73.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.974 0.416 . . . . 1.0 110.765 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 27.9 tp -58.64 -42.71 88.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.86 -50.85 70.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.45 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.8 t -45.19 -48.42 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.24 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 95.4 t -74.03 -39.23 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.571 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 57.3 tt0 -46.18 -35.57 5.22 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 108.057 -1.09 . . . . 1.0 108.057 178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.3 tp -71.44 -38.37 71.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 114.685 -1.143 . . . . 1.0 109.35 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 9.8 tp -56.28 -31.04 63.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.686 . . . . 1.0 109.631 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.402 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -72.28 -36.41 68.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.903 -0.589 . . . . 1.0 109.602 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -59.57 -38.75 81.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.872 -0.604 . . . . 1.0 109.747 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -52.74 -55.15 24.81 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.82 -40.5 76.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.286 -0.87 . . . . 1.0 109.904 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 157' ' ' MET . 6.1 t -52.02 -35.53 47.24 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 75.2 mt -79.12 -36.75 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.081 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.72 -47.22 63.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 111.062 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.472 HD12 ' CD2' ' A' ' 31' ' ' LEU . 2.8 tp -61.0 -33.48 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.551 -0.537 . . . . 1.0 109.551 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.428 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -75.51 -53.9 7.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.691 -0.686 . . . . 1.0 109.967 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -55.34 -28.31 52.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -34.86 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.294 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -56.51 -40.25 74.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.198 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 200' ' ' LEU . 10.6 mp -68.29 -56.59 8.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.435 -0.348 . . . . 1.0 111.172 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 20.4 m -58.32 -45.59 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.831 0.348 . . . . 1.0 110.292 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 20.9 mt . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.427 179.638 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.909 HBD2 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 202' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.912 0.386 . . . . 1.0 110.549 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -58.46 -50.55 73.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.317 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -61.77 -48.6 79.95 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.298 0.481 . . . . 1.0 112.298 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.675 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -62.54 -29.34 46.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.604 ' O ' HG22 ' A' ' 38' ' ' THR . 96.6 mt -77.85 -20.93 52.2 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.606 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' O ' HG12 ' A' ' 39' ' ' VAL . 73.4 mtp180 -72.44 -34.16 67.58 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.032 178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -82.18 -29.19 31.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.349 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 35' ' ' LEU . 2.5 t -74.29 -44.87 50.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.55 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 38' ' ' THR . 4.2 p -55.69 -36.02 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -72.59 -36.86 68.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.021 0.438 . . . . 1.0 110.872 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -66.55 -52.15 48.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.979 -179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.15 -51.22 75.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -49.17 -43.93 42.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.61 69.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.781 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -80.21 -47.43 14.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.77 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 mt -76.91 -6.62 53.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.76 16.67 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.714 -0.676 . . . . 1.0 112.458 178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.651 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.4 m -75.01 144.66 42.98 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.391 -0.524 . . . . 1.0 110.083 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.622 ' O ' ' N ' ' A' ' 70' ' ' GLY . 92.0 m-20 -57.21 -34.29 68.38 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.882 0.697 . . . . 1.0 112.882 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.651 ' H ' HG22 ' A' ' 48' ' ' THR . 29.5 ttm180 -149.55 124.14 9.75 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.212 -0.995 . . . . 1.0 113.526 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 11.9 t -135.21 131.57 52.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.054 -1.091 . . . . 1.0 108.054 177.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -143.74 152.04 40.77 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.331 -0.548 . . . . 1.0 111.569 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.9 t -98.46 139.77 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.795 -0.639 . . . . 1.0 109.983 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.471 ' O ' ' N ' ' A' ' 165' ' ' LEU . 60.0 t80 -124.76 121.63 35.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.001 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -99.95 171.78 7.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.236 -0.438 . . . . 1.0 109.86 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 34.9 t80 -134.12 138.19 45.06 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.558 -0.457 . . . . 1.0 112.15 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 2.9 m-20 -104.81 149.33 37.39 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.269 178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -63.21 -26.64 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.741 2.294 . . . . 1.0 112.946 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -76.54 -3.73 39.02 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.584 -0.446 . . . . 1.0 111.055 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.88 -10.29 57.13 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 121.032 -0.604 . . . . 1.0 112.811 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 95.9 m-70 -90.42 147.06 23.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.338 0.569 . . . . 1.0 110.941 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 82' ' ' PHE . . . -130.12 151.41 19.4 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.45 -1.06 . . . . 1.0 110.45 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.8 p -131.3 149.69 52.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.256 0.55 . . . . 1.0 112.274 -178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.4 t -90.73 115.61 30.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 N-CA-C 108.023 -1.103 . . . . 1.0 108.023 176.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.2 m -107.69 -2.41 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 112.635 0.606 . . . . 1.0 112.635 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.6 149.15 20.06 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.611 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 88.7 tt0 -167.41 127.14 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.332 -0.947 . . . . 1.0 113.159 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 142.05 37.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.119 -1.067 . . . . 1.0 108.119 176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' O ' ' NH2' ' A' ' 43' ' ' ARG . 35.9 ptt-85 -132.87 141.96 48.68 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.255 -0.578 . . . . 1.0 111.544 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.622 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.33 111.54 3.7 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.363 -1.095 . . . . 1.0 110.363 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 42.32 40.05 3.41 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.309 -1.116 . . . . 1.0 110.309 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 48.53 26.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.119 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -54.13 -56.34 19.05 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 10.7 mt -93.76 152.03 40.38 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 107.889 -1.152 . . . . 1.0 107.889 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.542 ' C ' HH22 ' A' ' 50' ' ' ARG . 56.4 Cg_endo -69.58 156.97 62.36 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 122.114 1.876 . . . . 1.0 112.573 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.8 m -76.44 113.98 14.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.096 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.611 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 56.5 mt -87.39 -6.76 58.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.595 -178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.528 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 19.2 tp -60.25 139.98 57.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.305 0.574 . . . . 1.0 112.209 -177.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.82 -3.51 84.84 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.355 -0.839 . . . . 1.0 111.088 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.8 mt -99.58 136.61 39.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.88 0.372 . . . . 1.0 110.737 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 81' ' ' THR . 15.4 t -94.3 120.62 34.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.482 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 62' ' ' GLY . 7.3 m-85 -108.73 133.26 20.71 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.283 178.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.54 149.29 34.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.147 1.898 . . . . 1.0 111.719 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -59.34 -25.63 64.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.779 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.01 -20.95 0.18 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' O ' ' NC ' ' A' ' 203' ' ' CYC . 32.6 t70 -51.78 -23.38 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.798 0.332 . . . . 1.0 110.608 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 87' ' ' ILE . 29.4 mt -127.15 132.73 24.46 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.083 -0.508 . . . . 1.0 111.34 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.58 -108.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.53 2.154 . . . . 1.0 112.319 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -142.58 -72.46 0.31 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.782 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' ALA . 21.1 pt-20 -41.42 -43.17 2.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.509 . . . . 1.0 111.721 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.854 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -63.65 -49.48 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.954 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -58.23 -29.08 65.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.534 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' NH2' ' CD2' ' A' ' 121' ' ' LEU . 33.2 mtm180 -55.81 -47.63 76.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.218 -179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 94' ' ' LEU . 8.4 mp -54.45 -38.68 66.63 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.851 -0.34 . . . . 1.0 110.572 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.637 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.4 m-85 -60.03 -24.99 64.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.227 0.537 . . . . 1.0 109.572 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' C ' HD12 ' A' ' 97' ' ' LEU . 60.5 mtp85 -94.74 -19.02 20.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.577 -0.738 . . . . 1.0 110.123 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.0 mp -109.5 -45.51 3.69 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.03 -11.08 15.37 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.398 0.888 . . . . 1.0 113.398 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.581 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 82.7 mt-30 25.35 70.77 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 114.082 1.141 . . . . 1.0 114.082 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.711 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -141.77 -55.19 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 104.44 -2.43 . . . . 1.0 104.44 175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.711 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.6 mmp_? 52.84 103.85 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 114.038 -1.437 . . . . 1.0 114.297 173.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 102' ' ' VAL . 19.2 m -144.77 132.66 16.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 C-N-CA 120.457 -0.497 . . . . 1.0 111.768 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.411 HG12 HG21 ' A' ' 135' ' ' VAL . 58.3 mt -108.64 123.86 64.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.5 m -83.71 168.08 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 113.285 0.846 . . . . 1.0 113.285 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.58 120.43 5.15 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.706 -1.134 . . . . 1.0 112.242 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -56.73 -10.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.781 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -86.61 -37.08 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.941 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.39 -17.84 55.94 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.372 0.606 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 53.44 60.43 3.71 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.056 -0.974 . . . . 1.0 113.384 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 m -93.51 135.16 35.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.391 -2.077 . . . . 1.0 105.391 175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.0 mtp-105 -130.06 142.44 50.61 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 115.054 1.501 . . . . 1.0 115.054 -176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.555 ' O ' HG23 ' A' ' 113' ' ' ILE . 1.5 m -106.96 155.78 19.42 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 114.189 -1.368 . . . . 1.0 107.357 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 112' ' ' SER . 17.7 pt -156.31 159.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 119.769 -0.772 . . . . 1.0 112.223 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.442 ' O ' ' NE2' ' A' ' 115' ' ' GLN . 86.4 p -86.51 163.64 17.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.464 -0.789 . . . . 1.0 110.214 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 114' ' ' SER . 8.2 mp0 -137.2 158.76 71.9 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.666 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.47 -12.3 18.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.662 2.241 . . . . 1.0 112.239 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -152.24 125.98 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.458 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 3.4 t 175.08 114.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.655 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -150.6 -173.64 4.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.479 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.86 4.5 56.81 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.648 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.0 mp -63.11 -31.03 72.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.815 0.34 . . . . 1.0 110.559 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.4 m -54.23 -26.77 30.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.61 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -52.97 -27.48 19.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.827 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 58.56 90.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.896 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.3 m -107.03 104.52 52.35 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.16 129.35 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.498 2.132 . . . . 1.0 111.211 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.1 tp 43.15 -110.57 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 49.32 31.44 12.94 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.599 -0.6 . . . . 1.0 111.599 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.413 ' O ' ' O ' ' A' ' 130' ' ' PRO . 33.7 mt-10 -134.78 154.26 79.3 Favored Pre-proline 0 C--N 1.328 -0.334 0 C-N-CA 120.968 -0.293 . . . . 1.0 110.651 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 129' ' ' GLU . 78.4 Cg_exo -42.0 167.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.41 2.073 . . . . 1.0 111.658 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 25.9 mt -78.55 -6.95 56.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.254 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -134.06 168.51 18.68 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.646 -0.422 . . . . 1.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.462 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 15.8 mmm180 -133.85 86.58 37.93 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.294 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.479 ' O ' ' OG ' ' A' ' 112' ' ' SER . 73.7 Cg_exo -47.72 145.36 9.65 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.536 2.157 . . . . 1.0 111.774 178.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.615 HG13 HBD2 ' A' ' 203' ' ' CYC . 15.7 t -128.46 135.34 62.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.994 0.426 . . . . 1.0 111.354 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -44.2 154.73 0.38 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.502 -0.772 . . . . 1.0 110.883 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -56.32 -7.16 1.76 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.243 1.962 . . . . 1.0 111.266 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.403 ' H ' ' C ' ' A' ' 136' ' ' ASP . 42.0 t -58.42 -50.58 73.2 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.028 -0.731 . . . . 1.0 109.028 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.569 ' ND1' HD12 ' A' ' 143' ' ' LEU . 0.1 OUTLIER -73.32 -27.38 61.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.329 -0.851 . . . . 1.0 110.689 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.433 ' N ' ' CD2' ' A' ' 139' ' ' HIS . 22.3 t -52.01 -54.45 13.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 1.0 110.362 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' A' ' 145' ' ' SER . 10.2 m80 -68.99 -46.06 69.01 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.215 178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' CD2' HBA1 ' A' ' 203' ' ' CYC . 6.3 t80 -47.43 -55.96 7.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.48 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.569 HD12 ' ND1' ' A' ' 139' ' ' HIS . 89.1 mt -66.83 -50.48 62.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.514 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 147' ' ' GLY . 42.7 tptt -57.56 -42.09 82.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 141' ' ' HIS . 47.8 m -54.28 -34.92 61.93 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 26.6 mtt -84.73 -3.77 58.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.242 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 73.97 25.84 70.47 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.261 -0.881 . . . . 1.0 112.324 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 150' ' ' SER . 14.2 t -106.71 114.92 47.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.011 0.405 . . . . 1.0 109.945 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -74.78 -30.1 61.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.743 0.646 . . . . 1.0 112.743 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.526 ' O ' HG12 ' A' ' 148' ' ' VAL . 97.4 p -138.67 170.14 16.54 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.21 -0.596 . . . . 1.0 111.615 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.9 p -161.85 130.86 4.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.2 tp -108.46 114.97 29.23 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.752 -0.833 . . . . 1.0 108.752 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.491 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.7 p -113.42 157.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.455 0.645 . . . . 1.0 111.853 -179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.9 t -157.7 124.54 2.59 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.281 -177.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -79.33 149.87 22.06 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 123.602 2.868 . . . . 1.0 113.906 -178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 27.6 mt -115.52 107.43 15.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.409 -0.814 . . . . 1.0 109.799 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.581 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 81.5 mtp -121.23 140.63 51.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 111.834 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.485 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 22.2 t-80 -118.15 113.9 22.25 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.467 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 46.9 t60 68.08 -129.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 -176.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 58.8 mt-30 -95.33 8.78 42.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -120.99 159.84 24.77 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.963 1.097 . . . . 1.0 113.963 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -110.71 117.97 34.91 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.543 -1.208 . . . . 1.0 108.896 178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 94.0 m95 -96.24 -28.47 14.51 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.95 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -157.2 -173.95 26.29 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.215 -0.993 . . . . 1.0 112.006 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.1 tp -140.99 126.38 18.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.786 0.327 . . . . 1.0 111.278 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 1.011 HD12 ' N ' ' A' ' 167' ' ' VAL . 0.6 OUTLIER -95.14 135.61 36.49 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 1.011 ' N ' HD12 ' A' ' 166' ' ' LEU . 85.3 t -145.55 137.2 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.391 -0.524 . . . . 1.0 111.567 -177.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.527 ' C ' ' ND1' ' A' ' 169' ' ' HIS . 20.6 m -125.26 144.49 50.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.827 -0.624 . . . . 1.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.608 ' N ' ' ND1' ' A' ' 169' ' ' HIS . 0.0 OUTLIER -149.33 152.82 36.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.083 0.468 . . . . 1.0 111.013 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.517 ' NE2' ' OG ' ' A' ' 150' ' ' SER . 1.1 p-80 -158.15 154.08 26.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.539 -0.755 . . . . 1.0 109.738 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.03 67.91 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.421 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -177.62 131.43 0.33 Allowed Pre-proline 0 N--CA 1.465 0.292 0 C-N-CA 120.376 -0.529 . . . . 1.0 112.348 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -38.16 -51.22 2.05 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.695 2.263 . . . . 1.0 110.918 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 31.41 84.44 0.17 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.033 -0.985 . . . . 1.0 112.691 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.69 151.09 78.81 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 122.773 2.315 . . . . 1.0 111.114 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -114.49 137.85 51.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 1.0 110.789 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 50.3 m -92.31 150.04 21.08 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.304 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 179' ' ' GLU . 12.3 pt20 -67.34 -42.94 82.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.625 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.449 ' N ' ' CG ' ' A' ' 178' ' ' GLN . 79.1 mm-40 -61.74 -55.14 33.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 111.359 -178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.33 -30.69 71.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.969 0.414 . . . . 1.0 110.698 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.3 tp -61.72 -34.83 76.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.964 -0.562 . . . . 1.0 111.499 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.49 -53.7 21.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.376 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 49.3 t -44.34 -47.39 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.226 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.24 -37.44 45.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -48.63 -37.14 17.44 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 21.1 tp -72.79 -40.62 65.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.71 -1.132 . . . . 1.0 109.3 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.22 -32.29 62.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.687 -0.688 . . . . 1.0 109.633 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -74.03 -37.24 64.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.671 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -56.8 -41.54 77.94 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.758 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -52.63 -54.31 34.98 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.125 -0.694 . . . . 1.0 109.125 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.69 -41.55 47.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.837 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.1 m -50.46 -29.67 10.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.2 mm -77.26 -42.35 30.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.049 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.6 -45.05 88.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.82 -0.627 . . . . 1.0 111.1 -178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 14.6 tt -63.09 -31.31 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.485 ' CB ' ' CD2' ' A' ' 158' ' ' HIS . . . -76.33 -56.29 4.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -55.04 -28.88 55.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.95 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.56 -34.2 53.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.304 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -58.42 -38.59 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 200' ' ' LEU . 2.4 tt -67.63 -61.06 2.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.036 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.3 t -69.77 -55.57 9.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 1.0 110.316 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.408 HD13 ' N ' ' A' ' 31' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.054 -0.974 . . . . 1.0 110.435 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.854 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.502 HD23 ' NH1' ' A' ' 55' ' ' ARG . 61.0 tp . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.903 0.382 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -51.86 -49.5 62.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.22 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -63.43 -46.56 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.873 ' O ' HG23 ' A' ' 38' ' ' THR . 1.5 mp -59.9 -40.03 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.621 0.6 . . . . 1.0 112.621 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.3 mt -74.97 -22.04 58.79 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.693 -0.403 . . . . 1.0 111.504 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.52 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.1 ttm-85 -68.57 -36.77 79.22 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.652 -0.419 . . . . 1.0 109.991 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.01 -29.3 39.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.369 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.873 HG23 ' O ' ' A' ' 34' ' ' ILE . 62.1 p -71.14 -48.39 52.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 36' ' ' ARG . 2.8 p -54.05 -35.16 28.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.842 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.12 -39.89 75.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -62.88 -40.65 98.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.763 -0.653 . . . . 1.0 111.932 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.32 -51.21 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.661 -0.416 . . . . 1.0 110.867 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.574 ' HD3' ' HB1' ' A' ' 68' ' ' ALA . 23.4 ttp85 -50.78 -44.94 58.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.909 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.4 79.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.848 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -79.56 -51.44 9.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.751 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 mt -77.11 -6.51 53.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.009 0.433 . . . . 1.0 110.081 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.1 16.99 0.54 Allowed Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.695 -0.684 . . . . 1.0 112.45 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.521 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.0 OUTLIER -73.73 141.66 46.34 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.354 -0.538 . . . . 1.0 110.118 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' O ' ' N ' ' A' ' 70' ' ' GLY . 78.9 m-20 -60.13 -29.21 68.48 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.912 0.708 . . . . 1.0 112.912 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.521 ' H ' HG22 ' A' ' 48' ' ' THR . 59.8 ttp180 -154.4 119.07 4.88 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 119.17 -1.012 . . . . 1.0 113.578 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.4 p -138.85 136.09 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.935 -1.135 . . . . 1.0 107.935 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.694 ' NZ ' HBB3 ' A' ' 203' ' ' CYC . 18.0 pttp -145.63 160.87 41.04 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.41 -0.516 . . . . 1.0 111.579 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.9 t -97.76 137.03 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.999 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.461 ' CD1' HAB1 ' A' ' 203' ' ' CYC . 60.9 t80 -121.29 119.35 31.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.421 . . . . 1.0 111.031 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' NH1' HD23 ' A' ' 31' ' ' LEU . 63.8 mtm180 -99.97 170.47 8.48 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' CZ ' ' O ' ' A' ' 57' ' ' ASP . 6.7 t80 -134.96 137.61 43.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.061 0.458 . . . . 1.0 112.172 -178.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.567 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -103.14 148.59 35.87 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 115.773 -0.649 . . . . 1.0 109.325 179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.92 -23.87 67.95 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.739 2.293 . . . . 1.0 112.902 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.61 -2.9 41.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.994 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.27 -12.71 51.8 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.954 -0.641 . . . . 1.0 112.876 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -88.79 146.2 25.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.326 0.563 . . . . 1.0 110.95 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -125.35 145.58 15.77 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.467 -1.053 . . . . 1.0 110.467 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.9 p -128.36 146.96 50.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.291 0.567 . . . . 1.0 112.341 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 87.7 t -106.1 118.2 53.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 107.985 -1.117 . . . . 1.0 107.985 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.561 ' O ' HG22 ' A' ' 65' ' ' VAL . 8.6 p -115.12 9.2 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.661 0.615 . . . . 1.0 112.661 -177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.9 142.8 23.01 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.419 -0.586 . . . . 1.0 109.419 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 48.9 tt0 -165.99 126.67 1.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.368 -0.933 . . . . 1.0 113.181 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.574 ' HB1' ' HD3' ' A' ' 43' ' ' ARG . . . -110.66 140.66 44.81 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.523 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 36.4 ptt85 -132.2 143.38 49.91 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.203 -0.599 . . . . 1.0 111.539 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.84 106.94 3.18 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.366 -1.094 . . . . 1.0 110.366 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 55.2 -89.44 0.01 OUTLIER Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.282 -1.127 . . . . 1.0 110.282 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 70' ' ' GLY . 44.7 tt0 -176.94 35.11 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.089 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -72.94 -51.98 16.36 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 107.792 -1.188 . . . . 1.0 107.792 176.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -95.07 121.16 63.05 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 107.803 -1.184 . . . . 1.0 107.803 176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.39 162.92 11.23 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.054 1.836 . . . . 1.0 112.557 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 21.1 t -83.83 135.16 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.16 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.454 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.3 mt -109.64 -7.66 15.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.592 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 tp -49.4 138.06 13.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.347 0.594 . . . . 1.0 112.288 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.54 -4.04 79.34 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.396 -0.82 . . . . 1.0 111.063 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 81' ' ' THR . 3.6 tt -98.22 115.22 27.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.933 0.397 . . . . 1.0 110.742 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.617 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -78.8 126.41 30.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.445 -178.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 80' ' ' LEU . 61.5 m-85 -108.26 139.82 21.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.287 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.82 152.28 19.28 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.131 1.887 . . . . 1.0 111.675 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.405 ' O ' ' OD1' ' A' ' 86' ' ' ASP . . . -59.8 -26.45 65.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.819 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.05 -21.7 1.05 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.112 -0.795 . . . . 1.0 111.112 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 87' ' ' ILE . 49.0 p-10 -58.0 -29.67 65.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.841 0.353 . . . . 1.0 110.664 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.685 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.4 mm -110.17 99.8 41.29 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.228 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.588 ' O ' ' O ' ' A' ' 87' ' ' ILE . 98.7 Cg_exo -48.41 -126.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.437 2.091 . . . . 1.0 112.3 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.79 -60.64 0.54 Allowed 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.668 -0.413 . . . . 1.0 111.811 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -54.59 -41.02 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.758 -178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.725 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -63.18 -42.96 99.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 1.0 110.932 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.685 ' HE ' HG21 ' A' ' 87' ' ' ILE . 34.9 ttm180 -63.82 -28.86 70.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.591 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.452 ' O ' ' N ' ' A' ' 97' ' ' LEU . 31.9 mmt180 -56.73 -53.77 53.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.574 -0.285 . . . . 1.0 111.286 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ALA . 32.3 mt -54.02 -36.01 62.54 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.651 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -66.49 -35.95 81.55 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.602 -0.518 . . . . 1.0 109.602 178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 51.2 mtm180 -85.05 -16.15 41.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.114 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 93' ' ' ARG . 7.1 mp -106.04 -42.84 4.99 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -114.25 -4.58 13.03 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.527 0.936 . . . . 1.0 113.527 -176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.538 ' O ' ' NH2' ' A' ' 101' ' ' ARG . 94.1 mt-30 27.93 69.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.05 1.13 . . . . 1.0 114.05 178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 ' C ' ' HE ' ' A' ' 101' ' ' ARG . 58.3 t -110.73 -50.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 104.417 -2.438 . . . . 1.0 104.417 175.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.693 HH12 ' NE2' ' A' ' 185' ' ' GLN . 10.5 mtm180 63.72 72.02 0.48 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.088 -1.414 . . . . 1.0 114.269 172.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.597 ' C ' HD12 ' A' ' 103' ' ' ILE . 87.7 t -152.1 133.91 5.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.569 -0.453 . . . . 1.0 111.782 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 102' ' ' VAL . 1.7 mp -107.41 127.56 63.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 105' ' ' ASP . 12.7 p -83.01 167.23 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 113.266 0.839 . . . . 1.0 113.266 -176.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.651 ' N ' HG22 ' A' ' 104' ' ' VAL . 5.9 m-20 -54.62 120.03 6.12 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 114.74 -1.118 . . . . 1.0 112.315 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.9 m -58.53 -10.99 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.36 -0.837 . . . . 1.0 110.771 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 108' ' ' ALA . 17.4 pt-20 -85.38 -40.42 16.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.876 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.438 ' N ' ' CG ' ' A' ' 107' ' ' GLU . . . -58.23 -12.61 3.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.433 0.635 . . . . 1.0 110.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 49.4 52.0 15.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.051 -0.977 . . . . 1.0 113.396 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.6 m -94.44 136.56 34.61 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.363 -2.088 . . . . 1.0 105.363 175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -128.12 141.71 51.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.974 1.472 . . . . 1.0 114.974 -176.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 113' ' ' ILE . 4.2 t -99.33 153.66 18.8 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.098 -1.41 . . . . 1.0 107.323 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 112' ' ' SER . 19.7 pt -155.03 159.52 2.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 119.663 -0.815 . . . . 1.0 112.164 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.8 p -87.15 167.84 13.79 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.254 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -146.06 154.11 50.11 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.433 -0.348 . . . . 1.0 110.689 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.54 -39.81 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.637 2.225 . . . . 1.0 112.264 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.62 -33.74 74.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.489 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.3 t -71.69 162.27 29.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.481 ' O ' ' CG ' ' A' ' 119' ' ' TRP . 73.8 t-105 -146.21 27.79 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.548 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 83.93 17.67 64.91 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.996 -0.841 . . . . 1.0 110.996 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.4 mt 44.52 47.5 8.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.882 0.372 . . . . 1.0 110.562 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.1 t -56.53 -26.69 55.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.604 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -58.96 -16.95 20.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.828 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 61.59 79.97 0.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.858 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.2 t -85.19 131.0 49.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.081 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 127' ' ' LEU . 97.6 Cg_endo -75.56 141.61 25.28 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.562 2.175 . . . . 1.0 111.187 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.428 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 21.0 mt 41.42 -160.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.09 27.69 57.66 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.579 -0.608 . . . . 1.0 111.579 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 127' ' ' LEU . 8.3 mp0 -118.13 152.33 50.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.635 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.538 ' CG ' ' NH2' ' A' ' 133' ' ' ARG . 61.1 Cg_endo -70.69 164.95 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.404 2.069 . . . . 1.0 111.65 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 131' ' ' LEU . 8.7 mp -77.99 -7.26 56.6 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.316 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -134.42 168.26 19.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.068 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.538 ' NH2' ' CG ' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -129.88 84.44 60.84 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.284 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -46.06 142.86 7.92 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.56 2.174 . . . . 1.0 111.768 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -107.26 117.54 53.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.016 0.436 . . . . 1.0 111.312 -177.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 112' ' ' SER . 0.8 OUTLIER -39.85 153.95 0.19 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.947 177.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -56.96 -20.43 36.58 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.237 1.958 . . . . 1.0 111.233 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 32.6 t -65.79 -46.97 76.74 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.017 -0.734 . . . . 1.0 109.017 178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.806 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -74.7 -27.94 60.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.269 -0.878 . . . . 1.0 110.632 179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -52.48 -54.72 13.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.318 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -65.93 -44.48 84.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.279 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -44.49 -51.69 8.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.482 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.78 -47.03 50.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.522 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.8 OUTLIER -59.45 -42.06 91.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.503 -179.75 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 85.0 p -53.77 -30.65 45.51 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 30.6 mtt -86.91 -0.47 56.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.238 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 69.97 24.41 76.48 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.22 -0.9 . . . . 1.0 112.36 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 150' ' ' SER . 11.4 t -106.9 122.57 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.15 -26.27 42.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.764 0.653 . . . . 1.0 112.764 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.1 p -142.58 171.87 13.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.162 -0.615 . . . . 1.0 111.573 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.02 136.78 12.4 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -178.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 49.2 tp -112.51 136.23 52.28 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.7 OUTLIER -135.02 155.41 38.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.436 0.636 . . . . 1.0 111.845 -178.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 153' ' ' VAL . 65.4 t -157.67 90.0 2.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -52.22 140.24 52.02 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 123.552 2.835 . . . . 1.0 113.923 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 31.1 mt -98.52 105.65 17.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.799 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 81.3 mtp -119.42 141.13 49.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.262 0.553 . . . . 1.0 111.818 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.45 ' CD2' ' CB ' ' A' ' 196' ' ' ALA . 42.0 t-80 -116.61 112.03 20.71 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.431 ' CG ' ' H ' ' A' ' 160' ' ' GLN . 4.9 t60 62.86 -123.7 0.63 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 -176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.431 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 17.2 pt20 -94.64 7.72 44.77 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 162' ' ' LEU . 26.4 tp10 -117.23 153.4 32.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 114.0 1.111 . . . . 1.0 114.0 -176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 161' ' ' GLU . 6.5 tt -107.72 117.36 33.9 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 114.55 -1.205 . . . . 1.0 108.816 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.442 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.0 m95 -96.97 -27.87 14.44 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.712 -0.395 . . . . 1.0 111.858 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.06 23.53 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.188 -1.006 . . . . 1.0 111.93 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.63 HD23 HMB3 ' A' ' 203' ' ' CYC . 3.1 tp -141.59 127.81 19.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.0 111.263 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.3 tp -92.92 134.06 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.55 134.84 14.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.396 -0.522 . . . . 1.0 111.578 -178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.78 142.43 47.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.742 -0.663 . . . . 1.0 109.99 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -134.56 132.17 38.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.128 0.489 . . . . 1.0 110.96 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.709 ' CD2' ' N ' ' A' ' 171' ' ' ALA . 19.0 t60 -168.53 161.41 11.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.766 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.709 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -46.22 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.546 -0.297 . . . . 1.0 111.428 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.661 ' N ' ' OE1' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -91.78 107.29 21.34 Favored Pre-proline 0 N--CA 1.465 0.309 0 C-N-CA 120.391 -0.523 . . . . 1.0 112.343 179.717 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 171' ' ' ALA . 26.7 Cg_endo -92.61 -156.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.67 2.247 . . . . 1.0 110.849 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -91.0 173.83 5.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.046 -0.979 . . . . 1.0 112.698 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -57.34 155.96 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 122.876 2.384 . . . . 1.0 111.108 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 0.1 OUTLIER -108.23 150.19 27.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.856 0.36 . . . . 1.0 110.795 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -106.43 143.95 33.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.254 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.79 -28.3 66.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.617 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.14 -54.58 27.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.594 -0.275 . . . . 1.0 111.325 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.58 -33.88 76.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.944 0.402 . . . . 1.0 110.688 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 31.8 tp -59.66 -39.99 86.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.501 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.548 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 78.5 mm-40 -61.98 -51.96 65.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.352 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.1 t -45.27 -48.95 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.318 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 187' ' ' LEU . 63.9 t -74.27 -38.71 48.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.47 -0.567 . . . . 1.0 109.47 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.693 ' NE2' HH12 ' A' ' 101' ' ' ARG . 56.9 tt0 -45.93 -36.02 5.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.59 -39.68 67.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.764 -1.107 . . . . 1.0 109.333 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 184' ' ' VAL . 35.0 tp -54.95 -32.92 61.82 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.669 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.85 65.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.655 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -56.91 -39.36 74.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.905 -0.589 . . . . 1.0 109.697 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -53.38 -53.91 44.37 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 87.2 t -56.7 -43.67 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.36 -0.836 . . . . 1.0 109.869 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 9.3 p -51.7 -37.43 50.73 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 77.2 mt -78.39 -32.01 16.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.586 -0.734 . . . . 1.0 110.025 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -71.01 -46.36 62.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.757 -0.656 . . . . 1.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 196' ' ' ALA . 2.6 pp -66.62 -26.15 36.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.601 -0.518 . . . . 1.0 109.601 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.52 -55.71 5.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.846 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -57.26 -26.88 61.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.95 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.48 -35.73 58.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.401 . . . . 1.0 111.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -56.94 -39.34 74.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.221 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.5 tp -66.97 -56.31 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.119 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.9 m -47.16 -39.16 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 1.0 110.307 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.081 -0.961 . . . . 1.0 110.47 179.78 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 1.008 HBA2 HBC2 ' A' ' 203' ' ' CYC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD21 ' NH2' ' A' ' 55' ' ' ARG . 4.4 tp . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.823 0.344 . . . . 1.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 40.6 p-10 -65.33 -37.88 88.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.101 -0.499 . . . . 1.0 111.313 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.517 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 97.0 mt-30 -73.3 -53.71 10.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.799 HD13 ' O ' ' A' ' 34' ' ' ILE . 0.3 OUTLIER -57.2 -40.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.496 ' N ' ' CG2' ' A' ' 34' ' ' ILE . 69.9 mt -71.29 -33.28 69.58 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.631 -0.427 . . . . 1.0 111.589 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.5 ttt85 -49.53 -37.96 28.89 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.634 -0.426 . . . . 1.0 109.993 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.16 -26.4 52.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.35 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 34' ' ' ILE . 46.5 p -74.85 -44.33 49.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.557 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 53' ' ' VAL . 56.8 t -59.13 -38.89 76.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.993 -0.548 . . . . 1.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -76.27 -38.22 56.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.847 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -62.55 -49.35 75.65 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.995 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -62.92 -47.99 90.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.942 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.558 ' O ' ' N ' ' A' ' 47' ' ' GLY . 43.2 ttp180 -49.71 -43.99 47.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.853 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -81.52 -47.95 12.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.804 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -78.0 -7.08 56.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.428 . . . . 1.0 110.084 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 50.18 19.51 2.76 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.668 -0.696 . . . . 1.0 112.494 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.703 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.9 m -76.91 141.9 40.34 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.371 -0.532 . . . . 1.0 110.065 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.607 ' O ' ' N ' ' A' ' 70' ' ' GLY . 93.0 m-20 -62.6 -28.45 69.9 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.896 0.702 . . . . 1.0 112.896 -178.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.703 ' H ' HG22 ' A' ' 48' ' ' THR . 60.5 ttp180 -152.98 124.87 7.88 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 119.145 -1.022 . . . . 1.0 113.54 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.9 p -146.7 136.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 107.975 -1.12 . . . . 1.0 107.975 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -146.81 162.45 38.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.325 -0.55 . . . . 1.0 111.566 -177.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 39' ' ' VAL . 70.6 t -97.71 136.47 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.035 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -122.89 121.67 36.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.271 -0.422 . . . . 1.0 111.024 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.854 ' NH2' HD11 ' A' ' 195' ' ' ILE . 36.6 ttm-85 -101.47 168.93 9.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.85 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.457 ' N ' ' CG ' ' A' ' 55' ' ' ARG . 71.0 t80 -131.2 136.7 48.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.053 0.454 . . . . 1.0 112.124 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -101.5 148.74 35.63 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 115.814 -0.63 . . . . 1.0 109.379 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.69 -22.53 64.15 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.728 2.286 . . . . 1.0 112.94 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -79.69 -3.09 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.544 -0.463 . . . . 1.0 111.041 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.7 -10.42 52.86 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.815 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -90.19 145.83 24.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.377 0.588 . . . . 1.0 110.93 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.61 142.92 14.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.489 -1.044 . . . . 1.0 110.489 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.3 p -128.39 147.5 50.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.152 0.501 . . . . 1.0 112.346 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.7 t -101.14 121.35 51.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 176.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 m -108.98 1.84 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.63 0.604 . . . . 1.0 112.63 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.468 ' CB ' HG21 ' A' ' 39' ' ' VAL . . . -155.62 149.12 24.98 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 84.6 tt0 -166.83 127.18 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.394 -0.922 . . . . 1.0 113.248 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.26 133.89 54.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.12 -1.067 . . . . 1.0 108.12 177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.549 ' O ' ' NH1' ' A' ' 43' ' ' ARG . 58.6 mtm180 -117.45 139.74 50.51 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.292 -0.563 . . . . 1.0 111.586 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.607 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -80.22 107.05 2.56 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.473 -1.051 . . . . 1.0 110.473 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.32 18.17 0.06 OUTLIER Glycine 0 CA--C 1.519 0.312 0 N-CA-C 110.268 -1.133 . . . . 1.0 110.268 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' A' ' 70' ' ' GLY . 43.6 tt0 70.57 30.91 3.01 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.115 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 49' ' ' ASP . 36.7 ttm180 -57.83 -59.57 5.03 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.9 mt -92.8 164.8 20.67 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 107.882 -1.155 . . . . 1.0 107.882 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -76.81 171.75 17.43 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.043 1.829 . . . . 1.0 112.533 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -90.42 121.37 32.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.135 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 33.0 mt -92.76 -11.85 32.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.0 111.624 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.481 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 tp -50.4 137.23 19.14 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.274 0.559 . . . . 1.0 112.252 -177.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.67 -7.17 82.37 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.384 -0.825 . . . . 1.0 111.051 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 81' ' ' THR . 4.3 tt -97.68 115.9 28.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.876 0.37 . . . . 1.0 110.761 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.625 ' N ' HD23 ' A' ' 80' ' ' LEU . 8.0 t -76.46 122.5 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.465 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -106.75 132.16 21.13 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.318 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -78.11 152.39 27.73 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.195 1.93 . . . . 1.0 111.698 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 86' ' ' ASP . . . -63.36 -21.14 66.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.81 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -42.73 -22.29 0.14 Allowed Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' HB3' ' HHB' ' A' ' 203' ' ' CYC . 91.3 m-20 -48.44 -23.96 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.794 0.331 . . . . 1.0 110.641 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.544 ' CD1' HH21 ' A' ' 92' ' ' ARG . 2.9 pt -133.67 142.04 42.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.556 ' HD3' HMC3 ' A' ' 203' ' ' CYC . 43.1 Cg_endo -83.55 -104.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.525 2.15 . . . . 1.0 112.346 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.415 ' HA ' HH12 ' A' ' 92' ' ' ARG . 82.3 tt0 -147.64 -64.01 0.27 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 1.0 111.788 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.04 -41.12 46.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.716 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.035 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -63.15 -41.63 99.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.96 0.41 . . . . 1.0 111.005 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.544 HH21 ' CD1' ' A' ' 87' ' ' ILE . 23.6 ttm105 -64.54 -27.93 69.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.941 -0.572 . . . . 1.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 97' ' ' LEU . 68.7 mtm180 -58.53 -53.56 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.327 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.665 ' N ' HD12 ' A' ' 94' ' ' LEU . 8.4 mp -52.73 -41.33 63.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.55 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 4.2 m-85 -64.1 -35.91 82.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.587 -0.523 . . . . 1.0 109.587 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.3 mtp85 -85.2 -8.96 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.072 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 93' ' ' ARG . 3.4 tp -105.86 -43.34 4.9 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.343 0.868 . . . . 1.0 113.343 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -116.42 -0.08 12.62 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.518 0.933 . . . . 1.0 113.518 -177.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.447 ' C ' ' O ' ' A' ' 98' ' ' ALA . 93.6 mt-30 28.45 68.28 0.08 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 114.087 1.143 . . . . 1.0 114.087 178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.0 t -117.73 -48.35 3.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 104.381 -2.452 . . . . 1.0 104.381 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' HD2' HH11 ' A' ' 101' ' ' ARG . 6.2 mtp180 50.57 76.5 0.15 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.107 -1.406 . . . . 1.0 114.26 171.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.537 ' C ' HD12 ' A' ' 103' ' ' ILE . 11.2 m -145.15 139.17 22.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 120.448 -0.501 . . . . 1.0 111.757 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 103' ' ' ILE . 2.8 mp -107.24 125.2 63.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.673 HG12 ' N ' ' A' ' 105' ' ' ASP . 24.3 t -83.49 166.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 113.256 0.835 . . . . 1.0 113.256 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.673 ' N ' HG12 ' A' ' 104' ' ' VAL . 3.1 m-20 -48.85 120.32 3.77 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.252 -178.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.1 m -57.77 -12.18 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.764 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -87.01 -37.33 17.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.885 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -61.46 -16.19 44.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.372 0.606 . . . . 1.0 110.074 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 53.06 60.32 3.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.002 -0.999 . . . . 1.0 113.427 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.1 m -92.89 133.98 35.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 105.423 -2.066 . . . . 1.0 105.423 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -128.35 141.67 51.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.486 ' OG ' ' O ' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -101.81 150.74 22.85 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 114.073 -1.422 . . . . 1.0 107.298 176.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG23 ' O ' ' A' ' 112' ' ' SER . 22.4 pt -155.12 159.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.678 -0.809 . . . . 1.0 112.162 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.2 t -88.11 162.03 16.97 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.456 -0.793 . . . . 1.0 110.186 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -150.21 154.54 36.47 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.668 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.11 165.18 24.14 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.626 2.217 . . . . 1.0 112.236 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 119' ' ' TRP . 85.0 tt0 46.22 -100.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.586 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 119' ' ' TRP . 34.3 t 41.96 -93.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.59 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.529 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 51.9 t-105 45.87 -174.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.566 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.529 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 92.2 1.68 69.31 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.977 -0.849 . . . . 1.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 11.9 tp -70.86 -33.19 70.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 1.0 110.525 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.8 p -55.95 -20.01 14.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.57 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.77 -23.04 4.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.816 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 58.8 84.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -98.54 140.77 22.03 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.109 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -74.53 137.65 23.17 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.525 2.15 . . . . 1.0 111.205 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt 43.66 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.02 -24.87 13.65 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 111.641 -0.584 . . . . 1.0 111.641 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -73.76 152.85 89.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.627 ' CG ' HH21 ' A' ' 133' ' ' ARG . 55.6 Cg_endo -67.05 166.28 23.51 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 1.0 111.686 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.35 0.15 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.381 -0.372 . . . . 1.0 111.309 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -137.99 168.72 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.627 HH21 ' CG ' ' A' ' 130' ' ' PRO . 2.5 mmp_? -133.09 83.63 50.86 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.338 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.486 ' O ' ' OG ' ' A' ' 112' ' ' SER . 88.2 Cg_exo -46.0 145.21 5.33 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.525 2.15 . . . . 1.0 111.797 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.777 HG21 ' ND1' ' A' ' 139' ' ' HIS . 6.5 m -118.1 127.01 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.043 0.449 . . . . 1.0 111.361 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.86 ' H ' HMD2 ' A' ' 203' ' ' CYC . 2.7 m-20 -43.12 139.39 2.29 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.9 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -39.91 -46.8 3.85 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.163 1.909 . . . . 1.0 111.24 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 9.9 p -43.83 -41.68 5.2 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.046 -0.724 . . . . 1.0 109.046 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.777 ' ND1' HG21 ' A' ' 135' ' ' VAL . 13.1 t-80 -79.94 -38.52 32.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.368 -0.833 . . . . 1.0 110.687 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 46.6 t -50.9 -50.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.372 -0.376 . . . . 1.0 110.3 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.528 ' CD2' ' OG ' ' A' ' 145' ' ' SER . 77.0 t60 -64.13 -39.86 94.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.253 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -43.95 -47.48 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.447 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.4 mt -71.78 -45.4 61.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.511 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' O ' ' N ' ' A' ' 147' ' ' GLY . 0.0 OUTLIER -60.17 -42.49 95.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.492 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.528 ' OG ' ' CD2' ' A' ' 141' ' ' HIS . 20.8 m -54.17 -33.33 57.78 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.126 -0.694 . . . . 1.0 109.126 179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 34.6 mtt -86.99 -4.86 59.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.156 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 75.26 26.16 66.75 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.301 -0.863 . . . . 1.0 112.291 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.763 HG11 ' HB3' ' A' ' 169' ' ' HIS . 48.0 t -106.74 120.87 58.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.33 33.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 173' ' ' PRO . 37.7 m -127.89 153.99 46.03 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.155 -0.618 . . . . 1.0 111.585 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.573 ' OG ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -143.87 129.55 19.23 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.052 0.453 . . . . 1.0 112.178 -179.505 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 19.0 tp -121.96 141.78 50.97 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' C ' ' CG2' ' A' ' 154' ' ' VAL . 2.3 m -129.65 155.42 41.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.077 -0.649 . . . . 1.0 111.845 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 166' ' ' LEU . 2.1 t -150.72 97.82 3.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 114.891 -1.05 . . . . 1.0 109.287 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.84 139.52 36.65 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 123.536 2.824 . . . . 1.0 113.889 -173.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.4 mt -99.24 104.52 16.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.375 -0.829 . . . . 1.0 109.718 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 88.3 mtp -119.06 141.07 49.06 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.35 -0.54 . . . . 1.0 111.843 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.46 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 39.3 t-80 -125.31 112.93 16.94 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.495 ' CD2' ' H ' ' A' ' 160' ' ' GLN . 26.4 t60 75.08 -135.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.699 -0.482 . . . . 1.0 109.699 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.495 ' H ' ' CD2' ' A' ' 159' ' ' HIS . 25.4 mt-30 -96.16 12.38 31.02 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.914 0.338 . . . . 1.0 111.914 -179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' OE1' ' CZ2' ' A' ' 163' ' ' TRP . 63.7 mt-10 -120.19 161.43 21.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.945 1.091 . . . . 1.0 113.945 -176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 19.4 tp -109.79 116.83 32.39 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 114.544 -1.207 . . . . 1.0 108.851 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.46 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 79.4 m95 -99.04 -29.3 12.97 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.847 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.96 179.7 28.31 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.217 -0.992 . . . . 1.0 111.927 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.401 ' CD2' HMB2 ' A' ' 203' ' ' CYC . 5.1 tp -139.96 130.68 25.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.815 0.34 . . . . 1.0 111.193 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 154' ' ' VAL . 2.9 tp -99.6 145.27 27.74 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 167' ' ' VAL . 7.1 p -151.62 125.81 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.422 -0.511 . . . . 1.0 111.556 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -110.51 143.25 41.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.049 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.763 ' HB3' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -141.95 143.53 33.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 49' ' ' ASP . 19.2 t60 -153.29 153.24 32.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.657 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.445 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -82.59 68.46 9.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.433 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.431 ' O ' ' OG ' ' A' ' 150' ' ' SER . 35.1 tp10 -177.04 131.41 0.35 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 120.401 -0.52 . . . . 1.0 112.302 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 174' ' ' ARG . 21.4 Cg_exo -39.08 -44.73 2.65 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.68 2.253 . . . . 1.0 110.885 176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.483 ' O ' ' O ' ' A' ' 173' ' ' PRO . 42.3 ttm180 23.17 104.6 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.009 -0.996 . . . . 1.0 112.689 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.72 156.18 24.22 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.793 2.329 . . . . 1.0 111.1 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -115.18 137.67 51.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.913 0.387 . . . . 1.0 110.804 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.7 t -91.21 143.44 26.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.234 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.61 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -62.57 -55.3 28.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.661 0.267 . . . . 1.0 111.388 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -65.07 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 1.0 110.653 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.71 -30.47 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.576 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -73.88 -52.67 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.406 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 61.3 t -43.94 -45.63 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.283 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' LEU . 5.4 p -73.18 -39.38 56.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.457 -0.571 . . . . 1.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -49.8 -36.59 26.91 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.5 tp -69.88 -31.22 68.91 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 114.704 -1.134 . . . . 1.0 109.41 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 184' ' ' VAL . 6.6 tt -63.32 -28.17 69.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.684 -0.689 . . . . 1.0 109.631 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.78 -38.72 70.28 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.664 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -53.36 -44.61 68.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.657 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -52.56 -55.53 21.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.047 -0.724 . . . . 1.0 109.047 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 90.8 t -55.66 -40.77 61.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.247 -0.888 . . . . 1.0 109.903 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.8 m -50.22 -29.13 8.8 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.135 -0.691 . . . . 1.0 109.135 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.451 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 11.2 mm -77.28 -48.53 24.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.064 178.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.63 87.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.084 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.854 HD11 ' NH2' ' A' ' 55' ' ' ARG . 4.0 tp -59.91 -37.48 72.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' N ' ' CG2' ' A' ' 195' ' ' ILE . . . -72.97 -51.64 17.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.848 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 193' ' ' ILE . 2.9 mp0 -55.61 -26.59 44.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.954 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -77.36 -33.81 55.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -59.08 -41.37 87.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.161 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.05 -60.14 3.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.445 -0.343 . . . . 1.0 111.024 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 85.2 p -58.97 -43.84 91.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.328 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.036 -0.983 . . . . 1.0 110.422 179.793 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 1.035 HAD1 ' HB1' ' A' ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD21 ' HB3' ' A' ' 198' ' ' ALA . 32.3 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.886 0.374 . . . . 1.0 110.555 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 33' ' ' GLN . 27.8 p-10 -63.66 -44.63 93.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.251 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 93.8 mt-30 -67.0 -53.19 33.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.237 0.458 . . . . 1.0 112.237 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mt -55.24 -48.88 75.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.629 0.603 . . . . 1.0 112.629 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.0 mt -62.81 -25.25 68.16 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.641 -0.423 . . . . 1.0 111.609 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.562 ' O ' HG12 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -57.42 -36.63 71.59 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.636 -0.426 . . . . 1.0 110.036 178.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.42 -26.68 41.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.391 178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -73.57 -48.4 33.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.556 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 36' ' ' ARG . 3.2 p -53.3 -35.12 23.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.836 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 95.4 mt-10 -77.76 -33.71 52.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.764 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -62.44 -50.51 71.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.978 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG13 ' N ' ' A' ' 43' ' ' ARG . 12.4 p -64.24 -45.56 95.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 120.591 -0.444 . . . . 1.0 110.91 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' N ' HG13 ' A' ' 42' ' ' VAL . 18.3 ttt-85 -49.09 -46.42 44.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -39.05 82.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.782 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -78.31 -52.11 9.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.761 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.55 -5.61 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.046 0.45 . . . . 1.0 110.167 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 46.75 18.0 0.33 Allowed Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.599 -0.728 . . . . 1.0 112.399 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.1 m -75.86 144.0 41.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.434 -0.506 . . . . 1.0 110.14 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.596 ' O ' ' N ' ' A' ' 70' ' ' GLY . 97.4 m-20 -64.29 -26.81 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.87 0.693 . . . . 1.0 112.87 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.595 ' H ' HG22 ' A' ' 48' ' ' THR . 24.4 ttt180 -149.98 121.27 7.84 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 119.103 -1.039 . . . . 1.0 113.476 -178.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' A' ' 39' ' ' VAL . 3.2 t -140.32 130.53 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.957 -1.127 . . . . 1.0 107.957 177.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -143.33 155.32 44.42 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.626 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.79 137.44 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.009 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -121.36 119.7 32.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.033 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -99.76 170.29 8.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 1.0 109.871 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.549 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 48.9 t80 -135.05 141.66 46.16 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.568 -0.453 . . . . 1.0 112.155 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.52 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 4.0 m-20 -104.0 150.47 38.31 Favored Pre-proline 0 CA--C 1.529 0.147 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.269 178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -65.49 -29.18 53.31 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 122.699 2.266 . . . . 1.0 112.901 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.47 -4.99 37.16 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.586 -0.446 . . . . 1.0 110.935 -179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.36 -14.54 36.16 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 120.931 -0.652 . . . . 1.0 112.803 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.418 ' O ' ' OD2' ' A' ' 57' ' ' ASP . 99.2 m-70 -84.65 143.79 29.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 117.398 0.599 . . . . 1.0 110.959 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' A' ' 82' ' ' PHE . . . -119.67 139.28 13.89 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.423 -1.071 . . . . 1.0 110.423 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -125.08 143.85 50.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.289 0.566 . . . . 1.0 112.25 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.1 t -98.27 120.16 47.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -109.61 3.47 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.642 0.608 . . . . 1.0 112.642 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.52 149.87 24.4 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 77' ' ' LEU . 79.2 tt0 -166.15 125.46 1.6 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.433 -0.907 . . . . 1.0 113.266 -178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.13 135.86 47.95 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.116 -1.068 . . . . 1.0 108.116 176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 76' ' ' SER . 7.1 ptp85 -129.78 141.97 50.77 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.27 -0.572 . . . . 1.0 111.552 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -86.36 106.32 3.08 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.454 -1.058 . . . . 1.0 110.454 178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.19 -88.55 0.01 OUTLIER Glycine 0 CA--C 1.519 0.341 0 N-CA-C 110.261 -1.136 . . . . 1.0 110.261 -177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 70' ' ' GLY . 45.7 tt0 -177.36 32.13 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.802 -0.359 . . . . 1.0 111.064 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -69.57 -33.94 73.45 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.9 mt -116.73 142.63 29.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' O ' ' NH2' ' A' ' 50' ' ' ARG . 64.0 Cg_endo -73.36 170.35 20.1 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.077 1.851 . . . . 1.0 112.535 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 69' ' ' ARG . 14.9 m -93.53 137.93 32.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.189 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 37.8 mt -109.63 -3.9 16.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.641 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 14.2 tp -56.69 137.75 53.74 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.278 0.561 . . . . 1.0 112.286 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.89 -2.97 86.03 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 81' ' ' THR . 2.8 tt -101.61 118.77 37.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.907 0.384 . . . . 1.0 110.746 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.607 ' N ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -76.69 122.43 24.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.089 -0.505 . . . . 1.0 111.463 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' GLY . 6.7 m-85 -106.26 133.69 20.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.336 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -78.7 152.28 25.56 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.175 1.917 . . . . 1.0 111.71 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -63.9 -23.39 67.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.796 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -44.86 -22.93 0.51 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -54.05 -21.72 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.407 ' HB ' HH21 ' A' ' 92' ' ' ARG . 18.1 mt -129.0 132.83 24.62 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.0 111.302 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.471 ' HG3' HMD3 ' A' ' 203' ' ' CYC . 89.8 Cg_endo -77.17 -107.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.531 2.154 . . . . 1.0 112.341 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.11 -69.09 0.34 Allowed 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.718 -0.393 . . . . 1.0 111.815 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -42.34 -42.38 3.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.044 -0.526 . . . . 1.0 111.778 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -66.14 -52.96 43.5 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.976 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.407 HH21 ' HB ' ' A' ' 87' ' ' ILE . 35.4 ttm180 -56.44 -30.37 62.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.566 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -57.47 -45.11 85.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.508 -0.314 . . . . 1.0 111.231 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 98' ' ' ALA . 50.5 mt -54.96 -36.68 65.59 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 1.0 110.582 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.624 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 7.6 m-85 -61.17 -26.53 67.77 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.618 -0.512 . . . . 1.0 109.618 178.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 97' ' ' LEU . 48.0 mtp85 -93.87 -18.23 22.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.12 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 96' ' ' ARG . 9.1 mp -109.44 -46.86 3.47 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 113.374 0.879 . . . . 1.0 113.374 -176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.475 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -107.96 -10.87 15.43 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -174.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.596 ' NE2' ' SD ' ' A' ' 157' ' ' MET . 79.8 mt-30 26.12 69.29 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 114.079 1.14 . . . . 1.0 114.079 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.69 HG23 ' H ' ' A' ' 101' ' ' ARG . 2.7 m -137.46 -54.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 104.377 -2.453 . . . . 1.0 104.377 175.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.69 ' H ' HG23 ' A' ' 100' ' ' VAL . 5.4 mmp_? 49.57 101.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.111 -1.404 . . . . 1.0 114.288 171.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -145.61 136.44 19.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 120.464 -0.494 . . . . 1.0 111.743 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.454 ' CD1' HMA2 ' A' ' 203' ' ' CYC . 70.8 mt -107.61 123.16 62.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.688 HG12 ' N ' ' A' ' 105' ' ' ASP . 23.4 t -84.17 168.11 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.688 ' N ' HG12 ' A' ' 104' ' ' VAL . 4.0 m-20 -50.4 118.48 3.04 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 114.734 -1.121 . . . . 1.0 112.262 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 106' ' ' VAL . 7.9 p -55.54 -11.26 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.313 -0.858 . . . . 1.0 110.75 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 109' ' ' GLN . 4.8 pt-20 -88.61 -35.86 16.61 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.915 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.59 0.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.4 0.619 . . . . 1.0 110.113 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.521 ' H ' ' C ' ' A' ' 107' ' ' GLU . 10.1 pt20 35.35 60.65 0.71 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.106 -0.952 . . . . 1.0 113.504 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -93.96 134.99 35.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.384 -2.08 . . . . 1.0 105.384 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptp180 -131.09 141.85 50.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.047 1.499 . . . . 1.0 115.047 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.448 ' O ' ' OD2' ' A' ' 136' ' ' ASP . 1.9 t -142.89 116.56 9.21 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 114.184 -1.371 . . . . 1.0 107.354 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.663 HG22 ' H ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -119.34 -163.74 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 119.673 -0.811 . . . . 1.0 112.181 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.663 ' H ' HG22 ' A' ' 113' ' ' ILE . 49.0 m -88.02 164.43 15.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.24 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 116' ' ' PRO . 39.2 mt-30 -143.12 151.29 55.25 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.651 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 115' ' ' GLN . 41.5 Cg_exo -35.09 -40.7 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.686 2.257 . . . . 1.0 112.241 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -145.76 147.68 32.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.538 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.2 p -130.19 152.79 49.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.577 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.545 ' CG ' ' N ' ' A' ' 120' ' ' GLY . 87.4 t90 -153.01 171.74 17.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.537 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.545 ' N ' ' CG ' ' A' ' 119' ' ' TRP . . . 92.73 6.32 63.93 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.994 -0.842 . . . . 1.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 121' ' ' LEU . 10.1 mp -81.63 -72.3 0.44 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.83 0.348 . . . . 1.0 110.595 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.9 p -65.25 -20.43 66.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.586 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.6 75.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.826 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 56.23 86.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.84 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.8 142.94 25.6 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.132 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.29 130.31 13.93 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.597 2.198 . . . . 1.0 111.151 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' CG ' ' H ' ' A' ' 128' ' ' GLY . 5.3 tp 47.66 -134.48 1.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 127' ' ' LEU . . . 55.06 16.47 8.34 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.678 -0.569 . . . . 1.0 111.678 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -102.05 152.23 38.18 Favored Pre-proline 0 C--N 1.329 -0.289 0 C-N-CA 120.929 -0.309 . . . . 1.0 110.599 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.92 160.0 50.75 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.408 2.072 . . . . 1.0 111.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 34.4 mt -77.94 -14.47 59.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.297 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -134.57 169.41 17.33 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.63 -0.428 . . . . 1.0 111.076 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.514 HH21 HH22 ' A' ' 101' ' ' ARG . 11.3 tpp180 -138.72 73.46 40.67 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.336 -179.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.457 ' C ' ' O ' ' A' ' 133' ' ' ARG . 3.5 Cg_exo -30.36 143.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.615 2.21 . . . . 1.0 111.774 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.599 HG11 ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -104.8 115.69 47.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.107 0.479 . . . . 1.0 111.363 -178.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -40.27 147.14 0.38 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.912 178.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.567 ' O ' HG22 ' A' ' 140' ' ' VAL . 17.7 Cg_endo -52.86 -12.41 1.94 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.221 1.947 . . . . 1.0 111.258 -177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.607 ' O ' HBC1 ' A' ' 203' ' ' CYC . 36.0 t -77.02 -39.32 50.62 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.599 ' CE1' HG11 ' A' ' 135' ' ' VAL . 3.3 t-80 -83.34 -34.2 25.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.366 -0.834 . . . . 1.0 110.633 -177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 137' ' ' PRO . 2.9 m -53.94 -45.88 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.299 -178.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.553 ' N ' HG23 ' A' ' 140' ' ' VAL . 42.7 t-80 -67.41 -44.92 77.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.197 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -46.59 -51.16 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.47 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.2 tp -69.3 -49.22 57.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.516 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 147' ' ' GLY . 17.8 tptp -58.0 -40.25 80.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.449 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 141' ' ' HIS . 34.9 m -53.73 -33.47 55.75 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 27.3 mtt -83.62 0.88 44.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.191 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 144' ' ' LYS . . . 68.62 23.96 75.36 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.247 -0.888 . . . . 1.0 112.334 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 170' ' ' HIS . 25.3 t -107.46 121.8 60.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.913 -0.402 . . . . 1.0 109.913 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -78.3 -33.72 49.2 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.783 0.66 . . . . 1.0 112.783 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.441 ' O ' HG12 ' A' ' 148' ' ' VAL . 32.4 t -135.53 170.12 16.45 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.112 -0.635 . . . . 1.0 111.593 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 10.7 t -162.05 139.82 8.72 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.176 0.436 . . . . 1.0 112.176 -177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 35.9 tp -115.33 133.58 55.9 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 154' ' ' VAL . 1.4 p -132.37 155.58 41.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.06 -0.656 . . . . 1.0 111.818 -178.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 153' ' ' VAL . 77.2 t -156.53 109.93 2.02 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 114.88 -1.055 . . . . 1.0 109.334 -178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.62 114.17 3.42 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.634 2.889 . . . . 1.0 113.87 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 35.7 mt -75.51 107.02 7.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.419 -0.809 . . . . 1.0 109.808 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.596 ' SD ' ' NE2' ' A' ' 99' ' ' GLN . 17.0 ptm -132.15 144.19 50.51 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.33 -0.548 . . . . 1.0 111.824 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.439 ' HB3' ' HE1' ' A' ' 163' ' ' TRP . 70.8 t60 -114.31 114.73 26.33 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.972 -1.122 . . . . 1.0 107.972 177.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 160' ' ' GLN . 46.8 t-80 61.48 -123.69 0.83 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.507 ' N ' ' ND1' ' A' ' 159' ' ' HIS . 5.2 tt0 -94.04 6.16 49.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.901 0.334 . . . . 1.0 111.901 -179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.497 ' OE1' ' N ' ' A' ' 161' ' ' GLU . 43.9 mp0 -115.65 149.82 37.72 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.991 1.108 . . . . 1.0 113.991 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.28 116.83 32.6 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 114.562 -1.199 . . . . 1.0 108.912 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . 0.439 ' HE1' ' HB3' ' A' ' 158' ' ' HIS . 98.9 m95 -99.22 -30.47 12.25 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.917 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -155.26 -174.1 24.76 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.187 -1.006 . . . . 1.0 111.958 -179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.9 tp -141.09 131.11 24.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 1.0 111.201 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 153' ' ' VAL . 5.4 tp -93.7 136.21 34.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.56 ' CG1' ' NE2' ' A' ' 169' ' ' HIS . 31.0 t -148.52 122.74 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.332 -0.547 . . . . 1.0 111.527 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 2.0 p -108.09 143.27 37.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.971 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.56 ' NE2' ' CG1' ' A' ' 167' ' ' VAL . 54.3 m-70 -137.03 143.2 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.096 0.474 . . . . 1.0 111.048 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.732 ' CG ' ' HE ' ' A' ' 174' ' ' ARG . 2.5 p-80 -152.95 151.92 30.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.703 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.56 68.97 9.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.403 -178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 179.67 153.91 0.62 Allowed Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 112.349 0.5 . . . . 1.0 112.349 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -89.54 101.76 0.34 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.695 2.263 . . . . 1.0 110.934 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.732 ' HE ' ' CG ' ' A' ' 170' ' ' HIS . 6.9 ptt85 -128.62 100.11 22.43 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.068 -0.969 . . . . 1.0 112.686 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.99 152.65 17.42 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.89 2.394 . . . . 1.0 111.089 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -110.53 145.8 37.13 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.864 -0.335 . . . . 1.0 110.799 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 38.5 t -96.26 139.2 32.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.288 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -63.17 -40.34 97.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.671 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -65.49 -55.73 16.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.601 -0.272 . . . . 1.0 111.31 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.89 -35.42 80.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.894 0.378 . . . . 1.0 110.64 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.2 tp -59.56 -40.23 86.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.539 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.418 ' NE2' ' OE1' ' A' ' 185' ' ' GLN . 62.6 tp60 -60.76 -50.84 71.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.416 -0.357 . . . . 1.0 111.358 -179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 57.2 t -45.39 -47.16 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 C-N-CA 120.65 -0.42 . . . . 1.0 110.28 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 187' ' ' LEU . 75.3 t -73.39 -40.71 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.418 ' OE1' ' NE2' ' A' ' 182' ' ' GLN . 57.0 tt0 -45.99 -34.83 4.27 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.075 -1.083 . . . . 1.0 108.075 177.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.67 -38.07 70.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.672 -1.149 . . . . 1.0 109.404 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 184' ' ' VAL . 10.9 tp -54.84 -31.36 59.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.698 179.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.74 -36.55 70.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.648 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -57.19 -42.1 80.58 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.845 -0.616 . . . . 1.0 109.72 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -52.7 -55.35 23.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.136 -0.69 . . . . 1.0 109.136 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.07 -43.17 84.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.826 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 8.3 p -52.0 -37.27 52.64 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 78.1 mt -78.11 -33.36 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.079 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.12 -45.71 66.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.705 -0.68 . . . . 1.0 111.037 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.7 pp -67.13 -23.78 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.672 ' N ' HD12 ' A' ' 195' ' ' ILE . . . -76.53 -56.14 4.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.794 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.2 -26.9 63.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.909 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.507 ' HB3' HD21 ' A' ' 31' ' ' LEU . . . -76.41 -36.27 58.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 1.0 111.263 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -56.2 -38.13 70.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.462 -0.335 . . . . 1.0 111.175 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 34.8 mt -68.08 -55.94 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.055 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.2 p -53.0 -41.16 64.39 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.281 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 202' ' ' LEU . 10.7 mp . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.02 -0.99 . . . . 1.0 110.423 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.607 HBC1 ' O ' ' A' ' 138' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 8.3 tp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.847 0.356 . . . . 1.0 110.523 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 65' ' ' VAL . 64.1 t0 -53.6 -53.07 56.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.306 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.02 -46.42 90.81 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.853 ' O ' HG23 ' A' ' 38' ' ' THR . 18.4 mm -60.63 -38.98 80.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.38 -21.15 60.58 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.555 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 85.4 mtt-85 -70.32 -40.21 74.31 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.621 -0.432 . . . . 1.0 110.034 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.43 -33.56 62.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.349 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 34' ' ' ILE . 41.2 p -68.17 -46.39 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.573 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.618 HG12 ' HB2' ' A' ' 68' ' ' ALA . 5.2 t -56.18 -38.89 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.874 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -76.64 -37.43 56.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.821 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -57.43 -53.14 61.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.951 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 43' ' ' ARG . 10.7 p -63.35 -40.5 89.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.896 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.546 ' O ' ' N ' ' A' ' 47' ' ' GLY . 2.3 ttp-105 -51.13 -47.21 62.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.905 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.46 -37.71 78.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.829 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -79.4 -50.93 10.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.754 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.3 tp -77.26 -5.59 49.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.037 0.446 . . . . 1.0 110.206 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.546 ' N ' ' O ' ' A' ' 43' ' ' ARG . . . 48.3 19.2 1.07 Allowed Glycine 0 CA--C 1.528 0.89 0 CA-C-N 115.613 -0.721 . . . . 1.0 112.442 178.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 50' ' ' ARG . 1.3 m -76.08 141.99 41.86 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.374 -0.531 . . . . 1.0 110.029 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 70' ' ' GLY . 37.3 p30 -67.8 -24.16 65.27 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.631 ' H ' HG22 ' A' ' 48' ' ' THR . 71.2 ttt-85 -153.98 120.31 5.44 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 119.176 -1.01 . . . . 1.0 113.538 -179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.21 139.18 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 107.981 -1.118 . . . . 1.0 107.981 177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.674 ' CE ' HAB1 ' A' ' 203' ' ' CYC . 28.4 pttt -148.04 160.59 42.7 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.383 -0.527 . . . . 1.0 111.553 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.2 t -99.41 139.15 21.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.078 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.454 ' O ' ' N ' ' A' ' 165' ' ' LEU . 16.0 t80 -121.58 120.47 34.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.01 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.406 HH11 ' HB2' ' A' ' 55' ' ' ARG . 20.2 ttp-105 -99.43 166.59 11.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.256 -0.429 . . . . 1.0 109.911 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 84' ' ' ALA . 43.2 t80 -132.36 142.77 49.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.074 0.464 . . . . 1.0 112.117 -177.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.535 ' O ' ' CZ ' ' A' ' 56' ' ' PHE . 3.3 m-20 -105.34 149.88 38.26 Favored Pre-proline 0 C--N 1.333 -0.148 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.32 178.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -64.78 -30.32 58.95 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.735 2.29 . . . . 1.0 112.896 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -71.95 -5.43 34.7 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.607 -0.437 . . . . 1.0 111.022 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 107.77 -14.24 38.19 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.998 -0.62 . . . . 1.0 112.83 177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.64 142.77 29.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 117.436 0.618 . . . . 1.0 110.896 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -120.35 140.17 14.25 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.0 p -127.1 145.71 50.64 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.242 0.544 . . . . 1.0 112.253 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 64' ' ' VAL . 7.5 p -104.54 121.26 56.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.016 -1.105 . . . . 1.0 108.016 176.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 32' ' ' ASP . 1.3 p -115.97 9.01 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.651 0.611 . . . . 1.0 112.651 -176.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 52' ' ' LYS . . . -155.71 145.52 21.31 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' A' ' 78' ' ' LEU . 86.2 tt0 -168.69 129.93 1.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 119.447 -0.901 . . . . 1.0 113.212 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.618 ' HB2' HG12 ' A' ' 39' ' ' VAL . . . -110.36 140.42 44.57 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.133 -1.062 . . . . 1.0 108.133 176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -131.39 143.85 50.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.268 -0.573 . . . . 1.0 111.523 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ASP . . . -87.6 108.19 3.36 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.21 -84.92 0.01 OUTLIER Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.224 -1.15 . . . . 1.0 110.224 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 70' ' ' GLY . 16.1 pt-20 177.89 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.859 -0.337 . . . . 1.0 111.15 178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.591 ' NH1' ' NE2' ' A' ' 170' ' ' HIS . 10.4 ptp180 -65.76 -31.6 72.68 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.707 -1.22 . . . . 1.0 107.707 177.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 12.8 mt -116.3 150.28 45.07 Favored Pre-proline 0 C--N 1.33 -0.245 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 177.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 74' ' ' LEU . 4.8 Cg_exo -78.01 162.88 28.79 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 C-N-CA 122.066 1.844 . . . . 1.0 112.494 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.4 t -90.79 113.62 25.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.103 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 53.3 mt -87.98 -1.18 57.83 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.622 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.554 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 6.2 tp -52.8 135.63 35.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.284 0.564 . . . . 1.0 112.216 -177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 64' ' ' VAL . . . 90.89 -1.43 78.05 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 81' ' ' THR . 3.7 tt -95.22 120.31 35.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 1.0 110.743 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.706 ' N ' HD23 ' A' ' 80' ' ' LEU . 6.2 p -87.75 127.34 35.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.037 -0.529 . . . . 1.0 111.446 -179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.429 ' CG ' HBB3 ' A' ' 203' ' ' CYC . 35.1 m-85 -109.23 139.02 20.62 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.288 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.67 161.48 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.214 1.943 . . . . 1.0 111.608 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -68.27 -28.87 67.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.781 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -48.43 -23.43 3.08 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.68 -26.9 68.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.8 0.333 . . . . 1.0 110.663 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' ' O ' ' A' ' 88' ' ' PRO . 60.8 mt -112.18 99.98 47.95 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.3 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.543 ' O ' ' O ' ' A' ' 87' ' ' ILE . 84.2 Cg_exo -49.4 -121.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.584 2.189 . . . . 1.0 112.318 178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -145.64 -58.32 0.32 Allowed 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.706 -0.398 . . . . 1.0 111.8 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -51.3 -42.09 60.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.805 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' HAD1 ' A' ' 203' ' ' CYC . . . -65.85 -49.87 66.61 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.968 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 55.3 ttp180 -60.01 -29.92 68.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.534 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -58.18 -48.27 80.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.278 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HB2' ' HE ' ' A' ' 133' ' ' ARG . 74.2 mt -51.89 -40.2 60.27 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.652 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -62.7 -24.91 67.9 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.58 -0.526 . . . . 1.0 109.58 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.484 ' HE ' ' CA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -90.98 -21.29 21.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.501 -0.772 . . . . 1.0 110.16 -179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.443 HD23 HG21 ' A' ' 125' ' ' VAL . 9.4 mp -105.57 -45.94 4.3 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.404 0.89 . . . . 1.0 113.404 -177.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.494 ' O ' ' C ' ' A' ' 99' ' ' GLN . . . -108.72 -5.83 16.18 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' C ' ' O ' ' A' ' 98' ' ' ALA . 96.3 mt-30 24.68 66.87 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.579 HG23 ' H ' ' A' ' 101' ' ' ARG . 3.1 m -108.44 -50.78 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.43 -2.433 . . . . 1.0 104.43 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.832 ' H ' HH22 ' A' ' 133' ' ' ARG . 1.2 mtt180 65.67 68.03 0.48 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.069 -1.423 . . . . 1.0 114.233 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.538 ' H ' HH12 ' A' ' 133' ' ' ARG . 44.6 t -148.92 130.85 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 120.491 -0.483 . . . . 1.0 111.754 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 139' ' ' HIS . 89.8 mt -110.93 128.51 67.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.655 HG12 ' N ' ' A' ' 105' ' ' ASP . 12.9 t -82.39 168.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 113.307 0.854 . . . . 1.0 113.307 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.655 ' N ' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -47.49 117.34 1.76 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.805 -1.088 . . . . 1.0 112.325 -178.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.1 m -57.08 -10.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.416 -0.811 . . . . 1.0 110.745 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -87.4 -35.41 18.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.872 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.04 -16.03 48.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.367 0.603 . . . . 1.0 110.149 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 52.78 59.41 4.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.974 . . . . 1.0 113.456 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 m -93.79 138.61 31.78 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 105.421 -2.066 . . . . 1.0 105.421 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -133.82 144.12 48.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 115.003 1.483 . . . . 1.0 115.003 -176.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 t -129.49 113.99 15.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.127 -1.397 . . . . 1.0 107.404 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.858 ' H ' HD13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -119.93 -168.62 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 119.745 -0.782 . . . . 1.0 112.214 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.401 ' O ' HG12 ' A' ' 113' ' ' ILE . 40.2 t -88.25 154.65 20.25 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.482 -0.781 . . . . 1.0 110.207 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.47 ' N ' ' CD ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -151.37 153.61 32.62 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.578 -178.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 115' ' ' GLN . 39.5 Cg_exo -35.44 157.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.635 2.223 . . . . 1.0 112.27 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.66 142.0 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.515 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 33.8 t -150.69 146.84 26.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -56.92 -44.57 82.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.48 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 56.92 32.32 62.2 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.949 -0.861 . . . . 1.0 110.949 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 121' ' ' LEU . 9.3 mp 50.83 78.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 1.0 110.559 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.4 m -58.39 -33.95 70.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.529 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -57.76 -53.46 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.826 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -171.94 143.91 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.974 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.443 HG21 HD23 ' A' ' 97' ' ' LEU . 3.0 m -114.35 84.18 9.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.073 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.486 ' O ' ' C ' ' A' ' 127' ' ' LEU . 78.9 Cg_endo -84.35 126.67 3.71 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.529 2.153 . . . . 1.0 111.208 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.486 ' C ' ' O ' ' A' ' 126' ' ' PRO . 69.5 mt 36.63 -108.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 62.51 8.17 18.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.609 -0.597 . . . . 1.0 111.609 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -153.96 149.91 21.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.977 -0.289 . . . . 1.0 110.662 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.25 168.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.446 2.097 . . . . 1.0 111.675 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 27.6 mt -79.29 19.9 0.56 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.286 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.4 HE22 ' CG1' ' A' ' 102' ' ' VAL . 18.7 mm100 -133.47 171.38 14.15 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.036 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.832 HH22 ' H ' ' A' ' 101' ' ' ARG . 17.8 ttm105 -131.41 80.53 67.29 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.28 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -44.23 145.79 2.17 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.512 2.141 . . . . 1.0 111.833 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.447 HG12 HBD2 ' A' ' 203' ' ' CYC . 12.5 m -122.38 130.07 74.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.014 0.435 . . . . 1.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.685 ' OD1' HMD2 ' A' ' 203' ' ' CYC . 0.0 OUTLIER -42.47 163.45 0.14 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.913 179.113 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.3 -11.07 17.7 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.226 1.951 . . . . 1.0 111.257 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.727 ' SG ' ' N ' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -60.23 -55.42 33.98 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.976 -0.749 . . . . 1.0 108.976 178.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.727 ' N ' ' SG ' ' A' ' 138' ' ' CYS . 18.0 t-80 -72.34 -27.16 62.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.365 -0.834 . . . . 1.0 110.631 -178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -52.05 -60.59 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.335 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -66.1 -41.98 89.89 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.24 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -42.51 -48.72 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.546 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.697 HD11 ' CE1' ' A' ' 139' ' ' HIS . 30.2 mt -72.08 -47.01 54.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.46 178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 147' ' ' GLY . 38.7 tptt -55.99 -42.97 77.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.444 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 26.0 t -55.1 -30.2 59.21 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.238 -0.653 . . . . 1.0 109.238 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' MET . . . . . . . . . . . . . 41.7 mtt -90.02 -7.98 52.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.564 -0.744 . . . . 1.0 109.118 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 144' ' ' LYS . . . 75.96 28.96 59.7 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.337 -0.847 . . . . 1.0 112.327 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.589 HG11 ' CB ' ' A' ' 169' ' ' HIS . 14.4 t -108.94 124.36 65.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.898 -0.408 . . . . 1.0 109.898 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -80.03 -31.17 39.6 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.41 ' O ' HG12 ' A' ' 148' ' ' VAL . 83.6 p -134.12 169.4 17.22 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.594 -177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.2 p -159.06 139.47 12.32 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.023 0.439 . . . . 1.0 112.161 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.8 tp -119.02 141.89 48.3 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.538 ' O ' HG23 ' A' ' 154' ' ' VAL . 1.0 OUTLIER -132.96 156.66 42.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.418 0.628 . . . . 1.0 111.914 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.563 HG13 ' NE2' ' A' ' 185' ' ' GLN . 53.3 t -157.62 98.53 1.91 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 114.898 -1.046 . . . . 1.0 109.337 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.24 117.74 4.83 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 123.571 2.848 . . . . 1.0 113.9 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 40.1 mt -76.82 106.3 8.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.432 -0.803 . . . . 1.0 109.809 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.2 ptm -129.34 143.33 50.8 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.34 -0.544 . . . . 1.0 111.848 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 159' ' ' HIS . 70.0 t60 -110.42 113.96 27.01 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.943 -1.132 . . . . 1.0 107.943 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 158' ' ' HIS . 21.3 m-70 57.97 -119.67 1.16 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -93.63 2.55 56.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -112.56 150.69 30.97 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.959 1.096 . . . . 1.0 113.959 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.3 tt -107.03 116.84 32.62 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.491 -1.231 . . . . 1.0 108.867 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -96.96 -28.52 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.921 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -159.41 -173.81 28.33 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.949 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.528 HD23 HMB2 ' A' ' 203' ' ' CYC . 4.0 tp -138.18 133.54 33.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.826 0.346 . . . . 1.0 111.214 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 4.4 tp -99.45 140.03 34.22 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.628 HG13 ' O ' ' A' ' 167' ' ' VAL . 8.9 p -149.44 111.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.374 -0.53 . . . . 1.0 111.512 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.35 142.04 31.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.106 178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.589 ' CB ' HG11 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -146.71 148.51 32.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.141 0.496 . . . . 1.0 111.043 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.591 ' NE2' ' NH1' ' A' ' 73' ' ' ARG . 7.0 t60 -152.63 148.57 27.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.749 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 170' ' ' HIS . . . -72.74 69.11 0.89 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.572 -0.285 . . . . 1.0 111.39 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -173.22 167.09 2.82 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 120.345 -0.542 . . . . 1.0 112.293 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -89.74 6.75 4.21 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.64 2.227 . . . . 1.0 110.831 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 60.9 ttt-85 -34.25 115.12 0.48 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.104 -0.953 . . . . 1.0 112.669 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.26 155.28 22.17 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.804 2.336 . . . . 1.0 111.056 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -108.83 141.75 40.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.779 0.324 . . . . 1.0 110.85 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 49.8 m -94.01 149.3 21.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.291 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.93 -40.78 78.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.678 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.87 -55.81 20.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.366 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -62.15 -31.34 71.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.881 0.372 . . . . 1.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 29.2 tp -60.82 -38.12 84.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.456 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -63.42 -52.98 59.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.476 -0.329 . . . . 1.0 111.395 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 48.5 t -43.95 -49.95 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.317 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 187' ' ' LEU . 28.7 m -75.06 -36.28 37.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.635 ' NE2' ' NH1' ' A' ' 101' ' ' ARG . 47.6 tp60 -46.89 -36.64 7.77 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.099 -1.075 . . . . 1.0 108.099 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 16.4 tp -72.53 -40.76 66.53 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.654 -1.157 . . . . 1.0 109.374 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 184' ' ' VAL . 33.9 tp -54.76 -33.1 60.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.633 -0.712 . . . . 1.0 109.645 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.451 ' CB ' HG11 ' A' ' 154' ' ' VAL . . . -75.14 -35.94 61.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.603 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . 0.464 ' O ' ' OG ' ' A' ' 192' ' ' SER . 50.6 t0 -57.37 -41.15 79.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.661 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -52.33 -52.38 53.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 72.3 t -56.89 -43.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.888 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 189' ' ' ASP . 9.6 p -51.92 -38.07 54.95 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.6 mp -77.65 -32.64 18.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.027 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.42 -46.13 64.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.773 -0.649 . . . . 1.0 111.117 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.416 ' C ' HD12 ' A' ' 195' ' ' ILE . 2.6 pp -66.74 -26.0 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.43 ' CB ' ' CE1' ' A' ' 158' ' ' HIS . . . -77.03 -56.31 4.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.651 -0.704 . . . . 1.0 109.946 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.13 -26.77 63.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.869 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -76.84 -35.81 57.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.382 -0.372 . . . . 1.0 111.24 -179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -56.91 -38.98 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 46.0 tp -67.8 -57.16 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.09 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 18.9 t -60.4 -46.08 91.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.842 0.353 . . . . 1.0 110.321 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.427 179.768 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' CYC . . . . . 0.685 HMD2 ' OD1' ' A' ' 136' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_